data_2fz0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fz0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' CG2' HG13 ' A' ' 108' ' ' ILE . 4.2 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.021 0.439 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.476 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -40.46 -51.26 2.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.719 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.593 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 14.3 m-85 -148.8 120.08 7.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.851 0.357 . . . . 0.0 111.464 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.446 HG23 ' CG1' ' A' ' 6' ' ' VAL . 1.5 t -110.0 95.28 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.979 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.448 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -100.54 111.37 23.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.743 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 18' ' ' ILE . 38.7 t -81.97 160.19 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.5 mt -140.7 127.05 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -118.96 111.77 18.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m120 64.04 34.75 11.07 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.991 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.48 26.14 61.84 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.544 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -148.27 120.05 8.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 3.1 m -48.38 125.45 9.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.238 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.494 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -99.57 -45.46 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.738 0.78 . . . . 0.0 109.512 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -124.66 175.37 7.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.9 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.431 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 20.4 m -170.59 134.63 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.431 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 33.2 t -123.45 69.34 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.2 m-85 -107.23 100.18 9.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.165 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.428 -179.662 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.8 m-80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.774 0.321 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.73 25.71 4.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.08 0.467 . . . . 0.0 110.864 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -110.24 -34.86 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.667 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.568 ' CG2' ' HB ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -55.6 133.62 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.918 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.508 ' CG2' HG12 ' A' ' 45' ' ' ILE . 5.1 t -92.55 150.88 40.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.85 -24.27 4.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.946 1.764 . . . . 0.0 111.072 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 42' ' ' THR . 90.4 t -66.95 -35.95 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.681 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.568 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 13.4 mm -63.0 -42.63 97.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE1' ' CG2' ' A' ' 41' ' ' ILE . 18.3 m-85 -77.14 -38.3 52.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.144 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.487 ' CD2' ' C ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -65.73 -31.53 72.58 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.032 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.94 -29.1 22.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.447 HD13 HG13 ' A' ' 74' ' ' ILE . 4.2 mt -61.24 -60.15 4.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.591 HG22 ' HB ' ' A' ' 54' ' ' VAL . 7.0 mt -50.2 -63.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.847 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.0 OUTLIER -53.66 -37.35 63.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.81 -1.541 . . . . 0.0 113.116 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.11 -23.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 49' ' ' LEU . 74.7 mmm -117.03 -57.18 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 50' ' ' ILE . 52.9 t -63.45 -63.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.887 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.575 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 3.0 mm? -44.43 -53.43 14.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.5 Cg_exo -68.53 4.62 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.231 1.954 . . . . 0.0 112.412 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -150.32 25.26 0.8 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.006 0.432 . . . . 0.0 110.578 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.534 HG22 ' CD1' ' A' ' 81' ' ' TYR . 4.3 p -87.03 166.05 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.447 -0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.328 179.458 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.581 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 4.6 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.656 0.265 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.478 ' CG2' ' CE1' ' A' ' 81' ' ' TYR . 2.5 t -102.61 139.19 38.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.848 0.356 . . . . 0.0 111.279 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -79.38 135.47 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.51 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.469 ' HG3' ' CG2' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -51.53 -29.02 15.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 53.12 25.42 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.0 tpp -110.31 -5.0 15.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.737 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.05 56.87 3.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 7.5 mp -53.22 -48.02 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG13 HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -142.74 162.23 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.41 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.421 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 11.2 t70 -104.5 137.49 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.185 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.84 -32.96 5.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.244 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -132.9 162.56 31.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.197 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.477 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 52.8 m-20 -103.46 133.77 47.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.853 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 95' ' ' PHE . 0.6 OUTLIER -119.05 121.84 40.76 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -126.82 164.87 20.43 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.716 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.534 ' CD1' HG22 ' A' ' 58' ' ' VAL . 19.5 p90 -138.74 129.06 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.381 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 5.0 t -129.94 112.4 13.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.594 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 33.0 p -74.32 156.8 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.939 0.4 . . . . 0.0 111.176 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -52.84 153.3 3.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.61 -9.14 57.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.71 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.28 23.14 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.69 87.28 4.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.772 0.32 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.17 -20.25 18.66 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.637 2.224 . . . . 0.0 112.577 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -93.79 29.57 2.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 52.7 m -149.85 73.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.342 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.585 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.6 OUTLIER -75.01 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.724 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 82' ' ' SER . 39.3 m-85 -144.52 93.55 2.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.544 ' CG1' HG12 ' A' ' 50' ' ' ILE . 41.0 t -98.44 127.62 50.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.53 . . . . 0.0 111.622 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 7.4 p -110.1 152.9 25.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 8' ' ' TYR . 1.4 m-85 -130.91 74.59 1.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.686 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 58.7 p -75.08 -169.52 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 100' ' ' ILE . 24.1 mt -102.43 137.01 41.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.536 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -30.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.806 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.12 -33.34 73.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.021 0.439 . . . . 0.0 110.57 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.2 mm -67.51 127.12 93.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.968 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.75 -168.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -106.65 66.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.647 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.421 ' CA ' HD11 ' A' ' 106' ' ' ILE . 2.9 tp -151.14 -36.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.813 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.655 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -64.03 -63.27 4.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 3.5 Cg_endo -44.95 -29.27 3.61 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.657 2.238 . . . . 0.0 111.331 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.581 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.1 mp -69.63 -45.17 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.746 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -76.43 -22.44 54.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.602 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.655 HG12 ' O ' ' A' ' 104' ' ' LEU . 33.7 mm -67.11 -59.4 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -63.09 -56.64 15.16 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 p -57.06 -25.4 58.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.434 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -75.32 -45.37 19.3 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.497 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 18.5 mt -56.6 -28.11 59.63 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.71 -15.9 61.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.279 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.19 -27.26 64.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.572 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 4.6 m-85 -98.73 -167.97 1.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.496 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -121.53 -0.63 9.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.485 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.4 m -125.1 137.53 54.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.756 0.789 . . . . 0.0 111.108 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.474 ' O ' ' OG ' ' A' ' 19' ' ' SER . 19.6 p30 174.02 35.92 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.164 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.12 34.07 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -146.12 155.52 42.8 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.98 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HA ' ' N ' ' A' ' 20' ' ' SER . 15.7 m-80 -75.78 24.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -165.09 25.9 0.06 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.447 HD23 ' C ' ' A' ' 117' ' ' SER . 6.5 tt -123.75 -56.73 1.67 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.871 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -52.78 -41.39 64.05 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.458 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 85.3 p -50.33 -28.45 7.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.215 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.07 -64.22 0.97 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.224 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.572 ' CE1' ' CB ' ' A' ' 115' ' ' TYR . 31.1 m170 -59.57 -30.98 69.02 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.987 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.421 ' O ' HD13 ' A' ' 132' ' ' LEU . 48.0 t -57.15 -42.69 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.99 -38.5 22.77 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.764 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -22.82 63.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.388 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.485 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 46.9 mt -90.19 -27.09 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.486 HD13 ' CD1' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -62.33 -49.0 77.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.524 178.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -44.96 83.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.8 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 m -70.83 -19.04 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.8 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.451 ' HB3' ' O ' ' A' ' 132' ' ' LEU . 54.7 t80 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.206 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.472 HG23 HG13 ' A' ' 108' ' ' ILE . 3.5 t . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -61.71 -59.83 4.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.237 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.652 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 2.8 m-85 -144.14 109.25 5.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 t -108.08 100.7 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.801 0.334 . . . . 0.0 111.356 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.501 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 2.2 mt-10 -111.24 120.13 41.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' THR . 46.7 t -79.86 156.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.8 mt -133.98 111.28 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 15.7 tptt -91.16 99.74 12.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 58.35 41.04 23.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 55' ' ' LEU . . . 81.1 23.34 59.36 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.607 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -140.27 109.39 6.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -45.12 128.9 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.23 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -110.24 -45.85 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.07 172.86 8.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.511 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.476 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.3 m -167.48 126.92 1.37 Allowed 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 20.1 t -116.93 69.34 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.55 92.73 4.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.107 -178.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.399 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.685 0.278 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.32 26.08 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 110.859 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.61 -37.31 6.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.599 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.521 ' CG2' ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -52.59 123.02 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.564 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.471 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 10.9 t -83.55 150.6 60.24 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.642 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 86.0 Cg_exo -45.75 -22.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.259 1.973 . . . . 0.0 111.908 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 36.6 t -68.62 -41.07 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.103 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.458 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 1.6 mp -60.4 -34.57 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.521 ' CE1' ' CG2' ' A' ' 41' ' ' ILE . 56.0 m-85 -81.17 -42.37 20.95 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.995 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.19 -30.48 71.1 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.684 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 27.4 p30 -90.24 -26.43 20.07 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.1 mt -63.15 -60.24 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.531 HG22 ' HB ' ' A' ' 54' ' ' VAL . 5.0 mt -52.14 -63.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.893 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.589 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -52.76 -41.46 64.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.356 -179.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.2 t0 -90.73 -20.27 22.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.446 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 77.8 mmm -119.39 -60.93 1.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.531 ' HB ' HG22 ' A' ' 50' ' ' ILE . 59.3 t -61.58 -56.02 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.579 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 2.0 mm? -50.44 -54.63 32.9 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.0 Cg_exo -62.89 -0.04 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.151 1.901 . . . . 0.0 112.78 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -149.86 27.75 0.78 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.458 HG23 ' CG ' ' A' ' 81' ' ' TYR . 2.6 p -86.29 157.0 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.982 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.198 179.206 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 25.3 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.698 0.285 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 83.9 m -112.65 127.23 56.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -80.69 144.83 31.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.416 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.445 ' HG3' ' CB ' ' A' ' 71' ' ' MET . 49.2 tpp -71.63 -35.39 70.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.977 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m 61.21 29.84 18.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.445 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 2.8 tpt -110.97 -12.48 14.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 62.79 63.49 0.97 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.001 0.429 . . . . 0.0 110.427 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.2 mp -62.2 -48.42 80.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.45 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.48 HG23 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -131.15 151.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -93.48 140.67 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.592 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.97 -34.33 5.5 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.166 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.48 ' CE1' HG23 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -120.92 -167.36 1.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.923 0.392 . . . . 0.0 111.208 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -137.65 128.89 27.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.38 105.98 17.99 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 51.1 m-85 -115.93 123.99 49.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.851 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.458 ' CG ' HG23 ' A' ' 58' ' ' VAL . 13.3 p90 -115.85 132.48 56.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.347 0.594 . . . . 0.0 112.133 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.476 ' CB ' ' HA ' ' A' ' 66' ' ' VAL . 0.8 OUTLIER -133.7 129.26 36.5 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.175 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 10.9 p -93.76 153.43 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.895 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -45.29 148.57 0.61 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -21.28 24.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.834 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.87 23.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.05 91.29 8.97 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.688 0.28 . . . . 0.0 110.842 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.88 -15.39 42.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.455 2.103 . . . . 0.0 112.145 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -96.36 29.42 2.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.092 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.416 ' O ' ' CE2' ' A' ' 92' ' ' TYR . 52.3 m -153.19 68.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.709 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -67.94 -178.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.174 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.468 ' CD1' HG13 ' A' ' 11' ' ' VAL . 91.8 m-85 -157.14 99.67 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.515 ' CG1' HG12 ' A' ' 50' ' ' ILE . 15.0 t -104.83 118.84 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.047 0.451 . . . . 0.0 111.52 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 32.0 p -112.02 131.03 55.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.873 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.5 m-85 -102.16 91.02 4.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.928 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -88.05 176.41 7.31 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.445 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 100' ' ' ILE . 7.4 mt -90.58 128.85 36.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.849 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.0 -33.46 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.663 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 110.593 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 97' ' ' LEU . 64.1 mt -76.15 138.08 68.58 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.3 167.74 5.75 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.406 2.071 . . . . 0.0 112.128 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.6 58.08 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.792 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.2 tp -141.09 -37.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.625 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.611 ' O ' HG12 ' A' ' 108' ' ' ILE . 16.1 tp -61.54 -59.8 12.37 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 6.3 Cg_endo -47.76 -33.54 19.34 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.494 2.129 . . . . 0.0 110.908 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.546 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.2 mp -67.96 -38.97 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.822 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 111' ' ' GLY . 6.6 mtt-85 -76.36 -29.78 57.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.424 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.611 HG12 ' O ' ' A' ' 104' ' ' LEU . 9.4 mm -61.63 -51.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.465 ' HB2' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -69.24 -61.66 1.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.418 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 48.2 t -56.0 -24.48 39.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . -80.06 -43.01 10.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.444 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -59.19 -35.08 72.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 10.4 pt20 -77.97 -9.92 59.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.728 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.39 -23.02 46.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.577 ' HB2' ' CE1' ' A' ' 127' ' ' HIS . 3.5 m-85 -87.16 -96.31 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.064 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 160.81 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.549 0.34 . . . . 0.0 110.817 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.685 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 53.6 m -117.55 96.23 5.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.263 0.554 . . . . 0.0 111.195 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -151.27 46.35 0.82 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.713 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.97 33.81 4.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -145.7 161.99 38.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.158 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.476 ' HA ' ' N ' ' A' ' 20' ' ' SER . 8.4 p30 -78.74 24.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.639 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 tm-20 -170.15 28.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 117' ' ' SER . 5.8 tt -132.43 -45.67 0.9 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -59.46 -42.44 91.99 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 82.7 p -48.58 -28.03 3.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.152 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -56.99 -59.04 5.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.685 ' CE1' ' O ' ' A' ' 117' ' ' SER . 9.6 m170 -60.04 -33.67 72.34 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.438 ' O ' ' CD1' ' A' ' 132' ' ' LEU . 48.4 t -53.31 -43.04 49.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.961 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.91 -44.67 18.66 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 119.928 -1.13 . . . . 0.0 112.629 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -69.07 -21.02 64.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 111.059 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 127' ' ' HIS . 55.6 mt -90.47 -27.86 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.453 ' CD1' HD13 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -63.76 -48.19 77.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.153 178.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.88 -40.71 95.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -86.29 4.42 39.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.316 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.71 0.291 . . . . 0.0 110.599 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' CG2' HG13 ' A' ' 108' ' ' ILE . 27.8 t . . . . . 0 C--O 1.23 0.073 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.699 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 15.8 m-85 -139.98 107.01 5.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.422 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 1.9 t -116.1 99.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.105 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 28.1 tt0 -108.1 123.15 48.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.393 . . . . 0.0 111.809 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.416 HG12 HD12 ' A' ' 18' ' ' ILE . 11.0 t -85.73 138.06 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 1.4 mp -113.56 114.79 47.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.431 ' N ' HG12 ' A' ' 18' ' ' ILE . 2.0 tppt? -97.36 104.93 16.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.632 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.06 26.91 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.298 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.446 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . 77.7 34.55 38.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.911 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.47 17.93 2.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 58.69 155.97 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.346 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.431 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -145.49 -50.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.632 178.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -123.94 176.32 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.969 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -170.06 129.0 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.457 . . . . 0.0 111.349 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.9 t -116.46 69.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.872 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.699 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 3.0 m-85 -106.41 86.51 2.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.878 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.934 -178.822 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.739 0.304 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -123.55 28.28 7.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -110.91 -37.9 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.475 ' CG2' ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -51.74 134.73 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.66 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.504 HG21 HG12 ' A' ' 45' ' ' ILE . 1.9 t -94.79 151.15 38.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.501 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 72.1 Cg_exo -47.17 -26.7 5.61 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.88 1.72 . . . . 0.0 110.8 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.5 ' HB ' HG21 ' A' ' 42' ' ' THR . 57.4 t -61.89 -40.62 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.581 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 42' ' ' THR . 16.8 mm -58.12 -45.13 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.593 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.516 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 27.6 m-85 -75.22 -40.14 59.38 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.399 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.74 -28.79 70.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 44' ' ' VAL . 32.5 m-20 -89.25 -29.63 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 53' ' ' MET . 5.2 mt -60.92 -59.67 5.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.536 HG22 ' CD2' ' A' ' 55' ' ' LEU . 4.6 mt -53.28 -64.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.212 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.7 tpp -49.69 -43.16 47.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.552 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.08 -11.41 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' LEU . 32.9 mmm -127.68 -68.29 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HB ' HG22 ' A' ' 50' ' ' ILE . 63.8 t -58.16 -56.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.68 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.536 ' CD2' HG22 ' A' ' 50' ' ' ILE . 2.8 mm? -44.86 -57.82 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.809 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 37.9 Cg_endo -66.96 5.04 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.049 1.833 . . . . 0.0 112.25 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -145.62 22.42 1.46 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.071 0.462 . . . . 0.0 110.14 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.488 HG23 ' CD2' ' A' ' 81' ' ' TYR . 4.9 p -84.93 166.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.858 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.541 179.209 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 2.9 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.88 0.371 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.7 m -98.97 126.26 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.314 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 5.0 ttpt -73.99 132.58 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.356 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.411 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 16.5 mmm -55.62 -32.81 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.741 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t 59.52 24.62 13.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.994 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.409 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 28.0 mmm -103.82 -5.08 22.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.094 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.32 55.49 4.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.126 0.488 . . . . 0.0 110.044 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 54' ' ' VAL . 10.3 mp -57.41 -52.17 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.008 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.452 HG21 ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -131.99 155.17 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.852 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -96.7 140.63 31.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.316 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.62 -33.8 5.86 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.121 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -130.71 168.23 17.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.023 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 81.7 m-20 -108.2 130.6 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.392 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 11.3 p -90.53 112.35 23.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 53.4 m-85 -121.57 149.7 42.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.563 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.488 ' CD2' HG23 ' A' ' 58' ' ' VAL . 44.7 p90 -144.39 128.98 18.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.05 0.452 . . . . 0.0 111.19 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 3.3 t -132.89 116.4 16.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.521 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 34.6 p -77.61 148.48 35.1 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.32 163.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.332 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.64 -15.28 35.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.485 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 16.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.37 100.21 2.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.13 -13.03 37.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.322 2.015 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 30.14 2.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.073 0.464 . . . . 0.0 110.469 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.433 ' O ' ' CE2' ' A' ' 92' ' ' TYR . 17.5 m -153.74 70.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.66 0.743 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.655 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -71.12 175.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.126 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.433 ' CE2' ' O ' ' A' ' 90' ' ' THR . 45.3 m-85 -144.97 100.12 3.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.324 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.508 HG22 HD12 ' A' ' 12' ' ' ILE . 41.0 t -93.16 130.03 42.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.425 . . . . 0.0 111.384 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.56 133.45 49.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.623 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -114.49 97.58 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.804 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.431 HG21 HD21 ' A' ' 104' ' ' LEU . 2.6 p -102.27 127.64 49.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 100' ' ' ILE . 34.3 mt -37.05 133.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.055 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.41 -31.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.23 -30.4 71.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 110.157 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.3 mm -67.38 136.66 93.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.923 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.45 179.55 5.0 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.246 1.964 . . . . 0.0 111.574 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.38 60.0 4.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.416 ' CA ' HD11 ' A' ' 106' ' ' ILE . 3.3 tp -148.73 -38.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.834 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.668 ' O ' HG12 ' A' ' 108' ' ' ILE . 9.4 tp -62.19 -60.72 9.3 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.658 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 6.6 Cg_endo -47.85 -32.47 17.44 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.563 2.176 . . . . 0.0 111.239 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.562 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.7 mp -67.93 -36.45 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.106 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.405 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -83.73 -19.95 34.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.117 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 104' ' ' LEU . 11.7 mm -72.36 -49.47 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.809 0.338 . . . . 0.0 110.133 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -49.4 31.4 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.7 p -63.95 -30.27 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.407 ' HA3' HD12 ' A' ' 131' ' ' ILE . . . -74.71 -43.32 29.26 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 11.5 mt -56.17 -35.36 67.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -13.35 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.133 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -22.43 55.78 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.472 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.459 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 5.9 m-85 -86.46 -94.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.886 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 162.19 -25.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.66 0.267 . . . . 0.0 110.904 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.408 ' CB ' HD23 ' A' ' 123' ' ' LEU . 4.4 m -91.82 -91.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.485 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 124' ' ' LEU . 3.1 p30 39.27 32.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.674 0.273 . . . . 0.0 111.097 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.15 33.83 5.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.537 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -148.59 150.78 33.9 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.48 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.425 ' HA ' ' N ' ' A' ' 20' ' ' SER . 5.0 p30 -71.34 29.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.569 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 120' ' ' THR . 10.3 tt0 -170.91 27.53 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.408 HD23 ' CB ' ' A' ' 117' ' ' SER . 6.2 tt -133.26 -49.77 0.86 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.689 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.433 ' O ' HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -55.31 -45.54 76.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 78.4 p -47.64 -30.12 3.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.375 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -56.27 23.67 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.973 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.4 m170 -60.91 -31.75 71.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.407 HG23 ' CG2' ' A' ' 108' ' ' ILE . 47.7 t -55.63 -46.43 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.924 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.31 -40.69 18.91 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.33 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.98 -24.25 65.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.518 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 63.0 mt -88.17 -28.02 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.402 ' CD1' HD13 ' A' ' 108' ' ' ILE . 0.6 OUTLIER -61.78 -49.84 74.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.526 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -46.48 82.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.991 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 t -72.51 -15.1 61.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.473 ' CZ ' ' HA ' ' A' ' 104' ' ' LEU . 23.4 t80 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.233 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.478 ' CG2' HG13 ' A' ' 108' ' ' ILE . 54.9 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -69.48 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.793 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.657 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 8.4 m-85 -136.13 116.03 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 111.845 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.444 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 2.3 t -106.84 92.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.961 0.41 . . . . 0.0 110.868 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.2 tt0 -95.82 108.69 21.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.8 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.435 ' CG2' HD11 ' A' ' 124' ' ' LEU . 33.5 t -81.07 145.32 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.2 mp -129.34 124.89 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.91 102.62 11.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.381 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.79 39.56 6.1 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.881 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.78 20.8 67.47 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.78 118.57 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.957 0.408 . . . . 0.0 110.26 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.412 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 3.6 m -47.84 128.55 13.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.338 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.508 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -105.62 -42.26 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.643 0.735 . . . . 0.0 109.362 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -131.29 176.35 8.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.197 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.43 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.0 m -170.5 121.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.444 ' HB3' ' CB ' ' A' ' 9' ' ' VAL . 33.9 t -107.58 70.22 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.1 m-85 -105.97 84.25 2.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.609 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.42 -179.458 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.82 0.343 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -129.54 28.38 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -111.77 -35.74 5.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.959 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.487 ' CG2' ' CE1' ' A' ' 46' ' ' PHE . 1.1 mt -51.24 116.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.79 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.428 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 1.8 t -77.08 153.18 82.51 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.522 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.1 Cg_exo -48.16 -21.78 3.19 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.785 1.656 . . . . 0.0 110.788 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 48' ' ' ASN . 90.7 t -65.3 -49.35 79.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.058 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.427 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 1.8 mp -57.28 -31.29 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.487 ' CE1' ' CG2' ' A' ' 41' ' ' ILE . 98.3 m-85 -80.8 -44.05 19.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.569 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.605 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -65.17 -26.02 67.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.291 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -89.99 -29.54 18.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 53' ' ' MET . 2.7 mt -60.75 -59.51 5.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.619 HG23 HD21 ' A' ' 55' ' ' LEU . 4.9 mt -53.87 -64.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.984 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.605 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.8 OUTLIER -49.73 -40.72 41.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.902 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -91.16 -19.74 22.75 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 49' ' ' LEU . 93.8 mmm -120.14 -60.14 1.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.571 ' HB ' HG23 ' A' ' 50' ' ' ILE . 96.4 t -64.55 -51.38 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.619 HD21 HG23 ' A' ' 50' ' ' ILE . 2.0 mm? -55.63 -52.45 71.93 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 14.7 Cg_exo -69.07 3.66 2.32 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.352 2.034 . . . . 0.0 112.159 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.93 23.61 1.37 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.03 0.443 . . . . 0.0 110.192 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 81' ' ' TYR . 4.4 p -85.92 165.35 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.135 179.201 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.616 ' HB ' HG13 ' A' ' 106' ' ' ILE . 3.1 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.918 0.39 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.0 m -80.7 125.41 30.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.283 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.444 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -71.75 130.67 41.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.412 ' HE3' ' CE2' ' A' ' 81' ' ' TYR . 53.3 tpp -57.53 -25.24 59.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 t 53.04 26.96 5.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.085 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.411 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 8.9 tpt -106.45 -11.0 16.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.149 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.87 58.06 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.371 . . . . 0.0 110.515 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 53' ' ' MET . 8.5 mp -59.86 -46.05 90.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.529 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -133.25 157.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.686 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.95 140.84 33.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.394 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.41 -33.92 5.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.241 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.529 ' CE1' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -132.79 168.36 18.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.882 0.372 . . . . 0.0 111.088 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 94.7 m-20 -106.57 143.25 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.402 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.4 m -106.98 114.77 29.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 87.7 m-85 -121.78 137.74 54.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 58' ' ' VAL . 49.2 p90 -127.05 128.82 46.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.0 0.429 . . . . 0.0 111.467 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -133.35 118.91 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.96 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 40.3 p -80.63 150.43 29.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -46.14 146.84 1.2 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.276 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.03 -15.81 57.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.89 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 22.03 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.659 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.74 95.0 3.76 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.471 0.177 . . . . 0.0 111.178 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.33 -15.55 45.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -96.23 30.39 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.042 0.448 . . . . 0.0 110.093 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 65.1 m -154.36 73.72 0.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.66 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -72.83 176.0 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.223 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.427 ' CD2' HG12 ' A' ' 11' ' ' VAL . 97.4 m-85 -150.68 94.88 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.826 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.584 ' CG2' HG22 ' A' ' 50' ' ' ILE . 44.0 t -98.09 121.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.246 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.5 t -114.51 139.98 49.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.312 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.8 m-85 -115.04 102.66 10.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.511 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.9 p -109.69 127.46 54.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 100' ' ' ILE . 44.5 mt -38.32 132.9 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.326 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -44.94 -30.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.685 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.11 -28.08 67.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.742 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.2 mm -68.26 131.57 91.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.205 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -60.0 179.65 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -98.72 62.58 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.682 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.41 ' CA ' HD13 ' A' ' 106' ' ' ILE . 4.3 tp -155.08 -37.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.783 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 108' ' ' ILE . 5.3 tp -60.51 -61.55 7.73 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 3.3 Cg_endo -45.48 -37.54 14.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.794 2.329 . . . . 0.0 111.147 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 66' ' ' VAL . 4.1 mp -63.62 -37.44 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.152 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -83.49 -18.23 39.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.841 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 104' ' ' LEU . 15.4 mm -70.63 -47.89 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.419 HD23 ' CG1' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -74.37 -47.42 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.5 t -64.53 -29.11 70.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . -75.73 -45.55 16.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.173 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.76 -33.93 67.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -70.79 -16.11 62.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.209 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.08 -21.6 59.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.363 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.492 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.5 m-85 -85.39 -94.13 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 4.9 tp10 161.57 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 110.659 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.41 ' CB ' HD23 ' A' ' 123' ' ' LEU . 13.5 m -91.32 -91.07 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.368 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.407 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.1 p-10 39.04 32.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.595 0.236 . . . . 0.0 111.021 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.37 34.81 4.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.54 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -150.13 151.1 32.6 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.708 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.43 ' HA ' ' N ' ' A' ' 20' ' ' SER . 7.3 p30 -70.67 28.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.919 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 tt0 -172.17 28.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.41 HD23 ' CB ' ' A' ' 117' ' ' SER . 5.9 tt -131.74 -50.33 0.97 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.497 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -55.93 -44.94 78.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.497 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 19.1 t -47.7 -30.22 3.65 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.168 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -58.17 8.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 6.7 m170 -57.66 -39.36 76.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.643 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -50.52 -46.2 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.412 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.03 -47.28 47.0 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.324 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -65.28 -23.39 67.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.82 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 127' ' ' HIS . 37.8 mt -85.49 -27.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -65.66 -46.52 78.84 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.678 179.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.66 -44.0 78.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.7 m -80.3 -4.17 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.815 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 104' ' ' LEU . 26.6 t80 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.514 ' CG2' HG13 ' A' ' 108' ' ' ILE . 3.5 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -53.93 -55.73 24.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.49 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.64 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 6.5 m-85 -145.47 140.52 27.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 0.0 111.653 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.407 HG23 HG11 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -131.35 97.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.348 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.2 mt-10 -112.86 124.7 53.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 111.647 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.507 HG11 ' N ' ' A' ' 12' ' ' ILE . 98.2 t -89.79 159.9 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.507 ' N ' HG11 ' A' ' 11' ' ' VAL . 3.3 mt -137.66 117.4 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.2 tttp -107.36 115.5 30.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.056 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 61.4 32.74 18.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.573 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.0 27.91 57.44 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.283 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -144.92 121.57 11.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.086 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -51.88 122.55 8.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.145 -178.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.19 -47.94 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 109.603 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 124' ' ' LEU . 54.7 p -122.08 171.35 9.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.625 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 11.8 m -166.54 128.05 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.985 0.421 . . . . 0.0 112.021 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 32.0 t -119.91 69.39 0.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.5 m-85 -112.04 94.2 4.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.718 -179.318 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m120 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.678 0.275 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.31 29.89 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.926 0.393 . . . . 0.0 110.95 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -115.31 -38.61 3.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.352 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.459 HG23 ' CZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -53.57 118.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.505 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 9.5 t -81.43 152.19 69.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.6 Cg_exo -46.51 -23.06 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.066 1.844 . . . . 0.0 111.239 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.505 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 49.2 t -64.82 -47.51 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.518 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 ' HB ' HG21 ' A' ' 41' ' ' ILE . 1.9 mp -58.94 -33.32 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.214 0.53 . . . . 0.0 109.618 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CZ ' HG23 ' A' ' 41' ' ' ILE . 66.1 m-85 -81.06 -41.98 21.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.541 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.575 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.69 -29.15 70.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.023 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -88.27 -27.31 21.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 46' ' ' PHE . 4.4 mt -63.79 -61.11 2.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.519 HG12 ' CG1' ' A' ' 93' ' ' VAL . 6.8 mt -49.63 -62.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.736 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.575 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -54.33 -41.09 68.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.591 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -90.89 -20.42 22.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.438 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 69.0 mmm -119.66 -52.3 2.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.51 ' HB ' HG21 ' A' ' 50' ' ' ILE . 84.3 t -69.59 -60.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.559 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 1.3 mm? -46.41 -51.09 37.1 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 12.6 Cg_exo -70.08 2.87 3.31 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.262 1.975 . . . . 0.0 112.059 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -145.49 23.97 1.42 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.058 0.456 . . . . 0.0 110.086 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 ' CD1' ' A' ' 81' ' ' TYR . 5.0 p -87.67 166.06 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.914 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.899 179.083 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 106' ' ' ILE . 2.6 t . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -78.61 139.84 38.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.365 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.31 127.45 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.511 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.474 ' CG ' ' CG ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -54.04 -36.5 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m 63.97 25.44 13.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.894 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.474 ' CG ' ' CG ' ' A' ' 69' ' ' MET . 23.6 mmt -104.82 -0.66 26.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.944 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.06 56.28 5.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.098 0.475 . . . . 0.0 110.507 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.458 HD11 ' HG2' ' A' ' 69' ' ' MET . 7.5 mp -60.44 -39.45 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.652 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.497 HG21 HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -147.01 151.77 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.489 179.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 74' ' ' ILE . 13.8 t0 -96.77 138.67 33.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.335 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.94 -31.91 6.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -129.48 163.92 24.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.15 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 75.8 m-20 -103.49 132.03 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.432 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 20.9 p -94.83 95.72 8.87 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 73.2 m-85 -110.33 133.59 53.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.494 ' CD1' HG21 ' A' ' 58' ' ' VAL . 46.6 p90 -127.31 139.84 52.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.455 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 1.5 t -143.55 125.09 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.779 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 41.4 p -86.94 158.12 19.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.95 153.37 2.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.83 -9.71 58.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.765 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 22.56 0.24 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.667 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 98.97 2.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.477 0.18 . . . . 0.0 111.23 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -13.61 40.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.445 2.097 . . . . 0.0 112.009 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -97.56 28.81 3.57 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.023 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.442 ' O ' ' CE2' ' A' ' 92' ' ' TYR . 32.3 m -152.73 73.63 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.408 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -73.55 -179.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.435 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.442 ' CE2' ' O ' ' A' ' 90' ' ' THR . 69.1 m-85 -156.06 98.61 1.89 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.754 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.519 ' CG1' HG12 ' A' ' 50' ' ' ILE . 65.0 t -106.86 133.52 51.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.98 0.419 . . . . 0.0 111.151 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.21 122.45 29.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.087 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 2.7 m-85 -92.05 87.45 6.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.725 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -75.72 -170.94 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.775 0.322 . . . . 0.0 110.931 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 100' ' ' ILE . 82.0 mt -105.95 125.77 51.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -41.49 -30.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.608 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 36.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.465 HD13 HG22 ' A' ' 100' ' ' ILE . 47.9 mt -139.48 129.48 14.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.39 151.51 4.59 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.307 2.005 . . . . 0.0 112.395 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.46 58.03 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.496 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.418 ' CA ' HD13 ' A' ' 106' ' ' ILE . 3.2 tp -144.1 -35.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.762 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.615 ' O ' HG12 ' A' ' 108' ' ' ILE . 6.3 tp -60.45 -63.99 3.62 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.672 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.499 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 2.8 Cg_endo -45.25 -35.51 11.33 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.726 2.284 . . . . 0.0 111.501 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.575 HG13 ' HB ' ' A' ' 66' ' ' VAL . 3.5 mp -63.35 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.061 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER -79.35 -19.68 49.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.813 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.615 HG12 ' O ' ' A' ' 104' ' ' LEU . 19.9 mm -68.32 -49.99 61.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.522 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -72.23 -50.16 29.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -27.43 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -78.6 -42.15 14.42 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 20.4 mt -58.88 -28.23 65.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -18.56 58.38 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.227 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.5 OUTLIER -73.57 -22.21 60.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.509 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 6.4 m-85 -83.64 -93.24 0.07 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 20.7 tt0 156.5 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.352 0.261 . . . . 0.0 111.064 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.445 ' CB ' HD23 ' A' ' 123' ' ' LEU . 4.6 m -94.19 -90.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 41.12 31.2 0.13 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.15 34.01 4.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -149.92 154.85 38.99 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.523 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -74.06 22.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.394 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 120' ' ' THR . 6.9 pt-20 -164.97 26.32 0.06 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.445 HD23 ' CB ' ' A' ' 117' ' ' SER . 5.6 tt -127.11 -50.87 1.43 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.683 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -55.52 -44.69 76.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.423 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.5 p -47.66 -30.36 3.69 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.231 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.48 -56.27 21.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.326 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.532 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.0 m170 -60.39 -35.2 75.17 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.677 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.436 ' O ' ' CD1' ' A' ' 132' ' ' LEU . 46.1 t -54.59 -45.66 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.02 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.51 28.77 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.435 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -69.31 -21.16 63.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.871 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.497 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 62.4 mt -90.16 -27.38 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER -64.59 -47.84 77.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.359 178.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -63.42 -44.62 94.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.575 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 t -76.49 -8.71 57.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 104' ' ' LEU . 16.8 t80 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' CG2' HG13 ' A' ' 108' ' ' ILE . 92.9 t . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 121.079 0.466 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.436 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.68 -59.02 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.701 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.657 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 5.8 m-85 -149.35 115.84 5.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.848 0.356 . . . . 0.0 111.78 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.43 HG21 ' CG1' ' A' ' 6' ' ' VAL . 1.9 t -108.15 93.03 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.865 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -101.14 114.83 29.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.685 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 17' ' ' THR . 56.0 t -81.59 161.19 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.0 mp -142.01 121.08 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.693 -0.403 . . . . 0.0 112.045 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 12.8 tttt -107.07 97.24 7.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.703 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 69.85 37.59 1.78 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.58 62.01 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.695 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 7.6 pt-20 -144.8 119.22 9.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.6 m -50.14 130.78 23.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.507 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.36 -41.49 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.137 178.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.471 ' OG ' ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -127.21 175.57 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.072 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.43 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 17.0 p -170.38 134.65 1.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 34.4 t -122.7 69.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.746 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -106.95 88.72 2.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.684 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.487 -179.514 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.15 28.59 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.033 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -110.22 -38.39 5.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.887 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.515 HG22 ' HB ' ' A' ' 45' ' ' ILE . 1.1 mt -51.31 142.15 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.68 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.498 HG23 HG12 ' A' ' 45' ' ' ILE . 2.3 t -96.67 152.5 38.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 83.2 Cg_exo -46.43 -28.83 6.45 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.895 1.73 . . . . 0.0 110.669 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 42' ' ' THR . 60.9 t -58.81 -40.28 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.548 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.515 ' HB ' HG22 ' A' ' 41' ' ' ILE . 23.5 mm -57.62 -46.34 86.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.51 ' CE1' HG23 ' A' ' 41' ' ' ILE . 68.7 m-85 -75.41 -38.51 59.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.246 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.26 -30.15 71.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.155 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' VAL . 3.7 m-80 -87.59 -28.03 22.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 53' ' ' MET . 6.6 mt -64.21 -61.15 2.43 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.558 HG12 ' CG1' ' A' ' 93' ' ' VAL . 6.2 mt -48.9 -61.19 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.997 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.513 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.4 ttm -57.28 -40.85 78.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.186 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.5 t0 -91.18 -15.13 29.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.479 ' N ' ' O ' ' A' ' 49' ' ' LEU . 84.2 mmm -124.28 -56.48 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG13 ' CD2' ' A' ' 81' ' ' TYR . 72.1 t -64.44 -60.02 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.563 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -51.96 -50.35 78.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.563 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.9 Cg_exo -62.68 -2.28 3.31 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.383 2.055 . . . . 0.0 112.602 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -146.97 23.15 1.21 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.289 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.7 p -78.78 164.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.931 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 179.267 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.597 ' HB ' HG13 ' A' ' 106' ' ' ILE . 3.4 t . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 120.967 0.413 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.8 m -78.0 129.37 35.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 7.0 tttm -79.45 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.264 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.429 ' HG3' ' CB ' ' A' ' 71' ' ' MET . 20.0 tpp -56.78 -29.94 63.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m 56.43 28.64 13.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.429 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 37.8 tpp -108.66 -10.87 15.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.029 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.58 59.14 1.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 110.43 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.434 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.6 mp -59.5 -50.1 75.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.774 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.442 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -128.75 155.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.651 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.61 140.35 31.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.458 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.7 -32.25 7.1 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' CE1' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -133.87 167.96 19.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 111.25 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 84.0 m-20 -108.37 145.28 34.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.383 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.8 m -109.75 118.43 36.51 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 32.5 m-85 -126.13 138.97 53.72 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.12 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.524 ' CD1' HG23 ' A' ' 58' ' ' VAL . 26.8 p90 -124.78 133.69 53.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.073 0.463 . . . . 0.0 111.359 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.18 117.6 14.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.031 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 18.0 p -79.35 153.58 29.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.37 146.42 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.096 0.474 . . . . 0.0 111.25 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -22.35 14.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.056 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.05 23.54 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.587 0.232 . . . . 0.0 111.582 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.56 94.57 5.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -15.28 47.35 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.395 2.063 . . . . 0.0 111.98 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.35 28.2 3.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.171 0.51 . . . . 0.0 110.272 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 51.7 m -152.04 70.91 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.641 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -72.34 177.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.445 ' CD1' HG13 ' A' ' 11' ' ' VAL . 92.7 m-85 -151.1 93.69 1.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.112 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.558 ' CG1' HG12 ' A' ' 50' ' ' ILE . 51.5 t -95.6 120.54 45.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 111.05 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.8 t -112.85 137.48 51.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.108 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 8.6 m-85 -112.88 99.2 7.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.0 p -104.33 125.72 50.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 111.078 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.5 mt -39.9 134.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.057 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.2 -29.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.705 0.288 . . . . 0.0 111.493 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -28.24 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 110.478 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.449 HG22 HD12 ' A' ' 100' ' ' ILE . 16.4 mm -66.95 134.12 93.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.129 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.28 -159.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.134 1.889 . . . . 0.0 111.617 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -114.44 64.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.539 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 104' ' ' LEU . 1.4 tp -161.79 -35.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.918 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.64 ' O ' HG12 ' A' ' 108' ' ' ILE . 4.7 tp -58.73 -61.54 7.51 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.048 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 3.8 Cg_endo -45.38 -36.36 12.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.592 2.195 . . . . 0.0 111.015 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.597 HG13 ' HB ' ' A' ' 66' ' ' VAL . 4.1 mp -67.79 -37.31 78.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.06 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 104' ' ' LEU . 1.1 mmp_? -80.77 -24.34 38.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.701 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 104' ' ' LEU . 31.9 mm -67.01 -54.36 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.766 0.317 . . . . 0.0 110.223 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -53.33 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.907 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -59.91 -27.93 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.425 ' HA3' HG23 ' A' ' 131' ' ' ILE . . . -74.92 -45.89 19.17 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 8.3 mt -56.16 -31.14 63.11 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -76.89 -15.76 59.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.058 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -75.43 -25.19 57.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.313 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.537 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 3.5 m-85 -84.42 -92.57 0.08 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.911 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 163.43 -29.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.059 0.457 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 26.3 m -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.476 0.655 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.549 ' HA ' HD21 ' A' ' 123' ' ' LEU . 1.7 p30 -169.67 36.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.944 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.89 33.38 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -144.28 155.15 43.72 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.901 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.43 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.2 m120 -75.25 19.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 pm0 -161.53 24.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.549 HD21 ' HA ' ' A' ' 118' ' ' ASN . 7.4 tt -123.07 -58.26 1.65 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.7 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.433 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -50.81 -44.79 59.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.6 p -49.32 -29.58 6.24 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.461 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -59.98 4.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.427 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.537 ' CE1' ' CB ' ' A' ' 115' ' ' TYR . 42.4 m170 -59.64 -32.17 70.19 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.9 t -55.26 -46.92 78.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.528 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -67.92 -42.9 84.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.11 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.62 -22.9 63.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.919 0.39 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 127' ' ' HIS . 40.5 mt -90.38 -27.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.556 HD23 ' CD2' ' A' ' 104' ' ' LEU . 2.9 mt -65.02 -52.33 56.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.919 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -71.57 -32.65 68.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -95.77 24.27 5.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.957 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.44 HG23 HG13 ' A' ' 108' ' ' ILE . 1.4 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.92 0.391 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -63.16 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.792 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.555 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.1 m-85 -144.98 140.35 28.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.309 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 1.5 t -129.63 90.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.1 tt0 -99.52 116.02 30.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.004 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' A' ' 92' ' ' TYR . 40.1 t -82.39 158.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.4 mt -141.01 119.58 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB2' HG12 ' A' ' 18' ' ' ILE . 1.8 tttt -104.68 99.76 9.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.482 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.77 40.39 5.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.855 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 21.32 63.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.05 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -141.38 116.27 9.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.194 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.3 m -50.84 126.03 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.823 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.424 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -103.96 -44.0 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.457 0.646 . . . . 0.0 109.792 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.573 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -127.7 177.11 7.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.432 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.448 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 2.8 t -170.47 139.04 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.564 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 13.7 t -130.52 73.08 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.605 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.1 m-85 -107.35 88.78 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.815 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.212 -179.61 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.43 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 27.6 m-20 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.791 0.329 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 28.67 7.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -117.4 -34.35 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.512 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -53.98 121.59 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.978 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.501 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 8.8 t -83.39 151.48 62.52 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 82.8 Cg_exo -46.0 -22.56 1.42 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.189 1.926 . . . . 0.0 111.474 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.501 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 97.1 t -65.58 -46.28 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.045 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.483 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 1.8 mp -59.41 -33.91 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.512 ' CZ ' ' CE1' ' A' ' 8' ' ' TYR . 88.1 m-85 -79.36 -43.28 23.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.204 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.6 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.83 -27.83 69.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.069 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 25.8 m-20 -88.33 -29.18 20.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.5 mt -62.57 -61.11 2.65 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.552 HG12 ' CG1' ' A' ' 93' ' ' VAL . 5.7 mt -50.44 -61.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.262 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.6 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -53.21 -46.01 68.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.055 -1.43 . . . . 0.0 113.198 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.91 -14.14 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.484 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 74.1 mmm -123.02 -63.27 1.27 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.49 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 67.5 t -59.35 -55.73 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.636 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -53.17 -54.37 45.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 31.3 Cg_exo -60.85 -4.24 3.45 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.15 1.9 . . . . 0.0 112.175 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -144.43 26.89 1.42 Allowed 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.487 HG23 ' CD1' ' A' ' 81' ' ' TYR . 2.5 p -84.99 159.12 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.904 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.021 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 14.4 t . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.468 0.175 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.5 m -119.41 142.71 47.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 111.892 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.36 133.93 34.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.426 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.49 ' CE ' ' HA ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -58.79 -30.09 67.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.126 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.67 30.08 16.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.971 0.415 . . . . 0.0 110.804 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.419 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 2.4 tpt -111.06 -13.2 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.097 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.75 55.1 1.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.437 ' CD2' ' HB2' ' A' ' 53' ' ' MET . 9.5 mp -54.42 -43.38 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.818 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.474 HG22 ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -135.44 159.18 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.735 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 74' ' ' ILE . 29.6 t70 -99.74 142.18 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.471 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.03 -34.7 5.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.127 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.474 ' CE2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.5 176.14 8.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 110.766 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 91.7 m-20 -110.98 162.24 15.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.069 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.5 t -121.97 101.49 7.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 57.9 m-85 -108.67 147.07 32.45 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.575 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CD1' HG23 ' A' ' 58' ' ' VAL . 33.9 p90 -137.66 123.14 19.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.091 0.472 . . . . 0.0 111.441 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.86 119.09 27.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.396 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 23.8 p -82.13 156.93 24.25 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.095 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -53.41 152.12 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -28.49 53.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.891 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 23.55 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.654 0.264 . . . . 0.0 111.398 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.89 85.68 19.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.636 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.14 -18.19 22.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.523 2.149 . . . . 0.0 112.063 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 28.79 1.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 110.216 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 82.3 m -153.8 72.81 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.474 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -75.82 178.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.342 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CD2' HG13 ' A' ' 11' ' ' VAL . 72.5 m-85 -152.15 88.48 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.116 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.552 ' CG1' HG12 ' A' ' 50' ' ' ILE . 44.0 t -90.91 125.14 43.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.483 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 45.2 t -125.27 115.35 20.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.76 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.2 m-85 -82.97 122.7 28.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -122.6 129.8 52.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 111.972 -179.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.0 mt -44.13 124.33 3.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.019 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -31.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.88 -31.41 72.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 68.4 mt -76.39 138.2 67.67 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.049 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.6 -164.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.501 2.134 . . . . 0.0 111.928 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 57.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.963 0.411 . . . . 0.0 111.138 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 104' ' ' LEU . 6.3 tp -142.04 -35.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.605 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.554 ' O ' HG12 ' A' ' 108' ' ' ILE . 5.0 tp -62.8 -62.57 5.45 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.49 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 3.2 Cg_endo -46.61 -30.4 8.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.442 2.094 . . . . 0.0 111.034 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.579 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.4 mp -71.35 -40.23 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.182 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.72 -25.81 44.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 104' ' ' LEU . 15.8 mm -68.1 -46.02 82.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.457 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.498 ' HB2' HG22 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -72.01 -58.08 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -28.6 62.29 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -74.02 -47.3 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 7.9 mt -54.43 -26.07 28.55 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -71.89 -18.63 62.03 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.772 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.32 -21.37 59.74 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.047 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.501 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 8.9 m-85 -95.42 -49.98 5.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 84.68 -22.72 0.19 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 123' ' ' LEU . 3.1 t -85.51 8.22 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.684 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.7 p-10 -69.84 55.43 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.82 34.96 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -150.96 149.22 29.35 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.041 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.439 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.9 m-80 -69.63 25.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.609 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.9 tt0 -167.0 25.7 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.684 HD22 ' HA ' ' A' ' 118' ' ' ASN . 6.6 tt -128.0 -49.46 1.34 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -56.65 -45.19 81.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.1 m -46.39 -31.27 2.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.117 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.77 -58.04 8.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.98 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.501 ' CD2' ' CD2' ' A' ' 115' ' ' TYR . 2.6 m170 -58.76 -36.05 73.73 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.488 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.2 t -52.59 -48.53 47.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.511 ' HA2' HD11 ' A' ' 132' ' ' LEU . . . -71.29 -51.46 17.34 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.394 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -61.98 -20.92 64.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.756 0.312 . . . . 0.0 111.038 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.499 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 66.8 mt -91.2 -27.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.511 HD11 ' HA2' ' A' ' 129' ' ' GLY . 0.3 OUTLIER -63.8 -36.99 85.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.287 178.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -64.52 -34.2 77.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.87 -14.43 54.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.957 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 132' ' ' LEU . 43.2 t80 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.027 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.464 ' CG2' HG13 ' A' ' 108' ' ' ILE . 97.5 t . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.771 0.32 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -81.72 -62.92 1.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.713 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 7.5 m-85 -143.48 111.78 6.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 3.2 t -106.35 97.35 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.577 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.417 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 2.5 tt0 -98.96 110.04 22.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.256 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 92' ' ' TYR . 58.4 t -77.6 158.79 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.4 mp -147.16 120.41 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HB2' HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.54 113.89 27.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 178.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.58 34.61 17.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.534 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 22.93 62.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.688 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.45 119.52 13.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 3.2 m -50.95 128.61 21.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.121 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -107.08 -42.02 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.617 0.723 . . . . 0.0 109.476 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -128.62 175.24 8.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.331 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -170.11 124.16 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.385 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 35.2 t -109.56 73.0 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.713 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -107.17 82.85 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.312 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.47 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 11.2 m120 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.77 0.319 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.48 26.46 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.135 0.493 . . . . 0.0 110.691 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -114.08 -30.2 6.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.213 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.463 ' CG2' ' CE1' ' A' ' 46' ' ' PHE . 2.6 mm -56.31 113.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.458 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.511 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 8.9 t -78.56 151.54 77.44 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.474 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 87.2 Cg_exo -45.83 -22.37 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.099 1.866 . . . . 0.0 111.184 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.511 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 66.1 t -66.24 -49.61 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.414 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.417 HD13 ' CG2' ' A' ' 42' ' ' THR . 2.3 mp -58.76 -31.97 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.498 ' CZ ' ' CE1' ' A' ' 8' ' ' TYR . 72.3 m-85 -80.09 -42.71 23.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.05 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.627 ' HD2' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -69.98 -23.9 63.24 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.162 0.505 . . . . 0.0 110.595 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.627 ' N ' ' HD2' ' A' ' 47' ' ' HIS . 4.9 t-20 -89.01 -33.83 17.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.857 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 53' ' ' MET . 4.9 mt -56.9 -61.36 2.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.699 HG21 HD23 ' A' ' 55' ' ' LEU . 5.3 mt -51.95 -62.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.431 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.603 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.05 -44.6 41.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.119 -178.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 48' ' ' ASN . 17.2 m-20 -91.15 -19.49 23.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.45 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 71.5 mmm -114.84 -61.18 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HB ' HG21 ' A' ' 50' ' ' ILE . 91.9 t -68.04 -56.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.699 HD23 HG21 ' A' ' 50' ' ' ILE . 2.7 mm? -46.54 -51.69 34.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 13.2 Cg_exo -69.91 3.22 2.97 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.519 2.146 . . . . 0.0 112.07 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.13 22.96 1.36 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.334 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG22 HG11 ' A' ' 91' ' ' VAL . 3.0 p -86.73 154.84 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.716 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.872 178.866 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.583 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 29.3 t . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 120.626 0.25 . . . . 0.0 111.5 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.422 HG21 ' CZ ' ' A' ' 81' ' ' TYR . 89.7 m -103.71 138.19 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 111.65 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 8.6 ttpt -94.25 135.79 35.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -29.56 41.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m 51.28 27.21 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.05 0.452 . . . . 0.0 110.816 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.0 tpt -112.7 -13.28 13.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 62.67 69.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 0.0 110.599 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.447 ' CD2' ' HB2' ' A' ' 53' ' ' MET . 6.8 mp -70.7 -49.65 44.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.514 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -126.69 158.34 37.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' N ' HG23 ' A' ' 74' ' ' ILE . 24.2 t0 -99.34 141.12 32.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.431 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.59 -34.06 5.71 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.098 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.514 ' CE1' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -131.58 168.89 16.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.105 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 64.9 m-20 -112.75 125.76 54.68 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 10.7 m -86.17 121.65 29.07 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 74.7 m-85 -124.02 164.61 19.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.344 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.477 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 29.9 p90 -154.98 121.46 5.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.438 . . . . 0.0 111.149 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.412 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -125.08 119.26 28.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.378 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 23.8 p -85.31 143.53 28.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.9 0.381 . . . . 0.0 111.073 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -46.82 135.97 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.11 -30.07 66.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.258 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 18.9 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.624 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -154.98 92.16 2.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.441 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.07 -17.0 53.87 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.325 2.017 . . . . 0.0 111.779 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -95.13 33.55 1.52 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.413 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 16.2 m -152.87 69.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 1.2 t -65.91 173.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.148 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 11' ' ' VAL . 56.1 m-85 -147.1 95.04 2.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.224 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.5 ' CG2' ' CD1' ' A' ' 12' ' ' ILE . 21.5 t -86.21 137.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 111.542 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -132.08 128.79 38.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.798 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 6.5 m-85 -109.97 85.64 2.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.437 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.31 128.2 37.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.156 0.503 . . . . 0.0 111.179 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.1 mt -46.35 127.35 8.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.213 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -44.24 -30.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.695 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -32.22 70.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.67 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 43.0 mt -83.31 136.94 42.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.808 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.28 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.501 2.134 . . . . 0.0 112.311 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 63.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.938 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.457 HG21 ' CZ ' ' A' ' 135' ' ' PHE . 5.5 tp -145.13 -43.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.67 ' O ' HG12 ' A' ' 108' ' ' ILE . 2.8 tp -58.08 -60.21 10.83 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 5.9 Cg_endo -47.28 -35.39 20.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.641 2.227 . . . . 0.0 111.18 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.583 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.5 mp -67.02 -38.07 80.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.775 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 111' ' ' GLY . 21.5 mmm180 -79.42 -26.95 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.177 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 104' ' ' LEU . 22.6 mm -62.97 -47.87 90.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.069 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.499 ' HB2' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -70.73 -56.34 6.62 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.0 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -56.3 -26.15 51.04 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.501 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -74.38 -47.17 17.63 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.499 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 9.9 mt -54.98 -31.33 60.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -72.08 -17.72 61.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.253 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.37 -22.38 60.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.28 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.514 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 5.5 m-85 -85.68 -93.66 0.08 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 8.0 tt0 161.89 -25.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.674 0.273 . . . . 0.0 111.031 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.23 -89.48 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.652 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.435 ' HA ' HD21 ' A' ' 123' ' ' LEU . 2.0 p-10 40.87 31.37 0.12 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.89 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.5 34.38 4.37 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -145.99 151.58 38.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.606 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.437 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.9 p30 -72.0 22.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.517 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.6 tt0 -165.71 26.93 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.448 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 6.2 tt -130.0 -50.23 1.12 Allowed 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -54.36 -46.89 73.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.148 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.474 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 11.7 p -47.48 -29.65 2.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.544 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.45 -59.1 5.76 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.114 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' CD2' ' A' ' 115' ' ' TYR . 5.5 m170 -55.99 -38.5 70.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.527 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 132' ' ' LEU . 46.0 t -49.61 -51.14 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.95 -48.65 68.94 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.152 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -20.97 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 111.091 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.508 HD11 ' C ' ' A' ' 127' ' ' HIS . 31.3 mt -90.66 -29.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.468 ' HG ' ' CD1' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -62.02 -42.18 98.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.153 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.72 -32.19 73.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.658 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -80.04 -12.66 59.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 5.9 t80 . . . . . 0 C--N 1.332 -0.159 0 CA-C-O 120.923 0.392 . . . . 0.0 111.105 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.481 ' CG2' HG13 ' A' ' 108' ' ' ILE . 51.7 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.824 0.345 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.458 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -62.48 -61.43 2.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.111 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.633 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 6.2 m-85 -148.56 112.41 5.12 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.48 HG22 ' CG1' ' A' ' 6' ' ' VAL . 4.7 t -105.19 101.45 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.536 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.1 tt0 -109.96 121.58 45.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.844 0.354 . . . . 0.0 111.726 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.453 HG12 ' CD1' ' A' ' 92' ' ' TYR . 98.1 t -80.65 161.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.9 mp -142.89 113.21 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HB2' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -98.95 110.29 22.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.892 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.86 34.45 17.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.06 26.1 60.72 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.032 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 12' ' ' ILE . 64.8 mm-40 -138.23 114.25 10.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.955 0.407 . . . . 0.0 109.938 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.479 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -49.46 130.84 20.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.959 -178.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.491 HG12 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.61 -47.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 109.993 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.452 ' OG ' ' CD2' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -118.44 172.01 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.224 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 58.0 p -170.16 125.99 0.79 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.555 ' HB2' HD23 ' A' ' 124' ' ' LEU . 15.8 t -113.24 69.68 0.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.633 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -105.3 90.59 3.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.933 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.333 -0.146 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.393 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 10.4 m120 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.694 0.283 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.43 26.77 6.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.068 0.461 . . . . 0.0 110.666 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -121.64 29.22 7.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.771 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.51 ' CG2' ' HB ' ' A' ' 45' ' ' ILE . 1.1 mt -124.5 122.18 63.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.417 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 8.9 t -83.14 151.34 63.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.459 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 85.5 Cg_exo -45.29 -22.92 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.27 1.98 . . . . 0.0 111.697 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 47.4 t -66.56 -44.74 89.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.071 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.51 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 1.8 mp -59.1 -32.01 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 38.6 m-85 -81.58 -43.47 18.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.059 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.63 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.66 -29.13 70.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.346 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.11 -28.37 19.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.3 mt -62.68 -60.39 3.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.517 HG21 ' HB ' ' A' ' 54' ' ' VAL . 5.3 mt -51.79 -63.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.73 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.63 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.27 -43.43 61.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.18 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.64 -15.65 30.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.451 ' N ' ' O ' ' A' ' 49' ' ' LEU . 65.2 mmm -123.57 -69.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.517 ' HB ' HG21 ' A' ' 50' ' ' ILE . 93.0 t -52.33 -51.7 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.694 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.444 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mm? -53.87 -59.15 10.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.669 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 30.4 Cg_endo -64.27 3.93 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.093 1.862 . . . . 0.0 112.487 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -144.62 22.7 1.63 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.099 0.476 . . . . 0.0 110.129 179.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.522 HG22 ' CD2' ' A' ' 81' ' ' TYR . 4.6 p -87.8 166.88 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.244 179.221 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.617 ' HB ' HG13 ' A' ' 106' ' ' ILE . 11.8 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.839 0.352 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.5 m -93.31 144.74 25.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 111.694 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -90.9 133.72 35.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.43 ' HB3' ' HG2' ' A' ' 71' ' ' MET . 10.7 mmm -54.4 -32.51 57.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.9 m 58.34 27.32 15.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.43 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 40.3 mmm -107.71 -15.68 14.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.03 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 66.89 61.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.896 0.379 . . . . 0.0 110.374 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.44 -46.95 86.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.131 0.491 . . . . 0.0 110.382 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 74' ' ' ILE . 1.5 mt -136.47 154.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.447 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 74' ' ' ILE . 6.3 t0 -94.06 139.47 30.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.629 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.06 -32.42 7.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.506 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 74' ' ' ILE . 6.2 m-85 -110.31 -179.47 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.03 0.443 . . . . 0.0 111.876 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -129.4 113.17 14.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.936 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.1 p -83.66 108.79 16.97 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.439 ' CE2' ' HD2' ' A' ' 68' ' ' LYS . 47.4 m-85 -121.97 155.73 34.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.199 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.522 ' CD2' HG22 ' A' ' 58' ' ' VAL . 17.8 p90 -147.57 137.64 22.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.06 0.457 . . . . 0.0 111.263 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -140.85 117.66 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.775 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 6.8 p -82.53 146.89 28.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.802 0.334 . . . . 0.0 110.786 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.52 138.4 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.0 0.429 . . . . 0.0 111.209 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -51.91 -24.93 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.981 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 20.52 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -146.48 93.41 4.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.66 0.267 . . . . 0.0 111.129 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.3 -14.59 43.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.309 2.006 . . . . 0.0 111.934 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.13 30.98 2.27 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.313 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.3 m -154.58 71.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.52 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -70.07 175.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.668 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.453 ' CD1' HG12 ' A' ' 11' ' ' VAL . 43.3 m-85 -151.12 97.88 2.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.931 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.498 ' CG2' HG23 ' A' ' 50' ' ' ILE . 24.5 t -101.44 127.13 55.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 111.692 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.95 117.43 30.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.06 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 1.1 m-85 -92.66 73.92 5.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.65 -174.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.012 0.434 . . . . 0.0 111.22 -178.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.414 ' HB2' HG13 ' A' ' 100' ' ' ILE . 57.4 mt -101.1 126.08 47.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.288 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -42.61 -36.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -38.83 92.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.493 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.414 HG13 ' HB2' ' A' ' 97' ' ' LEU . 86.1 mt -65.28 139.07 97.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.803 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -57.48 -171.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.528 2.152 . . . . 0.0 112.277 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.22 67.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.462 HG21 ' CZ ' ' A' ' 135' ' ' PHE . 8.1 tp -154.66 -38.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.633 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.625 ' O ' HG12 ' A' ' 108' ' ' ILE . 19.1 tp -57.7 -61.03 8.09 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 5.6 Cg_endo -48.39 -34.98 26.85 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.575 2.183 . . . . 0.0 111.08 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.617 HG13 ' HB ' ' A' ' 66' ' ' VAL . 4.1 mp -67.02 -34.54 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.939 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -81.92 -27.76 33.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 179.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 104' ' ' LEU . 7.9 mm -64.19 -46.69 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.427 ' HB2' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -74.92 -49.59 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.188 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.1 t -62.97 -27.91 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . -78.15 -46.37 9.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 7.6 mt -57.39 -32.04 66.42 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -73.51 -17.07 61.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.929 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -22.4 59.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.499 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 6.8 m-85 -85.02 -94.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.7 tt0 159.25 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.346 0.259 . . . . 0.0 110.856 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.41 ' CB ' HD21 ' A' ' 123' ' ' LEU . 7.9 m -92.12 -93.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.681 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 2.0 p30 41.27 30.94 0.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.51 31.17 5.81 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.47 157.46 44.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.24 178.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.427 ' HA ' ' N ' ' A' ' 20' ' ' SER . 3.6 p30 -78.13 20.73 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.0 tp10 -163.63 25.48 0.08 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.441 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 6.0 tt -126.35 -49.06 1.55 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -55.93 -45.68 78.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.59 -30.61 1.54 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.178 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.45 -57.85 11.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.956 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.526 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 4.4 m170 -58.87 -37.3 76.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 43.6 t -51.78 -45.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.414 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.3 -45.7 37.6 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.153 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -66.17 -22.52 66.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.946 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 127' ' ' HIS . 32.8 mt -90.32 -28.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.419 ' CD1' HD13 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -63.6 -42.52 98.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.355 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.18 -40.45 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -81.41 -15.86 53.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.151 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.991 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.48 ' CG1' HG23 ' A' ' 9' ' ' VAL . 2.9 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.708 0.29 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.449 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -90.26 -61.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.796 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.662 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 5.1 m-85 -131.37 141.77 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.51 ' O ' HD22 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -148.69 100.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 12.0 pt-20 -115.02 138.41 50.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 92' ' ' TYR . 53.0 t -90.86 151.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 91' ' ' VAL . 4.1 mp -131.53 123.8 53.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 2.7 tttt -113.09 114.83 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.54 33.75 8.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.618 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.422 ' HA2' ' CD1' ' A' ' 55' ' ' LEU . . . 81.68 24.12 56.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.939 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 1.3 tt0 -114.58 -142.91 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.647 0.26 . . . . 0.0 110.583 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.8 m -153.68 75.26 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.49 -43.08 86.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.704 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.44 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 4.0 p -122.41 170.01 10.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.865 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 30.6 m -168.23 118.27 0.77 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.0 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.655 ' HB2' HD23 ' A' ' 124' ' ' LEU . 15.8 t -111.48 68.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.662 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -116.1 87.72 2.74 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.84 -179.027 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.427 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 73.7 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.917 0.389 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.29 27.54 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -107.95 -36.27 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.772 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.469 HG21 ' CZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -56.58 119.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.68 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.59 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 13.2 t -81.14 157.23 71.23 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.389 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.59 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 54.2 Cg_exo -50.88 -21.74 8.96 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 121.917 1.744 . . . . 0.0 111.051 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.575 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 48.1 t -66.16 -47.8 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.402 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.445 ' HB ' HG22 ' A' ' 41' ' ' ILE . 1.9 mp -58.58 -33.3 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.469 ' CZ ' HG21 ' A' ' 41' ' ' ILE . 68.3 m-85 -81.36 -40.84 22.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.732 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.571 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -67.09 -27.28 67.22 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 44' ' ' VAL . 5.6 m-80 -88.28 -28.64 20.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.8 mt -61.47 -60.23 4.03 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.591 HG22 ' CD2' ' A' ' 55' ' ' LEU . 6.4 mt -51.52 -64.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.723 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.571 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -49.8 -40.37 41.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.661 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -91.14 -16.62 27.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.495 ' N ' ' O ' ' A' ' 49' ' ' LEU . 69.3 mmm -124.64 -68.69 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 90.5 t -51.99 -51.52 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.697 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.591 ' CD2' HG22 ' A' ' 50' ' ' ILE . 1.8 mm? -56.59 -58.19 18.76 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.849 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 28.0 Cg_endo -63.25 1.73 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.113 1.875 . . . . 0.0 112.662 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 55' ' ' LEU . 3.2 tptt -147.24 26.35 1.07 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.106 0.479 . . . . 0.0 109.942 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 81' ' ' TYR . 5.7 p -85.27 167.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.895 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.157 179.086 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.581 ' HB ' HG13 ' A' ' 106' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.847 0.356 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.9 m -92.82 135.38 34.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.436 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 3.2 tttt -87.09 125.6 34.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.414 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.564 ' HG2' HD11 ' A' ' 73' ' ' LEU . 1.4 ttm -52.34 -36.08 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m 58.47 24.48 11.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.494 ' CG ' ' HG2' ' A' ' 69' ' ' MET . 17.3 mmt -101.2 6.43 43.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.39 53.05 10.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.564 HD11 ' HG2' ' A' ' 69' ' ' MET . 8.2 mp -59.98 -32.83 71.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.623 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.456 HD11 HG23 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -153.42 151.49 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -95.71 138.9 32.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.31 -32.8 6.22 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.204 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.432 ' CD1' HG23 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -131.74 175.46 9.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.342 . . . . 0.0 111.004 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -119.56 123.92 45.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.8 t -82.01 101.03 10.06 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 19.6 m-85 -109.26 126.09 52.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.491 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.484 ' CD2' HG23 ' A' ' 58' ' ' VAL . 52.5 p90 -120.12 135.64 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.072 0.463 . . . . 0.0 111.28 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.91 116.29 11.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 74.5 p -86.11 154.16 21.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -49.6 155.21 0.83 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -68.25 -20.85 64.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.2 22.27 0.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.611 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.59 89.88 7.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.2 -16.93 43.22 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.362 2.041 . . . . 0.0 111.982 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.67 30.59 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.447 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.0 m -154.84 73.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.806 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.7 OUTLIER -75.96 177.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.47 ' CD2' HG12 ' A' ' 11' ' ' VAL . 36.2 m-85 -149.42 106.89 3.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.517 ' CG1' HG12 ' A' ' 50' ' ' ILE . 44.3 t -104.89 137.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.19 0.519 . . . . 0.0 111.754 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 45.3 t -138.7 110.27 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.727 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.5 m-85 -87.0 83.93 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.451 ' CG2' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -82.01 130.18 35.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.885 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.0 mt -46.61 126.88 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.698 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -44.45 -33.06 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.03 -18.18 56.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.342 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 4.7 mt -87.26 136.47 33.54 Favored Pre-proline 0 N--CA 1.461 0.113 0 CA-C-O 120.501 0.191 . . . . 0.0 110.773 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 100' ' ' ILE . 38.0 Cg_exo -59.56 -157.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.304 2.003 . . . . 0.0 111.645 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.83 63.7 0.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.693 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.421 ' CA ' HD13 ' A' ' 106' ' ' ILE . 3.3 tp -150.91 -40.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.843 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.59 ' O ' HG12 ' A' ' 108' ' ' ILE . 29.1 tp -58.14 -62.28 5.83 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.125 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 6.7 Cg_endo -49.05 -27.32 11.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.265 1.976 . . . . 0.0 111.486 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.581 HG13 ' HB ' ' A' ' 66' ' ' VAL . 4.3 mp -76.15 -34.68 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -84.07 -27.51 28.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.395 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.59 HG12 ' O ' ' A' ' 104' ' ' LEU . 7.7 mm -71.35 -51.6 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -55.71 14.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.595 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -60.78 -25.86 66.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.563 ' HA3' HD12 ' A' ' 131' ' ' ILE . . . -71.32 -50.8 19.96 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.431 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 5.3 mt -52.94 -27.84 20.77 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.82 -21.47 57.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HG3' ' CD1' ' A' ' 115' ' ' TYR . 0.4 OUTLIER -75.18 -19.53 59.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.452 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.45 ' O ' ' CB ' ' A' ' 116' ' ' GLU . 29.7 m-85 -82.12 -92.57 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.71 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 16.0 tt0 157.94 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.697 0.399 . . . . 0.0 110.621 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -92.89 -92.75 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.424 ' HA ' HD22 ' A' ' 123' ' ' LEU . 4.0 p-10 40.61 31.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 110.98 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.93 33.64 4.48 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.93 159.62 42.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.751 0.31 . . . . 0.0 110.421 179.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HA ' ' N ' ' A' ' 20' ' ' SER . 6.1 p30 -78.78 19.43 0.51 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -163.41 24.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.054 0.454 . . . . 0.0 109.799 178.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.442 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 6.0 tt -124.53 -49.66 1.77 Allowed 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.463 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.655 HD23 ' HB2' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -55.23 -47.43 75.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 96.6 p -46.23 -31.94 2.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.301 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -55.36 34.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 7.8 m170 -58.3 -37.29 74.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.431 ' O ' HD13 ' A' ' 132' ' ' LEU . 46.9 t -50.48 -49.89 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.976 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -69.72 -49.24 37.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.843 -1.17 . . . . 0.0 112.334 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -64.18 -18.77 64.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.645 0.26 . . . . 0.0 111.246 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.563 HD12 ' HA3' ' A' ' 111' ' ' GLY . 53.6 mt -90.71 -28.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.488 HD12 ' HA2' ' A' ' 129' ' ' GLY . 0.3 OUTLIER -64.1 -40.71 96.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.06 178.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.75 -32.4 74.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.433 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.99 -15.92 37.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.927 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 132' ' ' LEU . 34.3 t80 . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.714 0.293 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.518 HG12 ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.637 0.256 . . . . 0.0 110.438 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.444 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -83.44 -59.9 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.0 111.563 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.636 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 11.4 m-85 -146.66 125.11 12.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.732 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 6' ' ' VAL . 2.4 t -120.19 93.76 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.0 OUTLIER -100.95 116.83 33.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 HG22 ' OG ' ' A' ' 19' ' ' SER . 95.0 t -89.28 136.34 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.2 mp -114.2 119.11 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 3.5 tttt -104.86 107.88 19.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.083 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 61.96 37.71 14.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.629 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 26.24 60.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.637 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.72 115.9 6.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.0 109.993 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 24.7 m -47.1 127.74 10.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.208 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -99.91 -42.38 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 11' ' ' VAL . 94.4 p -132.7 177.12 7.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -169.85 125.8 0.83 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 36.5 t -107.64 69.79 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.825 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -106.12 84.83 2.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.548 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 m120 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.662 0.267 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -131.54 27.39 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.978 0.418 . . . . 0.0 110.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -109.92 -36.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.805 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.497 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -50.93 116.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.754 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.418 ' H ' HD13 ' A' ' 45' ' ' ILE . 2.7 t -78.68 149.66 74.84 Favored Pre-proline 0 CA--C 1.518 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.623 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.8 Cg_endo -45.19 -22.57 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 111.079 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.51 -47.29 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.893 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 42' ' ' THR . 1.7 mp -58.33 -32.71 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 90.0 m-85 -80.71 -43.29 20.52 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.337 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.639 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.03 -28.19 69.92 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.82 -30.73 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 53' ' ' MET . 5.3 mt -61.71 -61.61 2.39 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.505 HG23 ' HB ' ' A' ' 54' ' ' VAL . 5.6 mt -50.04 -61.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.976 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.639 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -51.72 -43.4 62.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.066 -1.424 . . . . 0.0 113.075 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.86 -19.58 23.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 49' ' ' LEU . 85.0 mmm -118.23 -65.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 ' HB ' HG23 ' A' ' 50' ' ' ILE . 94.9 t -58.3 -57.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.8 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.446 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mm? -44.91 -57.15 7.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.7 Cg_endo -65.92 4.63 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 121.969 1.779 . . . . 0.0 112.426 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -145.89 23.38 1.38 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.124 0.488 . . . . 0.0 110.07 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.517 HG21 ' CD2' ' A' ' 81' ' ' TYR . 5.1 p -86.33 166.65 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.878 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.6 m . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.101 178.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.603 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 2.7 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.917 0.389 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -92.3 135.68 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.46 ' CE ' ' CZ ' ' A' ' 80' ' ' PHE . 8.0 ttmt -81.44 128.39 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.448 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 16.3 mmm -52.8 -25.59 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.193 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 m 53.97 25.89 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.9 tpt -104.34 -17.15 14.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 65.94 62.2 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.18 -52.6 46.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.739 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.489 HG22 ' CE2' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -122.35 158.86 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.414 ' N ' HG23 ' A' ' 74' ' ' ILE . 23.3 t0 -104.23 141.53 36.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.424 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.39 -34.48 5.37 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.164 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.489 ' CE2' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -126.17 -171.76 2.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.672 0.272 . . . . 0.0 110.56 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 2.4 m-20 -127.97 127.4 43.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.2 p -82.5 103.41 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.46 ' CZ ' ' CE ' ' A' ' 68' ' ' LYS . 29.5 m-85 -115.91 136.34 53.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.517 ' CD2' HG21 ' A' ' 58' ' ' VAL . 48.8 p90 -130.92 140.01 50.14 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.846 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 2.0 t -144.28 123.34 12.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.45 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 44.8 p -87.0 153.28 21.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 0.0 110.964 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -47.09 158.36 0.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.209 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.51 0.73 45.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.559 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.48 21.63 0.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.77 102.08 1.31 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.53 0.205 . . . . 0.0 111.329 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.28 -15.11 48.55 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.452 2.101 . . . . 0.0 111.803 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -95.81 30.37 2.39 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.144 0.497 . . . . 0.0 110.14 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.412 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 86.0 m -151.51 71.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -73.55 178.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.451 ' CD2' HG21 ' A' ' 11' ' ' VAL . 49.1 m-85 -152.98 84.19 1.21 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.175 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.484 ' CG1' HG12 ' A' ' 50' ' ' ILE . 59.8 t -98.52 132.32 43.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.411 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 21.5 p -139.48 131.44 27.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.097 0.475 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 37.7 m-85 -89.33 91.07 8.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.061 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -85.92 137.0 33.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 7' ' ' SER . 89.1 mt -48.5 127.75 13.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -37.91 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.358 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.15 -25.33 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.405 HG13 ' HB2' ' A' ' 97' ' ' LEU . 76.2 mt -80.2 138.43 52.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.876 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.98 176.99 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.459 2.106 . . . . 0.0 112.069 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -94.37 61.15 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 104' ' ' LEU . 6.1 tp -149.59 -32.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.996 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.554 ' O ' HG12 ' A' ' 108' ' ' ILE . 16.4 tp -61.59 -62.17 6.42 Favored Pre-proline 0 C--O 1.226 -0.143 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.049 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.482 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 7.6 Cg_endo -49.02 -29.71 16.35 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.397 2.065 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.603 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.3 mp -72.73 -35.94 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.83 -26.62 34.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.077 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 104' ' ' LEU . 19.6 mm -73.83 -51.27 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.419 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -67.28 -57.37 6.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -59.22 -25.91 64.41 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.452 ' HA3' HD12 ' A' ' 131' ' ' ILE . . . -73.97 -45.98 24.5 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.507 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 10.4 mt -55.2 -26.7 40.96 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.62 -18.92 62.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.91 -21.55 61.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.93 0.395 . . . . 0.0 109.966 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.499 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 3.4 m-85 -93.14 -170.68 2.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.468 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -127.12 2.4 6.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.718 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.3 p -114.81 -93.53 0.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.414 ' HA ' HD21 ' A' ' 123' ' ' LEU . 1.5 p-10 41.13 31.82 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.49 35.2 4.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.555 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -151.1 149.86 30.01 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.396 178.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -69.64 28.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.781 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -169.92 27.1 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 126' ' ' SER . 6.0 tt -132.28 -49.64 0.93 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.432 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -54.7 -45.98 74.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 t -47.67 -29.78 3.26 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.359 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.25 -57.82 11.34 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.015 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.507 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 4.1 m170 -57.06 -36.65 70.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.609 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.43 ' O ' HD11 ' A' ' 132' ' ' LEU . 44.3 t -51.79 -48.3 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.21 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.442 ' HA2' HD13 ' A' ' 132' ' ' LEU . . . -72.26 -48.93 22.8 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.54 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -20.69 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 110.701 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 70.3 mt -90.89 -28.2 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.442 HD13 ' HA2' ' A' ' 129' ' ' GLY . 1.1 mt -61.49 -43.69 98.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.028 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.55 -31.0 70.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.25 16.55 26.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CE1' ' HB2' ' A' ' 104' ' ' LEU . 1.1 t80 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.446 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' CG2' HG13 ' A' ' 108' ' ' ILE . 1.5 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.058 0.456 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -53.74 -55.92 21.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.963 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.637 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 4.4 m-85 -147.57 116.38 6.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 3.1 t -108.51 97.27 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.474 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.4 tt0 -105.46 115.63 30.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 124' ' ' LEU . 6.1 t -79.98 159.54 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.5 mp -140.15 114.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.458 ' N ' HG12 ' A' ' 18' ' ' ILE . 21.4 tttm -96.93 106.54 18.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.459 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 57.68 39.96 26.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.301 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.92 26.74 59.8 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.228 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -144.56 110.82 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.042 0.448 . . . . 0.0 110.069 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.468 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -42.99 130.23 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.478 -178.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.76 -47.56 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.997 178.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.558 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -127.53 176.62 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.217 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.445 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 2.0 m -168.67 128.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.504 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.495 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 35.9 t -115.29 69.42 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.637 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.73 91.93 3.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.785 -178.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.505 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.3 m-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.91 0.386 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.73 26.58 7.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -108.33 -37.34 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.605 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.504 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.19 117.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.56 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.415 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 3.8 t -78.28 151.06 77.9 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.484 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 72.4 Cg_exo -47.32 -21.05 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.848 1.699 . . . . 0.0 111.042 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 48' ' ' ASN . 46.7 t -65.79 -45.97 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.183 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 1.7 mp -59.57 -33.5 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.504 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 74.3 m-85 -80.11 -43.82 21.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.447 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.24 -28.24 69.6 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.414 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' VAL . 1.6 t-20 -89.49 -29.7 18.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.6 mt -60.67 -60.5 3.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.529 ' CG2' HD23 ' A' ' 55' ' ' LEU . 5.1 mt -51.95 -64.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.704 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.72 -38.18 32.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.787 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -91.04 -23.27 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LEU . 40.7 mmm -119.14 -69.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.49 ' HB ' HG21 ' A' ' 50' ' ' ILE . 88.8 t -53.52 -53.29 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.848 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD23 ' CG2' ' A' ' 50' ' ' ILE . 3.3 mm? -51.85 -58.74 10.04 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.0 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 33.2 Cg_endo -65.38 6.44 0.41 Allowed 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.197 1.931 . . . . 0.0 112.719 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -151.0 25.04 0.74 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.099 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' VAL . 9.8 p -82.49 146.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 179.517 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 5.4 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.699 0.285 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.504 HG22 ' CE1' ' A' ' 81' ' ' TYR . 1.4 t -92.8 144.56 25.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.748 0.309 . . . . 0.0 111.113 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.452 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.23 142.2 31.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.406 ' HB3' ' HG2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -60.18 -33.4 72.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.802 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m 59.2 26.21 14.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.306 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.406 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 14.2 mmm -111.66 -0.25 16.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.469 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.87 59.62 3.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.123 0.487 . . . . 0.0 110.516 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 73' ' ' LEU . 7.9 mp -60.45 -45.79 92.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.485 HG21 ' CE1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -139.26 156.32 27.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.684 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.417 ' N ' HG22 ' A' ' 74' ' ' ILE . 13.0 t0 -102.47 138.84 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.375 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.7 -31.35 6.64 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.416 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -125.74 -165.0 1.36 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.929 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 1.9 m-20 -137.83 117.94 13.49 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.4 p -87.38 115.51 24.84 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 49.4 m-85 -123.83 151.74 43.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.867 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.504 ' CE1' HG22 ' A' ' 67' ' ' THR . 30.0 p90 -141.87 135.36 29.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.676 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.4 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -140.06 123.78 17.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.591 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 29.0 p -82.09 147.61 29.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 111.029 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -46.93 141.38 4.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -69.05 -11.65 60.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.621 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.22 19.26 1.74 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 111.568 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -161.98 91.24 1.39 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.2 -18.54 30.24 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.482 2.121 . . . . 0.0 111.99 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -92.7 30.91 1.45 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.485 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 20.5 m -152.74 70.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.639 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -65.5 178.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.124 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.429 ' CE1' ' O ' ' A' ' 90' ' ' THR . 97.3 m-85 -153.56 92.38 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.758 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.477 ' CG2' HG23 ' A' ' 50' ' ' ILE . 24.6 t -97.05 122.87 49.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.786 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.412 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -108.92 145.67 35.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.63 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 2.4 m-85 -121.82 80.48 1.69 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.46 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -77.4 177.72 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 100' ' ' ILE . 12.7 mt -93.9 127.78 39.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -40.55 -32.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.21 -34.51 78.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 110.576 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 100' ' ' ILE . 29.2 mt -73.16 136.95 78.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.879 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.24 -168.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.386 2.058 . . . . 0.0 112.232 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.04 67.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.66 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 104' ' ' LEU . 1.6 tp -150.51 -33.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.503 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 19.8 tp -59.6 -60.14 11.55 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.241 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 9.4 Cg_endo -51.21 -36.72 57.2 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.285 1.99 . . . . 0.0 111.193 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.662 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.2 mp -62.02 -40.47 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.231 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -23.99 36.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.983 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.475 HD13 ' CD1' ' A' ' 132' ' ' LEU . 10.3 mm -71.85 -44.32 67.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.425 HD22 ' CG1' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -75.07 -50.9 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -60.64 -30.8 70.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.406 ' C ' ' CD1' ' A' ' 131' ' ' ILE . . . -73.8 -48.94 15.19 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.503 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.13 -32.15 63.97 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.5 -17.26 61.76 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.09 -24.94 62.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.498 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 10.0 m-85 -86.75 -171.54 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -121.32 -1.19 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.613 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 m -114.8 -94.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 124' ' ' LEU . 4.4 p30 40.26 32.33 0.13 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.782 0.325 . . . . 0.0 111.078 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.94 36.09 4.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.558 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.0 OUTLIER -148.81 151.42 34.76 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.008 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.445 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.6 m-80 -70.54 21.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.582 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.1 tt0 -166.23 28.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.444 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 5.9 tt -132.34 -50.1 0.93 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.449 HD11 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.59 -45.58 77.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.3 p -46.37 -30.24 2.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.0 -57.13 14.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.687 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.503 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.3 m170 -61.25 -31.44 71.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.698 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 132' ' ' LEU . 48.4 t -56.41 -42.23 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.839 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' A' ' 132' ' ' LEU . . . -74.94 -50.4 8.79 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.11 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -26.74 67.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.446 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.486 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 61.7 mt -89.94 -25.82 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.523 ' HB2' ' HA2' ' A' ' 129' ' ' GLY . 2.9 tp -55.91 -45.7 78.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.782 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -44.84 64.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.802 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.43 -26.23 67.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.897 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.477 ' CD2' HD11 ' A' ' 104' ' ' LEU . 1.6 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.766 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 9' ' ' VAL . 20.2 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.774 0.321 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.445 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -55.79 -54.88 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.607 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 6.6 m-85 -142.49 135.44 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.841 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -129.76 93.11 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.793 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 2.2 mt-10 -106.11 120.77 42.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.577 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 17' ' ' THR . 23.6 t -85.32 159.87 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.727 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.6 mt -138.42 117.54 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.449 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -106.04 109.3 21.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.88 0.371 . . . . 0.0 111.487 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 61.18 37.34 17.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.633 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.6 58.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.483 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -146.1 117.54 7.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.279 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -48.01 126.99 11.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.142 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.466 HD12 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -104.76 -45.39 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.457 0.646 . . . . 0.0 109.927 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -125.16 175.87 7.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.397 -179.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 59.5 p -170.19 127.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.509 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.41 ' HB3' HG21 ' A' ' 9' ' ' VAL . 25.5 t -121.58 69.72 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -106.56 97.66 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.53 -179.31 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 75.2 m-20 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.839 0.352 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 26.28 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.172 0.51 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -111.59 -32.31 6.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.032 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.478 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.63 119.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.63 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 10.1 t -82.9 150.77 62.68 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.469 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 84.6 Cg_exo -44.79 -23.43 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.294 1.996 . . . . 0.0 111.779 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 33.6 t -66.76 -46.45 85.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.176 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.421 HD11 ' CG2' ' A' ' 42' ' ' THR . 2.1 mp -58.26 -33.87 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 88.6 m-85 -80.33 -41.48 24.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.401 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.6 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.59 -28.05 69.36 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.933 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 44' ' ' VAL . 5.7 m-20 -89.2 -28.55 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 46' ' ' PHE . 4.1 mt -62.33 -60.96 2.82 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.594 HG23 ' HB ' ' A' ' 54' ' ' VAL . 6.3 mt -50.48 -63.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.703 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.6 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -51.55 -41.57 61.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.068 -179.18 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.94 -22.42 20.87 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' LEU . 33.2 mmm -116.77 -60.0 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' HG23 ' A' ' 50' ' ' ILE . 82.7 t -61.38 -60.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.952 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 2.0 mm? -45.4 -54.95 13.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 17.6 Cg_exo -66.61 3.3 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.266 1.977 . . . . 0.0 112.45 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.56 24.89 1.09 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.974 0.416 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 54' ' ' VAL . 5.6 p -86.28 169.15 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.833 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.38 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.612 ' HB ' HG13 ' A' ' 106' ' ' ILE . 17.6 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.782 0.325 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.459 ' CG2' ' CE1' ' A' ' 81' ' ' TYR . 4.1 t -99.22 151.31 21.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 10.6 ttmt -86.14 141.38 29.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.443 ' HG3' ' CG2' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -55.31 -30.23 59.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.957 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m 60.98 26.26 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.059 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 mmm -115.89 -2.72 12.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.187 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.95 59.09 3.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 110.629 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.418 ' CD2' ' HB2' ' A' ' 53' ' ' MET . 7.1 mp -57.75 -53.99 51.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.498 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -130.3 158.31 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.845 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.0 t0 -102.98 138.58 39.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.231 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.52 -30.45 7.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.498 ' CE1' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -135.49 165.83 24.6 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.741 0.305 . . . . 0.0 110.806 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 5.8 m-20 -104.65 126.29 51.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.439 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 27.7 t -93.57 105.83 17.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 34.1 m-85 -116.13 137.35 52.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.545 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.5 ' HB3' HG13 ' A' ' 54' ' ' VAL . 7.5 p90 -124.67 139.81 53.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.428 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 2.5 t -141.5 118.48 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.527 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 74.3 p -81.58 150.48 28.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -46.39 148.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.17 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.25 -8.46 53.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.706 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.28 22.9 0.3 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.606 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.47 88.94 2.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.745 0.307 . . . . 0.0 111.304 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.49 -19.51 23.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.604 2.202 . . . . 0.0 112.133 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.2 32.66 1.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.975 0.416 . . . . 0.0 110.397 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 21.7 m -156.42 71.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -71.35 178.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.196 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.432 ' CE2' ' O ' ' A' ' 90' ' ' THR . 84.8 m-85 -153.01 98.59 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.514 ' CG1' HG12 ' A' ' 50' ' ' ILE . 43.1 t -106.17 129.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.372 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.2 p -128.41 117.46 21.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.546 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 16.0 m-85 -85.72 78.13 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.787 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -65.52 -172.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.758 0.314 . . . . 0.0 110.599 -179.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 100' ' ' ILE . 71.7 mt -102.26 129.82 48.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -46.01 -36.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.815 0.34 . . . . 0.0 111.617 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.82 -29.61 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' LEU . 60.2 mt -81.48 129.96 63.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.82 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.66 -176.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.491 2.127 . . . . 0.0 111.932 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.91 63.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.422 ' CA ' HD11 ' A' ' 106' ' ' ILE . 4.6 tp -144.02 -37.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.609 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 108' ' ' ILE . 2.5 tp -63.89 -63.61 3.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.495 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 2.8 Cg_endo -45.47 -30.19 5.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.627 2.218 . . . . 0.0 111.388 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.612 HG13 ' HB ' ' A' ' 66' ' ' VAL . 2.3 mp -66.92 -41.71 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.727 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 104' ' ' LEU . 6.9 mmt180 -80.95 -17.76 49.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.678 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 104' ' ' LEU . 16.2 mm -70.53 -48.62 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.405 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -73.12 -51.49 17.77 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.69 -43.88 17.23 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 16.9 mt -56.82 -35.62 69.0 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -14.52 61.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.16 -23.86 59.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.239 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.491 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.7 m-85 -84.33 -93.08 0.08 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 161.26 -26.38 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 111.068 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.411 ' CB ' HD23 ' A' ' 123' ' ' LEU . 4.3 m -92.13 -90.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.6 p30 40.73 32.47 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.99 34.52 4.8 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -150.71 149.24 29.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 178.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HA ' ' N ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -68.91 28.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.858 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.571 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.6 tp10 -169.93 27.93 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 126' ' ' SER . 5.8 tt -132.9 -49.32 0.88 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.507 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.428 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.66 -44.71 77.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 89.2 p -47.63 -30.73 3.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.16 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.91 -60.4 3.85 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.105 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 5.3 m170 -57.98 -36.88 73.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.28 -43.97 52.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.219 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.06 -44.82 12.76 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.109 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -65.25 -23.0 66.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.485 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 57.3 mt -90.03 -26.34 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.485 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -63.72 -47.83 79.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.545 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.68 -44.32 82.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.889 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -73.21 -18.06 61.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 104' ' ' LEU . 15.9 t80 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.463 HG12 ' CG2' ' A' ' 9' ' ' VAL . 2.1 t . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.448 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -87.88 -49.9 6.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.548 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.686 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 10.1 m-85 -143.57 134.71 25.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.96 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CG2' HG12 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -134.65 93.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.821 179.162 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.52 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.5 mt-10 -107.72 120.23 41.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.994 0.426 . . . . 0.0 111.812 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 12' ' ' ILE . 75.8 t -82.69 158.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 4.4 mt -137.51 115.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -105.28 109.34 21.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.0 111.284 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 63.81 34.28 12.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.611 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.66 26.39 58.95 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.347 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.93 117.34 9.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.039 0.447 . . . . 0.0 109.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.432 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -51.61 125.21 14.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.727 -178.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.42 ' CD1' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -102.19 -49.47 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.445 0.64 . . . . 0.0 109.87 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 120' ' ' THR . 55.0 p -120.87 174.38 6.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.695 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 92.1 p -170.06 134.44 1.26 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.155 0.502 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 28.7 t -124.86 69.71 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.434 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.617 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.9 m-85 -106.95 101.91 11.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.054 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.721 -179.629 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 24.1 m-20 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.803 0.335 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -128.86 26.9 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.16 0.505 . . . . 0.0 110.832 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -113.66 -33.49 5.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.155 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.558 ' CG2' ' HB ' ' A' ' 45' ' ' ILE . 2.2 mm -52.87 130.62 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.676 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.483 ' CG2' HG12 ' A' ' 45' ' ' ILE . 11.2 t -91.24 151.25 42.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.714 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 75.0 Cg_exo -46.71 -25.93 4.07 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.293 1.995 . . . . 0.0 111.384 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.47 ' HB ' HG22 ' A' ' 42' ' ' THR . 74.2 t -66.65 -38.45 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.714 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.558 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 15.2 mm -59.8 -44.21 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.481 ' HB3' ' CE2' ' A' ' 95' ' ' PHE . 10.7 m-85 -75.83 -40.09 55.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.178 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.73 -30.27 71.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.178 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -87.65 -29.56 21.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 53' ' ' MET . 4.1 mt -61.53 -59.72 4.8 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.554 HG12 ' CG1' ' A' ' 93' ' ' VAL . 7.0 mt -50.79 -63.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.016 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.518 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.4 OUTLIER -52.21 -41.74 62.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.99 -1.459 . . . . 0.0 113.048 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.76 -20.62 22.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.484 ' N ' ' O ' ' A' ' 49' ' ' LEU . 47.9 mmm -118.28 -59.95 1.84 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.536 ' HB ' HG23 ' A' ' 50' ' ' ILE . 90.8 t -63.55 -60.18 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.575 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 2.4 mm? -44.57 -53.69 14.29 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.8 Cg_exo -67.0 3.95 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.225 1.95 . . . . 0.0 112.457 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.28 28.07 0.58 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.139 0.495 . . . . 0.0 110.194 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 81' ' ' TYR . 9.4 p -83.76 150.35 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.94 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 t . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.429 179.934 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.58 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 3.0 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.688 0.28 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.9 m -101.2 130.06 47.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -81.74 134.95 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -26.25 62.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.7 t 50.94 28.46 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.5 tpp -107.3 -18.1 13.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.61 63.76 0.41 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.406 HD23 HD22 ' A' ' 49' ' ' LEU . 7.1 mp -65.32 -59.22 4.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.446 HG21 ' CE1' ' A' ' 77' ' ' PHE . 1.3 mt -121.51 155.44 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 17.0 t0 -97.3 140.02 32.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.47 -33.15 6.54 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.293 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 2.1 m-85 -116.35 175.26 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.6 OUTLIER -120.75 121.68 38.74 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.1 m -86.98 106.19 17.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.459 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 65.8 m-85 -120.81 149.0 43.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.505 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.462 ' CD1' HG22 ' A' ' 58' ' ' VAL . 35.3 p90 -144.87 131.07 19.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.154 0.502 . . . . 0.0 111.585 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 2.2 t -132.05 120.75 22.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.638 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 63.1 p -89.97 150.13 22.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.969 0.414 . . . . 0.0 111.133 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.66 149.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -69.97 -16.47 63.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.69 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.75 20.13 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.0 93.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.554 0.216 . . . . 0.0 111.263 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.31 -16.28 50.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.387 2.058 . . . . 0.0 111.896 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 30.39 2.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.098 0.475 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 m -150.84 69.59 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.535 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -72.47 176.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.512 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.436 ' CD1' HG12 ' A' ' 11' ' ' VAL . 38.3 m-85 -151.21 91.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG1' HG12 ' A' ' 50' ' ' ILE . 41.5 t -99.27 132.6 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.154 0.502 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.38 123.15 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.148 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.686 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -95.8 84.45 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.79 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.456 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -74.45 -167.38 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.973 0.416 . . . . 0.0 110.907 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 7' ' ' SER . 13.5 mt -106.36 127.48 53.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.351 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -45.54 -35.93 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.75 0.309 . . . . 0.0 111.697 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.0 -31.27 71.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.383 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.421 HG21 ' HD2' ' A' ' 101' ' ' PRO . 62.9 mt -76.34 132.99 71.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.764 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.421 ' HD2' HG21 ' A' ' 100' ' ' ILE . 52.2 Cg_exo -54.56 -168.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.369 2.046 . . . . 0.0 112.127 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 67.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.642 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.7 tp -152.03 -40.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.574 ' O ' HG12 ' A' ' 108' ' ' ILE . 12.1 tp -56.15 -63.99 2.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.129 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.478 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 6.1 Cg_endo -47.57 -30.02 11.5 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.447 2.098 . . . . 0.0 111.51 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.58 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.8 mp -72.0 -41.05 68.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.575 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.01 -28.12 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 104' ' ' LEU . 7.8 mm -68.08 -49.81 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.529 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.417 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -67.25 -54.8 17.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.1 p -60.38 -27.39 67.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.409 ' HA3' HD12 ' A' ' 131' ' ' ILE . . . -74.02 -44.36 30.31 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.498 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 17.0 mt -55.24 -28.87 56.25 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.02 -19.07 63.33 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.365 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.06 -20.88 61.6 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.494 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 6.3 m-85 -101.45 -29.88 11.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.063 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 4.6 mt-10 83.33 -51.86 0.15 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.005 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.8 m -46.43 -95.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.691 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.432 ' HA ' HD22 ' A' ' 123' ' ' LEU . 2.4 p30 42.07 31.9 0.27 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.725 0.298 . . . . 0.0 110.706 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.57 33.01 4.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.558 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -152.95 148.85 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.559 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -69.95 23.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.424 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.4 tt0 -163.84 24.86 0.08 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 118' ' ' ASN . 5.7 tt -123.81 -56.89 1.65 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.727 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.458 ' CD1' HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.13 -45.16 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.413 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 90.0 p -47.76 -31.42 4.82 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.365 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.08 -56.69 16.33 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.264 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.4 m170 -60.17 -35.29 75.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.408 ' O ' ' CD1' ' A' ' 132' ' ' LEU . 46.7 t -53.16 -47.18 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.827 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA2' HD11 ' A' ' 132' ' ' LEU . . . -72.71 -37.74 57.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.193 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.43 -18.45 60.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 0.0 111.344 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 127' ' ' HIS . 26.4 mt -90.56 -28.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.434 ' HG ' HD13 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -67.63 -52.04 42.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.485 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.52 -29.45 64.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.0 m -98.27 -12.08 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.999 -179.853 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.47 HG23 HG13 ' A' ' 108' ' ' ILE . 1.4 t . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.782 0.325 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.436 ' OG ' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.98 -63.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.16 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.618 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.0 m-85 -140.34 131.19 25.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.954 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 21' ' ' CYS . 2.1 t -117.42 85.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.378 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.419 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 0.9 OUTLIER -91.32 111.99 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 92' ' ' TYR . 97.6 t -85.22 158.35 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.1 mt -138.69 121.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.833 0.349 . . . . 0.0 111.686 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 6.2 tttt -110.82 102.94 11.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 111.582 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 67.81 37.99 3.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.87 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 55' ' ' LEU . . . 79.35 24.79 60.38 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.815 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.41 120.57 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.887 0.375 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -53.31 120.84 6.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.753 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -95.37 -51.09 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.016 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 120' ' ' THR . 57.9 p -123.08 177.93 5.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.435 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 29.5 m -170.5 142.95 2.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.411 . . . . 0.0 111.322 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 23.6 t -125.64 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.862 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.618 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 3.8 m-85 -106.2 88.83 2.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.401 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.724 0.297 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.6 26.16 4.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.016 0.436 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.53 -35.83 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.491 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -52.69 115.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.514 178.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.418 ' H ' HD13 ' A' ' 45' ' ' ILE . 1.4 t -76.01 152.29 84.38 Favored Pre-proline 0 CA--C 1.517 -0.327 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.671 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 74.4 Cg_exo -47.88 -21.73 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.84 1.693 . . . . 0.0 110.709 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.86 -48.68 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.175 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 42' ' ' THR . 1.7 mp -57.4 -33.27 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.545 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 89.4 m-85 -81.0 -42.71 20.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.427 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.623 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.98 -28.19 69.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.011 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -88.5 -30.07 19.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' MET . 4.8 mt -60.84 -60.23 4.13 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.532 HG23 ' HB ' ' A' ' 54' ' ' VAL . 5.7 mt -52.09 -62.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.065 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.623 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -50.26 -44.89 53.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.909 -179.067 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.86 -15.25 30.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -122.12 -69.38 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.532 ' HB ' HG23 ' A' ' 50' ' ' ILE . 70.9 t -53.93 -51.3 46.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.786 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.449 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mm? -54.09 -58.39 13.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 25.3 Cg_endo -63.19 2.8 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.154 1.902 . . . . 0.0 112.662 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -146.48 25.23 1.22 Allowed 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.941 0.401 . . . . 0.0 110.092 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.523 HG23 ' CD2' ' A' ' 81' ' ' TYR . 3.9 p -87.78 165.27 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.934 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.068 179.338 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 3.3 t . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.868 0.366 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.44 ' HB ' ' CE2' ' A' ' 81' ' ' TYR . 97.3 m -95.13 144.34 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -93.48 125.54 38.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.783 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.405 ' HE2' ' CB ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -46.92 -33.85 4.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.06 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.1 p 56.71 26.92 11.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.16 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 mmt -107.83 -3.51 18.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.964 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.87 55.29 4.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.092 0.473 . . . . 0.0 110.408 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 73' ' ' LEU . 10.7 mp -55.77 -49.94 71.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.453 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -136.25 161.3 37.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.5 t70 -100.09 140.25 34.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.275 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.54 -34.73 5.21 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.039 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.453 ' CE1' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -129.12 -179.02 4.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.633 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 19.6 m-20 -123.45 125.22 44.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.5 p -80.97 101.61 9.62 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 63.4 m-85 -110.19 157.96 18.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.255 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.523 ' CD2' HG23 ' A' ' 58' ' ' VAL . 9.8 p90 -149.99 132.09 15.35 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.17 0.51 . . . . 0.0 111.463 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 28.6 t -134.81 117.39 15.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 5.0 p -84.79 148.21 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.946 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.02 144.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.88 -21.99 8.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.952 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 23.29 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.69 0.281 . . . . 0.0 111.507 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.57 92.34 6.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.002 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.56 -15.13 43.97 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.27 1.98 . . . . 0.0 111.98 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -95.97 29.79 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.242 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.4 m -153.05 69.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.582 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -71.29 177.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.566 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 11' ' ' VAL . 53.7 m-85 -151.64 83.34 1.29 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.387 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.514 ' CG1' HG12 ' A' ' 50' ' ' ILE . 32.5 t -89.08 133.47 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 0.0 110.998 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -131.07 119.17 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.882 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.1 m-85 -86.95 83.3 7.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.383 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -83.49 133.66 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 111.985 -178.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.436 ' HG ' ' OG ' ' A' ' 7' ' ' SER . 61.9 mt -46.57 125.4 7.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -47.03 -33.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.748 0.309 . . . . 0.0 111.32 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.9 mt -78.77 132.32 64.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.899 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.06 -167.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.393 2.062 . . . . 0.0 112.007 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -108.67 67.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 104' ' ' LEU . 3.0 tp -150.97 -38.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.749 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.569 ' O ' HG12 ' A' ' 108' ' ' ILE . 5.0 tp -60.36 -62.3 6.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.781 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.482 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 2.8 Cg_endo -46.23 -34.21 13.29 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.335 2.024 . . . . 0.0 111.308 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.57 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 4.2 mp -65.98 -38.77 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.02 -27.12 33.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 104' ' ' LEU . 10.8 mm -68.09 -47.98 76.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.428 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -54.93 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 t -59.32 -28.78 67.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.415 ' HA3' HG23 ' A' ' 131' ' ' ILE . . . -73.88 -47.66 18.95 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.282 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.416 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -56.36 -31.56 63.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.95 -14.3 60.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.148 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -75.74 -24.41 56.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.343 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.542 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 8.1 m-85 -86.17 -93.15 0.09 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.979 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER 160.38 -28.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.782 0.433 . . . . 0.0 110.297 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.485 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 72.4 p -107.33 127.27 53.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.491 0.662 . . . . 0.0 111.191 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.49 ' HA ' HD21 ' A' ' 123' ' ' LEU . 5.6 p30 -172.65 36.2 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.053 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.73 32.83 4.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.316 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.589 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -148.39 144.96 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.279 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.435 ' HA ' ' N ' ' A' ' 20' ' ' SER . 2.2 m120 -68.5 29.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.882 0.372 . . . . 0.0 111.834 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 120' ' ' THR . 11.1 tt0 -169.78 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 118' ' ' ASN . 8.5 tt -124.08 -58.01 1.57 Allowed 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -51.26 -43.84 61.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.446 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.4 p -47.7 -29.31 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.509 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.3 -61.81 2.11 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.126 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.542 ' CE1' ' CB ' ' A' ' 115' ' ' TYR . 35.2 m170 -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.754 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 132' ' ' LEU . 50.0 t -51.58 -48.88 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.442 ' HA2' HD11 ' A' ' 132' ' ' LEU . . . -69.06 -46.9 57.09 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.987 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -64.01 -20.33 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.734 0.302 . . . . 0.0 110.659 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 127' ' ' HIS . 44.7 mt -90.7 -28.45 4.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -62.36 -39.85 94.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.94 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -32.96 72.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.455 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.26 24.29 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.843 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 103' ' ' ILE . 1.1 t80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.376 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.5 HG11 ' CG2' ' A' ' 9' ' ' VAL . 1.2 t . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.742 0.306 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB3' ' CD1' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -69.52 -71.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.291 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.668 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 3.4 m-85 -134.23 142.03 47.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.992 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' CG2' HG11 ' A' ' 6' ' ' VAL . 1.7 t -129.77 94.89 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.169 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.8 mt-10 -105.17 118.15 35.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.942 0.401 . . . . 0.0 111.978 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.8 t -84.53 158.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.1 mp -141.52 117.24 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 10.1 tttt -101.35 107.53 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.276 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.22 37.63 23.72 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.809 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.26 24.65 56.68 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.757 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -143.3 112.97 6.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.947 0.404 . . . . 0.0 110.108 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 m -46.46 125.69 7.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.333 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -100.98 -39.74 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.253 178.452 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -131.49 174.68 9.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.106 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.441 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 8.9 p -170.32 123.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 26.0 t -113.97 69.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.668 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -110.29 88.24 2.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.21 0.529 . . . . 0.0 110.982 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.508 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.791 0.329 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.75 28.58 5.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.7 -33.89 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.908 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.512 HG22 ' CE1' ' A' ' 46' ' ' PHE . 1.5 mt -51.73 140.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.767 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.505 HG23 HG12 ' A' ' 45' ' ' ILE . 1.5 t -94.6 151.66 39.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 80.0 Cg_exo -46.57 -28.25 6.11 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.825 1.683 . . . . 0.0 110.652 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.466 ' HB ' HG23 ' A' ' 42' ' ' THR . 58.8 t -59.44 -42.14 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.566 178.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 HG23 ' A' ' 42' ' ' THR . 23.4 mm -55.72 -51.68 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.686 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.512 ' CE1' HG22 ' A' ' 41' ' ' ILE . 44.0 m-85 -71.34 -37.74 71.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.505 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.493 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.02 -31.04 72.09 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.224 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -87.46 -28.69 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 46' ' ' PHE . 3.7 mt -61.91 -59.97 4.33 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.498 HG12 ' CG1' ' A' ' 93' ' ' VAL . 6.5 mt -50.31 -64.05 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.898 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -53.13 -40.32 64.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.348 -178.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.72 -21.85 21.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.464 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 83.1 mmm -118.38 -59.34 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HB ' HG23 ' A' ' 50' ' ' ILE . 84.2 t -62.81 -59.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.559 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 2.9 mm? -45.33 -54.26 15.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.0 Cg_exo -67.78 4.32 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.269 1.98 . . . . 0.0 112.465 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -145.49 21.86 1.5 Allowed 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 120.94 0.4 . . . . 0.0 110.461 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 81' ' ' TYR . 4.4 p -87.22 167.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.928 178.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 106' ' ' ILE . 98.7 t . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.473 ' CG2' ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -98.34 168.5 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 111.628 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -105.53 139.11 40.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.569 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -29.01 5.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.042 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 p 52.12 26.29 3.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.5 tpp -113.95 -10.87 12.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.157 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.72 58.88 2.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.87 -62.38 1.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.76 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.436 HG22 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -120.03 155.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.673 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 74' ' ' ILE . 34.4 t0 -96.9 140.68 31.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.432 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.0 -32.74 6.64 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.275 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -126.62 163.1 24.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 111.114 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -105.88 130.25 53.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.515 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.0 m -94.99 112.71 24.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 44.0 m-85 -122.54 140.84 52.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.473 ' CE1' ' CG2' ' A' ' 67' ' ' THR . 7.2 p90 -131.5 134.3 46.0 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.142 0.496 . . . . 0.0 111.305 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 11.4 t -136.17 118.57 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.61 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 64.8 p -85.0 144.41 28.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -43.65 148.19 0.37 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.588 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.31 -20.43 60.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.618 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 19.59 2.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.549 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -159.87 90.1 1.86 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.445 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -56.78 -18.8 28.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.619 2.212 . . . . 0.0 111.915 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -92.85 29.84 1.71 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.104 0.478 . . . . 0.0 110.679 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.421 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 23.3 m -149.51 68.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.26 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.7 OUTLIER -64.27 179.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.211 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.468 ' CD2' HG13 ' A' ' 11' ' ' VAL . 98.0 m-85 -154.89 79.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.85 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.498 ' CG1' HG12 ' A' ' 50' ' ' ILE . 86.8 t -88.29 127.31 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.104 0.478 . . . . 0.0 111.312 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.4 t -125.9 117.51 23.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.5 m-85 -87.28 78.81 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.088 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.464 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -64.5 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.898 0.38 . . . . 0.0 111.162 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.411 ' CD2' ' OG ' ' A' ' 7' ' ' SER . 56.4 mt -105.71 131.68 52.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.271 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -46.84 -34.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 111.336 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -33.63 74.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.525 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 98.0 mt -72.76 129.96 86.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.816 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.81 -172.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.251 1.967 . . . . 0.0 111.516 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 64.13 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.908 0.385 . . . . 0.0 110.724 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.42 -38.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.86 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.56 ' O ' HG12 ' A' ' 108' ' ' ILE . 16.9 tp -62.5 -62.25 6.08 Favored Pre-proline 0 CA--C 1.521 -0.136 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.735 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 8.1 Cg_endo -48.71 -28.09 12.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.256 1.971 . . . . 0.0 110.908 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.586 ' HA ' HG21 ' A' ' 66' ' ' VAL . 13.2 mt -70.72 -64.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.691 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -24.37 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.236 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 104' ' ' LEU . 8.2 mm -72.58 -47.04 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.973 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.415 ' CB ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.47 -65.56 0.67 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -51.94 -27.85 14.55 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.497 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -68.75 -50.2 37.7 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.714 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 5.4 mt -54.85 -35.04 63.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.95 -16.35 61.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.197 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.61 -22.84 58.73 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.341 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.501 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 4.0 m-85 -82.37 -91.94 0.07 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 25.5 tt0 164.55 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.629 0.252 . . . . 0.0 110.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.2 -90.27 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.712 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.477 ' HA ' HD21 ' A' ' 123' ' ' LEU . 1.2 p-10 38.42 33.2 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 110.977 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.09 34.52 4.61 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -147.39 152.92 38.96 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.603 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.441 ' HA ' ' N ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -71.75 28.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 0.0 111.737 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -172.29 28.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 118' ' ' ASN . 5.9 tt -134.69 -49.5 0.77 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.6 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -55.79 -44.96 78.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 21' ' ' CYS . 78.7 p -47.69 -30.25 3.65 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.252 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.04 -59.93 4.59 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.254 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.501 ' CD2' ' CD2' ' A' ' 115' ' ' TYR . 8.4 m170 -54.89 -37.99 67.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.617 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.461 ' O ' HD13 ' A' ' 132' ' ' LEU . 41.9 t -51.67 -50.29 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.547 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.477 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -70.28 -48.82 36.05 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.656 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -19.5 65.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 111.233 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.497 HD13 ' HA3' ' A' ' 111' ' ' GLY . 69.9 mt -90.81 -27.4 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.483 ' HG ' ' CD1' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -63.24 -46.09 88.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.113 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -39.49 79.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.738 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 0.92 48.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.056 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 104' ' ' LEU . 17.1 t80 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' HB ' ' CG2' ' A' ' 9' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.101 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.443 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -37.37 -49.78 1.01 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.927 -178.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.595 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 9.1 m-85 -146.17 112.3 5.76 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.612 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' SER . 2.3 t -110.78 95.92 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.131 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.523 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -104.17 112.51 25.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 111.882 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 91' ' ' VAL . 76.4 t -81.68 156.06 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.2 mp -132.62 123.31 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.74 0.305 . . . . 0.0 111.428 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 6.3 tttm -108.06 90.41 3.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 74.01 40.86 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.879 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.24 63.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.344 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.56 118.98 8.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.11 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -51.81 124.9 13.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.852 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -100.3 -50.31 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 120' ' ' THR . 45.0 p -121.54 176.11 5.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.006 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -170.24 141.83 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.987 0.422 . . . . 0.0 111.766 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 37.6 t -128.74 69.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.444 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -105.97 99.91 9.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.088 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.397 -179.793 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.728 0.299 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.05 26.8 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.042 0.449 . . . . 0.0 110.949 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.49 -36.53 5.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.548 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -47.14 135.73 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.0 178.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.52 HG22 HG12 ' A' ' 45' ' ' ILE . 1.3 t -94.14 151.76 39.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.635 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.22 -27.01 6.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.852 1.701 . . . . 0.0 110.513 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HB ' HG22 ' A' ' 42' ' ' THR . 58.9 t -61.21 -42.68 94.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.571 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.535 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 16.0 mm -56.94 -46.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.501 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 26.1 m-85 -73.17 -39.89 65.27 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.401 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.29 -31.26 72.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.318 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.48 -29.64 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 53' ' ' MET . 6.1 mt -61.11 -60.79 3.21 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.524 ' CG2' HD23 ' A' ' 55' ' ' LEU . 5.6 mt -51.1 -63.97 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.839 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 6.0 tpp -50.08 -40.55 45.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.965 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.16 -21.45 21.15 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.505 ' N ' ' O ' ' A' ' 49' ' ' LEU . 56.1 mmm -117.69 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' CG1' ' CD1' ' A' ' 81' ' ' TYR . 65.4 t -56.01 -55.9 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.786 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 50' ' ' ILE . 3.4 mm? -47.13 -58.29 7.51 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.044 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.8 Cg_endo -65.99 6.82 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.143 1.895 . . . . 0.0 112.742 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -151.95 25.12 0.65 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.036 0.446 . . . . 0.0 110.099 179.428 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' A' ' 81' ' ' TYR . 8.8 p -81.84 150.85 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.084 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.531 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.566 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 4.4 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.828 0.347 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 m -104.65 141.28 36.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 111.176 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 4.0 ttpt -84.62 141.99 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 6.4 mmm -58.27 -32.51 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.766 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m 61.79 26.97 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.988 0.423 . . . . 0.0 110.945 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.4 mmm -110.81 -11.27 14.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.86 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.84 59.85 1.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.415 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.6 mp -58.63 -49.96 75.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.696 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.467 HG22 ' CE2' ' A' ' 77' ' ' PHE . 1.1 mt -137.26 154.7 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.791 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.6 t70 -95.3 142.96 27.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.89 -35.36 5.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.954 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE2' HG22 ' A' ' 74' ' ' ILE . 2.3 m-85 -113.01 -170.08 1.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -144.06 118.36 9.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.199 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -86.36 103.2 14.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.478 ' CD2' ' HG3' ' A' ' 68' ' ' LYS . 41.5 m-85 -118.46 119.48 34.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.976 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.468 ' CD2' HG22 ' A' ' 58' ' ' VAL . 33.0 p90 -109.83 151.45 26.99 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.304 0.573 . . . . 0.0 112.092 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 3.1 t -149.12 119.35 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 76.8 p -88.92 151.54 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.384 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.09 140.83 8.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.072 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -60.7 -16.74 42.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.889 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.35 22.29 0.94 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -151.46 97.33 3.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 111.377 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.08 -14.71 46.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.247 1.964 . . . . 0.0 111.976 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 30.04 2.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.285 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 23.9 m -152.73 69.98 0.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.657 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -74.09 178.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.324 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 11' ' ' VAL . 49.6 m-85 -151.78 104.68 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.521 ' CG2' HG21 ' A' ' 50' ' ' ILE . 28.1 t -108.29 115.35 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.189 0.519 . . . . 0.0 111.493 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.3 p -111.17 116.06 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.101 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 46' ' ' PHE . 2.6 m-85 -89.23 84.22 6.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.537 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 78' ' ' ASP . 8.1 p -85.89 156.91 20.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.776 0.322 . . . . 0.0 110.881 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.417 ' HB2' HG13 ' A' ' 100' ' ' ILE . 34.5 mt -69.59 127.81 34.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.573 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -42.66 -34.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.057 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -36.68 83.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.38 136.39 96.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.775 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.68 -167.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.184 1.923 . . . . 0.0 111.914 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.75 66.78 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.895 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.436 HG22 ' CE1' ' A' ' 135' ' ' PHE . 6.3 tp -151.65 -44.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.656 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.598 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -57.97 -62.59 5.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.48 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 3.8 Cg_endo -46.53 -34.87 15.63 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.547 2.164 . . . . 0.0 111.098 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.566 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.8 mp -68.69 -37.27 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.897 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -81.41 -22.54 38.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.602 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 104' ' ' LEU . 35.5 mm -68.36 -48.16 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.361 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.415 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -73.88 -52.61 12.41 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t -58.93 -29.18 66.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.47 -46.82 13.9 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 17.2 mt -56.22 -32.19 64.2 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -76.26 -15.88 59.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -74.3 -25.46 59.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 110.138 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 3.6 m-85 -86.15 -90.68 0.1 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 1.2 tt0 159.69 -30.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.865 0.466 . . . . 0.0 109.767 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.492 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -103.32 137.15 41.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.482 ' HA ' HD21 ' A' ' 123' ' ' LEU . 0.9 OUTLIER 176.61 34.47 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.349 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.23 32.94 4.76 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.578 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -145.94 146.39 31.03 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.479 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.444 ' HA ' ' N ' ' A' ' 20' ' ' SER . 10.6 p30 -69.25 26.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.0 mt-10 -167.6 26.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 118' ' ' ASN . 8.2 tt -124.76 -57.25 1.55 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.435 ' CD1' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.67 -41.49 63.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.423 ' HA ' HG21 ' A' ' 128' ' ' VAL . 13.5 t -49.61 -29.28 6.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.233 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.73 -63.74 1.17 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.297 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.504 ' CE1' ' CB ' ' A' ' 115' ' ' TYR . 18.7 m170 -59.21 -30.6 68.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.03 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 125' ' ' SER . 49.0 t -57.67 -41.95 80.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.0 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.36 -48.71 10.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.137 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.71 -26.5 68.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.585 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.486 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 70.6 mt -85.49 -26.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.48 HD11 ' CD1' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -60.95 -46.47 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.146 178.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -43.93 73.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.052 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.18 -24.75 64.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.436 ' CE1' HG22 ' A' ' 103' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.458 HG23 HG23 ' A' ' 96' ' ' THR . 80.3 t . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.788 0.328 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.41 -71.11 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.899 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.691 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 27.4 m-85 -128.87 111.97 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.332 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 2.3 t -103.91 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.403 ' HB2' ' HZ ' ' A' ' 22' ' ' PHE . 1.2 tt0 -100.05 114.19 27.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.673 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 26.3 t -84.27 159.62 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.6 mp -141.3 122.2 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 112.046 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 18' ' ' ILE . 12.1 tttm -104.15 99.05 8.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.363 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 63.34 41.68 7.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.387 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 55' ' ' LEU . . . 78.39 23.64 64.96 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.582 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -143.25 111.9 6.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.93 0.395 . . . . 0.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -45.15 126.41 6.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.309 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.505 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -105.18 -44.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.914 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.9 OUTLIER -127.76 178.16 6.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.375 -179.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.47 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 18.0 m -170.75 131.16 0.85 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.54 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.458 ' HB3' ' CB ' ' A' ' 9' ' ' VAL . 29.2 t -115.13 69.46 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.691 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.7 m-85 -107.66 87.65 2.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.941 -179.671 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 5.3 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.816 0.341 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.8 26.75 7.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -112.37 -35.36 5.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.858 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.492 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -55.38 123.79 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.955 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 8.9 t -86.08 149.36 50.0 Favored Pre-proline 0 CA--C 1.519 -0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.435 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HA ' ' CE1' ' A' ' 22' ' ' PHE . 2.0 Cg_endo -44.15 -22.75 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.713 2.275 . . . . 0.0 112.071 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' ASN . 5.3 t -67.73 -44.18 85.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.479 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 2.1 mp -59.12 -31.74 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.493 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 66.3 m-85 -80.14 -43.44 21.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.349 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.599 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.27 -25.84 67.06 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.537 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' VAL . 15.0 m-20 -90.4 -29.82 17.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 53' ' ' MET . 2.7 mt -58.34 -57.8 11.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.553 HG23 ' CD2' ' A' ' 55' ' ' LEU . 4.3 mt -57.97 -66.01 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.209 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.599 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.3 tpp -46.91 -41.64 16.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.713 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.08 -25.45 19.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 49' ' ' LEU . 70.5 mmm -114.21 -63.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 81' ' ' TYR . 55.9 t -62.23 -58.87 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.553 ' CD2' HG23 ' A' ' 50' ' ' ILE . 3.1 mm? -44.38 -55.9 9.13 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.3 Cg_exo -68.5 5.11 1.36 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.305 2.003 . . . . 0.0 112.03 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -145.31 21.52 1.54 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.311 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.513 HG21 ' CD2' ' A' ' 81' ' ' TYR . 3.9 p -84.77 165.56 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.935 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.986 179.376 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 7.0 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.877 0.37 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.5 m -93.66 141.55 28.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.488 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 9.4 tttm -87.95 137.63 32.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.436 ' HG2' HD11 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -54.79 -25.97 31.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.709 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 t 53.93 25.5 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.374 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.418 ' HG2' HD11 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -118.23 1.9 11.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.177 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.71 78.6 0.21 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.087 0.47 . . . . 0.0 110.457 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.495 ' N ' HD13 ' A' ' 73' ' ' LEU . 11.0 mp -74.51 -42.77 58.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.488 HG21 ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -138.1 155.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.719 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -96.74 139.74 32.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.29 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.18 -33.63 5.88 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.156 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.26 176.26 8.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.826 0.346 . . . . 0.0 111.03 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 42.6 m-20 -113.67 129.2 56.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.564 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.4 112.55 24.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 44.8 m-85 -119.84 153.72 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.374 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.513 ' CD2' HG21 ' A' ' 58' ' ' VAL . 38.4 p90 -144.38 128.04 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.117 0.484 . . . . 0.0 111.645 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.441 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.8 t -133.71 121.76 22.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.667 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 19.4 p -80.94 153.49 27.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.978 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -49.13 151.52 1.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.97 -6.72 49.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.658 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.49 20.48 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -159.5 102.67 1.5 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 0.0 111.318 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.05 -13.35 39.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.394 2.062 . . . . 0.0 112.013 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -96.65 30.48 2.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 20.1 m -153.57 71.9 0.9 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.559 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -70.16 177.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.317 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.427 ' CB ' ' HG ' ' A' ' 109' ' ' LEU . 95.7 m-85 -152.38 96.8 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.863 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.511 ' CG1' HG12 ' A' ' 50' ' ' ILE . 77.4 t -100.28 128.2 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 20.4 p -124.85 138.07 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.508 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 7.3 m-85 -106.0 89.41 3.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.737 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.458 HG23 HG23 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -89.17 124.51 34.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.157 -179.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.8 mt -42.53 135.36 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.534 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -27.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.56 -22.03 64.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 100' ' ' ILE . 3.7 mm -70.49 135.99 86.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.287 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.14 -164.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.305 2.004 . . . . 0.0 111.583 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -108.08 66.49 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.764 0.316 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 104' ' ' LEU . 6.1 tp -164.67 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.717 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.8 tp -62.32 -62.8 5.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.652 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.508 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 2.2 Cg_endo -44.99 -31.74 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.502 2.135 . . . . 0.0 111.155 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.593 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 4.0 mp -73.18 -41.76 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.231 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 104' ' ' LEU . 1.9 mmt180 -76.77 -23.2 52.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.794 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 104' ' ' LEU . 7.1 mm -70.11 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.235 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.427 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -61.8 -55.59 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -59.6 -25.5 64.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.496 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -72.59 -47.02 29.15 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.526 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 8.1 mt -55.88 -26.26 46.42 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -18.01 61.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.34 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.13 -23.97 63.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.604 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 m-85 -100.43 -166.48 1.33 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -124.79 -2.4 7.82 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.528 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 49.6 m -127.69 123.34 35.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.094 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.513 ' HA ' HD23 ' A' ' 123' ' ' LEU . 0.6 OUTLIER -171.5 38.05 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.765 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -114.2 36.19 3.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.323 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.539 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -147.82 152.14 37.16 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.366 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.47 ' HA ' ' N ' ' A' ' 20' ' ' SER . 66.4 m-20 -71.6 22.13 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.2 tm-20 -164.66 26.21 0.06 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 118' ' ' ASN . 6.9 tt -124.92 -56.73 1.55 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.441 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -52.46 -41.07 62.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.457 ' HA ' HG21 ' A' ' 128' ' ' VAL . 78.4 p -51.46 -31.42 23.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.34 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.14 -61.54 2.49 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.453 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.604 ' CE1' ' CB ' ' A' ' 115' ' ' TYR . 54.2 m170 -59.15 -32.95 70.34 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 125' ' ' SER . 62.0 t -53.45 -45.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.92 27.42 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.803 -1.189 . . . . 0.0 111.574 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.7 -21.3 66.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.927 0.394 . . . . 0.0 110.601 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.496 HD13 ' HA3' ' A' ' 111' ' ' GLY . 28.0 mt -90.11 -27.24 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.462 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.3 OUTLIER -61.38 -41.97 97.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.172 178.308 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -65.64 -39.32 91.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.85 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.78 -15.63 44.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.429 ' CD2' HD12 ' A' ' 104' ' ' LEU . 2.8 t80 . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.023 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.505 ' CG2' HG13 ' A' ' 108' ' ' ILE . 71.0 t . . . . . 0 CA--C 1.527 0.062 0 CA-C-O 120.812 0.339 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.416 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -63.81 -67.15 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.251 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.619 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 2.2 m-85 -150.02 121.57 7.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.452 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.57 95.59 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.303 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 3.0 tt0 -105.31 117.29 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.973 0.416 . . . . 0.0 111.626 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.46 HG12 ' CD2' ' A' ' 92' ' ' TYR . 11.9 t -83.18 155.09 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.556 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.2 mp -131.63 118.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.2 tptt -103.68 104.8 14.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.386 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 65.8 23.33 11.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.512 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.474 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . 76.38 38.88 32.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.549 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.72 18.19 1.82 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 60.08 150.17 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.008 179.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -139.59 -47.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.921 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -126.56 175.02 8.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.346 -179.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.469 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 11.6 p -170.48 121.55 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.592 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.2 t -108.58 71.0 0.77 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.619 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -106.15 83.08 1.84 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.904 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.195 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.796 0.331 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.56 28.54 6.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -113.35 -35.75 5.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.502 ' CG2' ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -54.41 124.58 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.102 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.486 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 8.9 t -86.97 149.65 48.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.562 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 Cg_exo -43.52 -23.28 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.679 2.253 . . . . 0.0 112.098 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 3.5 t -66.88 -48.98 78.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.478 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 2.3 mp -54.09 -36.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.502 ' CE1' ' CG2' ' A' ' 41' ' ' ILE . 66.8 m-85 -76.49 -43.11 41.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.35 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.654 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.91 -23.49 67.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.346 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -86.47 -33.54 20.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.679 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 53' ' ' MET . 12.2 mt -58.78 -63.36 1.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.618 HG12 ' CG1' ' A' ' 93' ' ' VAL . 3.9 mt -49.39 -58.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.044 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.654 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -53.79 -56.78 14.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.345 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -9.71 44.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.555 ' N ' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -117.47 -62.14 1.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 81' ' ' TYR . 59.3 t -68.0 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 111.914 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.522 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -43.04 -51.48 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 24.6 Cg_endo -63.18 -1.63 3.12 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.809 1.672 . . . . 0.0 112.344 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -147.86 23.11 1.1 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.05 0.452 . . . . 0.0 109.993 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.8 p -76.37 155.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.318 -0.797 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.107 179.128 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.517 ' HB ' HG13 ' A' ' 106' ' ' ILE . 2.8 t . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.805 0.336 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -86.04 134.08 33.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.016 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 4.5 ttpp -85.03 130.06 34.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.827 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.474 ' HG2' HD11 ' A' ' 73' ' ' LEU . 6.7 tpt -50.79 -27.48 7.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.412 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.38 28.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 110.74 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.429 ' O ' ' HG3' ' A' ' 71' ' ' MET . 4.0 tpp -109.95 -12.31 14.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.987 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.51 61.79 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.463 . . . . 0.0 109.786 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.515 ' HG ' ' HG2' ' A' ' 53' ' ' MET . 9.5 mp -66.13 -45.23 81.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.03 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.459 HG23 ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -132.71 159.7 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.029 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.404 ' N ' HG21 ' A' ' 74' ' ' ILE . 7.7 t70 -101.97 142.03 33.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.397 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.68 -35.59 4.91 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.842 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CE1' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -133.38 175.25 9.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.788 0.328 . . . . 0.0 110.819 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 40.8 m-20 -113.11 152.58 29.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.508 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 4.9 t -111.65 116.06 30.16 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 85.5 m-85 -123.28 144.57 49.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.248 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CD2' HG22 ' A' ' 58' ' ' VAL . 39.1 p90 -135.17 125.01 25.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 111.533 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -129.21 121.06 26.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.668 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 8.4 p -82.18 150.75 27.23 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.699 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -46.51 149.65 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.984 0.421 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.56 -17.45 46.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.981 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 22.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -146.1 94.55 4.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.72 -15.09 46.74 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.166 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -96.0 26.32 4.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.072 0.463 . . . . 0.0 110.268 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.423 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 38.0 m -150.7 69.5 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -69.06 178.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.14 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.46 ' CD2' HG12 ' A' ' 11' ' ' VAL . 96.2 m-85 -153.16 91.6 1.54 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.446 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.618 ' CG1' HG12 ' A' ' 50' ' ' ILE . 35.4 t -91.43 125.17 44.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.066 0.46 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.44 126.12 49.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.29 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m-85 -99.06 116.86 32.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.372 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.463 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -119.9 132.86 55.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.085 0.469 . . . . 0.0 111.636 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 31.3 mt -49.91 125.59 12.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.036 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -43.73 -31.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.71 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.37 -35.14 78.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.78 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.416 ' CG2' ' HD2' ' A' ' 101' ' ' PRO . 40.5 mt -74.18 138.25 75.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.416 ' HD2' ' CG2' ' A' ' 100' ' ' ILE . 18.9 Cg_endo -57.9 -169.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.468 2.112 . . . . 0.0 112.273 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -109.03 67.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.454 HG21 ' CZ ' ' A' ' 135' ' ' PHE . 1.1 tp -153.27 -38.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.441 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 108' ' ' ILE . 25.1 tp -59.33 -57.17 29.02 Favored Pre-proline 0 C--N 1.331 -0.204 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.901 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 7.5 Cg_endo -49.9 -37.45 46.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.422 2.081 . . . . 0.0 111.039 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.517 HG13 ' HB ' ' A' ' 66' ' ' VAL . 2.9 mp -67.0 -32.4 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.815 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.442 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -81.73 -26.62 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.594 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 104' ' ' LEU . 5.9 mm -66.92 -47.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.372 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.77 -58.2 3.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 t -56.46 -30.57 63.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 107' ' ' ARG . . . -76.25 -43.3 21.13 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 7.0 mt -57.85 -31.51 66.74 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.67 -14.73 59.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.94 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.25 -21.31 56.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.451 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' A' ' 127' ' ' HIS . 5.1 m-85 -88.58 -97.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.999 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 34.6 tp10 159.04 -22.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.672 0.389 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.676 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 5.9 t -121.75 99.75 6.63 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.28 0.562 . . . . 0.0 111.243 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.543 ' HA ' HD22 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -152.34 45.43 0.73 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.21 33.89 4.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -144.11 157.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.236 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.469 ' HA ' ' N ' ' A' ' 20' ' ' SER . 78.7 m-20 -74.62 17.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.689 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.8 OUTLIER -163.67 29.03 0.08 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.557 ' CD2' ' O ' ' A' ' 117' ' ' SER . 5.9 tt -131.04 -45.82 1.02 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.575 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -59.78 -43.04 94.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.465 ' HA ' HG21 ' A' ' 128' ' ' VAL . 70.7 p -46.65 -27.15 1.07 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.64 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.06 -56.79 17.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.295 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 117' ' ' SER . 8.1 m170 -60.87 -36.5 79.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 125' ' ' SER . 46.0 t -52.06 -44.09 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.889 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.97 -47.05 12.03 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -64.94 -21.13 66.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 127' ' ' HIS . 60.7 mt -90.5 -28.09 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.452 ' CD1' ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -66.93 -35.07 79.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.351 178.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -69.57 -38.89 77.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.762 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.0 t -84.08 -13.62 52.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.984 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 13.2 t80 . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.996 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.475 ' CG2' HG13 ' A' ' 108' ' ' ILE . 3.4 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.926 0.393 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.471 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -39.18 -59.42 1.02 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.239 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.65 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 7.6 m-85 -148.68 113.12 5.3 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 2.8 t -107.12 100.75 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.412 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.506 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -111.36 128.89 56.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.105 0.478 . . . . 0.0 111.769 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.717 HG12 ' CD1' ' A' ' 18' ' ' ILE . 53.1 t -98.1 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.536 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.7 mp -117.24 118.32 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 7.0 tptt -99.72 102.24 13.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.419 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 62.01 39.75 12.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.562 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.4 60.77 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.827 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.406 ' N ' HG21 ' A' ' 12' ' ' ILE . 40.8 mt-10 -145.12 113.75 6.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 0.0 110.102 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.464 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -50.24 126.78 15.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.715 -179.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.717 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -105.01 -50.45 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.415 179.129 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 120' ' ' THR . 63.9 p -119.26 172.43 7.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.266 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.419 ' N ' HD23 ' A' ' 124' ' ' LEU . 6.5 m -168.28 133.47 1.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 112.054 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.506 ' HB2' HD21 ' A' ' 124' ' ' LEU . 36.0 t -116.88 69.42 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.65 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -104.62 96.58 6.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.298 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.501 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 2.9 m120 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -134.26 27.3 3.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.094 0.473 . . . . 0.0 110.971 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -118.42 -28.91 5.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.455 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.52 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 3.7 mm -55.98 125.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.934 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.487 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 8.9 t -85.44 149.54 52.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 2.2 Cg_endo -44.87 -22.04 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.354 2.036 . . . . 0.0 111.583 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 93.6 t -66.9 -45.73 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.11 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.516 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 2.1 mp -59.62 -34.55 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.52 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 39.1 m-85 -79.41 -42.87 24.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.316 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.639 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.54 -30.51 71.62 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.657 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 25.8 p30 -89.51 -26.04 21.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.6 mt -64.54 -61.16 2.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.526 HG22 ' HB ' ' A' ' 54' ' ' VAL . 6.4 mt -49.53 -62.93 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.493 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.639 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.21 -43.0 61.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.173 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -90.84 -15.16 30.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 49' ' ' LEU . 90.9 mmm -123.76 -70.49 0.76 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.526 ' HB ' HG22 ' A' ' 50' ' ' ILE . 88.6 t -51.39 -50.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.889 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.449 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 3.0 mm? -56.18 -58.9 13.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.032 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 23.5 Cg_endo -62.31 4.71 0.3 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.285 1.99 . . . . 0.0 113.12 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 1.6 tptp -153.25 26.98 0.52 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 81' ' ' TYR . 7.7 p -82.22 150.67 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.161 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.399 179.842 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.568 ' HB ' HG13 ' A' ' 106' ' ' ILE . 3.6 t . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -97.25 138.57 34.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.469 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 1.3 ttpm? -82.52 132.39 35.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.287 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.46 ' HG2' ' CB ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -53.83 -29.82 42.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.034 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.76 27.96 11.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.212 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.46 ' CB ' ' HG2' ' A' ' 69' ' ' MET . 6.1 tpt -106.97 -15.55 14.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.207 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 65.04 59.84 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 73' ' ' LEU . 8.0 mp -62.91 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.445 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.482 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -135.5 155.08 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.504 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.419 ' N ' HG23 ' A' ' 74' ' ' ILE . 4.3 t70 -99.71 138.62 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.517 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.24 -32.32 6.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.532 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 1.7 m-85 -118.21 -168.13 1.47 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.485 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -136.11 118.76 16.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.13 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 p -87.64 108.42 19.08 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 53.8 m-85 -121.55 151.1 40.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.896 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.496 ' HB3' HG11 ' A' ' 54' ' ' VAL . 11.9 p90 -144.52 139.61 28.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.09 0.472 . . . . 0.0 111.974 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -142.3 124.38 15.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.563 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 45.0 p -90.01 152.77 21.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.456 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -46.85 162.3 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 0.0 111.167 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -70.89 -22.91 62.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.682 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 22.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.93 91.48 10.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.26 . . . . 0.0 110.763 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.57 -14.23 38.4 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.378 2.052 . . . . 0.0 112.045 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 29.72 1.86 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -156.85 71.78 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.524 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.3 OUTLIER -81.26 173.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.935 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 91' ' ' VAL . 14.1 m-85 -141.72 153.17 44.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.213 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.502 ' CG1' HG12 ' A' ' 50' ' ' ILE . 14.6 t -152.63 122.18 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.977 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 13.9 m -112.41 114.14 26.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 111.824 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 46' ' ' PHE . 1.3 m-85 -90.15 71.53 7.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.751 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -72.37 -176.38 1.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.933 0.397 . . . . 0.0 111.489 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.41 127.87 43.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.321 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.64 -33.69 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.534 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -38.88 92.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.552 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 62.6 mt -66.93 138.34 95.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.902 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.94 -168.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.516 2.144 . . . . 0.0 112.348 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -108.69 67.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.459 HG22 ' CZ ' ' A' ' 135' ' ' PHE . 2.7 tp -154.54 -38.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.845 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.612 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -57.06 -64.98 1.97 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.02 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.502 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 5.6 Cg_endo -47.34 -31.17 12.42 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.565 2.177 . . . . 0.0 111.492 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' ' 66' ' ' VAL . 3.4 mp -68.91 -34.46 64.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.819 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 104' ' ' LEU . 14.0 mmp_? -84.85 -22.64 29.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.345 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 104' ' ' LEU . 21.0 mm -70.1 -45.18 77.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.148 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.429 ' CG ' ' OG ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -76.34 -50.13 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.5 t -61.95 -30.63 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . -75.48 -47.2 12.9 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.423 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 12.8 mt -56.58 -30.47 63.23 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.0 -16.72 56.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.196 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -25.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.75 0.31 . . . . 0.0 110.38 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.529 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.2 m-85 -82.33 -91.86 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.2 pt-20 160.56 -28.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.414 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.536 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 19.5 m -111.89 129.54 56.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.517 0.675 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.491 ' HA ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -172.3 35.19 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.039 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.86 33.28 4.32 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.547 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -145.62 148.06 32.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.469 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -69.73 22.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.526 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.2 tp10 -162.87 25.24 0.09 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 118' ' ' ASN . 7.7 tt -123.76 -57.22 1.64 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.614 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.506 HD21 ' HB2' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -52.5 -42.1 63.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.442 ' HA ' HG21 ' A' ' 128' ' ' VAL . 83.4 p -52.1 -28.68 18.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.243 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.21 -61.72 2.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.227 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 117' ' ' SER . 26.5 m170 -59.88 -31.56 69.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 125' ' ' SER . 56.2 t -56.54 -42.38 75.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.45 15.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.876 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.97 -21.4 65.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 59.4 mt -90.02 -28.07 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.449 HD11 ' CD1' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -62.86 -43.67 98.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.366 178.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -35.38 80.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.7 t -83.8 -20.84 32.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.079 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CZ ' HG22 ' A' ' 103' ' ' ILE . 1.5 t80 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.97 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.5 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.13 85.17 2.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.816 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.02 -173.36 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.461 ' CE1' HG22 ' A' ' 100' ' ' ILE . 38.1 m-85 -122.85 169.64 10.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -177.49 112.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.374 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' CG2' HG13 ' A' ' 108' ' ' ILE . 4.2 t -77.74 99.74 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.021 0.439 . . . . 0.0 110.028 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.476 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -40.46 -51.26 2.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.719 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.593 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 14.3 m-85 -148.8 120.08 7.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.851 0.357 . . . . 0.0 111.464 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.446 HG23 ' CG1' ' A' ' 6' ' ' VAL . 1.5 t -110.0 95.28 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.979 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.448 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -100.54 111.37 23.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.743 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.471 HG11 ' CD1' ' A' ' 18' ' ' ILE . 38.7 t -81.97 160.19 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.585 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.5 mt -140.7 127.05 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -118.96 111.77 18.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m120 64.04 34.75 11.07 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.991 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.48 26.14 61.84 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.544 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -148.27 120.05 8.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 3.1 m -48.38 125.45 9.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.238 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.494 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -99.57 -45.46 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.738 0.78 . . . . 0.0 109.512 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -124.66 175.37 7.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.9 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.431 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 20.4 m -170.59 134.63 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.431 ' HB3' ' CG2' ' A' ' 9' ' ' VAL . 33.2 t -123.45 69.34 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.2 m-85 -107.23 100.18 9.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.165 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.4 pm0 -141.58 124.31 9.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.428 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.17 -179.91 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.355 2.037 . . . . 0.0 111.718 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 23' ' ' GLN . 0.4 OUTLIER -172.29 -34.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 11.4 mt-30 63.93 56.46 1.45 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.891 0.377 . . . . 0.0 110.167 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER 32.11 78.66 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.035 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -73.99 -70.17 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.999 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -153.04 32.41 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.662 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -116.32 -70.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.015 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.451 ' CD2' ' CD1' ' A' ' 100' ' ' ILE . 0.3 OUTLIER -149.93 131.49 14.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.404 ' HA2' ' CB ' ' A' ' 27' ' ' LYS . . . -73.21 114.32 4.67 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.043 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.8 m -165.34 -76.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.725 0.297 . . . . 0.0 110.982 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 35' ' ' THR . 7.7 mt -74.44 147.83 8.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.154 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 171.37 -31.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.182 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.17 -51.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.41 24.88 3.21 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.8 m-80 -156.58 30.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 0.0 111.291 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.73 25.71 4.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.08 0.467 . . . . 0.0 110.864 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -110.24 -34.86 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.667 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.568 ' CG2' ' HB ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -55.6 133.62 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.918 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.508 ' CG2' HG12 ' A' ' 45' ' ' ILE . 5.1 t -92.55 150.88 40.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.85 -24.27 4.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.946 1.764 . . . . 0.0 111.072 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.499 ' HB ' HG23 ' A' ' 42' ' ' THR . 90.4 t -66.95 -35.95 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.681 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.568 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 13.4 mm -63.0 -42.63 97.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE1' ' CG2' ' A' ' 41' ' ' ILE . 18.3 m-85 -77.14 -38.3 52.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.144 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.487 ' CD2' ' C ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -65.73 -31.53 72.58 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.032 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.94 -29.1 22.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.447 HD13 HG13 ' A' ' 74' ' ' ILE . 4.2 mt -61.24 -60.15 4.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.591 HG22 ' HB ' ' A' ' 54' ' ' VAL . 7.0 mt -50.2 -63.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.847 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.0 OUTLIER -53.66 -37.35 63.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.81 -1.541 . . . . 0.0 113.116 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.11 -23.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.438 ' N ' ' O ' ' A' ' 49' ' ' LEU . 74.7 mmm -117.03 -57.18 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 50' ' ' ILE . 52.9 t -63.45 -63.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.887 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.575 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 3.0 mm? -44.43 -53.43 14.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.5 Cg_exo -68.53 4.62 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.231 1.954 . . . . 0.0 112.412 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -150.32 25.26 0.8 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.006 0.432 . . . . 0.0 110.578 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.534 HG22 ' CD1' ' A' ' 81' ' ' TYR . 4.3 p -87.03 166.05 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -145.21 149.46 41.66 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.328 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 61' ' ' ILE . 72.9 Cg_endo -80.66 25.84 0.61 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.27 1.98 . . . . 0.0 112.868 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 60' ' ' PRO . 1.6 mp 52.32 131.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.665 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -114.52 -23.58 9.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.613 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.67 38.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.066 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.07 -61.58 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 111.221 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 72.51 121.14 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.785 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.581 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 4.6 t 58.92 71.27 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.658 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.478 ' CG2' ' CE1' ' A' ' 81' ' ' TYR . 2.5 t -102.61 139.19 38.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.848 0.356 . . . . 0.0 111.279 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -79.38 135.47 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.51 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.469 ' HG3' ' CG2' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -51.53 -29.02 15.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 53.12 25.42 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.0 tpp -110.31 -5.0 15.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.737 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.05 56.87 3.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 7.5 mp -53.22 -48.02 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG13 HD13 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -142.74 162.23 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.41 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.421 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 11.2 t70 -104.5 137.49 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.185 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 115.84 -32.96 5.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.244 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.481 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -132.9 162.56 31.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.197 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.477 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 52.8 m-20 -103.46 133.77 47.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.853 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 95' ' ' PHE . 0.6 OUTLIER -119.05 121.84 40.76 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -126.82 164.87 20.43 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.716 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.534 ' CD1' HG22 ' A' ' 58' ' ' VAL . 19.5 p90 -138.74 129.06 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.381 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 5.0 t -129.94 112.4 13.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.594 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 33.0 p -74.32 156.8 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.939 0.4 . . . . 0.0 111.176 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -52.84 153.3 3.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.61 -9.14 57.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.71 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.28 23.14 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.69 87.28 4.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.772 0.32 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.17 -20.25 18.66 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.637 2.224 . . . . 0.0 112.577 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -93.79 29.57 2.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 52.7 m -149.85 73.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.342 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.585 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.6 OUTLIER -75.01 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.724 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 82' ' ' SER . 39.3 m-85 -144.52 93.55 2.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.544 ' CG1' HG12 ' A' ' 50' ' ' ILE . 41.0 t -98.44 127.62 50.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.53 . . . . 0.0 111.622 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 7.4 p -110.1 152.9 25.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 8' ' ' TYR . 1.4 m-85 -130.91 74.59 1.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.686 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 58.7 p -75.08 -169.52 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 100' ' ' ILE . 24.1 mt -102.43 137.01 41.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.536 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -44.04 -30.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.806 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.417 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 3.7 m-20 -69.12 -33.34 73.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.021 0.439 . . . . 0.0 110.57 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.461 HG22 ' CE1' ' A' ' 4' ' ' PHE . 1.2 mm -67.51 127.12 93.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.968 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 19.1 Cg_endo -59.75 -168.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -106.65 66.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.647 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.421 ' CA ' HD11 ' A' ' 106' ' ' ILE . 2.9 tp -151.14 -36.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.813 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.655 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -64.03 -63.27 4.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 3.5 Cg_endo -44.95 -29.27 3.61 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.657 2.238 . . . . 0.0 111.331 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.581 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.1 mp -69.63 -45.17 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.746 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -76.43 -22.44 54.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.602 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.655 HG12 ' O ' ' A' ' 104' ' ' LEU . 33.7 mm -67.11 -59.4 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.404 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -63.09 -56.64 15.16 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 p -57.06 -25.4 58.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.434 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -75.32 -45.37 19.3 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.497 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 18.5 mt -56.6 -28.11 59.63 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.71 -15.9 61.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.279 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.19 -27.26 64.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.572 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 4.6 m-85 -98.73 -167.97 1.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.496 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -121.53 -0.63 9.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.485 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 1.4 m -125.1 137.53 54.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.756 0.789 . . . . 0.0 111.108 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.474 ' O ' ' OG ' ' A' ' 19' ' ' SER . 19.6 p30 174.02 35.92 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.164 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.12 34.07 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -146.12 155.52 42.8 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.98 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HA ' ' N ' ' A' ' 20' ' ' SER . 15.7 m-80 -75.78 24.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -165.09 25.9 0.06 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.447 HD23 ' C ' ' A' ' 117' ' ' SER . 6.5 tt -123.75 -56.73 1.67 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.871 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.458 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -52.78 -41.39 64.05 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.458 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 85.3 p -50.33 -28.45 7.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.215 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.07 -64.22 0.97 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.224 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.572 ' CE1' ' CB ' ' A' ' 115' ' ' TYR . 31.1 m170 -59.57 -30.98 69.02 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.987 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.421 ' O ' HD13 ' A' ' 132' ' ' LEU . 48.0 t -57.15 -42.69 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.99 -38.5 22.77 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.764 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -22.82 63.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.388 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.485 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 46.9 mt -90.19 -27.09 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.486 HD13 ' CD1' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -62.33 -49.0 77.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.524 178.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -44.96 83.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.8 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 m -70.83 -19.04 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.8 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.451 ' HB3' ' O ' ' A' ' 132' ' ' LEU . 54.7 t80 -55.84 -59.41 4.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.206 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -52.8 -46.21 67.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.148 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -49.91 -31.45 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.908 0.385 . . . . 0.0 110.228 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -77.82 -36.31 50.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.907 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 27.1 mt -64.25 -32.74 74.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.198 0.523 . . . . 0.0 109.687 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.2 t -75.98 -47.37 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.055 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -32.15 71.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.948 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -23.28 66.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.596 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.9 48.19 1.5 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.972 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -176.49 36.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.82 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.2 -33.69 9.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 t -160.28 38.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.0 mt -108.48 163.59 13.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.935 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -75.31 -66.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.922 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.814 0.34 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.48 148.69 48.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.54 170.12 14.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.417 ' CD2' HG12 ' A' ' 100' ' ' ILE . 53.8 m-85 -140.98 -173.55 3.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.425 ' HA ' HD21 ' A' ' 132' ' ' LEU . 2.1 t-20 -174.38 107.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.728 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.472 HG23 HG13 ' A' ' 108' ' ' ILE . 3.5 t -60.98 127.91 21.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.715 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -61.71 -59.83 4.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.237 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.652 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 2.8 m-85 -144.14 109.25 5.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 4.1 t -108.08 100.7 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.801 0.334 . . . . 0.0 111.356 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.501 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 2.2 mt-10 -111.24 120.13 41.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' THR . 46.7 t -79.86 156.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.8 mt -133.98 111.28 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 15.7 tptt -91.16 99.74 12.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 58.35 41.04 23.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.418 ' HA2' ' CD1' ' A' ' 55' ' ' LEU . . . 81.1 23.34 59.36 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.607 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -140.27 109.39 6.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -45.12 128.9 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.23 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.457 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -110.24 -45.85 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.07 172.86 8.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.511 -179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.476 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.3 m -167.48 126.92 1.37 Allowed 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.507 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 20.1 t -116.93 69.34 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.652 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.55 92.73 4.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.107 -178.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.402 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -142.9 139.44 16.95 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.399 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.94 169.86 21.15 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.483 2.122 . . . . 0.0 111.626 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.417 ' O ' ' HG2' ' A' ' 26' ' ' GLN . 3.0 p90 -175.08 9.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 13.0 pm0 35.16 97.47 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -44.87 -40.99 6.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.466 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 57.12 -83.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.971 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -122.12 -165.17 1.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.697 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 1.9 m-80 62.76 -81.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.135 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.404 ' CG ' ' O ' ' A' ' 30' ' ' ASN . 3.5 m-85 -169.71 153.88 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.352 . . . . 0.0 111.083 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.22 -162.55 25.69 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.608 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.7 m -152.8 -44.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.905 0.383 . . . . 0.0 111.259 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 11.7 mt -47.58 153.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.322 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER 172.54 -33.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.403 ' CA ' ' HG3' ' A' ' 39' ' ' GLU . 0.2 OUTLIER 178.82 -40.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.86 0.362 . . . . 0.0 111.418 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.8 -25.01 52.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.523 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -113.82 38.54 2.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.137 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' ' CA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -131.32 26.08 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 110.859 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.61 -37.31 6.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.599 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.521 ' CG2' ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -52.59 123.02 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.564 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.471 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 10.9 t -83.55 150.6 60.24 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.642 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 86.0 Cg_exo -45.75 -22.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.259 1.973 . . . . 0.0 111.908 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 36.6 t -68.62 -41.07 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.103 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.458 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 1.6 mp -60.4 -34.57 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.521 ' CE1' ' CG2' ' A' ' 41' ' ' ILE . 56.0 m-85 -81.17 -42.37 20.95 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.995 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.589 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.19 -30.48 71.1 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.684 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 27.4 p30 -90.24 -26.43 20.07 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.1 mt -63.15 -60.24 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.531 HG22 ' HB ' ' A' ' 54' ' ' VAL . 5.0 mt -52.14 -63.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.893 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.589 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -52.76 -41.46 64.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.356 -179.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.2 t0 -90.73 -20.27 22.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.446 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 77.8 mmm -119.39 -60.93 1.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.531 ' HB ' HG22 ' A' ' 50' ' ' ILE . 59.3 t -61.58 -56.02 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.579 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 2.0 mm? -50.44 -54.63 32.9 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.579 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.0 Cg_exo -62.89 -0.04 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.151 1.901 . . . . 0.0 112.78 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 tppt? -149.86 27.75 0.78 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.458 HG23 ' CG ' ' A' ' 81' ' ' TYR . 2.6 p -86.29 157.0 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.982 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.2 m -143.86 150.24 49.13 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.198 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.489 ' HA ' ' CG2' ' A' ' 83' ' ' THR . 93.7 Cg_endo -83.67 25.04 0.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.129 1.886 . . . . 0.0 113.294 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.479 ' O ' ' O ' ' A' ' 60' ' ' PRO . 2.5 mp 51.6 163.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.748 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -59.03 -22.56 60.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.069 0.461 . . . . 0.0 110.082 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.4 52.82 0.2 Allowed Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.589 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 44.22 76.36 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.742 0.306 . . . . 0.0 111.124 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.09 29.42 4.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.852 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 25.3 t 58.64 105.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.698 0.285 . . . . 0.0 110.95 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 83.9 m -112.65 127.23 56.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -80.69 144.83 31.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.416 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.445 ' HG3' ' CB ' ' A' ' 71' ' ' MET . 49.2 tpp -71.63 -35.39 70.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.977 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m 61.21 29.84 18.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.445 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 2.8 tpt -110.97 -12.48 14.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 62.79 63.49 0.97 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.001 0.429 . . . . 0.0 110.427 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.2 mp -62.2 -48.42 80.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.45 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.48 HG23 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -131.15 151.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -93.48 140.67 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.592 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.97 -34.33 5.5 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.166 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.48 ' CE1' HG23 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -120.92 -167.36 1.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.923 0.392 . . . . 0.0 111.208 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -137.65 128.89 27.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.38 105.98 17.99 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 51.1 m-85 -115.93 123.99 49.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.851 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.458 ' CG ' HG23 ' A' ' 58' ' ' VAL . 13.3 p90 -115.85 132.48 56.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.347 0.594 . . . . 0.0 112.133 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.476 ' CB ' ' HA ' ' A' ' 66' ' ' VAL . 0.8 OUTLIER -133.7 129.26 36.5 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.175 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 10.9 p -93.76 153.43 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.895 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -45.29 148.57 0.61 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -21.28 24.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.834 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.87 23.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.05 91.29 8.97 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.688 0.28 . . . . 0.0 110.842 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.88 -15.39 42.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.455 2.103 . . . . 0.0 112.145 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -96.36 29.42 2.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.092 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.416 ' O ' ' CE2' ' A' ' 92' ' ' TYR . 52.3 m -153.19 68.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.709 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -67.94 -178.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.174 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.468 ' CD1' HG13 ' A' ' 11' ' ' VAL . 91.8 m-85 -157.14 99.67 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.515 ' CG1' HG12 ' A' ' 50' ' ' ILE . 15.0 t -104.83 118.84 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.047 0.451 . . . . 0.0 111.52 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 32.0 p -112.02 131.03 55.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.873 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.5 m-85 -102.16 91.02 4.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.928 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.425 ' O ' ' N ' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -88.05 176.41 7.31 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.445 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 100' ' ' ILE . 7.4 mt -90.58 128.85 36.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.849 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.0 -33.46 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.663 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 110.593 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.417 HG12 ' CD2' ' A' ' 4' ' ' PHE . 64.1 mt -76.15 138.08 68.58 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.3 167.74 5.75 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.406 2.071 . . . . 0.0 112.128 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.6 58.08 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.792 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.2 tp -141.09 -37.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.625 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.611 ' O ' HG12 ' A' ' 108' ' ' ILE . 16.1 tp -61.54 -59.8 12.37 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 6.3 Cg_endo -47.76 -33.54 19.34 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.494 2.129 . . . . 0.0 110.908 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.546 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.2 mp -67.96 -38.97 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.822 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.421 ' O ' ' N ' ' A' ' 111' ' ' GLY . 6.6 mtt-85 -76.36 -29.78 57.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.424 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.611 HG12 ' O ' ' A' ' 104' ' ' LEU . 9.4 mm -61.63 -51.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.465 ' HB2' HG22 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -69.24 -61.66 1.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.418 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 48.2 t -56.0 -24.48 39.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . -80.06 -43.01 10.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.444 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -59.19 -35.08 72.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 10.4 pt20 -77.97 -9.92 59.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.728 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.39 -23.02 46.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.577 ' HB2' ' CE1' ' A' ' 127' ' ' HIS . 3.5 m-85 -87.16 -96.31 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.064 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 160.81 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.549 0.34 . . . . 0.0 110.817 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.685 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 53.6 m -117.55 96.23 5.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.263 0.554 . . . . 0.0 111.195 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.514 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -151.27 46.35 0.82 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.713 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.97 33.81 4.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -145.7 161.99 38.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.158 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.476 ' HA ' ' N ' ' A' ' 20' ' ' SER . 8.4 p30 -78.74 24.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.639 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 tm-20 -170.15 28.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 117' ' ' SER . 5.8 tt -132.43 -45.67 0.9 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.514 ' HB2' ' HB2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -59.46 -42.44 91.99 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 82.7 p -48.58 -28.03 3.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.152 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -56.99 -59.04 5.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.685 ' CE1' ' O ' ' A' ' 117' ' ' SER . 9.6 m170 -60.04 -33.67 72.34 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.438 ' O ' ' CD1' ' A' ' 132' ' ' LEU . 48.4 t -53.31 -43.04 49.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.961 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.91 -44.67 18.66 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 119.928 -1.13 . . . . 0.0 112.629 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -69.07 -21.02 64.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 111.059 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 127' ' ' HIS . 55.6 mt -90.47 -27.86 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.453 ' CD1' HD13 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -63.76 -48.19 77.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.153 178.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.88 -40.71 95.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -86.29 4.42 39.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.316 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.457 ' CD2' ' N ' ' A' ' 136' ' ' HIS . 0.0 OUTLIER -78.35 -44.52 24.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.71 0.291 . . . . 0.0 110.599 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.457 ' N ' ' CD2' ' A' ' 135' ' ' PHE . 21.8 p80 -72.82 -38.32 67.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.778 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.422 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 1.7 mm-40 -51.6 -31.46 25.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.945 0.402 . . . . 0.0 110.101 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -75.52 -35.88 60.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.859 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.418 HD12 ' CZ ' ' A' ' 135' ' ' PHE . 27.3 mt -65.24 -33.26 75.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.79 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.7 t -76.02 -48.11 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.103 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.45 -32.47 72.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.966 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -26.43 67.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.531 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -84.83 55.57 3.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -178.07 37.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -112.59 -34.42 5.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.974 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -172.5 81.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.791 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 51.4 mt -141.2 -64.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -63.56 -31.61 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.946 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mmm . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.797 0.332 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.425 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -159.62 119.79 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 133.93 52.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.436 ' CE2' ' HD3' ' A' ' 101' ' ' PRO . 19.8 m-85 -113.86 127.09 55.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.782 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.445 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 0.7 OUTLIER -138.53 124.47 20.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.349 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' CG2' HG13 ' A' ' 108' ' ' ILE . 27.8 t -65.0 154.24 7.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.245 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 m -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.699 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 15.8 m-85 -139.98 107.01 5.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 1.9 t -116.1 99.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.105 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 28.1 tt0 -108.1 123.15 48.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.393 . . . . 0.0 111.809 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.416 HG12 HD12 ' A' ' 18' ' ' ILE . 11.0 t -85.73 138.06 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.54 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 1.4 mp -113.56 114.79 47.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.431 ' N ' HG12 ' A' ' 18' ' ' ILE . 2.0 tppt? -97.36 104.93 16.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.632 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.06 26.91 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.298 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.446 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . 77.7 34.55 38.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.911 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.47 17.93 2.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 58.69 155.97 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.346 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.431 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -145.49 -50.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.632 178.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -123.94 176.32 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.969 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -170.06 129.0 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.457 . . . . 0.0 111.349 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.9 t -116.46 69.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.872 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.699 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 3.0 m-85 -106.41 86.51 2.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.878 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.9 147.66 62.25 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.934 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.85 -179.14 4.89 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.746 2.297 . . . . 0.0 111.628 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' CZ ' HD11 ' A' ' 34' ' ' ILE . 2.0 p90 172.36 -24.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.479 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.417 ' HB3' ' OG1' ' A' ' 35' ' ' THR . 34.8 mt-30 65.8 140.08 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.321 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.435 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -53.56 -41.86 66.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.522 -179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.4 t30 74.51 -61.81 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.634 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -177.41 -37.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -68.04 -81.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.452 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 27' ' ' LYS . 17.4 p90 -89.26 110.33 21.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' HA2' ' CB ' ' A' ' 27' ' ' LYS . . . -86.15 124.04 6.71 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.715 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.408 ' HB ' ' CD2' ' A' ' 97' ' ' LEU . 0.0 OUTLIER 174.71 -82.73 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.742 0.306 . . . . 0.0 111.09 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' ' HB ' ' A' ' 35' ' ' THR . 10.5 mt -78.51 146.11 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.755 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.528 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 169.27 -31.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.482 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -172.94 -40.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.211 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.8 -35.02 51.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.273 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.9 31.44 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -123.55 28.28 7.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -110.91 -37.9 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.475 ' CG2' ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -51.74 134.73 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.66 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.504 HG21 HG12 ' A' ' 45' ' ' ILE . 1.9 t -94.79 151.15 38.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.501 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 72.1 Cg_exo -47.17 -26.7 5.61 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.88 1.72 . . . . 0.0 110.8 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.5 ' HB ' HG21 ' A' ' 42' ' ' THR . 57.4 t -61.89 -40.62 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.581 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.504 HG12 HG21 ' A' ' 42' ' ' THR . 16.8 mm -58.12 -45.13 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.593 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.516 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 27.6 m-85 -75.22 -40.14 59.38 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.399 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.74 -28.79 70.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 44' ' ' VAL . 32.5 m-20 -89.25 -29.63 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 53' ' ' MET . 5.2 mt -60.92 -59.67 5.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.536 HG22 ' CD2' ' A' ' 55' ' ' LEU . 4.6 mt -53.28 -64.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.212 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.569 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.7 tpp -49.69 -43.16 47.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.552 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.08 -11.41 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 49' ' ' LEU . 32.9 mmm -127.68 -68.29 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HB ' HG22 ' A' ' 50' ' ' ILE . 63.8 t -58.16 -56.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.68 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.536 ' CD2' HG22 ' A' ' 50' ' ' ILE . 2.8 mm? -44.86 -57.82 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.809 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 37.9 Cg_endo -66.96 5.04 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.049 1.833 . . . . 0.0 112.25 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.41 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -145.62 22.42 1.46 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.071 0.462 . . . . 0.0 110.14 179.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.488 HG23 ' CD2' ' A' ' 81' ' ' TYR . 4.9 p -84.93 166.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.858 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 61' ' ' ILE . 19.0 m -138.34 146.26 50.61 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.541 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.87 30.42 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.34 2.027 . . . . 0.0 112.325 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.437 ' H ' ' C ' ' A' ' 59' ' ' VAL . 34.7 mm 39.75 96.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.439 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -93.81 -24.3 17.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.002 0.43 . . . . 0.0 110.587 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.73 40.34 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.076 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -127.86 -66.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.913 0.387 . . . . 0.0 111.164 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HA ' HG21 ' A' ' 61' ' ' ILE . 0.2 OUTLIER 75.07 106.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.759 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.562 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 2.9 t 67.95 70.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.88 0.371 . . . . 0.0 110.541 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.7 m -98.97 126.26 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.314 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 5.0 ttpt -73.99 132.58 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.356 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.411 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 16.5 mmm -55.62 -32.81 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.741 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t 59.52 24.62 13.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.994 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.409 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 28.0 mmm -103.82 -5.08 22.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.094 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.32 55.49 4.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.126 0.488 . . . . 0.0 110.044 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.438 HD22 HG21 ' A' ' 54' ' ' VAL . 10.3 mp -57.41 -52.17 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.008 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.452 HG21 ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -131.99 155.17 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.852 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -96.7 140.63 31.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.316 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.62 -33.8 5.86 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.121 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.452 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -130.71 168.23 17.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.023 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 81.7 m-20 -108.2 130.6 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.392 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 11.3 p -90.53 112.35 23.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 53.4 m-85 -121.57 149.7 42.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.563 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.488 ' CD2' HG23 ' A' ' 58' ' ' VAL . 44.7 p90 -144.39 128.98 18.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.05 0.452 . . . . 0.0 111.19 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.496 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 3.3 t -132.89 116.4 16.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.521 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 34.6 p -77.61 148.48 35.1 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.32 163.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.332 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.64 -15.28 35.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.485 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 16.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.37 100.21 2.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.13 -13.03 37.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.322 2.015 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 30.14 2.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.073 0.464 . . . . 0.0 110.469 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.433 ' O ' ' CE2' ' A' ' 92' ' ' TYR . 17.5 m -153.74 70.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.66 0.743 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.655 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -71.12 175.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.126 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.433 ' CE2' ' O ' ' A' ' 90' ' ' THR . 45.3 m-85 -144.97 100.12 3.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.324 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.508 HG22 HD12 ' A' ' 12' ' ' ILE . 41.0 t -93.16 130.03 42.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.425 . . . . 0.0 111.384 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.56 133.45 49.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.623 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -114.49 97.58 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.804 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.431 HG21 HD21 ' A' ' 104' ' ' LEU . 2.6 p -102.27 127.64 49.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 100' ' ' ILE . 34.3 mt -37.05 133.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.055 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.41 -31.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.23 -30.4 71.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 110.157 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.3 mm -67.38 136.66 93.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.923 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.436 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 60.2 Cg_endo -72.45 179.55 5.0 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.246 1.964 . . . . 0.0 111.574 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.38 60.0 4.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.416 ' CA ' HD11 ' A' ' 106' ' ' ILE . 3.3 tp -148.73 -38.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.834 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.668 ' O ' HG12 ' A' ' 108' ' ' ILE . 9.4 tp -62.19 -60.72 9.3 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.658 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 6.6 Cg_endo -47.85 -32.47 17.44 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.563 2.176 . . . . 0.0 111.239 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.562 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.7 mp -67.93 -36.45 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.106 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.405 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 0.0 OUTLIER -83.73 -19.95 34.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.117 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 104' ' ' LEU . 11.7 mm -72.36 -49.47 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.809 0.338 . . . . 0.0 110.133 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.72 -49.4 31.4 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.7 p -63.95 -30.27 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.407 ' HA3' HD12 ' A' ' 131' ' ' ILE . . . -74.71 -43.32 29.26 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 11.5 mt -56.17 -35.36 67.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -13.35 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.133 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -22.43 55.78 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.472 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.459 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 5.9 m-85 -86.46 -94.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.886 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 162.19 -25.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.66 0.267 . . . . 0.0 110.904 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.408 ' CB ' HD23 ' A' ' 123' ' ' LEU . 4.4 m -91.82 -91.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.485 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 124' ' ' LEU . 3.1 p30 39.27 32.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.674 0.273 . . . . 0.0 111.097 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.15 33.83 5.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.537 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -148.59 150.78 33.9 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.48 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.425 ' HA ' ' N ' ' A' ' 20' ' ' SER . 5.0 p30 -71.34 29.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.569 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 120' ' ' THR . 10.3 tt0 -170.91 27.53 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.408 HD23 ' CB ' ' A' ' 117' ' ' SER . 6.2 tt -133.26 -49.77 0.86 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.689 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.433 ' O ' HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -55.31 -45.54 76.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.412 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 78.4 p -47.64 -30.12 3.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.375 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.16 -56.27 23.67 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.973 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.534 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.4 m170 -60.91 -31.75 71.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.407 HG23 ' CG2' ' A' ' 108' ' ' ILE . 47.7 t -55.63 -46.43 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.924 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.31 -40.69 18.91 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.33 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.98 -24.25 65.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.518 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 63.0 mt -88.17 -28.02 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.445 ' CD2' ' HA ' ' A' ' 5' ' ' ASN . 0.6 OUTLIER -61.78 -49.84 74.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.526 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -46.48 82.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.991 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 t -72.51 -15.1 61.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.473 ' CZ ' ' HA ' ' A' ' 104' ' ' LEU . 23.4 t80 -55.65 -56.45 20.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.233 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -51.76 -43.32 62.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.945 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.45 -30.54 41.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 0.0 110.106 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.406 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 7.6 mm-40 -80.25 -34.11 37.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.071 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 16.1 mt -69.74 -30.32 67.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.104 0.478 . . . . 0.0 110.091 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.1 t -77.45 -48.29 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.381 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.47 -33.9 76.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.026 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.406 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -63.03 -31.72 72.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.032 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -29.81 70.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.852 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.5 43.8 1.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.5 -46.71 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.9 p -147.04 72.31 1.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 mt -85.91 -176.22 5.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.19 35.91 20.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.92 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.851 0.357 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 tptt 60.98 71.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.406 ' HG3' ' CD2' ' A' ' 136' ' ' HIS . 0.4 OUTLIER -128.54 46.99 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.805 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' CZ ' ' HG2' ' A' ' 101' ' ' PRO . 27.1 m-85 62.11 -178.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -167.44 107.44 0.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.074 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.478 ' CG2' HG13 ' A' ' 108' ' ' ILE . 54.9 t -60.79 145.9 11.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.683 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -69.48 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.793 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.657 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 8.4 m-85 -136.13 116.03 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 111.845 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.444 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 2.3 t -106.84 92.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.961 0.41 . . . . 0.0 110.868 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.447 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.2 tt0 -95.82 108.69 21.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.8 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.435 ' CG2' HD11 ' A' ' 124' ' ' LEU . 33.5 t -81.07 145.32 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.2 mp -129.34 124.89 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.508 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.91 102.62 11.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.381 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.79 39.56 6.1 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.881 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.78 20.8 67.47 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.78 118.57 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.957 0.408 . . . . 0.0 110.26 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.412 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 3.6 m -47.84 128.55 13.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.338 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.508 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -105.62 -42.26 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.643 0.735 . . . . 0.0 109.362 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -131.29 176.35 8.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.197 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.43 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.0 m -170.5 121.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.444 ' HB3' ' CB ' ' A' ' 9' ' ' VAL . 33.9 t -107.58 70.22 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.1 m-85 -105.97 84.25 2.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.609 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 19.1 pt20 -105.26 139.0 19.71 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.42 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.73 147.47 19.5 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.616 2.211 . . . . 0.0 111.977 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CE1' ' O ' ' A' ' 23' ' ' GLN . 38.6 p90 179.04 119.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.892 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.751 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.6 pt20 -86.56 46.69 1.38 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.631 0.253 . . . . 0.0 111.151 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt 59.68 108.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.338 . . . . 0.0 110.812 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -170.22 136.44 1.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.043 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 57.84 21.98 8.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.262 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 174.41 161.77 0.19 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.934 0.397 . . . . 0.0 110.849 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.76 106.7 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.65 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -127.54 -176.86 14.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.756 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.3 m -155.87 -44.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.925 0.393 . . . . 0.0 110.921 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.751 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 27.1 mt -60.36 162.3 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 36' ' ' SER . 0.1 OUTLIER -164.78 -69.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.527 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.498 ' N ' ' OG1' ' A' ' 35' ' ' THR . 1.2 m -140.37 -44.75 0.41 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.185 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.3 -28.6 68.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.395 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -116.48 32.37 6.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.113 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -129.54 28.38 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -111.77 -35.74 5.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.959 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.487 ' CG2' ' CE1' ' A' ' 46' ' ' PHE . 1.1 mt -51.24 116.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.79 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.428 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 1.8 t -77.08 153.18 82.51 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.522 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.428 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.1 Cg_exo -48.16 -21.78 3.19 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.785 1.656 . . . . 0.0 110.788 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' A' ' 48' ' ' ASN . 90.7 t -65.3 -49.35 79.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.058 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.427 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 1.8 mp -57.28 -31.29 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.487 ' CE1' ' CG2' ' A' ' 41' ' ' ILE . 98.3 m-85 -80.8 -44.05 19.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.569 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.605 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -65.17 -26.02 67.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.291 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -89.99 -29.54 18.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 53' ' ' MET . 2.7 mt -60.75 -59.51 5.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.619 HG23 HD21 ' A' ' 55' ' ' LEU . 4.9 mt -53.87 -64.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.984 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.605 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.8 OUTLIER -49.73 -40.72 41.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.902 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -91.16 -19.74 22.75 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 49' ' ' LEU . 93.8 mmm -120.14 -60.14 1.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.571 ' HB ' HG23 ' A' ' 50' ' ' ILE . 96.4 t -64.55 -51.38 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.619 HD21 HG23 ' A' ' 50' ' ' ILE . 2.0 mm? -55.63 -52.45 71.93 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 14.7 Cg_exo -69.07 3.66 2.32 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.352 2.034 . . . . 0.0 112.159 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.93 23.61 1.37 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.03 0.443 . . . . 0.0 110.192 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG21 ' CD1' ' A' ' 81' ' ' TYR . 4.4 p -85.92 165.35 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 61' ' ' ILE . 15.3 m -141.96 146.35 40.14 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.135 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 61' ' ' ILE . 60.8 Cg_endo -74.94 23.38 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.953 1.768 . . . . 0.0 112.33 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 59' ' ' VAL . 21.0 mm 51.65 158.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.307 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.406 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 2.1 mptp? -134.02 -42.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.191 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.39 31.61 0.25 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.697 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 2.4 t-20 -121.55 -66.16 1.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.366 . . . . 0.0 111.21 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 12.6 mmtt 70.93 116.75 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.608 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.616 ' HB ' HG13 ' A' ' 106' ' ' ILE . 3.1 t 75.04 49.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.68 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.0 m -80.7 125.41 30.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.283 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.444 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -71.75 130.67 41.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.412 ' HE3' ' CE2' ' A' ' 81' ' ' TYR . 53.3 tpp -57.53 -25.24 59.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 t 53.04 26.96 5.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.085 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.411 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 8.9 tpt -106.45 -11.0 16.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.149 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.87 58.06 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.371 . . . . 0.0 110.515 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.427 ' CD2' ' HB2' ' A' ' 53' ' ' MET . 8.5 mp -59.86 -46.05 90.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.529 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -133.25 157.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.686 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.95 140.84 33.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.394 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.41 -33.92 5.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.241 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.529 ' CE1' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -132.79 168.36 18.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.882 0.372 . . . . 0.0 111.088 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 94.7 m-20 -106.57 143.25 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.402 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.4 m -106.98 114.77 29.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 87.7 m-85 -121.78 137.74 54.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.502 ' CD1' HG21 ' A' ' 58' ' ' VAL . 49.2 p90 -127.05 128.82 46.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.0 0.429 . . . . 0.0 111.467 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.433 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -133.35 118.91 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.96 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 40.3 p -80.63 150.43 29.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -46.14 146.84 1.2 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.276 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.03 -15.81 57.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.89 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 22.03 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.659 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.74 95.0 3.76 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.471 0.177 . . . . 0.0 111.178 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.33 -15.55 45.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -96.23 30.39 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.042 0.448 . . . . 0.0 110.093 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 65.1 m -154.36 73.72 0.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.66 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -72.83 176.0 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.223 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.427 ' CD2' HG12 ' A' ' 11' ' ' VAL . 97.4 m-85 -150.68 94.88 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.826 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.584 ' CG2' HG22 ' A' ' 50' ' ' ILE . 44.0 t -98.09 121.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.246 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 37.5 t -114.51 139.98 49.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.312 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.511 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.8 m-85 -115.04 102.66 10.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.511 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.9 p -109.69 127.46 54.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 100' ' ' ILE . 44.5 mt -38.32 132.9 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.326 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -44.94 -30.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.685 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.11 -28.08 67.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.742 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.406 ' N ' ' O ' ' A' ' 97' ' ' LEU . 5.2 mm -68.26 131.57 91.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.205 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 4' ' ' PHE . 39.1 Cg_exo -60.0 179.65 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -98.72 62.58 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.682 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.41 ' CA ' HD13 ' A' ' 106' ' ' ILE . 4.3 tp -155.08 -37.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.783 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 108' ' ' ILE . 5.3 tp -60.51 -61.55 7.73 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 3.3 Cg_endo -45.48 -37.54 14.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.794 2.329 . . . . 0.0 111.147 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.616 HG13 ' HB ' ' A' ' 66' ' ' VAL . 4.1 mp -63.62 -37.44 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.152 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 104' ' ' LEU . 0.7 OUTLIER -83.49 -18.23 39.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.841 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 104' ' ' LEU . 15.4 mm -70.63 -47.89 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.419 HD23 ' CG1' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -74.37 -47.42 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.5 t -64.53 -29.11 70.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . -75.73 -45.55 16.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.173 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.76 -33.93 67.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -70.79 -16.11 62.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.209 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.08 -21.6 59.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.363 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.492 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.5 m-85 -85.39 -94.13 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 4.9 tp10 161.57 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 110.659 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.41 ' CB ' HD23 ' A' ' 123' ' ' LEU . 13.5 m -91.32 -91.07 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.368 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.407 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.1 p-10 39.04 32.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.595 0.236 . . . . 0.0 111.021 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.37 34.81 4.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.54 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -150.13 151.1 32.6 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.708 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.43 ' HA ' ' N ' ' A' ' 20' ' ' SER . 7.3 p30 -70.67 28.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.919 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 tt0 -172.17 28.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.41 HD23 ' CB ' ' A' ' 117' ' ' SER . 5.9 tt -131.74 -50.33 0.97 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.497 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -55.93 -44.94 78.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.497 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 19.1 t -47.7 -30.22 3.65 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.168 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.13 -58.17 8.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.138 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 6.7 m170 -57.66 -39.36 76.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.643 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -50.52 -46.2 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.412 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.03 -47.28 47.0 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.324 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -65.28 -23.39 67.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.82 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 127' ' ' HIS . 37.8 mt -85.49 -27.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -65.66 -46.52 78.84 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.678 179.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.66 -44.0 78.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.7 m -80.3 -4.17 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.815 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 104' ' ' LEU . 26.6 t80 -55.62 -62.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.406 ' CD2' ' HG3' ' A' ' 3' ' ' ARG . 7.4 m-70 -50.68 -41.31 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.332 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.01 -33.01 23.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.935 0.398 . . . . 0.0 110.353 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.33 -34.02 42.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.966 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.426 HD22 ' CZ ' ' A' ' 135' ' ' PHE . 18.0 mt -69.84 -30.11 67.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.232 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.5 t -77.21 -47.49 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.583 0.706 . . . . 0.0 109.423 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -65.09 -32.0 73.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.093 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -32.88 74.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.484 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -21.4 65.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.153 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -104.1 35.43 2.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.054 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -126.87 -42.93 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 t -137.06 80.78 1.83 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.53 30.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.797 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.25 31.25 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.808 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.9 92.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.39 161.04 23.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.462 ' CZ ' ' CD ' ' A' ' 101' ' ' PRO . 6.1 m-85 -145.69 161.54 39.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.415 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 3.9 t-20 -168.88 111.33 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.966 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.514 ' CG2' HG13 ' A' ' 108' ' ' ILE . 3.5 t -54.19 123.09 4.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.616 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -53.93 -55.73 24.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.49 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.64 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 6.5 m-85 -145.47 140.52 27.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 0.0 111.653 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.407 HG23 HG11 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -131.35 97.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.348 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.2 mt-10 -112.86 124.7 53.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 111.647 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.507 HG11 ' N ' ' A' ' 12' ' ' ILE . 98.2 t -89.79 159.9 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.507 ' N ' HG11 ' A' ' 11' ' ' VAL . 3.3 mt -137.66 117.4 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.2 tttp -107.36 115.5 30.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.056 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 61.4 32.74 18.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.573 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.0 27.91 57.44 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.283 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -144.92 121.57 11.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.086 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -51.88 122.55 8.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.145 -178.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.19 -47.94 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 109.603 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 124' ' ' LEU . 54.7 p -122.08 171.35 9.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.625 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 11.8 m -166.54 128.05 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.985 0.421 . . . . 0.0 112.021 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 32.0 t -119.91 69.39 0.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.5 m-85 -112.04 94.2 4.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.414 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 2.2 pp0? -139.13 149.38 60.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.718 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.99 177.88 3.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.725 2.283 . . . . 0.0 111.673 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 7' ' ' SER . 3.4 p90 176.86 -26.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.418 ' HB3' ' OG1' ' A' ' 35' ' ' THR . 7.2 mt-30 64.99 139.61 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.258 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 0.7 OUTLIER -51.46 156.85 1.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.247 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -122.7 46.58 2.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.48 -62.4 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.969 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -53.79 -67.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 40.5 p90 -101.32 108.31 19.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.812 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.422 ' HA2' ' CB ' ' A' ' 27' ' ' LYS . . . -97.34 133.37 11.34 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.57 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -178.44 -78.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.905 0.384 . . . . 0.0 111.401 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.527 ' O ' ' HB ' ' A' ' 35' ' ' THR . 4.2 mt -84.46 150.24 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.83 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 169.22 -31.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.549 179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.45 -78.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.401 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.19 -37.88 37.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.782 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -98.22 33.41 2.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.026 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.31 29.89 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.926 0.393 . . . . 0.0 110.95 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -115.31 -38.61 3.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.352 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.459 HG23 ' CZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -53.57 118.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.505 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 9.5 t -81.43 152.19 69.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.6 Cg_exo -46.51 -23.06 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.066 1.844 . . . . 0.0 111.239 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.505 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 49.2 t -64.82 -47.51 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.518 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 ' HB ' HG21 ' A' ' 41' ' ' ILE . 1.9 mp -58.94 -33.32 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.214 0.53 . . . . 0.0 109.618 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CZ ' HG23 ' A' ' 41' ' ' ILE . 66.1 m-85 -81.06 -41.98 21.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.541 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.575 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.69 -29.15 70.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.023 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -88.27 -27.31 21.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 46' ' ' PHE . 4.4 mt -63.79 -61.11 2.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.519 HG12 ' CG1' ' A' ' 93' ' ' VAL . 6.8 mt -49.63 -62.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.736 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.575 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -54.33 -41.09 68.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.591 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -90.89 -20.42 22.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.438 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 69.0 mmm -119.66 -52.3 2.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.51 ' HB ' HG21 ' A' ' 50' ' ' ILE . 84.3 t -69.59 -60.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.559 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 1.3 mm? -46.41 -51.09 37.1 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 12.6 Cg_exo -70.08 2.87 3.31 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.262 1.975 . . . . 0.0 112.059 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -145.49 23.97 1.42 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.058 0.456 . . . . 0.0 110.086 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 ' CD1' ' A' ' 81' ' ' TYR . 5.0 p -87.67 166.06 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.914 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' A' ' 61' ' ' ILE . 12.1 m -140.57 146.16 43.7 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.899 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' O ' ' O ' ' A' ' 61' ' ' ILE . 58.5 Cg_endo -73.71 24.08 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.931 1.754 . . . . 0.0 112.476 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.498 ' H ' ' C ' ' A' ' 59' ' ' VAL . 30.0 mm 50.12 158.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.394 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.41 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 6.4 mmtm -135.84 -44.94 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.175 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.17 29.69 0.41 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.545 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.51 -71.28 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.963 0.411 . . . . 0.0 110.985 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.72 120.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.554 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.575 ' HB ' HG13 ' A' ' 106' ' ' ILE . 2.6 t 76.25 44.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.497 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -78.61 139.84 38.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.365 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.31 127.45 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.511 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.474 ' CG ' ' CG ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -54.04 -36.5 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m 63.97 25.44 13.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.894 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.474 ' CG ' ' CG ' ' A' ' 69' ' ' MET . 23.6 mmt -104.82 -0.66 26.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.944 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.06 56.28 5.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.098 0.475 . . . . 0.0 110.507 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD11 ' HG2' ' A' ' 69' ' ' MET . 7.5 mp -60.44 -39.45 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.652 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.497 HG21 HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -147.01 151.77 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.489 179.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 74' ' ' ILE . 13.8 t0 -96.77 138.67 33.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.335 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.94 -31.91 6.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -129.48 163.92 24.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.15 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 75.8 m-20 -103.49 132.03 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.432 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 20.9 p -94.83 95.72 8.87 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 73.2 m-85 -110.33 133.59 53.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.494 ' CD1' HG21 ' A' ' 58' ' ' VAL . 46.6 p90 -127.31 139.84 52.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.455 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 1.5 t -143.55 125.09 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.779 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.558 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 41.4 p -86.94 158.12 19.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.95 153.37 2.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.83 -9.71 58.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.765 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 22.56 0.24 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.667 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 98.97 2.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.477 0.18 . . . . 0.0 111.23 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -13.61 40.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.445 2.097 . . . . 0.0 112.009 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -97.56 28.81 3.57 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.023 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.442 ' O ' ' CE2' ' A' ' 92' ' ' TYR . 32.3 m -152.73 73.63 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.408 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -73.55 -179.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.435 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.442 ' CE2' ' O ' ' A' ' 90' ' ' THR . 69.1 m-85 -156.06 98.61 1.89 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.754 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.519 ' CG1' HG12 ' A' ' 50' ' ' ILE . 65.0 t -106.86 133.52 51.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.98 0.419 . . . . 0.0 111.151 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.21 122.45 29.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.087 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.476 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 2.7 m-85 -92.05 87.45 6.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.725 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -75.72 -170.94 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.775 0.322 . . . . 0.0 110.931 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.405 ' HB2' ' CD1' ' A' ' 100' ' ' ILE . 82.0 mt -105.95 125.77 51.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -41.49 -30.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.608 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 36.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.465 HD13 HG22 ' A' ' 100' ' ' ILE . 47.9 mt -139.48 129.48 14.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.462 ' CD ' ' CZ ' ' A' ' 4' ' ' PHE . 72.9 Cg_exo -48.39 151.51 4.59 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.307 2.005 . . . . 0.0 112.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.46 58.03 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.496 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.418 ' CA ' HD13 ' A' ' 106' ' ' ILE . 3.2 tp -144.1 -35.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.762 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.615 ' O ' HG12 ' A' ' 108' ' ' ILE . 6.3 tp -60.45 -63.99 3.62 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.672 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.499 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 2.8 Cg_endo -45.25 -35.51 11.33 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.726 2.284 . . . . 0.0 111.501 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.575 HG13 ' HB ' ' A' ' 66' ' ' VAL . 3.5 mp -63.35 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.061 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER -79.35 -19.68 49.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.813 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.615 HG12 ' O ' ' A' ' 104' ' ' LEU . 19.9 mm -68.32 -49.99 61.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.522 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -72.23 -50.16 29.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -27.43 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -78.6 -42.15 14.42 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 20.4 mt -58.88 -28.23 65.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -18.56 58.38 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.227 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.5 OUTLIER -73.57 -22.21 60.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.509 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 6.4 m-85 -83.64 -93.24 0.07 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 20.7 tt0 156.5 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.352 0.261 . . . . 0.0 111.064 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.445 ' CB ' HD23 ' A' ' 123' ' ' LEU . 4.6 m -94.19 -90.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 41.12 31.2 0.13 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 -179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.15 34.01 4.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -149.92 154.85 38.99 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.523 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -74.06 22.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.394 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 120' ' ' THR . 6.9 pt-20 -164.97 26.32 0.06 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.445 HD23 ' CB ' ' A' ' 117' ' ' SER . 5.6 tt -127.11 -50.87 1.43 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.683 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 19' ' ' SER . 0.0 OUTLIER -55.52 -44.69 76.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.423 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.5 p -47.66 -30.36 3.69 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.231 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.48 -56.27 21.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.326 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.532 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.0 m170 -60.39 -35.2 75.17 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.677 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.436 ' O ' ' CD1' ' A' ' 132' ' ' LEU . 46.1 t -54.59 -45.66 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.02 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.51 28.77 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.435 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -69.31 -21.16 63.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.871 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.497 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 62.4 mt -90.16 -27.38 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER -64.59 -47.84 77.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.359 178.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -63.42 -44.62 94.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.575 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 t -76.49 -8.71 57.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 104' ' ' LEU . 16.8 t80 -51.57 -57.76 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -58.87 -40.72 85.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.76 -31.21 36.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.972 0.415 . . . . 0.0 110.007 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -77.82 -35.52 51.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.971 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 20.5 mt -67.17 -29.92 69.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.185 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.19 -49.01 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.484 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.76 -31.35 72.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.041 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.84 -33.01 74.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.29 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -28.91 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.89 85.31 2.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.43 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.6 p -108.91 39.98 1.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.849 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.34 130.78 53.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.967 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -33.12 48.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.809 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.856 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.77 0.319 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.403 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER 60.34 97.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.824 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -174.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -148.35 159.25 44.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.914 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.31 113.49 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.827 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' CG2' HG13 ' A' ' 108' ' ' ILE . 92.9 t -58.93 140.1 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.079 0.466 . . . . 0.0 110.978 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.436 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.68 -59.02 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.701 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.657 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 5.8 m-85 -149.35 115.84 5.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.848 0.356 . . . . 0.0 111.78 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.43 HG21 ' CG1' ' A' ' 6' ' ' VAL . 1.9 t -108.15 93.03 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.865 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 0.1 OUTLIER -101.14 114.83 29.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.685 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 17' ' ' THR . 56.0 t -81.59 161.19 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.527 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.0 mp -142.01 121.08 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.693 -0.403 . . . . 0.0 112.045 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.506 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 12.8 tttt -107.07 97.24 7.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.703 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 69.85 37.59 1.78 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.58 62.01 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.695 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 7.6 pt-20 -144.8 119.22 9.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.6 m -50.14 130.78 23.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.507 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.506 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.36 -41.49 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.137 178.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.471 ' OG ' ' HB ' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -127.21 175.57 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.072 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.43 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 17.0 p -170.38 134.65 1.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 34.4 t -122.7 69.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.746 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.657 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -106.95 88.72 2.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.684 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 39.5 mt-30 -127.88 139.48 35.46 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.487 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.69 -179.07 4.78 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.546 2.164 . . . . 0.0 111.755 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' O ' ' A' ' 23' ' ' GLN . 1.0 OUTLIER 176.78 -29.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.675 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER 74.7 122.19 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.77 0.319 . . . . 0.0 110.413 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -51.82 -46.64 64.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 69.4 -66.16 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -158.58 -45.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -58.65 177.32 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD1' ' HE2' ' A' ' 2' ' ' LYS . 20.4 m-85 -58.95 110.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.978 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.478 ' HA2' ' CD1' ' A' ' 97' ' ' LEU . . . -173.97 -165.55 30.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.94 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.8 m -157.61 -44.12 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.884 0.373 . . . . 0.0 111.017 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 35' ' ' THR . 26.5 mt -55.06 154.58 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.951 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 169.5 -32.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.449 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.9 t -179.64 -60.33 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.021 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.06 -29.25 63.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.378 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -117.49 32.28 6.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.051 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.15 28.59 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.033 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -110.22 -38.39 5.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.887 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.515 HG22 ' HB ' ' A' ' 45' ' ' ILE . 1.1 mt -51.31 142.15 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.68 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.498 HG23 HG12 ' A' ' 45' ' ' ILE . 2.3 t -96.67 152.5 38.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.422 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 83.2 Cg_exo -46.43 -28.83 6.45 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.895 1.73 . . . . 0.0 110.669 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 42' ' ' THR . 60.9 t -58.81 -40.28 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.548 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.515 ' HB ' HG22 ' A' ' 41' ' ' ILE . 23.5 mm -57.62 -46.34 86.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.51 ' CE1' HG23 ' A' ' 41' ' ' ILE . 68.7 m-85 -75.41 -38.51 59.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.246 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.513 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.26 -30.15 71.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.155 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' VAL . 3.7 m-80 -87.59 -28.03 22.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 53' ' ' MET . 6.6 mt -64.21 -61.15 2.43 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.558 HG12 ' CG1' ' A' ' 93' ' ' VAL . 6.2 mt -48.9 -61.19 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.997 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.513 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.4 ttm -57.28 -40.85 78.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.186 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.5 t0 -91.18 -15.13 29.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.479 ' N ' ' O ' ' A' ' 49' ' ' LEU . 84.2 mmm -124.28 -56.48 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG13 ' CD2' ' A' ' 81' ' ' TYR . 72.1 t -64.44 -60.02 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.563 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 0.3 OUTLIER -51.96 -50.35 78.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.563 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.9 Cg_exo -62.68 -2.28 3.31 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.383 2.055 . . . . 0.0 112.602 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -146.97 23.15 1.21 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.289 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.7 p -78.78 164.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.931 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.441 ' C ' ' H ' ' A' ' 61' ' ' ILE . 29.7 m -147.3 147.17 27.65 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' O ' ' O ' ' A' ' 61' ' ' ILE . 64.0 Cg_endo -76.18 25.3 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.968 1.778 . . . . 0.0 112.83 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.481 ' CG2' ' N ' ' A' ' 62' ' ' LYS . 1.6 mp 51.31 159.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.083 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -123.7 -41.0 2.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.849 179.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.92 40.31 0.23 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.086 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -136.74 -60.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 72.89 128.9 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.479 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.597 ' HB ' HG13 ' A' ' 106' ' ' ILE . 3.4 t 73.89 49.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.967 0.413 . . . . 0.0 110.725 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.8 m -78.0 129.37 35.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 7.0 tttm -79.45 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.264 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.429 ' HG3' ' CB ' ' A' ' 71' ' ' MET . 20.0 tpp -56.78 -29.94 63.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m 56.43 28.64 13.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.429 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 37.8 tpp -108.66 -10.87 15.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.029 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.58 59.14 1.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 110.43 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.434 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.6 mp -59.5 -50.1 75.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.774 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.442 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -128.75 155.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.651 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.61 140.35 31.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.458 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.7 -32.25 7.1 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' CE1' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -133.87 167.96 19.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 111.25 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 84.0 m-20 -108.37 145.28 34.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.383 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.8 m -109.75 118.43 36.51 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 32.5 m-85 -126.13 138.97 53.72 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.12 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.524 ' CD1' HG23 ' A' ' 58' ' ' VAL . 26.8 p90 -124.78 133.69 53.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.073 0.463 . . . . 0.0 111.359 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.18 117.6 14.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.031 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 18.0 p -79.35 153.58 29.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.37 146.42 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.096 0.474 . . . . 0.0 111.25 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -22.35 14.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.056 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.05 23.54 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.587 0.232 . . . . 0.0 111.582 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.56 94.57 5.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -15.28 47.35 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.395 2.063 . . . . 0.0 111.98 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.35 28.2 3.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.171 0.51 . . . . 0.0 110.272 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 51.7 m -152.04 70.91 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.641 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.585 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -72.34 177.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.445 ' CD1' HG13 ' A' ' 11' ' ' VAL . 92.7 m-85 -151.1 93.69 1.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.112 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.558 ' CG1' HG12 ' A' ' 50' ' ' ILE . 51.5 t -95.6 120.54 45.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 111.05 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 35.8 t -112.85 137.48 51.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.108 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.532 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 8.6 m-85 -112.88 99.2 7.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.0 p -104.33 125.72 50.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 111.078 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.478 ' CD1' ' HA2' ' A' ' 32' ' ' GLY . 16.5 mt -39.9 134.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.2 -29.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.705 0.288 . . . . 0.0 111.493 -179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -28.24 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 110.478 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.449 HG22 HD12 ' A' ' 100' ' ' ILE . 16.4 mm -66.95 134.12 93.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.129 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.28 -159.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.134 1.889 . . . . 0.0 111.617 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -114.44 64.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.539 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 104' ' ' LEU . 1.4 tp -161.79 -35.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.918 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.64 ' O ' HG12 ' A' ' 108' ' ' ILE . 4.7 tp -58.73 -61.54 7.51 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.048 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 3.8 Cg_endo -45.38 -36.36 12.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.592 2.195 . . . . 0.0 111.015 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.597 HG13 ' HB ' ' A' ' 66' ' ' VAL . 4.1 mp -67.79 -37.31 78.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.06 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.453 ' N ' ' O ' ' A' ' 104' ' ' LEU . 1.1 mmp_? -80.77 -24.34 38.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.701 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.64 HG12 ' O ' ' A' ' 104' ' ' LEU . 31.9 mm -67.01 -54.36 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.766 0.317 . . . . 0.0 110.223 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.33 -53.33 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.907 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -59.91 -27.93 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.425 ' HA3' HG23 ' A' ' 131' ' ' ILE . . . -74.92 -45.89 19.17 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 8.3 mt -56.16 -31.14 63.11 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -76.89 -15.76 59.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.058 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -75.43 -25.19 57.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.313 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.537 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 3.5 m-85 -84.42 -92.57 0.08 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.911 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 163.43 -29.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.059 0.457 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 26.3 m -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.476 0.655 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.549 ' HA ' HD21 ' A' ' 123' ' ' LEU . 1.7 p30 -169.67 36.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.944 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.89 33.38 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -144.28 155.15 43.72 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.901 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.43 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.2 m120 -75.25 19.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 pm0 -161.53 24.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.549 HD21 ' HA ' ' A' ' 118' ' ' ASN . 7.4 tt -123.07 -58.26 1.65 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.7 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.433 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -50.81 -44.79 59.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 78.6 p -49.32 -29.58 6.24 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.461 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -59.98 4.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.427 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.537 ' CE1' ' CB ' ' A' ' 115' ' ' TYR . 42.4 m170 -59.64 -32.17 70.19 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 56.9 t -55.26 -46.92 78.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.528 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -67.92 -42.9 84.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.11 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.62 -22.9 63.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.919 0.39 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 127' ' ' HIS . 40.5 mt -90.38 -27.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.556 HD23 ' CD2' ' A' ' 104' ' ' LEU . 2.9 mt -65.02 -52.33 56.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.919 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -71.57 -32.65 68.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -95.77 24.27 5.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.957 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.457 ' CE2' ' HA ' ' A' ' 104' ' ' LEU . 0.0 OUTLIER -100.25 -44.03 6.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -71.73 -36.57 70.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.946 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -52.59 -29.27 24.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.993 0.425 . . . . 0.0 110.396 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 93.4 mt-10 -78.8 -36.39 42.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.305 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.429 HD11 ' CE2' ' A' ' 135' ' ' PHE . 16.5 mt -68.89 -30.3 68.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.429 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.9 t -77.13 -48.05 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.465 0.65 . . . . 0.0 109.55 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -64.19 -30.78 71.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.0 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -68.24 -20.99 64.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.573 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -89.67 16.28 8.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.452 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -160.05 29.26 0.18 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.759 0.314 . . . . 0.0 110.859 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -113.77 -36.37 4.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.8 t -143.65 83.96 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.829 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 33.6 mt -140.79 96.79 3.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -125.64 81.18 1.96 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.845 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.806 0.336 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.54 119.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.1 173.38 7.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.436 ' CE1' HG12 ' A' ' 100' ' ' ILE . 2.0 m-85 -131.53 -173.11 3.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.031 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -159.72 111.74 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.278 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.44 HG23 HG13 ' A' ' 108' ' ' ILE . 1.4 t -71.94 133.54 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.552 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -63.16 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.792 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.555 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.1 m-85 -144.98 140.35 28.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.309 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 1.5 t -129.63 90.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.1 tt0 -99.52 116.02 30.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.004 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.528 HG13 ' CD2' ' A' ' 92' ' ' TYR . 40.1 t -82.39 158.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.4 mt -141.01 119.58 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HB2' HG12 ' A' ' 18' ' ' ILE . 1.8 tttt -104.68 99.76 9.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.482 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.77 40.39 5.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.855 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 21.32 63.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.05 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -141.38 116.27 9.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.194 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.3 m -50.84 126.03 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.823 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.424 HG13 HG11 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -103.96 -44.0 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.457 0.646 . . . . 0.0 109.792 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.573 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -127.7 177.11 7.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.432 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.448 ' OG ' ' CE2' ' A' ' 22' ' ' PHE . 2.8 t -170.47 139.04 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.564 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 13.7 t -130.52 73.08 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.605 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.1 m-85 -107.35 88.78 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.815 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -101.78 126.24 34.61 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.212 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.39 149.35 35.01 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.466 2.111 . . . . 0.0 112.131 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -178.93 151.22 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.834 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 4.0 pt20 -104.2 62.18 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.744 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER 40.41 -170.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.008 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 66.9 m-80 -158.53 74.83 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.829 0.347 . . . . 0.0 111.202 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 61.18 -81.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.297 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -85.4 -80.62 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.178 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 28' ' ' ASN . 22.1 p90 -69.49 131.95 45.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.47 158.82 11.18 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.382 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.5 m -144.15 -43.6 0.26 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.747 0.308 . . . . 0.0 111.113 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 13.0 mt -57.83 155.42 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.349 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -175.91 -83.27 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.493 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -133.38 63.49 1.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.83 -38.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.43 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 27.6 m-20 -112.47 31.37 6.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.741 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 28.67 7.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -117.4 -34.35 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.512 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -53.98 121.59 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.978 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.501 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 8.8 t -83.39 151.48 62.52 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.483 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 82.8 Cg_exo -46.0 -22.56 1.42 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.189 1.926 . . . . 0.0 111.474 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.501 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 97.1 t -65.58 -46.28 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.045 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.483 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 1.8 mp -59.41 -33.91 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.512 ' CZ ' ' CE1' ' A' ' 8' ' ' TYR . 88.1 m-85 -79.36 -43.28 23.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.204 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.6 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.83 -27.83 69.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.069 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 25.8 m-20 -88.33 -29.18 20.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.5 mt -62.57 -61.11 2.65 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.552 HG12 ' CG1' ' A' ' 93' ' ' VAL . 5.7 mt -50.44 -61.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.262 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.6 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -53.21 -46.01 68.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.055 -1.43 . . . . 0.0 113.198 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.91 -14.14 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.484 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 74.1 mmm -123.02 -63.27 1.27 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.49 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 67.5 t -59.35 -55.73 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.636 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -53.17 -54.37 45.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.636 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 31.3 Cg_exo -60.85 -4.24 3.45 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.15 1.9 . . . . 0.0 112.175 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -144.43 26.89 1.42 Allowed 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.487 HG23 ' CD1' ' A' ' 81' ' ' TYR . 2.5 p -84.99 159.12 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.904 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.445 ' C ' ' H ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -144.57 148.75 41.27 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.021 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.448 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 72.9 Cg_endo -78.8 24.58 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.894 1.729 . . . . 0.0 112.029 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.498 ' C ' ' H ' ' A' ' 63' ' ' GLY . 23.6 mt 36.96 31.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.686 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.63 -12.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.036 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.498 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 168.72 40.91 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.805 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 83' ' ' THR . 0.9 OUTLIER 55.24 117.46 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.997 0.427 . . . . 0.0 111.462 -179.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HB2' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -159.07 25.08 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.022 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.579 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 14.4 t 45.14 96.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.286 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.44 ' N ' HD11 ' A' ' 61' ' ' ILE . 96.5 m -119.41 142.71 47.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 111.892 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.36 133.93 34.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.426 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.49 ' CE ' ' HA ' ' A' ' 54' ' ' VAL . 0.6 OUTLIER -58.79 -30.09 67.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.126 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.67 30.08 16.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.971 0.415 . . . . 0.0 110.804 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.419 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 2.4 tpt -111.06 -13.2 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.097 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.75 55.1 1.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.437 ' CD2' ' HB2' ' A' ' 53' ' ' MET . 9.5 mp -54.42 -43.38 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.818 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.474 HG22 ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -135.44 159.18 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.735 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 74' ' ' ILE . 29.6 t70 -99.74 142.18 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.471 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.03 -34.7 5.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.127 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.474 ' CE2' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.5 176.14 8.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 110.766 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 91.7 m-20 -110.98 162.24 15.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.069 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.5 t -121.97 101.49 7.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 57.9 m-85 -108.67 147.07 32.45 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.575 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CD1' HG23 ' A' ' 58' ' ' VAL . 33.9 p90 -137.66 123.14 19.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.091 0.472 . . . . 0.0 111.441 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.86 119.09 27.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.396 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 23.8 p -82.13 156.93 24.25 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.095 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -53.41 152.12 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -28.49 53.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.891 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 23.55 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.654 0.264 . . . . 0.0 111.398 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.89 85.68 19.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.636 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.14 -18.19 22.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.523 2.149 . . . . 0.0 112.063 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 28.79 1.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 110.216 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 82.3 m -153.8 72.81 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.474 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -75.82 178.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.342 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.528 ' CD2' HG13 ' A' ' 11' ' ' VAL . 72.5 m-85 -152.15 88.48 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.116 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.552 ' CG1' HG12 ' A' ' 50' ' ' ILE . 44.0 t -90.91 125.14 43.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.483 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 45.2 t -125.27 115.35 20.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.76 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.2 m-85 -82.97 122.7 28.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -122.6 129.8 52.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 111.972 -179.044 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.0 mt -44.13 124.33 3.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.019 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -31.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.88 -31.41 72.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' A' ' 4' ' ' PHE . 68.4 mt -76.39 138.2 67.67 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.049 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.6 -164.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.501 2.134 . . . . 0.0 111.928 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 57.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.963 0.411 . . . . 0.0 111.138 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 104' ' ' LEU . 6.3 tp -142.04 -35.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.605 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.554 ' O ' HG12 ' A' ' 108' ' ' ILE . 5.0 tp -62.8 -62.57 5.45 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.49 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 3.2 Cg_endo -46.61 -30.4 8.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.442 2.094 . . . . 0.0 111.034 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.579 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.4 mp -71.35 -40.23 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.182 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.72 -25.81 44.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 104' ' ' LEU . 15.8 mm -68.1 -46.02 82.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.457 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.498 ' HB2' HG22 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -72.01 -58.08 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -28.6 62.29 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -74.02 -47.3 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.485 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 7.9 mt -54.43 -26.07 28.55 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -71.89 -18.63 62.03 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.772 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.32 -21.37 59.74 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.047 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.501 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 8.9 m-85 -95.42 -49.98 5.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.441 ' HB3' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 84.68 -22.72 0.19 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.496 ' O ' ' CD2' ' A' ' 123' ' ' LEU . 3.1 t -85.51 8.22 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.684 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.7 p-10 -69.84 55.43 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -118.82 34.96 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.573 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -150.96 149.22 29.35 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.041 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.439 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.9 m-80 -69.63 25.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.609 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.9 tt0 -167.0 25.7 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.684 HD22 ' HA ' ' A' ' 118' ' ' ASN . 6.6 tt -128.0 -49.46 1.34 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.589 ' HB2' ' HB2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -56.65 -45.19 81.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.1 m -46.39 -31.27 2.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.117 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.77 -58.04 8.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.98 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.501 ' CD2' ' CD2' ' A' ' 115' ' ' TYR . 2.6 m170 -58.76 -36.05 73.73 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.488 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.2 t -52.59 -48.53 47.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.511 ' HA2' HD11 ' A' ' 132' ' ' LEU . . . -71.29 -51.46 17.34 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.394 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -61.98 -20.92 64.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.756 0.312 . . . . 0.0 111.038 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.499 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 66.8 mt -91.2 -27.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.511 HD11 ' HA2' ' A' ' 129' ' ' GLY . 0.3 OUTLIER -63.8 -36.99 85.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.287 178.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -64.52 -34.2 77.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.87 -14.43 54.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.957 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 132' ' ' LEU . 43.2 t80 -53.29 -60.16 3.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.027 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.428 ' CE1' ' HG2' ' A' ' 137' ' ' GLU . 27.6 p80 -56.31 -37.8 70.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.034 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 1.3 mm-40 -56.91 -30.9 64.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 110.009 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -34.93 44.78 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.968 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.429 HD13 ' CE1' ' A' ' 135' ' ' PHE . 25.3 mt -65.41 -32.46 74.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.627 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 82.9 t -75.49 -47.12 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.239 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -31.41 72.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.097 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -29.74 69.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.729 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -57.29 -26.62 61.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.994 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -102.51 38.05 1.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 111.061 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -114.23 -36.16 4.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 t -155.42 86.88 1.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 12.8 mt -155.39 -176.88 6.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -59.41 -74.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.772 0.32 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.16 123.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.2 95.2 3.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.417 ' CD1' HG12 ' A' ' 100' ' ' ILE . 16.0 m-85 -60.05 -177.12 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.48 116.79 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.094 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.464 ' CG2' HG13 ' A' ' 108' ' ' ILE . 97.5 t -70.16 146.77 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.686 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -81.72 -62.92 1.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.713 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 7.5 m-85 -143.48 111.78 6.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 3.2 t -106.35 97.35 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.577 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.417 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 2.5 tt0 -98.96 110.04 22.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.256 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 92' ' ' TYR . 58.4 t -77.6 158.79 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 91' ' ' VAL . 1.4 mp -147.16 120.41 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HB2' HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.54 113.89 27.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 178.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.58 34.61 17.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.534 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 22.93 62.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.688 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.45 119.52 13.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 3.2 m -50.95 128.61 21.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.121 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -107.08 -42.02 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.617 0.723 . . . . 0.0 109.476 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -128.62 175.24 8.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.331 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.473 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -170.11 124.16 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.385 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 35.2 t -109.56 73.0 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.713 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -107.17 82.85 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.312 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.24 141.6 23.28 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.47 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.47 141.29 11.15 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.758 2.305 . . . . 0.0 112.04 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -179.16 143.67 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.861 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.533 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -100.89 54.29 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.896 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 71.12 3.15 4.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.877 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.75 -82.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 111.317 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 27' ' ' LYS . 1.3 tt0 -176.73 -39.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.816 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -72.08 -80.65 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.985 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.2 139.64 50.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.866 0.365 . . . . 0.0 110.861 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.28 -166.82 40.0 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.6 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 89.1 m -155.23 -44.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 111.144 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 23.6 mt -59.83 153.13 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -175.07 -79.6 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.673 179.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.5 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.8 OUTLIER -134.48 60.66 1.69 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.54 -43.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.972 0.415 . . . . 0.0 111.401 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.426 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 11.2 m120 -101.85 30.48 4.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.03 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.48 26.46 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.135 0.493 . . . . 0.0 110.691 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -114.08 -30.2 6.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.213 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.463 ' CG2' ' CE1' ' A' ' 46' ' ' PHE . 2.6 mm -56.31 113.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.458 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.511 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 8.9 t -78.56 151.54 77.44 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.474 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 87.2 Cg_exo -45.83 -22.37 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.099 1.866 . . . . 0.0 111.184 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.511 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 66.1 t -66.24 -49.61 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.414 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.417 HD13 ' CG2' ' A' ' 42' ' ' THR . 2.3 mp -58.76 -31.97 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.498 ' CZ ' ' CE1' ' A' ' 8' ' ' TYR . 72.3 m-85 -80.09 -42.71 23.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.05 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.627 ' HD2' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -69.98 -23.9 63.24 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.162 0.505 . . . . 0.0 110.595 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.627 ' N ' ' HD2' ' A' ' 47' ' ' HIS . 4.9 t-20 -89.01 -33.83 17.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.857 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 53' ' ' MET . 4.9 mt -56.9 -61.36 2.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.699 HG21 HD23 ' A' ' 55' ' ' LEU . 5.3 mt -51.95 -62.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.431 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.603 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.05 -44.6 41.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.119 -178.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 48' ' ' ASN . 17.2 m-20 -91.15 -19.49 23.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.45 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 71.5 mmm -114.84 -61.18 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.513 ' HB ' HG21 ' A' ' 50' ' ' ILE . 91.9 t -68.04 -56.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.699 HD23 HG21 ' A' ' 50' ' ' ILE . 2.7 mm? -46.54 -51.69 34.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 13.2 Cg_exo -69.91 3.22 2.97 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.519 2.146 . . . . 0.0 112.07 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.13 22.96 1.36 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.334 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.438 HG22 HG11 ' A' ' 91' ' ' VAL . 3.0 p -86.73 154.84 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.716 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.458 ' C ' ' H ' ' A' ' 61' ' ' ILE . 3.4 m -129.82 148.0 67.73 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.872 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 91.4 Cg_endo -78.15 23.33 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.668 1.579 . . . . 0.0 112.014 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.458 ' H ' ' C ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER 41.73 -168.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.404 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -96.29 -17.35 20.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 110.175 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.72 40.59 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.517 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 71.6 74.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.296 . . . . 0.0 110.448 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.413 ' HG2' HG23 ' A' ' 61' ' ' ILE . 6.9 mmtt -116.0 21.3 13.87 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.583 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 29.3 t 44.72 96.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.5 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.422 HG21 ' CZ ' ' A' ' 81' ' ' TYR . 89.7 m -103.71 138.19 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 111.65 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 8.6 ttpt -94.25 135.79 35.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.81 -29.56 41.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m 51.28 27.21 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.05 0.452 . . . . 0.0 110.816 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.0 tpt -112.7 -13.28 13.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 62.67 69.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 0.0 110.599 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.447 ' CD2' ' HB2' ' A' ' 53' ' ' MET . 6.8 mp -70.7 -49.65 44.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.514 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -126.69 158.34 37.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' N ' HG23 ' A' ' 74' ' ' ILE . 24.2 t0 -99.34 141.12 32.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.431 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.59 -34.06 5.71 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.098 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.514 ' CE1' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -131.58 168.89 16.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.105 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 64.9 m-20 -112.75 125.76 54.68 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 10.7 m -86.17 121.65 29.07 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 74.7 m-85 -124.02 164.61 19.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.344 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 29.9 p90 -154.98 121.46 5.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.438 . . . . 0.0 111.149 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.412 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -125.08 119.26 28.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.378 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 23.8 p -85.31 143.53 28.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.9 0.381 . . . . 0.0 111.073 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -46.82 135.97 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.11 -30.07 66.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.258 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 18.9 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.624 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -154.98 92.16 2.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.441 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.07 -17.0 53.87 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.325 2.017 . . . . 0.0 111.779 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -95.13 33.55 1.52 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.413 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 16.2 m -152.87 69.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 1.2 t -65.91 173.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.148 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 11' ' ' VAL . 56.1 m-85 -147.1 95.04 2.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.224 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.5 ' CG2' ' CD1' ' A' ' 12' ' ' ILE . 21.5 t -86.21 137.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 111.542 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 0.0 OUTLIER -132.08 128.79 38.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.798 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.491 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 6.5 m-85 -109.97 85.64 2.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.437 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.31 128.2 37.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.156 0.503 . . . . 0.0 111.179 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' CD2' HG13 ' A' ' 34' ' ' ILE . 13.1 mt -46.35 127.35 8.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.213 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -44.24 -30.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.695 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -32.22 70.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.67 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.417 HG12 ' CD1' ' A' ' 4' ' ' PHE . 43.0 mt -83.31 136.94 42.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.808 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.28 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.501 2.134 . . . . 0.0 112.311 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.56 63.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.938 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.457 HG21 ' CZ ' ' A' ' 135' ' ' PHE . 5.5 tp -145.13 -43.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.67 ' O ' HG12 ' A' ' 108' ' ' ILE . 2.8 tp -58.08 -60.21 10.83 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 5.9 Cg_endo -47.28 -35.39 20.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.641 2.227 . . . . 0.0 111.18 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.583 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.5 mp -67.02 -38.07 80.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.775 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.414 ' O ' ' N ' ' A' ' 111' ' ' GLY . 21.5 mmm180 -79.42 -26.95 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.177 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 104' ' ' LEU . 22.6 mm -62.97 -47.87 90.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.069 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.499 ' HB2' HG23 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -70.73 -56.34 6.62 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.0 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -56.3 -26.15 51.04 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.501 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -74.38 -47.17 17.63 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.499 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 9.9 mt -54.98 -31.33 60.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -72.08 -17.72 61.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.253 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.37 -22.38 60.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.28 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.514 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 5.5 m-85 -85.68 -93.66 0.08 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 8.0 tt0 161.89 -25.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.674 0.273 . . . . 0.0 111.031 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.23 -89.48 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.652 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.435 ' HA ' HD21 ' A' ' 123' ' ' LEU . 2.0 p-10 40.87 31.37 0.12 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.89 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.5 34.38 4.37 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.0 OUTLIER -145.99 151.58 38.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.606 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.437 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.9 p30 -72.0 22.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.517 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.6 tt0 -165.71 26.93 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.448 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 6.2 tt -130.0 -50.23 1.12 Allowed 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -54.36 -46.89 73.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.148 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.474 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 11.7 p -47.48 -29.65 2.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.544 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.45 -59.1 5.76 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.114 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' CD2' ' A' ' 115' ' ' TYR . 5.5 m170 -55.99 -38.5 70.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.527 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 132' ' ' LEU . 46.0 t -49.61 -51.14 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.95 -48.65 68.94 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.152 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -20.97 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 111.091 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.508 HD11 ' C ' ' A' ' 127' ' ' HIS . 31.3 mt -90.66 -29.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.468 ' HG ' ' CD1' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -62.02 -42.18 98.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.153 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.72 -32.19 73.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.658 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -80.04 -12.66 59.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.457 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 5.9 t80 -47.67 -52.12 19.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.923 0.392 . . . . 0.0 111.105 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -56.65 -42.36 78.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -51.08 -32.25 21.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 110.237 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -78.15 -35.41 48.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.914 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.456 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 24.6 mt -66.09 -33.07 74.95 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.796 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.47 -47.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.076 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -33.28 74.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.891 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -34.28 77.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.276 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 63.71 2.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.828 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.85 -42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.954 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -80.07 135.45 36.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 t 43.6 54.98 5.2 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.47 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 tp -85.37 110.99 19.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -79.86 71.55 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.763 -179.892 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.741 0.305 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 136' ' ' HIS . 0.8 OUTLIER -74.0 154.09 39.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.45 76.3 1.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CD2' HG12 ' A' ' 100' ' ' ILE . 5.8 m-85 -78.12 -175.23 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.76 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.401 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 3.9 t-20 -171.21 110.13 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.24 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.481 ' CG2' HG13 ' A' ' 108' ' ' ILE . 51.7 t -62.33 133.11 28.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.617 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.458 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -62.48 -61.43 2.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.111 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.633 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 6.2 m-85 -148.56 112.41 5.12 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.48 HG22 ' CG1' ' A' ' 6' ' ' VAL . 4.7 t -105.19 101.45 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.536 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.51 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.1 tt0 -109.96 121.58 45.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.844 0.354 . . . . 0.0 111.726 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.453 HG12 ' CD1' ' A' ' 92' ' ' TYR . 98.1 t -80.65 161.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.9 mp -142.89 113.21 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.491 ' HB2' HG12 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -98.95 110.29 22.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.892 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.86 34.45 17.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.06 26.1 60.72 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.032 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.441 ' N ' HG23 ' A' ' 12' ' ' ILE . 64.8 mm-40 -138.23 114.25 10.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.955 0.407 . . . . 0.0 109.938 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.479 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -49.46 130.84 20.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.959 -178.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.491 HG12 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.61 -47.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 109.993 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.452 ' OG ' ' CD2' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -118.44 172.01 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.224 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 58.0 p -170.16 125.99 0.79 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.555 ' HB2' HD23 ' A' ' 124' ' ' LEU . 15.8 t -113.24 69.68 0.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.633 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -105.3 90.59 3.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.933 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.07 139.94 21.87 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.393 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.31 147.84 18.43 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.646 2.231 . . . . 0.0 112.261 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.5 p90 178.77 136.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.792 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 22.3 mt-30 -99.1 60.37 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.988 0.423 . . . . 0.0 110.707 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt 64.17 129.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.819 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -85.17 -80.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.191 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -134.59 75.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.154 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 55.2 23.84 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 4.3 m-85 -123.82 31.3 5.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.719 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.428 ' HA2' ' CD1' ' A' ' 97' ' ' LEU . . . -150.21 -152.55 5.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.602 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 94.5 m -159.73 -41.93 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.693 0.282 . . . . 0.0 111.089 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 6.3 mt -59.41 141.24 16.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.329 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -173.04 -78.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.812 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.499 ' N ' ' OG1' ' A' ' 35' ' ' THR . 26.0 m -131.85 61.53 1.65 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.784 0.326 . . . . 0.0 111.015 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 176.79 -35.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.568 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 77' ' ' PHE . 10.4 m120 -110.8 32.26 5.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.508 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.43 26.77 6.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.068 0.461 . . . . 0.0 110.666 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -121.64 29.22 7.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.771 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.51 ' CG2' ' HB ' ' A' ' 45' ' ' ILE . 1.1 mt -124.5 122.18 63.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.417 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 8.9 t -83.14 151.34 63.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.459 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 85.5 Cg_exo -45.29 -22.92 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.27 1.98 . . . . 0.0 111.697 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 47.4 t -66.56 -44.74 89.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.071 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.51 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 1.8 mp -59.1 -32.01 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.505 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 38.6 m-85 -81.58 -43.47 18.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.059 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.63 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.66 -29.13 70.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.346 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.11 -28.37 19.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.3 mt -62.68 -60.39 3.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.517 HG21 ' HB ' ' A' ' 54' ' ' VAL . 5.3 mt -51.79 -63.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.73 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.63 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.27 -43.43 61.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.18 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.64 -15.65 30.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.451 ' N ' ' O ' ' A' ' 49' ' ' LEU . 65.2 mmm -123.57 -69.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.517 ' HB ' HG21 ' A' ' 50' ' ' ILE . 93.0 t -52.33 -51.7 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.694 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.444 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mm? -53.87 -59.15 10.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.669 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 30.4 Cg_endo -64.27 3.93 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.093 1.862 . . . . 0.0 112.487 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.414 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.4 OUTLIER -144.62 22.7 1.63 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.099 0.476 . . . . 0.0 110.129 179.443 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.522 HG22 ' CD2' ' A' ' 81' ' ' TYR . 4.6 p -87.8 166.88 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' A' ' 61' ' ' ILE . 34.6 m -148.67 148.04 26.75 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.244 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 61' ' ' ILE . 64.3 Cg_endo -78.18 25.73 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.048 1.832 . . . . 0.0 112.762 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.476 HG21 ' C ' ' A' ' 64' ' ' ASN . 3.4 mp 53.04 160.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.315 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.74 -65.81 1.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.055 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.4 31.8 3.2 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.602 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.476 ' C ' HG21 ' A' ' 61' ' ' ILE . 6.8 t30 -146.5 -146.0 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.67 141.46 0.15 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.597 0.237 . . . . 0.0 110.738 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.617 ' HB ' HG13 ' A' ' 106' ' ' ILE . 11.8 t 66.35 72.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 CA-C-O 120.839 0.352 . . . . 0.0 110.457 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.5 m -93.31 144.74 25.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 111.694 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HD2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -90.9 133.72 35.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.43 ' HB3' ' HG2' ' A' ' 71' ' ' MET . 10.7 mmm -54.4 -32.51 57.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.9 m 58.34 27.32 15.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.43 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 40.3 mmm -107.71 -15.68 14.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.03 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 66.89 61.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.896 0.379 . . . . 0.0 110.374 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.44 -46.95 86.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.131 0.491 . . . . 0.0 110.382 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 74' ' ' ILE . 1.5 mt -136.47 154.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.447 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.432 ' N ' HG23 ' A' ' 74' ' ' ILE . 6.3 t0 -94.06 139.47 30.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.629 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.06 -32.42 7.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.506 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 74' ' ' ILE . 6.2 m-85 -110.31 -179.47 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.03 0.443 . . . . 0.0 111.876 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -129.4 113.17 14.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.936 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.1 p -83.66 108.79 16.97 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.439 ' CE2' ' HD2' ' A' ' 68' ' ' LYS . 47.4 m-85 -121.97 155.73 34.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.199 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.522 ' CD2' HG22 ' A' ' 58' ' ' VAL . 17.8 p90 -147.57 137.64 22.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.06 0.457 . . . . 0.0 111.263 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -140.85 117.66 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.775 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 6.8 p -82.53 146.89 28.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.802 0.334 . . . . 0.0 110.786 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.52 138.4 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.0 0.429 . . . . 0.0 111.209 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -51.91 -24.93 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.981 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 20.52 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -146.48 93.41 4.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.66 0.267 . . . . 0.0 111.129 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.3 -14.59 43.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.309 2.006 . . . . 0.0 111.934 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.13 30.98 2.27 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.313 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.3 m -154.58 71.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.52 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -70.07 175.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.668 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.453 ' CD1' HG12 ' A' ' 11' ' ' VAL . 43.3 m-85 -151.12 97.88 2.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.931 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.498 ' CG2' HG23 ' A' ' 50' ' ' ILE . 24.5 t -101.44 127.13 55.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 111.692 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.95 117.43 30.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.06 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 1.1 m-85 -92.66 73.92 5.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.65 -174.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.012 0.434 . . . . 0.0 111.22 -178.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' CD1' ' HA2' ' A' ' 32' ' ' GLY . 57.4 mt -101.1 126.08 47.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.288 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -42.61 -36.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -38.83 92.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.493 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.445 HG12 ' CD2' ' A' ' 4' ' ' PHE . 86.1 mt -65.28 139.07 97.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.803 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -57.48 -171.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.528 2.152 . . . . 0.0 112.277 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.22 67.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.462 HG21 ' CZ ' ' A' ' 135' ' ' PHE . 8.1 tp -154.66 -38.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.633 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.625 ' O ' HG12 ' A' ' 108' ' ' ILE . 19.1 tp -57.7 -61.03 8.09 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 5.6 Cg_endo -48.39 -34.98 26.85 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.575 2.183 . . . . 0.0 111.08 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.617 HG13 ' HB ' ' A' ' 66' ' ' VAL . 4.1 mp -67.02 -34.54 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.939 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -81.92 -27.76 33.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 179.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 104' ' ' LEU . 7.9 mm -64.19 -46.69 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.427 ' HB2' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -74.92 -49.59 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.188 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.1 t -62.97 -27.91 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . -78.15 -46.37 9.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 7.6 mt -57.39 -32.04 66.42 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -73.51 -17.07 61.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.929 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -22.4 59.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.499 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 6.8 m-85 -85.02 -94.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.7 tt0 159.25 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.346 0.259 . . . . 0.0 110.856 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.41 ' CB ' HD21 ' A' ' 123' ' ' LEU . 7.9 m -92.12 -93.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.681 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 2.0 p30 41.27 30.94 0.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.51 31.17 5.81 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.441 ' OG1' ' HB2' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.47 157.46 44.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.24 178.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.427 ' HA ' ' N ' ' A' ' 20' ' ' SER . 3.6 p30 -78.13 20.73 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.0 tp10 -163.63 25.48 0.08 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.441 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 6.0 tt -126.35 -49.06 1.55 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -55.93 -45.68 78.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -45.59 -30.61 1.54 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.178 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.45 -57.85 11.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.956 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.526 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 4.4 m170 -58.87 -37.3 76.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 43.6 t -51.78 -45.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.414 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.3 -45.7 37.6 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.153 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -66.17 -22.52 66.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.946 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 127' ' ' HIS . 32.8 mt -90.32 -28.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.419 ' CD1' HD13 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -63.6 -42.52 98.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.355 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.18 -40.45 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -81.41 -15.86 53.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.151 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.466 ' CE2' ' CD1' ' A' ' 139' ' ' LEU . 0.3 OUTLIER -53.3 -57.9 8.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.991 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.427 ' CE1' ' HB3' ' A' ' 2' ' ' LYS . 97.7 m-70 -61.21 -45.9 92.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.714 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -50.0 -29.11 7.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.938 0.399 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -77.62 -36.39 51.71 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.11 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.466 ' CD1' ' CE2' ' A' ' 135' ' ' PHE . 19.2 mt -67.08 -29.36 69.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.247 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.6 t -77.62 -48.03 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.504 0.668 . . . . 0.0 109.522 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -65.43 -33.23 75.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.12 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -64.38 -33.23 75.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.267 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.29 -25.45 67.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.99 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.23 55.67 0.65 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -145.92 101.3 3.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.86 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t 43.15 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.56 141.59 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -130.91 33.14 4.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.956 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.953 0.406 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.08 107.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -140.34 -169.63 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.686 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 2.7 m-85 -100.15 152.44 20.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.971 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 179.77 107.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.176 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.48 ' CG1' HG23 ' A' ' 9' ' ' VAL . 2.9 t -68.03 144.74 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.47 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.449 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -90.26 -61.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.796 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.662 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 5.1 m-85 -131.37 141.77 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.51 ' O ' HD22 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -148.69 100.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 12.0 pt-20 -115.02 138.41 50.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.47 HG12 ' CD2' ' A' ' 92' ' ' TYR . 53.0 t -90.86 151.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 91' ' ' VAL . 4.1 mp -131.53 123.8 53.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.534 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 2.7 tttt -113.09 114.83 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.54 33.75 8.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.618 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.422 ' HA2' ' CD1' ' A' ' 55' ' ' LEU . . . 81.68 24.12 56.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.939 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 1.3 tt0 -114.58 -142.91 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.647 0.26 . . . . 0.0 110.583 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.8 m -153.68 75.26 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.534 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.49 -43.08 86.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.704 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.44 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 4.0 p -122.41 170.01 10.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.865 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.535 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 30.6 m -168.23 118.27 0.77 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.0 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.655 ' HB2' HD23 ' A' ' 124' ' ' LEU . 15.8 t -111.48 68.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.662 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -116.1 87.72 2.74 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 1.2 mp0 -125.2 148.76 61.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.84 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.36 140.46 15.33 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.788 2.325 . . . . 0.0 111.359 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 7' ' ' SER . 0.3 OUTLIER -137.82 -33.24 0.72 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.776 -179.367 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.564 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 2.5 tt0 56.0 53.2 9.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER 38.16 91.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.529 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -91.76 97.04 10.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.593 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.54 -72.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.915 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -83.44 143.6 30.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.971 0.415 . . . . 0.0 111.616 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.469 ' OH ' HG13 ' A' ' 100' ' ' ILE . 1.7 t80 59.71 158.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.263 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 27' ' ' LYS . . . -152.69 123.5 1.46 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.906 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.9 m -163.93 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.898 0.38 . . . . 0.0 111.365 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.441 ' C ' ' CG2' ' A' ' 35' ' ' THR . 10.6 mt -77.76 151.1 5.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.498 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 36' ' ' SER . 0.6 OUTLIER -174.31 -84.8 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.178 178.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.488 ' N ' ' OG1' ' A' ' 35' ' ' THR . 65.8 m -128.25 42.87 3.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.88 -46.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.427 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 73.7 m-20 -106.21 30.57 5.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.871 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.29 27.54 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -107.95 -36.27 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.772 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.469 HG21 ' CZ ' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -56.58 119.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.68 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.59 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 13.2 t -81.14 157.23 71.23 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.389 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.59 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 54.2 Cg_exo -50.88 -21.74 8.96 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 121.917 1.744 . . . . 0.0 111.051 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.575 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 48.1 t -66.16 -47.8 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.402 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.445 ' HB ' HG22 ' A' ' 41' ' ' ILE . 1.9 mp -58.58 -33.3 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.469 ' CZ ' HG21 ' A' ' 41' ' ' ILE . 68.3 m-85 -81.36 -40.84 22.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.732 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.571 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -67.09 -27.28 67.22 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 44' ' ' VAL . 5.6 m-80 -88.28 -28.64 20.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.8 mt -61.47 -60.23 4.03 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.591 HG22 ' CD2' ' A' ' 55' ' ' LEU . 6.4 mt -51.52 -64.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.723 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.571 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -49.8 -40.37 41.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.661 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -91.14 -16.62 27.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.495 ' N ' ' O ' ' A' ' 49' ' ' LEU . 69.3 mmm -124.64 -68.69 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 90.5 t -51.99 -51.52 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.697 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.591 ' CD2' HG22 ' A' ' 50' ' ' ILE . 1.8 mm? -56.59 -58.19 18.76 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.849 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 28.0 Cg_endo -63.25 1.73 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.113 1.875 . . . . 0.0 112.662 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 55' ' ' LEU . 3.2 tptt -147.24 26.35 1.07 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.106 0.479 . . . . 0.0 109.942 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.484 HG23 ' CD2' ' A' ' 81' ' ' TYR . 5.7 p -85.27 167.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.895 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.462 ' C ' ' H ' ' A' ' 61' ' ' ILE . 17.3 m -137.74 146.34 52.48 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.157 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.72 29.75 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.121 1.881 . . . . 0.0 112.19 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 59' ' ' VAL . 31.6 mm 41.72 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.217 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.0 -25.75 17.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.573 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.29 40.22 0.1 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.988 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -126.64 -62.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 111.166 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.421 ' HA ' HG21 ' A' ' 61' ' ' ILE . 0.1 OUTLIER 68.74 99.78 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.979 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.581 ' HB ' HG13 ' A' ' 106' ' ' ILE . 3.5 t 76.06 65.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.664 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.9 m -92.82 135.38 34.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.436 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 3.2 tttt -87.09 125.6 34.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.414 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.564 ' HG2' HD11 ' A' ' 73' ' ' LEU . 1.4 ttm -52.34 -36.08 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m 58.47 24.48 11.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.494 ' CG ' ' HG2' ' A' ' 69' ' ' MET . 17.3 mmt -101.2 6.43 43.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.39 53.05 10.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.564 HD11 ' HG2' ' A' ' 69' ' ' MET . 8.2 mp -59.98 -32.83 71.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.623 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.456 HD11 HG23 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -153.42 151.49 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -95.71 138.9 32.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.31 -32.8 6.22 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.204 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.432 ' CD1' HG23 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -131.74 175.46 9.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.342 . . . . 0.0 111.004 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -119.56 123.92 45.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.8 t -82.01 101.03 10.06 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 19.6 m-85 -109.26 126.09 52.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.491 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.484 ' CD2' HG23 ' A' ' 58' ' ' VAL . 52.5 p90 -120.12 135.64 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.072 0.463 . . . . 0.0 111.28 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.91 116.29 11.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.418 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 74.5 p -86.11 154.16 21.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -49.6 155.21 0.83 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -68.25 -20.85 64.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.2 22.27 0.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.611 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.59 89.88 7.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.2 -16.93 43.22 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.362 2.041 . . . . 0.0 111.982 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.67 30.59 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.447 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.0 m -154.84 73.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.806 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.575 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.7 OUTLIER -75.96 177.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.47 ' CD2' HG12 ' A' ' 11' ' ' VAL . 36.2 m-85 -149.42 106.89 3.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.517 ' CG1' HG12 ' A' ' 50' ' ' ILE . 44.3 t -104.89 137.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.19 0.519 . . . . 0.0 111.754 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 45.3 t -138.7 110.27 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.727 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.508 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.5 m-85 -87.0 83.93 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.451 ' CG2' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -82.01 130.18 35.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.885 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.406 HD12 ' CE2' ' A' ' 31' ' ' TYR . 87.0 mt -46.61 126.88 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.698 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -44.45 -33.06 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.419 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -61.03 -18.18 56.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.342 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.469 HG13 ' OH ' ' A' ' 31' ' ' TYR . 4.7 mt -87.26 136.47 33.54 Favored Pre-proline 0 N--CA 1.461 0.113 0 CA-C-O 120.501 0.191 . . . . 0.0 110.773 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 100' ' ' ILE . 38.0 Cg_exo -59.56 -157.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.304 2.003 . . . . 0.0 111.645 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -112.83 63.7 0.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.693 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.421 ' CA ' HD13 ' A' ' 106' ' ' ILE . 3.3 tp -150.91 -40.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.843 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.59 ' O ' HG12 ' A' ' 108' ' ' ILE . 29.1 tp -58.14 -62.28 5.83 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.125 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 6.7 Cg_endo -49.05 -27.32 11.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.265 1.976 . . . . 0.0 111.486 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.581 HG13 ' HB ' ' A' ' 66' ' ' VAL . 4.3 mp -76.15 -34.68 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -84.07 -27.51 28.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.395 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.59 HG12 ' O ' ' A' ' 104' ' ' LEU . 7.7 mm -71.35 -51.6 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.63 -55.71 14.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.595 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -60.78 -25.86 66.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.563 ' HA3' HD12 ' A' ' 131' ' ' ILE . . . -71.32 -50.8 19.96 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.431 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 5.3 mt -52.94 -27.84 20.77 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.82 -21.47 57.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' HG3' ' CD1' ' A' ' 115' ' ' TYR . 0.4 OUTLIER -75.18 -19.53 59.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.452 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.45 ' O ' ' CB ' ' A' ' 116' ' ' GLU . 29.7 m-85 -82.12 -92.57 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.71 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.45 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 16.0 tt0 157.94 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.697 0.399 . . . . 0.0 110.621 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -92.89 -92.75 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.424 ' HA ' HD22 ' A' ' 123' ' ' LEU . 4.0 p-10 40.61 31.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 110.98 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.93 33.64 4.48 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.93 159.62 42.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.751 0.31 . . . . 0.0 110.421 179.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HA ' ' N ' ' A' ' 20' ' ' SER . 6.1 p30 -78.78 19.43 0.51 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -163.41 24.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.054 0.454 . . . . 0.0 109.799 178.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.442 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 6.0 tt -124.53 -49.66 1.77 Allowed 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.463 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.655 HD23 ' HB2' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -55.23 -47.43 75.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 96.6 p -46.23 -31.94 2.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.301 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -55.36 34.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 7.8 m170 -58.3 -37.29 74.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.431 ' O ' HD13 ' A' ' 132' ' ' LEU . 46.9 t -50.48 -49.89 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.976 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.488 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -69.72 -49.24 37.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.843 -1.17 . . . . 0.0 112.334 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -64.18 -18.77 64.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.645 0.26 . . . . 0.0 111.246 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.563 HD12 ' HA3' ' A' ' 111' ' ' GLY . 53.6 mt -90.71 -28.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.488 HD12 ' HA2' ' A' ' 129' ' ' GLY . 0.3 OUTLIER -64.1 -40.71 96.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.06 178.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.75 -32.4 74.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.433 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.99 -15.92 37.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.927 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.451 ' CZ ' ' CE1' ' A' ' 4' ' ' PHE . 34.3 t80 -50.81 -38.41 48.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.714 0.293 . . . . 0.0 110.919 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.415 ' NE2' ' NH1' ' A' ' 3' ' ' ARG . 9.5 m170 -60.2 -45.92 91.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.616 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -50.35 -29.41 9.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.084 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -78.36 -35.99 46.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.888 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.426 HD21 ' CZ ' ' A' ' 135' ' ' PHE . 30.9 mt -63.72 -35.03 79.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.307 0.575 . . . . 0.0 109.558 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 79.5 t -74.62 -47.78 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.01 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -61.37 -30.08 70.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.989 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -16.35 63.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.701 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -90.55 21.89 3.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.367 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.16 -43.93 1.62 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.703 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.23 -77.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.97 127.98 56.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.872 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.6 mp -124.23 179.57 4.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 60.3 30.96 20.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.851 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.715 0.293 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 61.38 113.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.837 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -88.61 -167.01 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CD2' HG12 ' A' ' 100' ' ' ILE . 2.3 m-85 -142.84 -178.23 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.984 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.47 118.79 4.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.518 HG12 ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -71.98 146.07 11.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.438 179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.444 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -83.44 -59.9 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.0 111.563 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.636 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 11.4 m-85 -146.66 125.11 12.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.732 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 6' ' ' VAL . 2.4 t -120.19 93.76 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.0 OUTLIER -100.95 116.83 33.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG22 ' OG ' ' A' ' 19' ' ' SER . 95.0 t -89.28 136.34 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.2 mp -114.2 119.11 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 3.5 tttt -104.86 107.88 19.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.083 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 61.96 37.71 14.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.629 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 26.24 60.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.637 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.72 115.9 6.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.0 109.993 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 24.7 m -47.1 127.74 10.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.208 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -99.91 -42.38 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.467 ' OG ' HG22 ' A' ' 11' ' ' VAL . 94.4 p -132.7 177.12 7.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.3 OUTLIER -169.85 125.8 0.83 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 36.5 t -107.64 69.79 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.825 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.636 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -106.12 84.83 2.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.83 142.96 25.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.548 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.59 145.63 13.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.819 2.346 . . . . 0.0 112.253 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 p90 179.19 115.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.811 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.622 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.5 pt20 -78.8 59.15 2.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.753 0.311 . . . . 0.0 111.193 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 tttt 58.22 162.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.082 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -114.23 43.71 1.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.857 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 45.36 35.44 1.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.393 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -175.89 -55.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.807 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -123.5 102.69 8.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.947 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.46 -171.16 38.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.534 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.2 m -163.89 -42.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.622 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 13.8 mt -56.19 161.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.313 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' A' ' 36' ' ' SER . 0.4 OUTLIER -173.0 -79.27 0.01 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.673 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.51 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.4 OUTLIER -134.67 -57.46 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.929 0.395 . . . . 0.0 111.181 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.65 -26.24 65.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.336 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -120.36 32.14 6.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.195 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -131.54 27.39 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.978 0.418 . . . . 0.0 110.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -109.92 -36.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.805 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.497 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -50.93 116.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.754 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.418 ' H ' HD13 ' A' ' 45' ' ' ILE . 2.7 t -78.68 149.66 74.84 Favored Pre-proline 0 CA--C 1.518 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.623 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.532 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.8 Cg_endo -45.19 -22.57 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 111.079 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.6 t -64.51 -47.29 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.893 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 42' ' ' THR . 1.7 mp -58.33 -32.71 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.497 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 90.0 m-85 -80.71 -43.29 20.52 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.337 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.639 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.03 -28.19 69.92 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.82 -30.73 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 53' ' ' MET . 5.3 mt -61.71 -61.61 2.39 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.505 HG23 ' HB ' ' A' ' 54' ' ' VAL . 5.6 mt -50.04 -61.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.976 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.639 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -51.72 -43.4 62.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.066 -1.424 . . . . 0.0 113.075 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.86 -19.58 23.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.469 ' N ' ' O ' ' A' ' 49' ' ' LEU . 85.0 mmm -118.23 -65.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 ' HB ' HG23 ' A' ' 50' ' ' ILE . 94.9 t -58.3 -57.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.8 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.446 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mm? -44.91 -57.15 7.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.7 Cg_endo -65.92 4.63 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 121.969 1.779 . . . . 0.0 112.426 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -145.89 23.38 1.38 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.124 0.488 . . . . 0.0 110.07 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.517 HG21 ' CD2' ' A' ' 81' ' ' TYR . 5.1 p -86.33 166.65 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.878 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 61' ' ' ILE . 32.6 m -135.97 146.66 57.68 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.101 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.402 ' O ' ' O ' ' A' ' 61' ' ' ILE . 72.5 Cg_endo -75.84 28.81 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.166 1.911 . . . . 0.0 112.561 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.451 ' H ' ' C ' ' A' ' 59' ' ' VAL . 38.9 mm 41.13 103.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.631 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -26.43 14.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.56 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -173.69 39.27 0.14 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.274 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.11 -69.25 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 72.37 108.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.08 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.603 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 2.7 t 72.71 59.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.795 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -92.3 135.68 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.46 ' CE ' ' CZ ' ' A' ' 80' ' ' PHE . 8.0 ttmt -81.44 128.39 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.448 ' HG2' ' CE1' ' A' ' 81' ' ' TYR . 16.3 mmm -52.8 -25.59 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.193 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 m 53.97 25.89 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.9 tpt -104.34 -17.15 14.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 65.94 62.2 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.18 -52.6 46.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.739 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.489 HG22 ' CE2' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -122.35 158.86 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.414 ' N ' HG23 ' A' ' 74' ' ' ILE . 23.3 t0 -104.23 141.53 36.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.424 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.39 -34.48 5.37 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.164 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.489 ' CE2' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -126.17 -171.76 2.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.672 0.272 . . . . 0.0 110.56 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 2.4 m-20 -127.97 127.4 43.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.2 p -82.5 103.41 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.46 ' CZ ' ' CE ' ' A' ' 68' ' ' LYS . 29.5 m-85 -115.91 136.34 53.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.517 ' CD2' HG21 ' A' ' 58' ' ' VAL . 48.8 p90 -130.92 140.01 50.14 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.846 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 2.0 t -144.28 123.34 12.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.45 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 44.8 p -87.0 153.28 21.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 0.0 110.964 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -47.09 158.36 0.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.209 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.51 0.73 45.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.559 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.48 21.63 0.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.77 102.08 1.31 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.53 0.205 . . . . 0.0 111.329 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.28 -15.11 48.55 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.452 2.101 . . . . 0.0 111.803 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -95.81 30.37 2.39 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.144 0.497 . . . . 0.0 110.14 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.412 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 86.0 m -151.51 71.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -73.55 178.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.451 ' CD2' HG21 ' A' ' 11' ' ' VAL . 49.1 m-85 -152.98 84.19 1.21 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.175 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.484 ' CG1' HG12 ' A' ' 50' ' ' ILE . 59.8 t -98.52 132.32 43.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.411 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 9' ' ' VAL . 21.5 p -139.48 131.44 27.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.097 0.475 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 37.7 m-85 -89.33 91.07 8.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.061 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -85.92 137.0 33.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 7' ' ' SER . 89.1 mt -48.5 127.75 13.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -37.91 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.358 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.15 -25.33 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.463 HG12 ' CD2' ' A' ' 4' ' ' PHE . 76.2 mt -80.2 138.43 52.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.876 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -60.98 176.99 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.459 2.106 . . . . 0.0 112.069 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -94.37 61.15 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 104' ' ' LEU . 6.1 tp -149.59 -32.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.996 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.554 ' O ' HG12 ' A' ' 108' ' ' ILE . 16.4 tp -61.59 -62.17 6.42 Favored Pre-proline 0 C--O 1.226 -0.143 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.049 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.482 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 7.6 Cg_endo -49.02 -29.71 16.35 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.397 2.065 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.603 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.3 mp -72.73 -35.94 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.83 -26.62 34.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.077 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 104' ' ' LEU . 19.6 mm -73.83 -51.27 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -67.28 -57.37 6.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -59.22 -25.91 64.41 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.452 ' HA3' HD12 ' A' ' 131' ' ' ILE . . . -73.97 -45.98 24.5 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.507 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 10.4 mt -55.2 -26.7 40.96 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.62 -18.92 62.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.91 -21.55 61.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.93 0.395 . . . . 0.0 109.966 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.499 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 3.4 m-85 -93.14 -170.68 2.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.468 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -127.12 2.4 6.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.718 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.3 p -114.81 -93.53 0.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.414 ' HA ' HD21 ' A' ' 123' ' ' LEU . 1.5 p-10 41.13 31.82 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.49 35.2 4.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.555 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -151.1 149.86 30.01 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.396 178.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -69.64 28.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.781 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -169.92 27.1 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 126' ' ' SER . 6.0 tt -132.28 -49.64 0.93 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.432 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -54.7 -45.98 74.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 t -47.67 -29.78 3.26 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.359 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.25 -57.82 11.34 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.015 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.507 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 4.1 m170 -57.06 -36.65 70.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.609 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.43 ' O ' HD11 ' A' ' 132' ' ' LEU . 44.3 t -51.79 -48.3 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.21 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.442 ' HA2' HD13 ' A' ' 132' ' ' LEU . . . -72.26 -48.93 22.8 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.54 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -20.69 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 110.701 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 70.3 mt -90.89 -28.2 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.442 HD13 ' HA2' ' A' ' 129' ' ' GLY . 1.1 mt -61.49 -43.69 98.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.028 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.55 -31.0 70.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.25 16.55 26.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.449 ' CE1' ' HB2' ' A' ' 104' ' ' LEU . 1.1 t80 -88.64 -43.48 11.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.446 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.27 -30.94 60.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.79 -28.62 57.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.482 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -80.53 -35.86 33.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.419 HD13 ' CZ ' ' A' ' 135' ' ' PHE . 5.3 mt -70.79 -30.09 66.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 109.942 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.7 t -75.14 -46.8 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.97 -30.38 64.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.843 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.78 -36.61 70.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.382 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.56 -24.8 49.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.096 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -114.26 30.18 7.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.015 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.431 ' O ' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.91 94.79 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.864 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.431 ' CG2' ' O ' ' A' ' 145' ' ' GLN . 11.2 t 46.21 47.67 13.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.438 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.6 mt -117.01 79.52 1.34 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -99.44 91.78 5.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 0.0 110.828 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.975 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.784 0.326 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -158.5 151.1 22.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -117.25 -178.02 3.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.467 ' CD2' HG12 ' A' ' 100' ' ' ILE . 10.5 m-85 -157.63 -176.91 6.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 1.6 t30 -174.65 146.61 1.0 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.942 0.401 . . . . 0.0 111.282 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' CG2' HG13 ' A' ' 108' ' ' ILE . 1.5 t -93.05 122.3 44.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.842 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -53.74 -55.92 21.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.963 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.637 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 4.4 m-85 -147.57 116.38 6.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 3.1 t -108.51 97.27 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.474 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.4 tt0 -105.46 115.63 30.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.449 ' CG2' HD11 ' A' ' 124' ' ' LEU . 6.1 t -79.98 159.54 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.51 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.5 mp -140.15 114.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.458 ' N ' HG12 ' A' ' 18' ' ' ILE . 21.4 tttm -96.93 106.54 18.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.459 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 57.68 39.96 26.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.301 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.92 26.74 59.8 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.228 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -144.56 110.82 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.042 0.448 . . . . 0.0 110.069 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.468 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -42.99 130.23 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.478 -178.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.76 -47.56 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.997 178.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.558 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -127.53 176.62 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.217 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.445 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 2.0 m -168.67 128.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.504 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.495 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 35.9 t -115.29 69.42 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.637 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.73 91.93 3.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.785 -178.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.05 139.94 25.7 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.505 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.75 146.03 18.47 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.687 2.258 . . . . 0.0 111.619 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CD2' ' O ' ' A' ' 25' ' ' PHE . 45.4 p90 -179.34 126.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 111.31 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.615 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.3 pt20 -86.41 54.64 3.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.14 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HD2' HG23 ' A' ' 35' ' ' THR . 0.3 OUTLIER 66.34 -166.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.672 -179.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -135.31 -67.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.725 0.297 . . . . 0.0 111.101 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -124.09 -76.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -108.42 -52.15 2.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.437 ' CD1' ' HA ' ' A' ' 4' ' ' PHE . 45.7 p90 -63.27 -172.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.717 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.45 174.35 47.32 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.682 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 92.6 m -157.82 -43.19 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.8 0.333 . . . . 0.0 110.95 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.615 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 27.2 mt -59.31 159.16 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.491 ' OG1' ' N ' ' A' ' 36' ' ' SER . 0.4 OUTLIER -174.06 -79.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 178.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.491 ' N ' ' OG1' ' A' ' 35' ' ' THR . 2.6 m -143.67 64.06 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.943 0.402 . . . . 0.0 111.041 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.26 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.3 m-20 -101.64 30.81 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.649 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.73 26.58 7.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -108.33 -37.34 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.605 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.504 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.19 117.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.56 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.415 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 3.8 t -78.28 151.06 77.9 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.484 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 72.4 Cg_exo -47.32 -21.05 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.848 1.699 . . . . 0.0 111.042 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' O ' ' N ' ' A' ' 48' ' ' ASN . 46.7 t -65.79 -45.97 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.183 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 1.7 mp -59.57 -33.5 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.504 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 74.3 m-85 -80.11 -43.82 21.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.447 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.24 -28.24 69.6 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.414 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 44' ' ' VAL . 1.6 t-20 -89.49 -29.7 18.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.6 mt -60.67 -60.5 3.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.529 ' CG2' HD23 ' A' ' 55' ' ' LEU . 5.1 mt -51.95 -64.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.704 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.72 -38.18 32.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.787 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -91.04 -23.27 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LEU . 40.7 mmm -119.14 -69.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.49 ' HB ' HG21 ' A' ' 50' ' ' ILE . 88.8 t -53.52 -53.29 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.848 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD23 ' CG2' ' A' ' 50' ' ' ILE . 3.3 mm? -51.85 -58.74 10.04 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.0 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 33.2 Cg_endo -65.38 6.44 0.41 Allowed 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.197 1.931 . . . . 0.0 112.719 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -151.0 25.04 0.74 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.099 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' VAL . 9.8 p -82.49 146.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 61' ' ' ILE . 5.2 t -96.79 138.87 21.36 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.445 ' O ' ' C ' ' A' ' 61' ' ' ILE . 65.4 Cg_endo -74.19 28.16 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.814 1.676 . . . . 0.0 111.952 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.527 ' H ' ' C ' ' A' ' 59' ' ' VAL . 29.1 mm 18.52 85.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.959 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.71 -40.5 8.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.126 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -118.05 -32.22 1.44 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.928 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -82.89 -160.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.44 117.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.717 0.294 . . . . 0.0 111.122 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 5.4 t 65.33 60.97 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.699 0.285 . . . . 0.0 111.217 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.504 HG22 ' CE1' ' A' ' 81' ' ' TYR . 1.4 t -92.8 144.56 25.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.748 0.309 . . . . 0.0 111.113 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.452 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.23 142.2 31.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.406 ' HB3' ' HG2' ' A' ' 71' ' ' MET . 0.0 OUTLIER -60.18 -33.4 72.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.802 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m 59.2 26.21 14.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.306 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.406 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 14.2 mmm -111.66 -0.25 16.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.469 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.87 59.62 3.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.123 0.487 . . . . 0.0 110.516 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 73' ' ' LEU . 7.9 mp -60.45 -45.79 92.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.485 HG21 ' CE1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -139.26 156.32 27.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.684 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' N ' HG22 ' A' ' 74' ' ' ILE . 13.0 t0 -102.47 138.84 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.375 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.7 -31.35 6.64 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.416 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -125.74 -165.0 1.36 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.929 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 1.9 m-20 -137.83 117.94 13.49 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.4 p -87.38 115.51 24.84 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 49.4 m-85 -123.83 151.74 43.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.867 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.504 ' CE1' HG22 ' A' ' 67' ' ' THR . 30.0 p90 -141.87 135.36 29.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.676 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.4 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -140.06 123.78 17.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.591 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.584 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 29.0 p -82.09 147.61 29.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 111.029 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -46.93 141.38 4.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -69.05 -11.65 60.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.621 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.22 19.26 1.74 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 111.568 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -161.98 91.24 1.39 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.2 -18.54 30.24 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.482 2.121 . . . . 0.0 111.99 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -92.7 30.91 1.45 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.485 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 20.5 m -152.74 70.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.639 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -65.5 178.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.124 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.429 ' CE1' ' O ' ' A' ' 90' ' ' THR . 97.3 m-85 -153.56 92.38 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.758 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.477 ' CG2' HG23 ' A' ' 50' ' ' ILE . 24.6 t -97.05 122.87 49.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.786 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.412 ' HB2' ' CD2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -108.92 145.67 35.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.63 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 2.4 m-85 -121.82 80.48 1.69 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.46 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -77.4 177.72 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 100' ' ' ILE . 12.7 mt -93.9 127.78 39.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -40.55 -32.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.21 -34.51 78.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 110.576 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.467 HG12 ' CD2' ' A' ' 4' ' ' PHE . 29.2 mt -73.16 136.95 78.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.879 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.24 -168.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.386 2.058 . . . . 0.0 112.232 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.04 67.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.66 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 104' ' ' LEU . 1.6 tp -150.51 -33.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.503 ' N ' ' HD2' ' A' ' 105' ' ' PRO . 19.8 tp -59.6 -60.14 11.55 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.241 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 9.4 Cg_endo -51.21 -36.72 57.2 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.285 1.99 . . . . 0.0 111.193 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.662 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 2.2 mp -62.02 -40.47 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.231 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.73 -23.99 36.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.983 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.475 HD13 ' CD1' ' A' ' 132' ' ' LEU . 10.3 mm -71.85 -44.32 67.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.425 HD22 ' CG1' ' A' ' 66' ' ' VAL . 0.3 OUTLIER -75.07 -50.9 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -60.64 -30.8 70.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.406 ' C ' ' CD1' ' A' ' 131' ' ' ILE . . . -73.8 -48.94 15.19 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.503 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.13 -32.15 63.97 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.5 -17.26 61.76 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.09 -24.94 62.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.498 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 10.0 m-85 -86.75 -171.54 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -121.32 -1.19 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.613 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 m -114.8 -94.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 124' ' ' LEU . 4.4 p30 40.26 32.33 0.13 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.782 0.325 . . . . 0.0 111.078 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.94 36.09 4.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.558 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.0 OUTLIER -148.81 151.42 34.76 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.008 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.445 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.6 m-80 -70.54 21.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.582 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.533 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.1 tt0 -166.23 28.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.444 ' HB2' ' OG1' ' A' ' 120' ' ' THR . 5.9 tt -132.34 -50.1 0.93 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.449 HD11 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.59 -45.58 77.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.3 p -46.37 -30.24 2.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.0 -57.13 14.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.687 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.503 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.3 m170 -61.25 -31.44 71.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.698 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 132' ' ' LEU . 48.4 t -56.41 -42.23 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.839 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' A' ' 132' ' ' LEU . . . -74.94 -50.4 8.79 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.11 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -26.74 67.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.446 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.486 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 61.7 mt -89.94 -25.82 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.523 ' HB2' ' HA2' ' A' ' 129' ' ' GLY . 2.9 tp -55.91 -45.7 78.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.782 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -44.84 64.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.802 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.43 -26.23 67.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.897 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.477 ' CD2' HD11 ' A' ' 104' ' ' LEU . 1.6 t80 -54.46 -67.57 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.766 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -56.99 -41.36 78.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.813 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -52.35 -27.46 15.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.985 0.421 . . . . 0.0 110.317 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.88 -32.67 34.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.367 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.422 HD12 ' CZ ' ' A' ' 135' ' ' PHE . 11.4 mt -73.82 -29.3 62.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.365 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.0 t -76.3 -48.81 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.587 0.708 . . . . 0.0 109.202 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.48 -33.2 73.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.688 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -25.18 65.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.203 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -96.03 26.74 3.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.076 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -150.32 31.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.86 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -112.47 -76.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 t -134.35 99.75 4.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.998 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.4 mt -128.46 -71.91 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -85.49 -31.5 22.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.799 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.8 mtp . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.842 0.353 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.414 ' HE3' ' CE2' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -135.12 132.37 38.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -125.28 -166.43 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' ' HD2' ' A' ' 101' ' ' PRO . 6.2 m-85 -161.88 177.56 9.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.079 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.417 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 1.5 t-20 -175.68 100.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.299 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.47 HG11 HG22 ' A' ' 9' ' ' VAL . 20.2 t -61.32 119.97 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.378 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.445 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -55.79 -54.88 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.607 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 6.6 m-85 -142.49 135.44 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.841 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG22 HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -129.76 93.11 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.793 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 2.2 mt-10 -106.11 120.77 42.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.577 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 17' ' ' THR . 23.6 t -85.32 159.87 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.727 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.6 mt -138.42 117.54 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.449 ' N ' HG12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -106.04 109.3 21.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.88 0.371 . . . . 0.0 111.487 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 61.18 37.34 17.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.633 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.6 58.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.483 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -146.1 117.54 7.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.279 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -48.01 126.99 11.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.142 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.466 HD12 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -104.76 -45.39 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.457 0.646 . . . . 0.0 109.927 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -125.16 175.87 7.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.397 -179.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 59.5 p -170.19 127.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.509 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.41 ' HB3' HG21 ' A' ' 9' ' ' VAL . 25.5 t -121.58 69.72 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.607 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -106.56 97.66 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -113.69 144.11 30.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.53 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.42 141.08 9.89 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.747 2.298 . . . . 0.0 111.559 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 44.1 p90 -179.79 118.13 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.094 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.635 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 19.3 mt-30 -73.77 67.55 1.19 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.954 0.407 . . . . 0.0 110.654 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -55.51 90.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.979 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.04 90.38 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -176.16 -164.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.824 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -53.91 -25.74 21.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.285 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.417 ' CZ ' ' HB3' ' A' ' 3' ' ' ARG . 16.8 p90 -135.47 93.5 2.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.93 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.435 ' CA ' ' HB3' ' A' ' 27' ' ' LYS . . . 177.17 167.62 35.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.712 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 19.9 m -158.24 -43.01 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.771 0.32 . . . . 0.0 111.73 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 8.1 mt -64.96 151.95 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -165.9 -70.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.567 178.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.522 ' N ' ' OG1' ' A' ' 35' ' ' THR . 50.7 p -143.12 -46.72 0.3 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.074 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.78 -30.66 71.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.175 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 75.2 m-20 -116.13 30.71 7.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.987 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 26.28 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.172 0.51 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -111.59 -32.31 6.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.032 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.478 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.63 119.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.63 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.489 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 10.1 t -82.9 150.77 62.68 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.469 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 84.6 Cg_exo -44.79 -23.43 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.294 1.996 . . . . 0.0 111.779 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.467 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 33.6 t -66.76 -46.45 85.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.176 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.421 HD11 ' CG2' ' A' ' 42' ' ' THR . 2.1 mp -58.26 -33.87 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 88.6 m-85 -80.33 -41.48 24.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.401 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.6 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.59 -28.05 69.36 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.933 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.404 ' N ' ' O ' ' A' ' 44' ' ' VAL . 5.7 m-20 -89.2 -28.55 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 46' ' ' PHE . 4.1 mt -62.33 -60.96 2.82 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.594 HG23 ' HB ' ' A' ' 54' ' ' VAL . 6.3 mt -50.48 -63.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.703 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.6 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -51.55 -41.57 61.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.068 -179.18 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.94 -22.42 20.87 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 49' ' ' LEU . 33.2 mmm -116.77 -60.0 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' HG23 ' A' ' 50' ' ' ILE . 82.7 t -61.38 -60.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.952 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 2.0 mm? -45.4 -54.95 13.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 17.6 Cg_exo -66.61 3.3 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.266 1.977 . . . . 0.0 112.45 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.56 24.89 1.09 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.974 0.416 . . . . 0.0 110.254 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 54' ' ' VAL . 5.6 p -86.28 169.15 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.833 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.437 ' C ' ' H ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -136.38 148.18 63.09 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.38 179.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.18 27.35 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.08 1.853 . . . . 0.0 111.662 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.485 HD11 ' HA ' ' A' ' 65' ' ' LYS . 4.3 mt 36.55 101.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.94 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -60.66 2.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.539 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.95 -23.17 2.79 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.717 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.33 -157.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.598 0.237 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HA ' HD11 ' A' ' 61' ' ' ILE . 5.0 mmtt 178.11 118.35 0.04 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.61 0.243 . . . . 0.0 111.072 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.612 ' HB ' HG13 ' A' ' 106' ' ' ILE . 17.6 t 61.77 68.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.782 0.325 . . . . 0.0 110.914 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.459 ' CG2' ' CE1' ' A' ' 81' ' ' TYR . 4.1 t -99.22 151.31 21.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 10.6 ttmt -86.14 141.38 29.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.443 ' HG3' ' CG2' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -55.31 -30.23 59.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.957 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m 60.98 26.26 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.059 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 mmm -115.89 -2.72 12.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.187 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.95 59.09 3.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 110.629 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.418 ' CD2' ' HB2' ' A' ' 53' ' ' MET . 7.1 mp -57.75 -53.99 51.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.498 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -130.3 158.31 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.845 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.0 t0 -102.98 138.58 39.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.231 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.52 -30.45 7.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.498 ' CE1' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -135.49 165.83 24.6 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.741 0.305 . . . . 0.0 110.806 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 5.8 m-20 -104.65 126.29 51.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.439 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 27.7 t -93.57 105.83 17.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.447 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 34.1 m-85 -116.13 137.35 52.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.545 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.5 ' HB3' HG13 ' A' ' 54' ' ' VAL . 7.5 p90 -124.67 139.81 53.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.45 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 2.5 t -141.5 118.48 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.527 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 74.3 p -81.58 150.48 28.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -46.39 148.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.17 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.25 -8.46 53.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.706 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.28 22.9 0.3 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.606 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.47 88.94 2.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.745 0.307 . . . . 0.0 111.304 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.49 -19.51 23.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.604 2.202 . . . . 0.0 112.133 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.2 32.66 1.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.975 0.416 . . . . 0.0 110.397 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 21.7 m -156.42 71.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -71.35 178.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.196 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.432 ' CE2' ' O ' ' A' ' 90' ' ' THR . 84.8 m-85 -153.01 98.59 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.514 ' CG1' HG12 ' A' ' 50' ' ' ILE . 43.1 t -106.17 129.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.372 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.2 p -128.41 117.46 21.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.308 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.546 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 16.0 m-85 -85.72 78.13 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.787 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -65.52 -172.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.758 0.314 . . . . 0.0 110.599 -179.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 100' ' ' ILE . 71.7 mt -102.26 129.82 48.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -46.01 -36.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.815 0.34 . . . . 0.0 111.617 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.82 -29.61 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' LEU . 60.2 mt -81.48 129.96 63.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.82 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.451 ' HD2' ' CE2' ' A' ' 4' ' ' PHE . 16.4 Cg_endo -57.66 -176.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.491 2.127 . . . . 0.0 111.932 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.91 63.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.422 ' CA ' HD11 ' A' ' 106' ' ' ILE . 4.6 tp -144.02 -37.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.609 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 108' ' ' ILE . 2.5 tp -63.89 -63.61 3.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.495 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 2.8 Cg_endo -45.47 -30.19 5.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.627 2.218 . . . . 0.0 111.388 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.612 HG13 ' HB ' ' A' ' 66' ' ' VAL . 2.3 mp -66.92 -41.71 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.727 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 104' ' ' LEU . 6.9 mmt180 -80.95 -17.76 49.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.678 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 104' ' ' LEU . 16.2 mm -70.53 -48.62 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.405 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -73.12 -51.49 17.77 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -76.69 -43.88 17.23 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 16.9 mt -56.82 -35.62 69.0 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -14.52 61.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.16 -23.86 59.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.239 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.491 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.7 m-85 -84.33 -93.08 0.08 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 161.26 -26.38 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 111.068 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.411 ' CB ' HD23 ' A' ' 123' ' ' LEU . 4.3 m -92.13 -90.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.6 p30 40.73 32.47 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.99 34.52 4.8 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.571 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -150.71 149.24 29.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 178.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HA ' ' N ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -68.91 28.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.858 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.571 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.6 tp10 -169.93 27.93 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.415 ' O ' ' HB2' ' A' ' 126' ' ' SER . 5.8 tt -132.9 -49.32 0.88 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.507 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.428 ' CD1' ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.66 -44.71 77.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 89.2 p -47.63 -30.73 3.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.16 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.91 -60.4 3.85 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.105 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 5.3 m170 -57.98 -36.88 73.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.4 t -53.28 -43.97 52.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.219 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.06 -44.82 12.76 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.109 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -65.25 -23.0 66.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.485 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 57.3 mt -90.03 -26.34 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.485 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -63.72 -47.83 79.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.545 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.68 -44.32 82.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.889 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -73.21 -18.06 61.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 104' ' ' LEU . 15.9 t80 -50.62 -66.68 0.35 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -50.82 -48.35 59.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -49.29 -31.25 8.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.001 0.429 . . . . 0.0 110.383 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -80.11 -34.74 37.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.98 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.417 HD23 ' CE1' ' A' ' 135' ' ' PHE . 18.8 mt -67.95 -33.68 75.14 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.101 0.476 . . . . 0.0 109.781 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.3 t -73.92 -47.1 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 121.645 0.736 . . . . 0.0 109.031 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -35.6 77.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.672 178.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -28.48 68.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.175 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -3.29 41.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.574 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -104.6 -37.04 7.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.712 0.291 . . . . 0.0 111.085 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -75.88 -73.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.39 145.78 29.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.86 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.48 48.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -97.73 37.33 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.902 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.77 0.319 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -176.45 85.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -73.0 91.56 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.912 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -58.81 159.64 6.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -168.07 115.85 0.72 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.461 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.463 HG12 ' CG2' ' A' ' 9' ' ' VAL . 2.1 t -72.35 147.42 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.342 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -87.88 -49.9 6.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.548 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.686 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 10.1 m-85 -143.57 134.71 25.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.96 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CG2' HG12 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -134.65 93.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.821 179.162 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.52 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.5 mt-10 -107.72 120.23 41.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.994 0.426 . . . . 0.0 111.812 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 12' ' ' ILE . 75.8 t -82.69 158.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 91' ' ' VAL . 4.4 mt -137.51 115.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -105.28 109.34 21.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.0 111.284 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 63.81 34.28 12.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.611 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.66 26.39 58.95 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.347 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.93 117.34 9.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.039 0.447 . . . . 0.0 109.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.432 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -51.61 125.21 14.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.727 -178.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.42 ' CD1' HG13 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -102.19 -49.47 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.445 0.64 . . . . 0.0 109.87 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 120' ' ' THR . 55.0 p -120.87 174.38 6.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.695 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 92.1 p -170.06 134.44 1.26 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.155 0.502 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 28.7 t -124.86 69.71 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.434 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.617 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.9 m-85 -106.95 101.91 11.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.054 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -143.24 145.29 31.83 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.721 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 79.2 Cg_endo -77.1 -176.44 3.2 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.693 2.262 . . . . 0.0 111.759 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.484 ' CZ ' ' HA ' ' A' ' 7' ' ' SER . 1.5 p90 172.7 -6.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.464 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.9 tt0 63.94 145.71 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.813 0.34 . . . . 0.0 110.514 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 34' ' ' ILE . 5.3 tmtt? -80.91 141.57 34.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -124.45 -166.1 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.83 119.22 3.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.603 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.0 m120 61.31 157.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.285 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.445 ' CG ' ' O ' ' A' ' 30' ' ' ASN . 48.2 p90 45.67 -168.19 0.01 OUTLIER 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.122 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.407 ' HA2' ' CD1' ' A' ' 97' ' ' LEU . . . 71.08 164.34 5.73 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.403 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.6 m -164.38 -42.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 111.159 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.511 ' O ' ' HB ' ' A' ' 35' ' ' THR . 12.0 mt -55.89 156.88 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.331 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER 169.69 -32.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.767 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.65 -74.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.185 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.35 -27.41 3.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.393 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.46 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 24.1 m-20 -118.35 31.34 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.809 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -128.86 26.9 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.16 0.505 . . . . 0.0 110.832 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -113.66 -33.49 5.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.155 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.558 ' CG2' ' HB ' ' A' ' 45' ' ' ILE . 2.2 mm -52.87 130.62 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.676 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.483 ' CG2' HG12 ' A' ' 45' ' ' ILE . 11.2 t -91.24 151.25 42.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.714 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 75.0 Cg_exo -46.71 -25.93 4.07 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.293 1.995 . . . . 0.0 111.384 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.47 ' HB ' HG22 ' A' ' 42' ' ' THR . 74.2 t -66.65 -38.45 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.714 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.558 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 15.2 mm -59.8 -44.21 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.481 ' HB3' ' CE2' ' A' ' 95' ' ' PHE . 10.7 m-85 -75.83 -40.09 55.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.178 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.73 -30.27 71.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.178 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -87.65 -29.56 21.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 53' ' ' MET . 4.1 mt -61.53 -59.72 4.8 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.554 HG12 ' CG1' ' A' ' 93' ' ' VAL . 7.0 mt -50.79 -63.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.016 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.518 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.4 OUTLIER -52.21 -41.74 62.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.99 -1.459 . . . . 0.0 113.048 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.76 -20.62 22.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.484 ' N ' ' O ' ' A' ' 49' ' ' LEU . 47.9 mmm -118.28 -59.95 1.84 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.536 ' HB ' HG23 ' A' ' 50' ' ' ILE . 90.8 t -63.55 -60.18 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.575 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 2.4 mm? -44.57 -53.69 14.29 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.8 Cg_exo -67.0 3.95 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.225 1.95 . . . . 0.0 112.457 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.28 28.07 0.58 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.139 0.495 . . . . 0.0 110.194 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 81' ' ' TYR . 9.4 p -83.76 150.35 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.94 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 61' ' ' ILE . 3.8 t -102.58 138.77 19.73 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.429 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.421 ' HD2' ' CG1' ' A' ' 59' ' ' VAL . 67.7 Cg_endo -74.45 28.03 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.795 1.664 . . . . 0.0 111.575 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.539 ' H ' ' C ' ' A' ' 59' ' ' VAL . 18.3 mm 23.22 101.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.266 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.54 -26.91 10.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.573 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.15 30.22 0.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.491 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -118.12 -51.5 2.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HA ' HG23 ' A' ' 61' ' ' ILE . 0.0 OUTLIER 63.29 105.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.215 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.58 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 3.0 t 69.78 79.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.13 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.9 m -101.2 130.06 47.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -81.74 134.95 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -26.25 62.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.7 t 50.94 28.46 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.5 tpp -107.3 -18.1 13.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.61 63.76 0.41 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.406 HD23 HD22 ' A' ' 49' ' ' LEU . 7.1 mp -65.32 -59.22 4.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.446 HG21 ' CE1' ' A' ' 77' ' ' PHE . 1.3 mt -121.51 155.44 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 17.0 t0 -97.3 140.02 32.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.47 -33.15 6.54 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.293 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 2.1 m-85 -116.35 175.26 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.6 OUTLIER -120.75 121.68 38.74 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.1 m -86.98 106.19 17.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.459 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 65.8 m-85 -120.81 149.0 43.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.505 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.462 ' CD1' HG22 ' A' ' 58' ' ' VAL . 35.3 p90 -144.87 131.07 19.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.154 0.502 . . . . 0.0 111.585 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.424 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 2.2 t -132.05 120.75 22.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.638 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 63.1 p -89.97 150.13 22.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.969 0.414 . . . . 0.0 111.133 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.66 149.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -69.97 -16.47 63.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.69 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.75 20.13 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.0 93.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.554 0.216 . . . . 0.0 111.263 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.31 -16.28 50.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.387 2.058 . . . . 0.0 111.896 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 30.39 2.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.098 0.475 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 34.5 m -150.84 69.59 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.535 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -72.47 176.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.512 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.436 ' CD1' HG12 ' A' ' 11' ' ' VAL . 38.3 m-85 -151.21 91.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.554 ' CG1' HG12 ' A' ' 50' ' ' ILE . 41.5 t -99.27 132.6 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.154 0.502 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.38 123.15 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.148 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.686 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -95.8 84.45 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.79 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.456 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -74.45 -167.38 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.973 0.416 . . . . 0.0 110.907 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 7' ' ' SER . 13.5 mt -106.36 127.48 53.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.351 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -45.54 -35.93 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.75 0.309 . . . . 0.0 111.697 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.0 -31.27 71.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.383 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.421 HG21 ' HD2' ' A' ' 101' ' ' PRO . 62.9 mt -76.34 132.99 71.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.764 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.421 ' HD2' HG21 ' A' ' 100' ' ' ILE . 52.2 Cg_exo -54.56 -168.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.369 2.046 . . . . 0.0 112.127 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 67.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.642 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.7 tp -152.03 -40.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.574 ' O ' HG12 ' A' ' 108' ' ' ILE . 12.1 tp -56.15 -63.99 2.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.129 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 6.1 Cg_endo -47.57 -30.02 11.5 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.447 2.098 . . . . 0.0 111.51 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.58 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.8 mp -72.0 -41.05 68.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.575 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.01 -28.12 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 104' ' ' LEU . 7.8 mm -68.08 -49.81 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.529 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.417 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -67.25 -54.8 17.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.1 p -60.38 -27.39 67.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.409 ' HA3' HD12 ' A' ' 131' ' ' ILE . . . -74.02 -44.36 30.31 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.498 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 17.0 mt -55.24 -28.87 56.25 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.02 -19.07 63.33 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.365 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.06 -20.88 61.6 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.494 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 6.3 m-85 -101.45 -29.88 11.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.063 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 4.6 mt-10 83.33 -51.86 0.15 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.005 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.8 m -46.43 -95.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.691 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.432 ' HA ' HD22 ' A' ' 123' ' ' LEU . 2.4 p30 42.07 31.9 0.27 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.725 0.298 . . . . 0.0 110.706 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.57 33.01 4.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.558 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -152.95 148.85 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.559 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -69.95 23.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.424 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.558 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.4 tt0 -163.84 24.86 0.08 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 118' ' ' ASN . 5.7 tt -123.81 -56.89 1.65 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.727 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.458 ' CD1' HG21 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.13 -45.16 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.413 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 90.0 p -47.76 -31.42 4.82 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.365 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.08 -56.69 16.33 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.264 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.498 ' HB2' ' CD2' ' A' ' 112' ' ' LEU . 3.4 m170 -60.17 -35.29 75.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.408 ' O ' ' CD1' ' A' ' 132' ' ' LEU . 46.7 t -53.16 -47.18 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.827 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.401 ' HA2' HD11 ' A' ' 132' ' ' LEU . . . -72.71 -37.74 57.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.193 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.43 -18.45 60.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 0.0 111.344 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 127' ' ' HIS . 26.4 mt -90.56 -28.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.434 ' HG ' HD13 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -67.63 -52.04 42.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.485 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.52 -29.45 64.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.0 m -98.27 -12.08 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 139' ' ' LEU . 6.6 t80 -58.44 -57.54 12.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.999 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.404 ' ND1' ' N ' ' A' ' 137' ' ' GLU . 18.3 p80 -49.67 -37.8 30.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.024 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.4 OUTLIER -55.52 -29.73 59.42 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -36.12 58.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.819 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 135' ' ' PHE . 22.8 mt -66.05 -30.44 70.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.062 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.7 t -78.01 -49.15 22.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.437 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -63.15 -32.15 73.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.013 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -31.72 72.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.222 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.27 -26.13 62.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.035 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -119.37 62.79 0.8 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.977 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -131.31 -45.76 1.0 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 t -150.58 85.3 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.82 177.76 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -79.14 78.19 5.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.808 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.874 179.968 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.1 132.59 48.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.84 30.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.497 ' CE1' ' CE2' ' A' ' 31' ' ' TYR . 2.3 m-85 54.67 175.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -177.67 108.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.307 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.47 HG23 HG13 ' A' ' 108' ' ' ILE . 1.4 t -68.05 141.16 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.31 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.436 ' OG ' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.98 -63.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.16 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.618 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.0 m-85 -140.34 131.19 25.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.954 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 21' ' ' CYS . 2.1 t -117.42 85.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.378 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.419 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 0.9 OUTLIER -91.32 111.99 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 92' ' ' TYR . 97.6 t -85.22 158.35 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.532 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.1 mt -138.69 121.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.833 0.349 . . . . 0.0 111.686 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 6.2 tttt -110.82 102.94 11.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 111.582 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 67.81 37.99 3.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.87 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' HA2' HD13 ' A' ' 55' ' ' LEU . . . 79.35 24.79 60.38 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.815 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.41 120.57 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.887 0.375 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -53.31 120.84 6.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.753 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.444 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -95.37 -51.09 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.016 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 120' ' ' THR . 57.9 p -123.08 177.93 5.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.435 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 29.5 m -170.5 142.95 2.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.411 . . . . 0.0 111.322 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 23.6 t -125.64 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.862 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.618 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 3.8 m-85 -106.2 88.83 2.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.406 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -125.82 141.66 39.97 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.401 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 71.7 Cg_endo -74.7 -178.12 3.86 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.531 2.154 . . . . 0.0 111.791 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.466 ' CZ ' ' CD1' ' A' ' 34' ' ' ILE . 1.1 p90 174.38 -21.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 68.95 132.63 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -51.24 -55.86 15.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.125 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.58 -81.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.415 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -167.72 -35.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.239 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -68.61 64.56 0.11 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.217 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' CE2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 45.49 93.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.462 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.76 159.95 32.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.578 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 37.8 m -129.03 -39.71 1.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.137 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 8.3 mt -51.7 158.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.346 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.5 ' OG1' ' N ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -176.01 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.966 178.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.5 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -133.91 -40.95 0.84 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.734 0.302 . . . . 0.0 111.273 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.78 -28.56 55.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.559 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -115.12 31.9 6.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.249 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.6 26.16 4.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.016 0.436 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.53 -35.83 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.491 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -52.69 115.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.514 178.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.418 ' H ' HD13 ' A' ' 45' ' ' ILE . 1.4 t -76.01 152.29 84.38 Favored Pre-proline 0 CA--C 1.517 -0.327 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.671 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 74.4 Cg_exo -47.88 -21.73 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.84 1.693 . . . . 0.0 110.709 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 96.0 t -65.86 -48.68 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.175 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.418 HD13 ' H ' ' A' ' 42' ' ' THR . 1.7 mp -57.4 -33.27 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.545 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 89.4 m-85 -81.0 -42.71 20.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.427 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.623 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.98 -28.19 69.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.011 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -88.5 -30.07 19.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' MET . 4.8 mt -60.84 -60.23 4.13 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.532 HG23 ' HB ' ' A' ' 54' ' ' VAL . 5.7 mt -52.09 -62.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.065 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.623 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -50.26 -44.89 53.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.909 -179.067 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.86 -15.25 30.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -122.12 -69.38 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' HB ' HG23 ' A' ' 50' ' ' ILE . 70.9 t -53.93 -51.3 46.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.786 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.449 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 2.3 mm? -54.09 -58.39 13.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 25.3 Cg_endo -63.19 2.8 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.154 1.902 . . . . 0.0 112.662 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -146.48 25.23 1.22 Allowed 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.941 0.401 . . . . 0.0 110.092 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.523 HG23 ' CD2' ' A' ' 81' ' ' TYR . 3.9 p -87.78 165.27 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.934 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.2 m -151.3 147.65 20.86 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.068 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 66.6 Cg_endo -78.53 24.89 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.123 1.882 . . . . 0.0 112.939 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER 46.94 176.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.831 178.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -139.54 -46.16 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 110.808 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.76 45.2 0.69 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.039 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 177.55 59.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.766 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -43.39 156.41 0.05 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.57 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 3.3 t 71.27 69.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.868 0.366 . . . . 0.0 110.174 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.44 ' HB ' ' CE2' ' A' ' 81' ' ' TYR . 97.3 m -95.13 144.34 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -93.48 125.54 38.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.783 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.405 ' HE2' ' CB ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -46.92 -33.85 4.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.06 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.1 p 56.71 26.92 11.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.16 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 1.5 mmt -107.83 -3.51 18.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.964 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.87 55.29 4.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.092 0.473 . . . . 0.0 110.408 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 73' ' ' LEU . 10.7 mp -55.77 -49.94 71.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.453 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -136.25 161.3 37.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.435 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.5 t70 -100.09 140.25 34.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.275 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.54 -34.73 5.21 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.039 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.453 ' CE1' HG22 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -129.12 -179.02 4.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.633 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 19.6 m-20 -123.45 125.22 44.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 6.5 p -80.97 101.61 9.62 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 63.4 m-85 -110.19 157.96 18.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.255 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.523 ' CD2' HG23 ' A' ' 58' ' ' VAL . 9.8 p90 -149.99 132.09 15.35 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.17 0.51 . . . . 0.0 111.463 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.475 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 28.6 t -134.81 117.39 15.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 5.0 p -84.79 148.21 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.946 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.02 144.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.88 -21.99 8.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.952 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 23.29 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.69 0.281 . . . . 0.0 111.507 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.57 92.34 6.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.002 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.56 -15.13 43.97 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.27 1.98 . . . . 0.0 111.98 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -95.97 29.79 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.242 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 32.4 m -153.05 69.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.582 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -71.29 177.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.566 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 11' ' ' VAL . 53.7 m-85 -151.64 83.34 1.29 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.387 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.514 ' CG1' HG12 ' A' ' 50' ' ' ILE . 32.5 t -89.08 133.47 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 0.0 110.998 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -131.07 119.17 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.882 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.1 m-85 -86.95 83.3 7.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.383 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -83.49 133.66 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 111.985 -178.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.436 ' HG ' ' OG ' ' A' ' 7' ' ' SER . 61.9 mt -46.57 125.4 7.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -47.03 -33.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.748 0.309 . . . . 0.0 111.32 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.44 HG23 ' CE2' ' A' ' 4' ' ' PHE . 58.9 mt -78.77 132.32 64.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.899 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.06 -167.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.393 2.062 . . . . 0.0 112.007 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -108.67 67.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.453 HG21 ' N ' ' A' ' 104' ' ' LEU . 3.0 tp -150.97 -38.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.749 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.569 ' O ' HG12 ' A' ' 108' ' ' ILE . 5.0 tp -60.36 -62.3 6.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.781 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.482 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 2.8 Cg_endo -46.23 -34.21 13.29 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.335 2.024 . . . . 0.0 111.308 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.57 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 4.2 mp -65.98 -38.77 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.02 -27.12 33.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 104' ' ' LEU . 10.8 mm -68.09 -47.98 76.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.428 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -54.93 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 t -59.32 -28.78 67.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.415 ' HA3' HG23 ' A' ' 131' ' ' ILE . . . -73.88 -47.66 18.95 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.282 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.416 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -56.36 -31.56 63.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.95 -14.3 60.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.148 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -75.74 -24.41 56.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.343 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.542 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 8.1 m-85 -86.17 -93.15 0.09 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.979 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER 160.38 -28.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.782 0.433 . . . . 0.0 110.297 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.485 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 72.4 p -107.33 127.27 53.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.491 0.662 . . . . 0.0 111.191 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.49 ' HA ' HD21 ' A' ' 123' ' ' LEU . 5.6 p30 -172.65 36.2 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.053 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.73 32.83 4.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.316 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.589 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -148.39 144.96 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.279 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.435 ' HA ' ' N ' ' A' ' 20' ' ' SER . 2.2 m120 -68.5 29.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.882 0.372 . . . . 0.0 111.834 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.589 ' H ' ' C ' ' A' ' 120' ' ' THR . 11.1 tt0 -169.78 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 118' ' ' ASN . 8.5 tt -124.08 -58.01 1.57 Allowed 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.448 ' HB2' ' HB2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -51.26 -43.84 61.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.446 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.4 p -47.7 -29.31 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.509 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.3 -61.81 2.11 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.126 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.542 ' CE1' ' CB ' ' A' ' 115' ' ' TYR . 35.2 m170 -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.754 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.467 ' O ' HD12 ' A' ' 132' ' ' LEU . 50.0 t -51.58 -48.88 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.442 ' HA2' HD11 ' A' ' 132' ' ' LEU . . . -69.06 -46.9 57.09 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.987 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -64.01 -20.33 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.734 0.302 . . . . 0.0 110.659 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 127' ' ' HIS . 44.7 mt -90.7 -28.45 4.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -62.36 -39.85 94.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.94 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -32.96 72.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.455 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.26 24.29 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.843 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.432 ' CE2' HG21 ' A' ' 103' ' ' ILE . 1.1 t80 -93.54 -40.27 10.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.376 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -66.83 -30.78 71.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.593 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -30.02 31.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.417 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -36.22 45.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.984 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.429 HD12 ' CE1' ' A' ' 135' ' ' PHE . 22.5 mt -65.42 -33.48 76.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.766 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.9 t -74.71 -47.32 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.628 0.727 . . . . 0.0 109.183 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.31 -32.55 73.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.017 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -34.04 76.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.474 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -23.44 55.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.087 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -84.83 -52.55 5.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -78.25 123.8 27.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.81 105.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 tt -171.86 -45.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -97.11 29.77 3.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.876 179.898 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.802 0.334 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -97.97 175.98 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.3 mmm-85 -147.18 -177.78 5.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.01 139.15 23.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.715 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.12 106.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.215 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.5 HG11 ' CG2' ' A' ' 9' ' ' VAL . 1.2 t -60.34 144.95 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.357 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.501 ' HA ' ' HZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -69.52 -71.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.291 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.668 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 3.4 m-85 -134.23 142.03 47.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.992 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' CG2' HG11 ' A' ' 6' ' ' VAL . 1.7 t -129.77 94.89 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.169 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.8 mt-10 -105.17 118.15 35.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.942 0.401 . . . . 0.0 111.978 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 17' ' ' THR . 16.8 t -84.53 158.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.1 mp -141.52 117.24 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.476 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 10.1 tttt -101.35 107.53 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.276 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.22 37.63 23.72 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.809 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.26 24.65 56.68 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.757 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -143.3 112.97 6.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.947 0.404 . . . . 0.0 110.108 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 m -46.46 125.69 7.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.333 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.476 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -100.98 -39.74 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.253 178.452 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -131.49 174.68 9.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.106 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.441 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 8.9 p -170.32 123.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 26.0 t -113.97 69.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.668 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -110.29 88.24 2.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.21 0.529 . . . . 0.0 110.982 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.404 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -130.32 148.57 70.4 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.508 -179.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.74 179.24 6.19 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.735 2.29 . . . . 0.0 111.949 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.501 ' HZ ' ' HA ' ' A' ' 7' ' ' SER . 2.3 p90 174.87 -25.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.604 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 9.6 tt0 71.61 60.9 0.15 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.042 0.449 . . . . 0.0 110.836 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -80.88 125.64 30.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.861 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -176.92 -51.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.996 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.47 -26.82 55.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -106.08 -61.52 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.948 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -178.28 94.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.918 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.74 -143.51 5.29 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.782 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.8 m -164.05 -39.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 111.349 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.461 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 3.1 mt -48.23 151.14 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.73 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.504 ' OG1' ' N ' ' A' ' 36' ' ' SER . 0.5 OUTLIER -173.93 -80.79 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.821 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.504 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -141.21 -44.39 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.943 0.401 . . . . 0.0 111.225 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.04 -33.96 77.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.324 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -112.43 31.68 6.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.044 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.75 28.58 5.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.7 -33.89 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.908 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.512 HG22 ' CE1' ' A' ' 46' ' ' PHE . 1.5 mt -51.73 140.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.767 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.505 HG23 HG12 ' A' ' 45' ' ' ILE . 1.5 t -94.6 151.66 39.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 80.0 Cg_exo -46.57 -28.25 6.11 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.825 1.683 . . . . 0.0 110.652 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.466 ' HB ' HG23 ' A' ' 42' ' ' THR . 58.8 t -59.44 -42.14 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.566 178.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 HG23 ' A' ' 42' ' ' THR . 23.4 mm -55.72 -51.68 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.686 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.512 ' CE1' HG22 ' A' ' 41' ' ' ILE . 44.0 m-85 -71.34 -37.74 71.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.505 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.493 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.02 -31.04 72.09 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.224 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -87.46 -28.69 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 46' ' ' PHE . 3.7 mt -61.91 -59.97 4.33 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.498 HG12 ' CG1' ' A' ' 93' ' ' VAL . 6.5 mt -50.31 -64.05 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.898 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.493 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -53.13 -40.32 64.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.348 -178.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.72 -21.85 21.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.464 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 83.1 mmm -118.38 -59.34 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HB ' HG23 ' A' ' 50' ' ' ILE . 84.2 t -62.81 -59.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.559 ' HB2' ' HD3' ' A' ' 56' ' ' PRO . 2.9 mm? -45.33 -54.26 15.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.0 Cg_exo -67.78 4.32 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.269 1.98 . . . . 0.0 112.465 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -145.49 21.86 1.5 Allowed 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 120.94 0.4 . . . . 0.0 110.461 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.423 HG21 ' CD1' ' A' ' 81' ' ' TYR . 4.4 p -87.22 167.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.429 ' C ' ' H ' ' A' ' 61' ' ' ILE . 34.3 m -137.1 147.58 59.21 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.928 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 61' ' ' ILE . 72.3 Cg_endo -76.69 19.86 0.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.858 1.705 . . . . 0.0 112.546 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.464 HG21 ' CB ' ' A' ' 65' ' ' LYS . 8.5 mm 50.47 164.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.142 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -69.57 -12.18 61.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.088 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.01 -28.21 0.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.789 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 173.27 108.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.647 0.26 . . . . 0.0 110.725 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.464 ' CB ' HG21 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -161.67 169.88 20.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.077 0.465 . . . . 0.0 111.466 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 106' ' ' ILE . 98.7 t -131.29 90.53 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.17 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.473 ' CG2' ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -98.34 168.5 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 111.628 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -105.53 139.11 40.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.569 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.27 -29.01 5.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.042 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 p 52.12 26.29 3.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.5 tpp -113.95 -10.87 12.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.157 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.72 58.88 2.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.87 -62.38 1.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.76 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.436 HG22 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -120.03 155.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.673 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 74' ' ' ILE . 34.4 t0 -96.9 140.68 31.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.432 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.0 -32.74 6.64 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.275 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -126.62 163.1 24.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 111.114 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -105.88 130.25 53.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.515 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.0 m -94.99 112.71 24.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.514 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 44.0 m-85 -122.54 140.84 52.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.473 ' CE1' ' CG2' ' A' ' 67' ' ' THR . 7.2 p90 -131.5 134.3 46.0 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.142 0.496 . . . . 0.0 111.305 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.486 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 11.4 t -136.17 118.57 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.61 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 64.8 p -85.0 144.41 28.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -43.65 148.19 0.37 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.588 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.31 -20.43 60.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.618 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 19.59 2.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.549 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -159.87 90.1 1.86 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.445 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -56.78 -18.8 28.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.619 2.212 . . . . 0.0 111.915 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -92.85 29.84 1.71 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.104 0.478 . . . . 0.0 110.679 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.421 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 23.3 m -149.51 68.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.26 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.6 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.7 OUTLIER -64.27 179.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.211 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.468 ' CD2' HG13 ' A' ' 11' ' ' VAL . 98.0 m-85 -154.89 79.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.85 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.498 ' CG1' HG12 ' A' ' 50' ' ' ILE . 86.8 t -88.29 127.31 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.104 0.478 . . . . 0.0 111.312 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 43.4 t -125.9 117.51 23.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.495 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.5 m-85 -87.28 78.81 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.088 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.464 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -64.5 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.898 0.38 . . . . 0.0 111.162 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.411 ' CD2' ' OG ' ' A' ' 7' ' ' SER . 56.4 mt -105.71 131.68 52.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.271 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -46.84 -34.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 111.336 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -33.63 74.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.525 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 98.0 mt -72.76 129.96 86.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.816 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.81 -172.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.251 1.967 . . . . 0.0 111.516 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 64.13 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.908 0.385 . . . . 0.0 110.724 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.42 -38.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.86 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.56 ' O ' HG12 ' A' ' 108' ' ' ILE . 16.9 tp -62.5 -62.25 6.08 Favored Pre-proline 0 CA--C 1.521 -0.136 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.735 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 8.1 Cg_endo -48.71 -28.09 12.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.256 1.971 . . . . 0.0 110.908 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.586 ' HA ' HG21 ' A' ' 66' ' ' VAL . 13.2 mt -70.72 -64.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.691 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -24.37 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.236 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.56 HG12 ' O ' ' A' ' 104' ' ' LEU . 8.2 mm -72.58 -47.04 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.973 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.415 ' CB ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.47 -65.56 0.67 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -51.94 -27.85 14.55 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.497 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -68.75 -50.2 37.7 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.714 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 5.4 mt -54.85 -35.04 63.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.95 -16.35 61.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.197 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.61 -22.84 58.73 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.341 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.501 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 4.0 m-85 -82.37 -91.94 0.07 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 25.5 tt0 164.55 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.629 0.252 . . . . 0.0 110.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.2 -90.27 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.712 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.477 ' HA ' HD21 ' A' ' 123' ' ' LEU . 1.2 p-10 38.42 33.2 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 110.977 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.09 34.52 4.61 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.534 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -147.39 152.92 38.96 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.603 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.441 ' HA ' ' N ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -71.75 28.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 0.0 111.737 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -172.29 28.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.477 HD21 ' HA ' ' A' ' 118' ' ' ASN . 5.9 tt -134.69 -49.5 0.77 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.6 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -55.79 -44.96 78.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.4 ' HB3' ' CB ' ' A' ' 21' ' ' CYS . 78.7 p -47.69 -30.25 3.65 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.252 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.04 -59.93 4.59 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.254 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.501 ' CD2' ' CD2' ' A' ' 115' ' ' TYR . 8.4 m170 -54.89 -37.99 67.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.617 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.461 ' O ' HD13 ' A' ' 132' ' ' LEU . 41.9 t -51.67 -50.29 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.547 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.477 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -70.28 -48.82 36.05 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.656 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -19.5 65.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 111.233 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.497 HD13 ' HA3' ' A' ' 111' ' ' GLY . 69.9 mt -90.81 -27.4 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.483 ' HG ' ' CD1' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -63.24 -46.09 88.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.113 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -39.49 79.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.738 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 0.92 48.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.056 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 104' ' ' LEU . 17.1 t80 -65.96 -51.37 59.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.835 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -54.44 -31.07 54.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -31.54 63.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.026 0.441 . . . . 0.0 110.362 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -80.0 -34.2 38.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.201 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.19 -31.69 67.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.014 0.435 . . . . 0.0 110.068 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.6 t -74.11 -47.34 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -30.92 63.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.773 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -29.18 66.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.497 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.26 59.83 2.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.888 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -177.68 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -123.54 140.21 53.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 60.5 77.95 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.81 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 21.2 mt -145.75 141.89 28.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.985 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -84.44 77.9 9.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.823 0.344 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HD3' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -93.72 159.13 15.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 10.1 mtm180 -131.77 159.81 37.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CD1' HG23 ' A' ' 100' ' ' ILE . 22.1 m-85 -135.14 162.69 31.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.608 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.85 118.89 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.475 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' HB ' ' CG2' ' A' ' 9' ' ' VAL . 0.9 OUTLIER -80.53 90.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.443 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -37.37 -49.78 1.01 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.927 -178.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.595 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 9.1 m-85 -146.17 112.3 5.76 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.612 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' SER . 2.3 t -110.78 95.92 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.131 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.523 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -104.17 112.51 25.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 111.882 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 91' ' ' VAL . 76.4 t -81.68 156.06 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.542 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.2 mp -132.62 123.31 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.74 0.305 . . . . 0.0 111.428 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 6.3 tttm -108.06 90.41 3.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 74.01 40.86 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.879 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.24 63.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.344 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -146.56 118.98 8.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.11 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -51.81 124.9 13.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.852 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.455 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -100.3 -50.31 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' ' 120' ' ' THR . 45.0 p -121.54 176.11 5.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.006 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -170.24 141.83 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.987 0.422 . . . . 0.0 111.766 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.452 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 37.6 t -128.74 69.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.444 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -105.97 99.91 9.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.088 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 3.1 mp0 -141.45 138.77 17.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.397 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.18 178.77 6.15 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.559 2.173 . . . . 0.0 111.842 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CE2' ' HG3' ' A' ' 27' ' ' LYS . 1.9 p90 178.52 -25.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' HB3' ' OG1' ' A' ' 35' ' ' THR . 12.8 mt-30 73.85 57.01 0.1 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.007 0.432 . . . . 0.0 110.756 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HG3' ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -72.18 108.11 5.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.771 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.28 176.07 6.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 57.8 77.85 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.413 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 11.9 t-20 60.41 159.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.742 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 3' ' ' ARG . 17.9 p90 42.77 33.93 0.53 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.398 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.414 ' HA2' ' CD1' ' A' ' 97' ' ' LEU . . . -151.65 165.01 30.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.952 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -163.86 -43.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.735 0.303 . . . . 0.0 111.0 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.494 ' O ' ' HB ' ' A' ' 35' ' ' THR . 24.2 mt -64.92 153.59 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.252 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 170.81 -31.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.645 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -176.92 -68.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.06 -26.52 6.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.395 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -123.85 31.27 5.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.05 26.8 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.042 0.449 . . . . 0.0 110.949 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.49 -36.53 5.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.548 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -47.14 135.73 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.0 178.834 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.52 HG22 HG12 ' A' ' 45' ' ' ILE . 1.3 t -94.14 151.76 39.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.635 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.22 -27.01 6.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.852 1.701 . . . . 0.0 110.513 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HB ' HG22 ' A' ' 42' ' ' THR . 58.9 t -61.21 -42.68 94.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.571 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.535 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 16.0 mm -56.94 -46.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.501 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 26.1 m-85 -73.17 -39.89 65.27 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.401 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.588 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.29 -31.26 72.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.318 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.48 -29.64 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 53' ' ' MET . 6.1 mt -61.11 -60.79 3.21 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.524 ' CG2' HD23 ' A' ' 55' ' ' LEU . 5.6 mt -51.1 -63.97 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.839 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 6.0 tpp -50.08 -40.55 45.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.965 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.16 -21.45 21.15 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.505 ' N ' ' O ' ' A' ' 49' ' ' LEU . 56.1 mmm -117.69 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' CG1' ' CD1' ' A' ' 81' ' ' TYR . 65.4 t -56.01 -55.9 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.786 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 50' ' ' ILE . 3.4 mm? -47.13 -58.29 7.51 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.044 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.8 Cg_endo -65.99 6.82 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.143 1.895 . . . . 0.0 112.742 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -151.95 25.12 0.65 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.036 0.446 . . . . 0.0 110.099 179.428 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' A' ' 81' ' ' TYR . 8.8 p -81.84 150.85 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.084 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 61' ' ' ILE . 14.9 t -103.14 137.92 19.4 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.531 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 61' ' ' ILE . 74.5 Cg_endo -74.25 29.76 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.241 1.961 . . . . 0.0 112.126 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.514 ' H ' ' C ' ' A' ' 59' ' ' VAL . 26.1 mm 14.53 93.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.977 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.83 -50.52 3.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 110.161 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.73 -28.86 4.35 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.652 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.433 ' O ' HG23 ' A' ' 61' ' ' ILE . 2.7 m-80 -84.46 -161.91 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.65 114.7 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.58 0.229 . . . . 0.0 110.974 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.566 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 4.4 t 67.79 75.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.828 0.347 . . . . 0.0 110.717 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 m -104.65 141.28 36.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 111.176 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 4.0 ttpt -84.62 141.99 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 6.4 mmm -58.27 -32.51 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.766 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m 61.79 26.97 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.988 0.423 . . . . 0.0 110.945 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.4 mmm -110.81 -11.27 14.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.86 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.84 59.85 1.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.415 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.6 mp -58.63 -49.96 75.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.696 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.467 HG22 ' CE2' ' A' ' 77' ' ' PHE . 1.1 mt -137.26 154.7 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.791 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.6 t70 -95.3 142.96 27.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.89 -35.36 5.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.954 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' CE2' HG22 ' A' ' 74' ' ' ILE . 2.3 m-85 -113.01 -170.08 1.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -144.06 118.36 9.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.199 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -86.36 103.2 14.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.478 ' CD2' ' HG3' ' A' ' 68' ' ' LYS . 41.5 m-85 -118.46 119.48 34.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.976 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.468 ' CD2' HG22 ' A' ' 58' ' ' VAL . 33.0 p90 -109.83 151.45 26.99 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.304 0.573 . . . . 0.0 112.092 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 3.1 t -149.12 119.35 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 76.8 p -88.92 151.54 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.384 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.09 140.83 8.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.072 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -60.7 -16.74 42.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.889 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.35 22.29 0.94 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -151.46 97.33 3.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 111.377 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.08 -14.71 46.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.247 1.964 . . . . 0.0 111.976 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 30.04 2.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.285 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 23.9 m -152.73 69.98 0.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.657 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -74.09 178.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.324 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 11' ' ' VAL . 49.6 m-85 -151.78 104.68 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.521 ' CG2' HG21 ' A' ' 50' ' ' ILE . 28.1 t -108.29 115.35 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.189 0.519 . . . . 0.0 111.493 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 28.3 p -111.17 116.06 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.101 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CE2' ' HB3' ' A' ' 46' ' ' PHE . 2.6 m-85 -89.23 84.22 6.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.537 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 78' ' ' ASP . 8.1 p -85.89 156.91 20.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.776 0.322 . . . . 0.0 110.881 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.417 ' HB2' HG13 ' A' ' 100' ' ' ILE . 34.5 mt -69.59 127.81 34.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.573 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -42.66 -34.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.057 -179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.403 ' HB3' ' N ' ' A' ' 31' ' ' TYR . 1.0 OUTLIER -62.44 -36.68 83.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.749 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.435 HG23 ' CD1' ' A' ' 4' ' ' PHE . 0.9 OUTLIER -63.38 136.39 96.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.775 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -61.68 -167.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.184 1.923 . . . . 0.0 111.914 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.75 66.78 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.895 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.436 HG22 ' CE1' ' A' ' 135' ' ' PHE . 6.3 tp -151.65 -44.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.656 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.598 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -57.97 -62.59 5.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.48 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 3.8 Cg_endo -46.53 -34.87 15.63 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.547 2.164 . . . . 0.0 111.098 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.566 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 3.8 mp -68.69 -37.27 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.897 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -81.41 -22.54 38.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.602 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 104' ' ' LEU . 35.5 mm -68.36 -48.16 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.361 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.415 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -73.88 -52.61 12.41 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t -58.93 -29.18 66.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.47 -46.82 13.9 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 108' ' ' ILE . 17.2 mt -56.22 -32.19 64.2 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -76.26 -15.88 59.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -74.3 -25.46 59.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 110.138 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 3.6 m-85 -86.15 -90.68 0.1 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 1.2 tt0 159.69 -30.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.865 0.466 . . . . 0.0 109.767 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.492 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -103.32 137.15 41.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.482 ' HA ' HD21 ' A' ' 123' ' ' LEU . 0.9 OUTLIER 176.61 34.47 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.349 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.23 32.94 4.76 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.578 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -145.94 146.39 31.03 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.479 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.444 ' HA ' ' N ' ' A' ' 20' ' ' SER . 10.6 p30 -69.25 26.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.578 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.0 mt-10 -167.6 26.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 118' ' ' ASN . 8.2 tt -124.76 -57.25 1.55 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.435 ' CD1' HG22 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.67 -41.49 63.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.423 ' HA ' HG21 ' A' ' 128' ' ' VAL . 13.5 t -49.61 -29.28 6.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.233 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.73 -63.74 1.17 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.297 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.504 ' CE1' ' CB ' ' A' ' 115' ' ' TYR . 18.7 m170 -59.21 -30.6 68.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.03 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 125' ' ' SER . 49.0 t -57.67 -41.95 80.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.0 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.36 -48.71 10.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.137 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.71 -26.5 68.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.585 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.486 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 70.6 mt -85.49 -26.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.48 HD11 ' CD1' ' A' ' 108' ' ' ILE . 0.9 OUTLIER -60.95 -46.47 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.146 178.421 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -43.93 73.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.052 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.18 -24.75 64.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.463 ' CE1' ' CD2' ' A' ' 139' ' ' LEU . 0.8 OUTLIER -56.41 -44.99 80.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -60.98 -45.23 95.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.826 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.8 -28.98 7.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.202 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.77 -35.45 51.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.105 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.463 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 17.7 mt -68.1 -28.59 67.48 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.327 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.34 -48.7 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.564 0.697 . . . . 0.0 109.585 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -65.53 -28.69 69.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.327 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.94 -31.48 71.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.47 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -54.91 -28.63 52.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.224 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -104.2 54.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -134.08 102.47 5.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.815 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.2 t 44.63 40.8 4.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.471 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 mt -113.69 -66.93 1.04 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 60.11 35.37 21.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.915 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.79 0.329 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 62.33 150.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' HB2' ' CB ' ' A' ' 99' ' ' ASP . 0.4 OUTLIER 59.72 42.87 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.99 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.473 ' CE2' ' HD3' ' A' ' 101' ' ' PRO . 1.5 m-30 -76.29 -166.07 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.043 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 78.11 138.41 0.07 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 111.592 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.458 HG23 HG23 ' A' ' 96' ' ' THR . 80.3 t -70.99 152.92 8.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.612 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.41 -71.11 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.899 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.691 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 27.4 m-85 -128.87 111.97 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.332 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 2.3 t -103.91 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.403 ' HB2' ' HZ ' ' A' ' 22' ' ' PHE . 1.2 tt0 -100.05 114.19 27.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.673 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 26.3 t -84.27 159.62 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.6 mp -141.3 122.2 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 112.046 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 18' ' ' ILE . 12.1 tttm -104.15 99.05 8.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.363 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 63.34 41.68 7.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.387 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.416 ' HA2' ' CD1' ' A' ' 55' ' ' LEU . . . 78.39 23.64 64.96 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.582 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -143.25 111.9 6.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.93 0.395 . . . . 0.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -45.15 126.41 6.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.309 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.505 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -105.18 -44.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.914 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.539 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.9 OUTLIER -127.76 178.16 6.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.375 -179.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.47 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 18.0 m -170.75 131.16 0.85 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.54 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.458 ' HB3' ' CB ' ' A' ' 9' ' ' VAL . 29.2 t -115.13 69.46 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.691 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.7 m-85 -107.66 87.65 2.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 4.0 mt-30 -126.06 111.77 24.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.941 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.76 164.89 10.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.49 2.126 . . . . 0.0 112.138 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -153.43 -31.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.478 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 33.5 tt0 67.91 37.95 2.96 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.994 0.426 . . . . 0.0 110.193 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? 58.37 91.91 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.572 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -51.9 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -150.64 -74.61 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.712 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.3 -30.65 27.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 3' ' ' ARG . 2.1 p90 -122.47 154.63 37.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.45 132.5 6.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.557 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.9 m -118.84 -36.02 3.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 0.0 110.684 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.475 HG22 HD12 ' A' ' 34' ' ' ILE . 10.3 mt -53.0 155.92 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.498 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -173.13 -86.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.609 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.531 ' N ' ' OG1' ' A' ' 35' ' ' THR . 30.8 m -126.27 -2.95 6.9 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.15 -26.9 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.656 0.265 . . . . 0.0 111.324 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.449 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 5.3 m-20 -124.47 31.09 5.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.0 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.8 26.75 7.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -112.37 -35.36 5.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.858 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.492 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -55.38 123.79 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.955 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 8.9 t -86.08 149.36 50.0 Favored Pre-proline 0 CA--C 1.519 -0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.435 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HA ' ' CE1' ' A' ' 22' ' ' PHE . 2.0 Cg_endo -44.15 -22.75 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.713 2.275 . . . . 0.0 112.071 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' ASN . 5.3 t -67.73 -44.18 85.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.479 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 2.1 mp -59.12 -31.74 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.493 ' O ' ' CD1' ' A' ' 50' ' ' ILE . 66.3 m-85 -80.14 -43.44 21.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.349 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.599 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.27 -25.84 67.06 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.537 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' VAL . 15.0 m-20 -90.4 -29.82 17.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.465 ' O ' ' N ' ' A' ' 53' ' ' MET . 2.7 mt -58.34 -57.8 11.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.553 HG23 ' CD2' ' A' ' 55' ' ' LEU . 4.3 mt -57.97 -66.01 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.209 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.599 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.3 tpp -46.91 -41.64 16.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.713 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.08 -25.45 19.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 49' ' ' LEU . 70.5 mmm -114.21 -63.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 81' ' ' TYR . 55.9 t -62.23 -58.87 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.553 ' CD2' HG23 ' A' ' 50' ' ' ILE . 3.1 mm? -44.38 -55.9 9.13 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.3 Cg_exo -68.5 5.11 1.36 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.305 2.003 . . . . 0.0 112.03 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -145.31 21.52 1.54 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.311 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.513 HG21 ' CD2' ' A' ' 81' ' ' TYR . 3.9 p -84.77 165.56 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.935 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.487 ' C ' ' H ' ' A' ' 61' ' ' ILE . 16.2 m -147.98 146.17 22.97 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.986 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 61' ' ' ILE . 59.7 Cg_endo -74.44 25.48 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.992 1.795 . . . . 0.0 112.548 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 59' ' ' VAL . 1.5 mp 52.05 155.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.221 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 4.2 mmtt -126.75 -39.91 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.655 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.55 43.41 0.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.819 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 1.5 m-20 -139.18 -57.53 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER 66.82 124.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.494 -179.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.593 ' CG2' ' HA ' ' A' ' 106' ' ' ILE . 7.0 t 68.94 62.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.877 0.37 . . . . 0.0 110.406 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.5 m -93.66 141.55 28.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.488 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 9.4 tttm -87.95 137.63 32.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.436 ' HG2' HD11 ' A' ' 73' ' ' LEU . 0.4 OUTLIER -54.79 -25.97 31.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.709 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 t 53.93 25.5 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.374 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.418 ' HG2' HD11 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -118.23 1.9 11.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.177 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.71 78.6 0.21 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.087 0.47 . . . . 0.0 110.457 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.495 ' N ' HD13 ' A' ' 73' ' ' LEU . 11.0 mp -74.51 -42.77 58.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.488 HG21 ' CE2' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -138.1 155.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.719 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -96.74 139.74 32.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.29 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 110.18 -33.63 5.88 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.156 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.26 176.26 8.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.826 0.346 . . . . 0.0 111.03 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 42.6 m-20 -113.67 129.2 56.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.564 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.4 112.55 24.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 44.8 m-85 -119.84 153.72 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.374 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.513 ' CD2' HG21 ' A' ' 58' ' ' VAL . 38.4 p90 -144.38 128.04 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.117 0.484 . . . . 0.0 111.645 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.441 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.8 t -133.71 121.76 22.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.667 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 19.4 p -80.94 153.49 27.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.978 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -49.13 151.52 1.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.97 -6.72 49.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.658 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.49 20.48 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -159.5 102.67 1.5 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 0.0 111.318 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.05 -13.35 39.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.394 2.062 . . . . 0.0 112.013 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -96.65 30.48 2.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 20.1 m -153.57 71.9 0.9 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.559 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -70.16 177.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.317 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.427 ' CB ' ' HG ' ' A' ' 109' ' ' LEU . 95.7 m-85 -152.38 96.8 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.863 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.511 ' CG1' HG12 ' A' ' 50' ' ' ILE . 77.4 t -100.28 128.2 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 20.4 p -124.85 138.07 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.508 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 7.3 m-85 -106.0 89.41 3.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.737 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.458 HG23 HG23 ' A' ' 6' ' ' VAL . 0.6 OUTLIER -89.17 124.51 34.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.157 -179.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.405 HD21 HG13 ' A' ' 34' ' ' ILE . 28.8 mt -42.53 135.36 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -27.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 3' ' ' ARG . 2.5 m-20 -68.56 -22.03 64.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 4' ' ' PHE . 3.7 mm -70.49 135.99 86.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.287 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.473 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 38.2 Cg_endo -66.14 -164.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.305 2.004 . . . . 0.0 111.583 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -108.08 66.49 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.764 0.316 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 104' ' ' LEU . 6.1 tp -164.67 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.717 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.8 tp -62.32 -62.8 5.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.652 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.508 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 2.2 Cg_endo -44.99 -31.74 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.502 2.135 . . . . 0.0 111.155 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.593 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 4.0 mp -73.18 -41.76 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.231 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 104' ' ' LEU . 1.9 mmt180 -76.77 -23.2 52.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.794 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.717 HG12 ' O ' ' A' ' 104' ' ' LEU . 7.1 mm -70.11 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.235 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.427 ' HG ' ' CB ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -61.8 -55.59 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -59.6 -25.5 64.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.496 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -72.59 -47.02 29.15 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.526 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.435 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 8.1 mt -55.88 -26.26 46.42 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -18.01 61.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.34 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.13 -23.97 63.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.604 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 m-85 -100.43 -166.48 1.33 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -124.79 -2.4 7.82 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.528 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 49.6 m -127.69 123.34 35.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.094 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.513 ' HA ' HD23 ' A' ' 123' ' ' LEU . 0.6 OUTLIER -171.5 38.05 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.765 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.407 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -114.2 36.19 3.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.323 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.539 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -147.82 152.14 37.16 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.366 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.47 ' HA ' ' N ' ' A' ' 20' ' ' SER . 66.4 m-20 -71.6 22.13 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.2 tm-20 -164.66 26.21 0.06 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 118' ' ' ASN . 6.9 tt -124.92 -56.73 1.55 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.441 ' HG ' ' N ' ' A' ' 125' ' ' SER . 0.0 OUTLIER -52.46 -41.07 62.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.457 ' HA ' HG21 ' A' ' 128' ' ' VAL . 78.4 p -51.46 -31.42 23.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.34 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.14 -61.54 2.49 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.453 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.604 ' CE1' ' CB ' ' A' ' 115' ' ' TYR . 54.2 m170 -59.15 -32.95 70.34 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 125' ' ' SER . 62.0 t -53.45 -45.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.92 27.42 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.803 -1.189 . . . . 0.0 111.574 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.7 -21.3 66.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.927 0.394 . . . . 0.0 110.601 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.496 HD13 ' HA3' ' A' ' 111' ' ' GLY . 28.0 mt -90.11 -27.24 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.462 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.3 OUTLIER -61.38 -41.97 97.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.172 178.308 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 29.6 m-20 -65.64 -39.32 91.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.85 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.78 -15.63 44.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.429 ' CD2' HD12 ' A' ' 104' ' ' LEU . 2.8 t80 -53.15 -56.64 14.8 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.402 ' CD2' ' O ' ' A' ' 133' ' ' ASP . 27.1 p80 -59.77 -42.56 93.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -50.46 -30.75 13.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.007 0.432 . . . . 0.0 110.026 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -75.62 -36.57 60.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.972 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.422 HD13 ' CZ ' ' A' ' 135' ' ' PHE . 23.2 mt -65.71 -30.57 71.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.229 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.4 t -78.03 -49.18 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.472 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.85 -31.29 72.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.974 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -25.45 67.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.421 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.14 56.79 2.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -179.83 -41.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.725 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -81.55 169.8 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.958 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.5 p 54.67 31.53 15.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.1 mt -127.89 -179.13 4.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.3 -31.21 14.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.85 -179.946 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.775 0.322 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.416 ' HD3' ' O ' ' A' ' 30' ' ' ASN . 10.0 tttt -166.7 147.72 6.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.9 43.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.724 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CE2' HG23 ' A' ' 100' ' ' ILE . 26.0 m-85 63.06 169.38 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.918 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.03 111.63 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.034 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.505 ' CG2' HG13 ' A' ' 108' ' ' ILE . 71.0 t -63.0 142.29 16.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.822 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.416 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -63.81 -67.15 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.251 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.619 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 2.2 m-85 -150.02 121.57 7.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.452 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.57 95.59 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.303 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 3.0 tt0 -105.31 117.29 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.973 0.416 . . . . 0.0 111.626 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.46 HG12 ' CD2' ' A' ' 92' ' ' TYR . 11.9 t -83.18 155.09 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.556 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 17' ' ' THR . 3.2 mp -131.63 118.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.527 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.2 tptt -103.68 104.8 14.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.386 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 65.8 23.33 11.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.512 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.474 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . 76.38 38.88 32.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.549 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.72 18.19 1.82 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 60.08 150.17 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.008 179.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.527 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -139.59 -47.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.921 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -126.56 175.02 8.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.346 -179.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.469 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 11.6 p -170.48 121.55 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.592 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.2 t -108.58 71.0 0.77 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.619 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -106.15 83.08 1.84 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.904 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.77 141.84 23.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.195 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.35 152.7 20.82 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.634 2.223 . . . . 0.0 112.38 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 27.2 p90 177.37 155.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.613 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.616 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 53.9 mt-30 -116.77 36.03 4.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.984 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 29' ' ' GLU . 7.3 tttt 80.5 -9.59 1.35 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.995 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 61.05 -81.16 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.812 0.339 . . . . 0.0 111.005 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 27' ' ' LYS . 5.2 tt0 -140.52 -48.26 0.43 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.784 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.416 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 1.7 t-20 -141.09 -177.22 5.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 40.44 77.35 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.608 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' HA2' ' CD1' ' A' ' 97' ' ' LEU . . . -176.61 -165.54 32.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.81 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 18.1 m -163.85 -43.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.897 0.38 . . . . 0.0 110.833 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 6.2 mt -61.87 142.74 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.278 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -172.75 -81.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.632 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.51 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -131.36 59.86 1.68 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.769 0.319 . . . . 0.0 110.992 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.19 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -105.94 30.09 6.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.56 28.54 6.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -113.35 -35.75 5.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.502 ' CG2' ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -54.41 124.58 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.102 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.486 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 8.9 t -86.97 149.65 48.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.562 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 Cg_exo -43.52 -23.28 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.679 2.253 . . . . 0.0 112.098 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.413 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 3.5 t -66.88 -48.98 78.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.478 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 2.3 mp -54.09 -36.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.502 ' CE1' ' CG2' ' A' ' 41' ' ' ILE . 66.8 m-85 -76.49 -43.11 41.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.35 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.654 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.91 -23.49 67.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.346 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -86.47 -33.54 20.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.679 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.555 ' O ' ' N ' ' A' ' 53' ' ' MET . 12.2 mt -58.78 -63.36 1.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.618 HG12 ' CG1' ' A' ' 93' ' ' VAL . 3.9 mt -49.39 -58.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.044 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.654 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -53.79 -56.78 14.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.345 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -9.71 44.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.555 ' N ' ' O ' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -117.47 -62.14 1.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.455 HG13 ' CD1' ' A' ' 81' ' ' TYR . 59.3 t -68.0 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 111.914 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.522 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 0.2 OUTLIER -43.04 -51.48 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 24.6 Cg_endo -63.18 -1.63 3.12 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.809 1.672 . . . . 0.0 112.344 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -147.86 23.11 1.1 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.05 0.452 . . . . 0.0 109.993 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.463 HG22 ' CD2' ' A' ' 81' ' ' TYR . 2.8 p -76.37 155.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 61' ' ' ILE . 33.0 m -146.08 147.07 30.55 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.107 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HA ' ' CG2' ' A' ' 83' ' ' THR . 60.6 Cg_endo -76.14 25.81 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.852 1.702 . . . . 0.0 112.214 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 59' ' ' VAL . 0.3 OUTLIER 47.5 173.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.082 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.0 mmtt -98.53 -75.81 0.55 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.931 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.65 17.35 2.43 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.984 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -117.02 -30.58 5.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.984 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.5 mptt 58.32 155.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.254 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.517 ' HB ' HG13 ' A' ' 106' ' ' ILE . 2.8 t 66.52 63.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -86.04 134.08 33.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.016 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 4.5 ttpp -85.03 130.06 34.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.827 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.474 ' HG2' HD11 ' A' ' 73' ' ' LEU . 6.7 tpt -50.79 -27.48 7.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.412 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.38 28.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 110.74 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.429 ' O ' ' HG3' ' A' ' 71' ' ' MET . 4.0 tpp -109.95 -12.31 14.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.987 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.51 61.79 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.463 . . . . 0.0 109.786 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.515 ' HG ' ' HG2' ' A' ' 53' ' ' MET . 9.5 mp -66.13 -45.23 81.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.03 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.459 HG23 ' CE1' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -132.71 159.7 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.029 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' N ' HG21 ' A' ' 74' ' ' ILE . 7.7 t70 -101.97 142.03 33.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.397 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.68 -35.59 4.91 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.842 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.459 ' CE1' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -133.38 175.25 9.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.788 0.328 . . . . 0.0 110.819 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 40.8 m-20 -113.11 152.58 29.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.508 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 4.9 t -111.65 116.06 30.16 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 85.5 m-85 -123.28 144.57 49.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.248 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.463 ' CD2' HG22 ' A' ' 58' ' ' VAL . 39.1 p90 -135.17 125.01 25.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 111.533 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.446 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -129.21 121.06 26.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.668 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 8.4 p -82.18 150.75 27.23 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.699 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -46.51 149.65 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.984 0.421 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.56 -17.45 46.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.981 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 22.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -146.1 94.55 4.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.72 -15.09 46.74 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.166 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -96.0 26.32 4.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.072 0.463 . . . . 0.0 110.268 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.423 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 38.0 m -150.7 69.5 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -69.06 178.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.14 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.46 ' CD2' HG12 ' A' ' 11' ' ' VAL . 96.2 m-85 -153.16 91.6 1.54 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.446 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.618 ' CG1' HG12 ' A' ' 50' ' ' ILE . 35.4 t -91.43 125.17 44.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.066 0.46 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 44.3 t -120.44 126.12 49.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.29 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.515 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m-85 -99.06 116.86 32.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.372 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.463 ' CG2' ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -119.9 132.86 55.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.085 0.469 . . . . 0.0 111.636 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.425 ' CD1' ' HA2' ' A' ' 32' ' ' GLY . 31.3 mt -49.91 125.59 12.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.036 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -43.73 -31.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.71 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.37 -35.14 78.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.78 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.444 HG23 ' CE2' ' A' ' 4' ' ' PHE . 40.5 mt -74.18 138.25 75.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.416 ' HD2' ' CG2' ' A' ' 100' ' ' ILE . 18.9 Cg_endo -57.9 -169.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.468 2.112 . . . . 0.0 112.273 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -109.03 67.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.454 HG21 ' CZ ' ' A' ' 135' ' ' PHE . 1.1 tp -153.27 -38.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.441 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.643 ' O ' HG12 ' A' ' 108' ' ' ILE . 25.1 tp -59.33 -57.17 29.02 Favored Pre-proline 0 C--N 1.331 -0.204 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.901 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 104' ' ' LEU . 7.5 Cg_endo -49.9 -37.45 46.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.422 2.081 . . . . 0.0 111.039 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.517 HG13 ' HB ' ' A' ' 66' ' ' VAL . 2.9 mp -67.0 -32.4 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.815 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.442 ' O ' ' HA3' ' A' ' 111' ' ' GLY . 0.1 OUTLIER -81.73 -26.62 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.594 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.643 HG12 ' O ' ' A' ' 104' ' ' LEU . 5.9 mm -66.92 -47.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.372 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.77 -58.2 3.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 t -56.46 -30.57 63.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 107' ' ' ARG . . . -76.25 -43.3 21.13 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 7.0 mt -57.85 -31.51 66.74 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.67 -14.73 59.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.94 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.25 -21.31 56.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.451 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.55 ' HB2' ' CE1' ' A' ' 127' ' ' HIS . 5.1 m-85 -88.58 -97.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.999 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 34.6 tp10 159.04 -22.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.672 0.389 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.676 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 5.9 t -121.75 99.75 6.63 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.28 0.562 . . . . 0.0 111.243 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.543 ' HA ' HD22 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -152.34 45.43 0.73 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.21 33.89 4.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 123' ' ' LEU . 0.0 OUTLIER -144.11 157.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.236 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.469 ' HA ' ' N ' ' A' ' 20' ' ' SER . 78.7 m-20 -74.62 17.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.689 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.8 OUTLIER -163.67 29.03 0.08 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.557 ' CD2' ' O ' ' A' ' 117' ' ' SER . 5.9 tt -131.04 -45.82 1.02 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.575 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 118' ' ' ASN . 0.0 OUTLIER -59.78 -43.04 94.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.465 ' HA ' HG21 ' A' ' 128' ' ' VAL . 70.7 p -46.65 -27.15 1.07 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.64 178.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.06 -56.79 17.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.295 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.676 ' CE1' ' O ' ' A' ' 117' ' ' SER . 8.1 m170 -60.87 -36.5 79.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 125' ' ' SER . 46.0 t -52.06 -44.09 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.889 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.97 -47.05 12.03 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -64.94 -21.13 66.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 127' ' ' HIS . 60.7 mt -90.5 -28.09 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.452 ' CD1' ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -66.93 -35.07 79.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.351 178.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 22.4 t0 -69.57 -38.89 77.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.762 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.0 t -84.08 -13.62 52.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.984 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 103' ' ' ILE . 13.2 t80 -54.91 -55.1 34.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.996 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.416 ' CE1' ' HG2' ' A' ' 137' ' ' GLU . 18.6 p80 -58.33 -38.09 76.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.883 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 6.0 mm-40 -54.56 -31.49 56.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.111 0.482 . . . . 0.0 110.225 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.42 -34.88 47.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.913 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.426 HD11 ' CE1' ' A' ' 135' ' ' PHE . 23.5 mt -66.74 -35.11 79.35 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.793 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 81.5 t -74.18 -47.33 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.818 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -33.87 74.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.743 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -16.97 64.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.414 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.62 33.49 1.27 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.255 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -148.99 29.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.851 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -152.92 -72.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 p -98.33 59.99 1.36 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tt -109.98 118.94 37.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -108.37 -31.53 7.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.988 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.911 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.871 0.367 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.77 147.41 51.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.88 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' O ' ' CD2' ' A' ' 4' ' ' PHE . 1.4 mmp_? -115.22 179.5 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.003 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' CE1' HG21 ' A' ' 100' ' ' ILE . 18.0 m-85 -159.64 173.12 16.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.935 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -175.72 132.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' CG2' HG13 ' A' ' 108' ' ' ILE . 3.4 t -82.08 109.23 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.425 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.471 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -39.18 -59.42 1.02 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.239 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.65 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 7.6 m-85 -148.68 113.12 5.3 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 21' ' ' CYS . 2.8 t -107.12 100.75 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.412 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.506 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 1.0 OUTLIER -111.36 128.89 56.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.105 0.478 . . . . 0.0 111.769 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.717 HG12 ' CD1' ' A' ' 18' ' ' ILE . 53.1 t -98.1 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.536 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.7 mp -117.24 118.32 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 7.0 tptt -99.72 102.24 13.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.419 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 62.01 39.75 12.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.562 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.4 60.77 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.827 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.406 ' N ' HG21 ' A' ' 12' ' ' ILE . 40.8 mt-10 -145.12 113.75 6.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 0.0 110.102 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.464 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -50.24 126.78 15.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.715 -179.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.717 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -105.01 -50.45 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.415 179.129 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 120' ' ' THR . 63.9 p -119.26 172.43 7.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.266 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.419 ' N ' HD23 ' A' ' 124' ' ' LEU . 6.5 m -168.28 133.47 1.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 112.054 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.506 ' HB2' HD21 ' A' ' 124' ' ' LEU . 36.0 t -116.88 69.42 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.65 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -104.62 96.58 6.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.298 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.62 129.23 18.37 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.36 151.37 17.64 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.658 2.239 . . . . 0.0 112.008 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.428 ' HZ ' ' HA ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -134.95 -29.87 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.813 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 22.1 tt0 78.27 29.42 0.45 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.963 0.411 . . . . 0.0 110.808 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.86 169.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.018 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -169.19 -159.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.502 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.48 63.92 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.891 0.377 . . . . 0.0 110.764 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -179.28 -168.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.546 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -75.84 103.57 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.072 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.85 -176.12 16.62 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.53 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.0 m -159.31 -43.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.827 0.346 . . . . 0.0 111.331 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.411 HD13 ' CZ ' ' A' ' 25' ' ' PHE . 8.5 mt -53.47 143.52 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.412 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER 176.62 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.434 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -167.07 -80.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.784 0.326 . . . . 0.0 111.454 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.08 -25.23 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.501 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 2.9 m120 -122.68 31.74 5.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.049 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -134.26 27.3 3.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.094 0.473 . . . . 0.0 110.971 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -118.42 -28.91 5.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.455 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.52 ' CG2' ' CE2' ' A' ' 46' ' ' PHE . 3.7 mm -55.98 125.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.934 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.487 ' CG2' ' HB ' ' A' ' 44' ' ' VAL . 8.9 t -85.44 149.54 52.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 2.2 Cg_endo -44.87 -22.04 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.354 2.036 . . . . 0.0 111.583 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.487 ' HB ' ' CG2' ' A' ' 42' ' ' THR . 93.6 t -66.9 -45.73 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.11 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.516 ' HB ' ' CG2' ' A' ' 41' ' ' ILE . 2.1 mp -59.62 -34.55 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.52 ' CE2' ' CG2' ' A' ' 41' ' ' ILE . 39.1 m-85 -79.41 -42.87 24.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.316 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.639 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.54 -30.51 71.62 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.657 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 25.8 p30 -89.51 -26.04 21.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 53' ' ' MET . 3.6 mt -64.54 -61.16 2.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.526 HG22 ' HB ' ' A' ' 54' ' ' VAL . 6.4 mt -49.53 -62.93 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.493 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.639 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.21 -43.0 61.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.173 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -90.84 -15.16 30.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.464 ' N ' ' O ' ' A' ' 49' ' ' LEU . 90.9 mmm -123.76 -70.49 0.76 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.526 ' HB ' HG22 ' A' ' 50' ' ' ILE . 88.6 t -51.39 -50.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.889 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.449 ' N ' ' HD2' ' A' ' 56' ' ' PRO . 3.0 mm? -56.18 -58.9 13.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.032 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 23.5 Cg_endo -62.31 4.71 0.3 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.285 1.99 . . . . 0.0 113.12 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 1.6 tptp -153.25 26.98 0.52 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.445 HG23 ' CD1' ' A' ' 81' ' ' TYR . 7.7 p -82.22 150.67 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.161 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 61' ' ' ILE . 9.0 t -97.71 138.41 21.05 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.399 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 61' ' ' ILE . 71.1 Cg_endo -76.23 27.83 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.912 1.741 . . . . 0.0 111.696 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 59' ' ' VAL . 26.4 mm 20.25 81.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.01 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 -42.8 11.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.174 0.511 . . . . 0.0 110.048 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.06 -26.51 1.86 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.113 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -79.61 -159.27 0.19 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 110.649 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HA ' HG21 ' A' ' 61' ' ' ILE . 0.0 OUTLIER 177.67 103.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.901 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.568 ' HB ' HG13 ' A' ' 106' ' ' ILE . 3.6 t 74.91 71.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.598 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -97.25 138.57 34.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.469 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 1.3 ttpm? -82.52 132.39 35.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.287 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.46 ' HG2' ' CB ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -53.83 -29.82 42.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.034 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.76 27.96 11.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.212 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.46 ' CB ' ' HG2' ' A' ' 69' ' ' MET . 6.1 tpt -106.97 -15.55 14.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.207 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 65.04 59.84 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 73' ' ' LEU . 8.0 mp -62.91 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.445 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.482 HG22 ' CE1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -135.5 155.08 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.504 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.419 ' N ' HG23 ' A' ' 74' ' ' ILE . 4.3 t70 -99.71 138.62 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.517 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 113.24 -32.32 6.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.532 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.501 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 1.7 m-85 -118.21 -168.13 1.47 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.485 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -136.11 118.76 16.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.13 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 p -87.64 108.42 19.08 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 53.8 m-85 -121.55 151.1 40.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.896 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.496 ' HB3' HG11 ' A' ' 54' ' ' VAL . 11.9 p90 -144.52 139.61 28.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.09 0.472 . . . . 0.0 111.974 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -142.3 124.38 15.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.563 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 45.0 p -90.01 152.77 21.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.456 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -46.85 162.3 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 0.0 111.167 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -70.89 -22.91 62.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.682 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 22.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.93 91.48 10.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.26 . . . . 0.0 110.763 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.57 -14.23 38.4 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.378 2.052 . . . . 0.0 112.045 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 29.72 1.86 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.0 m -156.85 71.78 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.524 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 12' ' ' ILE . 0.3 OUTLIER -81.26 173.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.935 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.469 ' CD2' ' O ' ' A' ' 91' ' ' VAL . 14.1 m-85 -141.72 153.17 44.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.213 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.502 ' CG1' HG12 ' A' ' 50' ' ' ILE . 14.6 t -152.63 122.18 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.977 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 13.9 m -112.41 114.14 26.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 111.824 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 46' ' ' PHE . 1.3 m-85 -90.15 71.53 7.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.751 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.419 ' O ' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -72.37 -176.38 1.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.933 0.397 . . . . 0.0 111.489 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.41 127.87 43.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.321 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -43.64 -33.69 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.534 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -38.88 92.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.552 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.424 HG21 ' CE1' ' A' ' 4' ' ' PHE . 62.6 mt -66.93 138.34 95.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.902 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.94 -168.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.516 2.144 . . . . 0.0 112.348 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -108.69 67.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.459 HG22 ' CZ ' ' A' ' 135' ' ' PHE . 2.7 tp -154.54 -38.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.845 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.612 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -57.06 -64.98 1.97 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.02 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.502 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 5.6 Cg_endo -47.34 -31.17 12.42 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.565 2.177 . . . . 0.0 111.492 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.568 HG13 ' HB ' ' A' ' 66' ' ' VAL . 3.4 mp -68.91 -34.46 64.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.819 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 104' ' ' LEU . 14.0 mmp_? -84.85 -22.64 29.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.345 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 104' ' ' LEU . 21.0 mm -70.1 -45.18 77.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.148 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.429 ' CG ' ' OG ' ' A' ' 82' ' ' SER . 0.2 OUTLIER -76.34 -50.13 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.855 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.5 t -61.95 -30.63 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 107' ' ' ARG . . . -75.48 -47.2 12.9 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.423 ' CD2' ' HB2' ' A' ' 127' ' ' HIS . 12.8 mt -56.58 -30.47 63.23 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.0 -16.72 56.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.196 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -25.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.75 0.31 . . . . 0.0 110.38 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.529 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.2 m-85 -82.33 -91.86 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.2 pt-20 160.56 -28.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.414 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.536 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 19.5 m -111.89 129.54 56.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.517 0.675 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.491 ' HA ' HD23 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -172.3 35.19 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.039 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.86 33.28 4.32 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.547 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -145.62 148.06 32.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.469 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -69.73 22.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.526 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.547 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.2 tp10 -162.87 25.24 0.09 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 118' ' ' ASN . 7.7 tt -123.76 -57.22 1.64 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.614 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.506 HD21 ' HB2' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -52.5 -42.1 63.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.442 ' HA ' HG21 ' A' ' 128' ' ' VAL . 83.4 p -52.1 -28.68 18.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.243 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.21 -61.72 2.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.227 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 117' ' ' SER . 26.5 m170 -59.88 -31.56 69.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 125' ' ' SER . 56.2 t -56.54 -42.38 75.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.45 15.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.876 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.97 -21.4 65.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.481 ' CG1' ' O ' ' A' ' 127' ' ' HIS . 59.4 mt -90.02 -28.07 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.449 HD11 ' CD1' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -62.86 -43.67 98.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.366 178.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -35.38 80.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.7 t -83.8 -20.84 32.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.079 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.459 ' CZ ' HG22 ' A' ' 103' ' ' ILE . 1.5 t80 -50.88 -53.87 28.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.97 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -59.34 -43.89 92.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.877 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -50.01 -30.15 10.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.074 0.464 . . . . 0.0 110.375 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -78.68 -34.17 46.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.058 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.42 ' CD2' ' CE2' ' A' ' 135' ' ' PHE . 15.9 mt -70.34 -28.93 65.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.25 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.2 t -77.21 -48.67 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.473 0.654 . . . . 0.0 109.472 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.97 -34.8 78.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.831 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.53 -24.99 67.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.135 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.03 44.94 1.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.062 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -143.52 30.95 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.838 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -128.7 -66.8 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.1 t -124.03 86.32 2.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.934 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.32 -28.59 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.77 37.81 9.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.942 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 104' ' ' LEU . 4.2 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.021 0.439 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.5 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -40.46 -51.26 2.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.719 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.615 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 14.3 m-85 -148.8 120.08 7.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.851 0.357 . . . . 0.0 111.464 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.771 HG21 HG11 ' A' ' 128' ' ' VAL . 1.5 t -110.0 95.28 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.979 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 0.5 OUTLIER -100.54 111.37 23.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.743 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.983 ' CG2' HD13 ' A' ' 124' ' ' LEU . 38.7 t -81.97 160.19 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 50' ' ' ILE . 2.5 mt -140.7 127.05 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.561 ' HB2' HD13 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -118.96 111.77 18.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 2.7 m120 64.04 34.75 11.07 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.991 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.48 26.14 61.84 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.544 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -148.27 120.05 8.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 11' ' ' VAL . 3.1 m -48.38 125.45 9.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.238 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -99.57 -45.46 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.738 0.78 . . . . 0.0 109.512 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.928 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.66 175.37 7.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.9 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.444 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 20.4 m -170.59 134.63 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HB3' HG23 ' A' ' 9' ' ' VAL . 33.2 t -123.45 69.34 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.2 m-85 -107.23 100.18 9.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.165 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.428 -179.662 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.491 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.8 m-80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.774 0.321 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.73 25.71 4.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.08 0.467 . . . . 0.0 110.864 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -110.24 -34.86 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.667 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.659 HG23 HG13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -55.6 133.62 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.918 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.606 HG23 ' HB ' ' A' ' 44' ' ' VAL . 5.1 t -92.55 150.88 40.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.85 -24.27 4.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.946 1.764 . . . . 0.0 111.072 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.606 ' HB ' HG23 ' A' ' 42' ' ' THR . 90.4 t -66.95 -35.95 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.681 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.659 HG13 HG23 ' A' ' 41' ' ' ILE . 13.4 mm -63.0 -42.63 97.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.627 ' CE1' HG22 ' A' ' 41' ' ' ILE . 18.3 m-85 -77.14 -38.3 52.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.144 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.613 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -65.73 -31.53 72.58 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.032 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.94 -29.1 22.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.2 mt -61.24 -60.15 4.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.071 HG12 HG11 ' A' ' 93' ' ' VAL . 7.0 mt -50.2 -63.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.847 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.0 OUTLIER -53.66 -37.35 63.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.81 -1.541 . . . . 0.0 113.116 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.11 -23.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.477 ' O ' ' HE1' ' A' ' 69' ' ' MET . 74.7 mmm -117.03 -57.18 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.969 HG22 ' HG3' ' A' ' 69' ' ' MET . 52.9 t -63.45 -63.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.887 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.955 HD23 HG22 ' A' ' 50' ' ' ILE . 3.0 mm? -44.43 -53.43 14.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.5 Cg_exo -68.53 4.62 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.231 1.954 . . . . 0.0 112.412 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -150.32 25.26 0.8 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.006 0.432 . . . . 0.0 110.578 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 59' ' ' VAL . 4.3 p -87.03 166.05 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 58' ' ' VAL . 28.9 m . . . . . 0 N--CA 1.447 -0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.328 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 106' ' ' ILE . 4.6 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.656 0.265 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.498 HG22 ' CE1' ' A' ' 81' ' ' TYR . 2.5 t -102.61 139.19 38.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.848 0.356 . . . . 0.0 111.279 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -79.38 135.47 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.51 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.969 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -51.53 -29.02 15.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 53.12 25.42 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.0 tpp -110.31 -5.0 15.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.737 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 59.05 56.87 3.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.85 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.5 mp -53.22 -48.02 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.544 HG13 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -142.74 162.23 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.41 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.2 t70 -104.5 137.49 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.185 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 115.84 -32.96 5.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.244 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -132.9 162.56 31.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.197 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.501 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 52.8 m-20 -103.46 133.77 47.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.853 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.491 ' SG ' HD13 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -119.05 121.84 40.76 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -126.82 164.87 20.43 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.716 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CD2' HG13 ' A' ' 54' ' ' VAL . 19.5 p90 -138.74 129.06 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.381 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.447 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 5.0 t -129.94 112.4 13.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.594 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 33.0 p -74.32 156.8 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.939 0.4 . . . . 0.0 111.176 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -52.84 153.3 3.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.61 -9.14 57.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.71 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.28 23.14 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.69 87.28 4.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.772 0.32 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.17 -20.25 18.66 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.637 2.224 . . . . 0.0 112.577 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -93.79 29.57 2.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 52.7 m -149.85 73.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.342 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -75.01 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.724 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.542 ' H ' HG12 ' A' ' 91' ' ' VAL . 39.3 m-85 -144.52 93.55 2.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.071 HG11 HG12 ' A' ' 50' ' ' ILE . 41.0 t -98.44 127.62 50.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.53 . . . . 0.0 111.622 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 7.4 p -110.1 152.9 25.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 8' ' ' TYR . 1.4 m-85 -130.91 74.59 1.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.686 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.611 HG21 ' HD3' ' A' ' 105' ' ' PRO . 58.7 p -75.08 -169.52 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 100' ' ' ILE . 24.1 mt -102.43 137.01 41.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.536 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.04 -30.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.806 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.12 -33.34 73.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.021 0.439 . . . . 0.0 110.57 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.2 mm -67.51 127.12 93.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.968 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.75 -168.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -106.65 66.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.647 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.617 ' CA ' HD13 ' A' ' 106' ' ' ILE . 2.9 tp -151.14 -36.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.813 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.674 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -64.03 -63.27 4.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.611 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.5 Cg_endo -44.95 -29.27 3.61 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.657 2.238 . . . . 0.0 111.331 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.804 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.1 mp -69.63 -45.17 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.746 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.483 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -76.43 -22.44 54.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.602 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.777 ' CD1' HD12 ' A' ' 132' ' ' LEU . 33.7 mm -67.11 -59.4 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.603 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.09 -56.64 15.16 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 p -57.06 -25.4 58.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.54 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -75.32 -45.37 19.3 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.497 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.939 HD23 ' HB2' ' A' ' 127' ' ' HIS . 18.5 mt -56.6 -28.11 59.63 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.71 -15.9 61.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.279 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.19 -27.26 64.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.588 ' CD1' ' CE1' ' A' ' 127' ' ' HIS . 4.6 m-85 -98.73 -167.97 1.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.496 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -121.53 -0.63 9.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.73 ' HB2' HD21 ' A' ' 123' ' ' LEU . 1.4 m -125.1 137.53 54.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.756 0.789 . . . . 0.0 111.108 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.567 ' N ' HD22 ' A' ' 123' ' ' LEU . 19.6 p30 174.02 35.92 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.164 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.12 34.07 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.516 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -146.12 155.52 42.8 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.98 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.444 ' HA ' ' N ' ' A' ' 20' ' ' SER . 15.7 m-80 -75.78 24.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -165.09 25.9 0.06 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.73 HD21 ' HB2' ' A' ' 117' ' ' SER . 6.5 tt -123.75 -56.73 1.67 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.871 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.983 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.78 -41.39 64.05 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.02 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.477 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 85.3 p -50.33 -28.45 7.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.215 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.07 -64.22 0.97 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.224 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.939 ' HB2' HD23 ' A' ' 112' ' ' LEU . 6.2 m-70 -59.57 -30.98 69.02 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.987 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 124' ' ' LEU . 48.0 t -57.15 -42.69 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.99 -38.5 22.77 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.764 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -22.82 63.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.388 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.54 HD13 ' HA3' ' A' ' 111' ' ' GLY . 46.9 mt -90.19 -27.09 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.777 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -62.33 -49.0 77.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.524 178.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -44.96 83.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.8 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 m -70.83 -19.04 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.8 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.578 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 54.7 t80 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.206 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.836 HG11 HG22 ' A' ' 9' ' ' VAL . 3.5 t . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -61.71 -59.83 4.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.237 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.677 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 2.8 m-85 -144.14 109.25 5.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.836 HG22 HG11 ' A' ' 6' ' ' VAL . 4.1 t -108.08 100.7 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.801 0.334 . . . . 0.0 111.356 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.488 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 2.2 mt-10 -111.24 120.13 41.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.059 HG23 HD13 ' A' ' 124' ' ' LEU . 46.7 t -79.86 156.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 50' ' ' ILE . 3.8 mt -133.98 111.28 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 15.7 tptt -91.16 99.74 12.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 58.35 41.04 23.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 12' ' ' ILE . . . 81.1 23.34 59.36 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.607 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -140.27 109.39 6.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -45.12 128.9 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.23 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.474 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -110.24 -45.85 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -123.07 172.86 8.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.511 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.49 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.3 m -167.48 126.92 1.37 Allowed 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 20.1 t -116.93 69.34 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.55 92.73 4.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.107 -178.174 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.2 mp0 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.399 -179.681 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.685 0.278 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.32 26.08 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 110.859 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.61 -37.31 6.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.599 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.718 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -52.59 123.02 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.564 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.921 HG22 HD12 ' A' ' 45' ' ' ILE . 10.9 t -83.55 150.6 60.24 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.642 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 86.0 Cg_exo -45.75 -22.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.259 1.973 . . . . 0.0 111.908 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.739 ' HB ' HG23 ' A' ' 42' ' ' THR . 36.6 t -68.62 -41.07 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.103 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 42' ' ' THR . 1.6 mp -60.4 -34.57 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.718 ' CE1' HG22 ' A' ' 41' ' ' ILE . 56.0 m-85 -81.17 -42.37 20.95 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.995 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.19 -30.48 71.1 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.684 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 27.4 p30 -90.24 -26.43 20.07 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.718 HD11 HG13 ' A' ' 74' ' ' ILE . 3.1 mt -63.15 -60.24 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.043 HG12 HG11 ' A' ' 93' ' ' VAL . 5.0 mt -52.14 -63.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.893 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -52.76 -41.46 64.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.356 -179.04 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.2 t0 -90.73 -20.27 22.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.463 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 77.8 mmm -119.39 -60.93 1.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 81' ' ' TYR . 59.3 t -61.58 -56.02 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.934 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -50.44 -54.63 32.9 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.0 Cg_exo -62.89 -0.04 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.151 1.901 . . . . 0.0 112.78 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.548 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 1.2 tppt? -149.86 27.75 0.78 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 HG11 ' A' ' 91' ' ' VAL . 2.6 p -86.29 157.0 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.982 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.484 HG22 ' HE1' ' A' ' 81' ' ' TYR . 35.2 m . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.198 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.754 HG21 ' HA ' ' A' ' 106' ' ' ILE . 25.3 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.698 0.285 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 83.9 m -112.65 127.23 56.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -80.69 144.83 31.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.416 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.548 ' HE3' ' HB3' ' A' ' 57' ' ' LYS . 49.2 tpp -71.63 -35.39 70.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.977 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m 61.21 29.84 18.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.47 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 2.8 tpt -110.97 -12.48 14.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 62.79 63.49 0.97 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.001 0.429 . . . . 0.0 110.427 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.61 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.2 mp -62.2 -48.42 80.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.45 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -131.15 151.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -93.48 140.67 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.592 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.97 -34.33 5.5 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.166 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.589 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -120.92 -167.36 1.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.923 0.392 . . . . 0.0 111.208 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -137.65 128.89 27.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.38 105.98 17.99 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 51.1 m-85 -115.93 123.99 49.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.851 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.786 ' CD2' HG13 ' A' ' 54' ' ' VAL . 13.3 p90 -115.85 132.48 56.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.347 0.594 . . . . 0.0 112.133 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.678 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 0.8 OUTLIER -133.7 129.26 36.5 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.175 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.848 HG22 HG13 ' A' ' 91' ' ' VAL . 10.9 p -93.76 153.43 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.895 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -45.29 148.57 0.61 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -21.28 24.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.834 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.87 23.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.05 91.29 8.97 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.688 0.28 . . . . 0.0 110.842 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.88 -15.39 42.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.455 2.103 . . . . 0.0 112.145 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -96.36 29.42 2.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.092 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' THR . 52.3 m -153.19 68.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.709 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.848 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -67.94 -178.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.174 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.503 ' H ' HG12 ' A' ' 91' ' ' VAL . 91.8 m-85 -157.14 99.67 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.043 HG11 HG12 ' A' ' 50' ' ' ILE . 15.0 t -104.83 118.84 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.047 0.451 . . . . 0.0 111.52 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.503 ' SG ' HD22 ' A' ' 109' ' ' LEU . 32.0 p -112.02 131.03 55.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.873 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.5 m-85 -102.16 91.02 4.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.928 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.901 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -88.05 176.41 7.31 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.445 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 100' ' ' ILE . 7.4 mt -90.58 128.85 36.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.849 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.0 -33.46 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.663 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 110.593 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 101' ' ' PRO . 64.1 mt -76.15 138.08 68.58 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.2 Cg_endo -59.3 167.74 5.75 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.406 2.071 . . . . 0.0 112.128 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.483 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -87.6 58.08 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.792 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.67 HG23 ' HE1' ' A' ' 135' ' ' PHE . 4.2 tp -141.09 -37.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.625 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.695 ' HG ' HD11 ' A' ' 108' ' ' ILE . 16.1 tp -61.54 -59.8 12.37 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.901 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.3 Cg_endo -47.76 -33.54 19.34 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.494 2.129 . . . . 0.0 110.908 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.754 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.2 mp -67.96 -38.97 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.822 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.59 ' O ' HG21 ' A' ' 131' ' ' ILE . 6.6 mtt-85 -76.36 -29.78 57.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.424 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.695 HD11 ' HG ' ' A' ' 104' ' ' LEU . 9.4 mm -61.63 -51.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.601 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -69.24 -61.66 1.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.412 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 48.2 t -56.0 -24.48 39.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.498 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -80.06 -43.01 10.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -59.19 -35.08 72.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 10.4 pt20 -77.97 -9.92 59.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.728 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.39 -23.02 46.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.621 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 3.5 m-85 -87.16 -96.31 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.064 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 160.81 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.549 0.34 . . . . 0.0 110.817 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.609 ' O ' ' CD2' ' A' ' 123' ' ' LEU . 53.6 m -117.55 96.23 5.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.263 0.554 . . . . 0.0 111.195 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 2.6 p-10 -151.27 46.35 0.82 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.713 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.97 33.81 4.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.493 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -145.7 161.99 38.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.158 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.49 ' HA ' ' N ' ' A' ' 20' ' ' SER . 8.4 p30 -78.74 24.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.639 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -170.15 28.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 117' ' ' SER . 5.8 tt -132.43 -45.67 0.9 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.059 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -59.46 -42.44 91.99 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 82.7 p -48.58 -28.03 3.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.152 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -56.99 -59.04 5.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.829 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.8 m-70 -60.04 -33.67 72.34 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.532 ' O ' HD13 ' A' ' 132' ' ' LEU . 48.4 t -53.31 -43.04 49.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.961 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.91 -44.67 18.66 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 119.928 -1.13 . . . . 0.0 112.629 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -69.07 -21.02 64.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 111.059 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 127' ' ' HIS . 55.6 mt -90.47 -27.86 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.684 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -63.76 -48.19 77.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.153 178.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.88 -40.71 95.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -86.29 4.42 39.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.316 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.67 ' HE1' HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.71 0.291 . . . . 0.0 110.599 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.898 HG11 HG22 ' A' ' 9' ' ' VAL . 27.8 t . . . . . 0 C--O 1.23 0.073 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.406 ' N ' HG12 ' A' ' 6' ' ' VAL . 1.5 m -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.709 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 15.8 m-85 -139.98 107.01 5.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.898 HG22 HG11 ' A' ' 6' ' ' VAL . 1.9 t -116.1 99.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.105 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 28.1 tt0 -108.1 123.15 48.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.393 . . . . 0.0 111.809 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.87 ' CG2' HD13 ' A' ' 124' ' ' LEU . 11.0 t -85.73 138.06 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.933 HD13 HG23 ' A' ' 93' ' ' VAL . 1.4 mp -113.56 114.79 47.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 2.0 tppt? -97.36 104.93 16.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.632 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.06 26.91 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.298 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.684 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 77.7 34.55 38.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.911 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.47 17.93 2.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 58.69 155.97 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.346 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.54 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -145.49 -50.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.632 178.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.775 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -123.94 176.32 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.969 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -170.06 129.0 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.457 . . . . 0.0 111.349 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.9 t -116.46 69.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.872 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.709 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 3.0 m-85 -106.41 86.51 2.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.878 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.934 -178.822 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.628 HD21 ' N ' ' A' ' 38' ' ' ASN . 0.7 OUTLIER . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.739 0.304 . . . . 0.0 110.869 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -123.55 28.28 7.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -110.91 -37.9 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.728 HG23 HG13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -51.74 134.73 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.66 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.564 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.9 t -94.79 151.15 38.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 72.1 Cg_exo -47.17 -26.7 5.61 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.88 1.72 . . . . 0.0 110.8 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.564 ' HB ' HG23 ' A' ' 42' ' ' THR . 57.4 t -61.89 -40.62 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.581 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.728 HG13 HG23 ' A' ' 41' ' ' ILE . 16.8 mm -58.12 -45.13 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.593 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.625 ' CE1' HG22 ' A' ' 41' ' ' ILE . 27.6 m-85 -75.22 -40.14 59.38 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.399 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.592 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.74 -28.79 70.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 44' ' ' VAL . 32.5 m-20 -89.25 -29.63 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 73' ' ' LEU . 5.2 mt -60.92 -59.67 5.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.057 HG22 HD23 ' A' ' 55' ' ' LEU . 4.6 mt -53.28 -64.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.212 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.7 tpp -49.69 -43.16 47.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.552 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.08 -11.41 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.746 ' HB2' HD21 ' A' ' 73' ' ' LEU . 32.9 mmm -127.68 -68.29 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.801 HG22 ' HG3' ' A' ' 69' ' ' MET . 63.8 t -58.16 -56.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.68 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.057 HD23 HG22 ' A' ' 50' ' ' ILE . 2.8 mm? -44.86 -57.82 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.809 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 37.9 Cg_endo -66.96 5.04 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.049 1.833 . . . . 0.0 112.25 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.62 22.42 1.46 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.071 0.462 . . . . 0.0 110.14 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 91' ' ' VAL . 4.9 p -84.93 166.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.858 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.467 HG22 ' HE2' ' A' ' 81' ' ' TYR . 19.0 m . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.541 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.845 ' N ' ' HG ' ' A' ' 82' ' ' SER . 2.9 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.88 0.371 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.7 m -98.97 126.26 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.314 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 5.0 ttpt -73.99 132.58 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.356 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.801 ' HG3' HG22 ' A' ' 54' ' ' VAL . 16.5 mmm -55.62 -32.81 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.741 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t 59.52 24.62 13.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.994 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.538 ' HB2' HD12 ' A' ' 73' ' ' LEU . 28.0 mmm -103.82 -5.08 22.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.094 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.32 55.49 4.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.126 0.488 . . . . 0.0 110.044 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 53' ' ' MET . 10.3 mp -57.41 -52.17 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.008 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.64 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -131.99 155.17 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.852 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -96.7 140.63 31.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.316 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.682 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.62 -33.8 5.86 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.121 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HD1' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -130.71 168.23 17.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.023 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 81.7 m-20 -108.2 130.6 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.392 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.462 ' SG ' HD13 ' A' ' 73' ' ' LEU . 11.3 p -90.53 112.35 23.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 53.4 m-85 -121.57 149.7 42.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.563 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD1' HG13 ' A' ' 54' ' ' VAL . 44.7 p90 -144.39 128.98 18.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.05 0.452 . . . . 0.0 111.19 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.845 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 3.3 t -132.89 116.4 16.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.521 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.901 HG22 HG13 ' A' ' 91' ' ' VAL . 34.6 p -77.61 148.48 35.1 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.32 163.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.332 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.64 -15.28 35.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.485 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 16.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.37 100.21 2.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.13 -13.03 37.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.322 2.015 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 30.14 2.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.073 0.464 . . . . 0.0 110.469 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.608 ' O ' HG22 ' A' ' 90' ' ' THR . 17.5 m -153.74 70.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.66 0.743 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.901 HG13 HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -71.12 175.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.126 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.544 ' H ' HG12 ' A' ' 91' ' ' VAL . 45.3 m-85 -144.97 100.12 3.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.324 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.99 HG11 HG12 ' A' ' 50' ' ' ILE . 41.0 t -93.16 130.03 42.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.425 . . . . 0.0 111.384 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.56 133.45 49.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.659 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -114.49 97.58 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.804 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.876 HG21 ' HD3' ' A' ' 105' ' ' PRO . 2.6 p -102.27 127.64 49.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.467 HD23 ' HD1' ' A' ' 77' ' ' PHE . 34.3 mt -37.05 133.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.055 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.41 -31.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.041 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.23 -30.4 71.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 110.157 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.3 mm -67.38 136.66 93.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.923 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HD2' HG23 ' A' ' 100' ' ' ILE . 60.2 Cg_endo -72.45 179.55 5.0 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.246 1.964 . . . . 0.0 111.574 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.46 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -91.38 60.0 4.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.57 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 3.3 tp -148.73 -38.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.834 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.679 HD11 ' CD1' ' A' ' 132' ' ' LEU . 9.4 tp -62.19 -60.72 9.3 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.658 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.876 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.6 Cg_endo -47.85 -32.47 17.44 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.563 2.176 . . . . 0.0 111.239 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.84 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.7 mp -67.93 -36.45 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.106 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.523 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -83.73 -19.95 34.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.117 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 104' ' ' LEU . 11.7 mm -72.36 -49.47 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.809 0.338 . . . . 0.0 110.133 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.77 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -72.72 -49.4 31.4 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.7 p -63.95 -30.27 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.494 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -74.71 -43.32 29.26 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.856 HD23 ' HB2' ' A' ' 127' ' ' HIS . 11.5 mt -56.17 -35.36 67.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -13.35 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.133 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -22.43 55.78 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.472 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.482 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 5.9 m-85 -86.46 -94.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.886 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 162.19 -25.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.66 0.267 . . . . 0.0 110.904 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -91.82 -91.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.485 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.5 p-10 39.27 32.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.674 0.273 . . . . 0.0 111.097 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.15 33.83 5.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -148.59 150.78 33.9 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.48 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.437 ' HA ' ' N ' ' A' ' 20' ' ' SER . 2.3 p-10 -71.34 29.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.569 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 120' ' ' THR . 10.3 tt0 -170.91 27.53 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.2 tt -133.26 -49.77 0.86 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.689 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.87 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.31 -45.54 76.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.447 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 78.4 p -47.64 -30.12 3.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.375 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -60.16 -56.27 23.67 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.973 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.856 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.5 m-70 -60.91 -31.75 71.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.634 HG13 ' CG2' ' A' ' 108' ' ' ILE . 47.7 t -55.63 -46.43 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.924 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.31 -40.69 18.91 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.33 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.98 -24.25 65.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.591 HD11 ' HB3' ' A' ' 127' ' ' HIS . 63.0 mt -88.17 -28.02 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.679 ' CD1' HD11 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -61.78 -49.84 74.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.526 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -46.48 82.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.991 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 t -72.51 -15.1 61.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.57 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 23.4 t80 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.233 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.923 HG11 HG22 ' A' ' 9' ' ' VAL . 54.9 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -69.48 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.793 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.674 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 8.4 m-85 -136.13 116.03 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 111.845 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.923 HG22 HG11 ' A' ' 6' ' ' VAL . 2.3 t -106.84 92.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.961 0.41 . . . . 0.0 110.868 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.2 tt0 -95.82 108.69 21.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.8 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.96 ' CG2' HD13 ' A' ' 124' ' ' LEU . 33.5 t -81.07 145.32 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.2 mp -129.34 124.89 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HG3' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.91 102.62 11.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.381 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.79 39.56 6.1 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.881 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.78 20.8 67.47 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.78 118.57 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.957 0.408 . . . . 0.0 110.26 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.415 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 3.6 m -47.84 128.55 13.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.338 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.568 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -105.62 -42.26 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.643 0.735 . . . . 0.0 109.362 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.901 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -131.29 176.35 8.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.197 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.441 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.0 m -170.5 121.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.521 ' HB3' HG23 ' A' ' 9' ' ' VAL . 33.9 t -107.58 70.22 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.674 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.1 m-85 -105.97 84.25 2.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.609 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.42 -179.458 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.82 0.343 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -129.54 28.38 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -111.77 -35.74 5.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.959 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.674 HG22 ' CE1' ' A' ' 46' ' ' PHE . 1.1 mt -51.24 116.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.79 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.85 HG22 HD12 ' A' ' 45' ' ' ILE . 1.8 t -77.08 153.18 82.51 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.522 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.438 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.1 Cg_exo -48.16 -21.78 3.19 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.785 1.656 . . . . 0.0 110.788 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 42' ' ' THR . 90.7 t -65.3 -49.35 79.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.058 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.85 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -57.28 -31.29 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.674 ' CE1' HG22 ' A' ' 41' ' ' ILE . 98.3 m-85 -80.8 -44.05 19.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.569 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.627 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -65.17 -26.02 67.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.291 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.99 -29.54 18.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.645 HD11 HG13 ' A' ' 74' ' ' ILE . 2.7 mt -60.75 -59.51 5.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.018 HG12 HG11 ' A' ' 93' ' ' VAL . 4.9 mt -53.87 -64.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.984 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.627 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.8 OUTLIER -49.73 -40.72 41.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.902 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -91.16 -19.74 22.75 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.487 ' HB2' HD21 ' A' ' 73' ' ' LEU . 93.8 mmm -120.14 -60.14 1.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' ' HE3' ' A' ' 69' ' ' MET . 96.4 t -64.55 -51.38 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.986 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -55.63 -52.45 71.93 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 14.7 Cg_exo -69.07 3.66 2.32 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.352 2.034 . . . . 0.0 112.159 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.93 23.61 1.37 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.03 0.443 . . . . 0.0 110.192 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.46 HG23 ' CD1' ' A' ' 81' ' ' TYR . 4.4 p -85.92 165.35 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 58' ' ' VAL . 15.3 m . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.135 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.898 HG13 HD23 ' A' ' 109' ' ' LEU . 3.1 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.918 0.39 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.0 m -80.7 125.41 30.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.283 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -71.75 130.67 41.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.497 ' HE3' ' HA ' ' A' ' 54' ' ' VAL . 53.3 tpp -57.53 -25.24 59.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 t 53.04 26.96 5.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.085 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.431 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 8.9 tpt -106.45 -11.0 16.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.149 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.87 58.06 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.371 . . . . 0.0 110.515 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.573 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.5 mp -59.86 -46.05 90.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.645 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -133.25 157.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.686 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.95 140.84 33.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.394 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.587 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.41 -33.92 5.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.241 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.54 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -132.79 168.36 18.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.882 0.372 . . . . 0.0 111.088 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 94.7 m-20 -106.57 143.25 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.402 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 6.4 m -106.98 114.77 29.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.538 ' HB3' HG12 ' A' ' 66' ' ' VAL . 87.7 m-85 -121.78 137.74 54.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.482 ' HB3' HG11 ' A' ' 54' ' ' VAL . 49.2 p90 -127.05 128.82 46.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.0 0.429 . . . . 0.0 111.467 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.867 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.5 t -133.35 118.91 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.96 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.634 HG22 HG13 ' A' ' 91' ' ' VAL . 40.3 p -80.63 150.43 29.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -46.14 146.84 1.2 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.276 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.03 -15.81 57.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.89 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 22.03 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.659 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.74 95.0 3.76 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.471 0.177 . . . . 0.0 111.178 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.33 -15.55 45.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -96.23 30.39 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.042 0.448 . . . . 0.0 110.093 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 65.1 m -154.36 73.72 0.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.66 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.634 HG13 HG22 ' A' ' 83' ' ' THR . 0.6 OUTLIER -72.83 176.0 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.223 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.583 ' H ' HG12 ' A' ' 91' ' ' VAL . 97.4 m-85 -150.68 94.88 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.826 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.018 HG11 HG12 ' A' ' 50' ' ' ILE . 44.0 t -98.09 121.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.246 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.567 ' CB ' HD21 ' A' ' 109' ' ' LEU . 37.5 t -114.51 139.98 49.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.312 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.8 m-85 -115.04 102.66 10.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.511 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.665 HG21 ' HD3' ' A' ' 105' ' ' PRO . 9.9 p -109.69 127.46 54.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -38.32 132.9 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.326 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.94 -30.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.685 -178.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.11 -28.08 67.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.742 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.26 131.57 91.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.205 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.426 ' HB2' HG22 ' A' ' 103' ' ' ILE . 39.1 Cg_exo -60.0 179.65 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -98.72 62.58 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.682 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.608 ' HA ' HD13 ' A' ' 106' ' ' ILE . 4.3 tp -155.08 -37.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.783 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.699 ' HG ' HD11 ' A' ' 108' ' ' ILE . 5.3 tp -60.51 -61.55 7.73 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.665 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.3 Cg_endo -45.48 -37.54 14.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.794 2.329 . . . . 0.0 111.147 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.861 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -63.62 -37.44 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.152 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.553 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -83.49 -18.23 39.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.841 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.867 HG23 HG13 ' A' ' 128' ' ' VAL . 15.4 mm -70.63 -47.89 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.898 HD23 HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -74.37 -47.42 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.5 t -64.53 -29.11 70.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -75.73 -45.55 16.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.173 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.952 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.76 -33.93 67.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -70.79 -16.11 62.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.209 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.08 -21.6 59.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.363 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 5.5 m-85 -85.39 -94.13 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 4.9 tp10 161.57 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 110.659 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.5 m -91.32 -91.07 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.368 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.549 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.1 p-10 39.04 32.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.595 0.236 . . . . 0.0 111.021 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.37 34.81 4.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -150.13 151.1 32.6 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.708 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.441 ' HA ' ' N ' ' A' ' 20' ' ' SER . 3.9 p-10 -70.67 28.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.919 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 tt0 -172.17 28.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.9 tt -131.74 -50.33 0.97 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.96 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.93 -44.94 78.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.213 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 19.1 t -47.7 -30.22 3.65 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.168 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.13 -58.17 8.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.138 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.952 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.7 m-70 -57.66 -39.36 76.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.643 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.867 HG13 HG23 ' A' ' 108' ' ' ILE . 42.9 t -50.52 -46.2 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.412 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.03 -47.28 47.0 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.324 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -65.28 -23.39 67.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.82 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 107' ' ' ARG . 37.8 mt -85.49 -27.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.604 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -65.66 -46.52 78.84 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.678 179.158 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.66 -44.0 78.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.7 m -80.3 -4.17 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.815 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.587 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 26.6 t80 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.932 HG11 HG22 ' A' ' 9' ' ' VAL . 3.5 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.45 ' HB3' ' CD2' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -53.93 -55.73 24.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.49 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.655 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 6.5 m-85 -145.47 140.52 27.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 0.0 111.653 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.932 HG22 HG11 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -131.35 97.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.348 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.2 mt-10 -112.86 124.7 53.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 111.647 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.956 HG23 HD13 ' A' ' 124' ' ' LEU . 98.2 t -89.79 159.9 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.83 HD11 HG21 ' A' ' 50' ' ' ILE . 3.3 mt -137.66 117.4 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.602 ' CG ' HD13 ' A' ' 18' ' ' ILE . 3.2 tttp -107.36 115.5 30.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.056 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 61.4 32.74 18.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.573 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.0 27.91 57.44 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.283 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -144.92 121.57 11.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.086 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -51.88 122.55 8.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.145 -178.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.602 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.19 -47.94 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 109.603 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 124' ' ' LEU . 54.7 p -122.08 171.35 9.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.625 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.607 ' N ' HD22 ' A' ' 124' ' ' LEU . 11.8 m -166.54 128.05 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.985 0.421 . . . . 0.0 112.021 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.486 ' N ' HD21 ' A' ' 124' ' ' LEU . 32.0 t -119.91 69.39 0.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.655 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.5 m-85 -112.04 94.2 4.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.718 -179.318 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m120 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.678 0.275 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.31 29.89 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.926 0.393 . . . . 0.0 110.95 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -115.31 -38.61 3.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.352 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.66 HD12 HD13 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -53.57 118.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.976 HG22 HD12 ' A' ' 45' ' ' ILE . 9.5 t -81.43 152.19 69.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.6 Cg_exo -46.51 -23.06 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.066 1.844 . . . . 0.0 111.239 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.736 ' HB ' HG23 ' A' ' 42' ' ' THR . 49.2 t -64.82 -47.51 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.518 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.976 HD12 HG22 ' A' ' 42' ' ' THR . 1.9 mp -58.94 -33.32 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.214 0.53 . . . . 0.0 109.618 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.491 ' O ' HD12 ' A' ' 50' ' ' ILE . 66.1 m-85 -81.06 -41.98 21.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.541 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.633 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -64.69 -29.15 70.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.023 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.27 -27.31 21.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.4 mt -63.79 -61.11 2.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.966 HG12 HG11 ' A' ' 93' ' ' VAL . 6.8 mt -49.63 -62.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.736 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.595 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -54.33 -41.09 68.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.591 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -90.89 -20.42 22.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.455 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 69.0 mmm -119.66 -52.3 2.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 84.3 t -69.59 -60.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.867 HD23 HG22 ' A' ' 50' ' ' ILE . 1.3 mm? -46.41 -51.09 37.1 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 12.6 Cg_exo -70.08 2.87 3.31 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.262 1.975 . . . . 0.0 112.059 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -145.49 23.97 1.42 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.058 0.456 . . . . 0.0 110.086 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.491 HG23 ' CD1' ' A' ' 81' ' ' TYR . 5.0 p -87.67 166.06 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.914 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 58' ' ' VAL . 12.1 m . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.899 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.799 HG21 ' HA ' ' A' ' 106' ' ' ILE . 2.6 t . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -78.61 139.84 38.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.365 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.31 127.45 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.511 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.498 ' HG2' ' CG ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -54.04 -36.5 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m 63.97 25.44 13.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.894 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.498 ' CG ' ' HG2' ' A' ' 69' ' ' MET . 23.6 mmt -104.82 -0.66 26.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.944 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.06 56.28 5.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.098 0.475 . . . . 0.0 110.507 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.71 ' HB3' HD22 ' A' ' 49' ' ' LEU . 7.5 mp -60.44 -39.45 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.652 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.66 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -147.01 151.77 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.489 179.02 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -96.77 138.67 33.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.335 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 111.94 -31.91 6.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -129.48 163.92 24.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.15 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 75.8 m-20 -103.49 132.03 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.432 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 20.9 p -94.83 95.72 8.87 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.561 ' HB3' HG12 ' A' ' 66' ' ' VAL . 73.2 m-85 -110.33 133.59 53.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.511 ' HB3' HG22 ' A' ' 93' ' ' VAL . 46.6 p90 -127.31 139.84 52.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.455 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.793 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.5 t -143.55 125.09 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.779 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.798 HG22 HG13 ' A' ' 91' ' ' VAL . 41.4 p -86.94 158.12 19.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.95 153.37 2.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.83 -9.71 58.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.765 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 22.56 0.24 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.667 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 98.97 2.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.477 0.18 . . . . 0.0 111.23 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -13.61 40.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.445 2.097 . . . . 0.0 112.009 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -97.56 28.81 3.57 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.023 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' THR . 32.3 m -152.73 73.63 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.408 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -73.55 -179.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.435 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.633 ' H ' HG12 ' A' ' 91' ' ' VAL . 69.1 m-85 -156.06 98.61 1.89 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.754 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.966 HG11 HG12 ' A' ' 50' ' ' ILE . 65.0 t -106.86 133.52 51.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.98 0.419 . . . . 0.0 111.151 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.21 122.45 29.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.087 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.501 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.7 m-85 -92.05 87.45 6.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.725 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.809 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -75.72 -170.94 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.775 0.322 . . . . 0.0 110.931 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.407 ' HB2' ' CD1' ' A' ' 100' ' ' ILE . 82.0 mt -105.95 125.77 51.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -41.49 -30.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.608 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 36.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 97' ' ' LEU . 47.9 mt -139.48 129.48 14.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.528 ' HB2' HG22 ' A' ' 103' ' ' ILE . 72.9 Cg_exo -48.39 151.51 4.59 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.307 2.005 . . . . 0.0 112.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.443 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -82.46 58.03 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.496 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.603 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 3.2 tp -144.1 -35.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.762 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.717 HD21 HG23 ' A' ' 6' ' ' VAL . 6.3 tp -60.45 -63.99 3.62 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.672 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.809 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -45.25 -35.51 11.33 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.726 2.284 . . . . 0.0 111.501 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.799 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.5 mp -63.35 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.061 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER -79.35 -19.68 49.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.813 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.888 HG13 HG21 ' A' ' 6' ' ' VAL . 19.9 mm -68.32 -49.99 61.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.522 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.725 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -72.23 -50.16 29.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -27.43 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -78.6 -42.15 14.42 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.852 HD23 ' HB2' ' A' ' 127' ' ' HIS . 20.4 mt -58.88 -28.23 65.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -18.56 58.38 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.227 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.5 OUTLIER -73.57 -22.21 60.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 116' ' ' GLU . 6.4 m-85 -83.64 -93.24 0.07 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 20.7 tt0 156.5 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.352 0.261 . . . . 0.0 111.064 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 m -94.19 -90.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.0 OUTLIER 41.12 31.2 0.13 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.15 34.01 4.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.484 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -149.92 154.85 38.99 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.523 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HA ' ' H ' ' A' ' 20' ' ' SER . 46.8 m-20 -74.06 22.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.394 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' A' ' 120' ' ' THR . 6.9 pt-20 -164.97 26.32 0.06 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.6 tt -127.11 -50.87 1.43 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.683 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.956 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.52 -44.69 76.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.107 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.5 p -47.66 -30.36 3.69 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.231 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.48 -56.27 21.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.326 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.852 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.3 m-70 -60.39 -35.2 75.17 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.677 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.781 HG21 HG21 ' A' ' 9' ' ' VAL . 46.1 t -54.59 -45.66 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.02 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.51 28.77 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.435 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -69.31 -21.16 63.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.871 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 127' ' ' HIS . 62.4 mt -90.16 -27.38 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.62 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -64.59 -47.84 77.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.359 178.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -63.42 -44.62 94.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.575 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 t -76.49 -8.71 57.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.603 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 16.8 t80 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.022 HG11 HG22 ' A' ' 9' ' ' VAL . 92.9 t . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 121.079 0.466 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.68 -59.02 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.701 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.675 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 5.8 m-85 -149.35 115.84 5.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.848 0.356 . . . . 0.0 111.78 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.022 HG22 HG11 ' A' ' 6' ' ' VAL . 1.9 t -108.15 93.03 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.865 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.632 ' OE2' HG21 ' A' ' 17' ' ' THR . 0.1 OUTLIER -101.14 114.83 29.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.685 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.984 HG23 HD13 ' A' ' 124' ' ' LEU . 56.0 t -81.59 161.19 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.566 HG21 HD11 ' A' ' 55' ' ' LEU . 2.0 mp -142.01 121.08 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.693 -0.403 . . . . 0.0 112.045 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 12.8 tttt -107.07 97.24 7.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.703 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 69.85 37.59 1.78 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.58 62.01 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.695 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 7.6 pt-20 -144.8 119.22 9.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.632 HG21 ' OE2' ' A' ' 10' ' ' GLU . 18.6 m -50.14 130.78 23.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.507 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.36 -41.49 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.137 178.234 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.885 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -127.21 175.57 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.072 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.458 ' N ' HD22 ' A' ' 124' ' ' LEU . 17.0 p -170.38 134.65 1.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' HB3' HG23 ' A' ' 9' ' ' VAL . 34.4 t -122.7 69.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.746 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.675 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -106.95 88.72 2.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.684 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.487 -179.514 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.15 28.59 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.033 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -110.22 -38.39 5.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.887 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.689 HD13 ' CD1' ' A' ' 74' ' ' ILE . 1.1 mt -51.31 142.15 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.68 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.603 HG23 ' HB ' ' A' ' 44' ' ' VAL . 2.3 t -96.67 152.5 38.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 83.2 Cg_exo -46.43 -28.83 6.45 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.895 1.73 . . . . 0.0 110.669 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.603 ' HB ' HG23 ' A' ' 42' ' ' THR . 60.9 t -58.81 -40.28 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.548 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.597 ' HB ' HG23 ' A' ' 41' ' ' ILE . 23.5 mm -57.62 -46.34 86.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.549 ' O ' HD12 ' A' ' 50' ' ' ILE . 68.7 m-85 -75.41 -38.51 59.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.246 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.611 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.26 -30.15 71.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.155 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' VAL . 1.2 m120 -87.59 -28.03 22.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.873 HD11 HG13 ' A' ' 74' ' ' ILE . 6.6 mt -64.21 -61.15 2.43 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.081 HG12 HG11 ' A' ' 93' ' ' VAL . 6.2 mt -48.9 -61.19 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.997 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.4 ttm -57.28 -40.85 78.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.186 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.5 t0 -91.18 -15.13 29.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.489 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 84.2 mmm -124.28 -56.48 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.478 HG13 ' CD2' ' A' ' 81' ' ' TYR . 72.1 t -64.44 -60.02 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -51.96 -50.35 78.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.9 Cg_exo -62.68 -2.28 3.31 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.383 2.055 . . . . 0.0 112.602 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -146.97 23.15 1.21 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.289 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.7 p -78.78 164.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.931 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 58' ' ' VAL . 29.7 m . . . . . 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.849 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.4 t . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 120.967 0.413 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.8 m -78.0 129.37 35.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 7.0 tttm -79.45 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.264 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.479 ' HG2' HD11 ' A' ' 73' ' ' LEU . 20.0 tpp -56.78 -29.94 63.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m 56.43 28.64 13.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.452 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 37.8 tpp -108.66 -10.87 15.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.029 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.58 59.14 1.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 110.43 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.654 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.6 mp -59.5 -50.1 75.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.774 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.873 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -128.75 155.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.651 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.61 140.35 31.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.458 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 108.7 -32.25 7.1 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.63 ' HD2' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -133.87 167.96 19.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 111.25 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 84.0 m-20 -108.37 145.28 34.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.383 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 1.8 m -109.75 118.43 36.51 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 32.5 m-85 -126.13 138.97 53.72 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.12 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.478 ' CD2' HG13 ' A' ' 54' ' ' VAL . 26.8 p90 -124.78 133.69 53.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.073 0.463 . . . . 0.0 111.359 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.807 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -136.18 117.6 14.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.031 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 18.0 p -79.35 153.58 29.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.37 146.42 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.096 0.474 . . . . 0.0 111.25 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -22.35 14.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.056 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.05 23.54 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.587 0.232 . . . . 0.0 111.582 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.56 94.57 5.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -15.28 47.35 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.395 2.063 . . . . 0.0 111.98 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.35 28.2 3.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.171 0.51 . . . . 0.0 110.272 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 90' ' ' THR . 51.7 m -152.04 70.91 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.641 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.611 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -72.34 177.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.57 ' H ' HG12 ' A' ' 91' ' ' VAL . 92.7 m-85 -151.1 93.69 1.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.112 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.081 HG11 HG12 ' A' ' 50' ' ' ILE . 51.5 t -95.6 120.54 45.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 111.05 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.497 ' CB ' HD21 ' A' ' 109' ' ' LEU . 35.8 t -112.85 137.48 51.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.108 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 8.6 m-85 -112.88 99.2 7.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.825 HG21 ' HD3' ' A' ' 105' ' ' PRO . 2.0 p -104.33 125.72 50.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 111.078 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.63 HD23 ' HD2' ' A' ' 77' ' ' PHE . 16.5 mt -39.9 134.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -46.2 -29.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.705 0.288 . . . . 0.0 111.493 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -28.24 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 110.478 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.4 mm -66.95 134.12 93.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.129 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.28 -159.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.134 1.889 . . . . 0.0 111.617 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -114.44 64.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.539 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.686 HG23 ' CE2' ' A' ' 135' ' ' PHE . 1.4 tp -161.79 -35.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.918 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.073 HD11 HD23 ' A' ' 132' ' ' LEU . 4.7 tp -58.73 -61.54 7.51 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.048 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.825 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.8 Cg_endo -45.38 -36.36 12.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.592 2.195 . . . . 0.0 111.015 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.849 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -67.79 -37.31 78.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.06 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.636 ' O ' HG21 ' A' ' 131' ' ' ILE . 1.1 mmp_? -80.77 -24.34 38.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.701 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.904 HG23 HG13 ' A' ' 128' ' ' VAL . 31.9 mm -67.01 -54.36 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.766 0.317 . . . . 0.0 110.223 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -69.33 -53.33 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.907 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -59.91 -27.93 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.498 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -74.92 -45.89 19.17 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.3 mt -56.16 -31.14 63.11 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -76.89 -15.76 59.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.058 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -75.43 -25.19 57.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.313 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.537 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 3.5 m-85 -84.42 -92.57 0.08 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.911 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 163.43 -29.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.059 0.457 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 26.3 m -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.476 0.655 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.496 ' HA ' HD22 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -169.67 36.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.944 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.89 33.38 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.529 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.28 155.15 43.72 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.901 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.2 m120 -75.25 19.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 pm0 -161.53 24.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.529 ' CB ' HG23 ' A' ' 120' ' ' THR . 7.4 tt -123.07 -58.26 1.65 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.7 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.984 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -50.81 -44.79 59.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.411 ' HB3' ' CB ' ' A' ' 21' ' ' CYS . 78.6 p -49.32 -29.58 6.24 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.461 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.07 -59.98 4.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.427 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.862 ' HB2' HD23 ' A' ' 112' ' ' LEU . 42.4 m170 -59.64 -32.17 70.19 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.904 HG13 HG23 ' A' ' 108' ' ' ILE . 56.9 t -55.26 -46.92 78.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -67.92 -42.9 84.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.11 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.62 -22.9 63.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.919 0.39 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.636 HG21 ' O ' ' A' ' 107' ' ' ARG . 40.5 mt -90.38 -27.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 1.073 HD23 HD11 ' A' ' 104' ' ' LEU . 2.9 mt -65.02 -52.33 56.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.919 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -71.57 -32.65 68.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -95.77 24.27 5.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.957 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.686 ' CE2' HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.927 HG11 HG22 ' A' ' 9' ' ' VAL . 1.4 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.92 0.391 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -63.16 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.792 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.577 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.1 m-85 -144.98 140.35 28.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.309 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.927 HG22 HG11 ' A' ' 6' ' ' VAL . 1.5 t -129.63 90.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.1 tt0 -99.52 116.02 30.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.004 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.89 HG23 HD13 ' A' ' 124' ' ' LEU . 40.1 t -82.39 158.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.78 HD11 HG21 ' A' ' 50' ' ' ILE . 3.4 mt -141.01 119.58 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.667 ' CG ' HD13 ' A' ' 18' ' ' ILE . 1.8 tttt -104.68 99.76 9.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.482 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.77 40.39 5.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.855 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 21.32 63.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.05 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -141.38 116.27 9.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.194 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.3 m -50.84 126.03 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.823 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.667 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -103.96 -44.0 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.457 0.646 . . . . 0.0 109.792 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -127.7 177.11 7.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.432 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.464 ' N ' HD22 ' A' ' 124' ' ' LEU . 2.8 t -170.47 139.04 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.564 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 13.7 t -130.52 73.08 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.605 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.1 m-85 -107.35 88.78 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.815 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.212 -179.61 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.452 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 27.6 m-20 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.791 0.329 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 28.67 7.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -117.4 -34.35 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.556 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -53.98 121.59 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.978 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.977 HG22 HD12 ' A' ' 45' ' ' ILE . 8.8 t -83.39 151.48 62.52 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 82.8 Cg_exo -46.0 -22.56 1.42 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.189 1.926 . . . . 0.0 111.474 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' A' ' 42' ' ' THR . 97.1 t -65.58 -46.28 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.045 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.977 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -59.41 -33.91 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.556 ' CE2' HG22 ' A' ' 41' ' ' ILE . 88.1 m-85 -79.36 -43.28 23.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.204 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.637 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.83 -27.83 69.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.069 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 25.8 m-20 -88.33 -29.18 20.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.614 HD11 HG13 ' A' ' 74' ' ' ILE . 3.5 mt -62.57 -61.11 2.65 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.076 HG12 HG11 ' A' ' 93' ' ' VAL . 5.7 mt -50.44 -61.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.262 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.622 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -53.21 -46.01 68.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.055 -1.43 . . . . 0.0 113.198 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.91 -14.14 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.496 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 74.1 mmm -123.02 -63.27 1.27 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.743 HG13 ' CD2' ' A' ' 81' ' ' TYR . 67.5 t -59.35 -55.73 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.755 HD23 HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -53.17 -54.37 45.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 31.3 Cg_exo -60.85 -4.24 3.45 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.15 1.9 . . . . 0.0 112.175 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -144.43 26.89 1.42 Allowed 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.544 HG23 ' CD1' ' A' ' 81' ' ' TYR . 2.5 p -84.99 159.12 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.904 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.021 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.859 HG13 HD23 ' A' ' 109' ' ' LEU . 14.4 t . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.468 0.175 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.5 m -119.41 142.71 47.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 111.892 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HG3' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.36 133.93 34.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.426 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.51 ' HE3' ' CE2' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -58.79 -30.09 67.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.126 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.67 30.08 16.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.971 0.415 . . . . 0.0 110.804 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 2.4 tpt -111.06 -13.2 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.097 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.75 55.1 1.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.56 ' HB3' HD22 ' A' ' 49' ' ' LEU . 9.5 mp -54.42 -43.38 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.818 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.614 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -135.44 159.18 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.735 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.436 ' N ' HG23 ' A' ' 74' ' ' ILE . 29.6 t70 -99.74 142.18 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.471 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 107.03 -34.7 5.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.127 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.486 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.5 176.14 8.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 110.766 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 91.7 m-20 -110.98 162.24 15.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.069 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.5 t -121.97 101.49 7.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CE1' ' HG3' ' A' ' 68' ' ' LYS . 57.9 m-85 -108.67 147.07 32.45 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.575 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.743 ' CD2' HG13 ' A' ' 54' ' ' VAL . 33.9 p90 -137.66 123.14 19.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.091 0.472 . . . . 0.0 111.441 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.716 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 0.9 OUTLIER -124.86 119.09 27.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.396 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.667 HG22 HG13 ' A' ' 91' ' ' VAL . 23.8 p -82.13 156.93 24.25 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.095 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 18.6 t70 -53.41 152.12 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -28.49 53.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.891 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 23.55 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.654 0.264 . . . . 0.0 111.398 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -137.89 85.68 19.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.636 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 87' ' ' ASP . 15.0 Cg_endo -56.14 -18.19 22.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.523 2.149 . . . . 0.0 112.063 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 28.79 1.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 110.216 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 82.3 m -153.8 72.81 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.474 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.667 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -75.82 178.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.342 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.602 ' CD2' HG13 ' A' ' 11' ' ' VAL . 72.5 m-85 -152.15 88.48 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.116 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.076 HG11 HG12 ' A' ' 50' ' ' ILE . 44.0 t -90.91 125.14 43.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.483 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.635 ' HB3' HD21 ' A' ' 109' ' ' LEU . 45.2 t -125.27 115.35 20.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.76 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.2 m-85 -82.97 122.7 28.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.88 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -122.6 129.8 52.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 111.972 -179.044 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.0 mt -44.13 124.33 3.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.019 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.3 -31.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.88 -31.41 72.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.506 HG23 ' HD2' ' A' ' 101' ' ' PRO . 68.4 mt -76.39 138.2 67.67 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.049 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 100' ' ' ILE . 19.4 Cg_endo -58.6 -164.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.501 2.134 . . . . 0.0 111.928 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.502 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -114.83 57.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.963 0.411 . . . . 0.0 111.138 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.767 HG23 ' CE2' ' A' ' 135' ' ' PHE . 6.3 tp -142.04 -35.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.605 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.843 HD21 HG23 ' A' ' 6' ' ' VAL . 5.0 tp -62.8 -62.57 5.45 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.88 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.2 Cg_endo -46.61 -30.4 8.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.442 2.094 . . . . 0.0 111.034 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 mp -71.35 -40.23 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.182 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.403 ' NH1' HD11 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -78.72 -25.81 44.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 132' ' ' LEU . 15.8 mm -68.1 -46.02 82.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.457 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.859 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -72.01 -58.08 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -28.6 62.29 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.57 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -74.02 -47.3 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.886 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.9 mt -54.43 -26.07 28.55 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -71.89 -18.63 62.03 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.772 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.32 -21.37 59.74 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.047 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.605 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 8.9 m-85 -95.42 -49.98 5.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 84.68 -22.72 0.19 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.729 ' O ' HD22 ' A' ' 123' ' ' LEU . 3.1 t -85.51 8.22 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.636 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 1.7 p-10 -69.84 55.43 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.439 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -118.82 34.96 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -150.96 149.22 29.35 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.041 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.453 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.9 m-80 -69.63 25.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.609 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.9 tt0 -167.0 25.7 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 117' ' ' SER . 6.6 tt -128.0 -49.46 1.34 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.89 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -56.65 -45.19 81.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.1 m -46.39 -31.27 2.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.117 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.77 -58.04 8.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.98 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.886 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.7 m-70 -58.76 -36.05 73.73 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.742 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.2 t -52.59 -48.53 47.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.29 -51.46 17.34 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.394 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -61.98 -20.92 64.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.756 0.312 . . . . 0.0 111.038 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.57 HD13 ' C ' ' A' ' 111' ' ' GLY . 66.8 mt -91.2 -27.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -63.8 -36.99 85.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.287 178.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -64.52 -34.2 77.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.87 -14.43 54.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.957 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.767 ' CE2' HG23 ' A' ' 103' ' ' ILE . 43.2 t80 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.027 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.738 HG11 HG22 ' A' ' 9' ' ' VAL . 97.5 t . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.771 0.32 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -81.72 -62.92 1.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.73 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 7.5 m-85 -143.48 111.78 6.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.738 HG22 HG11 ' A' ' 6' ' ' VAL . 3.2 t -106.35 97.35 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.577 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.474 ' CG ' HG23 ' A' ' 17' ' ' THR . 2.5 tt0 -98.96 110.04 22.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.256 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.965 HG23 HD13 ' A' ' 124' ' ' LEU . 58.4 t -77.6 158.79 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.581 ' CD1' HG23 ' A' ' 93' ' ' VAL . 1.4 mp -147.16 120.41 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.547 ' HB2' HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.54 113.89 27.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 178.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.58 34.61 17.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.534 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 22.93 62.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.688 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.45 119.52 13.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.474 HG23 ' CG ' ' A' ' 10' ' ' GLU . 3.2 m -50.95 128.61 21.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.121 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -107.08 -42.02 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.617 0.723 . . . . 0.0 109.476 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.665 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -128.62 175.24 8.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.331 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.512 ' N ' HD22 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -170.11 124.16 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.385 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 125' ' ' SER . 35.2 t -109.56 73.0 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.73 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -107.17 82.85 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.312 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.421 ' NE2' ' SG ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.47 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 11.2 m120 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.77 0.319 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.48 26.46 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.135 0.493 . . . . 0.0 110.691 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -114.08 -30.2 6.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.213 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.501 HG22 ' CE1' ' A' ' 46' ' ' PHE . 2.6 mm -56.31 113.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.458 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 1.007 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -78.56 151.54 77.44 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 87.2 Cg_exo -45.83 -22.37 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.099 1.866 . . . . 0.0 111.184 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 42' ' ' THR . 66.1 t -66.24 -49.61 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.414 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.007 HD12 HG22 ' A' ' 42' ' ' THR . 2.3 mp -58.76 -31.97 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.524 ' O ' HD12 ' A' ' 50' ' ' ILE . 72.3 m-85 -80.09 -42.71 23.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.05 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.632 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -69.98 -23.9 63.24 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.162 0.505 . . . . 0.0 110.595 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 4.9 t-20 -89.01 -33.83 17.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.857 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.9 mt -56.9 -61.36 2.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.065 HG22 HD23 ' A' ' 55' ' ' LEU . 5.3 mt -51.95 -62.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.431 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.623 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.05 -44.6 41.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.119 -178.55 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 48' ' ' ASN . 17.2 m-20 -91.15 -19.49 23.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.487 ' HB2' HD21 ' A' ' 73' ' ' LEU . 71.5 mmm -114.84 -61.18 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.836 HG22 ' HG3' ' A' ' 69' ' ' MET . 91.9 t -68.04 -56.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.065 HD23 HG22 ' A' ' 50' ' ' ILE . 2.7 mm? -46.54 -51.69 34.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 13.2 Cg_exo -69.91 3.22 2.97 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.519 2.146 . . . . 0.0 112.07 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.13 22.96 1.36 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.334 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.588 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.0 p -86.73 154.84 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.716 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.872 178.866 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.839 HG13 HD23 ' A' ' 109' ' ' LEU . 29.3 t . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 120.626 0.25 . . . . 0.0 111.5 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.413 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 89.7 m -103.71 138.19 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 111.65 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 8.6 ttpt -94.25 135.79 35.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.836 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -53.81 -29.56 41.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m 51.28 27.21 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.05 0.452 . . . . 0.0 110.816 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.0 tpt -112.7 -13.28 13.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 62.67 69.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 0.0 110.599 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.69 ' HB3' HD22 ' A' ' 49' ' ' LEU . 6.8 mp -70.7 -49.65 44.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.617 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -126.69 158.34 37.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' HG23 ' A' ' 74' ' ' ILE . 24.2 t0 -99.34 141.12 32.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.431 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.59 -34.06 5.71 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.098 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -131.58 168.89 16.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.105 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 64.9 m-20 -112.75 125.76 54.68 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 10.7 m -86.17 121.65 29.07 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 74.7 m-85 -124.02 164.61 19.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.344 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.707 ' CD2' HG13 ' A' ' 54' ' ' VAL . 29.9 p90 -154.98 121.46 5.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.438 . . . . 0.0 111.149 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -125.08 119.26 28.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.378 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 23.8 p -85.31 143.53 28.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.9 0.381 . . . . 0.0 111.073 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 2.8 t0 -46.82 135.97 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.11 -30.07 66.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.258 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 18.9 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.624 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -154.98 92.16 2.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.441 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.07 -17.0 53.87 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.325 2.017 . . . . 0.0 111.779 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -95.13 33.55 1.52 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.413 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.612 ' O ' HG22 ' A' ' 90' ' ' THR . 16.2 m -152.87 69.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 92' ' ' TYR . 1.2 t -65.91 173.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.148 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.605 ' H ' HG12 ' A' ' 91' ' ' VAL . 56.1 m-85 -147.1 95.04 2.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.224 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.964 HG21 HG21 ' A' ' 50' ' ' ILE . 21.5 t -86.21 137.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 111.542 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.801 ' HB2' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -132.08 128.79 38.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.798 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 6.5 m-85 -109.97 85.64 2.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.945 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.31 128.2 37.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.156 0.503 . . . . 0.0 111.179 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.1 mt -46.35 127.35 8.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.213 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.24 -30.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.695 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -32.22 70.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.67 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.431 HG23 ' HD2' ' A' ' 101' ' ' PRO . 43.0 mt -83.31 136.94 42.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.808 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HD2' HG23 ' A' ' 100' ' ' ILE . 19.4 Cg_endo -58.28 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.501 2.134 . . . . 0.0 112.311 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.485 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -111.56 63.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.938 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 5.5 tp -145.13 -43.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.012 HD11 ' HG ' ' A' ' 132' ' ' LEU . 2.8 tp -58.08 -60.21 10.83 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.945 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.9 Cg_endo -47.28 -35.39 20.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.641 2.227 . . . . 0.0 111.18 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.793 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.5 mp -67.02 -38.07 80.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.775 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.526 ' O ' HG21 ' A' ' 131' ' ' ILE . 21.5 mmm180 -79.42 -26.95 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.177 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.791 HG23 HG13 ' A' ' 128' ' ' VAL . 22.6 mm -62.97 -47.87 90.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.069 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.839 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -70.73 -56.34 6.62 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.0 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -56.3 -26.15 51.04 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -74.38 -47.17 17.63 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.955 HD23 ' HB2' ' A' ' 127' ' ' HIS . 9.9 mt -54.98 -31.33 60.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -72.08 -17.72 61.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.253 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.37 -22.38 60.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.28 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 5.5 m-85 -85.68 -93.66 0.08 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 8.0 tt0 161.89 -25.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.674 0.273 . . . . 0.0 111.031 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.23 -89.48 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.652 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.518 ' N ' HD22 ' A' ' 123' ' ' LEU . 2.0 p-10 40.87 31.37 0.12 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.89 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.5 34.38 4.37 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.502 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -145.99 151.58 38.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.606 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.449 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.9 p30 -72.0 22.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.6 tt0 -165.71 26.93 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.61 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.2 tt -130.0 -50.23 1.12 Allowed 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.965 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -54.36 -46.89 73.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.148 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 11.7 p -47.48 -29.65 2.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.544 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.45 -59.1 5.76 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.114 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.955 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.6 m-70 -55.99 -38.5 70.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.527 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.841 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.0 t -49.61 -51.14 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.95 -48.65 68.94 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.152 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -20.97 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 111.091 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.568 HD13 ' HA3' ' A' ' 111' ' ' GLY . 31.3 mt -90.66 -29.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 1.012 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -62.02 -42.18 98.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.153 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.72 -32.19 73.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.658 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -80.04 -12.66 59.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 5.9 t80 . . . . . 0 C--N 1.332 -0.159 0 CA-C-O 120.923 0.392 . . . . 0.0 111.105 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.806 HG21 HG13 ' A' ' 108' ' ' ILE . 51.7 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.824 0.345 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -62.48 -61.43 2.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.111 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.66 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 6.2 m-85 -148.56 112.41 5.12 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.805 HG22 HG11 ' A' ' 6' ' ' VAL . 4.7 t -105.19 101.45 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.536 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.611 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.1 tt0 -109.96 121.58 45.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.844 0.354 . . . . 0.0 111.726 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.916 HG23 HD13 ' A' ' 124' ' ' LEU . 98.1 t -80.65 161.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.573 HG21 HD11 ' A' ' 55' ' ' LEU . 2.9 mp -142.89 113.21 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.54 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -98.95 110.29 22.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.892 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.86 34.45 17.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 78.06 26.1 60.72 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.032 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 12' ' ' ILE . 64.8 mm-40 -138.23 114.25 10.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.955 0.407 . . . . 0.0 109.938 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.611 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -49.46 130.84 20.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.959 -178.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.54 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.61 -47.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 109.993 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.765 ' OG ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -118.44 172.01 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.224 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.58 ' N ' HD22 ' A' ' 124' ' ' LEU . 58.0 p -170.16 125.99 0.79 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 15.8 t -113.24 69.68 0.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.66 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -105.3 90.59 3.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.933 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.333 -0.146 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.393 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 10.4 m120 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.694 0.283 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.43 26.77 6.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.068 0.461 . . . . 0.0 110.666 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -121.64 29.22 7.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.771 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.792 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.1 mt -124.5 122.18 63.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.417 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.932 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -83.14 151.34 63.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.459 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.493 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 85.5 Cg_exo -45.29 -22.92 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.27 1.98 . . . . 0.0 111.697 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.761 ' HB ' HG23 ' A' ' 42' ' ' THR . 47.4 t -66.56 -44.74 89.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.071 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.932 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -59.1 -32.01 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.792 ' CE2' HG22 ' A' ' 41' ' ' ILE . 38.6 m-85 -81.58 -43.47 18.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.059 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.65 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.66 -29.13 70.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.346 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.11 -28.37 19.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 73' ' ' LEU . 3.3 mt -62.68 -60.39 3.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.003 HG12 HG11 ' A' ' 93' ' ' VAL . 5.3 mt -51.79 -63.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.73 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.65 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.27 -43.43 61.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.18 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.64 -15.65 30.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.574 ' HB2' HD21 ' A' ' 73' ' ' LEU . 65.2 mmm -123.57 -69.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.803 HG13 ' CD1' ' A' ' 81' ' ' TYR . 93.0 t -52.33 -51.7 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.694 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.9 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -53.87 -59.15 10.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.669 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 30.4 Cg_endo -64.27 3.93 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.093 1.862 . . . . 0.0 112.487 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.62 22.7 1.63 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.099 0.476 . . . . 0.0 110.129 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 81' ' ' TYR . 4.6 p -87.8 166.88 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.469 ' H ' HG22 ' A' ' 58' ' ' VAL . 34.6 m . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.244 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 109' ' ' LEU . 11.8 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.839 0.352 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.5 m -93.31 144.74 25.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 111.694 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HD2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -90.9 133.72 35.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 54' ' ' VAL . 10.7 mmm -54.4 -32.51 57.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.9 m 58.34 27.32 15.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 40.3 mmm -107.71 -15.68 14.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.03 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 66.89 61.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.896 0.379 . . . . 0.0 110.374 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.574 HD21 ' HB2' ' A' ' 53' ' ' MET . 7.8 mp -62.44 -46.95 86.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.131 0.491 . . . . 0.0 110.382 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.721 HD13 HD12 ' A' ' 41' ' ' ILE . 1.5 mt -136.47 154.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.447 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.403 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 6.3 t0 -94.06 139.47 30.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.629 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 105.06 -32.42 7.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.506 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.585 ' O ' HG13 ' A' ' 98' ' ' VAL . 6.2 m-85 -110.31 -179.47 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.03 0.443 . . . . 0.0 111.876 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -129.4 113.17 14.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.936 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.1 p -83.66 108.79 16.97 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.458 ' O ' HG13 ' A' ' 93' ' ' VAL . 47.4 m-85 -121.97 155.73 34.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.199 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.803 ' CD1' HG13 ' A' ' 54' ' ' VAL . 17.8 p90 -147.57 137.64 22.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.06 0.457 . . . . 0.0 111.263 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.572 ' OG ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -140.85 117.66 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.775 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 6.8 p -82.53 146.89 28.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.802 0.334 . . . . 0.0 110.786 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.52 138.4 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.0 0.429 . . . . 0.0 111.209 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -51.91 -24.93 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.981 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 20.52 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -146.48 93.41 4.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.66 0.267 . . . . 0.0 111.129 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.3 -14.59 43.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.309 2.006 . . . . 0.0 111.934 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.13 30.98 2.27 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.313 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 90' ' ' THR . 19.3 m -154.58 71.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -70.07 175.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.668 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.557 ' H ' HG12 ' A' ' 91' ' ' VAL . 43.3 m-85 -151.12 97.88 2.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.931 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.003 HG11 HG12 ' A' ' 50' ' ' ILE . 24.5 t -101.44 127.13 55.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 111.692 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.74 ' HB2' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -114.95 117.43 30.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.06 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 1.1 m-85 -92.66 73.92 5.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.909 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.65 -174.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.012 0.434 . . . . 0.0 111.22 -178.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' HB2' HG13 ' A' ' 100' ' ' ILE . 57.4 mt -101.1 126.08 47.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.288 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -42.61 -36.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.395 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -38.83 92.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.493 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 101' ' ' PRO . 86.1 mt -65.28 139.07 97.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.803 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 100' ' ' ILE . 16.6 Cg_endo -57.48 -171.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.528 2.152 . . . . 0.0 112.277 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.22 67.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.558 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 8.1 tp -154.66 -38.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.633 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.731 ' HG ' HD11 ' A' ' 108' ' ' ILE . 19.1 tp -57.7 -61.03 8.09 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.909 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.6 Cg_endo -48.39 -34.98 26.85 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.575 2.183 . . . . 0.0 111.08 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.846 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -67.02 -34.54 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.939 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.614 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.92 -27.76 33.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 179.127 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.806 HG13 HG21 ' A' ' 6' ' ' VAL . 7.9 mm -64.19 -46.69 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -74.92 -49.59 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.188 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.1 t -62.97 -27.91 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -78.15 -46.37 9.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.826 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.6 mt -57.39 -32.04 66.42 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -73.51 -17.07 61.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.929 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -22.4 59.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 6.8 m-85 -85.02 -94.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.7 tt0 159.25 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.346 0.259 . . . . 0.0 110.856 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 m -92.12 -93.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.681 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.524 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.8 p-10 41.27 30.94 0.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.51 31.17 5.81 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.504 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.47 157.46 44.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.24 178.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HA ' ' N ' ' A' ' 20' ' ' SER . 2.1 p-10 -78.13 20.73 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.0 tp10 -163.63 25.48 0.08 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.639 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt -126.35 -49.06 1.55 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.916 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.93 -45.68 78.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.434 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -45.59 -30.61 1.54 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.178 178.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.45 -57.85 11.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.956 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.826 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.6 m-70 -58.87 -37.3 76.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.68 HG13 HG23 ' A' ' 108' ' ' ILE . 43.6 t -51.78 -45.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.414 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.3 -45.7 37.6 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.153 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -66.17 -22.52 66.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.946 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.614 HG21 ' O ' ' A' ' 107' ' ' ARG . 32.8 mt -90.32 -28.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -63.6 -42.52 98.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.355 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.18 -40.45 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -81.41 -15.86 53.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.151 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.558 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.991 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 104' ' ' LEU . 2.9 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.708 0.29 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.451 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -90.26 -61.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.796 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.682 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 5.1 m-85 -131.37 141.77 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.742 ' O ' HD21 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -148.69 100.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 12.0 pt-20 -115.02 138.41 50.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.863 HG23 HD13 ' A' ' 124' ' ' LEU . 53.0 t -90.86 151.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.893 HD13 HG23 ' A' ' 93' ' ' VAL . 4.1 mp -131.53 123.8 53.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 2.7 tttt -113.09 114.83 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.54 33.75 8.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.618 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 81.68 24.12 56.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.939 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.791 ' O ' HG23 ' A' ' 12' ' ' ILE . 1.3 tt0 -114.58 -142.91 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.647 0.26 . . . . 0.0 110.583 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.8 m -153.68 75.26 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.49 -43.08 86.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.704 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.686 ' OG ' HD13 ' A' ' 124' ' ' LEU . 4.0 p -122.41 170.01 10.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.865 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 30.6 m -168.23 118.27 0.77 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.0 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 15.8 t -111.48 68.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.682 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -116.1 87.72 2.74 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.84 -179.027 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 73.7 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.917 0.389 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.29 27.54 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -107.95 -36.27 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.772 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.634 HD12 HD13 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -56.58 119.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.68 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 1.08 HG22 HD12 ' A' ' 45' ' ' ILE . 13.2 t -81.14 157.23 71.23 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.389 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.618 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 54.2 Cg_exo -50.88 -21.74 8.96 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 121.917 1.744 . . . . 0.0 111.051 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.703 ' HB ' HG23 ' A' ' 42' ' ' THR . 48.1 t -66.16 -47.8 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.402 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.08 HD12 HG22 ' A' ' 42' ' ' THR . 1.9 mp -58.58 -33.3 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 41' ' ' ILE . 68.3 m-85 -81.36 -40.84 22.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.732 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.658 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -67.09 -27.28 67.22 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -88.28 -28.64 20.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.656 HD22 ' HB3' ' A' ' 73' ' ' LEU . 3.8 mt -61.47 -60.23 4.03 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.014 HG22 HD23 ' A' ' 55' ' ' LEU . 6.4 mt -51.52 -64.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.723 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.594 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -49.8 -40.37 41.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.661 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -91.14 -16.62 27.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.495 ' N ' ' O ' ' A' ' 49' ' ' LEU . 69.3 mmm -124.64 -68.69 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 81' ' ' TYR . 90.5 t -51.99 -51.52 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.697 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.014 HD23 HG22 ' A' ' 50' ' ' ILE . 1.8 mm? -56.59 -58.19 18.76 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.849 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 28.0 Cg_endo -63.25 1.73 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.113 1.875 . . . . 0.0 112.662 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HB3' ' HE1' ' A' ' 69' ' ' MET . 3.2 tptt -147.24 26.35 1.07 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.106 0.479 . . . . 0.0 109.942 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.7 p -85.27 167.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.895 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.5 ' H ' HG22 ' A' ' 58' ' ' VAL . 17.3 m . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.157 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.849 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.847 0.356 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.9 m -92.82 135.38 34.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.436 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 3.2 tttt -87.09 125.6 34.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.414 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.565 ' HG2' HD11 ' A' ' 73' ' ' LEU . 1.4 ttm -52.34 -36.08 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m 58.47 24.48 11.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.519 ' CG ' ' HG2' ' A' ' 69' ' ' MET . 17.3 mmt -101.2 6.43 43.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 55.39 53.05 10.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.656 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.2 mp -59.98 -32.83 71.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.623 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.634 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -153.42 151.49 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -95.71 138.9 32.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 111.31 -32.8 6.22 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.204 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.483 ' HD2' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -131.74 175.46 9.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.342 . . . . 0.0 111.004 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -119.56 123.92 45.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 3.8 t -82.01 101.03 10.06 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 19.6 m-85 -109.26 126.09 52.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.491 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.537 ' HB3' HG11 ' A' ' 54' ' ' VAL . 52.5 p90 -120.12 135.64 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.072 0.463 . . . . 0.0 111.28 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.406 ' HB2' ' N ' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -138.91 116.29 11.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.418 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.885 HG22 HG13 ' A' ' 91' ' ' VAL . 74.5 p -86.11 154.16 21.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -49.6 155.21 0.83 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -68.25 -20.85 64.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.2 22.27 0.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.611 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.59 89.88 7.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.2 -16.93 43.22 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.362 2.041 . . . . 0.0 111.982 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.67 30.59 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.447 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.54 ' O ' HG22 ' A' ' 90' ' ' THR . 22.0 m -154.84 73.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.806 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.885 HG13 HG22 ' A' ' 83' ' ' THR . 0.7 OUTLIER -75.96 177.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.619 ' H ' HG12 ' A' ' 91' ' ' VAL . 36.2 m-85 -149.42 106.89 3.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.979 HG21 HG21 ' A' ' 50' ' ' ILE . 44.3 t -104.89 137.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.19 0.519 . . . . 0.0 111.754 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.565 ' SG ' HG13 ' A' ' 9' ' ' VAL . 45.3 t -138.7 110.27 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.727 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.5 m-85 -87.0 83.93 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.925 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -82.01 130.18 35.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.885 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.483 HD23 ' HD2' ' A' ' 77' ' ' PHE . 87.0 mt -46.61 126.88 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.698 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.45 -33.06 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.03 -18.18 56.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.342 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.423 HD13 ' CD2' ' A' ' 104' ' ' LEU . 4.7 mt -87.26 136.47 33.54 Favored Pre-proline 0 N--CA 1.461 0.113 0 CA-C-O 120.501 0.191 . . . . 0.0 110.773 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 100' ' ' ILE . 38.0 Cg_exo -59.56 -157.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.304 2.003 . . . . 0.0 111.645 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.415 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.4 OUTLIER -112.83 63.7 0.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.693 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.547 ' HA ' HD13 ' A' ' 106' ' ' ILE . 3.3 tp -150.91 -40.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.843 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 108' ' ' ILE . 29.1 tp -58.14 -62.28 5.83 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.125 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.925 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.7 Cg_endo -49.05 -27.32 11.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.265 1.976 . . . . 0.0 111.486 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.849 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.3 mp -76.15 -34.68 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.633 ' O ' HG21 ' A' ' 131' ' ' ILE . 4.0 mmp_? -84.07 -27.51 28.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.395 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.033 HD11 HD11 ' A' ' 104' ' ' LEU . 7.7 mm -71.35 -51.6 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.749 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.63 -55.71 14.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.595 178.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -60.78 -25.86 66.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.667 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -71.32 -50.8 19.96 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.431 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.986 HD23 ' HB2' ' A' ' 127' ' ' HIS . 5.3 mt -52.94 -27.84 20.77 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.82 -21.47 57.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.416 ' HG3' ' CD1' ' A' ' 115' ' ' TYR . 0.4 OUTLIER -75.18 -19.53 59.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.452 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 29.7 m-85 -82.12 -92.57 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.71 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 16.0 tt0 157.94 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.697 0.399 . . . . 0.0 110.621 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -92.89 -92.75 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.529 ' N ' HD22 ' A' ' 123' ' ' LEU . 4.0 p-10 40.61 31.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 110.98 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.93 33.64 4.48 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.487 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.93 159.62 42.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.751 0.31 . . . . 0.0 110.421 179.047 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.433 ' HA ' ' N ' ' A' ' 20' ' ' SER . 6.1 p30 -78.78 19.43 0.51 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.41 24.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.054 0.454 . . . . 0.0 109.799 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt -124.53 -49.66 1.77 Allowed 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.463 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.863 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.23 -47.43 75.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.837 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.515 ' H ' HD23 ' A' ' 124' ' ' LEU . 96.6 p -46.23 -31.94 2.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.301 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -55.36 34.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.986 ' HB2' HD23 ' A' ' 112' ' ' LEU . 7.8 m170 -58.3 -37.29 74.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.784 HG13 ' CG2' ' A' ' 108' ' ' ILE . 46.9 t -50.48 -49.89 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.976 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.72 -49.24 37.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.843 -1.17 . . . . 0.0 112.334 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -64.18 -18.77 64.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.645 0.26 . . . . 0.0 111.246 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.667 HD13 ' HA3' ' A' ' 111' ' ' GLY . 53.6 mt -90.71 -28.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -64.1 -40.71 96.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.06 178.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.75 -32.4 74.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.433 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.99 -15.92 37.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.927 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.497 ' CE1' HG23 ' A' ' 103' ' ' ILE . 34.3 t80 . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.714 0.293 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.806 HG11 ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.637 0.256 . . . . 0.0 110.438 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.462 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -83.44 -59.9 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.0 111.563 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.654 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 11.4 m-85 -146.66 125.11 12.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.732 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.806 ' CG2' HG11 ' A' ' 6' ' ' VAL . 2.4 t -120.19 93.76 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.0 OUTLIER -100.95 116.83 33.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.033 HG23 HD13 ' A' ' 124' ' ' LEU . 95.0 t -89.28 136.34 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.668 HG21 HD11 ' A' ' 55' ' ' LEU . 2.2 mp -114.2 119.11 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HB2' HD13 ' A' ' 18' ' ' ILE . 3.5 tttt -104.86 107.88 19.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.083 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 61.96 37.71 14.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.629 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 26.24 60.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.637 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.72 115.9 6.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.0 109.993 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 24.7 m -47.1 127.74 10.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.208 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.599 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -99.91 -42.38 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 120' ' ' THR . 94.4 p -132.7 177.12 7.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.592 ' N ' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -169.85 125.8 0.83 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.561 ' N ' HD21 ' A' ' 124' ' ' LEU . 36.5 t -107.64 69.79 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.825 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.654 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -106.12 84.83 2.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.548 -179.337 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 m120 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.662 0.267 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -131.54 27.39 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.978 0.418 . . . . 0.0 110.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -109.92 -36.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.805 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.713 HG22 ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -50.93 116.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.754 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.831 HG22 HD12 ' A' ' 45' ' ' ILE . 2.7 t -78.68 149.66 74.84 Favored Pre-proline 0 CA--C 1.518 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.623 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.52 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.8 Cg_endo -45.19 -22.57 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 111.079 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.655 ' HB ' HG23 ' A' ' 42' ' ' THR . 97.6 t -64.51 -47.29 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.893 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.831 HD12 HG22 ' A' ' 42' ' ' THR . 1.7 mp -58.33 -32.71 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.713 ' CE2' HG22 ' A' ' 41' ' ' ILE . 90.0 m-85 -80.71 -43.29 20.52 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.337 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.662 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.03 -28.19 69.92 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -87.82 -30.73 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.819 HD11 HG13 ' A' ' 74' ' ' ILE . 5.3 mt -61.71 -61.61 2.39 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.013 HG22 HD23 ' A' ' 55' ' ' LEU . 5.6 mt -50.04 -61.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.976 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.662 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -51.72 -43.4 62.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.066 -1.424 . . . . 0.0 113.075 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.86 -19.58 23.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.518 ' HB2' HD21 ' A' ' 73' ' ' LEU . 85.0 mmm -118.23 -65.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.665 HG22 ' HG3' ' A' ' 69' ' ' MET . 94.9 t -58.3 -57.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.8 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.013 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -44.91 -57.15 7.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.7 Cg_endo -65.92 4.63 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 121.969 1.779 . . . . 0.0 112.426 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -145.89 23.38 1.38 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.124 0.488 . . . . 0.0 110.07 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.486 HG23 ' CD2' ' A' ' 81' ' ' TYR . 5.1 p -86.33 166.65 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.878 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG22 ' HE2' ' A' ' 81' ' ' TYR . 32.6 m . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.101 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.961 HG21 ' HA ' ' A' ' 106' ' ' ILE . 2.7 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.917 0.389 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -92.3 135.68 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.46 ' CE ' ' CZ ' ' A' ' 80' ' ' PHE . 8.0 ttmt -81.44 128.39 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.665 ' HG3' HG22 ' A' ' 54' ' ' VAL . 16.3 mmm -52.8 -25.59 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.193 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 m 53.97 25.89 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.9 tpt -104.34 -17.15 14.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 65.94 62.2 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.546 ' HB3' HD13 ' A' ' 49' ' ' LEU . 7.9 mp -66.18 -52.6 46.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.739 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.819 HG13 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -122.35 158.86 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 74' ' ' ILE . 23.3 t0 -104.23 141.53 36.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.424 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.618 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.39 -34.48 5.37 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.164 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -126.17 -171.76 2.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.672 0.272 . . . . 0.0 110.56 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 2.4 m-20 -127.97 127.4 43.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.2 p -82.5 103.41 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.46 ' CZ ' ' CE ' ' A' ' 68' ' ' LYS . 29.5 m-85 -115.91 136.34 53.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.604 ' CB ' HG22 ' A' ' 93' ' ' VAL . 48.8 p90 -130.92 140.01 50.14 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.846 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.811 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 2.0 t -144.28 123.34 12.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.45 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.941 HG22 HG13 ' A' ' 91' ' ' VAL . 44.8 p -87.0 153.28 21.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 0.0 110.964 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -47.09 158.36 0.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.209 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.51 0.73 45.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.559 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.48 21.63 0.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.77 102.08 1.31 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.53 0.205 . . . . 0.0 111.329 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.28 -15.11 48.55 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.452 2.101 . . . . 0.0 111.803 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -95.81 30.37 2.39 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.144 0.497 . . . . 0.0 110.14 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.412 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 86.0 m -151.51 71.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.941 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -73.55 178.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.552 ' H ' HG12 ' A' ' 91' ' ' VAL . 49.1 m-85 -152.98 84.19 1.21 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.175 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.779 HG11 HG12 ' A' ' 50' ' ' ILE . 59.8 t -98.52 132.32 43.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.411 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.701 ' HB3' HG13 ' A' ' 9' ' ' VAL . 21.5 p -139.48 131.44 27.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.097 0.475 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 37.7 m-85 -89.33 91.07 8.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.061 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.899 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -85.92 137.0 33.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' HB2' HG13 ' A' ' 100' ' ' ILE . 89.1 mt -48.5 127.75 13.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -50.78 -37.91 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.358 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.15 -25.33 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' A' ' 101' ' ' PRO . 76.2 mt -80.2 138.43 52.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.876 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 100' ' ' ILE . 22.3 Cg_endo -60.98 176.99 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.459 2.106 . . . . 0.0 112.069 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -94.37 61.15 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.682 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 6.1 tp -149.59 -32.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.996 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 108' ' ' ILE . 16.4 tp -61.59 -62.17 6.42 Favored Pre-proline 0 C--O 1.226 -0.143 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.049 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.899 ' HD3' HG21 ' A' ' 96' ' ' THR . 7.6 Cg_endo -49.02 -29.71 16.35 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.397 2.065 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.961 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 mp -72.73 -35.94 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.54 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.83 -26.62 34.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.077 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 104' ' ' LEU . 19.6 mm -73.83 -51.27 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.543 ' HA ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -67.28 -57.37 6.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -59.22 -25.91 64.41 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.587 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -73.97 -45.98 24.5 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 127' ' ' HIS . 10.4 mt -55.2 -26.7 40.96 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.62 -18.92 62.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.91 -21.55 61.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.93 0.395 . . . . 0.0 109.966 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 3.4 m-85 -93.14 -170.68 2.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.468 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -127.12 2.4 6.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.718 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.3 p -114.81 -93.53 0.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.594 ' HB3' ' CD2' ' A' ' 127' ' ' HIS . 1.5 p-10 41.13 31.82 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.49 35.2 4.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -151.1 149.86 30.01 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.396 178.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.412 ' HA ' ' H ' ' A' ' 20' ' ' SER . 40.6 t-20 -69.64 28.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.781 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -169.92 27.1 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.117 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt -132.28 -49.64 0.93 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 1.033 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -54.7 -45.98 74.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 t -47.67 -29.78 3.26 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.359 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.25 -57.82 11.34 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.015 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.906 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.6 m-70 -57.06 -36.65 70.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.609 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.703 HG13 HD12 ' A' ' 108' ' ' ILE . 44.3 t -51.79 -48.3 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.21 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.679 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -72.26 -48.93 22.8 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.54 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -20.69 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 110.701 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.587 HD13 ' HA3' ' A' ' 111' ' ' GLY . 70.3 mt -90.89 -28.2 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.679 HD12 ' HA2' ' A' ' 129' ' ' GLY . 1.1 mt -61.49 -43.69 98.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.028 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.55 -31.0 70.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.25 16.55 26.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.682 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 1.1 t80 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.446 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.902 HG13 HG23 ' A' ' 96' ' ' THR . 1.5 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.058 0.456 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -53.74 -55.92 21.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.963 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.649 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 4.4 m-85 -147.57 116.38 6.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.762 HG13 ' SG ' ' A' ' 94' ' ' CYS . 3.1 t -108.51 97.27 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 1.4 tt0 -105.46 115.63 30.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.929 ' CG2' HD13 ' A' ' 124' ' ' LEU . 6.1 t -79.98 159.54 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.629 HD11 HG21 ' A' ' 50' ' ' ILE . 2.5 mp -140.15 114.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 18' ' ' ILE . 21.4 tttm -96.93 106.54 18.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.459 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 57.68 39.96 26.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.301 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.482 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 77.92 26.74 59.8 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.228 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -144.56 110.82 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.042 0.448 . . . . 0.0 110.069 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.472 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -42.99 130.23 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.478 -178.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.76 -47.56 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.997 178.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.591 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -127.53 176.62 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.217 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.527 ' N ' HD22 ' A' ' 124' ' ' LEU . 2.0 m -168.67 128.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.504 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 35.9 t -115.29 69.42 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.649 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.73 91.93 3.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.785 -178.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.505 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.3 m-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.91 0.386 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.73 26.58 7.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -108.33 -37.34 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.605 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.655 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.19 117.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.56 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.868 HG22 HD12 ' A' ' 45' ' ' ILE . 3.8 t -78.28 151.06 77.9 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 72.4 Cg_exo -47.32 -21.05 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.848 1.699 . . . . 0.0 111.042 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.667 ' HB ' HG23 ' A' ' 42' ' ' THR . 46.7 t -65.79 -45.97 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.183 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.868 HD12 HG22 ' A' ' 42' ' ' THR . 1.7 mp -59.57 -33.5 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CE2' HG22 ' A' ' 41' ' ' ILE . 74.3 m-85 -80.11 -43.82 21.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.447 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.611 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.24 -28.24 69.6 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.414 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.49 -29.7 18.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.858 HD11 HG13 ' A' ' 74' ' ' ILE . 3.6 mt -60.67 -60.5 3.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.049 HG22 HD23 ' A' ' 55' ' ' LEU . 5.1 mt -51.95 -64.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.704 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.72 -38.18 32.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.787 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -91.04 -23.27 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LEU . 40.7 mmm -119.14 -69.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.887 HG22 ' HG3' ' A' ' 69' ' ' MET . 88.8 t -53.52 -53.29 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.848 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.049 HD23 HG22 ' A' ' 50' ' ' ILE . 3.3 mm? -51.85 -58.74 10.04 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.0 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 33.2 Cg_endo -65.38 6.44 0.41 Allowed 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.197 1.931 . . . . 0.0 112.719 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 0.1 OUTLIER -151.0 25.04 0.74 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.099 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 81' ' ' TYR . 9.8 p -82.49 146.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG23 ' HE1' ' A' ' 81' ' ' TYR . 5.2 t . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 1.03 HG21 ' HA ' ' A' ' 106' ' ' ILE . 5.4 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.699 0.285 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.577 HG22 ' CE1' ' A' ' 81' ' ' TYR . 1.4 t -92.8 144.56 25.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.748 0.309 . . . . 0.0 111.113 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HD2' ' CE1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.23 142.2 31.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.887 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.18 -33.4 72.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.802 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m 59.2 26.21 14.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.306 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.418 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 14.2 mmm -111.66 -0.25 16.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.469 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.87 59.62 3.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.123 0.487 . . . . 0.0 110.516 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.851 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.9 mp -60.45 -45.79 92.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.858 HG13 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -139.26 156.32 27.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.684 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -102.47 138.84 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.375 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 113.7 -31.35 6.64 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.416 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -125.74 -165.0 1.36 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.929 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 1.9 m-20 -137.83 117.94 13.49 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.728 ' SG ' HD13 ' A' ' 73' ' ' LEU . 23.4 p -87.38 115.51 24.84 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 49.4 m-85 -123.83 151.74 43.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.867 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.832 ' CD2' HG13 ' A' ' 54' ' ' VAL . 30.0 p90 -141.87 135.36 29.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.676 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.713 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.5 t -140.06 123.78 17.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.591 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 29.0 p -82.09 147.61 29.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 111.029 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -46.93 141.38 4.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -69.05 -11.65 60.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.621 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.22 19.26 1.74 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 111.568 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -161.98 91.24 1.39 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.2 -18.54 30.24 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.482 2.121 . . . . 0.0 111.99 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -92.7 30.91 1.45 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.485 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.577 ' O ' HG22 ' A' ' 90' ' ' THR . 20.5 m -152.74 70.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.639 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -65.5 178.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.124 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.624 ' H ' HG12 ' A' ' 91' ' ' VAL . 97.3 m-85 -153.56 92.38 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.758 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.981 HG11 HG12 ' A' ' 50' ' ' ILE . 24.6 t -97.05 122.87 49.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.786 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.872 ' SG ' HG11 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -108.92 145.67 35.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.63 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 2.4 m-85 -121.82 80.48 1.69 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.902 HG23 HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -77.4 177.72 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 100' ' ' ILE . 12.7 mt -93.9 127.78 39.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -40.55 -32.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.501 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.21 -34.51 78.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 110.576 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.437 HG23 ' HD2' ' A' ' 101' ' ' PRO . 29.2 mt -73.16 136.95 78.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.879 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 100' ' ' ILE . 24.3 Cg_endo -61.24 -168.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.386 2.058 . . . . 0.0 112.232 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.558 ' HD3' HD11 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -108.04 67.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.66 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.735 HG23 ' CE1' ' A' ' 135' ' ' PHE . 1.6 tp -150.51 -33.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.982 HD11 HD12 ' A' ' 132' ' ' LEU . 19.8 tp -59.6 -60.14 11.55 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.241 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.847 ' HD3' HG21 ' A' ' 96' ' ' THR . 9.4 Cg_endo -51.21 -36.72 57.2 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.285 1.99 . . . . 0.0 111.193 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 1.03 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.2 mp -62.02 -40.47 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.231 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.46 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -81.73 -23.99 36.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.983 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.9 HD11 HD12 ' A' ' 132' ' ' LEU . 10.3 mm -71.85 -44.32 67.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.868 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -75.07 -50.9 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -60.64 -30.8 70.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.583 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -73.8 -48.94 15.19 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.13 -32.15 63.97 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.5 -17.26 61.76 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.09 -24.94 62.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.498 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 10.0 m-85 -86.75 -171.54 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -121.32 -1.19 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.613 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 m -114.8 -94.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.53 ' N ' HD22 ' A' ' 123' ' ' LEU . 2.5 p-10 40.26 32.33 0.13 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.782 0.325 . . . . 0.0 111.078 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.413 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -114.94 36.09 4.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.0 OUTLIER -148.81 151.42 34.76 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.008 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.458 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.6 m-80 -70.54 21.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.582 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.1 tt0 -166.23 28.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.601 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.9 tt -132.34 -50.1 0.93 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.929 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.59 -45.58 77.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.429 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 80.3 p -46.37 -30.24 2.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.0 -57.13 14.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.687 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.906 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.3 m170 -61.25 -31.44 71.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.698 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.889 HG13 HD12 ' A' ' 108' ' ' ILE . 48.4 t -56.41 -42.23 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.839 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 132' ' ' LEU . . . -74.94 -50.4 8.79 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.11 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -26.74 67.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.446 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.583 HD13 ' C ' ' A' ' 111' ' ' GLY . 61.7 mt -89.94 -25.82 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.982 HD12 HD11 ' A' ' 104' ' ' LEU . 2.9 tp -55.91 -45.7 78.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.782 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -44.84 64.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.802 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.43 -26.23 67.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.897 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.735 ' CE1' HG23 ' A' ' 103' ' ' ILE . 1.6 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.766 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.981 HG11 HG22 ' A' ' 9' ' ' VAL . 20.2 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.774 0.321 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.455 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -55.79 -54.88 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.628 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 6.6 m-85 -142.49 135.44 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.841 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.981 HG22 HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -129.76 93.11 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.793 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 2.2 mt-10 -106.11 120.77 42.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.577 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.994 HG23 HD13 ' A' ' 124' ' ' LEU . 23.6 t -85.32 159.87 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.727 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.838 HD11 HG21 ' A' ' 50' ' ' ILE . 3.6 mt -138.42 117.54 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.693 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -106.04 109.3 21.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.88 0.371 . . . . 0.0 111.487 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 61.18 37.34 17.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.633 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.6 58.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.483 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -146.1 117.54 7.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.279 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -48.01 126.99 11.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.142 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.76 -45.39 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.457 0.646 . . . . 0.0 109.927 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.828 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -125.16 175.87 7.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.397 -179.436 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 59.5 p -170.19 127.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.509 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 25.5 t -121.58 69.72 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.628 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -106.56 97.66 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.53 -179.31 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 75.2 m-20 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.839 0.352 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 26.28 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.172 0.51 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -111.59 -32.31 6.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.032 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.578 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.63 119.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.63 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.973 HG22 HD12 ' A' ' 45' ' ' ILE . 10.1 t -82.9 150.77 62.68 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.469 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 84.6 Cg_exo -44.79 -23.43 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.294 1.996 . . . . 0.0 111.779 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.76 ' HB ' HG23 ' A' ' 42' ' ' THR . 33.6 t -66.76 -46.45 85.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.176 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.973 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -58.26 -33.87 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CE2' HG22 ' A' ' 41' ' ' ILE . 88.6 m-85 -80.33 -41.48 24.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.401 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.623 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -64.59 -28.05 69.36 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.933 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -89.2 -28.55 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.832 HD11 HG13 ' A' ' 74' ' ' ILE . 4.1 mt -62.33 -60.96 2.82 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.031 HG12 HG11 ' A' ' 93' ' ' VAL . 6.3 mt -50.48 -63.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.703 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -51.55 -41.57 61.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.068 -179.18 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.94 -22.42 20.87 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.452 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 33.2 mmm -116.77 -60.0 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.944 HG22 ' HG3' ' A' ' 69' ' ' MET . 82.7 t -61.38 -60.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.952 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.967 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -45.4 -54.95 13.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.602 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 17.6 Cg_exo -66.61 3.3 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.266 1.977 . . . . 0.0 112.45 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -147.56 24.89 1.09 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.974 0.416 . . . . 0.0 110.254 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.6 p -86.28 169.15 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.833 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.553 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.38 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.77 HG21 ' HA ' ' A' ' 106' ' ' ILE . 17.6 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.782 0.325 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.484 HG22 ' CE1' ' A' ' 81' ' ' TYR . 4.1 t -99.22 151.31 21.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.449 ' HE2' ' CE1' ' A' ' 80' ' ' PHE . 10.6 ttmt -86.14 141.38 29.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.944 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -55.31 -30.23 59.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.957 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m 60.98 26.26 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.059 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 mmm -115.89 -2.72 12.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.187 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.95 59.09 3.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 110.629 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.74 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.1 mp -57.75 -53.99 51.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.832 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -130.3 158.31 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.845 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.422 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.0 t0 -102.98 138.58 39.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.231 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.52 -30.45 7.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -135.49 165.83 24.6 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.741 0.305 . . . . 0.0 110.806 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' OD2' HG12 ' A' ' 98' ' ' VAL . 5.8 m-20 -104.65 126.29 51.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 27.7 t -93.57 105.83 17.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 34.1 m-85 -116.13 137.35 52.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.545 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.863 ' CD2' HG13 ' A' ' 54' ' ' VAL . 7.5 p90 -124.67 139.81 53.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.596 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 2.5 t -141.5 118.48 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.527 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.846 HG22 HG13 ' A' ' 91' ' ' VAL . 74.3 p -81.58 150.48 28.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -46.39 148.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.17 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.25 -8.46 53.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.706 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.28 22.9 0.3 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.606 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.47 88.94 2.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.745 0.307 . . . . 0.0 111.304 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.49 -19.51 23.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.604 2.202 . . . . 0.0 112.133 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.2 32.66 1.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.975 0.416 . . . . 0.0 110.397 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.569 ' O ' HG22 ' A' ' 90' ' ' THR . 21.7 m -156.42 71.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.846 HG13 HG22 ' A' ' 83' ' ' THR . 0.6 OUTLIER -71.35 178.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.196 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.62 ' H ' HG12 ' A' ' 91' ' ' VAL . 84.8 m-85 -153.01 98.59 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.031 HG11 HG12 ' A' ' 50' ' ' ILE . 43.1 t -106.17 129.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.372 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.558 ' HB3' HG13 ' A' ' 9' ' ' VAL . 28.2 p -128.41 117.46 21.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.308 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 16.0 m-85 -85.72 78.13 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.787 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.862 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -65.52 -172.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.758 0.314 . . . . 0.0 110.599 -179.378 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 100' ' ' ILE . 71.7 mt -102.26 129.82 48.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.491 HG12 ' OD2' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -46.01 -36.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.815 0.34 . . . . 0.0 111.617 -179.189 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.82 -29.61 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' LEU . 60.2 mt -81.48 129.96 63.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.82 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.66 -176.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.491 2.127 . . . . 0.0 111.932 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.493 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -99.91 63.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.542 ' CA ' HD13 ' A' ' 106' ' ' ILE . 4.6 tp -144.02 -37.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.609 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.809 HD21 HG23 ' A' ' 6' ' ' VAL . 2.5 tp -63.89 -63.61 3.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.862 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -45.47 -30.19 5.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.627 2.218 . . . . 0.0 111.388 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.77 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 mp -66.92 -41.71 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.727 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.493 ' O ' HG21 ' A' ' 131' ' ' ILE . 6.9 mmt180 -80.95 -17.76 49.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.678 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.691 HG13 HG21 ' A' ' 6' ' ' VAL . 16.2 mm -70.53 -48.62 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.666 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -73.12 -51.49 17.77 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.496 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -76.69 -43.88 17.23 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.897 HD23 ' HB2' ' A' ' 127' ' ' HIS . 16.9 mt -56.82 -35.62 69.0 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -14.52 61.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.16 -23.86 59.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.239 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.471 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 5.7 m-85 -84.33 -93.08 0.08 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 161.26 -26.38 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 111.068 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.3 m -92.13 -90.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.557 ' N ' HD22 ' A' ' 123' ' ' LEU . 22.6 p30 40.73 32.47 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.99 34.52 4.8 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.559 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -150.71 149.24 29.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 178.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.443 ' HA ' ' N ' ' A' ' 20' ' ' SER . 5.2 p30 -68.91 28.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.858 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.6 tp10 -169.93 27.93 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.8 tt -132.9 -49.32 0.88 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.507 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.994 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.66 -44.71 77.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 89.2 p -47.63 -30.73 3.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.16 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.91 -60.4 3.85 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.105 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.897 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.6 m-70 -57.98 -36.88 73.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.636 HG11 HG21 ' A' ' 9' ' ' VAL . 42.4 t -53.28 -43.97 52.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.219 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.06 -44.82 12.76 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.109 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -65.25 -23.0 66.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 127' ' ' HIS . 57.3 mt -90.03 -26.34 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.671 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -63.72 -47.83 79.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.545 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.68 -44.32 82.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.889 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -73.21 -18.06 61.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.536 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 15.9 t80 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.049 HG11 HG22 ' A' ' 9' ' ' VAL . 2.1 t . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.449 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -87.88 -49.9 6.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.548 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.714 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 10.1 m-85 -143.57 134.71 25.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.96 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.049 HG22 HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -134.65 93.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.821 179.162 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.6 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.5 mt-10 -107.72 120.23 41.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.994 0.426 . . . . 0.0 111.812 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.987 HG23 HD13 ' A' ' 124' ' ' LEU . 75.8 t -82.69 158.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.83 HD11 HG21 ' A' ' 50' ' ' ILE . 4.4 mt -137.51 115.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.615 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -105.28 109.34 21.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.0 111.284 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 63.81 34.28 12.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.611 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.66 26.39 58.95 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.347 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.93 117.34 9.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.039 0.447 . . . . 0.0 109.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.6 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -51.61 125.21 14.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.727 -178.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.615 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.19 -49.47 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.445 0.64 . . . . 0.0 109.87 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 120' ' ' THR . 55.0 p -120.87 174.38 6.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.695 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.537 ' N ' HD22 ' A' ' 124' ' ' LEU . 92.1 p -170.06 134.44 1.26 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.155 0.502 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 28.7 t -124.86 69.71 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.434 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.637 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.9 m-85 -106.95 101.91 11.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.054 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.721 -179.629 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 24.1 m-20 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.803 0.335 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 51.5 tt0 -128.86 26.9 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.16 0.505 . . . . 0.0 110.832 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -113.66 -33.49 5.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.155 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.686 HG22 ' CE2' ' A' ' 46' ' ' PHE . 2.2 mm -52.87 130.62 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.676 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.71 HG23 ' HB ' ' A' ' 44' ' ' VAL . 11.2 t -91.24 151.25 42.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.714 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 75.0 Cg_exo -46.71 -25.93 4.07 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.293 1.995 . . . . 0.0 111.384 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.71 ' HB ' HG23 ' A' ' 42' ' ' THR . 74.2 t -66.65 -38.45 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.714 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.603 HG13 HG23 ' A' ' 41' ' ' ILE . 15.2 mm -59.8 -44.21 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.686 ' CE2' HG22 ' A' ' 41' ' ' ILE . 10.7 m-85 -75.83 -40.09 55.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.178 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.651 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -62.73 -30.27 71.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.178 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -87.65 -29.56 21.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 73' ' ' LEU . 4.1 mt -61.53 -59.72 4.8 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.069 HG12 HG11 ' A' ' 93' ' ' VAL . 7.0 mt -50.79 -63.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.016 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.4 OUTLIER -52.21 -41.74 62.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.99 -1.459 . . . . 0.0 113.048 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.76 -20.62 22.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.601 ' HB2' HD21 ' A' ' 73' ' ' LEU . 47.9 mmm -118.28 -59.95 1.84 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 69' ' ' MET . 90.8 t -63.55 -60.18 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.009 HD23 HG22 ' A' ' 50' ' ' ILE . 2.4 mm? -44.57 -53.69 14.29 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.8 Cg_exo -67.0 3.95 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.225 1.95 . . . . 0.0 112.457 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.28 28.07 0.58 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.139 0.495 . . . . 0.0 110.194 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 91' ' ' VAL . 9.4 p -83.76 150.35 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.94 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.584 HG23 ' HE1' ' A' ' 81' ' ' TYR . 3.8 t . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.839 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.0 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.688 0.28 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.9 m -101.2 130.06 47.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -81.74 134.95 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.778 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -58.13 -26.25 62.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.7 t 50.94 28.46 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.5 tpp -107.3 -18.1 13.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.61 63.76 0.41 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 49' ' ' LEU . 7.1 mp -65.32 -59.22 4.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.539 HG13 HD11 ' A' ' 49' ' ' LEU . 1.3 mt -121.51 155.44 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 17.0 t0 -97.3 140.02 32.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.754 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 107.47 -33.15 6.54 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.293 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 74' ' ' ILE . 2.1 m-85 -116.35 175.26 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.6 OUTLIER -120.75 121.68 38.74 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.45 ' HG ' ' HE1' ' A' ' 95' ' ' PHE . 6.1 m -86.98 106.19 17.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.459 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 65.8 m-85 -120.81 149.0 43.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.505 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 93' ' ' VAL . 35.3 p90 -144.87 131.07 19.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.154 0.502 . . . . 0.0 111.585 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.805 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 2.2 t -132.05 120.75 22.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.638 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.984 HG22 HG13 ' A' ' 91' ' ' VAL . 63.1 p -89.97 150.13 22.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.969 0.414 . . . . 0.0 111.133 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.66 149.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -69.97 -16.47 63.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.69 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.75 20.13 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.0 93.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.554 0.216 . . . . 0.0 111.263 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.31 -16.28 50.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.387 2.058 . . . . 0.0 111.896 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 30.39 2.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.098 0.475 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.532 ' O ' HG22 ' A' ' 90' ' ' THR . 34.5 m -150.84 69.59 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.535 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.984 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -72.47 176.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.512 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.562 ' H ' HG12 ' A' ' 91' ' ' VAL . 38.3 m-85 -151.21 91.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.069 HG11 HG12 ' A' ' 50' ' ' ILE . 41.5 t -99.27 132.6 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.154 0.502 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.38 123.15 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.148 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.714 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -95.8 84.45 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.79 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.912 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -74.45 -167.38 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.973 0.416 . . . . 0.0 110.907 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 100' ' ' ILE . 13.5 mt -106.36 127.48 53.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.351 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -45.54 -35.93 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.75 0.309 . . . . 0.0 111.697 -179.212 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.0 -31.27 71.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.383 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 97' ' ' LEU . 62.9 mt -76.34 132.99 71.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.764 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.56 -168.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.369 2.046 . . . . 0.0 112.127 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 67.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.642 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.503 ' HA ' HD13 ' A' ' 106' ' ' ILE . 4.7 tp -152.03 -40.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.953 HD11 HD11 ' A' ' 108' ' ' ILE . 12.1 tp -56.15 -63.99 2.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.129 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.912 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.1 Cg_endo -47.57 -30.02 11.5 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.447 2.098 . . . . 0.0 111.51 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.839 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.8 mp -72.0 -41.05 68.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.575 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.508 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -79.01 -28.12 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 104' ' ' LEU . 7.8 mm -68.08 -49.81 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.529 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -67.25 -54.8 17.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.1 p -60.38 -27.39 67.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.529 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -74.02 -44.36 30.31 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.933 HD23 ' HB2' ' A' ' 127' ' ' HIS . 17.0 mt -55.24 -28.87 56.25 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.02 -19.07 63.33 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.365 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.06 -20.88 61.6 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.633 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 6.3 m-85 -101.45 -29.88 11.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.063 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 4.6 mt-10 83.33 -51.86 0.15 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.005 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.8 m -46.43 -95.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.691 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.573 ' H ' HD22 ' A' ' 123' ' ' LEU . 0.9 OUTLIER 42.07 31.9 0.27 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.725 0.298 . . . . 0.0 110.706 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.57 33.01 4.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -152.95 148.85 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.559 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.41 ' HA ' ' H ' ' A' ' 20' ' ' SER . 2.1 p-10 -69.95 23.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.424 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.4 tt0 -163.84 24.86 0.08 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.7 tt -123.81 -56.89 1.65 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.727 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.987 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.13 -45.16 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 90.0 p -47.76 -31.42 4.82 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.365 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.08 -56.69 16.33 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.264 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.933 ' HB2' HD23 ' A' ' 112' ' ' LEU . 2.4 m-70 -60.17 -35.29 75.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.913 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.7 t -53.16 -47.18 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.827 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.71 -37.74 57.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.193 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.43 -18.45 60.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 0.0 111.344 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.529 HG21 ' HA3' ' A' ' 111' ' ' GLY . 26.4 mt -90.56 -28.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.913 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -67.63 -52.04 42.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.485 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.52 -29.45 64.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.0 m -98.27 -12.08 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.999 -179.853 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.948 HG11 HG22 ' A' ' 9' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.782 0.325 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.454 ' OG ' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.98 -63.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.16 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.64 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.0 m-85 -140.34 131.19 25.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.954 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.948 HG22 HG11 ' A' ' 6' ' ' VAL . 2.1 t -117.42 85.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.378 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.419 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 0.9 OUTLIER -91.32 111.99 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.053 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.922 HG23 HD13 ' A' ' 124' ' ' LEU . 97.6 t -85.22 158.35 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.95 HD11 HG21 ' A' ' 50' ' ' ILE . 3.1 mt -138.69 121.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.833 0.349 . . . . 0.0 111.686 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.573 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.2 tttt -110.82 102.94 11.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 111.582 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 67.81 37.99 3.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.87 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.35 24.79 60.38 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.815 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.41 120.57 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.887 0.375 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -53.31 120.84 6.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.753 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.573 HG23 ' HB3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -95.37 -51.09 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.016 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 120' ' ' THR . 57.9 p -123.08 177.93 5.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 121' ' ' ASN . 29.5 m -170.5 142.95 2.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.411 . . . . 0.0 111.322 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 23.6 t -125.64 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.862 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 3.8 m-85 -106.2 88.83 2.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.401 -179.594 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.724 0.297 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.6 26.16 4.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.016 0.436 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.53 -35.83 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.596 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -52.69 115.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.514 178.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.837 ' CG2' HD12 ' A' ' 45' ' ' ILE . 1.4 t -76.01 152.29 84.38 Favored Pre-proline 0 CA--C 1.517 -0.327 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.671 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 74.4 Cg_exo -47.88 -21.73 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.84 1.693 . . . . 0.0 110.709 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 42' ' ' THR . 96.0 t -65.86 -48.68 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.175 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.837 HD12 ' CG2' ' A' ' 42' ' ' THR . 1.7 mp -57.4 -33.27 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.596 ' CE2' HG22 ' A' ' 41' ' ' ILE . 89.4 m-85 -81.0 -42.71 20.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.427 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.643 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.98 -28.19 69.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.011 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -88.5 -30.07 19.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 73' ' ' LEU . 4.8 mt -60.84 -60.23 4.13 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.965 HG12 HG11 ' A' ' 93' ' ' VAL . 5.7 mt -52.09 -62.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.065 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.643 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -50.26 -44.89 53.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.909 -179.067 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.86 -15.25 30.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.674 ' HB2' HD21 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -122.12 -69.38 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.872 HG22 ' HG3' ' A' ' 69' ' ' MET . 70.9 t -53.93 -51.3 46.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.786 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.922 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -54.09 -58.39 13.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 25.3 Cg_endo -63.19 2.8 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.154 1.902 . . . . 0.0 112.662 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.422 ' CB ' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -146.48 25.23 1.22 Allowed 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.941 0.401 . . . . 0.0 110.092 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 59' ' ' VAL . 3.9 p -87.78 165.27 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.934 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 58' ' ' VAL . 35.2 m . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.068 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.884 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.3 t . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.868 0.366 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.458 ' HB ' ' CE2' ' A' ' 81' ' ' TYR . 97.3 m -95.13 144.34 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -93.48 125.54 38.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.783 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.872 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -46.92 -33.85 4.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.06 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.1 p 56.71 26.92 11.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.16 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.471 ' HB2' HD12 ' A' ' 73' ' ' LEU . 1.5 mmt -107.83 -3.51 18.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.964 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 58.87 55.29 4.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.092 0.473 . . . . 0.0 110.408 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.754 HD11 ' SD ' ' A' ' 69' ' ' MET . 10.7 mp -55.77 -49.94 71.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -136.25 161.3 37.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.5 t70 -100.09 140.25 34.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.275 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.54 -34.73 5.21 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.039 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.463 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -129.12 -179.02 4.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.633 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 19.6 m-20 -123.45 125.22 44.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.498 ' SG ' HD13 ' A' ' 73' ' ' LEU . 6.5 p -80.97 101.61 9.62 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.569 ' O ' HG13 ' A' ' 93' ' ' VAL . 63.4 m-85 -110.19 157.96 18.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.255 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.808 ' CD1' HG13 ' A' ' 54' ' ' VAL . 9.8 p90 -149.99 132.09 15.35 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.17 0.51 . . . . 0.0 111.463 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 28.6 t -134.81 117.39 15.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.659 HG22 HG13 ' A' ' 91' ' ' VAL . 5.0 p -84.79 148.21 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.946 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.02 144.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.88 -21.99 8.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.952 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 23.29 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.69 0.281 . . . . 0.0 111.507 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.57 92.34 6.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.002 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.56 -15.13 43.97 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.27 1.98 . . . . 0.0 111.98 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -95.97 29.79 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.242 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.542 ' O ' HG22 ' A' ' 90' ' ' THR . 32.4 m -153.05 69.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.582 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -71.29 177.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.566 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.511 ' H ' HG12 ' A' ' 91' ' ' VAL . 53.7 m-85 -151.64 83.34 1.29 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.387 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.965 HG11 HG12 ' A' ' 50' ' ' ILE . 32.5 t -89.08 133.47 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 0.0 110.998 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -131.07 119.17 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.882 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.508 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.1 m-85 -86.95 83.3 7.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.383 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.851 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -83.49 133.66 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 111.985 -178.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.454 ' HG ' ' OG ' ' A' ' 7' ' ' SER . 61.9 mt -46.57 125.4 7.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -47.03 -33.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.748 0.309 . . . . 0.0 111.32 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.9 mt -78.77 132.32 64.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.899 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.06 -167.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.393 2.062 . . . . 0.0 112.007 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.593 ' HG2' HD11 ' A' ' 106' ' ' ILE . 2.2 tttt -108.67 67.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.663 ' HA ' HD13 ' A' ' 106' ' ' ILE . 3.0 tp -150.97 -38.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.749 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.88 HD21 HG23 ' A' ' 6' ' ' VAL . 5.0 tp -60.36 -62.3 6.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.781 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.851 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -46.23 -34.21 13.29 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.335 2.024 . . . . 0.0 111.308 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.884 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.2 mp -65.98 -38.77 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.546 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -82.02 -27.12 33.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.872 ' CG2' HG13 ' A' ' 128' ' ' VAL . 10.8 mm -68.09 -47.98 76.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.428 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.806 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -71.78 -54.93 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 t -59.32 -28.78 67.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.54 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -73.88 -47.66 18.95 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.282 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.921 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -56.36 -31.56 63.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.95 -14.3 60.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.148 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -75.74 -24.41 56.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.343 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 127' ' ' HIS . 8.1 m-85 -86.17 -93.15 0.09 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.979 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER 160.38 -28.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.782 0.433 . . . . 0.0 110.297 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.413 ' CB ' HD21 ' A' ' 123' ' ' LEU . 72.4 p -107.33 127.27 53.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.491 0.662 . . . . 0.0 111.191 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 5.6 p30 -172.65 36.2 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.053 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.73 32.83 4.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.316 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.635 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -148.39 144.96 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.279 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.451 ' HA ' ' H ' ' A' ' 20' ' ' SER . 2.2 m120 -68.5 29.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.882 0.372 . . . . 0.0 111.834 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 120' ' ' THR . 11.1 tt0 -169.78 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.635 ' CB ' HG23 ' A' ' 120' ' ' THR . 8.5 tt -124.08 -58.01 1.57 Allowed 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.922 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -51.26 -43.84 61.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.465 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.4 p -47.7 -29.31 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.509 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.3 -61.81 2.11 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.126 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.921 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.3 m-70 -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.754 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.872 HG13 ' CG2' ' A' ' 108' ' ' ILE . 50.0 t -51.58 -48.88 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -69.06 -46.9 57.09 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.987 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -64.01 -20.33 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.734 0.302 . . . . 0.0 110.659 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.546 HG21 ' O ' ' A' ' 107' ' ' ARG . 44.7 mt -90.7 -28.45 4.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.764 ' CD2' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -62.36 -39.85 94.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.94 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -32.96 72.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.455 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.26 24.29 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.843 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.6 ' CE2' HG23 ' A' ' 103' ' ' ILE . 1.1 t80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.376 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.026 HG22 HG23 ' A' ' 96' ' ' THR . 1.2 t . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.742 0.306 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB3' ' CD1' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -69.52 -71.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.291 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.684 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 3.4 m-85 -134.23 142.03 47.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.992 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.811 HG22 HG11 ' A' ' 6' ' ' VAL . 1.7 t -129.77 94.89 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.169 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.8 mt-10 -105.17 118.15 35.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.942 0.401 . . . . 0.0 111.978 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.911 ' CG2' HD13 ' A' ' 124' ' ' LEU . 16.8 t -84.53 158.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 55' ' ' LEU . 2.1 mp -141.52 117.24 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 10.1 tttt -101.35 107.53 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.276 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.22 37.63 23.72 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.809 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.26 24.65 56.68 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.757 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -143.3 112.97 6.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.947 0.404 . . . . 0.0 110.108 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 m -46.46 125.69 7.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.333 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -100.98 -39.74 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.253 178.452 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.8 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -131.49 174.68 9.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.106 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.492 ' N ' HD22 ' A' ' 124' ' ' LEU . 8.9 p -170.32 123.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 26.0 t -113.97 69.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.684 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -110.29 88.24 2.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.21 0.529 . . . . 0.0 110.982 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.508 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.791 0.329 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.75 28.58 5.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.7 -33.89 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.908 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.643 HG23 ' HB ' ' A' ' 45' ' ' ILE . 1.5 mt -51.73 140.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.767 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.553 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.5 t -94.6 151.66 39.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 80.0 Cg_exo -46.57 -28.25 6.11 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.825 1.683 . . . . 0.0 110.652 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 42' ' ' THR . 58.8 t -59.44 -42.14 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.566 178.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.643 ' HB ' HG23 ' A' ' 41' ' ' ILE . 23.4 mm -55.72 -51.68 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.686 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.518 ' O ' HD12 ' A' ' 50' ' ' ILE . 44.0 m-85 -71.34 -37.74 71.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.505 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.646 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.02 -31.04 72.09 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.224 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -87.46 -28.69 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.658 HD11 HG13 ' A' ' 74' ' ' ILE . 3.7 mt -61.91 -59.97 4.33 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.995 HG22 HD23 ' A' ' 55' ' ' LEU . 6.5 mt -50.31 -64.05 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.898 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -53.13 -40.32 64.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.348 -178.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.72 -21.85 21.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.485 ' HB2' HD21 ' A' ' 73' ' ' LEU . 83.1 mmm -118.38 -59.34 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 81' ' ' TYR . 84.2 t -62.81 -59.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.995 HD23 HG22 ' A' ' 50' ' ' ILE . 2.9 mm? -45.33 -54.26 15.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.0 Cg_exo -67.78 4.32 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.269 1.98 . . . . 0.0 112.465 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 2.1 mptt -145.49 21.86 1.5 Allowed 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 120.94 0.4 . . . . 0.0 110.461 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 59' ' ' VAL . 4.4 p -87.22 167.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 58' ' ' VAL . 34.3 m . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.928 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 106' ' ' ILE . 98.7 t . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.473 ' CG2' ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -98.34 168.5 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 111.628 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -105.53 139.11 40.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.569 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.618 ' CG ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -49.27 -29.01 5.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.042 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 p 52.12 26.29 3.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.5 tpp -113.95 -10.87 12.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.157 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 59.72 58.88 2.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.503 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.5 mp -59.87 -62.38 1.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.76 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.658 HG13 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -120.03 155.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.673 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -96.9 140.68 31.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.432 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.661 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.0 -32.74 6.64 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.275 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -126.62 163.1 24.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 111.114 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -105.88 130.25 53.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.515 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.0 m -94.99 112.71 24.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 44.0 m-85 -122.54 140.84 52.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.772 ' CD2' HG13 ' A' ' 54' ' ' VAL . 7.2 p90 -131.5 134.3 46.0 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.142 0.496 . . . . 0.0 111.305 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.479 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 11.4 t -136.17 118.57 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.61 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.686 HG22 HG13 ' A' ' 91' ' ' VAL . 64.8 p -85.0 144.41 28.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 7.5 t0 -43.65 148.19 0.37 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.588 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.31 -20.43 60.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.618 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 19.59 2.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.549 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -159.87 90.1 1.86 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.445 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -56.78 -18.8 28.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.619 2.212 . . . . 0.0 111.915 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -92.85 29.84 1.71 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.104 0.478 . . . . 0.0 110.679 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.572 ' O ' HG22 ' A' ' 90' ' ' THR . 23.3 m -149.51 68.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.26 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.686 HG13 HG22 ' A' ' 83' ' ' THR . 0.7 OUTLIER -64.27 179.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.211 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.648 ' H ' HG12 ' A' ' 91' ' ' VAL . 98.0 m-85 -154.89 79.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.85 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.903 HG11 HG12 ' A' ' 50' ' ' ILE . 86.8 t -88.29 127.31 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.104 0.478 . . . . 0.0 111.312 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.466 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.4 t -125.9 117.51 23.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.5 m-85 -87.28 78.81 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.088 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 1.026 HG23 HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -64.5 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.898 0.38 . . . . 0.0 111.162 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.411 ' CD2' ' OG ' ' A' ' 7' ' ' SER . 56.4 mt -105.71 131.68 52.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.271 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -46.84 -34.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 111.336 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -33.63 74.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.525 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 98.0 mt -72.76 129.96 86.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.816 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.81 -172.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.251 1.967 . . . . 0.0 111.516 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 64.13 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.908 0.385 . . . . 0.0 110.724 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.541 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -148.42 -38.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.86 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.624 HD11 ' CD2' ' A' ' 132' ' ' LEU . 16.9 tp -62.5 -62.25 6.08 Favored Pre-proline 0 CA--C 1.521 -0.136 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.735 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.862 ' HD3' HG21 ' A' ' 96' ' ' THR . 8.1 Cg_endo -48.71 -28.09 12.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.256 1.971 . . . . 0.0 110.908 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.68 ' HA ' HG21 ' A' ' 66' ' ' VAL . 13.2 mt -70.72 -64.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.691 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -24.37 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.236 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.826 HD11 ' HG ' ' A' ' 132' ' ' LEU . 8.2 mm -72.58 -47.04 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.973 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.47 -65.56 0.67 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -51.94 -27.85 14.55 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -68.75 -50.2 37.7 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.714 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.969 HD23 ' HB2' ' A' ' 127' ' ' HIS . 5.4 mt -54.85 -35.04 63.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.95 -16.35 61.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.197 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.61 -22.84 58.73 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.341 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.493 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 4.0 m-85 -82.37 -91.94 0.07 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 25.5 tt0 164.55 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.629 0.252 . . . . 0.0 110.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.2 -90.27 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.712 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.2 p-10 38.42 33.2 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 110.977 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.09 34.52 4.61 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -147.39 152.92 38.96 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.603 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.454 ' HA ' ' N ' ' A' ' 20' ' ' SER . 3.6 p30 -71.75 28.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 0.0 111.737 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -172.29 28.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.9 tt -134.69 -49.5 0.77 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.6 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.911 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.79 -44.96 78.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.005 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.421 ' HB3' ' CB ' ' A' ' 21' ' ' CYS . 78.7 p -47.69 -30.25 3.65 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.252 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.04 -59.93 4.59 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.254 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.969 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.8 m-70 -54.89 -37.99 67.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.617 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.742 HG13 HD12 ' A' ' 108' ' ' ILE . 41.9 t -51.67 -50.29 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.547 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.28 -48.82 36.05 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.656 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -19.5 65.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 111.233 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 127' ' ' HIS . 69.9 mt -90.81 -27.4 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.826 ' HG ' HD11 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -63.24 -46.09 88.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.113 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -39.49 79.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.738 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 0.92 48.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.056 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.541 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 17.1 t80 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.689 ' CG1' HG22 ' A' ' 9' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.101 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.443 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -37.37 -49.78 1.01 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.927 -178.535 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.614 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 9.1 m-85 -146.17 112.3 5.76 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.612 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.689 HG22 ' CG1' ' A' ' 6' ' ' VAL . 2.3 t -110.78 95.92 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.131 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.62 ' CD ' HG21 ' A' ' 17' ' ' THR . 0.4 OUTLIER -104.17 112.51 25.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 111.882 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.949 HG23 HD13 ' A' ' 124' ' ' LEU . 76.4 t -81.68 156.06 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.671 HD11 HG21 ' A' ' 50' ' ' ILE . 2.2 mp -132.62 123.31 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.74 0.305 . . . . 0.0 111.428 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 18' ' ' ILE . 6.3 tttm -108.06 90.41 3.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.01 40.86 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.879 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.24 63.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.344 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 16' ' ' GLU . 5.1 pt-20 -146.56 118.98 8.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.11 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.62 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -51.81 124.9 13.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.852 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.56 HD11 ' CG1' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -100.3 -50.31 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 120' ' ' THR . 45.0 p -121.54 176.11 5.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.006 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -170.24 141.83 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.987 0.422 . . . . 0.0 111.766 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 37.6 t -128.74 69.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.444 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -105.97 99.91 9.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.088 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.397 -179.793 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.728 0.299 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.05 26.8 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.042 0.449 . . . . 0.0 110.949 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.49 -36.53 5.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.548 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.777 HG23 HG13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -47.14 135.73 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.0 178.834 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.515 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.3 t -94.14 151.76 39.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.635 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.22 -27.01 6.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.852 1.701 . . . . 0.0 110.513 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.515 ' HB ' HG23 ' A' ' 42' ' ' THR . 58.9 t -61.21 -42.68 94.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.571 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.777 HG13 HG23 ' A' ' 41' ' ' ILE . 16.0 mm -56.94 -46.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.653 ' O ' HD12 ' A' ' 50' ' ' ILE . 26.1 m-85 -73.17 -39.89 65.27 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.401 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.29 -31.26 72.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.318 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.48 -29.64 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.885 HD11 HG13 ' A' ' 74' ' ' ILE . 6.1 mt -61.11 -60.79 3.21 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.096 HG22 HD23 ' A' ' 55' ' ' LEU . 5.6 mt -51.1 -63.97 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.839 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.609 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 6.0 tpp -50.08 -40.55 45.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.965 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.16 -21.45 21.15 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.559 ' HB2' HD21 ' A' ' 73' ' ' LEU . 56.1 mmm -117.69 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.798 HG13 ' CD1' ' A' ' 81' ' ' TYR . 65.4 t -56.01 -55.9 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.786 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.096 HD23 HG22 ' A' ' 50' ' ' ILE . 3.4 mm? -47.13 -58.29 7.51 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.044 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.8 Cg_endo -65.99 6.82 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.143 1.895 . . . . 0.0 112.742 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.95 25.12 0.65 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.036 0.446 . . . . 0.0 110.099 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 91' ' ' VAL . 8.8 p -81.84 150.85 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.084 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.531 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.824 HG21 ' HA ' ' A' ' 106' ' ' ILE . 4.4 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.828 0.347 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 m -104.65 141.28 36.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 111.176 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 4.0 ttpt -84.62 141.99 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.641 ' CG ' HG22 ' A' ' 54' ' ' VAL . 6.4 mmm -58.27 -32.51 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.766 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m 61.79 26.97 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.988 0.423 . . . . 0.0 110.945 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 18.4 mmm -110.81 -11.27 14.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.86 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.84 59.85 1.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.709 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.6 mp -58.63 -49.96 75.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.696 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.885 HG13 HD11 ' A' ' 49' ' ' LEU . 1.1 mt -137.26 154.7 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.791 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.6 t70 -95.3 142.96 27.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.628 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 104.89 -35.36 5.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.954 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.798 ' O ' HG13 ' A' ' 98' ' ' VAL . 2.3 m-85 -113.01 -170.08 1.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -144.06 118.36 9.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.199 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.501 ' SG ' HG21 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -86.36 103.2 14.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.856 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.478 ' CD2' ' HG3' ' A' ' 68' ' ' LYS . 41.5 m-85 -118.46 119.48 34.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.976 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.798 ' CD1' HG13 ' A' ' 54' ' ' VAL . 33.0 p90 -109.83 151.45 26.99 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.304 0.573 . . . . 0.0 112.092 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.661 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 3.1 t -149.12 119.35 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.995 HG22 HG13 ' A' ' 91' ' ' VAL . 76.8 p -88.92 151.54 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.384 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.09 140.83 8.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.072 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -60.7 -16.74 42.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.889 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.35 22.29 0.94 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -151.46 97.33 3.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 111.377 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.08 -14.71 46.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.247 1.964 . . . . 0.0 111.976 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 30.04 2.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.285 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.568 ' O ' HG22 ' A' ' 90' ' ' THR . 23.9 m -152.73 69.98 0.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.657 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.995 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -74.09 178.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.324 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.576 ' H ' HG12 ' A' ' 91' ' ' VAL . 49.6 m-85 -151.78 104.68 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.988 HG11 HG12 ' A' ' 50' ' ' ILE . 28.1 t -108.29 115.35 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.189 0.519 . . . . 0.0 111.493 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.403 ' SG ' HD21 ' A' ' 109' ' ' LEU . 28.3 p -111.17 116.06 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.101 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.6 m-85 -89.23 84.22 6.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.537 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.528 ' CG2' HG13 ' A' ' 6' ' ' VAL . 8.1 p -85.89 156.91 20.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.776 0.322 . . . . 0.0 110.881 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.438 ' HB2' HG13 ' A' ' 100' ' ' ILE . 34.5 mt -69.59 127.81 34.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.573 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -42.66 -34.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.057 -179.229 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -36.68 83.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.38 136.39 96.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.775 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 100' ' ' ILE . 23.3 Cg_endo -61.68 -167.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.184 1.923 . . . . 0.0 111.914 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.464 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -108.75 66.78 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.895 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.462 HG23 ' CE1' ' A' ' 135' ' ' PHE . 6.3 tp -151.65 -44.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.656 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 132' ' ' LEU . 0.4 OUTLIER -57.97 -62.59 5.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.479 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 3.8 Cg_endo -46.53 -34.87 15.63 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.547 2.164 . . . . 0.0 111.098 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.8 mp -68.69 -37.27 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.897 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -81.41 -22.54 38.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.602 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 132' ' ' LEU . 35.5 mm -68.36 -48.16 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.361 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.819 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -73.88 -52.61 12.41 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t -58.93 -29.18 66.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.547 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -75.47 -46.82 13.9 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.844 HD23 ' HB2' ' A' ' 127' ' ' HIS . 17.2 mt -56.22 -32.19 64.2 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -76.26 -15.88 59.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -74.3 -25.46 59.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 110.138 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.57 ' CG ' ' CD2' ' A' ' 127' ' ' HIS . 3.6 m-85 -86.15 -90.68 0.1 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 1.2 tt0 159.69 -30.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.865 0.466 . . . . 0.0 109.767 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.883 ' HB3' HD21 ' A' ' 123' ' ' LEU . 0.3 OUTLIER -103.32 137.15 41.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.511 ' N ' HD22 ' A' ' 123' ' ' LEU . 0.9 OUTLIER 176.61 34.47 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.349 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.23 32.94 4.76 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -145.94 146.39 31.03 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.479 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.456 ' HA ' ' N ' ' A' ' 20' ' ' SER . 10.6 p30 -69.25 26.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.0 mt-10 -167.6 26.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.883 HD21 ' HB3' ' A' ' 117' ' ' SER . 8.2 tt -124.76 -57.25 1.55 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.949 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.67 -41.49 63.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.431 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 13.5 t -49.61 -29.28 6.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.233 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.73 -63.74 1.17 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.297 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.844 ' HB2' HD23 ' A' ' 112' ' ' LEU . 2.4 m-70 -59.21 -30.6 68.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.03 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 124' ' ' LEU . 49.0 t -57.67 -41.95 80.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.0 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.36 -48.71 10.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.137 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.71 -26.5 68.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.585 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.547 HD13 ' C ' ' A' ' 111' ' ' GLY . 70.6 mt -85.49 -26.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -60.95 -46.47 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.146 178.421 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -43.93 73.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.052 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.18 -24.75 64.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CE1' HG23 ' A' ' 103' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.952 HG11 HG22 ' A' ' 9' ' ' VAL . 80.3 t . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.788 0.328 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.41 -71.11 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.899 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.709 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 27.4 m-85 -128.87 111.97 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.332 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.952 HG22 HG11 ' A' ' 6' ' ' VAL . 2.3 t -103.91 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.491 ' HG2' HG23 ' A' ' 17' ' ' THR . 1.2 tt0 -100.05 114.19 27.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.673 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.97 ' CG2' HD13 ' A' ' 124' ' ' LEU . 26.3 t -84.27 159.62 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.6 mp -141.3 122.2 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 112.046 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.549 ' HB2' HD13 ' A' ' 18' ' ' ILE . 12.1 tttm -104.15 99.05 8.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.363 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 63.34 41.68 7.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.387 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 78.39 23.64 64.96 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.582 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -143.25 111.9 6.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.93 0.395 . . . . 0.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.491 HG23 ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -45.15 126.41 6.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.309 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -105.18 -44.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.914 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.773 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -127.76 178.16 6.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.375 -179.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.487 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 18.0 m -170.75 131.16 0.85 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.54 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.501 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 29.2 t -115.13 69.46 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.709 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.7 m-85 -107.66 87.65 2.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.941 -179.671 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 5.3 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.816 0.341 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.8 26.75 7.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -112.37 -35.36 5.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.858 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.666 HG22 ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -55.38 123.79 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.955 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.885 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -86.08 149.36 50.0 Favored Pre-proline 0 CA--C 1.519 -0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.435 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.554 ' HA ' ' CE1' ' A' ' 22' ' ' PHE . 2.0 Cg_endo -44.15 -22.75 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.713 2.275 . . . . 0.0 112.071 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.707 ' HB ' HG23 ' A' ' 42' ' ' THR . 5.3 t -67.73 -44.18 85.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.885 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -59.12 -31.74 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.666 ' CE2' HG22 ' A' ' 41' ' ' ILE . 66.3 m-85 -80.14 -43.44 21.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.349 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.622 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.27 -25.84 67.06 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.537 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' VAL . 15.0 m-20 -90.4 -29.82 17.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.588 HD22 ' HB3' ' A' ' 73' ' ' LEU . 2.7 mt -58.34 -57.8 11.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.041 HG22 HD23 ' A' ' 55' ' ' LEU . 4.3 mt -57.97 -66.01 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.209 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.622 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.3 tpp -46.91 -41.64 16.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.713 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.08 -25.45 19.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.477 ' HB2' HD21 ' A' ' 73' ' ' LEU . 70.5 mmm -114.21 -63.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.708 HG13 ' CD1' ' A' ' 81' ' ' TYR . 55.9 t -62.23 -58.87 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.041 HD23 HG22 ' A' ' 50' ' ' ILE . 3.1 mm? -44.38 -55.9 9.13 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.3 Cg_exo -68.5 5.11 1.36 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.305 2.003 . . . . 0.0 112.03 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -145.31 21.52 1.54 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.311 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.515 HG23 ' CD2' ' A' ' 81' ' ' TYR . 3.9 p -84.77 165.56 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.935 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 58' ' ' VAL . 16.2 m . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.986 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 106' ' ' ILE . 7.0 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.877 0.37 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.5 m -93.66 141.55 28.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 9.4 tttm -87.95 137.63 32.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.557 ' HE1' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -54.79 -25.97 31.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.709 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 t 53.93 25.5 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.374 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.626 ' HG2' HD12 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -118.23 1.9 11.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.177 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.71 78.6 0.21 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.087 0.47 . . . . 0.0 110.457 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.847 HD13 ' SG ' ' A' ' 79' ' ' CYS . 11.0 mp -74.51 -42.77 58.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.55 HD11 ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -138.1 155.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.719 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -96.74 139.74 32.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.29 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.18 -33.63 5.88 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.156 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.26 176.26 8.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.826 0.346 . . . . 0.0 111.03 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 42.6 m-20 -113.67 129.2 56.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.564 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.847 ' SG ' HD13 ' A' ' 73' ' ' LEU . 25.1 p -90.4 112.55 24.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.515 ' O ' HG13 ' A' ' 93' ' ' VAL . 44.8 m-85 -119.84 153.72 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.374 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.708 ' CD1' HG13 ' A' ' 54' ' ' VAL . 38.4 p90 -144.38 128.04 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.117 0.484 . . . . 0.0 111.645 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.7 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.8 t -133.71 121.76 22.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.667 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 19.4 p -80.94 153.49 27.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.978 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -49.13 151.52 1.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.97 -6.72 49.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.658 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.49 20.48 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -159.5 102.67 1.5 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 0.0 111.318 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.05 -13.35 39.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.394 2.062 . . . . 0.0 112.013 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -96.65 30.48 2.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 90' ' ' THR . 20.1 m -153.57 71.9 0.9 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.559 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -70.16 177.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.317 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.58 ' H ' HG12 ' A' ' 91' ' ' VAL . 95.7 m-85 -152.38 96.8 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.863 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.009 HG11 HG12 ' A' ' 50' ' ' ILE . 77.4 t -100.28 128.2 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 20.4 p -124.85 138.07 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.508 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 7.3 m-85 -106.0 89.41 3.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.737 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.849 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -89.17 124.51 34.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.157 -179.268 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.496 HD23 ' HD1' ' A' ' 77' ' ' PHE . 28.8 mt -42.53 135.36 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -46.26 -27.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.56 -22.03 64.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.7 mm -70.49 135.99 86.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.287 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.14 -164.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.305 2.004 . . . . 0.0 111.583 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -108.08 66.49 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.764 0.316 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.716 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 6.1 tp -164.67 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.744 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.8 tp -62.32 -62.8 5.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.652 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.849 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.2 Cg_endo -44.99 -31.74 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.502 2.135 . . . . 0.0 111.155 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.0 mp -73.18 -41.76 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.231 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.641 ' O ' HG21 ' A' ' 131' ' ' ILE . 1.9 mmt180 -76.77 -23.2 52.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.794 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.858 ' CG2' HG13 ' A' ' 128' ' ' VAL . 7.1 mm -70.11 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.235 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.544 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -61.8 -55.59 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.805 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -59.6 -25.5 64.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.525 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -72.59 -47.02 29.15 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.526 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.957 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.1 mt -55.88 -26.26 46.42 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -18.01 61.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.34 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.13 -23.97 63.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.606 ' CD1' ' CE1' ' A' ' 127' ' ' HIS . 2.4 m-85 -100.43 -166.48 1.33 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -124.79 -2.4 7.82 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.415 ' CB ' HD21 ' A' ' 123' ' ' LEU . 49.6 m -127.69 123.34 35.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.094 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.483 ' HA ' HD22 ' A' ' 123' ' ' LEU . 0.6 OUTLIER -171.5 38.05 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.765 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.462 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -114.2 36.19 3.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.323 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -147.82 152.14 37.16 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.366 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.487 ' HA ' ' N ' ' A' ' 20' ' ' SER . 66.4 m-20 -71.6 22.13 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.2 tm-20 -164.66 26.21 0.06 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.525 ' CB ' HG23 ' A' ' 120' ' ' THR . 6.9 tt -124.92 -56.73 1.55 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.97 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.46 -41.07 62.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.461 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 78.4 p -51.46 -31.42 23.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.34 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.14 -61.54 2.49 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.453 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.957 ' HB2' HD23 ' A' ' 112' ' ' LEU . 5.6 m-70 -59.15 -32.95 70.34 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.858 HG13 ' CG2' ' A' ' 108' ' ' ILE . 62.0 t -53.45 -45.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.92 27.42 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.803 -1.189 . . . . 0.0 111.574 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.7 -21.3 66.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.927 0.394 . . . . 0.0 110.601 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.641 HG21 ' O ' ' A' ' 107' ' ' ARG . 28.0 mt -90.11 -27.24 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.741 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.3 OUTLIER -61.38 -41.97 97.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.172 178.308 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -65.64 -39.32 91.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.85 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.78 -15.63 44.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.716 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 2.8 t80 . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.023 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.812 HG21 HG13 ' A' ' 108' ' ' ILE . 71.0 t . . . . . 0 CA--C 1.527 0.062 0 CA-C-O 120.812 0.339 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.441 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -63.81 -67.15 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.251 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.645 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 2.2 m-85 -150.02 121.57 7.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.452 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.699 HG22 HG11 ' A' ' 6' ' ' VAL . 2.1 t -107.57 95.59 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.303 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 3.0 tt0 -105.31 117.29 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.973 0.416 . . . . 0.0 111.626 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.903 HG23 HD13 ' A' ' 124' ' ' LEU . 11.9 t -83.18 155.09 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.556 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.681 HG21 HD11 ' A' ' 55' ' ' LEU . 3.2 mp -131.63 118.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.2 tptt -103.68 104.8 14.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.386 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 65.8 23.33 11.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.512 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . 76.38 38.88 32.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.549 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.72 18.19 1.82 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 60.08 150.17 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.008 179.04 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.54 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -139.59 -47.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.921 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.549 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -126.56 175.02 8.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.346 -179.059 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.483 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 11.6 p -170.48 121.55 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.592 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.2 t -108.58 71.0 0.77 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.645 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -106.15 83.08 1.84 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.904 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.195 -179.576 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.796 0.331 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.56 28.54 6.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -113.35 -35.75 5.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.715 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -54.41 124.58 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.102 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.904 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -86.97 149.65 48.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.562 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 Cg_exo -43.52 -23.28 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.679 2.253 . . . . 0.0 112.098 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.703 ' HB ' HG23 ' A' ' 42' ' ' THR . 3.5 t -66.88 -48.98 78.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.904 HD12 HG22 ' A' ' 42' ' ' THR . 2.3 mp -54.09 -36.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.715 ' CE1' HG22 ' A' ' 41' ' ' ILE . 66.8 m-85 -76.49 -43.11 41.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.35 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.675 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.91 -23.49 67.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.346 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -86.47 -33.54 20.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.679 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 73' ' ' LEU . 12.2 mt -58.78 -63.36 1.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.063 HG12 HG11 ' A' ' 93' ' ' VAL . 3.9 mt -49.39 -58.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.044 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.675 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -53.79 -56.78 14.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.345 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -9.71 44.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.646 ' HB3' HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -117.47 -62.14 1.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 81' ' ' TYR . 59.3 t -68.0 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 111.914 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD2' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -43.04 -51.48 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 24.6 Cg_endo -63.18 -1.63 3.12 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.809 1.672 . . . . 0.0 112.344 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HB3' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -147.86 23.11 1.1 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.05 0.452 . . . . 0.0 109.993 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 81' ' ' TYR . 2.8 p -76.37 155.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.402 HG22 ' HE2' ' A' ' 81' ' ' TYR . 33.0 m . . . . . 0 C--N 1.318 -0.797 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.107 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.873 ' N ' ' HG ' ' A' ' 82' ' ' SER . 2.8 t . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.805 0.336 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -86.04 134.08 33.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.016 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 4.5 ttpp -85.03 130.06 34.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.827 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.619 ' HG2' HD11 ' A' ' 73' ' ' LEU . 6.7 tpt -50.79 -27.48 7.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.412 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.38 28.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 110.74 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.424 ' O ' ' HG3' ' A' ' 71' ' ' MET . 4.0 tpp -109.95 -12.31 14.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.987 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 63.51 61.79 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.463 . . . . 0.0 109.786 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 49' ' ' LEU . 9.5 mp -66.13 -45.23 81.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.03 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.625 HD11 ' CG2' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -132.71 159.7 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.029 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.431 ' N ' HG23 ' A' ' 74' ' ' ILE . 7.7 t70 -101.97 142.03 33.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.397 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.68 -35.59 4.91 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.842 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -133.38 175.25 9.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.788 0.328 . . . . 0.0 110.819 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 40.8 m-20 -113.11 152.58 29.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.508 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 4.9 t -111.65 116.06 30.16 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 85.5 m-85 -123.28 144.57 49.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.248 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CD1' HG13 ' A' ' 54' ' ' VAL . 39.1 p90 -135.17 125.01 25.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 111.533 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.873 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.5 t -129.21 121.06 26.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.668 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.632 HG22 HG13 ' A' ' 91' ' ' VAL . 8.4 p -82.18 150.75 27.23 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.699 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -46.51 149.65 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.984 0.421 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.56 -17.45 46.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.981 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 22.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -146.1 94.55 4.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.72 -15.09 46.74 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.166 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -96.0 26.32 4.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.072 0.463 . . . . 0.0 110.268 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.531 ' O ' HG22 ' A' ' 90' ' ' THR . 38.0 m -150.7 69.5 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -69.06 178.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.14 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.537 ' H ' HG12 ' A' ' 91' ' ' VAL . 96.2 m-85 -153.16 91.6 1.54 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.446 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.063 HG11 HG12 ' A' ' 50' ' ' ILE . 35.4 t -91.43 125.17 44.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.066 0.46 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.431 ' SG ' HG11 ' A' ' 6' ' ' VAL . 44.3 t -120.44 126.12 49.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.29 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m-85 -99.06 116.86 32.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.372 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.956 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -119.9 132.86 55.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.085 0.469 . . . . 0.0 111.636 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.428 HD23 ' HD2' ' A' ' 77' ' ' PHE . 31.3 mt -49.91 125.59 12.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.036 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -43.73 -31.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.71 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.37 -35.14 78.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.78 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.499 HG23 ' HD2' ' A' ' 101' ' ' PRO . 40.5 mt -74.18 138.25 75.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.9 Cg_endo -57.9 -169.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.468 2.112 . . . . 0.0 112.273 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -109.03 67.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.693 HG23 ' CE2' ' A' ' 135' ' ' PHE . 1.1 tp -153.27 -38.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.441 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.803 ' HG ' HD11 ' A' ' 108' ' ' ILE . 25.1 tp -59.33 -57.17 29.02 Favored Pre-proline 0 C--N 1.331 -0.204 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.901 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.956 ' HD3' HG21 ' A' ' 96' ' ' THR . 7.5 Cg_endo -49.9 -37.45 46.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.422 2.081 . . . . 0.0 111.039 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.833 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.9 mp -67.0 -32.4 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.815 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.609 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.73 -26.62 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.594 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.812 HG13 HG21 ' A' ' 6' ' ' VAL . 5.9 mm -66.92 -47.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.372 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -73.77 -58.2 3.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 t -56.46 -30.57 63.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -76.25 -43.3 21.13 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.0 mt -57.85 -31.51 66.74 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.67 -14.73 59.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.94 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.25 -21.31 56.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.451 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 5.1 m-85 -88.58 -97.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.999 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 34.6 tp10 159.04 -22.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.672 0.389 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.588 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 5.9 t -121.75 99.75 6.63 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.28 0.562 . . . . 0.0 111.243 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -152.34 45.43 0.73 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.21 33.89 4.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.55 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -144.11 157.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.236 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.483 ' HA ' ' N ' ' A' ' 20' ' ' SER . 78.7 m-20 -74.62 17.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.689 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.8 OUTLIER -163.67 29.03 0.08 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 123' ' ' LEU . 5.9 tt -131.04 -45.82 1.02 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.575 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.903 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -59.78 -43.04 94.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.631 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.7 p -46.65 -27.15 1.07 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.64 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.06 -56.79 17.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.295 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.722 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.6 m-70 -60.87 -36.5 79.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.636 HG13 ' CG2' ' A' ' 108' ' ' ILE . 46.0 t -52.06 -44.09 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.889 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.97 -47.05 12.03 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -64.94 -21.13 66.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 127' ' ' HIS . 60.7 mt -90.5 -28.09 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.68 HD11 HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -66.93 -35.07 79.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.351 178.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -69.57 -38.89 77.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.762 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.0 t -84.08 -13.62 52.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.984 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.693 ' CE2' HG23 ' A' ' 103' ' ' ILE . 13.2 t80 . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.996 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.815 HG13 HG23 ' A' ' 96' ' ' THR . 3.4 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.926 0.393 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -39.18 -59.42 1.02 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.239 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.678 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 7.6 m-85 -148.68 113.12 5.3 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.861 HG13 ' SG ' ' A' ' 94' ' ' CYS . 2.8 t -107.12 100.75 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.412 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.677 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.0 OUTLIER -111.36 128.89 56.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.105 0.478 . . . . 0.0 111.769 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.886 HG23 HD13 ' A' ' 124' ' ' LEU . 53.1 t -98.1 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.536 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.967 HD11 HG21 ' A' ' 50' ' ' ILE . 2.7 mp -117.24 118.32 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.684 ' HB2' HD13 ' A' ' 18' ' ' ILE . 7.0 tptt -99.72 102.24 13.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.419 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 62.01 39.75 12.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.562 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.4 60.77 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.827 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -145.12 113.75 6.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 0.0 110.102 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.677 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -50.24 126.78 15.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.715 -179.241 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.684 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.7 OUTLIER -105.01 -50.45 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.415 179.129 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 120' ' ' THR . 63.9 p -119.26 172.43 7.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.266 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.548 ' N ' HD22 ' A' ' 124' ' ' LEU . 6.5 m -168.28 133.47 1.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 112.054 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 36.0 t -116.88 69.42 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.678 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -104.62 96.58 6.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.298 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.524 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 2.9 m120 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -134.26 27.3 3.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.094 0.473 . . . . 0.0 110.971 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -118.42 -28.91 5.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.455 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.672 HG22 ' CE2' ' A' ' 46' ' ' PHE . 3.7 mm -55.98 125.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.934 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.959 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -85.44 149.54 52.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.512 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 2.2 Cg_endo -44.87 -22.04 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.354 2.036 . . . . 0.0 111.583 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.761 ' HB ' HG23 ' A' ' 42' ' ' THR . 93.6 t -66.9 -45.73 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.11 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.959 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -59.62 -34.55 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.672 ' CE2' HG22 ' A' ' 41' ' ' ILE . 39.1 m-85 -79.41 -42.87 24.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.316 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.659 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.54 -30.51 71.62 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.657 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 25.8 p30 -89.51 -26.04 21.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.622 HD22 HD23 ' A' ' 73' ' ' LEU . 3.6 mt -64.54 -61.16 2.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 1.016 HG12 HG11 ' A' ' 93' ' ' VAL . 6.4 mt -49.53 -62.93 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.493 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.659 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.21 -43.0 61.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.173 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -90.84 -15.16 30.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.579 ' HB2' HD21 ' A' ' 73' ' ' LEU . 90.9 mmm -123.76 -70.49 0.76 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.855 HG13 ' CD2' ' A' ' 81' ' ' TYR . 88.6 t -51.39 -50.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.889 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.948 HD23 HG22 ' A' ' 50' ' ' ILE . 3.0 mm? -56.18 -58.9 13.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.032 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 23.5 Cg_endo -62.31 4.71 0.3 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.285 1.99 . . . . 0.0 113.12 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 1.6 tptp -153.25 26.98 0.52 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG21 HG11 ' A' ' 91' ' ' VAL . 7.7 p -82.22 150.67 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.161 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' A' ' 81' ' ' TYR . 9.0 t . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.399 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.903 HG13 HD23 ' A' ' 109' ' ' LEU . 3.6 t . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -97.25 138.57 34.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.469 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 1.3 ttpm? -82.52 132.39 35.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.287 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.483 ' HG2' ' CB ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -53.83 -29.82 42.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.034 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.76 27.96 11.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.212 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.483 ' CB ' ' HG2' ' A' ' 69' ' ' MET . 6.1 tpt -106.97 -15.55 14.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.207 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 65.04 59.84 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.622 HD23 HD22 ' A' ' 49' ' ' LEU . 8.0 mp -62.91 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.445 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.505 HG21 ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -135.5 155.08 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.504 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -99.71 138.62 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.517 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 113.24 -32.32 6.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.532 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.687 ' O ' HG13 ' A' ' 98' ' ' VAL . 1.7 m-85 -118.21 -168.13 1.47 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.485 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -136.11 118.76 16.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.13 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 p -87.64 108.42 19.08 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 53.8 m-85 -121.55 151.1 40.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.896 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.855 ' CD2' HG13 ' A' ' 54' ' ' VAL . 11.9 p90 -144.52 139.61 28.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.09 0.472 . . . . 0.0 111.974 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -142.3 124.38 15.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.563 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 1.032 HG22 HG13 ' A' ' 91' ' ' VAL . 45.0 p -90.01 152.77 21.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.456 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -46.85 162.3 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 0.0 111.167 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -70.89 -22.91 62.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.682 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 22.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.93 91.48 10.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.26 . . . . 0.0 110.763 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.57 -14.23 38.4 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.378 2.052 . . . . 0.0 112.045 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 29.72 1.86 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 90' ' ' THR . 18.0 m -156.85 71.78 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.524 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.032 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -81.26 173.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.935 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.628 ' HD2' HG13 ' A' ' 11' ' ' VAL . 14.1 m-85 -141.72 153.17 44.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.213 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.016 HG11 HG12 ' A' ' 50' ' ' ILE . 14.6 t -152.63 122.18 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.977 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' CYS . . . . . 0.861 ' SG ' HG13 ' A' ' 9' ' ' VAL . 13.9 m -112.41 114.14 26.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 111.824 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 46' ' ' PHE . 1.3 m-85 -90.15 71.53 7.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.751 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.864 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.37 -176.38 1.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.933 0.397 . . . . 0.0 111.489 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.41 127.87 43.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.321 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -43.64 -33.69 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.534 -179.279 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -38.88 92.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.552 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 101' ' ' PRO . 62.6 mt -66.93 138.34 95.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.902 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.7 Cg_endo -59.94 -168.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.516 2.144 . . . . 0.0 112.348 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -108.69 67.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.535 ' CA ' HD13 ' A' ' 106' ' ' ILE . 2.7 tp -154.54 -38.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.845 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.804 HD21 HG22 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -57.06 -64.98 1.97 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.02 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.864 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.6 Cg_endo -47.34 -31.17 12.42 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.565 2.177 . . . . 0.0 111.492 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.759 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 mp -68.91 -34.46 64.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.819 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.509 ' O ' HG21 ' A' ' 131' ' ' ILE . 14.0 mmp_? -84.85 -22.64 29.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.345 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.752 ' CG2' HG13 ' A' ' 128' ' ' VAL . 21.0 mm -70.1 -45.18 77.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.148 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.903 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -76.34 -50.13 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.855 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.5 t -61.95 -30.63 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.481 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -75.48 -47.2 12.9 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 127' ' ' HIS . 12.8 mt -56.58 -30.47 63.23 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -79.0 -16.72 56.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.196 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -25.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.75 0.31 . . . . 0.0 110.38 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.625 ' CG ' ' CD2' ' A' ' 127' ' ' HIS . 5.2 m-85 -82.33 -91.86 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.2 pt-20 160.56 -28.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.414 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.416 ' CB ' HD21 ' A' ' 123' ' ' LEU . 19.5 m -111.89 129.54 56.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.517 0.675 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.456 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -172.3 35.19 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.039 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.86 33.28 4.32 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.536 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -145.62 148.06 32.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.469 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 20' ' ' SER . 72.0 m-20 -69.73 22.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.526 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.2 tp10 -162.87 25.24 0.09 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.536 ' CB ' HG23 ' A' ' 120' ' ' THR . 7.7 tt -123.76 -57.22 1.64 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.614 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.886 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.5 -42.1 63.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.181 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.53 ' H ' HD23 ' A' ' 124' ' ' LEU . 83.4 p -52.1 -28.68 18.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.243 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.21 -61.72 2.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.227 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.829 ' HB2' HD23 ' A' ' 112' ' ' LEU . 2.4 m-70 -59.88 -31.56 69.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 124' ' ' LEU . 56.2 t -56.54 -42.38 75.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.45 15.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.876 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.97 -21.4 65.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 127' ' ' HIS . 59.4 mt -90.02 -28.07 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.667 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -62.86 -43.67 98.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.366 178.58 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -35.38 80.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.7 t -83.8 -20.84 32.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.079 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.531 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 1.5 t80 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.97 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.5 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.13 85.17 2.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.816 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.02 -173.36 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.813 ' HB3' HD13 ' A' ' 104' ' ' LEU . 38.1 m-85 -122.85 169.64 10.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.875 ' HA ' HD21 ' A' ' 132' ' ' LEU . 58.3 t-20 -177.49 112.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.374 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 104' ' ' LEU . 4.2 t -77.74 99.74 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.021 0.439 . . . . 0.0 110.028 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.5 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -40.46 -51.26 2.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.719 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.615 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 14.3 m-85 -148.8 120.08 7.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.851 0.357 . . . . 0.0 111.464 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.771 HG21 HG11 ' A' ' 128' ' ' VAL . 1.5 t -110.0 95.28 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.979 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 0.5 OUTLIER -100.54 111.37 23.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.743 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.983 ' CG2' HD13 ' A' ' 124' ' ' LEU . 38.7 t -81.97 160.19 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 50' ' ' ILE . 2.5 mt -140.7 127.05 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.561 ' HB2' HD13 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -118.96 111.77 18.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 2.7 m120 64.04 34.75 11.07 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.991 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.48 26.14 61.84 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.544 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -148.27 120.05 8.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 11' ' ' VAL . 3.1 m -48.38 125.45 9.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.238 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -99.57 -45.46 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.738 0.78 . . . . 0.0 109.512 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.928 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.66 175.37 7.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.9 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.444 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 20.4 m -170.59 134.63 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HB3' HG23 ' A' ' 9' ' ' VAL . 33.2 t -123.45 69.34 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.2 m-85 -107.23 100.18 9.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.165 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.4 pm0 -141.58 124.31 9.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.428 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.17 -179.91 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.355 2.037 . . . . 0.0 111.718 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.486 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -172.29 -34.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 11.4 mt-30 63.93 56.46 1.45 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.891 0.377 . . . . 0.0 110.167 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER 32.11 78.66 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.035 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -73.99 -70.17 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.999 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -153.04 32.41 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.662 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -116.32 -70.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.015 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CD2' HD13 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -149.93 131.49 14.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 27' ' ' LYS . . . -73.21 114.32 4.67 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.043 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.522 ' CG2' HD22 ' A' ' 97' ' ' LEU . 86.8 m -165.34 -76.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.725 0.297 . . . . 0.0 110.982 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.538 ' O ' ' HB ' ' A' ' 35' ' ' THR . 7.7 mt -74.44 147.83 8.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.154 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 171.37 -31.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.182 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.17 -51.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.41 24.88 3.21 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.491 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.8 m-80 -156.58 30.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 0.0 111.291 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.73 25.71 4.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.08 0.467 . . . . 0.0 110.864 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -110.24 -34.86 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.667 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.659 HG23 HG13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -55.6 133.62 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.918 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.606 HG23 ' HB ' ' A' ' 44' ' ' VAL . 5.1 t -92.55 150.88 40.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.85 -24.27 4.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.946 1.764 . . . . 0.0 111.072 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.606 ' HB ' HG23 ' A' ' 42' ' ' THR . 90.4 t -66.95 -35.95 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.681 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.659 HG13 HG23 ' A' ' 41' ' ' ILE . 13.4 mm -63.0 -42.63 97.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.627 ' CE1' HG22 ' A' ' 41' ' ' ILE . 18.3 m-85 -77.14 -38.3 52.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.144 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.613 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -65.73 -31.53 72.58 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.032 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.94 -29.1 22.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.2 mt -61.24 -60.15 4.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.071 HG12 HG11 ' A' ' 93' ' ' VAL . 7.0 mt -50.2 -63.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.847 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.0 OUTLIER -53.66 -37.35 63.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.81 -1.541 . . . . 0.0 113.116 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.11 -23.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.477 ' O ' ' HE1' ' A' ' 69' ' ' MET . 74.7 mmm -117.03 -57.18 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.969 HG22 ' HG3' ' A' ' 69' ' ' MET . 52.9 t -63.45 -63.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.887 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.955 HD23 HG22 ' A' ' 50' ' ' ILE . 3.0 mm? -44.43 -53.43 14.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.5 Cg_exo -68.53 4.62 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.231 1.954 . . . . 0.0 112.412 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -150.32 25.26 0.8 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.006 0.432 . . . . 0.0 110.578 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 59' ' ' VAL . 4.3 p -87.03 166.05 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 58' ' ' VAL . 28.9 m -145.21 149.46 41.66 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.328 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 61' ' ' ILE . 72.9 Cg_endo -80.66 25.84 0.61 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.27 1.98 . . . . 0.0 112.868 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 60' ' ' PRO . 1.6 mp 52.32 131.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.665 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -114.52 -23.58 9.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.613 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.67 38.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.066 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.466 ' H ' HG23 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -130.07 -61.58 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 111.221 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' H ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER 72.51 121.14 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.785 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 106' ' ' ILE . 4.6 t 58.92 71.27 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.658 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.498 HG22 ' CE1' ' A' ' 81' ' ' TYR . 2.5 t -102.61 139.19 38.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.848 0.356 . . . . 0.0 111.279 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -79.38 135.47 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.51 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.969 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -51.53 -29.02 15.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 53.12 25.42 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.0 tpp -110.31 -5.0 15.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.737 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 59.05 56.87 3.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.85 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.5 mp -53.22 -48.02 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.544 HG13 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -142.74 162.23 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.41 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.2 t70 -104.5 137.49 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.185 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 115.84 -32.96 5.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.244 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -132.9 162.56 31.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.197 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 52.8 m-20 -103.46 133.77 47.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.853 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.491 ' SG ' HD13 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -119.05 121.84 40.76 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -126.82 164.87 20.43 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.716 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CD2' HG13 ' A' ' 54' ' ' VAL . 19.5 p90 -138.74 129.06 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.381 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.483 ' HA ' HD11 ' A' ' 61' ' ' ILE . 5.0 t -129.94 112.4 13.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.594 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 33.0 p -74.32 156.8 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.939 0.4 . . . . 0.0 111.176 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -52.84 153.3 3.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.61 -9.14 57.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.71 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.28 23.14 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.69 87.28 4.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.772 0.32 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.17 -20.25 18.66 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.637 2.224 . . . . 0.0 112.577 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -93.79 29.57 2.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 52.7 m -149.85 73.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.342 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -75.01 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.724 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.542 ' H ' HG12 ' A' ' 91' ' ' VAL . 39.3 m-85 -144.52 93.55 2.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.071 HG11 HG12 ' A' ' 50' ' ' ILE . 41.0 t -98.44 127.62 50.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.53 . . . . 0.0 111.622 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 7.4 p -110.1 152.9 25.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 8' ' ' TYR . 1.4 m-85 -130.91 74.59 1.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.686 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.611 HG21 ' HD3' ' A' ' 105' ' ' PRO . 58.7 p -75.08 -169.52 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.522 HD22 ' CG2' ' A' ' 33' ' ' THR . 24.1 mt -102.43 137.01 41.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.536 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.04 -30.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.806 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.439 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 3.7 m-20 -69.12 -33.34 73.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.021 0.439 . . . . 0.0 110.57 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.528 HG23 ' CD1' ' A' ' 4' ' ' PHE . 1.2 mm -67.51 127.12 93.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.968 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.411 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 19.1 Cg_endo -59.75 -168.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -106.65 66.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.647 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.617 ' CA ' HD13 ' A' ' 106' ' ' ILE . 2.9 tp -151.14 -36.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.813 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.813 HD13 ' HB3' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -64.03 -63.27 4.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.611 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.5 Cg_endo -44.95 -29.27 3.61 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.657 2.238 . . . . 0.0 111.331 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.804 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.1 mp -69.63 -45.17 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.746 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.483 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -76.43 -22.44 54.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.602 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.777 ' CD1' HD12 ' A' ' 132' ' ' LEU . 33.7 mm -67.11 -59.4 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.603 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.09 -56.64 15.16 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 p -57.06 -25.4 58.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.54 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -75.32 -45.37 19.3 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.497 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.939 HD23 ' HB2' ' A' ' 127' ' ' HIS . 18.5 mt -56.6 -28.11 59.63 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.71 -15.9 61.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.279 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.19 -27.26 64.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.588 ' CD1' ' CE1' ' A' ' 127' ' ' HIS . 4.6 m-85 -98.73 -167.97 1.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.496 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -121.53 -0.63 9.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.73 ' HB2' HD21 ' A' ' 123' ' ' LEU . 1.4 m -125.1 137.53 54.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.756 0.789 . . . . 0.0 111.108 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.567 ' N ' HD22 ' A' ' 123' ' ' LEU . 19.6 p30 174.02 35.92 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.164 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.12 34.07 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.516 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -146.12 155.52 42.8 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.98 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.444 ' HA ' ' N ' ' A' ' 20' ' ' SER . 15.7 m-80 -75.78 24.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -165.09 25.9 0.06 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.73 HD21 ' HB2' ' A' ' 117' ' ' SER . 6.5 tt -123.75 -56.73 1.67 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.871 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.983 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.78 -41.39 64.05 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.02 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.477 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 85.3 p -50.33 -28.45 7.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.215 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.07 -64.22 0.97 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.224 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.939 ' HB2' HD23 ' A' ' 112' ' ' LEU . 6.2 m-70 -59.57 -30.98 69.02 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.987 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 124' ' ' LEU . 48.0 t -57.15 -42.69 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.99 -38.5 22.77 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.764 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -22.82 63.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.388 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.54 HD13 ' HA3' ' A' ' 111' ' ' GLY . 46.9 mt -90.19 -27.09 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.875 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.5 OUTLIER -62.33 -49.0 77.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.524 178.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -44.96 83.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.8 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 m -70.83 -19.04 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.8 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.578 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 54.7 t80 -55.84 -59.41 4.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.206 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.545 ' HA ' HD12 ' A' ' 139' ' ' LEU . 1.2 t-80 -52.8 -46.21 67.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.148 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -49.91 -31.45 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.908 0.385 . . . . 0.0 110.228 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -77.82 -36.31 50.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.907 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.55 HD11 ' CE2' ' A' ' 135' ' ' PHE . 27.1 mt -64.25 -32.74 74.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.198 0.523 . . . . 0.0 109.687 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.2 t -75.98 -47.37 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.055 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -32.15 71.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.948 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -23.28 66.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.596 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.728 HH11 HD13 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -90.9 48.19 1.5 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.972 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -176.49 36.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.82 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.2 -33.69 9.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 t -160.28 38.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.728 HD13 HH11 ' A' ' 143' ' ' ARG . 3.0 mt -108.48 163.59 13.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -75.31 -66.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.922 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.814 0.34 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.48 148.69 48.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.54 170.12 14.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' CD2' HG12 ' A' ' 100' ' ' ILE . 53.8 m-85 -140.98 -173.55 3.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.418 ' HA ' HD21 ' A' ' 132' ' ' LEU . 2.1 t-20 -174.38 107.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.728 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.836 HG11 HG22 ' A' ' 9' ' ' VAL . 3.5 t -60.98 127.91 21.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.715 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -61.71 -59.83 4.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.237 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.677 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 2.8 m-85 -144.14 109.25 5.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.836 HG22 HG11 ' A' ' 6' ' ' VAL . 4.1 t -108.08 100.7 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.801 0.334 . . . . 0.0 111.356 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.488 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 2.2 mt-10 -111.24 120.13 41.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.059 HG23 HD13 ' A' ' 124' ' ' LEU . 46.7 t -79.86 156.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 50' ' ' ILE . 3.8 mt -133.98 111.28 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 15.7 tptt -91.16 99.74 12.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 58.35 41.04 23.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 12' ' ' ILE . . . 81.1 23.34 59.36 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.607 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -140.27 109.39 6.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -45.12 128.9 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.23 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.474 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -110.24 -45.85 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -123.07 172.86 8.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.511 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.49 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.3 m -167.48 126.92 1.37 Allowed 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 20.1 t -116.93 69.34 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.55 92.73 4.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.107 -178.174 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.402 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 6.2 mp0 -142.9 139.44 16.95 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.399 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.94 169.86 21.15 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.483 2.122 . . . . 0.0 111.626 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.496 ' HE1' HD11 ' A' ' 97' ' ' LEU . 3.0 p90 -175.08 9.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 13.0 pm0 35.16 97.47 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -44.87 -40.99 6.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.466 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 57.12 -83.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.971 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -122.12 -165.17 1.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.697 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 1.9 m-80 62.76 -81.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.135 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.404 ' CG ' ' O ' ' A' ' 30' ' ' ASN . 3.5 m-85 -169.71 153.88 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.352 . . . . 0.0 111.083 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.763 ' CA ' HD13 ' A' ' 97' ' ' LEU . . . 138.22 -162.55 25.69 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.608 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.502 ' N ' HD22 ' A' ' 97' ' ' LEU . 10.7 m -152.8 -44.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.905 0.383 . . . . 0.0 111.259 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 11.7 mt -47.58 153.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.322 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER 172.54 -33.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.404 ' CA ' ' HG3' ' A' ' 39' ' ' GLU . 0.2 OUTLIER 178.82 -40.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.86 0.362 . . . . 0.0 111.418 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.8 -25.01 52.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.523 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -113.82 38.54 2.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.137 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.404 ' HG3' ' CA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -131.32 26.08 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 110.859 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.61 -37.31 6.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.599 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.718 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -52.59 123.02 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.564 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.921 HG22 HD12 ' A' ' 45' ' ' ILE . 10.9 t -83.55 150.6 60.24 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.642 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 86.0 Cg_exo -45.75 -22.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.259 1.973 . . . . 0.0 111.908 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.739 ' HB ' HG23 ' A' ' 42' ' ' THR . 36.6 t -68.62 -41.07 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.103 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 42' ' ' THR . 1.6 mp -60.4 -34.57 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.718 ' CE1' HG22 ' A' ' 41' ' ' ILE . 56.0 m-85 -81.17 -42.37 20.95 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.995 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.19 -30.48 71.1 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.684 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 27.4 p30 -90.24 -26.43 20.07 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.718 HD11 HG13 ' A' ' 74' ' ' ILE . 3.1 mt -63.15 -60.24 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.043 HG12 HG11 ' A' ' 93' ' ' VAL . 5.0 mt -52.14 -63.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.893 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -52.76 -41.46 64.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.356 -179.04 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.2 t0 -90.73 -20.27 22.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.463 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 77.8 mmm -119.39 -60.93 1.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 81' ' ' TYR . 59.3 t -61.58 -56.02 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.934 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -50.44 -54.63 32.9 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.0 Cg_exo -62.89 -0.04 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.151 1.901 . . . . 0.0 112.78 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.548 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 1.2 tppt? -149.86 27.75 0.78 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 HG11 ' A' ' 91' ' ' VAL . 2.6 p -86.29 157.0 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.982 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.484 HG22 ' HE1' ' A' ' 81' ' ' TYR . 35.2 m -143.86 150.24 49.13 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.198 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 61' ' ' ILE . 93.7 Cg_endo -83.67 25.04 0.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.129 1.886 . . . . 0.0 113.294 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 82' ' ' SER . 2.5 mp 51.6 163.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.748 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.477 ' N ' HG22 ' A' ' 61' ' ' ILE . 2.7 mmtt -59.03 -22.56 60.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.069 0.461 . . . . 0.0 110.082 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.4 52.82 0.2 Allowed Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.589 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.692 ' HA ' HD13 ' A' ' 61' ' ' ILE . 2.8 p30 44.22 76.36 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.742 0.306 . . . . 0.0 111.124 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' H ' HG21 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -131.09 29.42 4.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.852 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.754 HG21 ' HA ' ' A' ' 106' ' ' ILE . 25.3 t 58.64 105.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.698 0.285 . . . . 0.0 110.95 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 83.9 m -112.65 127.23 56.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -80.69 144.83 31.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.416 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.548 ' HE3' ' HB3' ' A' ' 57' ' ' LYS . 49.2 tpp -71.63 -35.39 70.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.977 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m 61.21 29.84 18.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.47 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 2.8 tpt -110.97 -12.48 14.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 62.79 63.49 0.97 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.001 0.429 . . . . 0.0 110.427 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.61 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.2 mp -62.2 -48.42 80.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.45 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -131.15 151.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -93.48 140.67 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.592 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.97 -34.33 5.5 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.166 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.589 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -120.92 -167.36 1.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.923 0.392 . . . . 0.0 111.208 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -137.65 128.89 27.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.38 105.98 17.99 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 51.1 m-85 -115.93 123.99 49.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.851 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.786 ' CD2' HG13 ' A' ' 54' ' ' VAL . 13.3 p90 -115.85 132.48 56.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.347 0.594 . . . . 0.0 112.133 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.702 ' HA ' HD11 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -133.7 129.26 36.5 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.175 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.848 HG22 HG13 ' A' ' 91' ' ' VAL . 10.9 p -93.76 153.43 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.895 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -45.29 148.57 0.61 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -21.28 24.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.834 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.87 23.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.05 91.29 8.97 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.688 0.28 . . . . 0.0 110.842 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.88 -15.39 42.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.455 2.103 . . . . 0.0 112.145 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -96.36 29.42 2.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.092 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' THR . 52.3 m -153.19 68.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.709 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.848 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -67.94 -178.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.174 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.503 ' H ' HG12 ' A' ' 91' ' ' VAL . 91.8 m-85 -157.14 99.67 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.043 HG11 HG12 ' A' ' 50' ' ' ILE . 15.0 t -104.83 118.84 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.047 0.451 . . . . 0.0 111.52 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.503 ' SG ' HD22 ' A' ' 109' ' ' LEU . 32.0 p -112.02 131.03 55.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.873 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.5 m-85 -102.16 91.02 4.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.928 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.901 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -88.05 176.41 7.31 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.445 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.763 HD13 ' CA ' ' A' ' 32' ' ' GLY . 7.4 mt -90.58 128.85 36.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.849 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.0 -33.46 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.663 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 110.593 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 101' ' ' PRO . 64.1 mt -76.15 138.08 68.58 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.2 Cg_endo -59.3 167.74 5.75 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.406 2.071 . . . . 0.0 112.128 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.483 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -87.6 58.08 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.792 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.67 HG23 ' HE1' ' A' ' 135' ' ' PHE . 4.2 tp -141.09 -37.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.625 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.695 ' HG ' HD11 ' A' ' 108' ' ' ILE . 16.1 tp -61.54 -59.8 12.37 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.901 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.3 Cg_endo -47.76 -33.54 19.34 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.494 2.129 . . . . 0.0 110.908 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.754 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.2 mp -67.96 -38.97 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.822 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.59 ' O ' HG21 ' A' ' 131' ' ' ILE . 6.6 mtt-85 -76.36 -29.78 57.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.424 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.695 HD11 ' HG ' ' A' ' 104' ' ' LEU . 9.4 mm -61.63 -51.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.601 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -69.24 -61.66 1.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.412 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 48.2 t -56.0 -24.48 39.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.498 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -80.06 -43.01 10.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -59.19 -35.08 72.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 3.9 pt20 -77.97 -9.92 59.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.728 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.39 -23.02 46.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.621 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 3.5 m-85 -87.16 -96.31 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.064 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 160.81 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.549 0.34 . . . . 0.0 110.817 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.609 ' O ' ' CD2' ' A' ' 123' ' ' LEU . 53.6 m -117.55 96.23 5.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.263 0.554 . . . . 0.0 111.195 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 2.6 p-10 -151.27 46.35 0.82 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.713 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.97 33.81 4.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.493 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -145.7 161.99 38.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.158 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.49 ' HA ' ' N ' ' A' ' 20' ' ' SER . 8.4 p30 -78.74 24.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.639 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -170.15 28.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 117' ' ' SER . 5.8 tt -132.43 -45.67 0.9 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.059 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -59.46 -42.44 91.99 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 82.7 p -48.58 -28.03 3.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.152 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -56.99 -59.04 5.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.829 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.8 m-70 -60.04 -33.67 72.34 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.532 ' O ' HD13 ' A' ' 132' ' ' LEU . 48.4 t -53.31 -43.04 49.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.961 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.91 -44.67 18.66 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 119.928 -1.13 . . . . 0.0 112.629 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -69.07 -21.02 64.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 111.059 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 127' ' ' HIS . 55.6 mt -90.47 -27.86 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.684 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -63.76 -48.19 77.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.153 178.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.88 -40.71 95.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -86.29 4.42 39.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.316 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.67 ' HE1' HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -78.35 -44.52 24.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.71 0.291 . . . . 0.0 110.599 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.508 ' HA ' HD12 ' A' ' 139' ' ' LEU . 21.8 p80 -72.82 -38.32 67.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.778 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 1.7 mm-40 -51.6 -31.46 25.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.945 0.402 . . . . 0.0 110.101 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -75.52 -35.88 60.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.859 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.525 HD21 HG12 ' A' ' 103' ' ' ILE . 27.3 mt -65.24 -33.26 75.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.79 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.7 t -76.02 -48.11 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.103 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.45 -32.47 72.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.966 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -26.43 67.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.531 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -84.83 55.57 3.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -178.07 37.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -112.59 -34.42 5.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.974 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -172.5 81.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.791 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 51.4 mt -141.2 -64.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -63.56 -31.61 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.946 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mmm . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.797 0.332 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -159.62 119.79 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 133.93 52.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 100' ' ' ILE . 19.8 m-85 -113.86 127.09 55.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.782 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.921 ' HA ' HD21 ' A' ' 132' ' ' LEU . 0.7 OUTLIER -138.53 124.47 20.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.349 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.898 HG11 HG22 ' A' ' 9' ' ' VAL . 27.8 t -65.0 154.24 7.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.245 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.406 ' N ' HG12 ' A' ' 6' ' ' VAL . 1.5 m -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.709 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 15.8 m-85 -139.98 107.01 5.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.898 HG22 HG11 ' A' ' 6' ' ' VAL . 1.9 t -116.1 99.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.105 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 28.1 tt0 -108.1 123.15 48.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.393 . . . . 0.0 111.809 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.87 ' CG2' HD13 ' A' ' 124' ' ' LEU . 11.0 t -85.73 138.06 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.933 HD13 HG23 ' A' ' 93' ' ' VAL . 1.4 mp -113.56 114.79 47.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 2.0 tppt? -97.36 104.93 16.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.632 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.06 26.91 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.298 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.684 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 77.7 34.55 38.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.911 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.47 17.93 2.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 58.69 155.97 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.346 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.54 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -145.49 -50.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.632 178.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.775 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -123.94 176.32 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.969 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -170.06 129.0 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.457 . . . . 0.0 111.349 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.9 t -116.46 69.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.872 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.709 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 3.0 m-85 -106.41 86.51 2.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.878 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -126.9 147.66 62.25 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.934 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.85 -179.14 4.89 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.746 2.297 . . . . 0.0 111.628 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.474 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 2.0 p90 172.36 -24.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.479 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 34.8 mt-30 65.8 140.08 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.321 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -53.56 -41.86 66.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.522 -179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.4 t30 74.51 -61.81 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.634 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -177.41 -37.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -68.04 -81.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.452 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 5' ' ' ASN . 17.4 p90 -89.26 110.33 21.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 33' ' ' THR . . . -86.15 124.04 6.71 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.715 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.846 ' CB ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER 174.71 -82.73 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.742 0.306 . . . . 0.0 111.09 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.574 ' O ' ' HB ' ' A' ' 35' ' ' THR . 10.5 mt -78.51 146.11 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.755 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 169.27 -31.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.482 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -172.94 -40.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.211 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.8 -35.02 51.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.273 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.9 31.44 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -123.55 28.28 7.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -110.91 -37.9 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.728 HG23 HG13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -51.74 134.73 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.66 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.564 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.9 t -94.79 151.15 38.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 72.1 Cg_exo -47.17 -26.7 5.61 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.88 1.72 . . . . 0.0 110.8 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.564 ' HB ' HG23 ' A' ' 42' ' ' THR . 57.4 t -61.89 -40.62 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.581 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.728 HG13 HG23 ' A' ' 41' ' ' ILE . 16.8 mm -58.12 -45.13 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.593 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.625 ' CE1' HG22 ' A' ' 41' ' ' ILE . 27.6 m-85 -75.22 -40.14 59.38 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.399 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.592 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.74 -28.79 70.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 44' ' ' VAL . 32.5 m-20 -89.25 -29.63 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 73' ' ' LEU . 5.2 mt -60.92 -59.67 5.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.057 HG22 HD23 ' A' ' 55' ' ' LEU . 4.6 mt -53.28 -64.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.212 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.7 tpp -49.69 -43.16 47.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.552 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.08 -11.41 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.746 ' HB2' HD21 ' A' ' 73' ' ' LEU . 32.9 mmm -127.68 -68.29 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.801 HG22 ' HG3' ' A' ' 69' ' ' MET . 63.8 t -58.16 -56.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.68 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.057 HD23 HG22 ' A' ' 50' ' ' ILE . 2.8 mm? -44.86 -57.82 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.809 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 37.9 Cg_endo -66.96 5.04 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.049 1.833 . . . . 0.0 112.25 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.62 22.42 1.46 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.071 0.462 . . . . 0.0 110.14 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 91' ' ' VAL . 4.9 p -84.93 166.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.858 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.467 HG22 ' HE2' ' A' ' 81' ' ' TYR . 19.0 m -138.34 146.26 50.61 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.541 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.41 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 83.4 Cg_endo -76.87 30.42 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.34 2.027 . . . . 0.0 112.325 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.805 HD12 ' H ' ' A' ' 65' ' ' LYS . 34.7 mm 39.75 96.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.439 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -93.81 -24.3 17.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.002 0.43 . . . . 0.0 110.587 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.73 40.34 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.076 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -127.86 -66.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.913 0.387 . . . . 0.0 111.164 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.805 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER 75.07 106.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.759 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.84 HG21 ' HA ' ' A' ' 106' ' ' ILE . 2.9 t 67.95 70.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.88 0.371 . . . . 0.0 110.541 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.7 m -98.97 126.26 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.314 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 5.0 ttpt -73.99 132.58 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.356 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.801 ' HG3' HG22 ' A' ' 54' ' ' VAL . 16.5 mmm -55.62 -32.81 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.741 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t 59.52 24.62 13.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.994 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.538 ' HB2' HD12 ' A' ' 73' ' ' LEU . 28.0 mmm -103.82 -5.08 22.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.094 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.32 55.49 4.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.126 0.488 . . . . 0.0 110.044 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 53' ' ' MET . 10.3 mp -57.41 -52.17 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.008 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.64 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -131.99 155.17 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.852 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -96.7 140.63 31.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.316 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.682 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.62 -33.8 5.86 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.121 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HD1' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -130.71 168.23 17.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.023 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 81.7 m-20 -108.2 130.6 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.392 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.462 ' SG ' HD13 ' A' ' 73' ' ' LEU . 11.3 p -90.53 112.35 23.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 53.4 m-85 -121.57 149.7 42.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.563 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD1' HG13 ' A' ' 54' ' ' VAL . 44.7 p90 -144.39 128.98 18.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.05 0.452 . . . . 0.0 111.19 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 3.3 t -132.89 116.4 16.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.521 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.901 HG22 HG13 ' A' ' 91' ' ' VAL . 34.6 p -77.61 148.48 35.1 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.32 163.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.332 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.64 -15.28 35.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.485 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 16.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.37 100.21 2.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.13 -13.03 37.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.322 2.015 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 30.14 2.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.073 0.464 . . . . 0.0 110.469 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.608 ' O ' HG22 ' A' ' 90' ' ' THR . 17.5 m -153.74 70.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.66 0.743 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.901 HG13 HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -71.12 175.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.126 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.544 ' H ' HG12 ' A' ' 91' ' ' VAL . 45.3 m-85 -144.97 100.12 3.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.324 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.99 HG11 HG12 ' A' ' 50' ' ' ILE . 41.0 t -93.16 130.03 42.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.425 . . . . 0.0 111.384 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.56 133.45 49.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.659 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -114.49 97.58 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.804 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.876 HG21 ' HD3' ' A' ' 105' ' ' PRO . 2.6 p -102.27 127.64 49.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.846 HD22 ' CB ' ' A' ' 33' ' ' THR . 34.3 mt -37.05 133.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.055 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.41 -31.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.041 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.23 -30.4 71.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 110.157 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.555 HD12 ' HB3' ' A' ' 4' ' ' PHE . 7.3 mm -67.38 136.66 93.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.923 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 60.2 Cg_endo -72.45 179.55 5.0 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.246 1.964 . . . . 0.0 111.574 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.46 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -91.38 60.0 4.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.57 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 3.3 tp -148.73 -38.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.834 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.679 HD11 ' CD1' ' A' ' 132' ' ' LEU . 9.4 tp -62.19 -60.72 9.3 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.658 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.876 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.6 Cg_endo -47.85 -32.47 17.44 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.563 2.176 . . . . 0.0 111.239 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.84 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.7 mp -67.93 -36.45 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.106 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.523 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -83.73 -19.95 34.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.117 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 104' ' ' LEU . 11.7 mm -72.36 -49.47 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.809 0.338 . . . . 0.0 110.133 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.77 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -72.72 -49.4 31.4 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.7 p -63.95 -30.27 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.494 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -74.71 -43.32 29.26 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.856 HD23 ' HB2' ' A' ' 127' ' ' HIS . 11.5 mt -56.17 -35.36 67.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -13.35 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.133 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -22.43 55.78 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.472 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.482 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 5.9 m-85 -86.46 -94.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.886 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 162.19 -25.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.66 0.267 . . . . 0.0 110.904 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -91.82 -91.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.485 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.5 p-10 39.27 32.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.674 0.273 . . . . 0.0 111.097 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.15 33.83 5.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -148.59 150.78 33.9 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.48 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.437 ' HA ' ' N ' ' A' ' 20' ' ' SER . 2.3 p-10 -71.34 29.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.569 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 120' ' ' THR . 10.3 tt0 -170.91 27.53 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.2 tt -133.26 -49.77 0.86 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.689 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.87 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.31 -45.54 76.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.447 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 78.4 p -47.64 -30.12 3.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.375 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -60.16 -56.27 23.67 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.973 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.856 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.5 m-70 -60.91 -31.75 71.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.634 HG13 ' CG2' ' A' ' 108' ' ' ILE . 47.7 t -55.63 -46.43 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.924 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.31 -40.69 18.91 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.33 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.98 -24.25 65.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.591 HD11 ' HB3' ' A' ' 127' ' ' HIS . 63.0 mt -88.17 -28.02 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.921 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.6 OUTLIER -61.78 -49.84 74.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.526 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -46.48 82.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.991 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 t -72.51 -15.1 61.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.57 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 23.4 t80 -55.65 -56.45 20.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.233 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -51.76 -43.32 62.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.945 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.45 -30.54 41.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 0.0 110.106 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 7.6 mm-40 -80.25 -34.11 37.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.071 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.554 HD21 ' CZ ' ' A' ' 135' ' ' PHE . 16.1 mt -69.74 -30.32 67.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.104 0.478 . . . . 0.0 110.091 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.1 t -77.45 -48.29 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.381 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.47 -33.9 76.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.026 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -63.03 -31.72 72.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.032 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.411 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -65.87 -29.81 70.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.852 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.5 43.8 1.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.5 -46.71 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.9 p -147.04 72.31 1.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 143' ' ' ARG . 1.6 mt -85.91 -176.22 5.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.19 35.91 20.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.92 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.851 0.357 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 tptt 60.98 71.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' HG3' ' CD2' ' A' ' 136' ' ' HIS . 0.4 OUTLIER -128.54 46.99 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.805 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 101' ' ' PRO . 27.1 m-85 62.11 -178.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.654 ' HA ' HD21 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -167.44 107.44 0.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.074 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.923 HG11 HG22 ' A' ' 9' ' ' VAL . 54.9 t -60.79 145.9 11.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.683 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.656 ' OG ' HD11 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -84.19 -69.48 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.793 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.674 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 8.4 m-85 -136.13 116.03 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 111.845 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.923 HG22 HG11 ' A' ' 6' ' ' VAL . 2.3 t -106.84 92.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.961 0.41 . . . . 0.0 110.868 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.2 tt0 -95.82 108.69 21.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.8 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.96 ' CG2' HD13 ' A' ' 124' ' ' LEU . 33.5 t -81.07 145.32 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.2 mp -129.34 124.89 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HG3' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.91 102.62 11.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.381 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.79 39.56 6.1 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.881 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.78 20.8 67.47 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.78 118.57 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.957 0.408 . . . . 0.0 110.26 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.415 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 3.6 m -47.84 128.55 13.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.338 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.568 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -105.62 -42.26 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.643 0.735 . . . . 0.0 109.362 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.901 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -131.29 176.35 8.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.197 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.441 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.0 m -170.5 121.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.521 ' HB3' HG23 ' A' ' 9' ' ' VAL . 33.9 t -107.58 70.22 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.674 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.1 m-85 -105.97 84.25 2.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.609 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 19.1 pt20 -105.26 139.0 19.71 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.42 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.73 147.47 19.5 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.616 2.211 . . . . 0.0 111.977 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CE1' ' O ' ' A' ' 23' ' ' GLN . 38.6 p90 179.04 119.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.892 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.766 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.6 pt20 -86.56 46.69 1.38 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.631 0.253 . . . . 0.0 111.151 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt 59.68 108.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.338 . . . . 0.0 110.812 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -170.22 136.44 1.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.043 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 57.84 21.98 8.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.262 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 174.41 161.77 0.19 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.934 0.397 . . . . 0.0 110.849 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.76 106.7 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.65 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.403 ' HA2' ' CD1' ' A' ' 97' ' ' LEU . . . -127.54 -176.86 14.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.756 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.561 ' HB ' HD22 ' A' ' 97' ' ' LEU . 11.3 m -155.87 -44.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.925 0.393 . . . . 0.0 110.921 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 27.1 mt -60.36 162.3 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -164.78 -69.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.527 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.498 ' N ' ' OG1' ' A' ' 35' ' ' THR . 1.2 m -140.37 -44.75 0.41 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.185 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.3 -28.6 68.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.395 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.457 ' O ' HG23 ' A' ' 34' ' ' ILE . 1.3 m-20 -116.48 32.37 6.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.113 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -129.54 28.38 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -111.77 -35.74 5.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.959 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.674 HG22 ' CE1' ' A' ' 46' ' ' PHE . 1.1 mt -51.24 116.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.79 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.85 HG22 HD12 ' A' ' 45' ' ' ILE . 1.8 t -77.08 153.18 82.51 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.522 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.438 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.1 Cg_exo -48.16 -21.78 3.19 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.785 1.656 . . . . 0.0 110.788 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 42' ' ' THR . 90.7 t -65.3 -49.35 79.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.058 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.85 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -57.28 -31.29 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.674 ' CE1' HG22 ' A' ' 41' ' ' ILE . 98.3 m-85 -80.8 -44.05 19.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.569 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.627 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -65.17 -26.02 67.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.291 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.99 -29.54 18.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.645 HD11 HG13 ' A' ' 74' ' ' ILE . 2.7 mt -60.75 -59.51 5.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.018 HG12 HG11 ' A' ' 93' ' ' VAL . 4.9 mt -53.87 -64.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.984 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.627 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.8 OUTLIER -49.73 -40.72 41.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.902 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -91.16 -19.74 22.75 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.487 ' HB2' HD21 ' A' ' 73' ' ' LEU . 93.8 mmm -120.14 -60.14 1.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' ' HE3' ' A' ' 69' ' ' MET . 96.4 t -64.55 -51.38 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.986 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -55.63 -52.45 71.93 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 14.7 Cg_exo -69.07 3.66 2.32 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.352 2.034 . . . . 0.0 112.159 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.93 23.61 1.37 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.03 0.443 . . . . 0.0 110.192 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.46 HG23 ' CD1' ' A' ' 81' ' ' TYR . 4.4 p -85.92 165.35 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 61' ' ' ILE . 15.3 m -141.96 146.35 40.14 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.135 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.481 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 60.8 Cg_endo -74.94 23.38 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.953 1.768 . . . . 0.0 112.33 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.566 HD12 ' H ' ' A' ' 65' ' ' LYS . 21.0 mm 51.65 158.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.307 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.505 ' N ' HG22 ' A' ' 61' ' ' ILE . 2.1 mptp? -134.02 -42.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.191 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.39 31.61 0.25 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.697 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 2.4 t-20 -121.55 -66.16 1.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.366 . . . . 0.0 111.21 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.566 ' H ' HD12 ' A' ' 61' ' ' ILE . 12.6 mmtt 70.93 116.75 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.608 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.898 HG13 HD23 ' A' ' 109' ' ' LEU . 3.1 t 75.04 49.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.68 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.0 m -80.7 125.41 30.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.283 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -71.75 130.67 41.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.497 ' HE3' ' HA ' ' A' ' 54' ' ' VAL . 53.3 tpp -57.53 -25.24 59.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 t 53.04 26.96 5.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.085 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.431 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 8.9 tpt -106.45 -11.0 16.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.149 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.87 58.06 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.371 . . . . 0.0 110.515 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.573 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.5 mp -59.86 -46.05 90.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.645 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -133.25 157.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.686 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.95 140.84 33.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.394 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.587 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.41 -33.92 5.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.241 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.54 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -132.79 168.36 18.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.882 0.372 . . . . 0.0 111.088 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 94.7 m-20 -106.57 143.25 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.402 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 6.4 m -106.98 114.77 29.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' HB3' HG12 ' A' ' 66' ' ' VAL . 87.7 m-85 -121.78 137.74 54.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.482 ' HB3' HG11 ' A' ' 54' ' ' VAL . 49.2 p90 -127.05 128.82 46.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.0 0.429 . . . . 0.0 111.467 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -133.35 118.91 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.96 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.634 HG22 HG13 ' A' ' 91' ' ' VAL . 40.3 p -80.63 150.43 29.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -46.14 146.84 1.2 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.276 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.03 -15.81 57.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.89 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 22.03 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.659 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.74 95.0 3.76 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.471 0.177 . . . . 0.0 111.178 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.33 -15.55 45.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -96.23 30.39 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.042 0.448 . . . . 0.0 110.093 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 65.1 m -154.36 73.72 0.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.66 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.634 HG13 HG22 ' A' ' 83' ' ' THR . 0.6 OUTLIER -72.83 176.0 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.223 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.583 ' H ' HG12 ' A' ' 91' ' ' VAL . 97.4 m-85 -150.68 94.88 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.826 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.018 HG11 HG12 ' A' ' 50' ' ' ILE . 44.0 t -98.09 121.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.246 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.567 ' CB ' HD21 ' A' ' 109' ' ' LEU . 37.5 t -114.51 139.98 49.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.312 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.8 m-85 -115.04 102.66 10.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.511 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.665 HG21 ' HD3' ' A' ' 105' ' ' PRO . 9.9 p -109.69 127.46 54.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.561 HD22 ' HB ' ' A' ' 33' ' ' THR . 44.5 mt -38.32 132.9 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.326 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.94 -30.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.685 -178.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.11 -28.08 67.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.742 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 4' ' ' PHE . 5.2 mm -68.26 131.57 91.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.205 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 4' ' ' PHE . 39.1 Cg_exo -60.0 179.65 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -98.72 62.58 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.682 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.608 ' HA ' HD13 ' A' ' 106' ' ' ILE . 4.3 tp -155.08 -37.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.783 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.699 ' HG ' HD11 ' A' ' 108' ' ' ILE . 5.3 tp -60.51 -61.55 7.73 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.665 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.3 Cg_endo -45.48 -37.54 14.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.794 2.329 . . . . 0.0 111.147 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.861 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -63.62 -37.44 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.152 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.553 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -83.49 -18.23 39.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.841 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.867 HG23 HG13 ' A' ' 128' ' ' VAL . 15.4 mm -70.63 -47.89 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.898 HD23 HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -74.37 -47.42 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.5 t -64.53 -29.11 70.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -75.73 -45.55 16.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.173 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.952 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.76 -33.93 67.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -70.79 -16.11 62.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.209 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.08 -21.6 59.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.363 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.496 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 5.5 m-85 -85.39 -94.13 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 4.9 tp10 161.57 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 110.659 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.5 m -91.32 -91.07 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.368 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.549 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.1 p-10 39.04 32.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.595 0.236 . . . . 0.0 111.021 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.37 34.81 4.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -150.13 151.1 32.6 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.708 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.441 ' HA ' ' N ' ' A' ' 20' ' ' SER . 3.9 p-10 -70.67 28.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.919 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 tt0 -172.17 28.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.9 tt -131.74 -50.33 0.97 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.96 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.93 -44.94 78.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.213 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 19.1 t -47.7 -30.22 3.65 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.168 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.13 -58.17 8.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.138 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.952 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.7 m-70 -57.66 -39.36 76.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.643 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.867 HG13 HG23 ' A' ' 108' ' ' ILE . 42.9 t -50.52 -46.2 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.412 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.03 -47.28 47.0 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.324 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -65.28 -23.39 67.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.82 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 107' ' ' ARG . 37.8 mt -85.49 -27.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.654 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.5 OUTLIER -65.66 -46.52 78.84 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.678 179.158 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.66 -44.0 78.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.7 m -80.3 -4.17 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.815 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.733 ' CE1' HD11 ' A' ' 139' ' ' LEU . 26.6 t80 -55.62 -62.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.54 ' HA ' HD12 ' A' ' 139' ' ' LEU . 7.4 m-70 -50.68 -41.31 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.332 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.01 -33.01 23.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.935 0.398 . . . . 0.0 110.353 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 1.5 mm-40 -79.33 -34.02 42.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.966 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.733 HD11 ' CE1' ' A' ' 135' ' ' PHE . 18.0 mt -69.84 -30.11 67.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.232 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.5 t -77.21 -47.49 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.583 0.706 . . . . 0.0 109.423 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -65.09 -32.0 73.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.093 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -65.9 -32.88 74.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.484 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.539 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -67.08 -21.4 65.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.153 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -104.1 35.43 2.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.054 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -126.87 -42.93 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 t -137.06 80.78 1.83 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 143' ' ' ARG . 0.2 OUTLIER -162.53 30.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.797 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.25 31.25 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.808 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.9 92.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.39 161.04 23.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CZ ' ' HD2' ' A' ' 101' ' ' PRO . 6.1 m-85 -145.69 161.54 39.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.746 ' HA ' HD21 ' A' ' 132' ' ' LEU . 3.9 t-20 -168.88 111.33 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.966 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.932 HG11 HG22 ' A' ' 9' ' ' VAL . 3.5 t -54.19 123.09 4.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.616 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -53.93 -55.73 24.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.49 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.655 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 6.5 m-85 -145.47 140.52 27.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 0.0 111.653 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.932 HG22 HG11 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -131.35 97.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.348 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.2 mt-10 -112.86 124.7 53.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 111.647 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.956 HG23 HD13 ' A' ' 124' ' ' LEU . 98.2 t -89.79 159.9 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.83 HD11 HG21 ' A' ' 50' ' ' ILE . 3.3 mt -137.66 117.4 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.602 ' CG ' HD13 ' A' ' 18' ' ' ILE . 3.2 tttp -107.36 115.5 30.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.056 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 61.4 32.74 18.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.573 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.0 27.91 57.44 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.283 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -144.92 121.57 11.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.086 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -51.88 122.55 8.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.145 -178.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.602 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.19 -47.94 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 109.603 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 124' ' ' LEU . 54.7 p -122.08 171.35 9.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.625 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.607 ' N ' HD22 ' A' ' 124' ' ' LEU . 11.8 m -166.54 128.05 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.985 0.421 . . . . 0.0 112.021 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.486 ' N ' HD21 ' A' ' 124' ' ' LEU . 32.0 t -119.91 69.39 0.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.655 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.5 m-85 -112.04 94.2 4.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.414 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 2.2 pp0? -139.13 149.38 60.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.718 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.99 177.88 3.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.725 2.283 . . . . 0.0 111.673 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 7' ' ' SER . 3.4 p90 176.86 -26.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' CG ' ' HA ' ' A' ' 35' ' ' THR . 7.2 mt-30 64.99 139.61 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.258 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 0.7 OUTLIER -51.46 156.85 1.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.247 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -122.7 46.58 2.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.48 -62.4 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.969 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -53.79 -67.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 31' ' ' TYR . 40.5 p90 -101.32 108.31 19.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.812 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' CB ' ' A' ' 27' ' ' LYS . . . -97.34 133.37 11.34 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.57 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.772 ' HB ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -178.44 -78.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.905 0.384 . . . . 0.0 111.401 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.568 ' O ' ' HB ' ' A' ' 35' ' ' THR . 4.2 mt -84.46 150.24 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.83 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 169.22 -31.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.549 179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.45 -78.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.401 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.19 -37.88 37.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.782 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -98.22 33.41 2.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.026 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.31 29.89 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.926 0.393 . . . . 0.0 110.95 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -115.31 -38.61 3.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.352 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.66 HD12 HD13 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -53.57 118.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.976 HG22 HD12 ' A' ' 45' ' ' ILE . 9.5 t -81.43 152.19 69.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.6 Cg_exo -46.51 -23.06 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.066 1.844 . . . . 0.0 111.239 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.736 ' HB ' HG23 ' A' ' 42' ' ' THR . 49.2 t -64.82 -47.51 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.518 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.976 HD12 HG22 ' A' ' 42' ' ' THR . 1.9 mp -58.94 -33.32 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.214 0.53 . . . . 0.0 109.618 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.491 ' O ' HD12 ' A' ' 50' ' ' ILE . 66.1 m-85 -81.06 -41.98 21.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.541 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.633 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -64.69 -29.15 70.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.023 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.27 -27.31 21.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.4 mt -63.79 -61.11 2.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.966 HG12 HG11 ' A' ' 93' ' ' VAL . 6.8 mt -49.63 -62.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.736 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.595 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -54.33 -41.09 68.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.591 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -90.89 -20.42 22.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.455 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 69.0 mmm -119.66 -52.3 2.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 84.3 t -69.59 -60.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.867 HD23 HG22 ' A' ' 50' ' ' ILE . 1.3 mm? -46.41 -51.09 37.1 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 12.6 Cg_exo -70.08 2.87 3.31 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.262 1.975 . . . . 0.0 112.059 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -145.49 23.97 1.42 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.058 0.456 . . . . 0.0 110.086 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.491 HG23 ' CD1' ' A' ' 81' ' ' TYR . 5.0 p -87.67 166.06 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.914 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.558 HG23 ' H ' ' A' ' 61' ' ' ILE . 12.1 m -140.57 146.16 43.7 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.899 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.506 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 58.5 Cg_endo -73.71 24.08 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.931 1.754 . . . . 0.0 112.476 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.708 HD12 ' H ' ' A' ' 65' ' ' LYS . 30.0 mm 50.12 158.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.394 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.498 ' N ' HG22 ' A' ' 61' ' ' ILE . 6.4 mmtm -135.84 -44.94 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.175 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.17 29.69 0.41 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.545 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.51 -71.28 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.963 0.411 . . . . 0.0 110.985 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.708 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.0 OUTLIER 71.72 120.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.554 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.799 HG21 ' HA ' ' A' ' 106' ' ' ILE . 2.6 t 76.25 44.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.497 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -78.61 139.84 38.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.365 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.31 127.45 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.511 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.498 ' HG2' ' CG ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -54.04 -36.5 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m 63.97 25.44 13.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.894 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.498 ' CG ' ' HG2' ' A' ' 69' ' ' MET . 23.6 mmt -104.82 -0.66 26.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.944 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.06 56.28 5.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.098 0.475 . . . . 0.0 110.507 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.71 ' HB3' HD22 ' A' ' 49' ' ' LEU . 7.5 mp -60.44 -39.45 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.652 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.66 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -147.01 151.77 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.489 179.02 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -96.77 138.67 33.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.335 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 111.94 -31.91 6.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -129.48 163.92 24.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.15 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 75.8 m-20 -103.49 132.03 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.432 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 20.9 p -94.83 95.72 8.87 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.561 ' HB3' HG12 ' A' ' 66' ' ' VAL . 73.2 m-85 -110.33 133.59 53.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.511 ' HB3' HG22 ' A' ' 93' ' ' VAL . 46.6 p90 -127.31 139.84 52.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.455 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -143.55 125.09 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.779 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.798 HG22 HG13 ' A' ' 91' ' ' VAL . 41.4 p -86.94 158.12 19.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.95 153.37 2.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.83 -9.71 58.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.765 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 22.56 0.24 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.667 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 98.97 2.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.477 0.18 . . . . 0.0 111.23 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -13.61 40.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.445 2.097 . . . . 0.0 112.009 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -97.56 28.81 3.57 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.023 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 90' ' ' THR . 32.3 m -152.73 73.63 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.408 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -73.55 -179.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.435 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.633 ' H ' HG12 ' A' ' 91' ' ' VAL . 69.1 m-85 -156.06 98.61 1.89 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.754 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.966 HG11 HG12 ' A' ' 50' ' ' ILE . 65.0 t -106.86 133.52 51.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.98 0.419 . . . . 0.0 111.151 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.21 122.45 29.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.087 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.501 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.7 m-85 -92.05 87.45 6.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.725 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.809 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -75.72 -170.94 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.775 0.322 . . . . 0.0 110.931 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.772 HD22 ' HB ' ' A' ' 33' ' ' THR . 82.0 mt -105.95 125.77 51.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -41.49 -30.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.608 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 36.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.415 HG12 ' CD1' ' A' ' 4' ' ' PHE . 47.9 mt -139.48 129.48 14.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.528 ' HB2' HG22 ' A' ' 103' ' ' ILE . 72.9 Cg_exo -48.39 151.51 4.59 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.307 2.005 . . . . 0.0 112.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.443 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -82.46 58.03 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.496 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.603 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 3.2 tp -144.1 -35.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.762 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.717 HD21 HG23 ' A' ' 6' ' ' VAL . 6.3 tp -60.45 -63.99 3.62 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.672 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.809 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -45.25 -35.51 11.33 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.726 2.284 . . . . 0.0 111.501 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.799 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.5 mp -63.35 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.061 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER -79.35 -19.68 49.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.813 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.888 HG13 HG21 ' A' ' 6' ' ' VAL . 19.9 mm -68.32 -49.99 61.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.522 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.725 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -72.23 -50.16 29.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -27.43 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -78.6 -42.15 14.42 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.852 HD23 ' HB2' ' A' ' 127' ' ' HIS . 20.4 mt -58.88 -28.23 65.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -18.56 58.38 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.227 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.5 OUTLIER -73.57 -22.21 60.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.485 ' O ' ' CB ' ' A' ' 116' ' ' GLU . 6.4 m-85 -83.64 -93.24 0.07 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 20.7 tt0 156.5 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.352 0.261 . . . . 0.0 111.064 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 m -94.19 -90.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.0 OUTLIER 41.12 31.2 0.13 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.15 34.01 4.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.484 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -149.92 154.85 38.99 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.523 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HA ' ' H ' ' A' ' 20' ' ' SER . 46.8 m-20 -74.06 22.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.394 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' A' ' 120' ' ' THR . 6.9 pt-20 -164.97 26.32 0.06 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.6 tt -127.11 -50.87 1.43 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.683 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.956 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.52 -44.69 76.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.107 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.5 p -47.66 -30.36 3.69 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.231 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.48 -56.27 21.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.326 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.852 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.3 m-70 -60.39 -35.2 75.17 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.677 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.781 HG21 HG21 ' A' ' 9' ' ' VAL . 46.1 t -54.59 -45.66 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.02 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.51 28.77 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.435 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -69.31 -21.16 63.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.871 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 127' ' ' HIS . 62.4 mt -90.16 -27.38 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.746 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -64.59 -47.84 77.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.359 178.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -63.42 -44.62 94.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.575 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 t -76.49 -8.71 57.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.603 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 16.8 t80 -51.57 -57.76 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.491 ' HA ' HD12 ' A' ' 139' ' ' LEU . 16.5 m170 -58.87 -40.72 85.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.76 -31.21 36.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.972 0.415 . . . . 0.0 110.007 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 18.2 mt-10 -77.82 -35.52 51.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.971 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 136' ' ' HIS . 20.5 mt -67.17 -29.92 69.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.185 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.19 -49.01 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.484 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.76 -31.35 72.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.041 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -63.84 -33.01 74.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.29 179.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -28.91 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.89 85.31 2.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.43 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.6 p -108.91 39.98 1.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.849 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.34 130.78 53.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.967 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -33.12 48.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.809 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.856 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.77 0.319 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER 60.34 97.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.824 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -174.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -148.35 159.25 44.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.914 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.31 113.49 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.827 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.022 HG11 HG22 ' A' ' 9' ' ' VAL . 92.9 t -58.93 140.1 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.079 0.466 . . . . 0.0 110.978 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.68 -59.02 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.701 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.675 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 5.8 m-85 -149.35 115.84 5.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.848 0.356 . . . . 0.0 111.78 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.022 HG22 HG11 ' A' ' 6' ' ' VAL . 1.9 t -108.15 93.03 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.865 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.632 ' OE2' HG21 ' A' ' 17' ' ' THR . 0.1 OUTLIER -101.14 114.83 29.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.685 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.984 HG23 HD13 ' A' ' 124' ' ' LEU . 56.0 t -81.59 161.19 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.566 HG21 HD11 ' A' ' 55' ' ' LEU . 2.0 mp -142.01 121.08 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.693 -0.403 . . . . 0.0 112.045 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 12.8 tttt -107.07 97.24 7.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.703 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 69.85 37.59 1.78 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.58 62.01 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.695 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 7.6 pt-20 -144.8 119.22 9.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.632 HG21 ' OE2' ' A' ' 10' ' ' GLU . 18.6 m -50.14 130.78 23.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.507 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.36 -41.49 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.137 178.234 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.885 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -127.21 175.57 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.072 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.458 ' N ' HD22 ' A' ' 124' ' ' LEU . 17.0 p -170.38 134.65 1.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' HB3' HG23 ' A' ' 9' ' ' VAL . 34.4 t -122.7 69.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.746 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.675 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -106.95 88.72 2.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.684 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 39.5 mt-30 -127.88 139.48 35.46 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.487 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.69 -179.07 4.78 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.546 2.164 . . . . 0.0 111.755 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' O ' ' A' ' 23' ' ' GLN . 1.0 OUTLIER 176.78 -29.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.675 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER 74.7 122.19 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.77 0.319 . . . . 0.0 110.413 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -51.82 -46.64 64.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 69.4 -66.16 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -158.58 -45.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -58.65 177.32 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CD1' ' HE2' ' A' ' 2' ' ' LYS . 20.4 m-85 -58.95 110.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.978 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.736 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . -173.97 -165.55 30.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.94 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.464 HG21 ' HA2' ' A' ' 76' ' ' GLY . 18.8 m -157.61 -44.12 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.884 0.373 . . . . 0.0 111.017 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.548 ' O ' ' HB ' ' A' ' 35' ' ' THR . 26.5 mt -55.06 154.58 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.951 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 169.5 -32.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.449 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.9 t -179.64 -60.33 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.021 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.06 -29.25 63.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.378 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -117.49 32.28 6.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.051 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.15 28.59 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.033 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -110.22 -38.39 5.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.887 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.689 HD13 ' CD1' ' A' ' 74' ' ' ILE . 1.1 mt -51.31 142.15 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.68 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.603 HG23 ' HB ' ' A' ' 44' ' ' VAL . 2.3 t -96.67 152.5 38.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 83.2 Cg_exo -46.43 -28.83 6.45 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.895 1.73 . . . . 0.0 110.669 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.603 ' HB ' HG23 ' A' ' 42' ' ' THR . 60.9 t -58.81 -40.28 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.548 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.597 ' HB ' HG23 ' A' ' 41' ' ' ILE . 23.5 mm -57.62 -46.34 86.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.549 ' O ' HD12 ' A' ' 50' ' ' ILE . 68.7 m-85 -75.41 -38.51 59.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.246 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.611 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.26 -30.15 71.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.155 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' VAL . 1.2 m120 -87.59 -28.03 22.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.873 HD11 HG13 ' A' ' 74' ' ' ILE . 6.6 mt -64.21 -61.15 2.43 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.081 HG12 HG11 ' A' ' 93' ' ' VAL . 6.2 mt -48.9 -61.19 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.997 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.4 ttm -57.28 -40.85 78.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.186 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.5 t0 -91.18 -15.13 29.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.489 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 84.2 mmm -124.28 -56.48 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.478 HG13 ' CD2' ' A' ' 81' ' ' TYR . 72.1 t -64.44 -60.02 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -51.96 -50.35 78.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.9 Cg_exo -62.68 -2.28 3.31 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.383 2.055 . . . . 0.0 112.602 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -146.97 23.15 1.21 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.289 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.7 p -78.78 164.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.931 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 58' ' ' VAL . 29.7 m -147.3 147.17 27.65 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.473 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 64.0 Cg_endo -76.18 25.3 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.968 1.778 . . . . 0.0 112.83 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 82' ' ' SER . 1.6 mp 51.31 159.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.083 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -123.7 -41.0 2.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.849 179.672 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.92 40.31 0.23 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.086 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 2.8 t-20 -136.74 -60.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.498 ' C ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER 72.89 128.9 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.479 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.849 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.4 t 73.89 49.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.967 0.413 . . . . 0.0 110.725 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.8 m -78.0 129.37 35.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 7.0 tttm -79.45 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.264 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.479 ' HG2' HD11 ' A' ' 73' ' ' LEU . 20.0 tpp -56.78 -29.94 63.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m 56.43 28.64 13.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.452 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 37.8 tpp -108.66 -10.87 15.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.029 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.58 59.14 1.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 110.43 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.654 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.6 mp -59.5 -50.1 75.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.774 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.873 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -128.75 155.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.651 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.61 140.35 31.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.458 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 108.7 -32.25 7.1 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.63 ' HD2' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -133.87 167.96 19.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 111.25 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 84.0 m-20 -108.37 145.28 34.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.383 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 1.8 m -109.75 118.43 36.51 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 32.5 m-85 -126.13 138.97 53.72 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.12 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.478 ' CD2' HG13 ' A' ' 54' ' ' VAL . 26.8 p90 -124.78 133.69 53.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.073 0.463 . . . . 0.0 111.359 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.563 ' HA ' HD11 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -136.18 117.6 14.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.031 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 18.0 p -79.35 153.58 29.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.37 146.42 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.096 0.474 . . . . 0.0 111.25 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -22.35 14.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.056 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.05 23.54 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.587 0.232 . . . . 0.0 111.582 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.56 94.57 5.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -15.28 47.35 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.395 2.063 . . . . 0.0 111.98 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.35 28.2 3.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.171 0.51 . . . . 0.0 110.272 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 90' ' ' THR . 51.7 m -152.04 70.91 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.641 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.611 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -72.34 177.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.57 ' H ' HG12 ' A' ' 91' ' ' VAL . 92.7 m-85 -151.1 93.69 1.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.112 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.081 HG11 HG12 ' A' ' 50' ' ' ILE . 51.5 t -95.6 120.54 45.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 111.05 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.497 ' CB ' HD21 ' A' ' 109' ' ' LEU . 35.8 t -112.85 137.48 51.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.108 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 8.6 m-85 -112.88 99.2 7.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.825 HG21 ' HD3' ' A' ' 105' ' ' PRO . 2.0 p -104.33 125.72 50.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 111.078 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.736 HD13 ' HA2' ' A' ' 32' ' ' GLY . 16.5 mt -39.9 134.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -46.2 -29.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.705 0.288 . . . . 0.0 111.493 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -28.24 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 110.478 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.4 mm -66.95 134.12 93.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.129 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.28 -159.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.134 1.889 . . . . 0.0 111.617 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -114.44 64.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.539 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.686 HG23 ' CE2' ' A' ' 135' ' ' PHE . 1.4 tp -161.79 -35.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.918 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.073 HD11 HD23 ' A' ' 132' ' ' LEU . 4.7 tp -58.73 -61.54 7.51 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.048 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.825 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.8 Cg_endo -45.38 -36.36 12.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.592 2.195 . . . . 0.0 111.015 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.849 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -67.79 -37.31 78.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.06 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.636 ' O ' HG21 ' A' ' 131' ' ' ILE . 1.1 mmp_? -80.77 -24.34 38.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.701 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.904 HG23 HG13 ' A' ' 128' ' ' VAL . 31.9 mm -67.01 -54.36 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.766 0.317 . . . . 0.0 110.223 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -69.33 -53.33 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.907 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -59.91 -27.93 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.498 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -74.92 -45.89 19.17 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.3 mt -56.16 -31.14 63.11 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -76.89 -15.76 59.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.058 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -75.43 -25.19 57.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.313 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.537 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 3.5 m-85 -84.42 -92.57 0.08 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.911 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 163.43 -29.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.059 0.457 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 26.3 m -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.476 0.655 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.496 ' HA ' HD22 ' A' ' 123' ' ' LEU . 0.7 OUTLIER -169.67 36.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.944 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.89 33.38 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.529 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.28 155.15 43.72 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.901 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.2 m120 -75.25 19.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 pm0 -161.53 24.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.529 ' CB ' HG23 ' A' ' 120' ' ' THR . 7.4 tt -123.07 -58.26 1.65 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.7 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.984 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -50.81 -44.79 59.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.411 ' HB3' ' CB ' ' A' ' 21' ' ' CYS . 78.6 p -49.32 -29.58 6.24 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.461 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.07 -59.98 4.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.427 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.862 ' HB2' HD23 ' A' ' 112' ' ' LEU . 42.4 m170 -59.64 -32.17 70.19 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.904 HG13 HG23 ' A' ' 108' ' ' ILE . 56.9 t -55.26 -46.92 78.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -67.92 -42.9 84.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.11 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.62 -22.9 63.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.919 0.39 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.636 HG21 ' O ' ' A' ' 107' ' ' ARG . 40.5 mt -90.38 -27.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 1.073 HD23 HD11 ' A' ' 104' ' ' LEU . 2.9 mt -65.02 -52.33 56.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.919 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.555 ' O ' ' CE1' ' A' ' 136' ' ' HIS . 14.2 t0 -71.57 -32.65 68.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -95.77 24.27 5.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.957 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -100.25 -44.03 6.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.555 ' CE1' ' O ' ' A' ' 133' ' ' ASP . 10.0 p80 -71.73 -36.57 70.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.946 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -52.59 -29.27 24.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.993 0.425 . . . . 0.0 110.396 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 93.4 mt-10 -78.8 -36.39 42.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.305 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.715 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 16.5 mt -68.89 -30.3 68.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.429 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.9 t -77.13 -48.05 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.465 0.65 . . . . 0.0 109.55 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -64.19 -30.78 71.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.0 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -68.24 -20.99 64.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.573 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -89.67 16.28 8.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.452 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -160.05 29.26 0.18 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.759 0.314 . . . . 0.0 110.859 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -113.77 -36.37 4.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.44 ' O ' HG23 ' A' ' 146' ' ' THR . 3.8 t -143.65 83.96 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.829 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 33.6 mt -140.79 96.79 3.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -125.64 81.18 1.96 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.845 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.806 0.336 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.54 119.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.1 173.38 7.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CE1' HG12 ' A' ' 100' ' ' ILE . 2.0 m-85 -131.53 -173.11 3.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.031 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -159.72 111.74 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.278 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.927 HG11 HG22 ' A' ' 9' ' ' VAL . 1.4 t -71.94 133.54 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.552 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -63.16 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.792 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.577 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.1 m-85 -144.98 140.35 28.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.309 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.927 HG22 HG11 ' A' ' 6' ' ' VAL . 1.5 t -129.63 90.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.1 tt0 -99.52 116.02 30.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.004 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.89 HG23 HD13 ' A' ' 124' ' ' LEU . 40.1 t -82.39 158.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.78 HD11 HG21 ' A' ' 50' ' ' ILE . 3.4 mt -141.01 119.58 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.667 ' CG ' HD13 ' A' ' 18' ' ' ILE . 1.8 tttt -104.68 99.76 9.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.482 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.77 40.39 5.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.855 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 21.32 63.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.05 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -141.38 116.27 9.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.194 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.3 m -50.84 126.03 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.823 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.667 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -103.96 -44.0 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.457 0.646 . . . . 0.0 109.792 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -127.7 177.11 7.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.432 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.464 ' N ' HD22 ' A' ' 124' ' ' LEU . 2.8 t -170.47 139.04 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.564 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 13.7 t -130.52 73.08 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.605 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.1 m-85 -107.35 88.78 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.815 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -101.78 126.24 34.61 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.212 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.39 149.35 35.01 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.466 2.111 . . . . 0.0 112.131 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -178.93 151.22 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.834 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.607 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 4.0 pt20 -104.2 62.18 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.744 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER 40.41 -170.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.008 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 66.9 m-80 -158.53 74.83 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.829 0.347 . . . . 0.0 111.202 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 61.18 -81.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.297 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -85.4 -80.62 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.178 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 28' ' ' ASN . 22.1 p90 -69.49 131.95 45.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.47 158.82 11.18 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.382 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.671 ' HB ' HD22 ' A' ' 97' ' ' LEU . 23.5 m -144.15 -43.6 0.26 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.747 0.308 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 35' ' ' THR . 13.0 mt -57.83 155.42 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.349 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -175.91 -83.27 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.493 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -133.38 63.49 1.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.83 -38.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.452 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 27.6 m-20 -112.47 31.37 6.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.741 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 28.67 7.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -117.4 -34.35 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.556 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -53.98 121.59 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.978 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.977 HG22 HD12 ' A' ' 45' ' ' ILE . 8.8 t -83.39 151.48 62.52 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 82.8 Cg_exo -46.0 -22.56 1.42 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.189 1.926 . . . . 0.0 111.474 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' A' ' 42' ' ' THR . 97.1 t -65.58 -46.28 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.045 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.977 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -59.41 -33.91 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.556 ' CE2' HG22 ' A' ' 41' ' ' ILE . 88.1 m-85 -79.36 -43.28 23.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.204 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.637 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.83 -27.83 69.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.069 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 25.8 m-20 -88.33 -29.18 20.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.614 HD11 HG13 ' A' ' 74' ' ' ILE . 3.5 mt -62.57 -61.11 2.65 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.076 HG12 HG11 ' A' ' 93' ' ' VAL . 5.7 mt -50.44 -61.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.262 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.622 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -53.21 -46.01 68.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.055 -1.43 . . . . 0.0 113.198 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.91 -14.14 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.496 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 74.1 mmm -123.02 -63.27 1.27 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.743 HG13 ' CD2' ' A' ' 81' ' ' TYR . 67.5 t -59.35 -55.73 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.755 HD23 HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -53.17 -54.37 45.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 31.3 Cg_exo -60.85 -4.24 3.45 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.15 1.9 . . . . 0.0 112.175 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -144.43 26.89 1.42 Allowed 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.544 HG23 ' CD1' ' A' ' 81' ' ' TYR . 2.5 p -84.99 159.12 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.904 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -144.57 148.75 41.27 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.021 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 72.9 Cg_endo -78.8 24.58 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.894 1.729 . . . . 0.0 112.029 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.7 HG21 ' HB3' ' A' ' 65' ' ' LYS . 23.6 mt 36.96 31.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.686 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.63 -12.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.036 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 168.72 40.91 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.805 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 63' ' ' GLY . 0.9 OUTLIER 55.24 117.46 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.997 0.427 . . . . 0.0 111.462 -179.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.7 ' HB3' HG21 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -159.07 25.08 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.022 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.859 HG13 HD23 ' A' ' 109' ' ' LEU . 14.4 t 45.14 96.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.286 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.503 ' OG1' HD13 ' A' ' 61' ' ' ILE . 96.5 m -119.41 142.71 47.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 111.892 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HG3' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.36 133.93 34.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.426 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.51 ' HE3' ' CE2' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -58.79 -30.09 67.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.126 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.67 30.08 16.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.971 0.415 . . . . 0.0 110.804 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 2.4 tpt -111.06 -13.2 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.097 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.75 55.1 1.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.56 ' HB3' HD22 ' A' ' 49' ' ' LEU . 9.5 mp -54.42 -43.38 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.818 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.614 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -135.44 159.18 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.735 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.436 ' N ' HG23 ' A' ' 74' ' ' ILE . 29.6 t70 -99.74 142.18 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.471 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 107.03 -34.7 5.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.127 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.486 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.5 176.14 8.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 110.766 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 91.7 m-20 -110.98 162.24 15.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.069 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.5 t -121.97 101.49 7.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CE1' ' HG3' ' A' ' 68' ' ' LYS . 57.9 m-85 -108.67 147.07 32.45 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.575 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.743 ' CD2' HG13 ' A' ' 54' ' ' VAL . 33.9 p90 -137.66 123.14 19.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.091 0.472 . . . . 0.0 111.441 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.86 119.09 27.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.396 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.667 HG22 HG13 ' A' ' 91' ' ' VAL . 23.8 p -82.13 156.93 24.25 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.095 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 18.6 t70 -53.41 152.12 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -28.49 53.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.891 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 23.55 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.654 0.264 . . . . 0.0 111.398 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -137.89 85.68 19.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.636 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 87' ' ' ASP . 15.0 Cg_endo -56.14 -18.19 22.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.523 2.149 . . . . 0.0 112.063 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 28.79 1.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 110.216 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 82.3 m -153.8 72.81 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.474 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.667 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -75.82 178.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.342 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.602 ' CD2' HG13 ' A' ' 11' ' ' VAL . 72.5 m-85 -152.15 88.48 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.116 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.076 HG11 HG12 ' A' ' 50' ' ' ILE . 44.0 t -90.91 125.14 43.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.483 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.635 ' HB3' HD21 ' A' ' 109' ' ' LEU . 45.2 t -125.27 115.35 20.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.76 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.2 m-85 -82.97 122.7 28.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.88 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -122.6 129.8 52.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 111.972 -179.044 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.671 HD22 ' HB ' ' A' ' 33' ' ' THR . 36.0 mt -44.13 124.33 3.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.019 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.3 -31.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.88 -31.41 72.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.506 HG23 ' HD2' ' A' ' 101' ' ' PRO . 68.4 mt -76.39 138.2 67.67 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.049 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 100' ' ' ILE . 19.4 Cg_endo -58.6 -164.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.501 2.134 . . . . 0.0 111.928 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.502 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -114.83 57.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.963 0.411 . . . . 0.0 111.138 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.767 HG23 ' CE2' ' A' ' 135' ' ' PHE . 6.3 tp -142.04 -35.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.605 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.843 HD21 HG23 ' A' ' 6' ' ' VAL . 5.0 tp -62.8 -62.57 5.45 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.88 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.2 Cg_endo -46.61 -30.4 8.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.442 2.094 . . . . 0.0 111.034 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 mp -71.35 -40.23 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.182 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.403 ' NH1' HD11 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -78.72 -25.81 44.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 132' ' ' LEU . 15.8 mm -68.1 -46.02 82.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.457 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.859 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -72.01 -58.08 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -28.6 62.29 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.57 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -74.02 -47.3 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.886 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.9 mt -54.43 -26.07 28.55 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -71.89 -18.63 62.03 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.772 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.32 -21.37 59.74 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.047 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.605 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 8.9 m-85 -95.42 -49.98 5.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 84.68 -22.72 0.19 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.729 ' O ' HD22 ' A' ' 123' ' ' LEU . 3.1 t -85.51 8.22 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.636 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 1.7 p-10 -69.84 55.43 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.439 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -118.82 34.96 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -150.96 149.22 29.35 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.041 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.453 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.9 m-80 -69.63 25.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.609 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.9 tt0 -167.0 25.7 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 117' ' ' SER . 6.6 tt -128.0 -49.46 1.34 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.89 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -56.65 -45.19 81.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.1 m -46.39 -31.27 2.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.117 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.77 -58.04 8.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.98 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.886 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.7 m-70 -58.76 -36.05 73.73 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.742 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.2 t -52.59 -48.53 47.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.29 -51.46 17.34 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.394 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -61.98 -20.92 64.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.756 0.312 . . . . 0.0 111.038 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.57 HD13 ' C ' ' A' ' 111' ' ' GLY . 66.8 mt -91.2 -27.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -63.8 -36.99 85.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.287 178.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -64.52 -34.2 77.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.87 -14.43 54.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.957 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.767 ' CE2' HG23 ' A' ' 103' ' ' ILE . 43.2 t80 -53.29 -60.16 3.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.027 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.555 ' HA ' HD12 ' A' ' 139' ' ' LEU . 27.6 p80 -56.31 -37.8 70.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.034 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.453 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 1.3 mm-40 -56.91 -30.9 64.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 110.009 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -34.93 44.78 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.968 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.765 HD11 ' CE1' ' A' ' 135' ' ' PHE . 25.3 mt -65.41 -32.46 74.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.627 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 82.9 t -75.49 -47.12 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.239 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -31.41 72.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.097 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -29.74 69.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.729 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.707 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -57.29 -26.62 61.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.994 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -102.51 38.05 1.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 111.061 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -114.23 -36.16 4.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 t -155.42 86.88 1.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 143' ' ' ARG . 12.8 mt -155.39 -176.88 6.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -59.41 -74.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.772 0.32 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.16 123.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.2 95.2 3.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' CD1' HG12 ' A' ' 100' ' ' ILE . 16.0 m-85 -60.05 -177.12 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.48 116.79 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.094 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.738 HG11 HG22 ' A' ' 9' ' ' VAL . 97.5 t -70.16 146.77 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.686 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.438 ' OG ' HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -81.72 -62.92 1.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.73 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 7.5 m-85 -143.48 111.78 6.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.738 HG22 HG11 ' A' ' 6' ' ' VAL . 3.2 t -106.35 97.35 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.577 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.474 ' CG ' HG23 ' A' ' 17' ' ' THR . 2.5 tt0 -98.96 110.04 22.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.256 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.965 HG23 HD13 ' A' ' 124' ' ' LEU . 58.4 t -77.6 158.79 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.581 ' CD1' HG23 ' A' ' 93' ' ' VAL . 1.4 mp -147.16 120.41 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.547 ' HB2' HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.54 113.89 27.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 178.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.58 34.61 17.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.534 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 22.93 62.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.688 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.45 119.52 13.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.474 HG23 ' CG ' ' A' ' 10' ' ' GLU . 3.2 m -50.95 128.61 21.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.121 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -107.08 -42.02 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.617 0.723 . . . . 0.0 109.476 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.665 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -128.62 175.24 8.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.331 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.512 ' N ' HD22 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -170.11 124.16 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.385 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 125' ' ' SER . 35.2 t -109.56 73.0 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.73 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -107.17 82.85 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.312 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.421 ' NE2' ' SG ' ' A' ' 21' ' ' CYS . 0.2 OUTLIER -97.24 141.6 23.28 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.47 -179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.47 141.29 11.15 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.758 2.305 . . . . 0.0 112.04 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.449 ' HE1' HD11 ' A' ' 97' ' ' LEU . 37.2 p90 -179.16 143.67 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.861 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -100.89 54.29 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.896 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 71.12 3.15 4.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.877 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.75 -82.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 111.317 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 27' ' ' LYS . 1.3 tt0 -176.73 -39.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.816 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -72.08 -80.65 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.985 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.2 139.64 50.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.866 0.365 . . . . 0.0 110.861 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.559 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . 170.28 -166.82 40.0 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.6 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.746 ' HB ' HD22 ' A' ' 97' ' ' LEU . 89.1 m -155.23 -44.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 111.144 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.644 ' O ' HG22 ' A' ' 35' ' ' THR . 23.6 mt -59.83 153.13 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -175.07 -79.6 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.673 179.279 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.5 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.8 OUTLIER -134.48 60.66 1.69 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.54 -43.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.972 0.415 . . . . 0.0 111.401 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 11.2 m120 -101.85 30.48 4.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.03 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.48 26.46 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.135 0.493 . . . . 0.0 110.691 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -114.08 -30.2 6.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.213 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.501 HG22 ' CE1' ' A' ' 46' ' ' PHE . 2.6 mm -56.31 113.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.458 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 1.007 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -78.56 151.54 77.44 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 87.2 Cg_exo -45.83 -22.37 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.099 1.866 . . . . 0.0 111.184 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 42' ' ' THR . 66.1 t -66.24 -49.61 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.414 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.007 HD12 HG22 ' A' ' 42' ' ' THR . 2.3 mp -58.76 -31.97 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.524 ' O ' HD12 ' A' ' 50' ' ' ILE . 72.3 m-85 -80.09 -42.71 23.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.05 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.632 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -69.98 -23.9 63.24 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.162 0.505 . . . . 0.0 110.595 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 52' ' ' ASP . 4.9 t-20 -89.01 -33.83 17.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.857 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.9 mt -56.9 -61.36 2.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.065 HG22 HD23 ' A' ' 55' ' ' LEU . 5.3 mt -51.95 -62.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.431 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.623 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.05 -44.6 41.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.119 -178.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 48' ' ' ASN . 17.2 m-20 -91.15 -19.49 23.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.487 ' HB2' HD21 ' A' ' 73' ' ' LEU . 71.5 mmm -114.84 -61.18 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.836 HG22 ' HG3' ' A' ' 69' ' ' MET . 91.9 t -68.04 -56.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.065 HD23 HG22 ' A' ' 50' ' ' ILE . 2.7 mm? -46.54 -51.69 34.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 13.2 Cg_exo -69.91 3.22 2.97 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.519 2.146 . . . . 0.0 112.07 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.13 22.96 1.36 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.334 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.588 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.0 p -86.73 154.84 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.716 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 61' ' ' ILE . 3.4 m -129.82 148.0 67.73 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.872 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HA ' HG21 ' A' ' 83' ' ' THR . 91.4 Cg_endo -78.15 23.33 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.668 1.579 . . . . 0.0 112.014 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.738 ' H ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER 41.73 -168.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.404 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.596 ' H ' HG22 ' A' ' 61' ' ' ILE . 16.4 tptt -96.29 -17.35 20.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 110.175 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.72 40.59 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.517 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.7 t30 71.6 74.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.296 . . . . 0.0 110.448 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.721 ' H ' HG21 ' A' ' 61' ' ' ILE . 6.9 mmtt -116.0 21.3 13.87 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.839 HG13 HD23 ' A' ' 109' ' ' LEU . 29.3 t 44.72 96.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.5 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.413 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 89.7 m -103.71 138.19 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 111.65 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 8.6 ttpt -94.25 135.79 35.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.836 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -53.81 -29.56 41.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m 51.28 27.21 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.05 0.452 . . . . 0.0 110.816 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.0 tpt -112.7 -13.28 13.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 62.67 69.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 0.0 110.599 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.69 ' HB3' HD22 ' A' ' 49' ' ' LEU . 6.8 mp -70.7 -49.65 44.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.617 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -126.69 158.34 37.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' HG23 ' A' ' 74' ' ' ILE . 24.2 t0 -99.34 141.12 32.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.431 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.59 -34.06 5.71 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.098 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -131.58 168.89 16.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.105 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 64.9 m-20 -112.75 125.76 54.68 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 10.7 m -86.17 121.65 29.07 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 74.7 m-85 -124.02 164.61 19.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.344 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.707 ' CD2' HG13 ' A' ' 54' ' ' VAL . 29.9 p90 -154.98 121.46 5.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.438 . . . . 0.0 111.149 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -125.08 119.26 28.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.378 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 23.8 p -85.31 143.53 28.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.9 0.381 . . . . 0.0 111.073 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 2.8 t0 -46.82 135.97 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.11 -30.07 66.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.258 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 18.9 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.624 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -154.98 92.16 2.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.441 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.07 -17.0 53.87 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.325 2.017 . . . . 0.0 111.779 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -95.13 33.55 1.52 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.413 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.612 ' O ' HG22 ' A' ' 90' ' ' THR . 16.2 m -152.87 69.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 92' ' ' TYR . 1.2 t -65.91 173.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.148 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.605 ' H ' HG12 ' A' ' 91' ' ' VAL . 56.1 m-85 -147.1 95.04 2.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.224 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.964 HG21 HG21 ' A' ' 50' ' ' ILE . 21.5 t -86.21 137.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 111.542 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.801 ' HB2' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -132.08 128.79 38.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.798 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 6.5 m-85 -109.97 85.64 2.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.945 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.31 128.2 37.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.156 0.503 . . . . 0.0 111.179 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.746 HD22 ' HB ' ' A' ' 33' ' ' THR . 13.1 mt -46.35 127.35 8.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.213 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.24 -30.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.695 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -32.22 70.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.67 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.431 HG23 ' HD2' ' A' ' 101' ' ' PRO . 43.0 mt -83.31 136.94 42.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.808 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HD2' HG23 ' A' ' 100' ' ' ILE . 19.4 Cg_endo -58.28 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.501 2.134 . . . . 0.0 112.311 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.485 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -111.56 63.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.938 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 5.5 tp -145.13 -43.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.012 HD11 ' HG ' ' A' ' 132' ' ' LEU . 2.8 tp -58.08 -60.21 10.83 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.945 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.9 Cg_endo -47.28 -35.39 20.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.641 2.227 . . . . 0.0 111.18 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.793 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.5 mp -67.02 -38.07 80.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.775 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.526 ' O ' HG21 ' A' ' 131' ' ' ILE . 21.5 mmm180 -79.42 -26.95 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.177 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.791 HG23 HG13 ' A' ' 128' ' ' VAL . 22.6 mm -62.97 -47.87 90.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.069 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.839 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -70.73 -56.34 6.62 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.0 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -56.3 -26.15 51.04 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -74.38 -47.17 17.63 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.955 HD23 ' HB2' ' A' ' 127' ' ' HIS . 9.9 mt -54.98 -31.33 60.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -72.08 -17.72 61.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.253 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.37 -22.38 60.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.28 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 5.5 m-85 -85.68 -93.66 0.08 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 8.0 tt0 161.89 -25.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.674 0.273 . . . . 0.0 111.031 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.23 -89.48 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.652 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.518 ' N ' HD22 ' A' ' 123' ' ' LEU . 2.0 p-10 40.87 31.37 0.12 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.89 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.5 34.38 4.37 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.502 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -145.99 151.58 38.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.606 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.449 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.9 p30 -72.0 22.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.6 tt0 -165.71 26.93 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.61 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.2 tt -130.0 -50.23 1.12 Allowed 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.965 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -54.36 -46.89 73.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.148 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 11.7 p -47.48 -29.65 2.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.544 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.45 -59.1 5.76 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.114 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.955 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.6 m-70 -55.99 -38.5 70.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.527 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.841 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.0 t -49.61 -51.14 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.95 -48.65 68.94 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.152 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -20.97 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 111.091 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.568 HD13 ' HA3' ' A' ' 111' ' ' GLY . 31.3 mt -90.66 -29.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 1.012 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -62.02 -42.18 98.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.153 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.72 -32.19 73.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.658 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -80.04 -12.66 59.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.973 ' CE2' HD21 ' A' ' 139' ' ' LEU . 5.9 t80 -47.67 -52.12 19.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.923 0.392 . . . . 0.0 111.105 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.551 ' HA ' HD12 ' A' ' 139' ' ' LEU . 94.5 m-70 -56.65 -42.36 78.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -51.08 -32.25 21.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 110.237 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -78.15 -35.41 48.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.914 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.973 HD21 ' CE2' ' A' ' 135' ' ' PHE . 24.6 mt -66.09 -33.07 74.95 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.796 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.47 -47.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.076 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -33.28 74.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.891 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -34.28 77.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.276 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 63.71 2.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.828 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.45 ' N ' HD13 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -177.85 -42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.954 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -80.07 135.45 36.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 t 43.6 54.98 5.2 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.47 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.45 HD13 ' N ' ' A' ' 144' ' ' ASN . 1.1 tp -85.37 110.99 19.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -79.86 71.55 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.763 -179.892 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.741 0.305 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HD2' ' CG ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -74.0 154.09 39.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.45 76.3 1.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CD2' HG12 ' A' ' 100' ' ' ILE . 5.8 m-85 -78.12 -175.23 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.76 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.678 ' HA ' HD21 ' A' ' 132' ' ' LEU . 3.9 t-20 -171.21 110.13 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.24 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.806 HG21 HG13 ' A' ' 108' ' ' ILE . 51.7 t -62.33 133.11 28.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.617 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -62.48 -61.43 2.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.111 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.66 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 6.2 m-85 -148.56 112.41 5.12 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.805 HG22 HG11 ' A' ' 6' ' ' VAL . 4.7 t -105.19 101.45 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.536 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.611 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.1 tt0 -109.96 121.58 45.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.844 0.354 . . . . 0.0 111.726 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.916 HG23 HD13 ' A' ' 124' ' ' LEU . 98.1 t -80.65 161.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.573 HG21 HD11 ' A' ' 55' ' ' LEU . 2.9 mp -142.89 113.21 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.54 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -98.95 110.29 22.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.892 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.86 34.45 17.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 78.06 26.1 60.72 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.032 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 12' ' ' ILE . 64.8 mm-40 -138.23 114.25 10.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.955 0.407 . . . . 0.0 109.938 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.611 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -49.46 130.84 20.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.959 -178.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.54 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.61 -47.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 109.993 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.765 ' OG ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -118.44 172.01 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.224 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.58 ' N ' HD22 ' A' ' 124' ' ' LEU . 58.0 p -170.16 125.99 0.79 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 15.8 t -113.24 69.68 0.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.66 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -105.3 90.59 3.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.933 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.07 139.94 21.87 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.393 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.31 147.84 18.43 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.646 2.231 . . . . 0.0 112.261 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' HZ ' ' HA ' ' A' ' 7' ' ' SER . 38.5 p90 178.77 136.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.792 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 50.3 mt-30 -99.1 60.37 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.988 0.423 . . . . 0.0 110.707 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt 64.17 129.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.819 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -85.17 -80.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.191 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -134.59 75.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.154 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 55.2 23.84 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.438 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 4.3 m-85 -123.82 31.3 5.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.719 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.618 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . -150.21 -152.55 5.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.602 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.773 ' HB ' HD22 ' A' ' 97' ' ' LEU . 94.5 m -159.73 -41.93 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.693 0.282 . . . . 0.0 111.089 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.732 HG13 HD21 ' A' ' 97' ' ' LEU . 6.3 mt -59.41 141.24 16.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.329 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -173.04 -78.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.812 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.499 ' N ' ' OG1' ' A' ' 35' ' ' THR . 26.0 m -131.85 61.53 1.65 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.784 0.326 . . . . 0.0 111.015 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 36' ' ' SER . . . 176.79 -35.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.568 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 10.4 m120 -110.8 32.26 5.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.508 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.43 26.77 6.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.068 0.461 . . . . 0.0 110.666 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -121.64 29.22 7.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.771 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.792 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.1 mt -124.5 122.18 63.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.417 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.932 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -83.14 151.34 63.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.459 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.493 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 85.5 Cg_exo -45.29 -22.92 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.27 1.98 . . . . 0.0 111.697 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.761 ' HB ' HG23 ' A' ' 42' ' ' THR . 47.4 t -66.56 -44.74 89.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.071 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.932 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -59.1 -32.01 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.792 ' CE2' HG22 ' A' ' 41' ' ' ILE . 38.6 m-85 -81.58 -43.47 18.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.059 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.65 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.66 -29.13 70.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.346 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.11 -28.37 19.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 73' ' ' LEU . 3.3 mt -62.68 -60.39 3.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.003 HG12 HG11 ' A' ' 93' ' ' VAL . 5.3 mt -51.79 -63.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.73 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.65 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.27 -43.43 61.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.18 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.64 -15.65 30.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.574 ' HB2' HD21 ' A' ' 73' ' ' LEU . 65.2 mmm -123.57 -69.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.803 HG13 ' CD1' ' A' ' 81' ' ' TYR . 93.0 t -52.33 -51.7 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.694 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.9 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -53.87 -59.15 10.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.669 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 30.4 Cg_endo -64.27 3.93 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.093 1.862 . . . . 0.0 112.487 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.62 22.7 1.63 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.099 0.476 . . . . 0.0 110.129 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 81' ' ' TYR . 4.6 p -87.8 166.88 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.469 ' H ' HG22 ' A' ' 58' ' ' VAL . 34.6 m -148.67 148.04 26.75 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.244 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 61' ' ' ILE . 64.3 Cg_endo -78.18 25.73 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.048 1.832 . . . . 0.0 112.762 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.542 HG21 ' C ' ' A' ' 64' ' ' ASN . 3.4 mp 53.04 160.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.315 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' N ' HG22 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -117.74 -65.81 1.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.055 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.4 31.8 3.2 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.602 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.542 ' C ' HG21 ' A' ' 61' ' ' ILE . 6.8 t30 -146.5 -146.0 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.67 141.46 0.15 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.597 0.237 . . . . 0.0 110.738 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 109' ' ' LEU . 11.8 t 66.35 72.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 CA-C-O 120.839 0.352 . . . . 0.0 110.457 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.5 m -93.31 144.74 25.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 111.694 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HD2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -90.9 133.72 35.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 54' ' ' VAL . 10.7 mmm -54.4 -32.51 57.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.9 m 58.34 27.32 15.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 40.3 mmm -107.71 -15.68 14.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.03 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 66.89 61.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.896 0.379 . . . . 0.0 110.374 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.574 HD21 ' HB2' ' A' ' 53' ' ' MET . 7.8 mp -62.44 -46.95 86.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.131 0.491 . . . . 0.0 110.382 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.721 HD13 HD12 ' A' ' 41' ' ' ILE . 1.5 mt -136.47 154.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.447 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 6.3 t0 -94.06 139.47 30.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.629 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 105.06 -32.42 7.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.506 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.585 ' O ' HG13 ' A' ' 98' ' ' VAL . 6.2 m-85 -110.31 -179.47 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.03 0.443 . . . . 0.0 111.876 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -129.4 113.17 14.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.936 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.1 p -83.66 108.79 16.97 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.458 ' O ' HG13 ' A' ' 93' ' ' VAL . 47.4 m-85 -121.97 155.73 34.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.199 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.803 ' CD1' HG13 ' A' ' 54' ' ' VAL . 17.8 p90 -147.57 137.64 22.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.06 0.457 . . . . 0.0 111.263 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.572 ' OG ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -140.85 117.66 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.775 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 6.8 p -82.53 146.89 28.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.802 0.334 . . . . 0.0 110.786 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.52 138.4 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.0 0.429 . . . . 0.0 111.209 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -51.91 -24.93 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.981 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 20.52 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -146.48 93.41 4.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.66 0.267 . . . . 0.0 111.129 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.3 -14.59 43.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.309 2.006 . . . . 0.0 111.934 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.13 30.98 2.27 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.313 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.579 ' O ' HG22 ' A' ' 90' ' ' THR . 19.3 m -154.58 71.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -70.07 175.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.668 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.557 ' H ' HG12 ' A' ' 91' ' ' VAL . 43.3 m-85 -151.12 97.88 2.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.931 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.003 HG11 HG12 ' A' ' 50' ' ' ILE . 24.5 t -101.44 127.13 55.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 111.692 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.74 ' HB2' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -114.95 117.43 30.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.06 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 1.1 m-85 -92.66 73.92 5.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.909 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.65 -174.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.012 0.434 . . . . 0.0 111.22 -178.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.773 HD22 ' HB ' ' A' ' 33' ' ' THR . 57.4 mt -101.1 126.08 47.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.288 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -42.61 -36.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.395 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -38.83 92.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.493 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 101' ' ' PRO . 86.1 mt -65.28 139.07 97.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.803 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 100' ' ' ILE . 16.6 Cg_endo -57.48 -171.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.528 2.152 . . . . 0.0 112.277 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.22 67.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.558 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 8.1 tp -154.66 -38.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.633 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.731 ' HG ' HD11 ' A' ' 108' ' ' ILE . 19.1 tp -57.7 -61.03 8.09 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.909 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.6 Cg_endo -48.39 -34.98 26.85 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.575 2.183 . . . . 0.0 111.08 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.846 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -67.02 -34.54 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.939 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.614 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.92 -27.76 33.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 179.127 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.806 HG13 HG21 ' A' ' 6' ' ' VAL . 7.9 mm -64.19 -46.69 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -74.92 -49.59 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.188 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.1 t -62.97 -27.91 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -78.15 -46.37 9.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.826 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.6 mt -57.39 -32.04 66.42 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -73.51 -17.07 61.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.929 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -22.4 59.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 6.8 m-85 -85.02 -94.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.7 tt0 159.25 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.346 0.259 . . . . 0.0 110.856 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 m -92.12 -93.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.681 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.524 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.8 p-10 41.27 30.94 0.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.51 31.17 5.81 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.504 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.47 157.46 44.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.24 178.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HA ' ' N ' ' A' ' 20' ' ' SER . 2.1 p-10 -78.13 20.73 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.0 tp10 -163.63 25.48 0.08 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.639 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt -126.35 -49.06 1.55 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.916 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.93 -45.68 78.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.434 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -45.59 -30.61 1.54 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.178 178.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.45 -57.85 11.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.956 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.826 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.6 m-70 -58.87 -37.3 76.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.68 HG13 HG23 ' A' ' 108' ' ' ILE . 43.6 t -51.78 -45.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.414 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.3 -45.7 37.6 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.153 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -66.17 -22.52 66.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.946 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.614 HG21 ' O ' ' A' ' 107' ' ' ARG . 32.8 mt -90.32 -28.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -63.6 -42.52 98.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.355 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.18 -40.45 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -81.41 -15.86 53.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.151 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.981 ' CE2' HD11 ' A' ' 139' ' ' LEU . 0.3 OUTLIER -53.3 -57.9 8.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.991 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 2' ' ' LYS . 97.7 m-70 -61.21 -45.9 92.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.714 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -50.0 -29.11 7.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.938 0.399 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -77.62 -36.39 51.71 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.11 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.981 HD11 ' CE2' ' A' ' 135' ' ' PHE . 19.2 mt -67.08 -29.36 69.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.247 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.6 t -77.62 -48.03 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.504 0.668 . . . . 0.0 109.522 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -65.43 -33.23 75.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.12 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -64.38 -33.23 75.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.267 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.48 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -61.29 -25.45 67.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.99 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.23 55.67 0.65 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -145.92 101.3 3.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.86 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t 43.15 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 143' ' ' ARG . 0.7 OUTLIER -121.56 141.59 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -130.91 33.14 4.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.956 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.953 0.406 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.08 107.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -140.34 -169.63 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.686 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 2.7 m-85 -100.15 152.44 20.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.971 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 179.77 107.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.176 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 104' ' ' LEU . 2.9 t -68.03 144.74 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.47 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.451 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -90.26 -61.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.796 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.682 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 5.1 m-85 -131.37 141.77 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.742 ' O ' HD21 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -148.69 100.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 12.0 pt-20 -115.02 138.41 50.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.863 HG23 HD13 ' A' ' 124' ' ' LEU . 53.0 t -90.86 151.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.893 HD13 HG23 ' A' ' 93' ' ' VAL . 4.1 mp -131.53 123.8 53.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 2.7 tttt -113.09 114.83 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.54 33.75 8.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.618 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 81.68 24.12 56.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.939 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.791 ' O ' HG23 ' A' ' 12' ' ' ILE . 1.3 tt0 -114.58 -142.91 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.647 0.26 . . . . 0.0 110.583 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.8 m -153.68 75.26 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.49 -43.08 86.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.704 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.686 ' OG ' HD13 ' A' ' 124' ' ' LEU . 4.0 p -122.41 170.01 10.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.865 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 30.6 m -168.23 118.27 0.77 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.0 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 15.8 t -111.48 68.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.682 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -116.1 87.72 2.74 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 1.2 mp0 -125.2 148.76 61.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.84 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.36 140.46 15.33 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.788 2.325 . . . . 0.0 111.359 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -137.82 -33.24 0.72 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.776 -179.367 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.565 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 2.5 tt0 56.0 53.2 9.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER 38.16 91.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.529 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -91.76 97.04 10.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.593 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.54 -72.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.915 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -83.44 143.6 30.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.971 0.415 . . . . 0.0 111.616 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.657 ' CE2' HD12 ' A' ' 97' ' ' LEU . 1.7 t80 59.71 158.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.263 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' HA2' ' CB ' ' A' ' 27' ' ' LYS . . . -152.69 123.5 1.46 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.906 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.717 HG21 HD22 ' A' ' 97' ' ' LEU . 19.9 m -163.93 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.898 0.38 . . . . 0.0 111.365 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.594 HG13 HD21 ' A' ' 97' ' ' LEU . 10.6 mt -77.76 151.1 5.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.498 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' C ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -174.31 -84.8 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.178 178.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.488 ' N ' ' OG1' ' A' ' 35' ' ' THR . 65.8 m -128.25 42.87 3.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.88 -46.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 73.7 m-20 -106.21 30.57 5.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.871 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.29 27.54 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -107.95 -36.27 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.772 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.634 HD12 HD13 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -56.58 119.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.68 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 1.08 HG22 HD12 ' A' ' 45' ' ' ILE . 13.2 t -81.14 157.23 71.23 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.389 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.618 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 54.2 Cg_exo -50.88 -21.74 8.96 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 121.917 1.744 . . . . 0.0 111.051 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.703 ' HB ' HG23 ' A' ' 42' ' ' THR . 48.1 t -66.16 -47.8 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.402 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.08 HD12 HG22 ' A' ' 42' ' ' THR . 1.9 mp -58.58 -33.3 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 41' ' ' ILE . 68.3 m-85 -81.36 -40.84 22.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.732 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.658 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -67.09 -27.28 67.22 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -88.28 -28.64 20.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.656 HD22 ' HB3' ' A' ' 73' ' ' LEU . 3.8 mt -61.47 -60.23 4.03 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.014 HG22 HD23 ' A' ' 55' ' ' LEU . 6.4 mt -51.52 -64.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.723 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.594 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -49.8 -40.37 41.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.661 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -91.14 -16.62 27.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.495 ' N ' ' O ' ' A' ' 49' ' ' LEU . 69.3 mmm -124.64 -68.69 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 81' ' ' TYR . 90.5 t -51.99 -51.52 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.697 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.014 HD23 HG22 ' A' ' 50' ' ' ILE . 1.8 mm? -56.59 -58.19 18.76 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.849 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 28.0 Cg_endo -63.25 1.73 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.113 1.875 . . . . 0.0 112.662 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HB3' ' HE1' ' A' ' 69' ' ' MET . 3.2 tptt -147.24 26.35 1.07 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.106 0.479 . . . . 0.0 109.942 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.7 p -85.27 167.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.895 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.5 ' H ' HG22 ' A' ' 58' ' ' VAL . 17.3 m -137.74 146.34 52.48 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.157 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 73.2 Cg_endo -75.72 29.75 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.121 1.881 . . . . 0.0 112.19 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.779 HD12 ' H ' ' A' ' 65' ' ' LYS . 31.6 mm 41.72 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.217 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.0 -25.75 17.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.573 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.29 40.22 0.1 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.988 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -126.64 -62.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 111.166 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.779 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER 68.74 99.78 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.979 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.849 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.5 t 76.06 65.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.664 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.9 m -92.82 135.38 34.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.436 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 3.2 tttt -87.09 125.6 34.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.414 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.565 ' HG2' HD11 ' A' ' 73' ' ' LEU . 1.4 ttm -52.34 -36.08 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m 58.47 24.48 11.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.519 ' CG ' ' HG2' ' A' ' 69' ' ' MET . 17.3 mmt -101.2 6.43 43.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 55.39 53.05 10.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.656 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.2 mp -59.98 -32.83 71.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.623 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.634 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -153.42 151.49 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -95.71 138.9 32.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 111.31 -32.8 6.22 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.204 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.483 ' HD2' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -131.74 175.46 9.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.342 . . . . 0.0 111.004 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -119.56 123.92 45.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 3.8 t -82.01 101.03 10.06 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 19.6 m-85 -109.26 126.09 52.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.491 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.537 ' HB3' HG11 ' A' ' 54' ' ' VAL . 52.5 p90 -120.12 135.64 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.072 0.463 . . . . 0.0 111.28 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.616 ' HG ' ' HB2' ' A' ' 92' ' ' TYR . 0.7 OUTLIER -138.91 116.29 11.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.418 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.885 HG22 HG13 ' A' ' 91' ' ' VAL . 74.5 p -86.11 154.16 21.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -49.6 155.21 0.83 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -68.25 -20.85 64.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.2 22.27 0.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.611 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.59 89.88 7.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.2 -16.93 43.22 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.362 2.041 . . . . 0.0 111.982 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.67 30.59 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.447 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.54 ' O ' HG22 ' A' ' 90' ' ' THR . 22.0 m -154.84 73.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.806 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.885 HG13 HG22 ' A' ' 83' ' ' THR . 0.7 OUTLIER -75.96 177.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.619 ' H ' HG12 ' A' ' 91' ' ' VAL . 36.2 m-85 -149.42 106.89 3.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.979 HG21 HG21 ' A' ' 50' ' ' ILE . 44.3 t -104.89 137.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.19 0.519 . . . . 0.0 111.754 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.565 ' SG ' HG13 ' A' ' 9' ' ' VAL . 45.3 t -138.7 110.27 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.727 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.5 m-85 -87.0 83.93 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.925 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -82.01 130.18 35.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.885 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 33' ' ' THR . 87.0 mt -46.61 126.88 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.698 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.45 -33.06 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.433 ' HB2' ' HH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -61.03 -18.18 56.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.342 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.496 HG13 ' OH ' ' A' ' 31' ' ' TYR . 4.7 mt -87.26 136.47 33.54 Favored Pre-proline 0 N--CA 1.461 0.113 0 CA-C-O 120.501 0.191 . . . . 0.0 110.773 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 38.0 Cg_exo -59.56 -157.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.304 2.003 . . . . 0.0 111.645 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.415 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.4 OUTLIER -112.83 63.7 0.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.693 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.547 ' HA ' HD13 ' A' ' 106' ' ' ILE . 3.3 tp -150.91 -40.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.843 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 108' ' ' ILE . 29.1 tp -58.14 -62.28 5.83 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.125 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.925 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.7 Cg_endo -49.05 -27.32 11.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.265 1.976 . . . . 0.0 111.486 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.849 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.3 mp -76.15 -34.68 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.633 ' O ' HG21 ' A' ' 131' ' ' ILE . 4.0 mmp_? -84.07 -27.51 28.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.395 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.033 HD11 HD11 ' A' ' 104' ' ' LEU . 7.7 mm -71.35 -51.6 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.749 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.63 -55.71 14.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.595 178.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -60.78 -25.86 66.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.667 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -71.32 -50.8 19.96 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.431 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.986 HD23 ' HB2' ' A' ' 127' ' ' HIS . 5.3 mt -52.94 -27.84 20.77 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.82 -21.47 57.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.416 ' HG3' ' CD1' ' A' ' 115' ' ' TYR . 0.4 OUTLIER -75.18 -19.53 59.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.452 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 29.7 m-85 -82.12 -92.57 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.71 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 16.0 tt0 157.94 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.697 0.399 . . . . 0.0 110.621 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -92.89 -92.75 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.529 ' N ' HD22 ' A' ' 123' ' ' LEU . 4.0 p-10 40.61 31.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 110.98 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.93 33.64 4.48 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.487 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.93 159.62 42.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.751 0.31 . . . . 0.0 110.421 179.047 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.433 ' HA ' ' N ' ' A' ' 20' ' ' SER . 6.1 p30 -78.78 19.43 0.51 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.41 24.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.054 0.454 . . . . 0.0 109.799 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt -124.53 -49.66 1.77 Allowed 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.463 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.863 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.23 -47.43 75.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.515 ' H ' HD23 ' A' ' 124' ' ' LEU . 96.6 p -46.23 -31.94 2.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.301 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -55.36 34.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.986 ' HB2' HD23 ' A' ' 112' ' ' LEU . 7.8 m170 -58.3 -37.29 74.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.784 HG13 ' CG2' ' A' ' 108' ' ' ILE . 46.9 t -50.48 -49.89 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.976 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.72 -49.24 37.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.843 -1.17 . . . . 0.0 112.334 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -64.18 -18.77 64.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.645 0.26 . . . . 0.0 111.246 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.667 HD13 ' HA3' ' A' ' 111' ' ' GLY . 53.6 mt -90.71 -28.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -64.1 -40.71 96.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.06 178.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.75 -32.4 74.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.433 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.99 -15.92 37.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.927 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.983 ' CZ ' HD21 ' A' ' 139' ' ' LEU . 34.3 t80 -50.81 -38.41 48.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.714 0.293 . . . . 0.0 110.919 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.497 ' HA ' HD12 ' A' ' 139' ' ' LEU . 9.5 m170 -60.2 -45.92 91.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.616 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -50.35 -29.41 9.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.084 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -78.36 -35.99 46.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.888 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.983 HD21 ' CZ ' ' A' ' 135' ' ' PHE . 30.9 mt -63.72 -35.03 79.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.307 0.575 . . . . 0.0 109.558 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 79.5 t -74.62 -47.78 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.01 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -61.37 -30.08 70.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.989 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -16.35 63.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.701 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.654 ' O ' HD11 ' A' ' 147' ' ' LEU . 2.9 ttp180 -90.55 21.89 3.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.16 -43.93 1.62 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.703 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.23 -77.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.97 127.98 56.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.872 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.654 HD11 ' O ' ' A' ' 143' ' ' ARG . 5.6 mp -124.23 179.57 4.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 60.3 30.96 20.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.851 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.715 0.293 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 61.38 113.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.837 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -88.61 -167.01 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CD2' HG12 ' A' ' 100' ' ' ILE . 2.3 m-85 -142.84 -178.23 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.984 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.47 118.79 4.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.806 HG11 ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -71.98 146.07 11.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.438 179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.462 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -83.44 -59.9 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.0 111.563 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.654 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 11.4 m-85 -146.66 125.11 12.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.732 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.806 ' CG2' HG11 ' A' ' 6' ' ' VAL . 2.4 t -120.19 93.76 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.0 OUTLIER -100.95 116.83 33.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.033 HG23 HD13 ' A' ' 124' ' ' LEU . 95.0 t -89.28 136.34 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.668 HG21 HD11 ' A' ' 55' ' ' LEU . 2.2 mp -114.2 119.11 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HB2' HD13 ' A' ' 18' ' ' ILE . 3.5 tttt -104.86 107.88 19.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.083 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 61.96 37.71 14.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.629 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 26.24 60.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.637 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.72 115.9 6.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.0 109.993 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 24.7 m -47.1 127.74 10.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.208 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.599 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -99.91 -42.38 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 120' ' ' THR . 94.4 p -132.7 177.12 7.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.592 ' N ' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -169.85 125.8 0.83 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.561 ' N ' HD21 ' A' ' 124' ' ' LEU . 36.5 t -107.64 69.79 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.825 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.654 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -106.12 84.83 2.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -105.83 142.96 25.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.548 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.59 145.63 13.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.819 2.346 . . . . 0.0 112.253 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 p90 179.19 115.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.811 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.5 pt20 -78.8 59.15 2.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.753 0.311 . . . . 0.0 111.193 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 tttt 58.22 162.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.082 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -114.23 43.71 1.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.857 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 45.36 35.44 1.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.393 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -175.89 -55.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.807 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -123.5 102.69 8.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.947 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.46 -171.16 38.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.534 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.743 ' HB ' HD22 ' A' ' 97' ' ' LEU . 23.2 m -163.89 -42.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.705 HG13 HD21 ' A' ' 97' ' ' LEU . 13.8 mt -56.19 161.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.313 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -173.0 -79.27 0.01 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.673 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.51 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.4 OUTLIER -134.67 -57.46 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.929 0.395 . . . . 0.0 111.181 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.65 -26.24 65.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.336 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 34' ' ' ILE . 8.2 m120 -120.36 32.14 6.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.195 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -131.54 27.39 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.978 0.418 . . . . 0.0 110.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -109.92 -36.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.805 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.713 HG22 ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -50.93 116.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.754 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.831 HG22 HD12 ' A' ' 45' ' ' ILE . 2.7 t -78.68 149.66 74.84 Favored Pre-proline 0 CA--C 1.518 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.623 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.52 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.8 Cg_endo -45.19 -22.57 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 111.079 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.655 ' HB ' HG23 ' A' ' 42' ' ' THR . 97.6 t -64.51 -47.29 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.893 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.831 HD12 HG22 ' A' ' 42' ' ' THR . 1.7 mp -58.33 -32.71 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.713 ' CE2' HG22 ' A' ' 41' ' ' ILE . 90.0 m-85 -80.71 -43.29 20.52 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.337 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.662 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.03 -28.19 69.92 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -87.82 -30.73 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.819 HD11 HG13 ' A' ' 74' ' ' ILE . 5.3 mt -61.71 -61.61 2.39 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.013 HG22 HD23 ' A' ' 55' ' ' LEU . 5.6 mt -50.04 -61.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.976 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.662 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -51.72 -43.4 62.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.066 -1.424 . . . . 0.0 113.075 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.86 -19.58 23.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.518 ' HB2' HD21 ' A' ' 73' ' ' LEU . 85.0 mmm -118.23 -65.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.665 HG22 ' HG3' ' A' ' 69' ' ' MET . 94.9 t -58.3 -57.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.8 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.013 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -44.91 -57.15 7.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.7 Cg_endo -65.92 4.63 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 121.969 1.779 . . . . 0.0 112.426 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -145.89 23.38 1.38 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.124 0.488 . . . . 0.0 110.07 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.486 HG23 ' CD2' ' A' ' 81' ' ' TYR . 5.1 p -86.33 166.65 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.878 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG22 ' HE2' ' A' ' 81' ' ' TYR . 32.6 m -135.97 146.66 57.68 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.101 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.416 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 72.5 Cg_endo -75.84 28.81 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.166 1.911 . . . . 0.0 112.561 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.846 HD12 ' H ' ' A' ' 65' ' ' LYS . 38.9 mm 41.13 103.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.631 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -26.43 14.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.56 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -173.69 39.27 0.14 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.274 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -130.11 -69.25 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.846 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.3 OUTLIER 72.37 108.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.08 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.961 HG21 ' HA ' ' A' ' 106' ' ' ILE . 2.7 t 72.71 59.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.795 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -92.3 135.68 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.46 ' CE ' ' CZ ' ' A' ' 80' ' ' PHE . 8.0 ttmt -81.44 128.39 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.665 ' HG3' HG22 ' A' ' 54' ' ' VAL . 16.3 mmm -52.8 -25.59 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.193 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 m 53.97 25.89 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.9 tpt -104.34 -17.15 14.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 65.94 62.2 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.546 ' HB3' HD13 ' A' ' 49' ' ' LEU . 7.9 mp -66.18 -52.6 46.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.739 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.819 HG13 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -122.35 158.86 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 74' ' ' ILE . 23.3 t0 -104.23 141.53 36.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.424 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.618 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.39 -34.48 5.37 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.164 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -126.17 -171.76 2.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.672 0.272 . . . . 0.0 110.56 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 2.4 m-20 -127.97 127.4 43.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.2 p -82.5 103.41 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.46 ' CZ ' ' CE ' ' A' ' 68' ' ' LYS . 29.5 m-85 -115.91 136.34 53.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.604 ' CB ' HG22 ' A' ' 93' ' ' VAL . 48.8 p90 -130.92 140.01 50.14 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.846 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.456 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 2.0 t -144.28 123.34 12.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.45 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.941 HG22 HG13 ' A' ' 91' ' ' VAL . 44.8 p -87.0 153.28 21.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 0.0 110.964 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -47.09 158.36 0.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.209 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.51 0.73 45.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.559 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.48 21.63 0.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.77 102.08 1.31 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.53 0.205 . . . . 0.0 111.329 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.28 -15.11 48.55 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.452 2.101 . . . . 0.0 111.803 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -95.81 30.37 2.39 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.144 0.497 . . . . 0.0 110.14 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.412 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 86.0 m -151.51 71.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.941 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -73.55 178.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.552 ' H ' HG12 ' A' ' 91' ' ' VAL . 49.1 m-85 -152.98 84.19 1.21 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.175 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.779 HG11 HG12 ' A' ' 50' ' ' ILE . 59.8 t -98.52 132.32 43.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.411 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.701 ' HB3' HG13 ' A' ' 9' ' ' VAL . 21.5 p -139.48 131.44 27.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.097 0.475 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 37.7 m-85 -89.33 91.07 8.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.061 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.899 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -85.92 137.0 33.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.743 HD22 ' HB ' ' A' ' 33' ' ' THR . 89.1 mt -48.5 127.75 13.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -50.78 -37.91 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.358 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.15 -25.33 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' A' ' 101' ' ' PRO . 76.2 mt -80.2 138.43 52.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.876 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 100' ' ' ILE . 22.3 Cg_endo -60.98 176.99 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.459 2.106 . . . . 0.0 112.069 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -94.37 61.15 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.682 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 6.1 tp -149.59 -32.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.996 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 108' ' ' ILE . 16.4 tp -61.59 -62.17 6.42 Favored Pre-proline 0 C--O 1.226 -0.143 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.049 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.899 ' HD3' HG21 ' A' ' 96' ' ' THR . 7.6 Cg_endo -49.02 -29.71 16.35 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.397 2.065 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.961 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 mp -72.73 -35.94 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.54 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.83 -26.62 34.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.077 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 104' ' ' LEU . 19.6 mm -73.83 -51.27 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.543 ' HA ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -67.28 -57.37 6.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -59.22 -25.91 64.41 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.587 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -73.97 -45.98 24.5 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 127' ' ' HIS . 10.4 mt -55.2 -26.7 40.96 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.62 -18.92 62.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.91 -21.55 61.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.93 0.395 . . . . 0.0 109.966 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.455 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 3.4 m-85 -93.14 -170.68 2.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.468 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -127.12 2.4 6.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.718 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.3 p -114.81 -93.53 0.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.594 ' HB3' ' CD2' ' A' ' 127' ' ' HIS . 1.5 p-10 41.13 31.82 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.49 35.2 4.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -151.1 149.86 30.01 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.396 178.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.412 ' HA ' ' H ' ' A' ' 20' ' ' SER . 40.6 t-20 -69.64 28.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.781 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -169.92 27.1 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.117 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt -132.28 -49.64 0.93 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 1.033 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -54.7 -45.98 74.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 t -47.67 -29.78 3.26 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.359 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.25 -57.82 11.34 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.015 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.906 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.6 m-70 -57.06 -36.65 70.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.609 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.703 HG13 HD12 ' A' ' 108' ' ' ILE . 44.3 t -51.79 -48.3 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.21 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.679 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -72.26 -48.93 22.8 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.54 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.03 -20.69 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 110.701 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.587 HD13 ' HA3' ' A' ' 111' ' ' GLY . 70.3 mt -90.89 -28.2 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.679 HD12 ' HA2' ' A' ' 129' ' ' GLY . 1.1 mt -61.49 -43.69 98.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.028 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.55 -31.0 70.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.25 16.55 26.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.682 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 1.1 t80 -88.64 -43.48 11.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.446 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.45 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -75.27 -30.94 60.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.79 -28.62 57.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.482 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -80.53 -35.86 33.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.567 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 5.3 mt -70.79 -30.09 66.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 109.942 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 136' ' ' HIS . 88.7 t -75.14 -46.8 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.97 -30.38 64.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.843 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.78 -36.61 70.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.382 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.56 -24.8 49.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.096 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -114.26 30.18 7.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.015 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.469 ' O ' HG22 ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.91 94.79 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.864 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 145' ' ' GLN . 11.2 t 46.21 47.67 13.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.438 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.6 mt -117.01 79.52 1.34 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -99.44 91.78 5.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 0.0 110.828 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.975 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.784 0.326 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -158.5 151.1 22.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.418 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -117.25 -178.02 3.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' CD2' HG12 ' A' ' 100' ' ' ILE . 10.5 m-85 -157.63 -176.91 6.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.793 ' HA ' HD21 ' A' ' 132' ' ' LEU . 1.6 t30 -174.65 146.61 1.0 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.942 0.401 . . . . 0.0 111.282 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.902 HG13 HG23 ' A' ' 96' ' ' THR . 1.5 t -93.05 122.3 44.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.842 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.544 ' OG ' HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -53.74 -55.92 21.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.963 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.649 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 4.4 m-85 -147.57 116.38 6.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.762 HG13 ' SG ' ' A' ' 94' ' ' CYS . 3.1 t -108.51 97.27 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 1.4 tt0 -105.46 115.63 30.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.929 ' CG2' HD13 ' A' ' 124' ' ' LEU . 6.1 t -79.98 159.54 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.629 HD11 HG21 ' A' ' 50' ' ' ILE . 2.5 mp -140.15 114.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 18' ' ' ILE . 21.4 tttm -96.93 106.54 18.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.459 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 57.68 39.96 26.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.301 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.482 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 77.92 26.74 59.8 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.228 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -144.56 110.82 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.042 0.448 . . . . 0.0 110.069 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.472 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -42.99 130.23 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.478 -178.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.76 -47.56 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.997 178.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.591 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -127.53 176.62 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.217 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.527 ' N ' HD22 ' A' ' 124' ' ' LEU . 2.0 m -168.67 128.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.504 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 35.9 t -115.29 69.42 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.649 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.73 91.93 3.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.785 -178.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.05 139.94 25.7 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.505 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.75 146.03 18.47 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.687 2.258 . . . . 0.0 111.619 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 45.4 p90 -179.34 126.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 111.31 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.63 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.3 pt20 -86.41 54.64 3.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.14 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.34 -166.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.672 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -135.31 -67.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.725 0.297 . . . . 0.0 111.101 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -124.09 -76.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -108.42 -52.15 2.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' CD1' ' HA ' ' A' ' 4' ' ' PHE . 45.7 p90 -63.27 -172.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.717 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . 88.45 174.35 47.32 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.682 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.873 ' HB ' HD22 ' A' ' 97' ' ' LEU . 92.6 m -157.82 -43.19 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.8 0.333 . . . . 0.0 110.95 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.63 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 27.2 mt -59.31 159.16 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -174.06 -79.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 178.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.491 ' N ' ' OG1' ' A' ' 35' ' ' THR . 2.6 m -143.67 64.06 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.943 0.402 . . . . 0.0 111.041 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.26 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.3 m-20 -101.64 30.81 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.649 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.73 26.58 7.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -108.33 -37.34 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.605 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.655 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.19 117.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.56 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.868 HG22 HD12 ' A' ' 45' ' ' ILE . 3.8 t -78.28 151.06 77.9 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 72.4 Cg_exo -47.32 -21.05 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.848 1.699 . . . . 0.0 111.042 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.667 ' HB ' HG23 ' A' ' 42' ' ' THR . 46.7 t -65.79 -45.97 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.183 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.868 HD12 HG22 ' A' ' 42' ' ' THR . 1.7 mp -59.57 -33.5 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CE2' HG22 ' A' ' 41' ' ' ILE . 74.3 m-85 -80.11 -43.82 21.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.447 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.611 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.24 -28.24 69.6 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.414 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.49 -29.7 18.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.858 HD11 HG13 ' A' ' 74' ' ' ILE . 3.6 mt -60.67 -60.5 3.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.049 HG22 HD23 ' A' ' 55' ' ' LEU . 5.1 mt -51.95 -64.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.704 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.72 -38.18 32.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.787 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -91.04 -23.27 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LEU . 40.7 mmm -119.14 -69.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.887 HG22 ' HG3' ' A' ' 69' ' ' MET . 88.8 t -53.52 -53.29 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.848 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.049 HD23 HG22 ' A' ' 50' ' ' ILE . 3.3 mm? -51.85 -58.74 10.04 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.0 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 33.2 Cg_endo -65.38 6.44 0.41 Allowed 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.197 1.931 . . . . 0.0 112.719 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 0.1 OUTLIER -151.0 25.04 0.74 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.099 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 81' ' ' TYR . 9.8 p -82.49 146.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.503 ' C ' ' H ' ' A' ' 61' ' ' ILE . 5.2 t -96.79 138.87 21.36 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.505 ' HA ' HG21 ' A' ' 83' ' ' THR . 65.4 Cg_endo -74.19 28.16 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.814 1.676 . . . . 0.0 111.952 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' H ' ' C ' ' A' ' 59' ' ' VAL . 29.1 mm 18.52 85.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.959 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.71 -40.5 8.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.126 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -118.05 -32.22 1.44 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.928 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 61' ' ' ILE . 1.4 t30 -82.89 -160.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.44 117.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.717 0.294 . . . . 0.0 111.122 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 1.03 HG21 ' HA ' ' A' ' 106' ' ' ILE . 5.4 t 65.33 60.97 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.699 0.285 . . . . 0.0 111.217 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.577 HG22 ' CE1' ' A' ' 81' ' ' TYR . 1.4 t -92.8 144.56 25.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.748 0.309 . . . . 0.0 111.113 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HD2' ' CE1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.23 142.2 31.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.887 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.18 -33.4 72.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.802 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m 59.2 26.21 14.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.306 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.418 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 14.2 mmm -111.66 -0.25 16.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.469 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 56.87 59.62 3.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.123 0.487 . . . . 0.0 110.516 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.851 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.9 mp -60.45 -45.79 92.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.858 HG13 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -139.26 156.32 27.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.684 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -102.47 138.84 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.375 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 113.7 -31.35 6.64 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.416 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -125.74 -165.0 1.36 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.929 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 1.9 m-20 -137.83 117.94 13.49 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.728 ' SG ' HD13 ' A' ' 73' ' ' LEU . 23.4 p -87.38 115.51 24.84 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 49.4 m-85 -123.83 151.74 43.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.867 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.832 ' CD2' HG13 ' A' ' 54' ' ' VAL . 30.0 p90 -141.87 135.36 29.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.676 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -140.06 123.78 17.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.591 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 29.0 p -82.09 147.61 29.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 111.029 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -46.93 141.38 4.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -69.05 -11.65 60.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.621 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.22 19.26 1.74 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 111.568 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -161.98 91.24 1.39 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.2 -18.54 30.24 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.482 2.121 . . . . 0.0 111.99 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -92.7 30.91 1.45 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.485 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.577 ' O ' HG22 ' A' ' 90' ' ' THR . 20.5 m -152.74 70.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.639 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -65.5 178.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.124 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.624 ' H ' HG12 ' A' ' 91' ' ' VAL . 97.3 m-85 -153.56 92.38 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.758 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.981 HG11 HG12 ' A' ' 50' ' ' ILE . 24.6 t -97.05 122.87 49.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.786 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.872 ' SG ' HG11 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -108.92 145.67 35.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.63 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 2.4 m-85 -121.82 80.48 1.69 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.902 HG23 HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -77.4 177.72 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.873 HD22 ' HB ' ' A' ' 33' ' ' THR . 12.7 mt -93.9 127.78 39.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -40.55 -32.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.21 -34.51 78.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 110.576 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 4' ' ' PHE . 29.2 mt -73.16 136.95 78.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.879 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 100' ' ' ILE . 24.3 Cg_endo -61.24 -168.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.386 2.058 . . . . 0.0 112.232 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.558 ' HD3' HD11 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -108.04 67.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.66 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.735 HG23 ' CE1' ' A' ' 135' ' ' PHE . 1.6 tp -150.51 -33.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.982 HD11 HD12 ' A' ' 132' ' ' LEU . 19.8 tp -59.6 -60.14 11.55 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.241 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.847 ' HD3' HG21 ' A' ' 96' ' ' THR . 9.4 Cg_endo -51.21 -36.72 57.2 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.285 1.99 . . . . 0.0 111.193 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 1.03 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.2 mp -62.02 -40.47 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.231 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.46 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -81.73 -23.99 36.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.983 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.9 HD11 HD12 ' A' ' 132' ' ' LEU . 10.3 mm -71.85 -44.32 67.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.868 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -75.07 -50.9 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -60.64 -30.8 70.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.583 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -73.8 -48.94 15.19 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.13 -32.15 63.97 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.5 -17.26 61.76 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.09 -24.94 62.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.498 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 10.0 m-85 -86.75 -171.54 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -121.32 -1.19 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.613 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 m -114.8 -94.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.53 ' N ' HD22 ' A' ' 123' ' ' LEU . 2.5 p-10 40.26 32.33 0.13 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.782 0.325 . . . . 0.0 111.078 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.413 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -114.94 36.09 4.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.0 OUTLIER -148.81 151.42 34.76 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.008 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.458 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.6 m-80 -70.54 21.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.582 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.1 tt0 -166.23 28.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.601 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.9 tt -132.34 -50.1 0.93 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.929 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.59 -45.58 77.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.429 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 80.3 p -46.37 -30.24 2.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.0 -57.13 14.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.687 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.906 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.3 m170 -61.25 -31.44 71.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.698 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.889 HG13 HD12 ' A' ' 108' ' ' ILE . 48.4 t -56.41 -42.23 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.839 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 132' ' ' LEU . . . -74.94 -50.4 8.79 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.11 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -26.74 67.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.446 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.583 HD13 ' C ' ' A' ' 111' ' ' GLY . 61.7 mt -89.94 -25.82 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.982 HD12 HD11 ' A' ' 104' ' ' LEU . 2.9 tp -55.91 -45.7 78.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.782 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -44.84 64.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.802 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.43 -26.23 67.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.897 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.852 ' CZ ' HD11 ' A' ' 139' ' ' LEU . 1.6 t80 -54.46 -67.57 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.766 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -56.99 -41.36 78.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.813 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -52.35 -27.46 15.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.985 0.421 . . . . 0.0 110.317 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.88 -32.67 34.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.367 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.852 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 11.4 mt -73.82 -29.3 62.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.365 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.0 t -76.3 -48.81 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.587 0.708 . . . . 0.0 109.202 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.48 -33.2 73.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.688 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -25.18 65.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.203 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.465 ' NH1' HD11 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -96.03 26.74 3.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.076 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -150.32 31.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.86 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -112.47 -76.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 146' ' ' THR . 3.3 t -134.35 99.75 4.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.998 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.465 HD11 ' NH1' ' A' ' 143' ' ' ARG . 9.4 mt -128.46 -71.91 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -85.49 -31.5 22.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.799 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.8 mtp . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.842 0.353 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' HE3' ' CE2' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -135.12 132.37 38.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -125.28 -166.43 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.523 ' CE2' HG23 ' A' ' 100' ' ' ILE . 6.2 m-85 -161.88 177.56 9.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.079 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.876 ' HA ' HD21 ' A' ' 132' ' ' LEU . 1.5 t-20 -175.68 100.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.299 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.981 HG11 HG22 ' A' ' 9' ' ' VAL . 20.2 t -61.32 119.97 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.378 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.526 ' HB3' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -55.79 -54.88 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.628 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 6.6 m-85 -142.49 135.44 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.841 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.981 HG22 HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -129.76 93.11 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.793 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 2.2 mt-10 -106.11 120.77 42.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.577 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.994 HG23 HD13 ' A' ' 124' ' ' LEU . 23.6 t -85.32 159.87 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.727 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.838 HD11 HG21 ' A' ' 50' ' ' ILE . 3.6 mt -138.42 117.54 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.693 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -106.04 109.3 21.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.88 0.371 . . . . 0.0 111.487 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 61.18 37.34 17.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.633 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.6 58.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.483 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -146.1 117.54 7.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.279 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -48.01 126.99 11.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.142 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.76 -45.39 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.457 0.646 . . . . 0.0 109.927 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.828 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -125.16 175.87 7.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.397 -179.436 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 59.5 p -170.19 127.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.509 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 25.5 t -121.58 69.72 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.628 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -106.56 97.66 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -113.69 144.11 30.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.53 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.42 141.08 9.89 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.747 2.298 . . . . 0.0 111.559 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 44.1 p90 -179.79 118.13 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.094 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 19.3 mt-30 -73.77 67.55 1.19 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.954 0.407 . . . . 0.0 110.654 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -55.51 90.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.979 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.04 90.38 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -176.16 -164.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.824 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -53.91 -25.74 21.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.285 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 3' ' ' ARG . 16.8 p90 -135.47 93.5 2.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.93 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . 177.17 167.62 35.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.712 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.822 ' HB ' HD22 ' A' ' 97' ' ' LEU . 19.9 m -158.24 -43.01 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.771 0.32 . . . . 0.0 111.73 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.827 HG13 HD21 ' A' ' 97' ' ' LEU . 8.1 mt -64.96 151.95 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.671 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -165.9 -70.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.567 178.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.522 ' N ' ' OG1' ' A' ' 35' ' ' THR . 50.7 p -143.12 -46.72 0.3 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.074 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.78 -30.66 71.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.175 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 75.2 m-20 -116.13 30.71 7.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.987 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 26.28 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.172 0.51 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -111.59 -32.31 6.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.032 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.578 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.63 119.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.63 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.973 HG22 HD12 ' A' ' 45' ' ' ILE . 10.1 t -82.9 150.77 62.68 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.469 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 84.6 Cg_exo -44.79 -23.43 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.294 1.996 . . . . 0.0 111.779 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.76 ' HB ' HG23 ' A' ' 42' ' ' THR . 33.6 t -66.76 -46.45 85.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.176 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.973 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -58.26 -33.87 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CE2' HG22 ' A' ' 41' ' ' ILE . 88.6 m-85 -80.33 -41.48 24.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.401 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.623 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -64.59 -28.05 69.36 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.933 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -89.2 -28.55 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.832 HD11 HG13 ' A' ' 74' ' ' ILE . 4.1 mt -62.33 -60.96 2.82 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.031 HG12 HG11 ' A' ' 93' ' ' VAL . 6.3 mt -50.48 -63.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.703 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -51.55 -41.57 61.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.068 -179.18 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.94 -22.42 20.87 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.452 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 33.2 mmm -116.77 -60.0 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.944 HG22 ' HG3' ' A' ' 69' ' ' MET . 82.7 t -61.38 -60.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.952 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.967 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -45.4 -54.95 13.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.602 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 17.6 Cg_exo -66.61 3.3 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.266 1.977 . . . . 0.0 112.45 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -147.56 24.89 1.09 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.974 0.416 . . . . 0.0 110.254 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.6 p -86.28 169.15 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.833 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.553 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -136.38 148.18 63.09 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.38 179.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 95.0 Cg_endo -80.18 27.35 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.08 1.853 . . . . 0.0 111.662 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.946 HD11 ' HA ' ' A' ' 82' ' ' SER . 4.3 mt 36.55 101.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.94 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -60.66 2.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.539 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.95 -23.17 2.79 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.717 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.33 -157.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.598 0.237 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.567 ' HA ' HD13 ' A' ' 61' ' ' ILE . 5.0 mmtt 178.11 118.35 0.04 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.61 0.243 . . . . 0.0 111.072 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.77 HG21 ' HA ' ' A' ' 106' ' ' ILE . 17.6 t 61.77 68.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.782 0.325 . . . . 0.0 110.914 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.484 HG22 ' CE1' ' A' ' 81' ' ' TYR . 4.1 t -99.22 151.31 21.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.449 ' HE2' ' CE1' ' A' ' 80' ' ' PHE . 10.6 ttmt -86.14 141.38 29.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.944 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -55.31 -30.23 59.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.957 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m 60.98 26.26 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.059 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 mmm -115.89 -2.72 12.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.187 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.95 59.09 3.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 110.629 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.74 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.1 mp -57.75 -53.99 51.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.832 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -130.3 158.31 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.845 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.422 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.0 t0 -102.98 138.58 39.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.231 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.52 -30.45 7.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -135.49 165.83 24.6 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.741 0.305 . . . . 0.0 110.806 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' OD2' HG12 ' A' ' 98' ' ' VAL . 5.8 m-20 -104.65 126.29 51.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 27.7 t -93.57 105.83 17.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 34.1 m-85 -116.13 137.35 52.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.545 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.863 ' CD2' HG13 ' A' ' 54' ' ' VAL . 7.5 p90 -124.67 139.81 53.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.946 ' HA ' HD11 ' A' ' 61' ' ' ILE . 2.5 t -141.5 118.48 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.527 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.846 HG22 HG13 ' A' ' 91' ' ' VAL . 74.3 p -81.58 150.48 28.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -46.39 148.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.17 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.25 -8.46 53.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.706 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.28 22.9 0.3 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.606 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.47 88.94 2.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.745 0.307 . . . . 0.0 111.304 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.49 -19.51 23.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.604 2.202 . . . . 0.0 112.133 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.2 32.66 1.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.975 0.416 . . . . 0.0 110.397 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.569 ' O ' HG22 ' A' ' 90' ' ' THR . 21.7 m -156.42 71.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.846 HG13 HG22 ' A' ' 83' ' ' THR . 0.6 OUTLIER -71.35 178.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.196 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.62 ' H ' HG12 ' A' ' 91' ' ' VAL . 84.8 m-85 -153.01 98.59 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.031 HG11 HG12 ' A' ' 50' ' ' ILE . 43.1 t -106.17 129.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.372 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.558 ' HB3' HG13 ' A' ' 9' ' ' VAL . 28.2 p -128.41 117.46 21.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.308 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 16.0 m-85 -85.72 78.13 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.787 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.862 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -65.52 -172.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.758 0.314 . . . . 0.0 110.599 -179.378 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.827 HD21 HG13 ' A' ' 34' ' ' ILE . 71.7 mt -102.26 129.82 48.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.491 HG12 ' OD2' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -46.01 -36.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.815 0.34 . . . . 0.0 111.617 -179.189 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.82 -29.61 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.523 HG23 ' CE2' ' A' ' 4' ' ' PHE . 60.2 mt -81.48 129.96 63.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.82 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.472 ' HD2' ' CE2' ' A' ' 4' ' ' PHE . 16.4 Cg_endo -57.66 -176.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.491 2.127 . . . . 0.0 111.932 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.493 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -99.91 63.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.542 ' CA ' HD13 ' A' ' 106' ' ' ILE . 4.6 tp -144.02 -37.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.609 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.809 HD21 HG23 ' A' ' 6' ' ' VAL . 2.5 tp -63.89 -63.61 3.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.862 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -45.47 -30.19 5.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.627 2.218 . . . . 0.0 111.388 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.77 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 mp -66.92 -41.71 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.727 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.493 ' O ' HG21 ' A' ' 131' ' ' ILE . 6.9 mmt180 -80.95 -17.76 49.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.678 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.691 HG13 HG21 ' A' ' 6' ' ' VAL . 16.2 mm -70.53 -48.62 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.666 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -73.12 -51.49 17.77 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.496 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -76.69 -43.88 17.23 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.897 HD23 ' HB2' ' A' ' 127' ' ' HIS . 16.9 mt -56.82 -35.62 69.0 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -14.52 61.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.16 -23.86 59.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.239 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.471 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 5.7 m-85 -84.33 -93.08 0.08 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 161.26 -26.38 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 111.068 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.3 m -92.13 -90.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.557 ' N ' HD22 ' A' ' 123' ' ' LEU . 22.6 p30 40.73 32.47 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.99 34.52 4.8 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.559 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -150.71 149.24 29.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 178.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.443 ' HA ' ' N ' ' A' ' 20' ' ' SER . 5.2 p30 -68.91 28.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.858 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.6 tp10 -169.93 27.93 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.8 tt -132.9 -49.32 0.88 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.507 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.994 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.66 -44.71 77.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 89.2 p -47.63 -30.73 3.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.16 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.91 -60.4 3.85 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.105 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.897 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.6 m-70 -57.98 -36.88 73.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.636 HG11 HG21 ' A' ' 9' ' ' VAL . 42.4 t -53.28 -43.97 52.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.219 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.06 -44.82 12.76 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.109 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -65.25 -23.0 66.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 127' ' ' HIS . 57.3 mt -90.03 -26.34 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.4 OUTLIER -63.72 -47.83 79.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.545 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.68 -44.32 82.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.889 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -73.21 -18.06 61.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.792 ' CE1' HD21 ' A' ' 139' ' ' LEU . 15.9 t80 -50.62 -66.68 0.35 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.418 ' HA ' HD12 ' A' ' 139' ' ' LEU . 0.3 OUTLIER -50.82 -48.35 59.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -49.29 -31.25 8.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.001 0.429 . . . . 0.0 110.383 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -80.11 -34.74 37.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.98 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.792 HD21 ' CE1' ' A' ' 135' ' ' PHE . 18.8 mt -67.95 -33.68 75.14 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.101 0.476 . . . . 0.0 109.781 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.3 t -73.92 -47.1 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 121.645 0.736 . . . . 0.0 109.031 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -35.6 77.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.672 178.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -28.48 68.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.175 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.565 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -77.98 -3.29 41.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.574 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -104.6 -37.04 7.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.712 0.291 . . . . 0.0 111.085 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -75.88 -73.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.39 145.78 29.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.86 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -170.48 48.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -97.73 37.33 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.902 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.77 0.319 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' HZ2' ' HB3' ' A' ' 31' ' ' TYR . 3.3 tttp -176.45 85.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -73.0 91.56 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.912 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.668 ' CE2' HG23 ' A' ' 100' ' ' ILE . 3.3 m-85 -58.81 159.64 6.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -168.07 115.85 0.72 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.461 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.049 HG11 HG22 ' A' ' 9' ' ' VAL . 2.1 t -72.35 147.42 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.342 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -87.88 -49.9 6.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.548 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.714 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 10.1 m-85 -143.57 134.71 25.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.96 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.049 HG22 HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -134.65 93.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.821 179.162 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.6 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.5 mt-10 -107.72 120.23 41.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.994 0.426 . . . . 0.0 111.812 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.987 HG23 HD13 ' A' ' 124' ' ' LEU . 75.8 t -82.69 158.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.83 HD11 HG21 ' A' ' 50' ' ' ILE . 4.4 mt -137.51 115.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.615 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -105.28 109.34 21.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.0 111.284 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 63.81 34.28 12.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.611 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.66 26.39 58.95 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.347 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.93 117.34 9.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.039 0.447 . . . . 0.0 109.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.6 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -51.61 125.21 14.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.727 -178.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.615 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.19 -49.47 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.445 0.64 . . . . 0.0 109.87 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 120' ' ' THR . 55.0 p -120.87 174.38 6.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.695 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.537 ' N ' HD22 ' A' ' 124' ' ' LEU . 92.1 p -170.06 134.44 1.26 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.155 0.502 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 28.7 t -124.86 69.71 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.434 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.637 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.9 m-85 -106.95 101.91 11.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.054 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -143.24 145.29 31.83 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.721 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 79.2 Cg_endo -77.1 -176.44 3.2 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.693 2.262 . . . . 0.0 111.759 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 7' ' ' SER . 1.5 p90 172.7 -6.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.9 tt0 63.94 145.71 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.813 0.34 . . . . 0.0 110.514 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 34' ' ' ILE . 5.3 tmtt? -80.91 141.57 34.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -124.45 -166.1 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.83 119.22 3.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.603 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.0 m120 61.31 157.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.285 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' HB3' ' HZ2' ' A' ' 2' ' ' LYS . 48.2 p90 45.67 -168.19 0.01 OUTLIER 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.122 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.798 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . 71.08 164.34 5.73 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.403 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.793 ' HB ' HD22 ' A' ' 97' ' ' LEU . 22.6 m -164.38 -42.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 111.159 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.742 HG13 HD21 ' A' ' 97' ' ' LEU . 12.0 mt -55.89 156.88 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.331 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER 169.69 -32.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.767 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.65 -74.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.185 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.35 -27.41 3.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.393 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 7.2 m120 -118.35 31.34 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.809 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 51.5 tt0 -128.86 26.9 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.16 0.505 . . . . 0.0 110.832 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -113.66 -33.49 5.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.155 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.686 HG22 ' CE2' ' A' ' 46' ' ' PHE . 2.2 mm -52.87 130.62 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.676 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.71 HG23 ' HB ' ' A' ' 44' ' ' VAL . 11.2 t -91.24 151.25 42.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.714 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 75.0 Cg_exo -46.71 -25.93 4.07 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.293 1.995 . . . . 0.0 111.384 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.71 ' HB ' HG23 ' A' ' 42' ' ' THR . 74.2 t -66.65 -38.45 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.714 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.603 HG13 HG23 ' A' ' 41' ' ' ILE . 15.2 mm -59.8 -44.21 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.686 ' CE2' HG22 ' A' ' 41' ' ' ILE . 10.7 m-85 -75.83 -40.09 55.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.178 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.651 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -62.73 -30.27 71.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.178 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -87.65 -29.56 21.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 73' ' ' LEU . 4.1 mt -61.53 -59.72 4.8 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.069 HG12 HG11 ' A' ' 93' ' ' VAL . 7.0 mt -50.79 -63.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.016 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.4 OUTLIER -52.21 -41.74 62.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.99 -1.459 . . . . 0.0 113.048 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.76 -20.62 22.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.601 ' HB2' HD21 ' A' ' 73' ' ' LEU . 47.9 mmm -118.28 -59.95 1.84 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 69' ' ' MET . 90.8 t -63.55 -60.18 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.009 HD23 HG22 ' A' ' 50' ' ' ILE . 2.4 mm? -44.57 -53.69 14.29 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.8 Cg_exo -67.0 3.95 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.225 1.95 . . . . 0.0 112.457 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.28 28.07 0.58 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.139 0.495 . . . . 0.0 110.194 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 91' ' ' VAL . 9.4 p -83.76 150.35 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.94 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.584 HG23 ' HE1' ' A' ' 81' ' ' TYR . 3.8 t -102.58 138.77 19.73 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.429 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' HD2' ' CG1' ' A' ' 59' ' ' VAL . 67.7 Cg_endo -74.45 28.03 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.795 1.664 . . . . 0.0 111.575 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.79 HD12 ' H ' ' A' ' 65' ' ' LYS . 18.3 mm 23.22 101.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.266 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.54 -26.91 10.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.573 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.15 30.22 0.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.491 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.12 -51.5 2.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.875 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.79 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.0 OUTLIER 63.29 105.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.215 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.839 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.0 t 69.78 79.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.13 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.9 m -101.2 130.06 47.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -81.74 134.95 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.778 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -58.13 -26.25 62.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.7 t 50.94 28.46 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.5 tpp -107.3 -18.1 13.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.61 63.76 0.41 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 49' ' ' LEU . 7.1 mp -65.32 -59.22 4.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.539 HG13 HD11 ' A' ' 49' ' ' LEU . 1.3 mt -121.51 155.44 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 17.0 t0 -97.3 140.02 32.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.754 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 107.47 -33.15 6.54 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.293 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 74' ' ' ILE . 2.1 m-85 -116.35 175.26 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.6 OUTLIER -120.75 121.68 38.74 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.45 ' HG ' ' HE1' ' A' ' 95' ' ' PHE . 6.1 m -86.98 106.19 17.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.459 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 65.8 m-85 -120.81 149.0 43.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.505 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 93' ' ' VAL . 35.3 p90 -144.87 131.07 19.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.154 0.502 . . . . 0.0 111.585 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 2.2 t -132.05 120.75 22.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.638 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.984 HG22 HG13 ' A' ' 91' ' ' VAL . 63.1 p -89.97 150.13 22.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.969 0.414 . . . . 0.0 111.133 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.66 149.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -69.97 -16.47 63.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.69 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.75 20.13 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.0 93.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.554 0.216 . . . . 0.0 111.263 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.31 -16.28 50.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.387 2.058 . . . . 0.0 111.896 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 30.39 2.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.098 0.475 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.532 ' O ' HG22 ' A' ' 90' ' ' THR . 34.5 m -150.84 69.59 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.535 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.984 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -72.47 176.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.512 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.562 ' H ' HG12 ' A' ' 91' ' ' VAL . 38.3 m-85 -151.21 91.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.069 HG11 HG12 ' A' ' 50' ' ' ILE . 41.5 t -99.27 132.6 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.154 0.502 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.38 123.15 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.148 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.714 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -95.8 84.45 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.79 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.912 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -74.45 -167.38 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.973 0.416 . . . . 0.0 110.907 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.798 HD13 ' HA2' ' A' ' 32' ' ' GLY . 13.5 mt -106.36 127.48 53.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.351 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -45.54 -35.93 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.75 0.309 . . . . 0.0 111.697 -179.212 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.0 -31.27 71.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.383 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.668 HG23 ' CE2' ' A' ' 4' ' ' PHE . 62.9 mt -76.34 132.99 71.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.764 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.56 -168.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.369 2.046 . . . . 0.0 112.127 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 67.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.642 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.503 ' HA ' HD13 ' A' ' 106' ' ' ILE . 4.7 tp -152.03 -40.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.953 HD11 HD11 ' A' ' 108' ' ' ILE . 12.1 tp -56.15 -63.99 2.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.129 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.912 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.1 Cg_endo -47.57 -30.02 11.5 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.447 2.098 . . . . 0.0 111.51 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.839 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.8 mp -72.0 -41.05 68.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.575 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.508 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -79.01 -28.12 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 104' ' ' LEU . 7.8 mm -68.08 -49.81 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.529 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -67.25 -54.8 17.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.1 p -60.38 -27.39 67.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.529 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -74.02 -44.36 30.31 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.933 HD23 ' HB2' ' A' ' 127' ' ' HIS . 17.0 mt -55.24 -28.87 56.25 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.02 -19.07 63.33 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.365 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.06 -20.88 61.6 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.633 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 6.3 m-85 -101.45 -29.88 11.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.063 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 4.6 mt-10 83.33 -51.86 0.15 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.005 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.8 m -46.43 -95.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.691 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.573 ' H ' HD22 ' A' ' 123' ' ' LEU . 0.9 OUTLIER 42.07 31.9 0.27 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.725 0.298 . . . . 0.0 110.706 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.57 33.01 4.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -152.95 148.85 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.559 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.41 ' HA ' ' H ' ' A' ' 20' ' ' SER . 2.1 p-10 -69.95 23.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.424 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.4 tt0 -163.84 24.86 0.08 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.7 tt -123.81 -56.89 1.65 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.727 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.987 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.13 -45.16 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 90.0 p -47.76 -31.42 4.82 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.365 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.08 -56.69 16.33 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.264 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.933 ' HB2' HD23 ' A' ' 112' ' ' LEU . 2.4 m-70 -60.17 -35.29 75.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.913 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.7 t -53.16 -47.18 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.827 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.71 -37.74 57.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.193 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.43 -18.45 60.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 0.0 111.344 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.529 HG21 ' HA3' ' A' ' 111' ' ' GLY . 26.4 mt -90.56 -28.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.913 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -67.63 -52.04 42.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.485 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.52 -29.45 64.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.0 m -98.27 -12.08 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CE2' HD21 ' A' ' 139' ' ' LEU . 6.6 t80 -58.44 -57.54 12.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.999 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.462 ' HA ' HD12 ' A' ' 139' ' ' LEU . 18.3 p80 -49.67 -37.8 30.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.024 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.4 OUTLIER -55.52 -29.73 59.42 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.085 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -36.12 58.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.819 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.786 HD21 ' CE2' ' A' ' 135' ' ' PHE . 22.8 mt -66.05 -30.44 70.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.062 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.7 t -78.01 -49.15 22.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.437 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -63.15 -32.15 73.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.013 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -31.72 72.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.222 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.797 ' O ' HD21 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -58.27 -26.13 62.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.035 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.629 ' HA ' HD21 ' A' ' 147' ' ' LEU . 42.8 m-20 -119.37 62.79 0.8 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.977 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -131.31 -45.76 1.0 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 t -150.58 85.3 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 143' ' ' ARG . 1.0 OUTLIER -106.82 177.76 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -79.14 78.19 5.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.808 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.874 179.968 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.1 132.59 48.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.84 30.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.734 ' CE2' HG23 ' A' ' 100' ' ' ILE . 2.3 m-85 54.67 175.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -177.67 108.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.307 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.948 HG11 HG22 ' A' ' 9' ' ' VAL . 1.4 t -68.05 141.16 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.31 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.454 ' OG ' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.98 -63.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.16 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.64 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.0 m-85 -140.34 131.19 25.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.954 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.948 HG22 HG11 ' A' ' 6' ' ' VAL . 2.1 t -117.42 85.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.378 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.419 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 0.9 OUTLIER -91.32 111.99 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.053 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.922 HG23 HD13 ' A' ' 124' ' ' LEU . 97.6 t -85.22 158.35 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.95 HD11 HG21 ' A' ' 50' ' ' ILE . 3.1 mt -138.69 121.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.833 0.349 . . . . 0.0 111.686 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.573 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.2 tttt -110.82 102.94 11.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 111.582 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 67.81 37.99 3.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.87 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.35 24.79 60.38 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.815 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.41 120.57 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.887 0.375 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -53.31 120.84 6.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.753 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.573 HG23 ' HB3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -95.37 -51.09 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.016 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 120' ' ' THR . 57.9 p -123.08 177.93 5.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 121' ' ' ASN . 29.5 m -170.5 142.95 2.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.411 . . . . 0.0 111.322 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 23.6 t -125.64 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.862 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 3.8 m-85 -106.2 88.83 2.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.406 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 1.2 pt20 -125.82 141.66 39.97 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.401 -179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 71.7 Cg_endo -74.7 -178.12 3.86 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.531 2.154 . . . . 0.0 111.791 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.728 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 1.1 p90 174.38 -21.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' HG3' ' HB ' ' A' ' 35' ' ' THR . 0.5 OUTLIER 68.95 132.63 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -51.24 -55.86 15.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.125 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.58 -81.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.415 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -167.72 -35.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.239 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -68.61 64.56 0.11 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.217 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' CE2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 45.49 93.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.462 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.76 159.95 32.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.578 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.928 ' HB ' HD22 ' A' ' 97' ' ' LEU . 37.8 m -129.03 -39.71 1.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.137 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.728 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 8.3 mt -51.7 158.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.346 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -176.01 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.966 178.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.5 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -133.91 -40.95 0.84 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.734 0.302 . . . . 0.0 111.273 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.78 -28.56 55.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.559 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -115.12 31.9 6.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.249 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.6 26.16 4.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.016 0.436 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.53 -35.83 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.596 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -52.69 115.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.514 178.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.837 ' CG2' HD12 ' A' ' 45' ' ' ILE . 1.4 t -76.01 152.29 84.38 Favored Pre-proline 0 CA--C 1.517 -0.327 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.671 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 74.4 Cg_exo -47.88 -21.73 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.84 1.693 . . . . 0.0 110.709 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 42' ' ' THR . 96.0 t -65.86 -48.68 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.175 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.837 HD12 ' CG2' ' A' ' 42' ' ' THR . 1.7 mp -57.4 -33.27 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.596 ' CE2' HG22 ' A' ' 41' ' ' ILE . 89.4 m-85 -81.0 -42.71 20.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.427 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.643 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.98 -28.19 69.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.011 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -88.5 -30.07 19.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 73' ' ' LEU . 4.8 mt -60.84 -60.23 4.13 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.965 HG12 HG11 ' A' ' 93' ' ' VAL . 5.7 mt -52.09 -62.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.065 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.643 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -50.26 -44.89 53.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.909 -179.067 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.86 -15.25 30.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.674 ' HB2' HD21 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -122.12 -69.38 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.872 HG22 ' HG3' ' A' ' 69' ' ' MET . 70.9 t -53.93 -51.3 46.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.786 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.922 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -54.09 -58.39 13.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 25.3 Cg_endo -63.19 2.8 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.154 1.902 . . . . 0.0 112.662 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' CB ' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -146.48 25.23 1.22 Allowed 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.941 0.401 . . . . 0.0 110.092 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 59' ' ' VAL . 3.9 p -87.78 165.27 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.934 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 58' ' ' VAL . 35.2 m -151.3 147.65 20.86 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.068 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.604 ' C ' HD12 ' A' ' 61' ' ' ILE . 66.6 Cg_endo -78.53 24.89 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.123 1.882 . . . . 0.0 112.939 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.691 HG22 ' H ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER 46.94 176.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.831 178.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.691 ' H ' HG22 ' A' ' 61' ' ' ILE . 43.0 mmtm -139.54 -46.16 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 110.808 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.76 45.2 0.69 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.039 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.623 ' C ' HG21 ' A' ' 61' ' ' ILE . 0.8 OUTLIER 177.55 59.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.766 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.483 ' N ' HG21 ' A' ' 61' ' ' ILE . 5.0 mmtp -43.39 156.41 0.05 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.884 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.3 t 71.27 69.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.868 0.366 . . . . 0.0 110.174 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.458 ' HB ' ' CE2' ' A' ' 81' ' ' TYR . 97.3 m -95.13 144.34 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -93.48 125.54 38.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.783 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.872 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -46.92 -33.85 4.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.06 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.1 p 56.71 26.92 11.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.16 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.471 ' HB2' HD12 ' A' ' 73' ' ' LEU . 1.5 mmt -107.83 -3.51 18.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.964 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 58.87 55.29 4.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.092 0.473 . . . . 0.0 110.408 -179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.754 HD11 ' SD ' ' A' ' 69' ' ' MET . 10.7 mp -55.77 -49.94 71.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -136.25 161.3 37.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.5 t70 -100.09 140.25 34.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.275 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.54 -34.73 5.21 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.039 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.463 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -129.12 -179.02 4.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.633 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 19.6 m-20 -123.45 125.22 44.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.498 ' SG ' HD13 ' A' ' 73' ' ' LEU . 6.5 p -80.97 101.61 9.62 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.569 ' O ' HG13 ' A' ' 93' ' ' VAL . 63.4 m-85 -110.19 157.96 18.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.255 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.808 ' CD1' HG13 ' A' ' 54' ' ' VAL . 9.8 p90 -149.99 132.09 15.35 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.17 0.51 . . . . 0.0 111.463 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 28.6 t -134.81 117.39 15.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.659 HG22 HG13 ' A' ' 91' ' ' VAL . 5.0 p -84.79 148.21 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.946 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.02 144.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.88 -21.99 8.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.952 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 23.29 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.69 0.281 . . . . 0.0 111.507 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.57 92.34 6.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.002 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.56 -15.13 43.97 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.27 1.98 . . . . 0.0 111.98 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -95.97 29.79 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.242 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.542 ' O ' HG22 ' A' ' 90' ' ' THR . 32.4 m -153.05 69.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.582 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -71.29 177.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.566 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.511 ' H ' HG12 ' A' ' 91' ' ' VAL . 53.7 m-85 -151.64 83.34 1.29 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.387 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.965 HG11 HG12 ' A' ' 50' ' ' ILE . 32.5 t -89.08 133.47 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 0.0 110.998 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -131.07 119.17 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.882 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.508 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.1 m-85 -86.95 83.3 7.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.383 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.851 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -83.49 133.66 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 111.985 -178.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.928 HD22 ' HB ' ' A' ' 33' ' ' THR . 61.9 mt -46.57 125.4 7.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -47.03 -33.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.748 0.309 . . . . 0.0 111.32 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.734 HG23 ' CE2' ' A' ' 4' ' ' PHE . 58.9 mt -78.77 132.32 64.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.899 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.06 -167.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.393 2.062 . . . . 0.0 112.007 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.593 ' HG2' HD11 ' A' ' 106' ' ' ILE . 2.2 tttt -108.67 67.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.663 ' HA ' HD13 ' A' ' 106' ' ' ILE . 3.0 tp -150.97 -38.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.749 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.88 HD21 HG23 ' A' ' 6' ' ' VAL . 5.0 tp -60.36 -62.3 6.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.781 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.851 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -46.23 -34.21 13.29 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.335 2.024 . . . . 0.0 111.308 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.884 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.2 mp -65.98 -38.77 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.546 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -82.02 -27.12 33.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.872 ' CG2' HG13 ' A' ' 128' ' ' VAL . 10.8 mm -68.09 -47.98 76.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.428 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.806 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -71.78 -54.93 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 t -59.32 -28.78 67.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.54 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -73.88 -47.66 18.95 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.282 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.921 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -56.36 -31.56 63.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.95 -14.3 60.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.148 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -75.74 -24.41 56.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.343 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.574 ' CG ' ' CD2' ' A' ' 127' ' ' HIS . 8.1 m-85 -86.17 -93.15 0.09 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.979 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER 160.38 -28.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.782 0.433 . . . . 0.0 110.297 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.413 ' CB ' HD21 ' A' ' 123' ' ' LEU . 72.4 p -107.33 127.27 53.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.491 0.662 . . . . 0.0 111.191 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 5.6 p30 -172.65 36.2 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.053 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.73 32.83 4.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.316 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.635 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -148.39 144.96 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.279 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.451 ' HA ' ' H ' ' A' ' 20' ' ' SER . 2.2 m120 -68.5 29.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.882 0.372 . . . . 0.0 111.834 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 120' ' ' THR . 11.1 tt0 -169.78 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.635 ' CB ' HG23 ' A' ' 120' ' ' THR . 8.5 tt -124.08 -58.01 1.57 Allowed 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.922 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -51.26 -43.84 61.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.465 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.4 p -47.7 -29.31 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.509 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.3 -61.81 2.11 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.126 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.921 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.3 m-70 -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.754 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.872 HG13 ' CG2' ' A' ' 108' ' ' ILE . 50.0 t -51.58 -48.88 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -69.06 -46.9 57.09 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.987 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -64.01 -20.33 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.734 0.302 . . . . 0.0 110.659 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.546 HG21 ' O ' ' A' ' 107' ' ' ARG . 44.7 mt -90.7 -28.45 4.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.764 ' CD2' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -62.36 -39.85 94.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.94 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -32.96 72.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.455 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.26 24.29 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.843 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.6 ' CE2' HG23 ' A' ' 103' ' ' ILE . 1.1 t80 -93.54 -40.27 10.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.376 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -66.83 -30.78 71.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.593 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -30.02 31.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.417 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -36.22 45.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.984 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.437 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 22.5 mt -65.42 -33.48 76.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.766 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.9 t -74.71 -47.32 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.628 0.727 . . . . 0.0 109.183 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.31 -32.55 73.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.017 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -34.04 76.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.474 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.678 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -58.23 -23.44 55.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.087 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -84.83 -52.55 5.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -78.25 123.8 27.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.81 105.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.678 HD13 ' O ' ' A' ' 143' ' ' ARG . 4.1 tt -171.86 -45.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -97.11 29.77 3.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.876 179.898 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.802 0.334 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -97.97 175.98 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.3 mmm-85 -147.18 -177.78 5.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.711 ' HE2' HG23 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -148.01 139.15 23.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.715 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -166.12 106.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.215 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.026 HG22 HG23 ' A' ' 96' ' ' THR . 1.2 t -60.34 144.95 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.357 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.519 ' HA ' ' HZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -69.52 -71.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.291 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.684 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 3.4 m-85 -134.23 142.03 47.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.992 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.811 HG22 HG11 ' A' ' 6' ' ' VAL . 1.7 t -129.77 94.89 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.169 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.8 mt-10 -105.17 118.15 35.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.942 0.401 . . . . 0.0 111.978 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.911 ' CG2' HD13 ' A' ' 124' ' ' LEU . 16.8 t -84.53 158.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 55' ' ' LEU . 2.1 mp -141.52 117.24 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 10.1 tttt -101.35 107.53 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.276 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.22 37.63 23.72 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.809 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.26 24.65 56.68 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.757 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -143.3 112.97 6.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.947 0.404 . . . . 0.0 110.108 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 m -46.46 125.69 7.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.333 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -100.98 -39.74 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.253 178.452 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.8 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -131.49 174.68 9.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.106 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.492 ' N ' HD22 ' A' ' 124' ' ' LEU . 8.9 p -170.32 123.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 26.0 t -113.97 69.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.684 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -110.29 88.24 2.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.21 0.529 . . . . 0.0 110.982 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.404 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -130.32 148.57 70.4 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.508 -179.603 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.74 179.24 6.19 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.735 2.29 . . . . 0.0 111.949 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' HZ ' ' HA ' ' A' ' 7' ' ' SER . 2.3 p90 174.87 -25.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.604 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 9.6 tt0 71.61 60.9 0.15 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.042 0.449 . . . . 0.0 110.836 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -80.88 125.64 30.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.861 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -176.92 -51.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.996 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.47 -26.82 55.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -106.08 -61.52 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.948 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -178.28 94.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.918 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.622 ' CA ' HD13 ' A' ' 97' ' ' LEU . . . -178.74 -143.51 5.29 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.782 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.57 ' O ' HG22 ' A' ' 35' ' ' THR . 61.8 m -164.05 -39.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 111.349 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.612 ' O ' HG22 ' A' ' 35' ' ' THR . 3.1 mt -48.23 151.14 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.73 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -173.93 -80.79 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.821 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.504 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -141.21 -44.39 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.943 0.401 . . . . 0.0 111.225 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.04 -33.96 77.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.324 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -112.43 31.68 6.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.044 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.75 28.58 5.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.7 -33.89 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.908 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.643 HG23 ' HB ' ' A' ' 45' ' ' ILE . 1.5 mt -51.73 140.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.767 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.553 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.5 t -94.6 151.66 39.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 80.0 Cg_exo -46.57 -28.25 6.11 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.825 1.683 . . . . 0.0 110.652 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 42' ' ' THR . 58.8 t -59.44 -42.14 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.566 178.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.643 ' HB ' HG23 ' A' ' 41' ' ' ILE . 23.4 mm -55.72 -51.68 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.686 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.518 ' O ' HD12 ' A' ' 50' ' ' ILE . 44.0 m-85 -71.34 -37.74 71.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.505 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.646 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.02 -31.04 72.09 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.224 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -87.46 -28.69 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.658 HD11 HG13 ' A' ' 74' ' ' ILE . 3.7 mt -61.91 -59.97 4.33 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.995 HG22 HD23 ' A' ' 55' ' ' LEU . 6.5 mt -50.31 -64.05 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.898 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -53.13 -40.32 64.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.348 -178.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.72 -21.85 21.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.485 ' HB2' HD21 ' A' ' 73' ' ' LEU . 83.1 mmm -118.38 -59.34 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 81' ' ' TYR . 84.2 t -62.81 -59.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.995 HD23 HG22 ' A' ' 50' ' ' ILE . 2.9 mm? -45.33 -54.26 15.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.0 Cg_exo -67.78 4.32 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.269 1.98 . . . . 0.0 112.465 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 2.1 mptt -145.49 21.86 1.5 Allowed 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 120.94 0.4 . . . . 0.0 110.461 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 59' ' ' VAL . 4.4 p -87.22 167.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 58' ' ' VAL . 34.3 m -137.1 147.58 59.21 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.928 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 61' ' ' ILE . 72.3 Cg_endo -76.69 19.86 0.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.858 1.705 . . . . 0.0 112.546 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.588 HG21 ' N ' ' A' ' 65' ' ' LYS . 8.5 mm 50.47 164.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.142 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.515 ' N ' HG22 ' A' ' 61' ' ' ILE . 11.6 mmtt -69.57 -12.18 61.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.088 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.01 -28.21 0.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.789 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 173.27 108.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.647 0.26 . . . . 0.0 110.725 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.588 ' N ' HG21 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -161.67 169.88 20.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.077 0.465 . . . . 0.0 111.466 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 106' ' ' ILE . 98.7 t -131.29 90.53 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.17 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.473 ' CG2' ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -98.34 168.5 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 111.628 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -105.53 139.11 40.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.569 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.618 ' CG ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -49.27 -29.01 5.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.042 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 p 52.12 26.29 3.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.5 tpp -113.95 -10.87 12.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.157 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 59.72 58.88 2.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.503 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.5 mp -59.87 -62.38 1.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.76 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.658 HG13 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -120.03 155.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.673 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -96.9 140.68 31.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.432 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.661 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.0 -32.74 6.64 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.275 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -126.62 163.1 24.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 111.114 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -105.88 130.25 53.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.515 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.0 m -94.99 112.71 24.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 44.0 m-85 -122.54 140.84 52.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.772 ' CD2' HG13 ' A' ' 54' ' ' VAL . 7.2 p90 -131.5 134.3 46.0 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.142 0.496 . . . . 0.0 111.305 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.479 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 11.4 t -136.17 118.57 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.61 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.686 HG22 HG13 ' A' ' 91' ' ' VAL . 64.8 p -85.0 144.41 28.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 7.5 t0 -43.65 148.19 0.37 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.588 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.31 -20.43 60.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.618 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 19.59 2.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.549 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -159.87 90.1 1.86 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.445 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -56.78 -18.8 28.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.619 2.212 . . . . 0.0 111.915 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -92.85 29.84 1.71 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.104 0.478 . . . . 0.0 110.679 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.572 ' O ' HG22 ' A' ' 90' ' ' THR . 23.3 m -149.51 68.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.26 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.686 HG13 HG22 ' A' ' 83' ' ' THR . 0.7 OUTLIER -64.27 179.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.211 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.648 ' H ' HG12 ' A' ' 91' ' ' VAL . 98.0 m-85 -154.89 79.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.85 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.903 HG11 HG12 ' A' ' 50' ' ' ILE . 86.8 t -88.29 127.31 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.104 0.478 . . . . 0.0 111.312 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.466 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.4 t -125.9 117.51 23.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.5 m-85 -87.28 78.81 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.088 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.026 HG23 HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -64.5 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.898 0.38 . . . . 0.0 111.162 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.622 HD13 ' CA ' ' A' ' 32' ' ' GLY . 56.4 mt -105.71 131.68 52.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.271 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -46.84 -34.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 111.336 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -33.63 74.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.525 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.711 HG23 ' HE2' ' A' ' 4' ' ' PHE . 98.0 mt -72.76 129.96 86.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.816 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.81 -172.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.251 1.967 . . . . 0.0 111.516 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 64.13 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.908 0.385 . . . . 0.0 110.724 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.541 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -148.42 -38.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.86 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.624 HD11 ' CD2' ' A' ' 132' ' ' LEU . 16.9 tp -62.5 -62.25 6.08 Favored Pre-proline 0 CA--C 1.521 -0.136 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.735 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.862 ' HD3' HG21 ' A' ' 96' ' ' THR . 8.1 Cg_endo -48.71 -28.09 12.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.256 1.971 . . . . 0.0 110.908 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.68 ' HA ' HG21 ' A' ' 66' ' ' VAL . 13.2 mt -70.72 -64.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.691 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -24.37 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.236 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.826 HD11 ' HG ' ' A' ' 132' ' ' LEU . 8.2 mm -72.58 -47.04 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.973 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.47 -65.56 0.67 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -51.94 -27.85 14.55 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -68.75 -50.2 37.7 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.714 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.969 HD23 ' HB2' ' A' ' 127' ' ' HIS . 5.4 mt -54.85 -35.04 63.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.95 -16.35 61.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.197 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.61 -22.84 58.73 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.341 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.493 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 4.0 m-85 -82.37 -91.94 0.07 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 25.5 tt0 164.55 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.629 0.252 . . . . 0.0 110.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.2 -90.27 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.712 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.2 p-10 38.42 33.2 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 110.977 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.09 34.52 4.61 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -147.39 152.92 38.96 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.603 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.454 ' HA ' ' N ' ' A' ' 20' ' ' SER . 3.6 p30 -71.75 28.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 0.0 111.737 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -172.29 28.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.9 tt -134.69 -49.5 0.77 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.6 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.911 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.79 -44.96 78.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.005 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.421 ' HB3' ' CB ' ' A' ' 21' ' ' CYS . 78.7 p -47.69 -30.25 3.65 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.252 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.04 -59.93 4.59 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.254 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.969 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.8 m-70 -54.89 -37.99 67.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.617 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.742 HG13 HD12 ' A' ' 108' ' ' ILE . 41.9 t -51.67 -50.29 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.547 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.28 -48.82 36.05 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.656 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -19.5 65.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 111.233 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 127' ' ' HIS . 69.9 mt -90.81 -27.4 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.826 ' HG ' HD11 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -63.24 -46.09 88.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.113 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -39.49 79.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.738 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 0.92 48.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.056 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.541 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 17.1 t80 -65.96 -51.37 59.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.835 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.498 ' O ' HG23 ' A' ' 140' ' ' VAL . 90.5 m-70 -54.44 -31.07 54.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -31.54 63.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.026 0.441 . . . . 0.0 110.362 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -80.0 -34.2 38.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.201 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.19 -31.69 67.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.014 0.435 . . . . 0.0 110.068 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 136' ' ' HIS . 91.6 t -74.11 -47.34 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -30.92 63.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.773 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -29.18 66.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.497 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.81 ' HA ' HD11 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -78.26 59.83 2.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.888 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -177.68 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -123.54 140.21 53.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 60.5 77.95 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.81 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 143' ' ' ARG . 21.2 mt -145.75 141.89 28.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -84.44 77.9 9.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.823 0.344 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' HD3' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -93.72 159.13 15.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.425 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 10.1 mtm180 -131.77 159.81 37.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.643 ' HB3' HD13 ' A' ' 104' ' ' LEU . 22.1 m-85 -135.14 162.69 31.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.608 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.766 ' HA ' HD21 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -177.85 118.89 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.475 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.689 ' CG1' HG22 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -80.53 90.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.443 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -37.37 -49.78 1.01 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.927 -178.535 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.614 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 9.1 m-85 -146.17 112.3 5.76 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.612 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.689 HG22 ' CG1' ' A' ' 6' ' ' VAL . 2.3 t -110.78 95.92 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.131 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.62 ' CD ' HG21 ' A' ' 17' ' ' THR . 0.4 OUTLIER -104.17 112.51 25.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 111.882 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.949 HG23 HD13 ' A' ' 124' ' ' LEU . 76.4 t -81.68 156.06 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.671 HD11 HG21 ' A' ' 50' ' ' ILE . 2.2 mp -132.62 123.31 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.74 0.305 . . . . 0.0 111.428 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 18' ' ' ILE . 6.3 tttm -108.06 90.41 3.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 74.01 40.86 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.879 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.24 63.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.344 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 16' ' ' GLU . 5.1 pt-20 -146.56 118.98 8.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.11 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.62 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -51.81 124.9 13.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.852 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.56 HD11 ' CG1' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -100.3 -50.31 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 120' ' ' THR . 45.0 p -121.54 176.11 5.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.006 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -170.24 141.83 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.987 0.422 . . . . 0.0 111.766 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 37.6 t -128.74 69.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.444 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -105.97 99.91 9.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.088 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 3.1 mp0 -141.45 138.77 17.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.397 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.18 178.77 6.15 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.559 2.173 . . . . 0.0 111.842 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.454 ' CE2' ' HG3' ' A' ' 27' ' ' LYS . 1.9 p90 178.52 -25.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 35' ' ' THR . 12.8 mt-30 73.85 57.01 0.1 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.007 0.432 . . . . 0.0 110.756 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -72.18 108.11 5.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.771 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.28 176.07 6.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 57.8 77.85 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.413 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 11.9 t-20 60.41 159.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.742 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 3' ' ' ARG . 17.9 p90 42.77 33.93 0.53 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.398 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.731 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . -151.65 165.01 30.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.952 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.528 ' HB ' HD22 ' A' ' 97' ' ' LEU . 17.1 m -163.86 -43.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.735 0.303 . . . . 0.0 111.0 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.53 ' O ' ' HB ' ' A' ' 35' ' ' THR . 24.2 mt -64.92 153.59 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.252 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 170.81 -31.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.645 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -176.92 -68.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.06 -26.52 6.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.395 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -123.85 31.27 5.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.05 26.8 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.042 0.449 . . . . 0.0 110.949 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.49 -36.53 5.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.548 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.777 HG23 HG13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -47.14 135.73 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.0 178.834 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.515 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.3 t -94.14 151.76 39.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.635 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.22 -27.01 6.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.852 1.701 . . . . 0.0 110.513 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.515 ' HB ' HG23 ' A' ' 42' ' ' THR . 58.9 t -61.21 -42.68 94.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.571 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.777 HG13 HG23 ' A' ' 41' ' ' ILE . 16.0 mm -56.94 -46.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.653 ' O ' HD12 ' A' ' 50' ' ' ILE . 26.1 m-85 -73.17 -39.89 65.27 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.401 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.29 -31.26 72.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.318 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.48 -29.64 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.885 HD11 HG13 ' A' ' 74' ' ' ILE . 6.1 mt -61.11 -60.79 3.21 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.096 HG22 HD23 ' A' ' 55' ' ' LEU . 5.6 mt -51.1 -63.97 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.839 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.609 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 6.0 tpp -50.08 -40.55 45.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.965 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.16 -21.45 21.15 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.559 ' HB2' HD21 ' A' ' 73' ' ' LEU . 56.1 mmm -117.69 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.798 HG13 ' CD1' ' A' ' 81' ' ' TYR . 65.4 t -56.01 -55.9 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.786 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.096 HD23 HG22 ' A' ' 50' ' ' ILE . 3.4 mm? -47.13 -58.29 7.51 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.044 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.8 Cg_endo -65.99 6.82 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.143 1.895 . . . . 0.0 112.742 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.95 25.12 0.65 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.036 0.446 . . . . 0.0 110.099 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 91' ' ' VAL . 8.8 p -81.84 150.85 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.084 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 61' ' ' ILE . 14.9 t -103.14 137.92 19.4 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.531 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 61' ' ' ILE . 74.5 Cg_endo -74.25 29.76 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.241 1.961 . . . . 0.0 112.126 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 59' ' ' VAL . 26.1 mm 14.53 93.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.977 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.83 -50.52 3.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 110.161 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.73 -28.86 4.35 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.652 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.439 ' O ' HG23 ' A' ' 61' ' ' ILE . 2.7 m-80 -84.46 -161.91 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.65 114.7 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.58 0.229 . . . . 0.0 110.974 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.824 HG21 ' HA ' ' A' ' 106' ' ' ILE . 4.4 t 67.79 75.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.828 0.347 . . . . 0.0 110.717 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 m -104.65 141.28 36.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 111.176 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 4.0 ttpt -84.62 141.99 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.641 ' CG ' HG22 ' A' ' 54' ' ' VAL . 6.4 mmm -58.27 -32.51 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.766 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m 61.79 26.97 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.988 0.423 . . . . 0.0 110.945 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 18.4 mmm -110.81 -11.27 14.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.86 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 62.84 59.85 1.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.709 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.6 mp -58.63 -49.96 75.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.696 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.885 HG13 HD11 ' A' ' 49' ' ' LEU . 1.1 mt -137.26 154.7 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.791 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.6 t70 -95.3 142.96 27.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.628 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 104.89 -35.36 5.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.954 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.798 ' O ' HG13 ' A' ' 98' ' ' VAL . 2.3 m-85 -113.01 -170.08 1.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -144.06 118.36 9.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.199 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.501 ' SG ' HG21 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -86.36 103.2 14.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.478 ' CD2' ' HG3' ' A' ' 68' ' ' LYS . 41.5 m-85 -118.46 119.48 34.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.976 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.798 ' CD1' HG13 ' A' ' 54' ' ' VAL . 33.0 p90 -109.83 151.45 26.99 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.304 0.573 . . . . 0.0 112.092 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 3.1 t -149.12 119.35 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.995 HG22 HG13 ' A' ' 91' ' ' VAL . 76.8 p -88.92 151.54 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.384 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.09 140.83 8.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.072 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -60.7 -16.74 42.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.889 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.35 22.29 0.94 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -151.46 97.33 3.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 111.377 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.08 -14.71 46.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.247 1.964 . . . . 0.0 111.976 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 30.04 2.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.285 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.568 ' O ' HG22 ' A' ' 90' ' ' THR . 23.9 m -152.73 69.98 0.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.657 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.995 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -74.09 178.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.324 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.576 ' H ' HG12 ' A' ' 91' ' ' VAL . 49.6 m-85 -151.78 104.68 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.988 HG11 HG12 ' A' ' 50' ' ' ILE . 28.1 t -108.29 115.35 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.189 0.519 . . . . 0.0 111.493 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.403 ' SG ' HD21 ' A' ' 109' ' ' LEU . 28.3 p -111.17 116.06 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.101 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.6 m-85 -89.23 84.22 6.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.537 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.528 ' CG2' HG13 ' A' ' 6' ' ' VAL . 8.1 p -85.89 156.91 20.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.776 0.322 . . . . 0.0 110.881 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.731 HD13 ' HA2' ' A' ' 32' ' ' GLY . 34.5 mt -69.59 127.81 34.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.573 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -42.66 -34.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.057 -179.229 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.412 ' HB3' ' N ' ' A' ' 31' ' ' TYR . 1.0 OUTLIER -62.44 -36.68 83.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.749 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.38 136.39 96.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.775 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 100' ' ' ILE . 23.3 Cg_endo -61.68 -167.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.184 1.923 . . . . 0.0 111.914 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.464 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -108.75 66.78 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.895 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.462 HG23 ' CE1' ' A' ' 135' ' ' PHE . 6.3 tp -151.65 -44.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.656 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -57.97 -62.59 5.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.479 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 3.8 Cg_endo -46.53 -34.87 15.63 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.547 2.164 . . . . 0.0 111.098 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.8 mp -68.69 -37.27 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.897 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -81.41 -22.54 38.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.602 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 132' ' ' LEU . 35.5 mm -68.36 -48.16 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.361 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.819 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -73.88 -52.61 12.41 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t -58.93 -29.18 66.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.547 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -75.47 -46.82 13.9 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.844 HD23 ' HB2' ' A' ' 127' ' ' HIS . 17.2 mt -56.22 -32.19 64.2 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -76.26 -15.88 59.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -74.3 -25.46 59.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 110.138 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.57 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 3.6 m-85 -86.15 -90.68 0.1 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 1.2 tt0 159.69 -30.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.865 0.466 . . . . 0.0 109.767 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.883 ' HB3' HD21 ' A' ' 123' ' ' LEU . 0.3 OUTLIER -103.32 137.15 41.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.511 ' N ' HD22 ' A' ' 123' ' ' LEU . 0.9 OUTLIER 176.61 34.47 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.349 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.23 32.94 4.76 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -145.94 146.39 31.03 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.479 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.456 ' HA ' ' N ' ' A' ' 20' ' ' SER . 10.6 p30 -69.25 26.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.0 mt-10 -167.6 26.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.883 HD21 ' HB3' ' A' ' 117' ' ' SER . 8.2 tt -124.76 -57.25 1.55 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.949 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.67 -41.49 63.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.431 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 13.5 t -49.61 -29.28 6.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.233 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.73 -63.74 1.17 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.297 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.844 ' HB2' HD23 ' A' ' 112' ' ' LEU . 2.4 m-70 -59.21 -30.6 68.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.03 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 124' ' ' LEU . 49.0 t -57.67 -41.95 80.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.0 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.36 -48.71 10.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.137 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.71 -26.5 68.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.585 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.547 HD13 ' C ' ' A' ' 111' ' ' GLY . 70.6 mt -85.49 -26.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -60.95 -46.47 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.146 178.421 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -43.93 73.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.052 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.18 -24.75 64.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.967 ' CZ ' HD11 ' A' ' 139' ' ' LEU . 0.8 OUTLIER -56.41 -44.99 80.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.425 ' HA ' HD12 ' A' ' 139' ' ' LEU . 9.8 m-70 -60.98 -45.23 95.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.826 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.8 -28.98 7.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.202 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -77.77 -35.45 51.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.105 179.154 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.967 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 17.7 mt -68.1 -28.59 67.48 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.327 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.34 -48.7 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.564 0.697 . . . . 0.0 109.585 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -65.53 -28.69 69.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.327 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -67.94 -31.48 71.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.47 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -54.91 -28.63 52.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.224 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -104.2 54.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 146' ' ' THR . 4.8 mm-40 -134.08 102.47 5.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 145' ' ' GLN . 15.2 t 44.63 40.8 4.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.471 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 mt -113.69 -66.93 1.04 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 60.11 35.37 21.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.915 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.79 0.329 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 62.33 150.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 99' ' ' ASP . 0.4 OUTLIER 59.72 42.87 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.99 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.809 ' HA ' HD13 ' A' ' 100' ' ' ILE . 1.5 m-30 -76.29 -166.07 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.043 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.934 ' HA ' HD21 ' A' ' 132' ' ' LEU . 43.1 t-20 78.11 138.41 0.07 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 111.592 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.952 HG11 HG22 ' A' ' 9' ' ' VAL . 80.3 t -70.99 152.92 8.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.612 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.808 ' OG ' HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -96.41 -71.11 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.899 -179.118 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.709 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 27.4 m-85 -128.87 111.97 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.332 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.952 HG22 HG11 ' A' ' 6' ' ' VAL . 2.3 t -103.91 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.491 ' HG2' HG23 ' A' ' 17' ' ' THR . 1.2 tt0 -100.05 114.19 27.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.673 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.97 ' CG2' HD13 ' A' ' 124' ' ' LEU . 26.3 t -84.27 159.62 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.6 mp -141.3 122.2 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 112.046 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.549 ' HB2' HD13 ' A' ' 18' ' ' ILE . 12.1 tttm -104.15 99.05 8.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.363 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 63.34 41.68 7.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.387 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 78.39 23.64 64.96 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.582 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -143.25 111.9 6.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.93 0.395 . . . . 0.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.491 HG23 ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -45.15 126.41 6.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.309 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -105.18 -44.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.914 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.773 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -127.76 178.16 6.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.375 -179.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.487 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 18.0 m -170.75 131.16 0.85 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.54 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.501 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 29.2 t -115.13 69.46 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.709 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.7 m-85 -107.66 87.65 2.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 21.3 mt-30 -126.06 111.77 24.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.941 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.76 164.89 10.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.49 2.126 . . . . 0.0 112.138 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -153.43 -31.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.478 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 33.5 tt0 67.91 37.95 2.96 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.994 0.426 . . . . 0.0 110.193 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? 58.37 91.91 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.572 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -51.9 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -150.64 -74.61 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.712 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.3 -30.65 27.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 3' ' ' ARG . 2.1 p90 -122.47 154.63 37.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.45 132.5 6.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.557 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.684 ' HB ' HD22 ' A' ' 97' ' ' LEU . 88.9 m -118.84 -36.02 3.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 0.0 110.684 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.808 HD11 ' OG ' ' A' ' 7' ' ' SER . 10.3 mt -53.0 155.92 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.498 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -173.13 -86.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.609 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.531 ' N ' ' OG1' ' A' ' 35' ' ' THR . 30.8 m -126.27 -2.95 6.9 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.15 -26.9 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.656 0.265 . . . . 0.0 111.324 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.573 ' O ' HG23 ' A' ' 34' ' ' ILE . 5.3 m-20 -124.47 31.09 5.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.0 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.555 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -124.8 26.75 7.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.029 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -112.37 -35.36 5.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.858 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.666 HG22 ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -55.38 123.79 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.955 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.885 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -86.08 149.36 50.0 Favored Pre-proline 0 CA--C 1.519 -0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.435 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.554 ' HA ' ' CE1' ' A' ' 22' ' ' PHE . 2.0 Cg_endo -44.15 -22.75 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.713 2.275 . . . . 0.0 112.071 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.707 ' HB ' HG23 ' A' ' 42' ' ' THR . 5.3 t -67.73 -44.18 85.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.885 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -59.12 -31.74 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.666 ' CE2' HG22 ' A' ' 41' ' ' ILE . 66.3 m-85 -80.14 -43.44 21.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.349 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.622 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.27 -25.84 67.06 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.537 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' VAL . 15.0 m-20 -90.4 -29.82 17.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.588 HD22 ' HB3' ' A' ' 73' ' ' LEU . 2.7 mt -58.34 -57.8 11.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.041 HG22 HD23 ' A' ' 55' ' ' LEU . 4.3 mt -57.97 -66.01 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.209 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.622 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.3 tpp -46.91 -41.64 16.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.713 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.08 -25.45 19.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.477 ' HB2' HD21 ' A' ' 73' ' ' LEU . 70.5 mmm -114.21 -63.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.708 HG13 ' CD1' ' A' ' 81' ' ' TYR . 55.9 t -62.23 -58.87 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.041 HD23 HG22 ' A' ' 50' ' ' ILE . 3.1 mm? -44.38 -55.9 9.13 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.3 Cg_exo -68.5 5.11 1.36 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.305 2.003 . . . . 0.0 112.03 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -145.31 21.52 1.54 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.311 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.515 HG23 ' CD2' ' A' ' 81' ' ' TYR . 3.9 p -84.77 165.56 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.935 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 61' ' ' ILE . 16.2 m -147.98 146.17 22.97 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.986 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.502 ' HA ' HG21 ' A' ' 83' ' ' THR . 59.7 Cg_endo -74.44 25.48 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.992 1.795 . . . . 0.0 112.548 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.799 HD13 ' HE3' ' A' ' 65' ' ' LYS . 1.5 mp 52.05 155.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.221 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 4.2 mmtt -126.75 -39.91 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.655 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.55 43.41 0.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.819 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 1.5 m-20 -139.18 -57.53 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.799 ' HE3' HD13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER 66.82 124.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.494 -179.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 106' ' ' ILE . 7.0 t 68.94 62.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.877 0.37 . . . . 0.0 110.406 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.5 m -93.66 141.55 28.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 9.4 tttm -87.95 137.63 32.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.557 ' HE1' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -54.79 -25.97 31.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.709 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 t 53.93 25.5 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.374 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.626 ' HG2' HD12 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -118.23 1.9 11.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.177 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.71 78.6 0.21 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.087 0.47 . . . . 0.0 110.457 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.847 HD13 ' SG ' ' A' ' 79' ' ' CYS . 11.0 mp -74.51 -42.77 58.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.55 HD11 ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -138.1 155.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.719 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -96.74 139.74 32.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.29 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.18 -33.63 5.88 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.156 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.26 176.26 8.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.826 0.346 . . . . 0.0 111.03 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 42.6 m-20 -113.67 129.2 56.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.564 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.847 ' SG ' HD13 ' A' ' 73' ' ' LEU . 25.1 p -90.4 112.55 24.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.515 ' O ' HG13 ' A' ' 93' ' ' VAL . 44.8 m-85 -119.84 153.72 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.374 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.708 ' CD1' HG13 ' A' ' 54' ' ' VAL . 38.4 p90 -144.38 128.04 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.117 0.484 . . . . 0.0 111.645 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.561 ' HA ' HD11 ' A' ' 61' ' ' ILE . 1.8 t -133.71 121.76 22.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.667 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 19.4 p -80.94 153.49 27.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.978 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -49.13 151.52 1.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.97 -6.72 49.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.658 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.49 20.48 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -159.5 102.67 1.5 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 0.0 111.318 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.05 -13.35 39.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.394 2.062 . . . . 0.0 112.013 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -96.65 30.48 2.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 90' ' ' THR . 20.1 m -153.57 71.9 0.9 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.559 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -70.16 177.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.317 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.58 ' H ' HG12 ' A' ' 91' ' ' VAL . 95.7 m-85 -152.38 96.8 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.863 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.009 HG11 HG12 ' A' ' 50' ' ' ILE . 77.4 t -100.28 128.2 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 20.4 p -124.85 138.07 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.508 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 7.3 m-85 -106.0 89.41 3.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.737 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.849 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -89.17 124.51 34.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.157 -179.268 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.684 HD22 ' HB ' ' A' ' 33' ' ' THR . 28.8 mt -42.53 135.36 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -46.26 -27.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 3' ' ' ARG . 2.5 m-20 -68.56 -22.03 64.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.809 HD13 ' HA ' ' A' ' 4' ' ' PHE . 3.7 mm -70.49 135.99 86.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.287 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 38.2 Cg_endo -66.14 -164.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.305 2.004 . . . . 0.0 111.583 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -108.08 66.49 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.764 0.316 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.716 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 6.1 tp -164.67 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.744 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.8 tp -62.32 -62.8 5.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.652 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.849 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.2 Cg_endo -44.99 -31.74 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.502 2.135 . . . . 0.0 111.155 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.0 mp -73.18 -41.76 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.231 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.641 ' O ' HG21 ' A' ' 131' ' ' ILE . 1.9 mmt180 -76.77 -23.2 52.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.794 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.858 ' CG2' HG13 ' A' ' 128' ' ' VAL . 7.1 mm -70.11 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.235 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.544 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -61.8 -55.59 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -59.6 -25.5 64.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.525 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -72.59 -47.02 29.15 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.526 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.957 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.1 mt -55.88 -26.26 46.42 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.5 -18.01 61.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.34 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.13 -23.97 63.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.606 ' CD1' ' CE1' ' A' ' 127' ' ' HIS . 2.4 m-85 -100.43 -166.48 1.33 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -124.79 -2.4 7.82 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.415 ' CB ' HD21 ' A' ' 123' ' ' LEU . 49.6 m -127.69 123.34 35.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.094 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.483 ' HA ' HD22 ' A' ' 123' ' ' LEU . 0.6 OUTLIER -171.5 38.05 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.765 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.462 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -114.2 36.19 3.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.323 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -147.82 152.14 37.16 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.366 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.487 ' HA ' ' N ' ' A' ' 20' ' ' SER . 66.4 m-20 -71.6 22.13 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.2 tm-20 -164.66 26.21 0.06 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.525 ' CB ' HG23 ' A' ' 120' ' ' THR . 6.9 tt -124.92 -56.73 1.55 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.97 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.46 -41.07 62.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.461 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 78.4 p -51.46 -31.42 23.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.34 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.14 -61.54 2.49 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.453 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.957 ' HB2' HD23 ' A' ' 112' ' ' LEU . 5.6 m-70 -59.15 -32.95 70.34 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.858 HG13 ' CG2' ' A' ' 108' ' ' ILE . 62.0 t -53.45 -45.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.92 27.42 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.803 -1.189 . . . . 0.0 111.574 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.7 -21.3 66.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.927 0.394 . . . . 0.0 110.601 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.641 HG21 ' O ' ' A' ' 107' ' ' ARG . 28.0 mt -90.11 -27.24 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.934 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -61.38 -41.97 97.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.172 178.308 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 29.6 m-20 -65.64 -39.32 91.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.85 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.78 -15.63 44.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.716 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 2.8 t80 -53.15 -56.64 14.8 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.494 ' HA ' HD12 ' A' ' 139' ' ' LEU . 27.1 p80 -59.77 -42.56 93.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -50.46 -30.75 13.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.007 0.432 . . . . 0.0 110.026 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 73.1 mm-40 -75.62 -36.57 60.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.972 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.56 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 23.2 mt -65.71 -30.57 71.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.229 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.4 t -78.03 -49.18 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.472 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.85 -31.29 72.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.974 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -64.76 -25.45 67.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.421 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.14 56.79 2.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.413 ' C ' HD12 ' A' ' 147' ' ' LEU . 25.6 t30 -179.83 -41.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.725 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -81.55 169.8 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.958 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.5 p 54.67 31.53 15.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 144' ' ' ASN . 3.1 mt -127.89 -179.13 4.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.938 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.3 -31.21 14.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.85 -179.946 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.775 0.322 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 30' ' ' ASN . 10.0 tttt -166.7 147.72 6.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' O ' HD23 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -107.9 43.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.724 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' HG23 ' A' ' 100' ' ' ILE . 26.0 m-85 63.06 169.38 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.918 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.494 ' HA ' HD21 ' A' ' 132' ' ' LEU . 1.3 t30 -166.03 111.63 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.034 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.812 HG21 HG13 ' A' ' 108' ' ' ILE . 71.0 t -63.0 142.29 16.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.822 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.441 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -63.81 -67.15 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.251 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.645 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 2.2 m-85 -150.02 121.57 7.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.452 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.699 HG22 HG11 ' A' ' 6' ' ' VAL . 2.1 t -107.57 95.59 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.303 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 3.0 tt0 -105.31 117.29 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.973 0.416 . . . . 0.0 111.626 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.903 HG23 HD13 ' A' ' 124' ' ' LEU . 11.9 t -83.18 155.09 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.556 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.681 HG21 HD11 ' A' ' 55' ' ' LEU . 3.2 mp -131.63 118.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.2 tptt -103.68 104.8 14.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.386 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 65.8 23.33 11.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.512 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . 76.38 38.88 32.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.549 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.72 18.19 1.82 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 60.08 150.17 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.008 179.04 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.54 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -139.59 -47.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.921 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.549 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -126.56 175.02 8.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.346 -179.059 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.483 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 11.6 p -170.48 121.55 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.592 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.2 t -108.58 71.0 0.77 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.645 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -106.15 83.08 1.84 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.904 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -98.77 141.84 23.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.195 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.35 152.7 20.82 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.634 2.223 . . . . 0.0 112.38 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 27.2 p90 177.37 155.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.613 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.635 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 53.9 mt-30 -116.77 36.03 4.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.984 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 29' ' ' GLU . 7.3 tttt 80.5 -9.59 1.35 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.995 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 61.05 -81.16 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.812 0.339 . . . . 0.0 111.005 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 27' ' ' LYS . 5.2 tt0 -140.52 -48.26 0.43 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.784 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.424 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 1.7 t-20 -141.09 -177.22 5.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 40.44 77.35 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.608 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . -176.61 -165.54 32.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.81 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.766 ' HB ' HD22 ' A' ' 97' ' ' LEU . 18.1 m -163.85 -43.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.897 0.38 . . . . 0.0 110.833 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.642 HG13 HD21 ' A' ' 97' ' ' LEU . 6.2 mt -61.87 142.74 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.278 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -172.75 -81.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.632 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.51 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -131.36 59.86 1.68 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.769 0.319 . . . . 0.0 110.992 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.19 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -105.94 30.09 6.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.56 28.54 6.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -113.35 -35.75 5.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.715 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -54.41 124.58 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.102 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.904 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -86.97 149.65 48.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.562 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 Cg_exo -43.52 -23.28 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.679 2.253 . . . . 0.0 112.098 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.703 ' HB ' HG23 ' A' ' 42' ' ' THR . 3.5 t -66.88 -48.98 78.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.904 HD12 HG22 ' A' ' 42' ' ' THR . 2.3 mp -54.09 -36.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.715 ' CE1' HG22 ' A' ' 41' ' ' ILE . 66.8 m-85 -76.49 -43.11 41.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.35 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.675 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.91 -23.49 67.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.346 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -86.47 -33.54 20.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.679 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 73' ' ' LEU . 12.2 mt -58.78 -63.36 1.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.063 HG12 HG11 ' A' ' 93' ' ' VAL . 3.9 mt -49.39 -58.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.044 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.675 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -53.79 -56.78 14.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.345 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -9.71 44.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.646 ' HB3' HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -117.47 -62.14 1.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 81' ' ' TYR . 59.3 t -68.0 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 111.914 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD2' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -43.04 -51.48 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 24.6 Cg_endo -63.18 -1.63 3.12 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.809 1.672 . . . . 0.0 112.344 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HB3' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -147.86 23.11 1.1 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.05 0.452 . . . . 0.0 109.993 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 81' ' ' TYR . 2.8 p -76.37 155.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 61' ' ' ILE . 33.0 m -146.08 147.07 30.55 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.107 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.776 ' C ' HD12 ' A' ' 61' ' ' ILE . 60.6 Cg_endo -76.14 25.81 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.852 1.702 . . . . 0.0 112.214 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.798 HD13 ' HG3' ' A' ' 65' ' ' LYS . 0.3 OUTLIER 47.5 173.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.082 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.564 ' H ' HG22 ' A' ' 61' ' ' ILE . 2.0 mmtt -98.53 -75.81 0.55 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.931 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.65 17.35 2.43 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.984 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -117.02 -30.58 5.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.984 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.798 ' HG3' HD13 ' A' ' 61' ' ' ILE . 6.5 mptt 58.32 155.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.254 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 109' ' ' LEU . 2.8 t 66.52 63.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -86.04 134.08 33.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.016 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 4.5 ttpp -85.03 130.06 34.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.827 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.619 ' HG2' HD11 ' A' ' 73' ' ' LEU . 6.7 tpt -50.79 -27.48 7.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.412 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.38 28.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 110.74 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.424 ' O ' ' HG3' ' A' ' 71' ' ' MET . 4.0 tpp -109.95 -12.31 14.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.987 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 63.51 61.79 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.463 . . . . 0.0 109.786 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 49' ' ' LEU . 9.5 mp -66.13 -45.23 81.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.03 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.625 HD11 ' CG2' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -132.71 159.7 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.029 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.431 ' N ' HG23 ' A' ' 74' ' ' ILE . 7.7 t70 -101.97 142.03 33.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.397 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.68 -35.59 4.91 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.842 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -133.38 175.25 9.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.788 0.328 . . . . 0.0 110.819 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 40.8 m-20 -113.11 152.58 29.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.508 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 4.9 t -111.65 116.06 30.16 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 85.5 m-85 -123.28 144.57 49.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.248 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CD1' HG13 ' A' ' 54' ' ' VAL . 39.1 p90 -135.17 125.01 25.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 111.533 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.453 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -129.21 121.06 26.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.668 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.68 ' H ' HD11 ' A' ' 61' ' ' ILE . 8.4 p -82.18 150.75 27.23 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.699 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -46.51 149.65 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.984 0.421 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.56 -17.45 46.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.981 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 22.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -146.1 94.55 4.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.72 -15.09 46.74 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.166 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -96.0 26.32 4.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.072 0.463 . . . . 0.0 110.268 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.531 ' O ' HG22 ' A' ' 90' ' ' THR . 38.0 m -150.7 69.5 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -69.06 178.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.14 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.537 ' H ' HG12 ' A' ' 91' ' ' VAL . 96.2 m-85 -153.16 91.6 1.54 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.446 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.063 HG11 HG12 ' A' ' 50' ' ' ILE . 35.4 t -91.43 125.17 44.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.066 0.46 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.431 ' SG ' HG11 ' A' ' 6' ' ' VAL . 44.3 t -120.44 126.12 49.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.29 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m-85 -99.06 116.86 32.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.372 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.956 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -119.9 132.86 55.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.085 0.469 . . . . 0.0 111.636 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.766 HD22 ' HB ' ' A' ' 33' ' ' THR . 31.3 mt -49.91 125.59 12.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.036 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -43.73 -31.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.71 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.37 -35.14 78.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.78 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.499 HG23 ' HD2' ' A' ' 101' ' ' PRO . 40.5 mt -74.18 138.25 75.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.9 Cg_endo -57.9 -169.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.468 2.112 . . . . 0.0 112.273 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -109.03 67.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.693 HG23 ' CE2' ' A' ' 135' ' ' PHE . 1.1 tp -153.27 -38.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.441 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.803 ' HG ' HD11 ' A' ' 108' ' ' ILE . 25.1 tp -59.33 -57.17 29.02 Favored Pre-proline 0 C--N 1.331 -0.204 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.901 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.956 ' HD3' HG21 ' A' ' 96' ' ' THR . 7.5 Cg_endo -49.9 -37.45 46.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.422 2.081 . . . . 0.0 111.039 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.833 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.9 mp -67.0 -32.4 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.815 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.609 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.73 -26.62 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.594 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.812 HG13 HG21 ' A' ' 6' ' ' VAL . 5.9 mm -66.92 -47.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.372 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -73.77 -58.2 3.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 t -56.46 -30.57 63.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -76.25 -43.3 21.13 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.0 mt -57.85 -31.51 66.74 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.67 -14.73 59.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.94 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.25 -21.31 56.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.451 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 127' ' ' HIS . 5.1 m-85 -88.58 -97.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.999 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 34.6 tp10 159.04 -22.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.672 0.389 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.588 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 5.9 t -121.75 99.75 6.63 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.28 0.562 . . . . 0.0 111.243 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -152.34 45.43 0.73 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.21 33.89 4.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.55 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -144.11 157.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.236 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.483 ' HA ' ' N ' ' A' ' 20' ' ' SER . 78.7 m-20 -74.62 17.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.689 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.8 OUTLIER -163.67 29.03 0.08 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 123' ' ' LEU . 5.9 tt -131.04 -45.82 1.02 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.575 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.903 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -59.78 -43.04 94.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.631 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.7 p -46.65 -27.15 1.07 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.64 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.06 -56.79 17.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.295 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.722 ' HB2' HD23 ' A' ' 112' ' ' LEU . 1.6 m-70 -60.87 -36.5 79.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.636 HG13 ' CG2' ' A' ' 108' ' ' ILE . 46.0 t -52.06 -44.09 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.889 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.97 -47.05 12.03 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -64.94 -21.13 66.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 127' ' ' HIS . 60.7 mt -90.5 -28.09 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.68 HD11 HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -66.93 -35.07 79.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.351 178.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 22.4 t0 -69.57 -38.89 77.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.762 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.0 t -84.08 -13.62 52.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.984 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.796 ' CE1' HD11 ' A' ' 139' ' ' LEU . 13.2 t80 -54.91 -55.1 34.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.996 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.525 ' HA ' HD12 ' A' ' 139' ' ' LEU . 18.6 p80 -58.33 -38.09 76.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.883 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 6.0 mm-40 -54.56 -31.49 56.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.111 0.482 . . . . 0.0 110.225 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.42 -34.88 47.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.913 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.796 HD11 ' CE1' ' A' ' 135' ' ' PHE . 23.5 mt -66.74 -35.11 79.35 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.793 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 81.5 t -74.18 -47.33 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.818 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -33.87 74.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.743 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -16.97 64.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.414 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.436 ' HD3' HD11 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -93.62 33.49 1.27 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.255 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -148.99 29.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.851 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -152.92 -72.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 p -98.33 59.99 1.36 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.436 HD11 ' HD3' ' A' ' 143' ' ' ARG . 2.3 tt -109.98 118.94 37.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -108.37 -31.53 7.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.988 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.911 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.871 0.367 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.77 147.41 51.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.88 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' O ' ' CD2' ' A' ' 4' ' ' PHE . 1.4 mmp_? -115.22 179.5 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.003 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.407 ' CE1' HG23 ' A' ' 100' ' ' ILE . 18.0 m-85 -159.64 173.12 16.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.935 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.69 ' HA ' HD21 ' A' ' 132' ' ' LEU . 1.7 m120 -175.72 132.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.815 HG13 HG23 ' A' ' 96' ' ' THR . 3.4 t -82.08 109.23 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.425 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -39.18 -59.42 1.02 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.239 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.678 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 7.6 m-85 -148.68 113.12 5.3 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.861 HG13 ' SG ' ' A' ' 94' ' ' CYS . 2.8 t -107.12 100.75 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.412 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.677 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.0 OUTLIER -111.36 128.89 56.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.105 0.478 . . . . 0.0 111.769 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.886 HG23 HD13 ' A' ' 124' ' ' LEU . 53.1 t -98.1 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.536 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.967 HD11 HG21 ' A' ' 50' ' ' ILE . 2.7 mp -117.24 118.32 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.684 ' HB2' HD13 ' A' ' 18' ' ' ILE . 7.0 tptt -99.72 102.24 13.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.419 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 62.01 39.75 12.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.562 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.4 60.77 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.827 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -145.12 113.75 6.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 0.0 110.102 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.677 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -50.24 126.78 15.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.715 -179.241 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.684 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.7 OUTLIER -105.01 -50.45 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.415 179.129 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 120' ' ' THR . 63.9 p -119.26 172.43 7.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.266 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.548 ' N ' HD22 ' A' ' 124' ' ' LEU . 6.5 m -168.28 133.47 1.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 112.054 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 36.0 t -116.88 69.42 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.678 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -104.62 96.58 6.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.298 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.62 129.23 18.37 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.36 151.37 17.64 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.658 2.239 . . . . 0.0 112.008 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' HZ ' ' HA ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -134.95 -29.87 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.813 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 22.1 tt0 78.27 29.42 0.45 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.963 0.411 . . . . 0.0 110.808 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.86 169.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.018 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -169.19 -159.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.502 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.48 63.92 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.891 0.377 . . . . 0.0 110.764 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -179.28 -168.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.546 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -75.84 103.57 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.072 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.579 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . -142.85 -176.12 16.62 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.53 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.854 ' HB ' HD22 ' A' ' 97' ' ' LEU . 96.0 m -159.31 -43.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.827 0.346 . . . . 0.0 111.331 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.647 HG13 HD21 ' A' ' 97' ' ' LEU . 8.5 mt -53.47 143.52 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.412 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER 176.62 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.434 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -167.07 -80.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.784 0.326 . . . . 0.0 111.454 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.08 -25.23 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.524 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 2.9 m120 -122.68 31.74 5.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.049 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -134.26 27.3 3.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.094 0.473 . . . . 0.0 110.971 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -118.42 -28.91 5.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.455 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.672 HG22 ' CE2' ' A' ' 46' ' ' PHE . 3.7 mm -55.98 125.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.934 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.959 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -85.44 149.54 52.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.512 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 2.2 Cg_endo -44.87 -22.04 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.354 2.036 . . . . 0.0 111.583 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.761 ' HB ' HG23 ' A' ' 42' ' ' THR . 93.6 t -66.9 -45.73 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.11 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.959 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -59.62 -34.55 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.672 ' CE2' HG22 ' A' ' 41' ' ' ILE . 39.1 m-85 -79.41 -42.87 24.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.316 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.659 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.54 -30.51 71.62 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.657 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 25.8 p30 -89.51 -26.04 21.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.622 HD22 HD23 ' A' ' 73' ' ' LEU . 3.6 mt -64.54 -61.16 2.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.016 HG12 HG11 ' A' ' 93' ' ' VAL . 6.4 mt -49.53 -62.93 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.493 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.659 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.21 -43.0 61.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.173 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -90.84 -15.16 30.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.579 ' HB2' HD21 ' A' ' 73' ' ' LEU . 90.9 mmm -123.76 -70.49 0.76 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.855 HG13 ' CD2' ' A' ' 81' ' ' TYR . 88.6 t -51.39 -50.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.889 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.948 HD23 HG22 ' A' ' 50' ' ' ILE . 3.0 mm? -56.18 -58.9 13.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.032 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 23.5 Cg_endo -62.31 4.71 0.3 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.285 1.99 . . . . 0.0 113.12 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 1.6 tptp -153.25 26.98 0.52 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG21 HG11 ' A' ' 91' ' ' VAL . 7.7 p -82.22 150.67 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.161 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' A' ' 81' ' ' TYR . 9.0 t -97.71 138.41 21.05 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.399 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 61' ' ' ILE . 71.1 Cg_endo -76.23 27.83 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.912 1.741 . . . . 0.0 111.696 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 61' ' ' ILE . 26.4 mm 20.25 81.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.01 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 -42.8 11.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.174 0.511 . . . . 0.0 110.048 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.06 -26.51 1.86 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.113 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.439 ' O ' HG23 ' A' ' 61' ' ' ILE . 10.7 m120 -79.61 -159.27 0.19 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 110.649 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.521 ' C ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 177.67 103.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.901 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.903 HG13 HD23 ' A' ' 109' ' ' LEU . 3.6 t 74.91 71.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.598 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -97.25 138.57 34.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.469 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 1.3 ttpm? -82.52 132.39 35.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.287 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.483 ' HG2' ' CB ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -53.83 -29.82 42.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.034 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.76 27.96 11.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.212 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.483 ' CB ' ' HG2' ' A' ' 69' ' ' MET . 6.1 tpt -106.97 -15.55 14.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.207 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 65.04 59.84 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.622 HD23 HD22 ' A' ' 49' ' ' LEU . 8.0 mp -62.91 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.445 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.505 HG21 ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -135.5 155.08 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.504 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -99.71 138.62 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.517 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 113.24 -32.32 6.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.532 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.687 ' O ' HG13 ' A' ' 98' ' ' VAL . 1.7 m-85 -118.21 -168.13 1.47 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.485 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -136.11 118.76 16.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.13 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 p -87.64 108.42 19.08 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 53.8 m-85 -121.55 151.1 40.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.896 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.855 ' CD2' HG13 ' A' ' 54' ' ' VAL . 11.9 p90 -144.52 139.61 28.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.09 0.472 . . . . 0.0 111.974 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -142.3 124.38 15.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.563 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 1.032 HG22 HG13 ' A' ' 91' ' ' VAL . 45.0 p -90.01 152.77 21.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.456 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -46.85 162.3 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 0.0 111.167 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -70.89 -22.91 62.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.682 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 22.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.93 91.48 10.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.26 . . . . 0.0 110.763 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.57 -14.23 38.4 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.378 2.052 . . . . 0.0 112.045 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 29.72 1.86 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 90' ' ' THR . 18.0 m -156.85 71.78 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.524 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.032 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -81.26 173.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.935 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.628 ' HD2' HG13 ' A' ' 11' ' ' VAL . 14.1 m-85 -141.72 153.17 44.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.213 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.016 HG11 HG12 ' A' ' 50' ' ' ILE . 14.6 t -152.63 122.18 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.977 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' CYS . . . . . 0.861 ' SG ' HG13 ' A' ' 9' ' ' VAL . 13.9 m -112.41 114.14 26.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 111.824 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 46' ' ' PHE . 1.3 m-85 -90.15 71.53 7.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.751 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.864 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.37 -176.38 1.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.933 0.397 . . . . 0.0 111.489 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.854 HD22 ' HB ' ' A' ' 33' ' ' THR . 23.0 mt -97.41 127.87 43.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.321 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -43.64 -33.69 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.534 -179.279 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -38.88 92.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.552 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 101' ' ' PRO . 62.6 mt -66.93 138.34 95.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.902 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.7 Cg_endo -59.94 -168.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.516 2.144 . . . . 0.0 112.348 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -108.69 67.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.535 ' CA ' HD13 ' A' ' 106' ' ' ILE . 2.7 tp -154.54 -38.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.845 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.804 HD21 HG22 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -57.06 -64.98 1.97 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.02 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.864 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.6 Cg_endo -47.34 -31.17 12.42 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.565 2.177 . . . . 0.0 111.492 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.759 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 mp -68.91 -34.46 64.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.819 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.509 ' O ' HG21 ' A' ' 131' ' ' ILE . 14.0 mmp_? -84.85 -22.64 29.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.345 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.752 ' CG2' HG13 ' A' ' 128' ' ' VAL . 21.0 mm -70.1 -45.18 77.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.148 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.903 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -76.34 -50.13 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.855 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.5 t -61.95 -30.63 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.481 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -75.48 -47.2 12.9 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 127' ' ' HIS . 12.8 mt -56.58 -30.47 63.23 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -79.0 -16.72 56.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.196 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -25.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.75 0.31 . . . . 0.0 110.38 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.625 ' CG ' ' CD2' ' A' ' 127' ' ' HIS . 5.2 m-85 -82.33 -91.86 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.2 pt-20 160.56 -28.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.414 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.416 ' CB ' HD21 ' A' ' 123' ' ' LEU . 19.5 m -111.89 129.54 56.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.517 0.675 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.456 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -172.3 35.19 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.039 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.86 33.28 4.32 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.536 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -145.62 148.06 32.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.469 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 20' ' ' SER . 72.0 m-20 -69.73 22.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.526 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.2 tp10 -162.87 25.24 0.09 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.536 ' CB ' HG23 ' A' ' 120' ' ' THR . 7.7 tt -123.76 -57.22 1.64 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.614 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.886 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.5 -42.1 63.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.53 ' H ' HD23 ' A' ' 124' ' ' LEU . 83.4 p -52.1 -28.68 18.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.243 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.21 -61.72 2.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.227 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.829 ' HB2' HD23 ' A' ' 112' ' ' LEU . 2.4 m-70 -59.88 -31.56 69.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 124' ' ' LEU . 56.2 t -56.54 -42.38 75.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.45 15.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.876 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.97 -21.4 65.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 127' ' ' HIS . 59.4 mt -90.02 -28.07 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.69 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.4 OUTLIER -62.86 -43.67 98.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.366 178.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -35.38 80.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.7 t -83.8 -20.84 32.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.079 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.921 ' CZ ' HD11 ' A' ' 139' ' ' LEU . 1.5 t80 -50.88 -53.87 28.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.97 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.468 ' HA ' HD12 ' A' ' 139' ' ' LEU . 62.5 m-70 -59.34 -43.89 92.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -50.01 -30.15 10.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.074 0.464 . . . . 0.0 110.375 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 1.7 mp0 -78.68 -34.17 46.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.058 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.921 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 15.9 mt -70.34 -28.93 65.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.25 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.2 t -77.21 -48.67 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.473 0.654 . . . . 0.0 109.472 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.97 -34.8 78.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.831 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.4 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -64.53 -24.99 67.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.135 179.25 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.519 ' CG ' HD11 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -91.03 44.94 1.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.062 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -143.52 30.95 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.838 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -128.7 -66.8 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 146' ' ' THR . 8.1 t -124.03 86.32 2.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.934 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.519 HD11 ' CG ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -107.32 -28.59 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.77 37.81 9.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.942 179.999 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 104' ' ' LEU . 4.2 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 121.021 0.439 . . . . 0.0 110.028 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.5 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -40.46 -51.26 2.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.719 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.615 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 14.3 m-85 -148.8 120.08 7.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.851 0.357 . . . . 0.0 111.464 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.771 HG21 HG11 ' A' ' 128' ' ' VAL . 1.5 t -110.0 95.28 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.979 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 0.5 OUTLIER -100.54 111.37 23.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.743 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.983 ' CG2' HD13 ' A' ' 124' ' ' LEU . 38.7 t -81.97 160.19 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 50' ' ' ILE . 2.5 mt -140.7 127.05 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.561 ' HB2' HD13 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -118.96 111.77 18.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 2.7 m120 64.04 34.75 11.07 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.991 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.48 26.14 61.84 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.544 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -148.27 120.05 8.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 11' ' ' VAL . 3.1 m -48.38 125.45 9.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.238 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -99.57 -45.46 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.738 0.78 . . . . 0.0 109.512 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.928 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.66 175.37 7.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.9 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.444 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 20.4 m -170.59 134.63 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HB3' HG23 ' A' ' 9' ' ' VAL . 33.2 t -123.45 69.34 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.2 m-85 -107.23 100.18 9.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.165 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.4 pm0 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.428 -179.662 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.491 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.8 m-80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.774 0.321 . . . . 0.0 111.291 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.73 25.71 4.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.08 0.467 . . . . 0.0 110.864 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -110.24 -34.86 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.667 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.659 HG23 HG13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -55.6 133.62 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.918 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.606 HG23 ' HB ' ' A' ' 44' ' ' VAL . 5.1 t -92.55 150.88 40.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.85 -24.27 4.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.946 1.764 . . . . 0.0 111.072 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.606 ' HB ' HG23 ' A' ' 42' ' ' THR . 90.4 t -66.95 -35.95 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.681 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.659 HG13 HG23 ' A' ' 41' ' ' ILE . 13.4 mm -63.0 -42.63 97.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.627 ' CE1' HG22 ' A' ' 41' ' ' ILE . 18.3 m-85 -77.14 -38.3 52.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.144 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.613 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -65.73 -31.53 72.58 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.032 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.94 -29.1 22.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.2 mt -61.24 -60.15 4.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.071 HG12 HG11 ' A' ' 93' ' ' VAL . 7.0 mt -50.2 -63.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.847 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.0 OUTLIER -53.66 -37.35 63.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.81 -1.541 . . . . 0.0 113.116 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.11 -23.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.477 ' O ' ' HE1' ' A' ' 69' ' ' MET . 74.7 mmm -117.03 -57.18 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.969 HG22 ' HG3' ' A' ' 69' ' ' MET . 52.9 t -63.45 -63.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.887 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.955 HD23 HG22 ' A' ' 50' ' ' ILE . 3.0 mm? -44.43 -53.43 14.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.5 Cg_exo -68.53 4.62 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.231 1.954 . . . . 0.0 112.412 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -150.32 25.26 0.8 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.006 0.432 . . . . 0.0 110.578 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 59' ' ' VAL . 4.3 p -87.03 166.05 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 58' ' ' VAL . 28.9 m . . . . . 0 N--CA 1.447 -0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.328 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 106' ' ' ILE . 4.6 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.656 0.265 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.498 HG22 ' CE1' ' A' ' 81' ' ' TYR . 2.5 t -102.61 139.19 38.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.848 0.356 . . . . 0.0 111.279 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -79.38 135.47 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.51 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.969 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -51.53 -29.02 15.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 53.12 25.42 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.0 tpp -110.31 -5.0 15.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.737 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.05 56.87 3.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.85 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.5 mp -53.22 -48.02 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.544 HG13 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -142.74 162.23 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.41 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.2 t70 -104.5 137.49 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.185 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 115.84 -32.96 5.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.244 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -132.9 162.56 31.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.197 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.501 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 52.8 m-20 -103.46 133.77 47.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.853 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.491 ' SG ' HD13 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -119.05 121.84 40.76 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -126.82 164.87 20.43 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.716 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CD2' HG13 ' A' ' 54' ' ' VAL . 19.5 p90 -138.74 129.06 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.381 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.447 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 5.0 t -129.94 112.4 13.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.594 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 33.0 p -74.32 156.8 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.939 0.4 . . . . 0.0 111.176 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -52.84 153.3 3.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.61 -9.14 57.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.71 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.28 23.14 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.69 87.28 4.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.772 0.32 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.17 -20.25 18.66 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.637 2.224 . . . . 0.0 112.577 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -93.79 29.57 2.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 52.7 m -149.85 73.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.342 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -75.01 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.724 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.542 ' H ' HG12 ' A' ' 91' ' ' VAL . 39.3 m-85 -144.52 93.55 2.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.071 HG11 HG12 ' A' ' 50' ' ' ILE . 41.0 t -98.44 127.62 50.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.53 . . . . 0.0 111.622 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 7.4 p -110.1 152.9 25.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 8' ' ' TYR . 1.4 m-85 -130.91 74.59 1.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.686 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.611 HG21 ' HD3' ' A' ' 105' ' ' PRO . 58.7 p -75.08 -169.52 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.444 ' O ' ' N ' ' A' ' 100' ' ' ILE . 24.1 mt -102.43 137.01 41.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.536 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.04 -30.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.806 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.12 -33.34 73.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.021 0.439 . . . . 0.0 110.57 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 97' ' ' LEU . 1.2 mm -67.51 127.12 93.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.968 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.75 -168.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -106.65 66.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.647 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.617 ' CA ' HD13 ' A' ' 106' ' ' ILE . 2.9 tp -151.14 -36.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.813 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.674 ' O ' HG12 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -64.03 -63.27 4.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.611 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.5 Cg_endo -44.95 -29.27 3.61 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.657 2.238 . . . . 0.0 111.331 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.804 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.1 mp -69.63 -45.17 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.746 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.483 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -76.43 -22.44 54.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.602 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.777 ' CD1' HD12 ' A' ' 132' ' ' LEU . 33.7 mm -67.11 -59.4 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.603 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.09 -56.64 15.16 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 p -57.06 -25.4 58.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.54 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -75.32 -45.37 19.3 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.497 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.939 HD23 ' HB2' ' A' ' 127' ' ' HIS . 18.5 mt -56.6 -28.11 59.63 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.71 -15.9 61.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.279 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.19 -27.26 64.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.572 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 4.6 m-85 -98.73 -167.97 1.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.496 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -121.53 -0.63 9.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.73 ' HB2' HD21 ' A' ' 123' ' ' LEU . 1.4 m -125.1 137.53 54.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.756 0.789 . . . . 0.0 111.108 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.567 ' N ' HD22 ' A' ' 123' ' ' LEU . 19.6 p30 174.02 35.92 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.164 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.12 34.07 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.516 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -146.12 155.52 42.8 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.98 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.444 ' HA ' ' N ' ' A' ' 20' ' ' SER . 15.7 m-80 -75.78 24.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -165.09 25.9 0.06 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.73 HD21 ' HB2' ' A' ' 117' ' ' SER . 6.5 tt -123.75 -56.73 1.67 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.871 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.983 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.78 -41.39 64.05 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.477 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 85.3 p -50.33 -28.45 7.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.215 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.07 -64.22 0.97 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.224 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.939 ' HB2' HD23 ' A' ' 112' ' ' LEU . 31.1 m170 -59.57 -30.98 69.02 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.987 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 124' ' ' LEU . 48.0 t -57.15 -42.69 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.99 -38.5 22.77 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.764 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -22.82 63.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.388 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.54 HD13 ' HA3' ' A' ' 111' ' ' GLY . 46.9 mt -90.19 -27.09 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.777 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.5 OUTLIER -62.33 -49.0 77.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.524 178.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -44.96 83.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.8 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 m -70.83 -19.04 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.8 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.578 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 54.7 t80 . . . . . 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.206 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.836 HG11 HG22 ' A' ' 9' ' ' VAL . 3.5 t . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -61.71 -59.83 4.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.237 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.677 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 2.8 m-85 -144.14 109.25 5.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.836 HG22 HG11 ' A' ' 6' ' ' VAL . 4.1 t -108.08 100.7 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.801 0.334 . . . . 0.0 111.356 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.488 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 2.2 mt-10 -111.24 120.13 41.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.059 HG23 HD13 ' A' ' 124' ' ' LEU . 46.7 t -79.86 156.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 50' ' ' ILE . 3.8 mt -133.98 111.28 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 15.7 tptt -91.16 99.74 12.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 58.35 41.04 23.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 12' ' ' ILE . . . 81.1 23.34 59.36 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.607 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -140.27 109.39 6.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -45.12 128.9 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.23 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.474 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -110.24 -45.85 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -123.07 172.86 8.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.511 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.49 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.3 m -167.48 126.92 1.37 Allowed 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 20.1 t -116.93 69.34 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.677 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.55 92.73 4.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.107 -178.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.399 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.685 0.278 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -131.32 26.08 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 110.859 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.61 -37.31 6.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.599 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.718 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -52.59 123.02 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.564 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.921 HG22 HD12 ' A' ' 45' ' ' ILE . 10.9 t -83.55 150.6 60.24 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.642 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 86.0 Cg_exo -45.75 -22.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.259 1.973 . . . . 0.0 111.908 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.739 ' HB ' HG23 ' A' ' 42' ' ' THR . 36.6 t -68.62 -41.07 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.103 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 42' ' ' THR . 1.6 mp -60.4 -34.57 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.718 ' CE1' HG22 ' A' ' 41' ' ' ILE . 56.0 m-85 -81.17 -42.37 20.95 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.995 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.19 -30.48 71.1 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.684 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 27.4 p30 -90.24 -26.43 20.07 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.718 HD11 HG13 ' A' ' 74' ' ' ILE . 3.1 mt -63.15 -60.24 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.043 HG12 HG11 ' A' ' 93' ' ' VAL . 5.0 mt -52.14 -63.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.893 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -52.76 -41.46 64.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.356 -179.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.2 t0 -90.73 -20.27 22.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.463 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 77.8 mmm -119.39 -60.93 1.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 81' ' ' TYR . 59.3 t -61.58 -56.02 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.934 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -50.44 -54.63 32.9 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.0 Cg_exo -62.89 -0.04 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.151 1.901 . . . . 0.0 112.78 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.548 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 1.2 tppt? -149.86 27.75 0.78 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 HG11 ' A' ' 91' ' ' VAL . 2.6 p -86.29 157.0 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.982 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.484 HG22 ' HE1' ' A' ' 81' ' ' TYR . 35.2 m . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.198 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.754 HG21 ' HA ' ' A' ' 106' ' ' ILE . 25.3 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.698 0.285 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 83.9 m -112.65 127.23 56.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -80.69 144.83 31.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.416 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.548 ' HE3' ' HB3' ' A' ' 57' ' ' LYS . 49.2 tpp -71.63 -35.39 70.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.977 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m 61.21 29.84 18.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.47 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 2.8 tpt -110.97 -12.48 14.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 62.79 63.49 0.97 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.001 0.429 . . . . 0.0 110.427 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.61 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.2 mp -62.2 -48.42 80.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.45 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -131.15 151.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -93.48 140.67 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.592 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.97 -34.33 5.5 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.166 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.589 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -120.92 -167.36 1.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.923 0.392 . . . . 0.0 111.208 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -137.65 128.89 27.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.38 105.98 17.99 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 51.1 m-85 -115.93 123.99 49.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.851 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.786 ' CD2' HG13 ' A' ' 54' ' ' VAL . 13.3 p90 -115.85 132.48 56.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.347 0.594 . . . . 0.0 112.133 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.678 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 0.8 OUTLIER -133.7 129.26 36.5 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.175 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.848 HG22 HG13 ' A' ' 91' ' ' VAL . 10.9 p -93.76 153.43 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.895 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -45.29 148.57 0.61 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -21.28 24.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.834 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.87 23.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.05 91.29 8.97 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.688 0.28 . . . . 0.0 110.842 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.88 -15.39 42.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.455 2.103 . . . . 0.0 112.145 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -96.36 29.42 2.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.092 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 90' ' ' THR . 52.3 m -153.19 68.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.709 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.848 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -67.94 -178.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.174 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.503 ' H ' HG12 ' A' ' 91' ' ' VAL . 91.8 m-85 -157.14 99.67 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.043 HG11 HG12 ' A' ' 50' ' ' ILE . 15.0 t -104.83 118.84 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.047 0.451 . . . . 0.0 111.52 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.503 ' SG ' HD22 ' A' ' 109' ' ' LEU . 32.0 p -112.02 131.03 55.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.873 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.5 m-85 -102.16 91.02 4.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.928 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.901 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -88.05 176.41 7.31 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.445 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' A' ' 100' ' ' ILE . 7.4 mt -90.58 128.85 36.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.849 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.0 -33.46 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.663 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 110.593 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 101' ' ' PRO . 64.1 mt -76.15 138.08 68.58 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.2 Cg_endo -59.3 167.74 5.75 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.406 2.071 . . . . 0.0 112.128 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.483 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -87.6 58.08 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.792 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.67 HG23 ' HE1' ' A' ' 135' ' ' PHE . 4.2 tp -141.09 -37.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.625 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.695 ' HG ' HD11 ' A' ' 108' ' ' ILE . 16.1 tp -61.54 -59.8 12.37 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.901 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.3 Cg_endo -47.76 -33.54 19.34 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.494 2.129 . . . . 0.0 110.908 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.754 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.2 mp -67.96 -38.97 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.822 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.59 ' O ' HG21 ' A' ' 131' ' ' ILE . 6.6 mtt-85 -76.36 -29.78 57.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.424 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.695 HD11 ' HG ' ' A' ' 104' ' ' LEU . 9.4 mm -61.63 -51.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.601 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -69.24 -61.66 1.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.412 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 48.2 t -56.0 -24.48 39.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.498 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -80.06 -43.01 10.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -59.19 -35.08 72.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 10.4 pt20 -77.97 -9.92 59.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.728 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.39 -23.02 46.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.599 ' HB2' ' CE1' ' A' ' 127' ' ' HIS . 3.5 m-85 -87.16 -96.31 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.064 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 160.81 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.549 0.34 . . . . 0.0 110.817 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.685 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 53.6 m -117.55 96.23 5.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.263 0.554 . . . . 0.0 111.195 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -151.27 46.35 0.82 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.713 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.97 33.81 4.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.493 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -145.7 161.99 38.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.158 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.49 ' HA ' ' N ' ' A' ' 20' ' ' SER . 8.4 p30 -78.74 24.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.639 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -170.15 28.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 117' ' ' SER . 5.8 tt -132.43 -45.67 0.9 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.059 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -59.46 -42.44 91.99 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 82.7 p -48.58 -28.03 3.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.152 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -56.99 -59.04 5.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.829 ' HB2' HD23 ' A' ' 112' ' ' LEU . 9.6 m170 -60.04 -33.67 72.34 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.532 ' O ' HD13 ' A' ' 132' ' ' LEU . 48.4 t -53.31 -43.04 49.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.961 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.91 -44.67 18.66 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 119.928 -1.13 . . . . 0.0 112.629 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -69.07 -21.02 64.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 111.059 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 127' ' ' HIS . 55.6 mt -90.47 -27.86 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.684 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -63.76 -48.19 77.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.153 178.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.88 -40.71 95.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -86.29 4.42 39.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.316 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.67 ' HE1' HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.229 0 CA-C-O 120.71 0.291 . . . . 0.0 110.599 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.898 HG11 HG22 ' A' ' 9' ' ' VAL . 27.8 t . . . . . 0 C--O 1.23 0.073 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.406 ' N ' HG12 ' A' ' 6' ' ' VAL . 1.5 m -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.709 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 15.8 m-85 -139.98 107.01 5.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.898 HG22 HG11 ' A' ' 6' ' ' VAL . 1.9 t -116.1 99.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.105 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 28.1 tt0 -108.1 123.15 48.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.393 . . . . 0.0 111.809 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.87 ' CG2' HD13 ' A' ' 124' ' ' LEU . 11.0 t -85.73 138.06 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.933 HD13 HG23 ' A' ' 93' ' ' VAL . 1.4 mp -113.56 114.79 47.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 2.0 tppt? -97.36 104.93 16.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.632 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.06 26.91 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.298 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.684 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 77.7 34.55 38.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.911 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.47 17.93 2.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 58.69 155.97 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.346 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.54 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -145.49 -50.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.632 178.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.775 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -123.94 176.32 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.969 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -170.06 129.0 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.457 . . . . 0.0 111.349 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.9 t -116.46 69.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.872 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.709 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 3.0 m-85 -106.41 86.51 2.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.878 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 . . . . . 0 C--N 1.327 -0.413 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.934 -178.822 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.739 0.304 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -123.55 28.28 7.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -110.91 -37.9 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.728 HG23 HG13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -51.74 134.73 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.66 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.564 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.9 t -94.79 151.15 38.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 72.1 Cg_exo -47.17 -26.7 5.61 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.88 1.72 . . . . 0.0 110.8 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.564 ' HB ' HG23 ' A' ' 42' ' ' THR . 57.4 t -61.89 -40.62 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.581 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.728 HG13 HG23 ' A' ' 41' ' ' ILE . 16.8 mm -58.12 -45.13 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.593 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.625 ' CE1' HG22 ' A' ' 41' ' ' ILE . 27.6 m-85 -75.22 -40.14 59.38 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.399 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.592 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.74 -28.79 70.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 44' ' ' VAL . 32.5 m-20 -89.25 -29.63 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 73' ' ' LEU . 5.2 mt -60.92 -59.67 5.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.057 HG22 HD23 ' A' ' 55' ' ' LEU . 4.6 mt -53.28 -64.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.212 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.7 tpp -49.69 -43.16 47.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.552 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.08 -11.41 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.746 ' HB2' HD21 ' A' ' 73' ' ' LEU . 32.9 mmm -127.68 -68.29 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.801 HG22 ' HG3' ' A' ' 69' ' ' MET . 63.8 t -58.16 -56.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.68 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.057 HD23 HG22 ' A' ' 50' ' ' ILE . 2.8 mm? -44.86 -57.82 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.809 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 37.9 Cg_endo -66.96 5.04 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.049 1.833 . . . . 0.0 112.25 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.62 22.42 1.46 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.071 0.462 . . . . 0.0 110.14 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 91' ' ' VAL . 4.9 p -84.93 166.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.858 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.467 HG22 ' HE2' ' A' ' 81' ' ' TYR . 19.0 m . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.541 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.845 ' N ' ' HG ' ' A' ' 82' ' ' SER . 2.9 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.88 0.371 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.7 m -98.97 126.26 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.314 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 5.0 ttpt -73.99 132.58 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.356 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.801 ' HG3' HG22 ' A' ' 54' ' ' VAL . 16.5 mmm -55.62 -32.81 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.741 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t 59.52 24.62 13.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.994 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.538 ' HB2' HD12 ' A' ' 73' ' ' LEU . 28.0 mmm -103.82 -5.08 22.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.094 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.32 55.49 4.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.126 0.488 . . . . 0.0 110.044 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 53' ' ' MET . 10.3 mp -57.41 -52.17 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.008 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.64 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -131.99 155.17 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.852 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -96.7 140.63 31.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.316 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.682 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.62 -33.8 5.86 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.121 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HD1' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -130.71 168.23 17.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.023 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 81.7 m-20 -108.2 130.6 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.392 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.462 ' SG ' HD13 ' A' ' 73' ' ' LEU . 11.3 p -90.53 112.35 23.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 53.4 m-85 -121.57 149.7 42.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.563 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD1' HG13 ' A' ' 54' ' ' VAL . 44.7 p90 -144.39 128.98 18.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.05 0.452 . . . . 0.0 111.19 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.845 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 3.3 t -132.89 116.4 16.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.521 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.901 HG22 HG13 ' A' ' 91' ' ' VAL . 34.6 p -77.61 148.48 35.1 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.32 163.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.332 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.64 -15.28 35.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.485 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 16.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.37 100.21 2.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.13 -13.03 37.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.322 2.015 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 30.14 2.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.073 0.464 . . . . 0.0 110.469 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 90' ' ' THR . 17.5 m -153.74 70.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.66 0.743 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.901 HG13 HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -71.12 175.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.126 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.544 ' H ' HG12 ' A' ' 91' ' ' VAL . 45.3 m-85 -144.97 100.12 3.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.324 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.99 HG11 HG12 ' A' ' 50' ' ' ILE . 41.0 t -93.16 130.03 42.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.425 . . . . 0.0 111.384 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.56 133.45 49.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.659 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -114.49 97.58 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.804 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.876 HG21 ' HD3' ' A' ' 105' ' ' PRO . 2.6 p -102.27 127.64 49.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.467 HD23 ' HD1' ' A' ' 77' ' ' PHE . 34.3 mt -37.05 133.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.055 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.41 -31.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.23 -30.4 71.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 110.157 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.424 ' N ' ' O ' ' A' ' 97' ' ' LEU . 7.3 mm -67.38 136.66 93.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.923 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.422 ' HD2' HG23 ' A' ' 100' ' ' ILE . 60.2 Cg_endo -72.45 179.55 5.0 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.246 1.964 . . . . 0.0 111.574 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.46 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -91.38 60.0 4.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.57 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 3.3 tp -148.73 -38.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.834 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.679 HD11 ' CD1' ' A' ' 132' ' ' LEU . 9.4 tp -62.19 -60.72 9.3 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.658 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.876 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.6 Cg_endo -47.85 -32.47 17.44 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.563 2.176 . . . . 0.0 111.239 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.84 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.7 mp -67.93 -36.45 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.106 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.523 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -83.73 -19.95 34.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.117 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 104' ' ' LEU . 11.7 mm -72.36 -49.47 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.809 0.338 . . . . 0.0 110.133 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.77 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -72.72 -49.4 31.4 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.7 p -63.95 -30.27 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.494 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -74.71 -43.32 29.26 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.856 HD23 ' HB2' ' A' ' 127' ' ' HIS . 11.5 mt -56.17 -35.36 67.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -13.35 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.133 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -22.43 55.78 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.472 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.482 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 5.9 m-85 -86.46 -94.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.886 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 162.19 -25.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.66 0.267 . . . . 0.0 110.904 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -91.82 -91.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.485 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 123' ' ' LEU . 3.1 p30 39.27 32.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.674 0.273 . . . . 0.0 111.097 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.15 33.83 5.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -148.59 150.78 33.9 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.48 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.437 ' HA ' ' N ' ' A' ' 20' ' ' SER . 5.0 p30 -71.34 29.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.569 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 120' ' ' THR . 10.3 tt0 -170.91 27.53 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.595 ' C ' HD23 ' A' ' 123' ' ' LEU . 6.2 tt -133.26 -49.77 0.86 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.689 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.87 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.31 -45.54 76.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.447 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 78.4 p -47.64 -30.12 3.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.375 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -60.16 -56.27 23.67 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.973 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.856 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.4 m170 -60.91 -31.75 71.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.634 HG13 ' CG2' ' A' ' 108' ' ' ILE . 47.7 t -55.63 -46.43 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.924 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.31 -40.69 18.91 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.33 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.98 -24.25 65.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.591 HD11 ' HB3' ' A' ' 127' ' ' HIS . 63.0 mt -88.17 -28.02 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.679 ' CD1' HD11 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -61.78 -49.84 74.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.526 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -46.48 82.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.991 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 t -72.51 -15.1 61.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.57 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 23.4 t80 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.233 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.923 HG11 HG22 ' A' ' 9' ' ' VAL . 54.9 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.837 0.351 . . . . 0.0 110.683 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.19 -69.48 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.793 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.674 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 8.4 m-85 -136.13 116.03 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 111.845 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.923 HG22 HG11 ' A' ' 6' ' ' VAL . 2.3 t -106.84 92.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.961 0.41 . . . . 0.0 110.868 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.2 tt0 -95.82 108.69 21.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.8 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.96 ' CG2' HD13 ' A' ' 124' ' ' LEU . 33.5 t -81.07 145.32 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.2 mp -129.34 124.89 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HG3' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.91 102.62 11.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.381 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.79 39.56 6.1 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.881 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.78 20.8 67.47 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.78 118.57 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.957 0.408 . . . . 0.0 110.26 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.415 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 3.6 m -47.84 128.55 13.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.338 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.568 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -105.62 -42.26 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.643 0.735 . . . . 0.0 109.362 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.901 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -131.29 176.35 8.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.197 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.441 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.0 m -170.5 121.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.521 ' HB3' HG23 ' A' ' 9' ' ' VAL . 33.9 t -107.58 70.22 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.674 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.1 m-85 -105.97 84.25 2.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.609 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.42 -179.458 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.82 0.343 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -129.54 28.38 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -111.77 -35.74 5.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.959 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.674 HG22 ' CE1' ' A' ' 46' ' ' PHE . 1.1 mt -51.24 116.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.79 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.85 HG22 HD12 ' A' ' 45' ' ' ILE . 1.8 t -77.08 153.18 82.51 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.522 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.438 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.1 Cg_exo -48.16 -21.78 3.19 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.785 1.656 . . . . 0.0 110.788 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 42' ' ' THR . 90.7 t -65.3 -49.35 79.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.058 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.85 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -57.28 -31.29 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.674 ' CE1' HG22 ' A' ' 41' ' ' ILE . 98.3 m-85 -80.8 -44.05 19.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.569 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.627 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -65.17 -26.02 67.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.291 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.99 -29.54 18.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.645 HD11 HG13 ' A' ' 74' ' ' ILE . 2.7 mt -60.75 -59.51 5.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.018 HG12 HG11 ' A' ' 93' ' ' VAL . 4.9 mt -53.87 -64.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.984 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.627 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.8 OUTLIER -49.73 -40.72 41.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.902 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -91.16 -19.74 22.75 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.487 ' HB2' HD21 ' A' ' 73' ' ' LEU . 93.8 mmm -120.14 -60.14 1.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' ' HE3' ' A' ' 69' ' ' MET . 96.4 t -64.55 -51.38 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.986 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -55.63 -52.45 71.93 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 14.7 Cg_exo -69.07 3.66 2.32 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.352 2.034 . . . . 0.0 112.159 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.93 23.61 1.37 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.03 0.443 . . . . 0.0 110.192 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.46 HG23 ' CD1' ' A' ' 81' ' ' TYR . 4.4 p -85.92 165.35 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 58' ' ' VAL . 15.3 m . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.135 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.898 HG13 HD23 ' A' ' 109' ' ' LEU . 3.1 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.918 0.39 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.0 m -80.7 125.41 30.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.283 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -71.75 130.67 41.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.497 ' HE3' ' HA ' ' A' ' 54' ' ' VAL . 53.3 tpp -57.53 -25.24 59.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 t 53.04 26.96 5.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.085 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.431 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 8.9 tpt -106.45 -11.0 16.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.149 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.87 58.06 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.371 . . . . 0.0 110.515 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.573 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.5 mp -59.86 -46.05 90.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.645 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -133.25 157.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.686 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.95 140.84 33.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.394 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.587 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.41 -33.92 5.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.241 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.54 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -132.79 168.36 18.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.882 0.372 . . . . 0.0 111.088 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 94.7 m-20 -106.57 143.25 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.402 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 6.4 m -106.98 114.77 29.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.538 ' HB3' HG12 ' A' ' 66' ' ' VAL . 87.7 m-85 -121.78 137.74 54.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.482 ' HB3' HG11 ' A' ' 54' ' ' VAL . 49.2 p90 -127.05 128.82 46.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.0 0.429 . . . . 0.0 111.467 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.867 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.5 t -133.35 118.91 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.96 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.634 HG22 HG13 ' A' ' 91' ' ' VAL . 40.3 p -80.63 150.43 29.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -46.14 146.84 1.2 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.276 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.03 -15.81 57.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.89 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 22.03 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.659 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.74 95.0 3.76 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.471 0.177 . . . . 0.0 111.178 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.33 -15.55 45.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -96.23 30.39 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.042 0.448 . . . . 0.0 110.093 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 65.1 m -154.36 73.72 0.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.66 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.634 HG13 HG22 ' A' ' 83' ' ' THR . 0.6 OUTLIER -72.83 176.0 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.223 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.583 ' H ' HG12 ' A' ' 91' ' ' VAL . 97.4 m-85 -150.68 94.88 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.826 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.018 HG11 HG12 ' A' ' 50' ' ' ILE . 44.0 t -98.09 121.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.246 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.567 ' CB ' HD21 ' A' ' 109' ' ' LEU . 37.5 t -114.51 139.98 49.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.312 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.8 m-85 -115.04 102.66 10.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.511 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.665 HG21 ' HD3' ' A' ' 105' ' ' PRO . 9.9 p -109.69 127.46 54.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.5 mt -38.32 132.9 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.326 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.94 -30.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.685 -178.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.11 -28.08 67.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.742 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.26 131.57 91.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.205 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.426 ' HB2' HG22 ' A' ' 103' ' ' ILE . 39.1 Cg_exo -60.0 179.65 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -98.72 62.58 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.682 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.608 ' HA ' HD13 ' A' ' 106' ' ' ILE . 4.3 tp -155.08 -37.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.783 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.699 ' HG ' HD11 ' A' ' 108' ' ' ILE . 5.3 tp -60.51 -61.55 7.73 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.665 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.3 Cg_endo -45.48 -37.54 14.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.794 2.329 . . . . 0.0 111.147 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.861 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -63.62 -37.44 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.152 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.553 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -83.49 -18.23 39.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.841 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.867 HG23 HG13 ' A' ' 128' ' ' VAL . 15.4 mm -70.63 -47.89 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.898 HD23 HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -74.37 -47.42 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.5 t -64.53 -29.11 70.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -75.73 -45.55 16.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.173 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.952 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.76 -33.93 67.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -70.79 -16.11 62.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.209 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.08 -21.6 59.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.363 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.492 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.5 m-85 -85.39 -94.13 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 4.9 tp10 161.57 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 110.659 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.5 m -91.32 -91.07 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.368 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.549 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.1 p-10 39.04 32.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.595 0.236 . . . . 0.0 111.021 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.37 34.81 4.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -150.13 151.1 32.6 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.708 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.441 ' HA ' ' N ' ' A' ' 20' ' ' SER . 7.3 p30 -70.67 28.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.919 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 tt0 -172.17 28.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.603 ' C ' HD23 ' A' ' 123' ' ' LEU . 5.9 tt -131.74 -50.33 0.97 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.96 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.93 -44.94 78.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 19.1 t -47.7 -30.22 3.65 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.168 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.13 -58.17 8.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.138 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.952 ' HB2' HD23 ' A' ' 112' ' ' LEU . 6.7 m170 -57.66 -39.36 76.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.643 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.867 HG13 HG23 ' A' ' 108' ' ' ILE . 42.9 t -50.52 -46.2 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.412 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.03 -47.28 47.0 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.324 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -65.28 -23.39 67.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.82 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 107' ' ' ARG . 37.8 mt -85.49 -27.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.604 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -65.66 -46.52 78.84 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.678 179.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.66 -44.0 78.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.7 m -80.3 -4.17 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.815 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.587 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 26.6 t80 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.932 HG11 HG22 ' A' ' 9' ' ' VAL . 3.5 t . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.872 0.368 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.45 ' HB3' ' CD2' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -53.93 -55.73 24.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.49 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.655 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 6.5 m-85 -145.47 140.52 27.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 0.0 111.653 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.932 HG22 HG11 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -131.35 97.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.348 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.562 ' HG2' ' HG ' ' A' ' 20' ' ' SER . 1.2 mt-10 -112.86 124.7 53.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 111.647 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.956 HG23 HD13 ' A' ' 124' ' ' LEU . 98.2 t -89.79 159.9 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.83 HD11 HG21 ' A' ' 50' ' ' ILE . 3.3 mt -137.66 117.4 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.602 ' CG ' HD13 ' A' ' 18' ' ' ILE . 3.2 tttp -107.36 115.5 30.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.056 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 61.4 32.74 18.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.573 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.0 27.91 57.44 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.283 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -144.92 121.57 11.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.086 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -51.88 122.55 8.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.145 -178.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.602 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.19 -47.94 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 109.603 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 124' ' ' LEU . 54.7 p -122.08 171.35 9.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.625 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.607 ' N ' HD22 ' A' ' 124' ' ' LEU . 11.8 m -166.54 128.05 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.985 0.421 . . . . 0.0 112.021 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.486 ' N ' HD21 ' A' ' 124' ' ' LEU . 32.0 t -119.91 69.39 0.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.655 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.5 m-85 -112.04 94.2 4.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.718 -179.318 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m120 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.678 0.275 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.31 29.89 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.926 0.393 . . . . 0.0 110.95 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -115.31 -38.61 3.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.352 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.66 HD12 HD13 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -53.57 118.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.976 HG22 HD12 ' A' ' 45' ' ' ILE . 9.5 t -81.43 152.19 69.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.6 Cg_exo -46.51 -23.06 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.066 1.844 . . . . 0.0 111.239 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.736 ' HB ' HG23 ' A' ' 42' ' ' THR . 49.2 t -64.82 -47.51 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.518 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.976 HD12 HG22 ' A' ' 42' ' ' THR . 1.9 mp -58.94 -33.32 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.214 0.53 . . . . 0.0 109.618 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.491 ' O ' HD12 ' A' ' 50' ' ' ILE . 66.1 m-85 -81.06 -41.98 21.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.541 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.633 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -64.69 -29.15 70.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.023 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -88.27 -27.31 21.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.4 mt -63.79 -61.11 2.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.966 HG12 HG11 ' A' ' 93' ' ' VAL . 6.8 mt -49.63 -62.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.736 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.595 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -54.33 -41.09 68.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.591 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -90.89 -20.42 22.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.455 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 69.0 mmm -119.66 -52.3 2.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 84.3 t -69.59 -60.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.867 HD23 HG22 ' A' ' 50' ' ' ILE . 1.3 mm? -46.41 -51.09 37.1 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 12.6 Cg_exo -70.08 2.87 3.31 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.262 1.975 . . . . 0.0 112.059 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -145.49 23.97 1.42 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.058 0.456 . . . . 0.0 110.086 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.491 HG23 ' CD1' ' A' ' 81' ' ' TYR . 5.0 p -87.67 166.06 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.914 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 58' ' ' VAL . 12.1 m . . . . . 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.899 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.799 HG21 ' HA ' ' A' ' 106' ' ' ILE . 2.6 t . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.957 0.408 . . . . 0.0 110.497 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -78.61 139.84 38.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.365 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.31 127.45 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.511 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.498 ' HG2' ' CG ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -54.04 -36.5 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m 63.97 25.44 13.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.894 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.498 ' CG ' ' HG2' ' A' ' 69' ' ' MET . 23.6 mmt -104.82 -0.66 26.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.944 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.06 56.28 5.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.098 0.475 . . . . 0.0 110.507 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.71 ' HB3' HD22 ' A' ' 49' ' ' LEU . 7.5 mp -60.44 -39.45 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.652 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.66 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -147.01 151.77 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.489 179.02 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -96.77 138.67 33.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.335 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 111.94 -31.91 6.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -129.48 163.92 24.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.15 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 75.8 m-20 -103.49 132.03 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.432 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 20.9 p -94.83 95.72 8.87 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.561 ' HB3' HG12 ' A' ' 66' ' ' VAL . 73.2 m-85 -110.33 133.59 53.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.511 ' HB3' HG22 ' A' ' 93' ' ' VAL . 46.6 p90 -127.31 139.84 52.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.455 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.793 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.5 t -143.55 125.09 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.779 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.798 HG22 HG13 ' A' ' 91' ' ' VAL . 41.4 p -86.94 158.12 19.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.95 153.37 2.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.83 -9.71 58.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.765 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 22.56 0.24 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.667 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 98.97 2.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.477 0.18 . . . . 0.0 111.23 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -13.61 40.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.445 2.097 . . . . 0.0 112.009 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -97.56 28.81 3.57 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.023 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 90' ' ' THR . 32.3 m -152.73 73.63 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.408 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -73.55 -179.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.435 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.633 ' H ' HG12 ' A' ' 91' ' ' VAL . 69.1 m-85 -156.06 98.61 1.89 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.754 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.966 HG11 HG12 ' A' ' 50' ' ' ILE . 65.0 t -106.86 133.52 51.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.98 0.419 . . . . 0.0 111.151 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.21 122.45 29.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.087 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.501 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.7 m-85 -92.05 87.45 6.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.725 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.809 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -75.72 -170.94 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.775 0.322 . . . . 0.0 110.931 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.407 ' HB2' ' CD1' ' A' ' 100' ' ' ILE . 82.0 mt -105.95 125.77 51.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -41.49 -30.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.608 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 36.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.407 ' CD1' ' HB2' ' A' ' 97' ' ' LEU . 47.9 mt -139.48 129.48 14.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.528 ' HB2' HG22 ' A' ' 103' ' ' ILE . 72.9 Cg_exo -48.39 151.51 4.59 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.307 2.005 . . . . 0.0 112.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.443 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -82.46 58.03 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.496 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.603 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 3.2 tp -144.1 -35.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.762 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.717 HD21 HG23 ' A' ' 6' ' ' VAL . 6.3 tp -60.45 -63.99 3.62 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.672 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.809 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -45.25 -35.51 11.33 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.726 2.284 . . . . 0.0 111.501 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.799 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.5 mp -63.35 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.061 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER -79.35 -19.68 49.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.813 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.888 HG13 HG21 ' A' ' 6' ' ' VAL . 19.9 mm -68.32 -49.99 61.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.522 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.725 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -72.23 -50.16 29.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -27.43 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -78.6 -42.15 14.42 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.852 HD23 ' HB2' ' A' ' 127' ' ' HIS . 20.4 mt -58.88 -28.23 65.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -18.56 58.38 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.227 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.5 OUTLIER -73.57 -22.21 60.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.509 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 6.4 m-85 -83.64 -93.24 0.07 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 20.7 tt0 156.5 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.352 0.261 . . . . 0.0 111.064 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 m -94.19 -90.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.0 OUTLIER 41.12 31.2 0.13 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.15 34.01 4.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.484 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -149.92 154.85 38.99 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.523 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HA ' ' H ' ' A' ' 20' ' ' SER . 12.6 m120 -74.06 22.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.394 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' A' ' 120' ' ' THR . 6.9 pt-20 -164.97 26.32 0.06 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.6 tt -127.11 -50.87 1.43 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.683 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.956 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.52 -44.69 76.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.5 p -47.66 -30.36 3.69 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.231 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.48 -56.27 21.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.326 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.852 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.0 m170 -60.39 -35.2 75.17 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.677 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.781 HG21 HG21 ' A' ' 9' ' ' VAL . 46.1 t -54.59 -45.66 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.02 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.51 28.77 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.435 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -69.31 -21.16 63.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.871 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 127' ' ' HIS . 62.4 mt -90.16 -27.38 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.62 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -64.59 -47.84 77.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.359 178.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -63.42 -44.62 94.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.575 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 t -76.49 -8.71 57.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.603 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 16.8 t80 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.022 HG11 HG22 ' A' ' 9' ' ' VAL . 92.9 t . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 121.079 0.466 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.68 -59.02 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.701 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.675 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 5.8 m-85 -149.35 115.84 5.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.848 0.356 . . . . 0.0 111.78 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.022 HG22 HG11 ' A' ' 6' ' ' VAL . 1.9 t -108.15 93.03 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.865 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.632 ' OE2' HG21 ' A' ' 17' ' ' THR . 0.1 OUTLIER -101.14 114.83 29.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.685 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.984 HG23 HD13 ' A' ' 124' ' ' LEU . 56.0 t -81.59 161.19 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.566 HG21 HD11 ' A' ' 55' ' ' LEU . 2.0 mp -142.01 121.08 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.693 -0.403 . . . . 0.0 112.045 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 12.8 tttt -107.07 97.24 7.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.703 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 69.85 37.59 1.78 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.58 62.01 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.695 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 7.6 pt-20 -144.8 119.22 9.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.632 HG21 ' OE2' ' A' ' 10' ' ' GLU . 18.6 m -50.14 130.78 23.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.507 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.36 -41.49 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.137 178.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.885 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -127.21 175.57 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.072 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.458 ' N ' HD22 ' A' ' 124' ' ' LEU . 17.0 p -170.38 134.65 1.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' HB3' HG23 ' A' ' 9' ' ' VAL . 34.4 t -122.7 69.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.746 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.675 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -106.95 88.72 2.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.684 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.487 -179.514 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.15 28.59 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.033 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -110.22 -38.39 5.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.887 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.689 HD13 ' CD1' ' A' ' 74' ' ' ILE . 1.1 mt -51.31 142.15 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.68 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.603 HG23 ' HB ' ' A' ' 44' ' ' VAL . 2.3 t -96.67 152.5 38.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 83.2 Cg_exo -46.43 -28.83 6.45 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.895 1.73 . . . . 0.0 110.669 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.603 ' HB ' HG23 ' A' ' 42' ' ' THR . 60.9 t -58.81 -40.28 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.548 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.597 ' HB ' HG23 ' A' ' 41' ' ' ILE . 23.5 mm -57.62 -46.34 86.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.549 ' O ' HD12 ' A' ' 50' ' ' ILE . 68.7 m-85 -75.41 -38.51 59.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.246 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.611 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.26 -30.15 71.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.155 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' VAL . 3.7 m-80 -87.59 -28.03 22.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.873 HD11 HG13 ' A' ' 74' ' ' ILE . 6.6 mt -64.21 -61.15 2.43 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.081 HG12 HG11 ' A' ' 93' ' ' VAL . 6.2 mt -48.9 -61.19 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.997 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.4 ttm -57.28 -40.85 78.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.186 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.5 t0 -91.18 -15.13 29.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.489 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 84.2 mmm -124.28 -56.48 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.478 HG13 ' CD2' ' A' ' 81' ' ' TYR . 72.1 t -64.44 -60.02 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -51.96 -50.35 78.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.9 Cg_exo -62.68 -2.28 3.31 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.383 2.055 . . . . 0.0 112.602 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -146.97 23.15 1.21 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.289 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.7 p -78.78 164.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.931 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 58' ' ' VAL . 29.7 m . . . . . 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.849 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.4 t . . . . . 0 N--CA 1.463 0.222 0 CA-C-O 120.967 0.413 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.8 m -78.0 129.37 35.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 7.0 tttm -79.45 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.264 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.479 ' HG2' HD11 ' A' ' 73' ' ' LEU . 20.0 tpp -56.78 -29.94 63.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m 56.43 28.64 13.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.452 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 37.8 tpp -108.66 -10.87 15.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.029 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.58 59.14 1.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 110.43 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.654 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.6 mp -59.5 -50.1 75.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.774 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.873 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -128.75 155.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.651 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.61 140.35 31.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.458 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 108.7 -32.25 7.1 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.63 ' HD2' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -133.87 167.96 19.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 111.25 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 84.0 m-20 -108.37 145.28 34.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.383 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 1.8 m -109.75 118.43 36.51 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 32.5 m-85 -126.13 138.97 53.72 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.12 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.478 ' CD2' HG13 ' A' ' 54' ' ' VAL . 26.8 p90 -124.78 133.69 53.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.073 0.463 . . . . 0.0 111.359 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.807 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.0 OUTLIER -136.18 117.6 14.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.031 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 18.0 p -79.35 153.58 29.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.37 146.42 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.096 0.474 . . . . 0.0 111.25 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -22.35 14.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.056 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.05 23.54 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.587 0.232 . . . . 0.0 111.582 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.56 94.57 5.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -15.28 47.35 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.395 2.063 . . . . 0.0 111.98 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.35 28.2 3.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.171 0.51 . . . . 0.0 110.272 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 90' ' ' THR . 51.7 m -152.04 70.91 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.641 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.611 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -72.34 177.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.57 ' H ' HG12 ' A' ' 91' ' ' VAL . 92.7 m-85 -151.1 93.69 1.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.112 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.081 HG11 HG12 ' A' ' 50' ' ' ILE . 51.5 t -95.6 120.54 45.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 111.05 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.497 ' CB ' HD21 ' A' ' 109' ' ' LEU . 35.8 t -112.85 137.48 51.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.108 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 8.6 m-85 -112.88 99.2 7.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.825 HG21 ' HD3' ' A' ' 105' ' ' PRO . 2.0 p -104.33 125.72 50.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 111.078 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.63 HD23 ' HD2' ' A' ' 77' ' ' PHE . 16.5 mt -39.9 134.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -46.2 -29.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.705 0.288 . . . . 0.0 111.493 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -28.24 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 110.478 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.4 mm -66.95 134.12 93.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.129 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.28 -159.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.134 1.889 . . . . 0.0 111.617 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -114.44 64.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.539 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.686 HG23 ' CE2' ' A' ' 135' ' ' PHE . 1.4 tp -161.79 -35.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.918 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.073 HD11 HD23 ' A' ' 132' ' ' LEU . 4.7 tp -58.73 -61.54 7.51 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.048 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.825 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.8 Cg_endo -45.38 -36.36 12.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.592 2.195 . . . . 0.0 111.015 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.849 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -67.79 -37.31 78.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.06 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.636 ' O ' HG21 ' A' ' 131' ' ' ILE . 1.1 mmp_? -80.77 -24.34 38.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.701 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.904 HG23 HG13 ' A' ' 128' ' ' VAL . 31.9 mm -67.01 -54.36 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.766 0.317 . . . . 0.0 110.223 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -69.33 -53.33 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.907 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -59.91 -27.93 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.498 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -74.92 -45.89 19.17 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.3 mt -56.16 -31.14 63.11 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -76.89 -15.76 59.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.058 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -75.43 -25.19 57.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.313 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.537 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 3.5 m-85 -84.42 -92.57 0.08 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.911 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 163.43 -29.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.059 0.457 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 26.3 m -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.476 0.655 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.496 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.7 p30 -169.67 36.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.944 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.89 33.38 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.529 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.28 155.15 43.72 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.901 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.2 m120 -75.25 19.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 pm0 -161.53 24.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.529 ' CB ' HG23 ' A' ' 120' ' ' THR . 7.4 tt -123.07 -58.26 1.65 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.7 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.984 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -50.81 -44.79 59.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.411 ' HB3' ' CB ' ' A' ' 21' ' ' CYS . 78.6 p -49.32 -29.58 6.24 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.461 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.07 -59.98 4.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.427 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.862 ' HB2' HD23 ' A' ' 112' ' ' LEU . 42.4 m170 -59.64 -32.17 70.19 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.904 HG13 HG23 ' A' ' 108' ' ' ILE . 56.9 t -55.26 -46.92 78.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -67.92 -42.9 84.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.11 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.62 -22.9 63.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.919 0.39 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.636 HG21 ' O ' ' A' ' 107' ' ' ARG . 40.5 mt -90.38 -27.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 1.073 HD23 HD11 ' A' ' 104' ' ' LEU . 2.9 mt -65.02 -52.33 56.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.919 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -71.57 -32.65 68.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -95.77 24.27 5.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.957 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.686 ' CE2' HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.927 HG11 HG22 ' A' ' 9' ' ' VAL . 1.4 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.92 0.391 . . . . 0.0 110.552 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -63.16 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.792 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.577 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.1 m-85 -144.98 140.35 28.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.309 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.927 HG22 HG11 ' A' ' 6' ' ' VAL . 1.5 t -129.63 90.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.1 tt0 -99.52 116.02 30.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.004 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.89 HG23 HD13 ' A' ' 124' ' ' LEU . 40.1 t -82.39 158.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.78 HD11 HG21 ' A' ' 50' ' ' ILE . 3.4 mt -141.01 119.58 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.667 ' CG ' HD13 ' A' ' 18' ' ' ILE . 1.8 tttt -104.68 99.76 9.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.482 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.77 40.39 5.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.855 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 21.32 63.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.05 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -141.38 116.27 9.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.194 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.3 m -50.84 126.03 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.823 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.667 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -103.96 -44.0 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.457 0.646 . . . . 0.0 109.792 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -127.7 177.11 7.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.432 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.464 ' N ' HD22 ' A' ' 124' ' ' LEU . 2.8 t -170.47 139.04 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.564 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 13.7 t -130.52 73.08 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.605 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.1 m-85 -107.35 88.78 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.815 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.212 -179.61 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.452 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 27.6 m-20 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.791 0.329 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 28.67 7.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -117.4 -34.35 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.556 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -53.98 121.59 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.978 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.977 HG22 HD12 ' A' ' 45' ' ' ILE . 8.8 t -83.39 151.48 62.52 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 82.8 Cg_exo -46.0 -22.56 1.42 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.189 1.926 . . . . 0.0 111.474 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' A' ' 42' ' ' THR . 97.1 t -65.58 -46.28 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.045 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.977 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -59.41 -33.91 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.556 ' CE2' HG22 ' A' ' 41' ' ' ILE . 88.1 m-85 -79.36 -43.28 23.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.204 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.637 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.83 -27.83 69.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.069 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 25.8 m-20 -88.33 -29.18 20.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.614 HD11 HG13 ' A' ' 74' ' ' ILE . 3.5 mt -62.57 -61.11 2.65 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.076 HG12 HG11 ' A' ' 93' ' ' VAL . 5.7 mt -50.44 -61.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.262 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.622 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -53.21 -46.01 68.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.055 -1.43 . . . . 0.0 113.198 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.91 -14.14 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.496 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 74.1 mmm -123.02 -63.27 1.27 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.743 HG13 ' CD2' ' A' ' 81' ' ' TYR . 67.5 t -59.35 -55.73 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.755 HD23 HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -53.17 -54.37 45.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 31.3 Cg_exo -60.85 -4.24 3.45 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.15 1.9 . . . . 0.0 112.175 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -144.43 26.89 1.42 Allowed 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.544 HG23 ' CD1' ' A' ' 81' ' ' TYR . 2.5 p -84.99 159.12 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.904 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.021 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.859 HG13 HD23 ' A' ' 109' ' ' LEU . 14.4 t . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 120.468 0.175 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 96.5 m -119.41 142.71 47.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 111.892 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HG3' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.36 133.93 34.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.426 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.51 ' HE3' ' CE2' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -58.79 -30.09 67.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.126 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.67 30.08 16.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.971 0.415 . . . . 0.0 110.804 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 2.4 tpt -111.06 -13.2 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.097 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.75 55.1 1.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.56 ' HB3' HD22 ' A' ' 49' ' ' LEU . 9.5 mp -54.42 -43.38 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.818 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.614 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -135.44 159.18 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.735 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.436 ' N ' HG23 ' A' ' 74' ' ' ILE . 29.6 t70 -99.74 142.18 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.471 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 107.03 -34.7 5.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.127 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.486 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.5 176.14 8.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 110.766 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 91.7 m-20 -110.98 162.24 15.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.069 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.5 t -121.97 101.49 7.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CE1' ' HG3' ' A' ' 68' ' ' LYS . 57.9 m-85 -108.67 147.07 32.45 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.575 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.743 ' CD2' HG13 ' A' ' 54' ' ' VAL . 33.9 p90 -137.66 123.14 19.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.091 0.472 . . . . 0.0 111.441 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.716 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 0.9 OUTLIER -124.86 119.09 27.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.396 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.667 HG22 HG13 ' A' ' 91' ' ' VAL . 23.8 p -82.13 156.93 24.25 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.095 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 18.6 t70 -53.41 152.12 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -28.49 53.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.891 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 23.55 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.654 0.264 . . . . 0.0 111.398 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -137.89 85.68 19.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.636 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 87' ' ' ASP . 15.0 Cg_endo -56.14 -18.19 22.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.523 2.149 . . . . 0.0 112.063 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 28.79 1.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 110.216 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 82.3 m -153.8 72.81 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.474 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.667 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -75.82 178.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.342 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.602 ' CD2' HG13 ' A' ' 11' ' ' VAL . 72.5 m-85 -152.15 88.48 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.116 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.076 HG11 HG12 ' A' ' 50' ' ' ILE . 44.0 t -90.91 125.14 43.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.483 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.635 ' HB3' HD21 ' A' ' 109' ' ' LEU . 45.2 t -125.27 115.35 20.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.76 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.2 m-85 -82.97 122.7 28.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.88 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -122.6 129.8 52.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 111.972 -179.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 36.0 mt -44.13 124.33 3.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.019 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.3 -31.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.88 -31.41 72.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.506 HG23 ' HD2' ' A' ' 101' ' ' PRO . 68.4 mt -76.39 138.2 67.67 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.049 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 100' ' ' ILE . 19.4 Cg_endo -58.6 -164.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.501 2.134 . . . . 0.0 111.928 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.502 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -114.83 57.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.963 0.411 . . . . 0.0 111.138 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.767 HG23 ' CE2' ' A' ' 135' ' ' PHE . 6.3 tp -142.04 -35.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.605 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.843 HD21 HG23 ' A' ' 6' ' ' VAL . 5.0 tp -62.8 -62.57 5.45 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.88 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.2 Cg_endo -46.61 -30.4 8.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.442 2.094 . . . . 0.0 111.034 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 mp -71.35 -40.23 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.182 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.403 ' NH1' HD11 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -78.72 -25.81 44.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 132' ' ' LEU . 15.8 mm -68.1 -46.02 82.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.457 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.859 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -72.01 -58.08 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -28.6 62.29 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.57 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -74.02 -47.3 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.886 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.9 mt -54.43 -26.07 28.55 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -71.89 -18.63 62.03 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.772 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.32 -21.37 59.74 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.047 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.501 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 8.9 m-85 -95.42 -49.98 5.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 84.68 -22.72 0.19 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.729 ' O ' HD22 ' A' ' 123' ' ' LEU . 3.1 t -85.51 8.22 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.636 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 1.7 p-10 -69.84 55.43 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.439 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -118.82 34.96 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -150.96 149.22 29.35 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.041 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.453 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.9 m-80 -69.63 25.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.609 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.9 tt0 -167.0 25.7 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 117' ' ' SER . 6.6 tt -128.0 -49.46 1.34 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.89 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -56.65 -45.19 81.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.1 m -46.39 -31.27 2.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.117 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.77 -58.04 8.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.98 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.886 ' HB2' HD23 ' A' ' 112' ' ' LEU . 2.6 m170 -58.76 -36.05 73.73 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.742 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.2 t -52.59 -48.53 47.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.29 -51.46 17.34 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.394 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -61.98 -20.92 64.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.756 0.312 . . . . 0.0 111.038 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.57 HD13 ' C ' ' A' ' 111' ' ' GLY . 66.8 mt -91.2 -27.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -63.8 -36.99 85.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.287 178.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -64.52 -34.2 77.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.87 -14.43 54.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.957 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.767 ' CE2' HG23 ' A' ' 103' ' ' ILE . 43.2 t80 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.027 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.738 HG11 HG22 ' A' ' 9' ' ' VAL . 97.5 t . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.771 0.32 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.413 ' CB ' ' O ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -81.72 -62.92 1.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.73 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 7.5 m-85 -143.48 111.78 6.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.738 HG22 HG11 ' A' ' 6' ' ' VAL . 3.2 t -106.35 97.35 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.577 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.474 ' CG ' HG23 ' A' ' 17' ' ' THR . 2.5 tt0 -98.96 110.04 22.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.256 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.965 HG23 HD13 ' A' ' 124' ' ' LEU . 58.4 t -77.6 158.79 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.581 ' CD1' HG23 ' A' ' 93' ' ' VAL . 1.4 mp -147.16 120.41 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.547 ' HB2' HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.54 113.89 27.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 178.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.58 34.61 17.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.534 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 22.93 62.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.688 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.45 119.52 13.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.474 HG23 ' CG ' ' A' ' 10' ' ' GLU . 3.2 m -50.95 128.61 21.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.121 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -107.08 -42.02 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.617 0.723 . . . . 0.0 109.476 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.665 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -128.62 175.24 8.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.331 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.512 ' N ' HD22 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -170.11 124.16 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.385 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 125' ' ' SER . 35.2 t -109.56 73.0 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.73 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -107.17 82.85 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.312 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.47 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 11.2 m120 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.77 0.319 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.48 26.46 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.135 0.493 . . . . 0.0 110.691 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -114.08 -30.2 6.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.213 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.501 HG22 ' CE1' ' A' ' 46' ' ' PHE . 2.6 mm -56.31 113.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.458 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 1.007 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -78.56 151.54 77.44 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 87.2 Cg_exo -45.83 -22.37 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.099 1.866 . . . . 0.0 111.184 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 42' ' ' THR . 66.1 t -66.24 -49.61 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.414 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.007 HD12 HG22 ' A' ' 42' ' ' THR . 2.3 mp -58.76 -31.97 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.524 ' O ' HD12 ' A' ' 50' ' ' ILE . 72.3 m-85 -80.09 -42.71 23.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.05 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.636 ' HD2' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -69.98 -23.9 63.24 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.162 0.505 . . . . 0.0 110.595 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.636 ' N ' ' HD2' ' A' ' 47' ' ' HIS . 4.9 t-20 -89.01 -33.83 17.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.857 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.9 mt -56.9 -61.36 2.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.065 HG22 HD23 ' A' ' 55' ' ' LEU . 5.3 mt -51.95 -62.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.431 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.623 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.05 -44.6 41.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.119 -178.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 48' ' ' ASN . 17.2 m-20 -91.15 -19.49 23.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.487 ' HB2' HD21 ' A' ' 73' ' ' LEU . 71.5 mmm -114.84 -61.18 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.836 HG22 ' HG3' ' A' ' 69' ' ' MET . 91.9 t -68.04 -56.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.065 HD23 HG22 ' A' ' 50' ' ' ILE . 2.7 mm? -46.54 -51.69 34.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 13.2 Cg_exo -69.91 3.22 2.97 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.519 2.146 . . . . 0.0 112.07 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.13 22.96 1.36 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.334 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.588 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.0 p -86.73 154.84 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.716 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.872 178.866 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.839 HG13 HD23 ' A' ' 109' ' ' LEU . 29.3 t . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 120.626 0.25 . . . . 0.0 111.5 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.413 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 89.7 m -103.71 138.19 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 111.65 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 8.6 ttpt -94.25 135.79 35.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.836 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -53.81 -29.56 41.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m 51.28 27.21 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.05 0.452 . . . . 0.0 110.816 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.0 tpt -112.7 -13.28 13.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 62.67 69.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 0.0 110.599 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.69 ' HB3' HD22 ' A' ' 49' ' ' LEU . 6.8 mp -70.7 -49.65 44.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.617 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -126.69 158.34 37.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' HG23 ' A' ' 74' ' ' ILE . 24.2 t0 -99.34 141.12 32.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.431 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.59 -34.06 5.71 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.098 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -131.58 168.89 16.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.105 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 64.9 m-20 -112.75 125.76 54.68 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 10.7 m -86.17 121.65 29.07 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 74.7 m-85 -124.02 164.61 19.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.344 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.707 ' CD2' HG13 ' A' ' 54' ' ' VAL . 29.9 p90 -154.98 121.46 5.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.438 . . . . 0.0 111.149 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -125.08 119.26 28.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.378 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 23.8 p -85.31 143.53 28.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.9 0.381 . . . . 0.0 111.073 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 2.8 t0 -46.82 135.97 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.11 -30.07 66.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.258 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 18.9 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.624 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -154.98 92.16 2.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.441 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.07 -17.0 53.87 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.325 2.017 . . . . 0.0 111.779 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -95.13 33.55 1.52 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.413 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 90' ' ' THR . 16.2 m -152.87 69.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 92' ' ' TYR . 1.2 t -65.91 173.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.148 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.605 ' H ' HG12 ' A' ' 91' ' ' VAL . 56.1 m-85 -147.1 95.04 2.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.224 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.964 HG21 HG21 ' A' ' 50' ' ' ILE . 21.5 t -86.21 137.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 111.542 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.801 ' HB2' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -132.08 128.79 38.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.798 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 6.5 m-85 -109.97 85.64 2.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.945 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.31 128.2 37.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.156 0.503 . . . . 0.0 111.179 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.1 mt -46.35 127.35 8.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.213 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.24 -30.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.695 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -32.22 70.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.67 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.431 HG23 ' HD2' ' A' ' 101' ' ' PRO . 43.0 mt -83.31 136.94 42.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.808 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HD2' HG23 ' A' ' 100' ' ' ILE . 19.4 Cg_endo -58.28 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.501 2.134 . . . . 0.0 112.311 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.485 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -111.56 63.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.938 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 5.5 tp -145.13 -43.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.012 HD11 ' HG ' ' A' ' 132' ' ' LEU . 2.8 tp -58.08 -60.21 10.83 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.945 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.9 Cg_endo -47.28 -35.39 20.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.641 2.227 . . . . 0.0 111.18 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.793 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.5 mp -67.02 -38.07 80.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.775 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.526 ' O ' HG21 ' A' ' 131' ' ' ILE . 21.5 mmm180 -79.42 -26.95 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.177 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.791 HG23 HG13 ' A' ' 128' ' ' VAL . 22.6 mm -62.97 -47.87 90.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.069 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.839 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -70.73 -56.34 6.62 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.0 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -56.3 -26.15 51.04 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -74.38 -47.17 17.63 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.955 HD23 ' HB2' ' A' ' 127' ' ' HIS . 9.9 mt -54.98 -31.33 60.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -72.08 -17.72 61.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.253 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.37 -22.38 60.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.28 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.514 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 5.5 m-85 -85.68 -93.66 0.08 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 8.0 tt0 161.89 -25.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.674 0.273 . . . . 0.0 111.031 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.23 -89.48 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.652 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.518 ' N ' HD22 ' A' ' 123' ' ' LEU . 2.0 p-10 40.87 31.37 0.12 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.89 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.5 34.38 4.37 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.502 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -145.99 151.58 38.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.606 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.449 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.9 p30 -72.0 22.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.6 tt0 -165.71 26.93 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.61 ' C ' HD23 ' A' ' 123' ' ' LEU . 6.2 tt -130.0 -50.23 1.12 Allowed 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.965 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -54.36 -46.89 73.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 11.7 p -47.48 -29.65 2.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.544 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.45 -59.1 5.76 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.114 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.955 ' HB2' HD23 ' A' ' 112' ' ' LEU . 5.5 m170 -55.99 -38.5 70.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.527 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.841 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.0 t -49.61 -51.14 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.95 -48.65 68.94 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.152 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -20.97 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 111.091 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.568 HD13 ' HA3' ' A' ' 111' ' ' GLY . 31.3 mt -90.66 -29.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 1.012 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -62.02 -42.18 98.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.153 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.72 -32.19 73.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.658 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -80.04 -12.66 59.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.487 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 5.9 t80 . . . . . 0 C--N 1.332 -0.159 0 CA-C-O 120.923 0.392 . . . . 0.0 111.105 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.806 HG21 HG13 ' A' ' 108' ' ' ILE . 51.7 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.824 0.345 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -62.48 -61.43 2.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.111 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.66 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 6.2 m-85 -148.56 112.41 5.12 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.805 HG22 HG11 ' A' ' 6' ' ' VAL . 4.7 t -105.19 101.45 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.536 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.611 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.1 tt0 -109.96 121.58 45.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.844 0.354 . . . . 0.0 111.726 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.916 HG23 HD13 ' A' ' 124' ' ' LEU . 98.1 t -80.65 161.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.573 HG21 HD11 ' A' ' 55' ' ' LEU . 2.9 mp -142.89 113.21 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.54 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -98.95 110.29 22.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.892 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.86 34.45 17.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 78.06 26.1 60.72 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.032 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 12' ' ' ILE . 64.8 mm-40 -138.23 114.25 10.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.955 0.407 . . . . 0.0 109.938 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.611 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -49.46 130.84 20.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.959 -178.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.54 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.61 -47.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 109.993 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.765 ' OG ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -118.44 172.01 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.224 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.58 ' N ' HD22 ' A' ' 124' ' ' LEU . 58.0 p -170.16 125.99 0.79 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 15.8 t -113.24 69.68 0.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.66 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -105.3 90.59 3.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.933 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.333 -0.146 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.393 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 10.4 m120 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.694 0.283 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.43 26.77 6.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.068 0.461 . . . . 0.0 110.666 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -121.64 29.22 7.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.771 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.792 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.1 mt -124.5 122.18 63.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.417 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.932 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -83.14 151.34 63.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.459 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.493 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 85.5 Cg_exo -45.29 -22.92 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.27 1.98 . . . . 0.0 111.697 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.761 ' HB ' HG23 ' A' ' 42' ' ' THR . 47.4 t -66.56 -44.74 89.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.071 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.932 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -59.1 -32.01 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.792 ' CE2' HG22 ' A' ' 41' ' ' ILE . 38.6 m-85 -81.58 -43.47 18.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.059 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.65 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.66 -29.13 70.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.346 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.11 -28.37 19.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.504 HD22 ' HB3' ' A' ' 73' ' ' LEU . 3.3 mt -62.68 -60.39 3.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.003 HG12 HG11 ' A' ' 93' ' ' VAL . 5.3 mt -51.79 -63.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.73 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.65 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.27 -43.43 61.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.18 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.64 -15.65 30.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.574 ' HB2' HD21 ' A' ' 73' ' ' LEU . 65.2 mmm -123.57 -69.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.803 HG13 ' CD1' ' A' ' 81' ' ' TYR . 93.0 t -52.33 -51.7 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.694 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.9 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -53.87 -59.15 10.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.669 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 30.4 Cg_endo -64.27 3.93 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.093 1.862 . . . . 0.0 112.487 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.62 22.7 1.63 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.099 0.476 . . . . 0.0 110.129 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 81' ' ' TYR . 4.6 p -87.8 166.88 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.469 ' H ' HG22 ' A' ' 58' ' ' VAL . 34.6 m . . . . . 0 C--N 1.319 -0.741 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.244 179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 109' ' ' LEU . 11.8 t . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.839 0.352 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.5 m -93.31 144.74 25.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 111.694 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HD2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -90.9 133.72 35.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 54' ' ' VAL . 10.7 mmm -54.4 -32.51 57.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.9 m 58.34 27.32 15.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 40.3 mmm -107.71 -15.68 14.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.03 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 66.89 61.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.896 0.379 . . . . 0.0 110.374 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.574 HD21 ' HB2' ' A' ' 53' ' ' MET . 7.8 mp -62.44 -46.95 86.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.131 0.491 . . . . 0.0 110.382 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.721 HD13 HD12 ' A' ' 41' ' ' ILE . 1.5 mt -136.47 154.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.447 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.403 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 6.3 t0 -94.06 139.47 30.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.629 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 105.06 -32.42 7.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.506 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.585 ' O ' HG13 ' A' ' 98' ' ' VAL . 6.2 m-85 -110.31 -179.47 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.03 0.443 . . . . 0.0 111.876 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -129.4 113.17 14.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.936 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.1 p -83.66 108.79 16.97 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.458 ' O ' HG13 ' A' ' 93' ' ' VAL . 47.4 m-85 -121.97 155.73 34.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.199 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.803 ' CD1' HG13 ' A' ' 54' ' ' VAL . 17.8 p90 -147.57 137.64 22.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.06 0.457 . . . . 0.0 111.263 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.572 ' OG ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -140.85 117.66 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.775 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 6.8 p -82.53 146.89 28.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.802 0.334 . . . . 0.0 110.786 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.52 138.4 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.0 0.429 . . . . 0.0 111.209 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -51.91 -24.93 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.981 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 20.52 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -146.48 93.41 4.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.66 0.267 . . . . 0.0 111.129 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.3 -14.59 43.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.309 2.006 . . . . 0.0 111.934 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.13 30.98 2.27 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.313 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 90' ' ' THR . 19.3 m -154.58 71.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -70.07 175.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.668 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.557 ' H ' HG12 ' A' ' 91' ' ' VAL . 43.3 m-85 -151.12 97.88 2.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.931 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.003 HG11 HG12 ' A' ' 50' ' ' ILE . 24.5 t -101.44 127.13 55.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 111.692 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.74 ' HB2' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -114.95 117.43 30.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.06 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 1.1 m-85 -92.66 73.92 5.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.909 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.65 -174.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.012 0.434 . . . . 0.0 111.22 -178.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' HB2' HG13 ' A' ' 100' ' ' ILE . 57.4 mt -101.1 126.08 47.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.288 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -42.61 -36.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -38.83 92.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.493 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 101' ' ' PRO . 86.1 mt -65.28 139.07 97.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.803 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 100' ' ' ILE . 16.6 Cg_endo -57.48 -171.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.528 2.152 . . . . 0.0 112.277 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.22 67.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.558 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 8.1 tp -154.66 -38.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.633 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.731 ' HG ' HD11 ' A' ' 108' ' ' ILE . 19.1 tp -57.7 -61.03 8.09 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.909 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.6 Cg_endo -48.39 -34.98 26.85 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.575 2.183 . . . . 0.0 111.08 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.846 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -67.02 -34.54 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.939 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.614 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.92 -27.76 33.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 179.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.806 HG13 HG21 ' A' ' 6' ' ' VAL . 7.9 mm -64.19 -46.69 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -74.92 -49.59 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.188 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.1 t -62.97 -27.91 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -78.15 -46.37 9.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.826 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.6 mt -57.39 -32.04 66.42 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -73.51 -17.07 61.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.929 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -22.4 59.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.499 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 6.8 m-85 -85.02 -94.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.7 tt0 159.25 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.346 0.259 . . . . 0.0 110.856 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 m -92.12 -93.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.681 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.524 ' N ' HD22 ' A' ' 123' ' ' LEU . 2.0 p30 41.27 30.94 0.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.51 31.17 5.81 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.504 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.47 157.46 44.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.24 178.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HA ' ' N ' ' A' ' 20' ' ' SER . 3.6 p30 -78.13 20.73 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.0 tp10 -163.63 25.48 0.08 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.639 ' C ' HD23 ' A' ' 123' ' ' LEU . 6.0 tt -126.35 -49.06 1.55 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.916 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.93 -45.68 78.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.434 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -45.59 -30.61 1.54 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.178 178.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.45 -57.85 11.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.956 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.826 ' HB2' HD23 ' A' ' 112' ' ' LEU . 4.4 m170 -58.87 -37.3 76.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.68 HG13 HG23 ' A' ' 108' ' ' ILE . 43.6 t -51.78 -45.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.414 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.3 -45.7 37.6 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.153 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -66.17 -22.52 66.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.946 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.614 HG21 ' O ' ' A' ' 107' ' ' ARG . 32.8 mt -90.32 -28.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -63.6 -42.52 98.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.355 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.18 -40.45 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -81.41 -15.86 53.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.151 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.558 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.991 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 104' ' ' LEU . 2.9 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.708 0.29 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.451 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -90.26 -61.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.796 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.682 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 5.1 m-85 -131.37 141.77 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.742 ' O ' HD21 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -148.69 100.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 12.0 pt-20 -115.02 138.41 50.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.863 HG23 HD13 ' A' ' 124' ' ' LEU . 53.0 t -90.86 151.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.893 HD13 HG23 ' A' ' 93' ' ' VAL . 4.1 mp -131.53 123.8 53.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 2.7 tttt -113.09 114.83 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.54 33.75 8.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.618 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 81.68 24.12 56.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.939 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.791 ' O ' HG23 ' A' ' 12' ' ' ILE . 1.3 tt0 -114.58 -142.91 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.647 0.26 . . . . 0.0 110.583 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.8 m -153.68 75.26 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.49 -43.08 86.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.704 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.686 ' OG ' HD13 ' A' ' 124' ' ' LEU . 4.0 p -122.41 170.01 10.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.865 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 30.6 m -168.23 118.27 0.77 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.0 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 15.8 t -111.48 68.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.682 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -116.1 87.72 2.74 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.84 -179.027 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 73.7 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.917 0.389 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.29 27.54 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -107.95 -36.27 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.772 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.634 HD12 HD13 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -56.58 119.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.68 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 1.08 HG22 HD12 ' A' ' 45' ' ' ILE . 13.2 t -81.14 157.23 71.23 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.389 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.618 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 54.2 Cg_exo -50.88 -21.74 8.96 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 121.917 1.744 . . . . 0.0 111.051 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.703 ' HB ' HG23 ' A' ' 42' ' ' THR . 48.1 t -66.16 -47.8 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.402 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.08 HD12 HG22 ' A' ' 42' ' ' THR . 1.9 mp -58.58 -33.3 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 41' ' ' ILE . 68.3 m-85 -81.36 -40.84 22.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.732 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.658 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -67.09 -27.28 67.22 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -88.28 -28.64 20.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.656 HD22 ' HB3' ' A' ' 73' ' ' LEU . 3.8 mt -61.47 -60.23 4.03 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.014 HG22 HD23 ' A' ' 55' ' ' LEU . 6.4 mt -51.52 -64.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.723 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.594 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -49.8 -40.37 41.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.661 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -91.14 -16.62 27.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.495 ' N ' ' O ' ' A' ' 49' ' ' LEU . 69.3 mmm -124.64 -68.69 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 81' ' ' TYR . 90.5 t -51.99 -51.52 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.697 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.014 HD23 HG22 ' A' ' 50' ' ' ILE . 1.8 mm? -56.59 -58.19 18.76 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.849 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 28.0 Cg_endo -63.25 1.73 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.113 1.875 . . . . 0.0 112.662 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HB3' ' HE1' ' A' ' 69' ' ' MET . 3.2 tptt -147.24 26.35 1.07 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.106 0.479 . . . . 0.0 109.942 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.7 p -85.27 167.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.895 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.5 ' H ' HG22 ' A' ' 58' ' ' VAL . 17.3 m . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.157 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.849 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.5 t . . . . . 0 N--CA 1.463 0.199 0 CA-C-O 120.847 0.356 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.9 m -92.82 135.38 34.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.436 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 3.2 tttt -87.09 125.6 34.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.414 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.565 ' HG2' HD11 ' A' ' 73' ' ' LEU . 1.4 ttm -52.34 -36.08 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m 58.47 24.48 11.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.519 ' CG ' ' HG2' ' A' ' 69' ' ' MET . 17.3 mmt -101.2 6.43 43.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.39 53.05 10.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.656 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.2 mp -59.98 -32.83 71.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.623 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.634 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -153.42 151.49 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -95.71 138.9 32.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 111.31 -32.8 6.22 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.204 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.483 ' HD2' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -131.74 175.46 9.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.342 . . . . 0.0 111.004 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -119.56 123.92 45.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 3.8 t -82.01 101.03 10.06 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 19.6 m-85 -109.26 126.09 52.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.491 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.537 ' HB3' HG11 ' A' ' 54' ' ' VAL . 52.5 p90 -120.12 135.64 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.072 0.463 . . . . 0.0 111.28 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.406 ' HB2' ' N ' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -138.91 116.29 11.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.418 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.885 HG22 HG13 ' A' ' 91' ' ' VAL . 74.5 p -86.11 154.16 21.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -49.6 155.21 0.83 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -68.25 -20.85 64.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.2 22.27 0.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.611 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.59 89.88 7.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.2 -16.93 43.22 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.362 2.041 . . . . 0.0 111.982 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.67 30.59 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.447 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 90' ' ' THR . 22.0 m -154.84 73.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.806 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.885 HG13 HG22 ' A' ' 83' ' ' THR . 0.7 OUTLIER -75.96 177.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.619 ' H ' HG12 ' A' ' 91' ' ' VAL . 36.2 m-85 -149.42 106.89 3.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.979 HG21 HG21 ' A' ' 50' ' ' ILE . 44.3 t -104.89 137.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.19 0.519 . . . . 0.0 111.754 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.565 ' SG ' HG13 ' A' ' 9' ' ' VAL . 45.3 t -138.7 110.27 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.727 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.5 m-85 -87.0 83.93 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.925 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -82.01 130.18 35.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.885 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.483 HD23 ' HD2' ' A' ' 77' ' ' PHE . 87.0 mt -46.61 126.88 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.698 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.45 -33.06 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.03 -18.18 56.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.342 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.423 HD13 ' CD2' ' A' ' 104' ' ' LEU . 4.7 mt -87.26 136.47 33.54 Favored Pre-proline 0 N--CA 1.461 0.113 0 CA-C-O 120.501 0.191 . . . . 0.0 110.773 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 100' ' ' ILE . 38.0 Cg_exo -59.56 -157.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.304 2.003 . . . . 0.0 111.645 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.415 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.4 OUTLIER -112.83 63.7 0.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.693 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.547 ' HA ' HD13 ' A' ' 106' ' ' ILE . 3.3 tp -150.91 -40.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.843 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 108' ' ' ILE . 29.1 tp -58.14 -62.28 5.83 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.125 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.925 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.7 Cg_endo -49.05 -27.32 11.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.265 1.976 . . . . 0.0 111.486 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.849 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.3 mp -76.15 -34.68 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.633 ' O ' HG21 ' A' ' 131' ' ' ILE . 4.0 mmp_? -84.07 -27.51 28.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.395 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.033 HD11 HD11 ' A' ' 104' ' ' LEU . 7.7 mm -71.35 -51.6 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.749 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.63 -55.71 14.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.595 178.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -60.78 -25.86 66.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.667 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -71.32 -50.8 19.96 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.431 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.986 HD23 ' HB2' ' A' ' 127' ' ' HIS . 5.3 mt -52.94 -27.84 20.77 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.82 -21.47 57.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.416 ' HG3' ' CD1' ' A' ' 115' ' ' TYR . 0.4 OUTLIER -75.18 -19.53 59.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.452 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 29.7 m-85 -82.12 -92.57 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.71 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 16.0 tt0 157.94 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.697 0.399 . . . . 0.0 110.621 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -92.89 -92.75 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.529 ' N ' HD22 ' A' ' 123' ' ' LEU . 4.0 p-10 40.61 31.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 110.98 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.93 33.64 4.48 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.487 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.93 159.62 42.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.751 0.31 . . . . 0.0 110.421 179.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.433 ' HA ' ' N ' ' A' ' 20' ' ' SER . 6.1 p30 -78.78 19.43 0.51 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.41 24.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.054 0.454 . . . . 0.0 109.799 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.623 ' C ' HD23 ' A' ' 123' ' ' LEU . 6.0 tt -124.53 -49.66 1.77 Allowed 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.463 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.863 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.23 -47.43 75.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.515 ' H ' HD23 ' A' ' 124' ' ' LEU . 96.6 p -46.23 -31.94 2.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.301 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -55.36 34.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.986 ' HB2' HD23 ' A' ' 112' ' ' LEU . 7.8 m170 -58.3 -37.29 74.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.784 HG13 ' CG2' ' A' ' 108' ' ' ILE . 46.9 t -50.48 -49.89 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.976 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.72 -49.24 37.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.843 -1.17 . . . . 0.0 112.334 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -64.18 -18.77 64.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.645 0.26 . . . . 0.0 111.246 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.667 HD13 ' HA3' ' A' ' 111' ' ' GLY . 53.6 mt -90.71 -28.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -64.1 -40.71 96.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.06 178.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.75 -32.4 74.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.433 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.99 -15.92 37.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.927 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.497 ' CE1' HG23 ' A' ' 103' ' ' ILE . 34.3 t80 . . . . . 0 C--N 1.332 -0.19 0 CA-C-O 120.714 0.293 . . . . 0.0 110.919 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.806 HG11 ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.637 0.256 . . . . 0.0 110.438 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.462 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -83.44 -59.9 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.0 111.563 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.654 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 11.4 m-85 -146.66 125.11 12.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.732 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.806 ' CG2' HG11 ' A' ' 6' ' ' VAL . 2.4 t -120.19 93.76 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.0 OUTLIER -100.95 116.83 33.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.033 HG23 HD13 ' A' ' 124' ' ' LEU . 95.0 t -89.28 136.34 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.668 HG21 HD11 ' A' ' 55' ' ' LEU . 2.2 mp -114.2 119.11 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HB2' HD13 ' A' ' 18' ' ' ILE . 3.5 tttt -104.86 107.88 19.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.083 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 61.96 37.71 14.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.629 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 26.24 60.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.637 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.72 115.9 6.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.0 109.993 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 24.7 m -47.1 127.74 10.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.208 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.599 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -99.91 -42.38 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 120' ' ' THR . 94.4 p -132.7 177.12 7.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.592 ' N ' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -169.85 125.8 0.83 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.561 ' N ' HD21 ' A' ' 124' ' ' LEU . 36.5 t -107.64 69.79 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.825 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.654 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -106.12 84.83 2.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.548 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 m120 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.662 0.267 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -131.54 27.39 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.978 0.418 . . . . 0.0 110.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -109.92 -36.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.805 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.713 HG22 ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -50.93 116.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.754 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.831 HG22 HD12 ' A' ' 45' ' ' ILE . 2.7 t -78.68 149.66 74.84 Favored Pre-proline 0 CA--C 1.518 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.623 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.52 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.8 Cg_endo -45.19 -22.57 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 111.079 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.655 ' HB ' HG23 ' A' ' 42' ' ' THR . 97.6 t -64.51 -47.29 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.893 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.831 HD12 HG22 ' A' ' 42' ' ' THR . 1.7 mp -58.33 -32.71 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.713 ' CE2' HG22 ' A' ' 41' ' ' ILE . 90.0 m-85 -80.71 -43.29 20.52 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.337 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.662 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.03 -28.19 69.92 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.82 -30.73 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.819 HD11 HG13 ' A' ' 74' ' ' ILE . 5.3 mt -61.71 -61.61 2.39 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.013 HG22 HD23 ' A' ' 55' ' ' LEU . 5.6 mt -50.04 -61.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.976 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.662 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -51.72 -43.4 62.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.066 -1.424 . . . . 0.0 113.075 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.86 -19.58 23.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.518 ' HB2' HD21 ' A' ' 73' ' ' LEU . 85.0 mmm -118.23 -65.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.665 HG22 ' HG3' ' A' ' 69' ' ' MET . 94.9 t -58.3 -57.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.8 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.013 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -44.91 -57.15 7.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.7 Cg_endo -65.92 4.63 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 121.969 1.779 . . . . 0.0 112.426 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -145.89 23.38 1.38 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.124 0.488 . . . . 0.0 110.07 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.486 HG23 ' CD2' ' A' ' 81' ' ' TYR . 5.1 p -86.33 166.65 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.878 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG22 ' HE2' ' A' ' 81' ' ' TYR . 32.6 m . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.101 178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.961 HG21 ' HA ' ' A' ' 106' ' ' ILE . 2.7 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.917 0.389 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -92.3 135.68 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.46 ' CE ' ' CZ ' ' A' ' 80' ' ' PHE . 8.0 ttmt -81.44 128.39 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.665 ' HG3' HG22 ' A' ' 54' ' ' VAL . 16.3 mmm -52.8 -25.59 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.193 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 m 53.97 25.89 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.9 tpt -104.34 -17.15 14.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 65.94 62.2 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.546 ' HB3' HD13 ' A' ' 49' ' ' LEU . 7.9 mp -66.18 -52.6 46.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.739 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.819 HG13 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -122.35 158.86 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 74' ' ' ILE . 23.3 t0 -104.23 141.53 36.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.424 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.618 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.39 -34.48 5.37 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.164 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -126.17 -171.76 2.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.672 0.272 . . . . 0.0 110.56 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 2.4 m-20 -127.97 127.4 43.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.2 p -82.5 103.41 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.46 ' CZ ' ' CE ' ' A' ' 68' ' ' LYS . 29.5 m-85 -115.91 136.34 53.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.604 ' CB ' HG22 ' A' ' 93' ' ' VAL . 48.8 p90 -130.92 140.01 50.14 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.846 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.811 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 2.0 t -144.28 123.34 12.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.45 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.941 HG22 HG13 ' A' ' 91' ' ' VAL . 44.8 p -87.0 153.28 21.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 0.0 110.964 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -47.09 158.36 0.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.209 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.51 0.73 45.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.559 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.48 21.63 0.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.77 102.08 1.31 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.53 0.205 . . . . 0.0 111.329 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.28 -15.11 48.55 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.452 2.101 . . . . 0.0 111.803 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -95.81 30.37 2.39 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.144 0.497 . . . . 0.0 110.14 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.412 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 86.0 m -151.51 71.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.941 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -73.55 178.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.552 ' H ' HG12 ' A' ' 91' ' ' VAL . 49.1 m-85 -152.98 84.19 1.21 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.175 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.779 HG11 HG12 ' A' ' 50' ' ' ILE . 59.8 t -98.52 132.32 43.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.411 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.701 ' HB3' HG13 ' A' ' 9' ' ' VAL . 21.5 p -139.48 131.44 27.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.097 0.475 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 37.7 m-85 -89.33 91.07 8.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.061 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.899 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -85.92 137.0 33.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' HB2' HG13 ' A' ' 100' ' ' ILE . 89.1 mt -48.5 127.75 13.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -50.78 -37.91 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.358 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.15 -25.33 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' A' ' 101' ' ' PRO . 76.2 mt -80.2 138.43 52.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.876 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 100' ' ' ILE . 22.3 Cg_endo -60.98 176.99 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.459 2.106 . . . . 0.0 112.069 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -94.37 61.15 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.682 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 6.1 tp -149.59 -32.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.996 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 108' ' ' ILE . 16.4 tp -61.59 -62.17 6.42 Favored Pre-proline 0 C--O 1.226 -0.143 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.049 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.899 ' HD3' HG21 ' A' ' 96' ' ' THR . 7.6 Cg_endo -49.02 -29.71 16.35 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.397 2.065 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.961 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 mp -72.73 -35.94 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.54 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.83 -26.62 34.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.077 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 104' ' ' LEU . 19.6 mm -73.83 -51.27 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.543 ' HA ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -67.28 -57.37 6.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -59.22 -25.91 64.41 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.587 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -73.97 -45.98 24.5 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 127' ' ' HIS . 10.4 mt -55.2 -26.7 40.96 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.62 -18.92 62.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.91 -21.55 61.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.93 0.395 . . . . 0.0 109.966 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.499 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 3.4 m-85 -93.14 -170.68 2.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.468 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -127.12 2.4 6.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.718 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.3 p -114.81 -93.53 0.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.554 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.5 p-10 41.13 31.82 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.49 35.2 4.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -151.1 149.86 30.01 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.396 178.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.412 ' HA ' ' H ' ' A' ' 20' ' ' SER . 40.6 t-20 -69.64 28.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.781 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -169.92 27.1 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 123' ' ' LEU . 6.0 tt -132.28 -49.64 0.93 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 1.033 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -54.7 -45.98 74.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 t -47.67 -29.78 3.26 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.359 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.25 -57.82 11.34 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.015 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.906 ' HB2' HD23 ' A' ' 112' ' ' LEU . 4.1 m170 -57.06 -36.65 70.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.609 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.703 HG13 HD12 ' A' ' 108' ' ' ILE . 44.3 t -51.79 -48.3 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.21 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.679 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -72.26 -48.93 22.8 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.54 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -20.69 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 110.701 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.587 HD13 ' HA3' ' A' ' 111' ' ' GLY . 70.3 mt -90.89 -28.2 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.679 HD12 ' HA2' ' A' ' 129' ' ' GLY . 1.1 mt -61.49 -43.69 98.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.028 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.55 -31.0 70.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.25 16.55 26.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.682 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 1.1 t80 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.446 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.902 HG13 HG23 ' A' ' 96' ' ' THR . 1.5 t . . . . . 0 C--O 1.231 0.093 0 CA-C-O 121.058 0.456 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.402 ' O ' ' CD1' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -53.74 -55.92 21.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.963 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.649 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 4.4 m-85 -147.57 116.38 6.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.762 HG13 ' SG ' ' A' ' 94' ' ' CYS . 3.1 t -108.51 97.27 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 1.4 tt0 -105.46 115.63 30.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.929 ' CG2' HD13 ' A' ' 124' ' ' LEU . 6.1 t -79.98 159.54 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.629 HD11 HG21 ' A' ' 50' ' ' ILE . 2.5 mp -140.15 114.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 18' ' ' ILE . 21.4 tttm -96.93 106.54 18.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.459 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 57.68 39.96 26.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.301 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.482 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 77.92 26.74 59.8 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.228 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -144.56 110.82 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.042 0.448 . . . . 0.0 110.069 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.472 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -42.99 130.23 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.478 -178.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.76 -47.56 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.997 178.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.591 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -127.53 176.62 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.217 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.527 ' N ' HD22 ' A' ' 124' ' ' LEU . 2.0 m -168.67 128.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.504 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 35.9 t -115.29 69.42 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.649 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.73 91.93 3.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.785 -178.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.505 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.3 m-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.91 0.386 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.73 26.58 7.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -108.33 -37.34 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.605 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.655 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.19 117.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.56 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.868 HG22 HD12 ' A' ' 45' ' ' ILE . 3.8 t -78.28 151.06 77.9 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 72.4 Cg_exo -47.32 -21.05 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.848 1.699 . . . . 0.0 111.042 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.667 ' HB ' HG23 ' A' ' 42' ' ' THR . 46.7 t -65.79 -45.97 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.183 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.868 HD12 HG22 ' A' ' 42' ' ' THR . 1.7 mp -59.57 -33.5 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CE2' HG22 ' A' ' 41' ' ' ILE . 74.3 m-85 -80.11 -43.82 21.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.447 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.611 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.24 -28.24 69.6 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.414 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.49 -29.7 18.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.858 HD11 HG13 ' A' ' 74' ' ' ILE . 3.6 mt -60.67 -60.5 3.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.049 HG22 HD23 ' A' ' 55' ' ' LEU . 5.1 mt -51.95 -64.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.704 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.72 -38.18 32.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.787 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -91.04 -23.27 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LEU . 40.7 mmm -119.14 -69.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.887 HG22 ' HG3' ' A' ' 69' ' ' MET . 88.8 t -53.52 -53.29 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.848 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.049 HD23 HG22 ' A' ' 50' ' ' ILE . 3.3 mm? -51.85 -58.74 10.04 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.0 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 33.2 Cg_endo -65.38 6.44 0.41 Allowed 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.197 1.931 . . . . 0.0 112.719 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 0.1 OUTLIER -151.0 25.04 0.74 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.099 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 81' ' ' TYR . 9.8 p -82.49 146.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG23 ' HE1' ' A' ' 81' ' ' TYR . 5.2 t . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 1.03 HG21 ' HA ' ' A' ' 106' ' ' ILE . 5.4 t . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.699 0.285 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.577 HG22 ' CE1' ' A' ' 81' ' ' TYR . 1.4 t -92.8 144.56 25.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.748 0.309 . . . . 0.0 111.113 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HD2' ' CE1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.23 142.2 31.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.887 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.18 -33.4 72.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.802 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m 59.2 26.21 14.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.306 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.418 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 14.2 mmm -111.66 -0.25 16.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.469 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.87 59.62 3.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.123 0.487 . . . . 0.0 110.516 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.851 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.9 mp -60.45 -45.79 92.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.858 HG13 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -139.26 156.32 27.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.684 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -102.47 138.84 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.375 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 113.7 -31.35 6.64 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.416 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -125.74 -165.0 1.36 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.929 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 1.9 m-20 -137.83 117.94 13.49 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.728 ' SG ' HD13 ' A' ' 73' ' ' LEU . 23.4 p -87.38 115.51 24.84 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 49.4 m-85 -123.83 151.74 43.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.867 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.832 ' CD2' HG13 ' A' ' 54' ' ' VAL . 30.0 p90 -141.87 135.36 29.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.676 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.713 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.5 t -140.06 123.78 17.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.591 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 29.0 p -82.09 147.61 29.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 111.029 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -46.93 141.38 4.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -69.05 -11.65 60.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.621 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.22 19.26 1.74 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 111.568 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -161.98 91.24 1.39 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.2 -18.54 30.24 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.482 2.121 . . . . 0.0 111.99 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -92.7 30.91 1.45 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.485 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 90' ' ' THR . 20.5 m -152.74 70.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.639 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -65.5 178.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.124 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.624 ' H ' HG12 ' A' ' 91' ' ' VAL . 97.3 m-85 -153.56 92.38 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.758 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.981 HG11 HG12 ' A' ' 50' ' ' ILE . 24.6 t -97.05 122.87 49.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.786 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.872 ' SG ' HG11 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -108.92 145.67 35.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.63 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 2.4 m-85 -121.82 80.48 1.69 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.902 HG23 HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -77.4 177.72 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 100' ' ' ILE . 12.7 mt -93.9 127.78 39.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -40.55 -32.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.21 -34.51 78.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 110.576 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.437 HG23 ' HD2' ' A' ' 101' ' ' PRO . 29.2 mt -73.16 136.95 78.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.879 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 100' ' ' ILE . 24.3 Cg_endo -61.24 -168.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.386 2.058 . . . . 0.0 112.232 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.558 ' HD3' HD11 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -108.04 67.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.66 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.735 HG23 ' CE1' ' A' ' 135' ' ' PHE . 1.6 tp -150.51 -33.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.982 HD11 HD12 ' A' ' 132' ' ' LEU . 19.8 tp -59.6 -60.14 11.55 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.241 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.847 ' HD3' HG21 ' A' ' 96' ' ' THR . 9.4 Cg_endo -51.21 -36.72 57.2 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.285 1.99 . . . . 0.0 111.193 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 1.03 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.2 mp -62.02 -40.47 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.231 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.46 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -81.73 -23.99 36.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.983 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.9 HD11 HD12 ' A' ' 132' ' ' LEU . 10.3 mm -71.85 -44.32 67.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.868 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -75.07 -50.9 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -60.64 -30.8 70.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.583 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -73.8 -48.94 15.19 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.13 -32.15 63.97 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.5 -17.26 61.76 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.09 -24.94 62.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.498 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 10.0 m-85 -86.75 -171.54 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -121.32 -1.19 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.613 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 m -114.8 -94.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.53 ' N ' HD22 ' A' ' 123' ' ' LEU . 4.4 p30 40.26 32.33 0.13 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.782 0.325 . . . . 0.0 111.078 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.413 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -114.94 36.09 4.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.0 OUTLIER -148.81 151.42 34.76 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.008 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.458 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.6 m-80 -70.54 21.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.582 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.1 tt0 -166.23 28.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.601 ' C ' HD23 ' A' ' 123' ' ' LEU . 5.9 tt -132.34 -50.1 0.93 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.929 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.59 -45.58 77.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.429 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 80.3 p -46.37 -30.24 2.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.0 -57.13 14.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.687 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.906 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.3 m170 -61.25 -31.44 71.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.698 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.889 HG13 HD12 ' A' ' 108' ' ' ILE . 48.4 t -56.41 -42.23 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.839 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 132' ' ' LEU . . . -74.94 -50.4 8.79 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.11 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -26.74 67.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.446 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.583 HD13 ' C ' ' A' ' 111' ' ' GLY . 61.7 mt -89.94 -25.82 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.982 HD12 HD11 ' A' ' 104' ' ' LEU . 2.9 tp -55.91 -45.7 78.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.782 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -44.84 64.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.802 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.43 -26.23 67.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.897 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.735 ' CE1' HG23 ' A' ' 103' ' ' ILE . 1.6 t80 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.766 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.981 HG11 HG22 ' A' ' 9' ' ' VAL . 20.2 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.774 0.321 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.455 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -55.79 -54.88 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.628 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 6.6 m-85 -142.49 135.44 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.841 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.981 HG22 HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -129.76 93.11 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.793 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 2.2 mt-10 -106.11 120.77 42.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.577 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.994 HG23 HD13 ' A' ' 124' ' ' LEU . 23.6 t -85.32 159.87 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.727 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.838 HD11 HG21 ' A' ' 50' ' ' ILE . 3.6 mt -138.42 117.54 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.693 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -106.04 109.3 21.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.88 0.371 . . . . 0.0 111.487 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 61.18 37.34 17.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.633 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.6 58.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.483 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -146.1 117.54 7.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.279 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -48.01 126.99 11.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.142 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.76 -45.39 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.457 0.646 . . . . 0.0 109.927 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.828 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -125.16 175.87 7.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.397 -179.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 59.5 p -170.19 127.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.509 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 25.5 t -121.58 69.72 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.628 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -106.56 97.66 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.53 -179.31 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 75.2 m-20 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.839 0.352 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 26.28 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.172 0.51 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -111.59 -32.31 6.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.032 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.578 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.63 119.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.63 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.973 HG22 HD12 ' A' ' 45' ' ' ILE . 10.1 t -82.9 150.77 62.68 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.469 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 84.6 Cg_exo -44.79 -23.43 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.294 1.996 . . . . 0.0 111.779 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.76 ' HB ' HG23 ' A' ' 42' ' ' THR . 33.6 t -66.76 -46.45 85.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.176 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.973 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -58.26 -33.87 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CE2' HG22 ' A' ' 41' ' ' ILE . 88.6 m-85 -80.33 -41.48 24.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.401 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.623 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -64.59 -28.05 69.36 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.933 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -89.2 -28.55 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.832 HD11 HG13 ' A' ' 74' ' ' ILE . 4.1 mt -62.33 -60.96 2.82 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.031 HG12 HG11 ' A' ' 93' ' ' VAL . 6.3 mt -50.48 -63.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.703 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -51.55 -41.57 61.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.068 -179.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.94 -22.42 20.87 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.452 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 33.2 mmm -116.77 -60.0 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.944 HG22 ' HG3' ' A' ' 69' ' ' MET . 82.7 t -61.38 -60.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.952 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.967 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -45.4 -54.95 13.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.602 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 17.6 Cg_exo -66.61 3.3 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.266 1.977 . . . . 0.0 112.45 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -147.56 24.89 1.09 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.974 0.416 . . . . 0.0 110.254 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.6 p -86.28 169.15 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.833 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.553 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.38 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.77 HG21 ' HA ' ' A' ' 106' ' ' ILE . 17.6 t . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.782 0.325 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.484 HG22 ' CE1' ' A' ' 81' ' ' TYR . 4.1 t -99.22 151.31 21.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.449 ' HE2' ' CE1' ' A' ' 80' ' ' PHE . 10.6 ttmt -86.14 141.38 29.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.944 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -55.31 -30.23 59.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.957 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m 60.98 26.26 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.059 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 mmm -115.89 -2.72 12.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.187 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.95 59.09 3.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 110.629 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.74 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.1 mp -57.75 -53.99 51.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.832 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -130.3 158.31 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.845 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.422 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.0 t0 -102.98 138.58 39.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.231 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.52 -30.45 7.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -135.49 165.83 24.6 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.741 0.305 . . . . 0.0 110.806 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.491 ' OD2' HG12 ' A' ' 98' ' ' VAL . 5.8 m-20 -104.65 126.29 51.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 27.7 t -93.57 105.83 17.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 34.1 m-85 -116.13 137.35 52.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.545 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.863 ' CD2' HG13 ' A' ' 54' ' ' VAL . 7.5 p90 -124.67 139.81 53.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.596 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 2.5 t -141.5 118.48 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.527 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.846 HG22 HG13 ' A' ' 91' ' ' VAL . 74.3 p -81.58 150.48 28.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -46.39 148.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.17 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.25 -8.46 53.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.706 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.28 22.9 0.3 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.606 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.47 88.94 2.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.745 0.307 . . . . 0.0 111.304 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.49 -19.51 23.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.604 2.202 . . . . 0.0 112.133 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.2 32.66 1.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.975 0.416 . . . . 0.0 110.397 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 90' ' ' THR . 21.7 m -156.42 71.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.846 HG13 HG22 ' A' ' 83' ' ' THR . 0.6 OUTLIER -71.35 178.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.196 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.62 ' H ' HG12 ' A' ' 91' ' ' VAL . 84.8 m-85 -153.01 98.59 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.031 HG11 HG12 ' A' ' 50' ' ' ILE . 43.1 t -106.17 129.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.372 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.558 ' HB3' HG13 ' A' ' 9' ' ' VAL . 28.2 p -128.41 117.46 21.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.308 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 16.0 m-85 -85.72 78.13 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.787 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.862 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -65.52 -172.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.758 0.314 . . . . 0.0 110.599 -179.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 100' ' ' ILE . 71.7 mt -102.26 129.82 48.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.491 HG12 ' OD2' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -46.01 -36.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.815 0.34 . . . . 0.0 111.617 -179.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.82 -29.61 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.418 ' N ' ' O ' ' A' ' 97' ' ' LEU . 60.2 mt -81.48 129.96 63.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.82 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.66 -176.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.491 2.127 . . . . 0.0 111.932 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.493 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -99.91 63.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.542 ' CA ' HD13 ' A' ' 106' ' ' ILE . 4.6 tp -144.02 -37.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.609 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.809 HD21 HG23 ' A' ' 6' ' ' VAL . 2.5 tp -63.89 -63.61 3.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.862 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -45.47 -30.19 5.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.627 2.218 . . . . 0.0 111.388 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.77 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 mp -66.92 -41.71 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.727 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.493 ' O ' HG21 ' A' ' 131' ' ' ILE . 6.9 mmt180 -80.95 -17.76 49.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.678 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.691 HG13 HG21 ' A' ' 6' ' ' VAL . 16.2 mm -70.53 -48.62 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.666 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -73.12 -51.49 17.77 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.496 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -76.69 -43.88 17.23 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.897 HD23 ' HB2' ' A' ' 127' ' ' HIS . 16.9 mt -56.82 -35.62 69.0 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -14.52 61.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.16 -23.86 59.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.239 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.491 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.7 m-85 -84.33 -93.08 0.08 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 161.26 -26.38 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 111.068 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.3 m -92.13 -90.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.557 ' N ' HD22 ' A' ' 123' ' ' LEU . 22.6 p30 40.73 32.47 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.99 34.52 4.8 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.559 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -150.71 149.24 29.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 178.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.443 ' HA ' ' N ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -68.91 28.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.858 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.6 tp10 -169.93 27.93 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.589 ' C ' HD23 ' A' ' 123' ' ' LEU . 5.8 tt -132.9 -49.32 0.88 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.507 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.994 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.66 -44.71 77.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 89.2 p -47.63 -30.73 3.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.16 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.91 -60.4 3.85 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.105 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.897 ' HB2' HD23 ' A' ' 112' ' ' LEU . 5.3 m170 -57.98 -36.88 73.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.636 HG11 HG21 ' A' ' 9' ' ' VAL . 42.4 t -53.28 -43.97 52.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.219 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.06 -44.82 12.76 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.109 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -65.25 -23.0 66.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 127' ' ' HIS . 57.3 mt -90.03 -26.34 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.671 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -63.72 -47.83 79.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.545 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.68 -44.32 82.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.889 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -73.21 -18.06 61.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.536 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 15.9 t80 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.049 HG11 HG22 ' A' ' 9' ' ' VAL . 2.1 t . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.449 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -87.88 -49.9 6.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.548 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.714 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 10.1 m-85 -143.57 134.71 25.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.96 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.049 HG22 HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -134.65 93.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.821 179.162 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.6 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.5 mt-10 -107.72 120.23 41.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.994 0.426 . . . . 0.0 111.812 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.987 HG23 HD13 ' A' ' 124' ' ' LEU . 75.8 t -82.69 158.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.83 HD11 HG21 ' A' ' 50' ' ' ILE . 4.4 mt -137.51 115.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.615 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -105.28 109.34 21.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.0 111.284 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 63.81 34.28 12.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.611 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.66 26.39 58.95 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.347 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.93 117.34 9.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.039 0.447 . . . . 0.0 109.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.6 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -51.61 125.21 14.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.727 -178.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.615 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.19 -49.47 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.445 0.64 . . . . 0.0 109.87 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 120' ' ' THR . 55.0 p -120.87 174.38 6.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.695 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.537 ' N ' HD22 ' A' ' 124' ' ' LEU . 92.1 p -170.06 134.44 1.26 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.155 0.502 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 28.7 t -124.86 69.71 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.434 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.637 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.9 m-85 -106.95 101.91 11.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.054 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.721 -179.629 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 24.1 m-20 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.803 0.335 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 51.5 tt0 -128.86 26.9 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.16 0.505 . . . . 0.0 110.832 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -113.66 -33.49 5.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.155 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.686 HG22 ' CE2' ' A' ' 46' ' ' PHE . 2.2 mm -52.87 130.62 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.676 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.71 HG23 ' HB ' ' A' ' 44' ' ' VAL . 11.2 t -91.24 151.25 42.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.714 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 75.0 Cg_exo -46.71 -25.93 4.07 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.293 1.995 . . . . 0.0 111.384 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.71 ' HB ' HG23 ' A' ' 42' ' ' THR . 74.2 t -66.65 -38.45 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.714 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.603 HG13 HG23 ' A' ' 41' ' ' ILE . 15.2 mm -59.8 -44.21 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.686 ' CE2' HG22 ' A' ' 41' ' ' ILE . 10.7 m-85 -75.83 -40.09 55.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.178 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.651 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -62.73 -30.27 71.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.178 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -87.65 -29.56 21.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 73' ' ' LEU . 4.1 mt -61.53 -59.72 4.8 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.069 HG12 HG11 ' A' ' 93' ' ' VAL . 7.0 mt -50.79 -63.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.016 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.4 OUTLIER -52.21 -41.74 62.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.99 -1.459 . . . . 0.0 113.048 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.76 -20.62 22.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.601 ' HB2' HD21 ' A' ' 73' ' ' LEU . 47.9 mmm -118.28 -59.95 1.84 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 69' ' ' MET . 90.8 t -63.55 -60.18 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.009 HD23 HG22 ' A' ' 50' ' ' ILE . 2.4 mm? -44.57 -53.69 14.29 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.8 Cg_exo -67.0 3.95 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.225 1.95 . . . . 0.0 112.457 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.28 28.07 0.58 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.139 0.495 . . . . 0.0 110.194 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 91' ' ' VAL . 9.4 p -83.76 150.35 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.94 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.584 HG23 ' HE1' ' A' ' 81' ' ' TYR . 3.8 t . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.429 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.839 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.0 t . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.688 0.28 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.9 m -101.2 130.06 47.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.459 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -81.74 134.95 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.778 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -58.13 -26.25 62.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.7 t 50.94 28.46 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.5 tpp -107.3 -18.1 13.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.61 63.76 0.41 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 49' ' ' LEU . 7.1 mp -65.32 -59.22 4.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.539 HG13 HD11 ' A' ' 49' ' ' LEU . 1.3 mt -121.51 155.44 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 17.0 t0 -97.3 140.02 32.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.754 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 107.47 -33.15 6.54 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.293 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 74' ' ' ILE . 2.1 m-85 -116.35 175.26 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.6 OUTLIER -120.75 121.68 38.74 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.45 ' HG ' ' HE1' ' A' ' 95' ' ' PHE . 6.1 m -86.98 106.19 17.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.459 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 65.8 m-85 -120.81 149.0 43.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.505 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 93' ' ' VAL . 35.3 p90 -144.87 131.07 19.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.154 0.502 . . . . 0.0 111.585 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.805 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 2.2 t -132.05 120.75 22.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.638 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.984 HG22 HG13 ' A' ' 91' ' ' VAL . 63.1 p -89.97 150.13 22.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.969 0.414 . . . . 0.0 111.133 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.66 149.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -69.97 -16.47 63.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.69 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.75 20.13 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.0 93.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.554 0.216 . . . . 0.0 111.263 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.31 -16.28 50.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.387 2.058 . . . . 0.0 111.896 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 30.39 2.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.098 0.475 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 90' ' ' THR . 34.5 m -150.84 69.59 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.535 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.984 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -72.47 176.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.512 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.562 ' H ' HG12 ' A' ' 91' ' ' VAL . 38.3 m-85 -151.21 91.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.069 HG11 HG12 ' A' ' 50' ' ' ILE . 41.5 t -99.27 132.6 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.154 0.502 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.38 123.15 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.148 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.714 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -95.8 84.45 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.79 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.912 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -74.45 -167.38 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.973 0.416 . . . . 0.0 110.907 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 100' ' ' ILE . 13.5 mt -106.36 127.48 53.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.351 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -45.54 -35.93 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.75 0.309 . . . . 0.0 111.697 -179.212 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.0 -31.27 71.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.383 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.415 ' N ' ' O ' ' A' ' 97' ' ' LEU . 62.9 mt -76.34 132.99 71.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.764 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.56 -168.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.369 2.046 . . . . 0.0 112.127 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 67.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.642 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.503 ' HA ' HD13 ' A' ' 106' ' ' ILE . 4.7 tp -152.03 -40.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.953 HD11 HD11 ' A' ' 108' ' ' ILE . 12.1 tp -56.15 -63.99 2.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.129 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.912 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.1 Cg_endo -47.57 -30.02 11.5 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.447 2.098 . . . . 0.0 111.51 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.839 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.8 mp -72.0 -41.05 68.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.575 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.508 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -79.01 -28.12 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 104' ' ' LEU . 7.8 mm -68.08 -49.81 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.529 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -67.25 -54.8 17.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.1 p -60.38 -27.39 67.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.529 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -74.02 -44.36 30.31 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.933 HD23 ' HB2' ' A' ' 127' ' ' HIS . 17.0 mt -55.24 -28.87 56.25 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.02 -19.07 63.33 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.365 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.06 -20.88 61.6 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.51 ' HB2' ' CE1' ' A' ' 127' ' ' HIS . 6.3 m-85 -101.45 -29.88 11.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.063 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 4.6 mt-10 83.33 -51.86 0.15 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.005 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.8 m -46.43 -95.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.691 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.573 ' H ' HD22 ' A' ' 123' ' ' LEU . 2.4 p30 42.07 31.9 0.27 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.725 0.298 . . . . 0.0 110.706 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.57 33.01 4.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -152.95 148.85 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.559 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.41 ' HA ' ' H ' ' A' ' 20' ' ' SER . 5.0 p30 -69.95 23.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.424 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.4 tt0 -163.84 24.86 0.08 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.618 ' C ' HD23 ' A' ' 123' ' ' LEU . 5.7 tt -123.81 -56.89 1.65 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.727 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.987 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.13 -45.16 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 90.0 p -47.76 -31.42 4.82 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.365 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.08 -56.69 16.33 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.264 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.933 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.4 m170 -60.17 -35.29 75.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.913 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.7 t -53.16 -47.18 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.827 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.71 -37.74 57.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.193 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.43 -18.45 60.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 0.0 111.344 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.529 HG21 ' HA3' ' A' ' 111' ' ' GLY . 26.4 mt -90.56 -28.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.913 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -67.63 -52.04 42.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.485 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.52 -29.45 64.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.0 m -98.27 -12.08 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 C--N 1.331 -0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.999 -179.853 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.948 HG11 HG22 ' A' ' 9' ' ' VAL . 1.4 t . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.782 0.325 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.454 ' OG ' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.98 -63.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.16 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.64 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.0 m-85 -140.34 131.19 25.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.954 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.948 HG22 HG11 ' A' ' 6' ' ' VAL . 2.1 t -117.42 85.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.378 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.419 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 0.9 OUTLIER -91.32 111.99 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.922 HG23 HD13 ' A' ' 124' ' ' LEU . 97.6 t -85.22 158.35 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.95 HD11 HG21 ' A' ' 50' ' ' ILE . 3.1 mt -138.69 121.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.833 0.349 . . . . 0.0 111.686 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.573 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.2 tttt -110.82 102.94 11.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 111.582 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 67.81 37.99 3.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.87 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.35 24.79 60.38 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.815 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.41 120.57 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.887 0.375 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -53.31 120.84 6.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.753 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.573 HG23 ' HB3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -95.37 -51.09 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.016 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 120' ' ' THR . 57.9 p -123.08 177.93 5.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 121' ' ' ASN . 29.5 m -170.5 142.95 2.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.411 . . . . 0.0 111.322 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 23.6 t -125.64 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.862 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 3.8 m-85 -106.2 88.83 2.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.401 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.724 0.297 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.6 26.16 4.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.016 0.436 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.53 -35.83 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.596 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -52.69 115.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.514 178.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.837 ' CG2' HD12 ' A' ' 45' ' ' ILE . 1.4 t -76.01 152.29 84.38 Favored Pre-proline 0 CA--C 1.517 -0.327 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.671 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 74.4 Cg_exo -47.88 -21.73 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.84 1.693 . . . . 0.0 110.709 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 42' ' ' THR . 96.0 t -65.86 -48.68 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.175 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.837 HD12 ' CG2' ' A' ' 42' ' ' THR . 1.7 mp -57.4 -33.27 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.596 ' CE2' HG22 ' A' ' 41' ' ' ILE . 89.4 m-85 -81.0 -42.71 20.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.427 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.643 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.98 -28.19 69.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.011 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -88.5 -30.07 19.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 73' ' ' LEU . 4.8 mt -60.84 -60.23 4.13 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.965 HG12 HG11 ' A' ' 93' ' ' VAL . 5.7 mt -52.09 -62.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.065 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.643 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -50.26 -44.89 53.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.909 -179.067 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.86 -15.25 30.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.674 ' HB2' HD21 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -122.12 -69.38 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.872 HG22 ' HG3' ' A' ' 69' ' ' MET . 70.9 t -53.93 -51.3 46.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.786 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.922 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -54.09 -58.39 13.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 25.3 Cg_endo -63.19 2.8 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.154 1.902 . . . . 0.0 112.662 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.422 ' CB ' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -146.48 25.23 1.22 Allowed 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.941 0.401 . . . . 0.0 110.092 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 59' ' ' VAL . 3.9 p -87.78 165.27 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.934 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 58' ' ' VAL . 35.2 m . . . . . 0 C--N 1.322 -0.622 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.068 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.884 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.3 t . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.868 0.366 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.458 ' HB ' ' CE2' ' A' ' 81' ' ' TYR . 97.3 m -95.13 144.34 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -93.48 125.54 38.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.783 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.872 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -46.92 -33.85 4.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.06 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.1 p 56.71 26.92 11.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.16 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.471 ' HB2' HD12 ' A' ' 73' ' ' LEU . 1.5 mmt -107.83 -3.51 18.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.964 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.87 55.29 4.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.092 0.473 . . . . 0.0 110.408 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.754 HD11 ' SD ' ' A' ' 69' ' ' MET . 10.7 mp -55.77 -49.94 71.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -136.25 161.3 37.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.5 t70 -100.09 140.25 34.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.275 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.54 -34.73 5.21 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.039 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.463 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -129.12 -179.02 4.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.633 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 19.6 m-20 -123.45 125.22 44.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.498 ' SG ' HD13 ' A' ' 73' ' ' LEU . 6.5 p -80.97 101.61 9.62 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.569 ' O ' HG13 ' A' ' 93' ' ' VAL . 63.4 m-85 -110.19 157.96 18.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.255 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.808 ' CD1' HG13 ' A' ' 54' ' ' VAL . 9.8 p90 -149.99 132.09 15.35 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.17 0.51 . . . . 0.0 111.463 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 28.6 t -134.81 117.39 15.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.659 HG22 HG13 ' A' ' 91' ' ' VAL . 5.0 p -84.79 148.21 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.946 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.02 144.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.88 -21.99 8.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.952 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 23.29 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.69 0.281 . . . . 0.0 111.507 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.57 92.34 6.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.002 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.56 -15.13 43.97 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.27 1.98 . . . . 0.0 111.98 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -95.97 29.79 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.242 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 90' ' ' THR . 32.4 m -153.05 69.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.582 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -71.29 177.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.566 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.511 ' H ' HG12 ' A' ' 91' ' ' VAL . 53.7 m-85 -151.64 83.34 1.29 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.387 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.965 HG11 HG12 ' A' ' 50' ' ' ILE . 32.5 t -89.08 133.47 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 0.0 110.998 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -131.07 119.17 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.882 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.508 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.1 m-85 -86.95 83.3 7.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.383 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.851 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -83.49 133.66 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 111.985 -178.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.454 ' HG ' ' OG ' ' A' ' 7' ' ' SER . 61.9 mt -46.57 125.4 7.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -47.03 -33.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.748 0.309 . . . . 0.0 111.32 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 58.9 mt -78.77 132.32 64.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.899 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.06 -167.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.393 2.062 . . . . 0.0 112.007 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.593 ' HG2' HD11 ' A' ' 106' ' ' ILE . 2.2 tttt -108.67 67.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.663 ' HA ' HD13 ' A' ' 106' ' ' ILE . 3.0 tp -150.97 -38.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.749 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.88 HD21 HG23 ' A' ' 6' ' ' VAL . 5.0 tp -60.36 -62.3 6.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.781 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.851 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -46.23 -34.21 13.29 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.335 2.024 . . . . 0.0 111.308 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.884 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.2 mp -65.98 -38.77 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.546 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -82.02 -27.12 33.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.872 ' CG2' HG13 ' A' ' 128' ' ' VAL . 10.8 mm -68.09 -47.98 76.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.428 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.806 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -71.78 -54.93 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 t -59.32 -28.78 67.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.54 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -73.88 -47.66 18.95 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.282 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.921 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -56.36 -31.56 63.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.95 -14.3 60.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.148 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -75.74 -24.41 56.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.343 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.542 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 8.1 m-85 -86.17 -93.15 0.09 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.979 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER 160.38 -28.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.782 0.433 . . . . 0.0 110.297 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.485 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 72.4 p -107.33 127.27 53.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.491 0.662 . . . . 0.0 111.191 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 5.6 p30 -172.65 36.2 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.053 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.73 32.83 4.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.316 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.635 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -148.39 144.96 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.279 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.451 ' HA ' ' H ' ' A' ' 20' ' ' SER . 2.2 m120 -68.5 29.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.882 0.372 . . . . 0.0 111.834 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 120' ' ' THR . 11.1 tt0 -169.78 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.635 ' CB ' HG23 ' A' ' 120' ' ' THR . 8.5 tt -124.08 -58.01 1.57 Allowed 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.922 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -51.26 -43.84 61.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.465 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.4 p -47.7 -29.31 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.509 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.3 -61.81 2.11 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.126 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.921 ' HB2' HD23 ' A' ' 112' ' ' LEU . 35.2 m170 -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.754 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.872 HG13 ' CG2' ' A' ' 108' ' ' ILE . 50.0 t -51.58 -48.88 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -69.06 -46.9 57.09 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.987 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -64.01 -20.33 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.734 0.302 . . . . 0.0 110.659 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.546 HG21 ' O ' ' A' ' 107' ' ' ARG . 44.7 mt -90.7 -28.45 4.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.764 ' CD2' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -62.36 -39.85 94.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.94 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -32.96 72.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.455 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.26 24.29 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.843 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.6 ' CE2' HG23 ' A' ' 103' ' ' ILE . 1.1 t80 . . . . . 0 C--N 1.331 -0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.376 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.026 HG22 HG23 ' A' ' 96' ' ' THR . 1.2 t . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.742 0.306 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB3' ' CD1' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -69.52 -71.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.291 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.684 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 3.4 m-85 -134.23 142.03 47.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.992 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.811 HG22 HG11 ' A' ' 6' ' ' VAL . 1.7 t -129.77 94.89 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.169 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.8 mt-10 -105.17 118.15 35.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.942 0.401 . . . . 0.0 111.978 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.911 ' CG2' HD13 ' A' ' 124' ' ' LEU . 16.8 t -84.53 158.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 55' ' ' LEU . 2.1 mp -141.52 117.24 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 10.1 tttt -101.35 107.53 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.276 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.22 37.63 23.72 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.809 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.26 24.65 56.68 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.757 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -143.3 112.97 6.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.947 0.404 . . . . 0.0 110.108 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 m -46.46 125.69 7.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.333 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -100.98 -39.74 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.253 178.452 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.8 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -131.49 174.68 9.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.106 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.492 ' N ' HD22 ' A' ' 124' ' ' LEU . 8.9 p -170.32 123.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 26.0 t -113.97 69.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.684 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -110.29 88.24 2.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.21 0.529 . . . . 0.0 110.982 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.508 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.791 0.329 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.75 28.58 5.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.7 -33.89 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.908 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.643 HG23 ' HB ' ' A' ' 45' ' ' ILE . 1.5 mt -51.73 140.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.767 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.553 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.5 t -94.6 151.66 39.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 80.0 Cg_exo -46.57 -28.25 6.11 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.825 1.683 . . . . 0.0 110.652 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 42' ' ' THR . 58.8 t -59.44 -42.14 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.566 178.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.643 ' HB ' HG23 ' A' ' 41' ' ' ILE . 23.4 mm -55.72 -51.68 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.686 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.518 ' O ' HD12 ' A' ' 50' ' ' ILE . 44.0 m-85 -71.34 -37.74 71.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.505 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.646 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.02 -31.04 72.09 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.224 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -87.46 -28.69 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.658 HD11 HG13 ' A' ' 74' ' ' ILE . 3.7 mt -61.91 -59.97 4.33 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.995 HG22 HD23 ' A' ' 55' ' ' LEU . 6.5 mt -50.31 -64.05 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.898 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -53.13 -40.32 64.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.348 -178.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.72 -21.85 21.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.485 ' HB2' HD21 ' A' ' 73' ' ' LEU . 83.1 mmm -118.38 -59.34 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 81' ' ' TYR . 84.2 t -62.81 -59.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.995 HD23 HG22 ' A' ' 50' ' ' ILE . 2.9 mm? -45.33 -54.26 15.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.0 Cg_exo -67.78 4.32 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.269 1.98 . . . . 0.0 112.465 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 2.1 mptt -145.49 21.86 1.5 Allowed 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 120.94 0.4 . . . . 0.0 110.461 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 59' ' ' VAL . 4.4 p -87.22 167.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 58' ' ' VAL . 34.3 m . . . . . 0 C--N 1.32 -0.715 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.928 178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 106' ' ' ILE . 98.7 t . . . . . 0 C--O 1.231 0.091 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.473 ' CG2' ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -98.34 168.5 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 111.628 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -105.53 139.11 40.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.569 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.618 ' CG ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -49.27 -29.01 5.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.042 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 p 52.12 26.29 3.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.5 tpp -113.95 -10.87 12.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.157 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.72 58.88 2.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.503 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.5 mp -59.87 -62.38 1.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.76 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.658 HG13 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -120.03 155.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.673 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -96.9 140.68 31.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.432 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.661 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.0 -32.74 6.64 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.275 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -126.62 163.1 24.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 111.114 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -105.88 130.25 53.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.515 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.0 m -94.99 112.71 24.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 44.0 m-85 -122.54 140.84 52.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.772 ' CD2' HG13 ' A' ' 54' ' ' VAL . 7.2 p90 -131.5 134.3 46.0 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.142 0.496 . . . . 0.0 111.305 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.479 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 11.4 t -136.17 118.57 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.61 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.686 HG22 HG13 ' A' ' 91' ' ' VAL . 64.8 p -85.0 144.41 28.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 7.5 t0 -43.65 148.19 0.37 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.588 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.31 -20.43 60.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.618 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 19.59 2.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.549 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -159.87 90.1 1.86 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.445 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -56.78 -18.8 28.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.619 2.212 . . . . 0.0 111.915 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -92.85 29.84 1.71 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.104 0.478 . . . . 0.0 110.679 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 90' ' ' THR . 23.3 m -149.51 68.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.26 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.686 HG13 HG22 ' A' ' 83' ' ' THR . 0.7 OUTLIER -64.27 179.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.211 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.648 ' H ' HG12 ' A' ' 91' ' ' VAL . 98.0 m-85 -154.89 79.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.85 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.903 HG11 HG12 ' A' ' 50' ' ' ILE . 86.8 t -88.29 127.31 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.104 0.478 . . . . 0.0 111.312 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.466 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.4 t -125.9 117.51 23.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.5 m-85 -87.28 78.81 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.088 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 1.026 HG23 HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -64.5 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.898 0.38 . . . . 0.0 111.162 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.411 ' CD2' ' OG ' ' A' ' 7' ' ' SER . 56.4 mt -105.71 131.68 52.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.271 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -46.84 -34.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 111.336 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -33.63 74.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.525 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 98.0 mt -72.76 129.96 86.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.816 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.81 -172.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.251 1.967 . . . . 0.0 111.516 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 64.13 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.908 0.385 . . . . 0.0 110.724 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.541 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -148.42 -38.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.86 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.624 HD11 ' CD2' ' A' ' 132' ' ' LEU . 16.9 tp -62.5 -62.25 6.08 Favored Pre-proline 0 CA--C 1.521 -0.136 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.735 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.862 ' HD3' HG21 ' A' ' 96' ' ' THR . 8.1 Cg_endo -48.71 -28.09 12.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.256 1.971 . . . . 0.0 110.908 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.68 ' HA ' HG21 ' A' ' 66' ' ' VAL . 13.2 mt -70.72 -64.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.691 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -24.37 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.236 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.826 HD11 ' HG ' ' A' ' 132' ' ' LEU . 8.2 mm -72.58 -47.04 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.973 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.47 -65.56 0.67 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -51.94 -27.85 14.55 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -68.75 -50.2 37.7 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.714 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.969 HD23 ' HB2' ' A' ' 127' ' ' HIS . 5.4 mt -54.85 -35.04 63.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.95 -16.35 61.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.197 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.61 -22.84 58.73 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.341 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.501 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 4.0 m-85 -82.37 -91.94 0.07 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 25.5 tt0 164.55 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.629 0.252 . . . . 0.0 110.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.2 -90.27 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.712 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.2 p-10 38.42 33.2 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 110.977 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.09 34.52 4.61 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -147.39 152.92 38.96 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.603 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.454 ' HA ' ' N ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -71.75 28.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 0.0 111.737 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -172.29 28.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.569 ' C ' HD23 ' A' ' 123' ' ' LEU . 5.9 tt -134.69 -49.5 0.77 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.6 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.911 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.79 -44.96 78.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.421 ' HB3' ' CB ' ' A' ' 21' ' ' CYS . 78.7 p -47.69 -30.25 3.65 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.252 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.04 -59.93 4.59 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.254 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.969 ' HB2' HD23 ' A' ' 112' ' ' LEU . 8.4 m170 -54.89 -37.99 67.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.617 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.742 HG13 HD12 ' A' ' 108' ' ' ILE . 41.9 t -51.67 -50.29 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.547 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.28 -48.82 36.05 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.656 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -19.5 65.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 111.233 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 127' ' ' HIS . 69.9 mt -90.81 -27.4 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.826 ' HG ' HD11 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -63.24 -46.09 88.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.113 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -39.49 79.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.738 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 0.92 48.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.056 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.541 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 17.1 t80 . . . . . 0 C--N 1.332 -0.19 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.835 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.689 ' CG1' HG22 ' A' ' 9' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.101 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.443 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -37.37 -49.78 1.01 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.927 -178.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.614 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 9.1 m-85 -146.17 112.3 5.76 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.612 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.689 HG22 ' CG1' ' A' ' 6' ' ' VAL . 2.3 t -110.78 95.92 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.131 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.62 ' CD ' HG21 ' A' ' 17' ' ' THR . 0.4 OUTLIER -104.17 112.51 25.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 111.882 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.949 HG23 HD13 ' A' ' 124' ' ' LEU . 76.4 t -81.68 156.06 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.671 HD11 HG21 ' A' ' 50' ' ' ILE . 2.2 mp -132.62 123.31 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.74 0.305 . . . . 0.0 111.428 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 18' ' ' ILE . 6.3 tttm -108.06 90.41 3.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 74.01 40.86 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.879 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.24 63.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.344 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 16' ' ' GLU . 5.1 pt-20 -146.56 118.98 8.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.11 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.62 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -51.81 124.9 13.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.852 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.56 HD11 ' CG1' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -100.3 -50.31 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 120' ' ' THR . 45.0 p -121.54 176.11 5.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.006 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -170.24 141.83 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.987 0.422 . . . . 0.0 111.766 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 37.6 t -128.74 69.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.444 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -105.97 99.91 9.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.088 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.397 -179.793 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.728 0.299 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.05 26.8 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.042 0.449 . . . . 0.0 110.949 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.49 -36.53 5.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.548 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.777 HG23 HG13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -47.14 135.73 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.0 178.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.515 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.3 t -94.14 151.76 39.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.635 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.22 -27.01 6.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.852 1.701 . . . . 0.0 110.513 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.515 ' HB ' HG23 ' A' ' 42' ' ' THR . 58.9 t -61.21 -42.68 94.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.571 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.777 HG13 HG23 ' A' ' 41' ' ' ILE . 16.0 mm -56.94 -46.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.653 ' O ' HD12 ' A' ' 50' ' ' ILE . 26.1 m-85 -73.17 -39.89 65.27 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.401 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.29 -31.26 72.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.318 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.48 -29.64 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.885 HD11 HG13 ' A' ' 74' ' ' ILE . 6.1 mt -61.11 -60.79 3.21 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.096 HG22 HD23 ' A' ' 55' ' ' LEU . 5.6 mt -51.1 -63.97 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.839 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.609 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 6.0 tpp -50.08 -40.55 45.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.965 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.16 -21.45 21.15 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.559 ' HB2' HD21 ' A' ' 73' ' ' LEU . 56.1 mmm -117.69 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.798 HG13 ' CD1' ' A' ' 81' ' ' TYR . 65.4 t -56.01 -55.9 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.786 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.096 HD23 HG22 ' A' ' 50' ' ' ILE . 3.4 mm? -47.13 -58.29 7.51 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.044 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.8 Cg_endo -65.99 6.82 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.143 1.895 . . . . 0.0 112.742 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.95 25.12 0.65 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.036 0.446 . . . . 0.0 110.099 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 91' ' ' VAL . 8.8 p -81.84 150.85 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.084 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.531 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.824 HG21 ' HA ' ' A' ' 106' ' ' ILE . 4.4 t . . . . . 0 C--O 1.233 0.195 0 CA-C-O 120.828 0.347 . . . . 0.0 110.717 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 m -104.65 141.28 36.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 111.176 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 4.0 ttpt -84.62 141.99 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.641 ' CG ' HG22 ' A' ' 54' ' ' VAL . 6.4 mmm -58.27 -32.51 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.766 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m 61.79 26.97 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.988 0.423 . . . . 0.0 110.945 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 18.4 mmm -110.81 -11.27 14.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.86 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.84 59.85 1.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.709 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.6 mp -58.63 -49.96 75.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.696 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.885 HG13 HD11 ' A' ' 49' ' ' LEU . 1.1 mt -137.26 154.7 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.791 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.6 t70 -95.3 142.96 27.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.628 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 104.89 -35.36 5.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.954 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.798 ' O ' HG13 ' A' ' 98' ' ' VAL . 2.3 m-85 -113.01 -170.08 1.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -144.06 118.36 9.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.199 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.501 ' SG ' HG21 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -86.36 103.2 14.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.478 ' CD2' ' HG3' ' A' ' 68' ' ' LYS . 41.5 m-85 -118.46 119.48 34.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.976 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.798 ' CD1' HG13 ' A' ' 54' ' ' VAL . 33.0 p90 -109.83 151.45 26.99 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.304 0.573 . . . . 0.0 112.092 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.661 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 3.1 t -149.12 119.35 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.995 HG22 HG13 ' A' ' 91' ' ' VAL . 76.8 p -88.92 151.54 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.384 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.09 140.83 8.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.072 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -60.7 -16.74 42.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.889 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.35 22.29 0.94 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -151.46 97.33 3.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 111.377 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.08 -14.71 46.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.247 1.964 . . . . 0.0 111.976 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 30.04 2.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.285 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 90' ' ' THR . 23.9 m -152.73 69.98 0.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.657 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.995 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -74.09 178.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.324 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.576 ' H ' HG12 ' A' ' 91' ' ' VAL . 49.6 m-85 -151.78 104.68 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.988 HG11 HG12 ' A' ' 50' ' ' ILE . 28.1 t -108.29 115.35 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.189 0.519 . . . . 0.0 111.493 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.403 ' SG ' HD21 ' A' ' 109' ' ' LEU . 28.3 p -111.17 116.06 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.101 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.6 m-85 -89.23 84.22 6.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.537 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.528 ' CG2' HG13 ' A' ' 6' ' ' VAL . 8.1 p -85.89 156.91 20.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.776 0.322 . . . . 0.0 110.881 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.438 ' HB2' HG13 ' A' ' 100' ' ' ILE . 34.5 mt -69.59 127.81 34.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.573 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -42.66 -34.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.057 -179.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.44 -36.68 83.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.749 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.38 136.39 96.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.775 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 100' ' ' ILE . 23.3 Cg_endo -61.68 -167.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.184 1.923 . . . . 0.0 111.914 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.464 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -108.75 66.78 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.895 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.462 HG23 ' CE1' ' A' ' 135' ' ' PHE . 6.3 tp -151.65 -44.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.656 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.624 HD11 ' CD1' ' A' ' 132' ' ' LEU . 0.4 OUTLIER -57.97 -62.59 5.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.479 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 3.8 Cg_endo -46.53 -34.87 15.63 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.547 2.164 . . . . 0.0 111.098 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.8 mp -68.69 -37.27 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.897 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -81.41 -22.54 38.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.602 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 132' ' ' LEU . 35.5 mm -68.36 -48.16 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.361 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.819 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -73.88 -52.61 12.41 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t -58.93 -29.18 66.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.547 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -75.47 -46.82 13.9 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.844 HD23 ' HB2' ' A' ' 127' ' ' HIS . 17.2 mt -56.22 -32.19 64.2 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -76.26 -15.88 59.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -74.3 -25.46 59.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 110.138 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 3.6 m-85 -86.15 -90.68 0.1 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 1.2 tt0 159.69 -30.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.865 0.466 . . . . 0.0 109.767 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.883 ' HB3' HD21 ' A' ' 123' ' ' LEU . 0.3 OUTLIER -103.32 137.15 41.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.511 ' N ' HD22 ' A' ' 123' ' ' LEU . 0.9 OUTLIER 176.61 34.47 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.349 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.23 32.94 4.76 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -145.94 146.39 31.03 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.479 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.456 ' HA ' ' N ' ' A' ' 20' ' ' SER . 10.6 p30 -69.25 26.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.0 mt-10 -167.6 26.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.883 HD21 ' HB3' ' A' ' 117' ' ' SER . 8.2 tt -124.76 -57.25 1.55 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.949 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.67 -41.49 63.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.431 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 13.5 t -49.61 -29.28 6.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.233 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.73 -63.74 1.17 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.297 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.844 ' HB2' HD23 ' A' ' 112' ' ' LEU . 18.7 m170 -59.21 -30.6 68.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.03 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 124' ' ' LEU . 49.0 t -57.67 -41.95 80.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.0 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.36 -48.71 10.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.137 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.71 -26.5 68.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.585 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.547 HD13 ' C ' ' A' ' 111' ' ' GLY . 70.6 mt -85.49 -26.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -60.95 -46.47 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.146 178.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -43.93 73.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.052 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.18 -24.75 64.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.462 ' CE1' HG23 ' A' ' 103' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.952 HG11 HG22 ' A' ' 9' ' ' VAL . 80.3 t . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.788 0.328 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.41 -71.11 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.899 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.709 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 27.4 m-85 -128.87 111.97 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.332 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.952 HG22 HG11 ' A' ' 6' ' ' VAL . 2.3 t -103.91 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.491 ' HG2' HG23 ' A' ' 17' ' ' THR . 1.2 tt0 -100.05 114.19 27.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.673 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.97 ' CG2' HD13 ' A' ' 124' ' ' LEU . 26.3 t -84.27 159.62 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.6 mp -141.3 122.2 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 112.046 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.549 ' HB2' HD13 ' A' ' 18' ' ' ILE . 12.1 tttm -104.15 99.05 8.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.363 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 63.34 41.68 7.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.387 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 78.39 23.64 64.96 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.582 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -143.25 111.9 6.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.93 0.395 . . . . 0.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.491 HG23 ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -45.15 126.41 6.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.309 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -105.18 -44.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.914 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.773 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -127.76 178.16 6.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.375 -179.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.487 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 18.0 m -170.75 131.16 0.85 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.54 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.501 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 29.2 t -115.13 69.46 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.709 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.7 m-85 -107.66 87.65 2.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.941 -179.671 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 5.3 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.816 0.341 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.8 26.75 7.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -112.37 -35.36 5.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.858 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.666 HG22 ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -55.38 123.79 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.955 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.885 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -86.08 149.36 50.0 Favored Pre-proline 0 CA--C 1.519 -0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.435 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.554 ' HA ' ' CE1' ' A' ' 22' ' ' PHE . 2.0 Cg_endo -44.15 -22.75 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.713 2.275 . . . . 0.0 112.071 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.707 ' HB ' HG23 ' A' ' 42' ' ' THR . 5.3 t -67.73 -44.18 85.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.885 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -59.12 -31.74 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.666 ' CE2' HG22 ' A' ' 41' ' ' ILE . 66.3 m-85 -80.14 -43.44 21.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.349 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.622 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.27 -25.84 67.06 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.537 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' VAL . 15.0 m-20 -90.4 -29.82 17.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.588 HD22 ' HB3' ' A' ' 73' ' ' LEU . 2.7 mt -58.34 -57.8 11.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.041 HG22 HD23 ' A' ' 55' ' ' LEU . 4.3 mt -57.97 -66.01 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.209 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.622 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.3 tpp -46.91 -41.64 16.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.713 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.08 -25.45 19.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.477 ' HB2' HD21 ' A' ' 73' ' ' LEU . 70.5 mmm -114.21 -63.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.708 HG13 ' CD1' ' A' ' 81' ' ' TYR . 55.9 t -62.23 -58.87 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.041 HD23 HG22 ' A' ' 50' ' ' ILE . 3.1 mm? -44.38 -55.9 9.13 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.3 Cg_exo -68.5 5.11 1.36 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.305 2.003 . . . . 0.0 112.03 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -145.31 21.52 1.54 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.311 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.515 HG23 ' CD2' ' A' ' 81' ' ' TYR . 3.9 p -84.77 165.56 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.935 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.448 ' H ' HG22 ' A' ' 58' ' ' VAL . 16.2 m . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.986 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 106' ' ' ILE . 7.0 t . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.877 0.37 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.5 m -93.66 141.55 28.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 9.4 tttm -87.95 137.63 32.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.557 ' HE1' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -54.79 -25.97 31.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.709 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 t 53.93 25.5 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.374 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.626 ' HG2' HD12 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -118.23 1.9 11.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.177 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.71 78.6 0.21 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.087 0.47 . . . . 0.0 110.457 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.847 HD13 ' SG ' ' A' ' 79' ' ' CYS . 11.0 mp -74.51 -42.77 58.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.55 HD11 ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -138.1 155.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.719 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -96.74 139.74 32.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.29 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.18 -33.63 5.88 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.156 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.26 176.26 8.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.826 0.346 . . . . 0.0 111.03 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 42.6 m-20 -113.67 129.2 56.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.564 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.847 ' SG ' HD13 ' A' ' 73' ' ' LEU . 25.1 p -90.4 112.55 24.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.515 ' O ' HG13 ' A' ' 93' ' ' VAL . 44.8 m-85 -119.84 153.72 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.374 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.708 ' CD1' HG13 ' A' ' 54' ' ' VAL . 38.4 p90 -144.38 128.04 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.117 0.484 . . . . 0.0 111.645 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.7 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.8 t -133.71 121.76 22.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.667 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 19.4 p -80.94 153.49 27.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.978 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -49.13 151.52 1.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.97 -6.72 49.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.658 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.49 20.48 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -159.5 102.67 1.5 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 0.0 111.318 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.05 -13.35 39.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.394 2.062 . . . . 0.0 112.013 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -96.65 30.48 2.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 90' ' ' THR . 20.1 m -153.57 71.9 0.9 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.559 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -70.16 177.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.317 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.58 ' H ' HG12 ' A' ' 91' ' ' VAL . 95.7 m-85 -152.38 96.8 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.863 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.009 HG11 HG12 ' A' ' 50' ' ' ILE . 77.4 t -100.28 128.2 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 20.4 p -124.85 138.07 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.508 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 7.3 m-85 -106.0 89.41 3.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.737 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.849 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -89.17 124.51 34.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.157 -179.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.496 HD23 ' HD1' ' A' ' 77' ' ' PHE . 28.8 mt -42.53 135.36 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -46.26 -27.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -68.56 -22.03 64.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.7 mm -70.49 135.99 86.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.287 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.14 -164.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.305 2.004 . . . . 0.0 111.583 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -108.08 66.49 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.764 0.316 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.716 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 6.1 tp -164.67 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.744 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.8 tp -62.32 -62.8 5.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.652 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.849 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.2 Cg_endo -44.99 -31.74 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.502 2.135 . . . . 0.0 111.155 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.0 mp -73.18 -41.76 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.231 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.641 ' O ' HG21 ' A' ' 131' ' ' ILE . 1.9 mmt180 -76.77 -23.2 52.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.794 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.858 ' CG2' HG13 ' A' ' 128' ' ' VAL . 7.1 mm -70.11 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.235 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.544 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -61.8 -55.59 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -59.6 -25.5 64.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.525 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -72.59 -47.02 29.15 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.526 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.957 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.1 mt -55.88 -26.26 46.42 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -18.01 61.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.34 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.13 -23.97 63.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.604 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 m-85 -100.43 -166.48 1.33 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -124.79 -2.4 7.82 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.528 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 49.6 m -127.69 123.34 35.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.094 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.483 ' HA ' HD22 ' A' ' 123' ' ' LEU . 0.6 OUTLIER -171.5 38.05 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.765 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.462 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -114.2 36.19 3.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.323 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -147.82 152.14 37.16 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.366 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.487 ' HA ' ' N ' ' A' ' 20' ' ' SER . 66.4 m-20 -71.6 22.13 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.2 tm-20 -164.66 26.21 0.06 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.525 ' CB ' HG23 ' A' ' 120' ' ' THR . 6.9 tt -124.92 -56.73 1.55 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.97 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.46 -41.07 62.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.461 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 78.4 p -51.46 -31.42 23.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.34 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.14 -61.54 2.49 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.453 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.957 ' HB2' HD23 ' A' ' 112' ' ' LEU . 54.2 m170 -59.15 -32.95 70.34 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.858 HG13 ' CG2' ' A' ' 108' ' ' ILE . 62.0 t -53.45 -45.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.92 27.42 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.803 -1.189 . . . . 0.0 111.574 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.7 -21.3 66.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.927 0.394 . . . . 0.0 110.601 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.641 HG21 ' O ' ' A' ' 107' ' ' ARG . 28.0 mt -90.11 -27.24 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.741 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.3 OUTLIER -61.38 -41.97 97.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.172 178.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -65.64 -39.32 91.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.85 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.78 -15.63 44.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.716 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 2.8 t80 . . . . . 0 C--N 1.333 -0.145 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.023 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.812 HG21 HG13 ' A' ' 108' ' ' ILE . 71.0 t . . . . . 0 CA--C 1.527 0.062 0 CA-C-O 120.812 0.339 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.441 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -63.81 -67.15 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.251 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.645 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 2.2 m-85 -150.02 121.57 7.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.452 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.699 HG22 HG11 ' A' ' 6' ' ' VAL . 2.1 t -107.57 95.59 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.303 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 3.0 tt0 -105.31 117.29 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.973 0.416 . . . . 0.0 111.626 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.903 HG23 HD13 ' A' ' 124' ' ' LEU . 11.9 t -83.18 155.09 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.556 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.681 HG21 HD11 ' A' ' 55' ' ' LEU . 3.2 mp -131.63 118.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.2 tptt -103.68 104.8 14.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.386 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 65.8 23.33 11.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.512 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . 76.38 38.88 32.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.549 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.72 18.19 1.82 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 60.08 150.17 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.008 179.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.54 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -139.59 -47.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.921 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.549 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -126.56 175.02 8.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.346 -179.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.483 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 11.6 p -170.48 121.55 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.592 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.2 t -108.58 71.0 0.77 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.645 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -106.15 83.08 1.84 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.904 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.195 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.796 0.331 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.56 28.54 6.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -113.35 -35.75 5.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.715 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -54.41 124.58 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.102 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.904 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -86.97 149.65 48.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.562 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 Cg_exo -43.52 -23.28 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.679 2.253 . . . . 0.0 112.098 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.703 ' HB ' HG23 ' A' ' 42' ' ' THR . 3.5 t -66.88 -48.98 78.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.904 HD12 HG22 ' A' ' 42' ' ' THR . 2.3 mp -54.09 -36.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.715 ' CE1' HG22 ' A' ' 41' ' ' ILE . 66.8 m-85 -76.49 -43.11 41.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.35 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.675 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.91 -23.49 67.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.346 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -86.47 -33.54 20.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.679 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 73' ' ' LEU . 12.2 mt -58.78 -63.36 1.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.063 HG12 HG11 ' A' ' 93' ' ' VAL . 3.9 mt -49.39 -58.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.044 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.675 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -53.79 -56.78 14.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.345 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -9.71 44.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.646 ' HB3' HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -117.47 -62.14 1.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 81' ' ' TYR . 59.3 t -68.0 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 111.914 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD2' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -43.04 -51.48 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 24.6 Cg_endo -63.18 -1.63 3.12 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.809 1.672 . . . . 0.0 112.344 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HB3' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -147.86 23.11 1.1 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.05 0.452 . . . . 0.0 109.993 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 81' ' ' TYR . 2.8 p -76.37 155.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.402 HG22 ' HE2' ' A' ' 81' ' ' TYR . 33.0 m . . . . . 0 C--N 1.318 -0.797 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.107 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.873 ' N ' ' HG ' ' A' ' 82' ' ' SER . 2.8 t . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.805 0.336 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -86.04 134.08 33.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.016 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 4.5 ttpp -85.03 130.06 34.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.827 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.619 ' HG2' HD11 ' A' ' 73' ' ' LEU . 6.7 tpt -50.79 -27.48 7.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.412 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.38 28.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 110.74 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.424 ' O ' ' HG3' ' A' ' 71' ' ' MET . 4.0 tpp -109.95 -12.31 14.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.987 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.51 61.79 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.463 . . . . 0.0 109.786 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 49' ' ' LEU . 9.5 mp -66.13 -45.23 81.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.03 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.625 HD11 ' CG2' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -132.71 159.7 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.029 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.431 ' N ' HG23 ' A' ' 74' ' ' ILE . 7.7 t70 -101.97 142.03 33.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.397 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.68 -35.59 4.91 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.842 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -133.38 175.25 9.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.788 0.328 . . . . 0.0 110.819 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 40.8 m-20 -113.11 152.58 29.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.508 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 4.9 t -111.65 116.06 30.16 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 85.5 m-85 -123.28 144.57 49.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.248 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CD1' HG13 ' A' ' 54' ' ' VAL . 39.1 p90 -135.17 125.01 25.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 111.533 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.873 ' HG ' ' N ' ' A' ' 66' ' ' VAL . 1.5 t -129.21 121.06 26.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.668 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.632 HG22 HG13 ' A' ' 91' ' ' VAL . 8.4 p -82.18 150.75 27.23 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.699 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -46.51 149.65 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.984 0.421 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.56 -17.45 46.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.981 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 22.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -146.1 94.55 4.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.72 -15.09 46.74 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.166 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -96.0 26.32 4.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.072 0.463 . . . . 0.0 110.268 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 90' ' ' THR . 38.0 m -150.7 69.5 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -69.06 178.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.14 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.537 ' H ' HG12 ' A' ' 91' ' ' VAL . 96.2 m-85 -153.16 91.6 1.54 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.446 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.063 HG11 HG12 ' A' ' 50' ' ' ILE . 35.4 t -91.43 125.17 44.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.066 0.46 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.431 ' SG ' HG11 ' A' ' 6' ' ' VAL . 44.3 t -120.44 126.12 49.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.29 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m-85 -99.06 116.86 32.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.372 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.956 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -119.9 132.86 55.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.085 0.469 . . . . 0.0 111.636 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.428 HD23 ' HD2' ' A' ' 77' ' ' PHE . 31.3 mt -49.91 125.59 12.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.036 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -43.73 -31.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.71 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.37 -35.14 78.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.78 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.499 HG23 ' HD2' ' A' ' 101' ' ' PRO . 40.5 mt -74.18 138.25 75.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.9 Cg_endo -57.9 -169.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.468 2.112 . . . . 0.0 112.273 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -109.03 67.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.693 HG23 ' CE2' ' A' ' 135' ' ' PHE . 1.1 tp -153.27 -38.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.441 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.803 ' HG ' HD11 ' A' ' 108' ' ' ILE . 25.1 tp -59.33 -57.17 29.02 Favored Pre-proline 0 C--N 1.331 -0.204 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.901 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.956 ' HD3' HG21 ' A' ' 96' ' ' THR . 7.5 Cg_endo -49.9 -37.45 46.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.422 2.081 . . . . 0.0 111.039 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.833 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.9 mp -67.0 -32.4 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.815 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.609 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.73 -26.62 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.594 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.812 HG13 HG21 ' A' ' 6' ' ' VAL . 5.9 mm -66.92 -47.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.372 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -73.77 -58.2 3.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 t -56.46 -30.57 63.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -76.25 -43.3 21.13 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.0 mt -57.85 -31.51 66.74 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.67 -14.73 59.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.94 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.25 -21.31 56.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.451 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.571 ' HB2' ' CE1' ' A' ' 127' ' ' HIS . 5.1 m-85 -88.58 -97.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.999 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 34.6 tp10 159.04 -22.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.672 0.389 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.676 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 5.9 t -121.75 99.75 6.63 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.28 0.562 . . . . 0.0 111.243 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -152.34 45.43 0.73 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.21 33.89 4.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.55 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -144.11 157.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.236 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.483 ' HA ' ' N ' ' A' ' 20' ' ' SER . 78.7 m-20 -74.62 17.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.689 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.8 OUTLIER -163.67 29.03 0.08 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 123' ' ' LEU . 5.9 tt -131.04 -45.82 1.02 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.575 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.903 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -59.78 -43.04 94.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.7 p -46.65 -27.15 1.07 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.64 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.06 -56.79 17.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.295 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.722 ' HB2' HD23 ' A' ' 112' ' ' LEU . 8.1 m170 -60.87 -36.5 79.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.636 HG13 ' CG2' ' A' ' 108' ' ' ILE . 46.0 t -52.06 -44.09 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.889 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.97 -47.05 12.03 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -64.94 -21.13 66.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 127' ' ' HIS . 60.7 mt -90.5 -28.09 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.68 HD11 HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -66.93 -35.07 79.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.351 178.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -69.57 -38.89 77.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.762 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.0 t -84.08 -13.62 52.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.984 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.693 ' CE2' HG23 ' A' ' 103' ' ' ILE . 13.2 t80 . . . . . 0 C--N 1.332 -0.169 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.996 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.815 HG13 HG23 ' A' ' 96' ' ' THR . 3.4 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.926 0.393 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -39.18 -59.42 1.02 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.239 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.678 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 7.6 m-85 -148.68 113.12 5.3 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.861 HG13 ' SG ' ' A' ' 94' ' ' CYS . 2.8 t -107.12 100.75 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.412 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.677 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.0 OUTLIER -111.36 128.89 56.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.105 0.478 . . . . 0.0 111.769 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.886 HG23 HD13 ' A' ' 124' ' ' LEU . 53.1 t -98.1 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.536 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.967 HD11 HG21 ' A' ' 50' ' ' ILE . 2.7 mp -117.24 118.32 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.684 ' HB2' HD13 ' A' ' 18' ' ' ILE . 7.0 tptt -99.72 102.24 13.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.419 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 62.01 39.75 12.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.562 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.4 60.77 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.827 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -145.12 113.75 6.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 0.0 110.102 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.677 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -50.24 126.78 15.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.715 -179.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.684 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.7 OUTLIER -105.01 -50.45 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.415 179.129 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 120' ' ' THR . 63.9 p -119.26 172.43 7.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.266 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.548 ' N ' HD22 ' A' ' 124' ' ' LEU . 6.5 m -168.28 133.47 1.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 112.054 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 36.0 t -116.88 69.42 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.678 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -104.62 96.58 6.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.298 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.331 -0.212 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.524 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 2.9 m120 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.86 0.362 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -134.26 27.3 3.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.094 0.473 . . . . 0.0 110.971 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -118.42 -28.91 5.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.455 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.672 HG22 ' CE2' ' A' ' 46' ' ' PHE . 3.7 mm -55.98 125.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.934 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.959 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -85.44 149.54 52.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.512 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 2.2 Cg_endo -44.87 -22.04 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.354 2.036 . . . . 0.0 111.583 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.761 ' HB ' HG23 ' A' ' 42' ' ' THR . 93.6 t -66.9 -45.73 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.11 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.959 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -59.62 -34.55 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.672 ' CE2' HG22 ' A' ' 41' ' ' ILE . 39.1 m-85 -79.41 -42.87 24.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.316 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.659 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.54 -30.51 71.62 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.657 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 25.8 p30 -89.51 -26.04 21.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.622 HD22 HD23 ' A' ' 73' ' ' LEU . 3.6 mt -64.54 -61.16 2.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 1.016 HG12 HG11 ' A' ' 93' ' ' VAL . 6.4 mt -49.53 -62.93 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.493 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.659 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.21 -43.0 61.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.173 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -90.84 -15.16 30.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.579 ' HB2' HD21 ' A' ' 73' ' ' LEU . 90.9 mmm -123.76 -70.49 0.76 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.855 HG13 ' CD2' ' A' ' 81' ' ' TYR . 88.6 t -51.39 -50.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.889 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.948 HD23 HG22 ' A' ' 50' ' ' ILE . 3.0 mm? -56.18 -58.9 13.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.032 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 23.5 Cg_endo -62.31 4.71 0.3 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.285 1.99 . . . . 0.0 113.12 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 1.6 tptp -153.25 26.98 0.52 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG21 HG11 ' A' ' 91' ' ' VAL . 7.7 p -82.22 150.67 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.161 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' A' ' 81' ' ' TYR . 9.0 t . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.399 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.903 HG13 HD23 ' A' ' 109' ' ' LEU . 3.6 t . . . . . 0 N--CA 1.464 0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -97.25 138.57 34.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.469 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 1.3 ttpm? -82.52 132.39 35.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.287 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.483 ' HG2' ' CB ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -53.83 -29.82 42.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.034 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.76 27.96 11.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.212 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.483 ' CB ' ' HG2' ' A' ' 69' ' ' MET . 6.1 tpt -106.97 -15.55 14.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.207 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 65.04 59.84 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.622 HD23 HD22 ' A' ' 49' ' ' LEU . 8.0 mp -62.91 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.445 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.505 HG21 ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -135.5 155.08 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.504 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -99.71 138.62 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.517 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 113.24 -32.32 6.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.532 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.687 ' O ' HG13 ' A' ' 98' ' ' VAL . 1.7 m-85 -118.21 -168.13 1.47 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.485 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -136.11 118.76 16.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.13 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 p -87.64 108.42 19.08 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 53.8 m-85 -121.55 151.1 40.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.896 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.855 ' CD2' HG13 ' A' ' 54' ' ' VAL . 11.9 p90 -144.52 139.61 28.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.09 0.472 . . . . 0.0 111.974 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -142.3 124.38 15.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.563 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 1.032 HG22 HG13 ' A' ' 91' ' ' VAL . 45.0 p -90.01 152.77 21.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.456 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -46.85 162.3 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 0.0 111.167 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -70.89 -22.91 62.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.682 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 22.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.93 91.48 10.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.26 . . . . 0.0 110.763 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.57 -14.23 38.4 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.378 2.052 . . . . 0.0 112.045 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 29.72 1.86 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 90' ' ' THR . 18.0 m -156.85 71.78 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.524 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.032 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -81.26 173.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.935 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.628 ' HD2' HG13 ' A' ' 11' ' ' VAL . 14.1 m-85 -141.72 153.17 44.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.213 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.016 HG11 HG12 ' A' ' 50' ' ' ILE . 14.6 t -152.63 122.18 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.977 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' CYS . . . . . 0.861 ' SG ' HG13 ' A' ' 9' ' ' VAL . 13.9 m -112.41 114.14 26.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 111.824 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 46' ' ' PHE . 1.3 m-85 -90.15 71.53 7.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.751 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.864 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.37 -176.38 1.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.933 0.397 . . . . 0.0 111.489 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 23.0 mt -97.41 127.87 43.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.321 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -43.64 -33.69 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.534 -179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -38.88 92.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.552 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 101' ' ' PRO . 62.6 mt -66.93 138.34 95.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.902 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.7 Cg_endo -59.94 -168.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.516 2.144 . . . . 0.0 112.348 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -108.69 67.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.535 ' CA ' HD13 ' A' ' 106' ' ' ILE . 2.7 tp -154.54 -38.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.845 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.804 HD21 HG22 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -57.06 -64.98 1.97 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.02 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.864 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.6 Cg_endo -47.34 -31.17 12.42 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.565 2.177 . . . . 0.0 111.492 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.759 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 mp -68.91 -34.46 64.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.819 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.509 ' O ' HG21 ' A' ' 131' ' ' ILE . 14.0 mmp_? -84.85 -22.64 29.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.345 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.752 ' CG2' HG13 ' A' ' 128' ' ' VAL . 21.0 mm -70.1 -45.18 77.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.148 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.903 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -76.34 -50.13 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.5 t -61.95 -30.63 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.481 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -75.48 -47.2 12.9 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 127' ' ' HIS . 12.8 mt -56.58 -30.47 63.23 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.0 -16.72 56.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.196 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -25.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.75 0.31 . . . . 0.0 110.38 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.529 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.2 m-85 -82.33 -91.86 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.2 pt-20 160.56 -28.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.414 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.536 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 19.5 m -111.89 129.54 56.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.517 0.675 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.456 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -172.3 35.19 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.039 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.86 33.28 4.32 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.536 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -145.62 148.06 32.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.469 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 20' ' ' SER . 72.0 m-20 -69.73 22.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.526 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.2 tp10 -162.87 25.24 0.09 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.536 ' CB ' HG23 ' A' ' 120' ' ' THR . 7.7 tt -123.76 -57.22 1.64 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.614 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.886 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.5 -42.1 63.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.53 ' H ' HD23 ' A' ' 124' ' ' LEU . 83.4 p -52.1 -28.68 18.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.243 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.21 -61.72 2.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.227 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.829 ' HB2' HD23 ' A' ' 112' ' ' LEU . 26.5 m170 -59.88 -31.56 69.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 124' ' ' LEU . 56.2 t -56.54 -42.38 75.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.45 15.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.876 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.97 -21.4 65.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 127' ' ' HIS . 59.4 mt -90.02 -28.07 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.667 HD12 ' CD1' ' A' ' 108' ' ' ILE . 0.4 OUTLIER -62.86 -43.67 98.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.366 178.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -35.38 80.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.7 t -83.8 -20.84 32.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.079 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.531 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 1.5 t80 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.97 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.5 mtp . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.13 85.17 2.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.816 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.02 -173.36 2.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.813 ' HB3' HD13 ' A' ' 104' ' ' LEU . 38.1 m-85 -122.85 169.64 10.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.0 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.875 ' HA ' HD21 ' A' ' 132' ' ' LEU . 58.3 t-20 -177.49 112.93 0.08 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.374 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 104' ' ' LEU . 4.2 t -77.74 99.74 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.021 0.439 . . . . 0.0 110.028 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.5 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -40.46 -51.26 2.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.719 -178.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.615 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 14.3 m-85 -148.8 120.08 7.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.851 0.357 . . . . 0.0 111.464 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.771 HG21 HG11 ' A' ' 128' ' ' VAL . 1.5 t -110.0 95.28 3.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.979 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.445 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 0.5 OUTLIER -100.54 111.37 23.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.743 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.983 ' CG2' HD13 ' A' ' 124' ' ' LEU . 38.7 t -81.97 160.19 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.723 HD11 HG21 ' A' ' 50' ' ' ILE . 2.5 mt -140.7 127.05 20.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.561 ' HB2' HD13 ' A' ' 18' ' ' ILE . 0.7 OUTLIER -118.96 111.77 18.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.244 178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' OD1' ' HG3' ' A' ' 13' ' ' LYS . 2.7 m120 64.04 34.75 11.07 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.991 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.48 26.14 61.84 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.544 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -148.27 120.05 8.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 11' ' ' VAL . 3.1 m -48.38 125.45 9.6 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.238 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.561 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -99.57 -45.46 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-O 121.738 0.78 . . . . 0.0 109.512 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.928 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -124.66 175.37 7.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.9 -179.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.444 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 20.4 m -170.59 134.63 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.5 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HB3' HG23 ' A' ' 9' ' ' VAL . 33.2 t -123.45 69.34 1.02 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.615 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.2 m-85 -107.23 100.18 9.66 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.165 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.44 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.4 pm0 -141.58 124.31 9.52 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.428 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.17 -179.91 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.355 2.037 . . . . 0.0 111.718 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.486 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -172.29 -34.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 11.4 mt-30 63.93 56.46 1.45 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.891 0.377 . . . . 0.0 110.167 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER 32.11 78.66 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.035 -179.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -73.99 -70.17 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.999 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -153.04 32.41 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.662 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -116.32 -70.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.015 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CD2' HD13 ' A' ' 100' ' ' ILE . 0.3 OUTLIER -149.93 131.49 14.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' HA2' ' CB ' ' A' ' 27' ' ' LYS . . . -73.21 114.32 4.67 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.043 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.522 ' CG2' HD22 ' A' ' 97' ' ' LEU . 86.8 m -165.34 -76.24 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.725 0.297 . . . . 0.0 110.982 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.538 ' O ' ' HB ' ' A' ' 35' ' ' THR . 7.7 mt -74.44 147.83 8.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.154 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 171.37 -31.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.182 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.17 -51.68 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -92.41 24.88 3.21 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.491 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.8 m-80 -156.58 30.85 0.32 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 0.0 111.291 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.73 25.71 4.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.08 0.467 . . . . 0.0 110.864 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -110.24 -34.86 6.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.667 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.659 HG23 HG13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -55.6 133.62 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.918 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.606 HG23 ' HB ' ' A' ' 44' ' ' VAL . 5.1 t -92.55 150.88 40.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.415 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.85 -24.27 4.86 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 121.946 1.764 . . . . 0.0 111.072 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.606 ' HB ' HG23 ' A' ' 42' ' ' THR . 90.4 t -66.95 -35.95 75.96 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.681 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.659 HG13 HG23 ' A' ' 41' ' ' ILE . 13.4 mm -63.0 -42.63 97.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.627 ' CE1' HG22 ' A' ' 41' ' ' ILE . 18.3 m-85 -77.14 -38.3 52.25 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.144 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.613 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -65.73 -31.53 72.58 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.032 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -86.94 -29.1 22.33 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.686 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.2 mt -61.24 -60.15 4.2 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.071 HG12 HG11 ' A' ' 93' ' ' VAL . 7.0 mt -50.2 -63.3 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 113.465 -1.698 . . . . 0.0 109.847 177.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.0 OUTLIER -53.66 -37.35 63.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.81 -1.541 . . . . 0.0 113.116 -179.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -91.11 -23.72 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.477 ' O ' ' HE1' ' A' ' 69' ' ' MET . 74.7 mmm -117.03 -57.18 2.19 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.969 HG22 ' HG3' ' A' ' 69' ' ' MET . 52.9 t -63.45 -63.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.887 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.955 HD23 HG22 ' A' ' 50' ' ' ILE . 3.0 mm? -44.43 -53.43 14.49 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.5 Cg_exo -68.53 4.62 1.6 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.231 1.954 . . . . 0.0 112.412 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -150.32 25.26 0.8 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.006 0.432 . . . . 0.0 110.578 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 59' ' ' VAL . 4.3 p -87.03 166.05 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.931 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' H ' HG22 ' A' ' 58' ' ' VAL . 28.9 m -145.21 149.46 41.66 Favored Pre-proline 0 N--CA 1.447 -0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.328 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 61' ' ' ILE . 72.9 Cg_endo -80.66 25.84 0.61 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.27 1.98 . . . . 0.0 112.868 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 60' ' ' PRO . 1.6 mp 52.32 131.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.665 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -114.52 -23.58 9.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.613 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.67 38.51 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.066 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.466 ' H ' HG23 ' A' ' 61' ' ' ILE . 0.6 OUTLIER -130.07 -61.58 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.937 0.399 . . . . 0.0 111.221 -179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' H ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER 72.51 121.14 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.785 -179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.804 HG21 ' HA ' ' A' ' 106' ' ' ILE . 4.6 t 58.92 71.27 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.658 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.498 HG22 ' CE1' ' A' ' 81' ' ' TYR . 2.5 t -102.61 139.19 38.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.848 0.356 . . . . 0.0 111.279 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -79.38 135.47 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.51 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.969 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -51.53 -29.02 15.35 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.397 -179.604 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 t 53.12 25.42 4.2 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.149 0.499 . . . . 0.0 110.462 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 37.0 tpp -110.31 -5.0 15.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.737 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.05 56.87 3.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.422 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.85 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.5 mp -53.22 -48.02 68.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.544 HG13 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -142.74 162.23 18.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.41 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 74' ' ' ILE . 11.2 t70 -104.5 137.49 42.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.185 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.551 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 115.84 -32.96 5.42 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.244 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -132.9 162.56 31.27 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.043 0.449 . . . . 0.0 111.197 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 52.8 m-20 -103.46 133.77 47.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.853 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.491 ' SG ' HD13 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -119.05 121.84 40.76 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -178.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 0.2 OUTLIER -126.82 164.87 20.43 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.716 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CD2' HG13 ' A' ' 54' ' ' VAL . 19.5 p90 -138.74 129.06 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.14 0.495 . . . . 0.0 111.381 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.483 ' HA ' HD11 ' A' ' 61' ' ' ILE . 5.0 t -129.94 112.4 13.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.594 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.613 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 33.0 p -74.32 156.8 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.939 0.4 . . . . 0.0 111.176 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -52.84 153.3 3.37 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.829 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -71.61 -9.14 57.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.71 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.28 23.14 0.19 Allowed 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -152.69 87.28 4.12 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.772 0.32 . . . . 0.0 110.891 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.17 -20.25 18.66 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.637 2.224 . . . . 0.0 112.577 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -93.79 29.57 2.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.999 0.428 . . . . 0.0 110.527 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 52.7 m -149.85 73.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.342 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -75.01 171.22 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.724 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.542 ' H ' HG12 ' A' ' 91' ' ' VAL . 39.3 m-85 -144.52 93.55 2.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.519 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.071 HG11 HG12 ' A' ' 50' ' ' ILE . 41.0 t -98.44 127.62 50.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.212 0.53 . . . . 0.0 111.622 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 7.4 p -110.1 152.9 25.42 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.666 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.5 ' N ' ' O ' ' A' ' 8' ' ' TYR . 1.4 m-85 -130.91 74.59 1.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.686 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.611 HG21 ' HD3' ' A' ' 105' ' ' PRO . 58.7 p -75.08 -169.52 0.95 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.371 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.522 HD22 ' CG2' ' A' ' 33' ' ' THR . 24.1 mt -102.43 137.01 41.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.536 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.04 -30.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.806 -179.093 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.439 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 3.7 m-20 -69.12 -33.34 73.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.021 0.439 . . . . 0.0 110.57 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.528 HG23 ' CD1' ' A' ' 4' ' ' PHE . 1.2 mm -67.51 127.12 93.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.968 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.411 ' HD2' ' CE1' ' A' ' 4' ' ' PHE . 19.1 Cg_endo -59.75 -168.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.1 tttm -106.65 66.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.647 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.617 ' CA ' HD13 ' A' ' 106' ' ' ILE . 2.9 tp -151.14 -36.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.813 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.813 HD13 ' HB3' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -64.03 -63.27 4.04 Favored Pre-proline 0 C--N 1.33 -0.248 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.611 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.5 Cg_endo -44.95 -29.27 3.61 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.657 2.238 . . . . 0.0 111.331 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.804 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.1 mp -69.63 -45.17 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.746 178.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.483 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.3 OUTLIER -76.43 -22.44 54.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.602 179.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.777 ' CD1' HD12 ' A' ' 132' ' ' LEU . 33.7 mm -67.11 -59.4 3.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.603 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.09 -56.64 15.16 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 18.5 p -57.06 -25.4 58.61 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.54 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -75.32 -45.37 19.3 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.497 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.939 HD23 ' HB2' ' A' ' 127' ' ' HIS . 18.5 mt -56.6 -28.11 59.63 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -72.71 -15.9 61.68 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.279 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -70.19 -27.26 64.36 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.572 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 4.6 m-85 -98.73 -167.97 1.57 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.496 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -121.53 -0.63 9.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.73 ' HB2' HD21 ' A' ' 123' ' ' LEU . 1.4 m -125.1 137.53 54.19 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.756 0.789 . . . . 0.0 111.108 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.567 ' N ' HD22 ' A' ' 123' ' ' LEU . 19.6 p30 174.02 35.92 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.164 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.12 34.07 4.88 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.516 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -146.12 155.52 42.8 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.98 179.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.444 ' HA ' ' N ' ' A' ' 20' ' ' SER . 15.7 m-80 -75.78 24.48 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.333 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -165.09 25.9 0.06 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.73 HD21 ' HB2' ' A' ' 117' ' ' SER . 6.5 tt -123.75 -56.73 1.67 Allowed 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.871 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.983 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.78 -41.39 64.05 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.477 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 85.3 p -50.33 -28.45 7.94 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.215 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.07 -64.22 0.97 Allowed 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.224 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.939 ' HB2' HD23 ' A' ' 112' ' ' LEU . 31.1 m170 -59.57 -30.98 69.02 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.987 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.875 HG23 ' O ' ' A' ' 124' ' ' LEU . 48.0 t -57.15 -42.69 80.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.99 -38.5 22.77 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.764 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.31 -22.82 63.75 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.03 0.443 . . . . 0.0 110.388 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.54 HD13 ' HA3' ' A' ' 111' ' ' GLY . 46.9 mt -90.19 -27.09 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.875 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.5 OUTLIER -62.33 -49.0 77.34 Favored 'General case' 0 N--CA 1.456 -0.175 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.524 178.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -44.96 83.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.8 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.7 m -70.83 -19.04 62.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.8 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.578 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 54.7 t80 -55.84 -59.41 4.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.206 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.545 ' HA ' HD12 ' A' ' 139' ' ' LEU . 2.1 t-160 -52.8 -46.21 67.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.148 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -49.91 -31.45 12.29 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.908 0.385 . . . . 0.0 110.228 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -77.82 -36.31 50.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.907 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.55 HD11 ' CE2' ' A' ' 135' ' ' PHE . 27.1 mt -64.25 -32.74 74.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.198 0.523 . . . . 0.0 109.687 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.2 t -75.98 -47.37 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.055 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.24 -32.15 71.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.948 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -23.28 66.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.596 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.728 HH11 HD13 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -90.9 48.19 1.5 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.972 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -176.49 36.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.82 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -102.2 -33.69 9.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 4.1 t -160.28 38.52 0.17 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.728 HD13 HH11 ' A' ' 143' ' ' ARG . 3.0 mt -108.48 163.59 13.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -75.31 -66.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.922 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmt . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.814 0.34 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.48 148.69 48.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.907 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.54 170.12 14.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.81 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' CD2' HG12 ' A' ' 100' ' ' ILE . 53.8 m-85 -140.98 -173.55 3.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.977 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.418 ' HA ' HD21 ' A' ' 132' ' ' LEU . 2.1 t-20 -174.38 107.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.728 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.836 HG11 HG22 ' A' ' 9' ' ' VAL . 3.5 t -60.98 127.91 21.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.715 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.7 m -61.71 -59.83 4.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.237 -178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.677 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 2.8 m-85 -144.14 109.25 5.03 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.836 HG22 HG11 ' A' ' 6' ' ' VAL . 4.1 t -108.08 100.7 11.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.801 0.334 . . . . 0.0 111.356 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.488 ' HG3' ' CE1' ' A' ' 22' ' ' PHE . 2.2 mt-10 -111.24 120.13 41.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.598 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.059 HG23 HD13 ' A' ' 124' ' ' LEU . 46.7 t -79.86 156.99 4.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.915 HD11 HG21 ' A' ' 50' ' ' ILE . 3.8 mt -133.98 111.28 15.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.468 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 15.7 tptt -91.16 99.74 12.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 58.35 41.04 23.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.269 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.456 ' H ' HG22 ' A' ' 12' ' ' ILE . . . 81.1 23.34 59.36 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.607 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -140.27 109.39 6.11 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.961 0.41 . . . . 0.0 110.221 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -45.12 128.9 7.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.23 -179.063 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.474 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -110.24 -45.85 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 CA-C-O 121.303 0.573 . . . . 0.0 110.319 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.41 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -123.07 172.86 8.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.511 -179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.49 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.3 m -167.48 126.92 1.37 Allowed 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 20.1 t -116.93 69.34 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.677 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.55 92.73 4.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.107 -178.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.402 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -142.9 139.44 16.95 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.399 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.94 169.86 21.15 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.483 2.122 . . . . 0.0 111.626 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.496 ' HE1' HD11 ' A' ' 97' ' ' LEU . 3.0 p90 -175.08 9.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 13.0 pm0 35.16 97.47 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -44.87 -40.99 6.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.466 -179.88 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 57.12 -83.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.971 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -122.12 -165.17 1.24 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.697 179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.404 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 1.9 m-80 62.76 -81.48 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.135 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.404 ' CG ' ' O ' ' A' ' 30' ' ' ASN . 3.5 m-85 -169.71 153.88 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.838 0.352 . . . . 0.0 111.083 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.763 ' CA ' HD13 ' A' ' 97' ' ' LEU . . . 138.22 -162.55 25.69 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.608 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.502 ' N ' HD22 ' A' ' 97' ' ' LEU . 10.7 m -152.8 -44.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.905 0.383 . . . . 0.0 111.259 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 11.7 mt -47.58 153.8 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.322 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER 172.54 -33.97 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.404 ' CA ' ' HG3' ' A' ' 39' ' ' GLU . 0.2 OUTLIER 178.82 -40.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.86 0.362 . . . . 0.0 111.418 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.8 -25.01 52.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.523 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -113.82 38.54 2.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.137 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.404 ' HG3' ' CA ' ' A' ' 36' ' ' SER . 0.9 OUTLIER -131.32 26.08 4.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.081 0.467 . . . . 0.0 110.859 179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -106.61 -37.31 6.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.599 178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.718 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -52.59 123.02 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.564 178.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.921 HG22 HD12 ' A' ' 45' ' ' ILE . 10.9 t -83.55 150.6 60.24 Favored Pre-proline 0 CA--C 1.519 -0.232 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.642 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.497 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 86.0 Cg_exo -45.75 -22.14 1.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.259 1.973 . . . . 0.0 111.908 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.739 ' HB ' HG23 ' A' ' 42' ' ' THR . 36.6 t -68.62 -41.07 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.103 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.921 HD12 HG22 ' A' ' 42' ' ' THR . 1.6 mp -60.4 -34.57 58.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.718 ' CE1' HG22 ' A' ' 41' ' ' ILE . 56.0 m-85 -81.17 -42.37 20.95 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.995 177.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.608 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.19 -30.48 71.1 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.684 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.431 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 27.4 p30 -90.24 -26.43 20.07 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.718 HD11 HG13 ' A' ' 74' ' ' ILE . 3.1 mt -63.15 -60.24 3.69 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.043 HG12 HG11 ' A' ' 93' ' ' VAL . 5.0 mt -52.14 -63.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 113.214 -1.812 . . . . 0.0 109.893 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.3 OUTLIER -52.76 -41.46 64.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.204 -1.362 . . . . 0.0 113.356 -179.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.2 t0 -90.73 -20.27 22.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.463 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 77.8 mmm -119.39 -60.93 1.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 81' ' ' TYR . 59.3 t -61.58 -56.02 20.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.934 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -50.44 -54.63 32.9 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.607 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.0 Cg_exo -62.89 -0.04 1.84 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.151 1.901 . . . . 0.0 112.78 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.548 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 1.2 tppt? -149.86 27.75 0.78 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.016 0.436 . . . . 0.0 110.454 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.494 HG21 HG11 ' A' ' 91' ' ' VAL . 2.6 p -86.29 157.0 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.982 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.484 HG22 ' HE1' ' A' ' 81' ' ' TYR . 35.2 m -143.86 150.24 49.13 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.198 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 61' ' ' ILE . 93.7 Cg_endo -83.67 25.04 0.71 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.129 1.886 . . . . 0.0 113.294 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 82' ' ' SER . 2.5 mp 51.6 163.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.748 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.477 ' N ' HG22 ' A' ' 61' ' ' ILE . 2.7 mmtt -59.03 -22.56 60.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.069 0.461 . . . . 0.0 110.082 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.4 52.82 0.2 Allowed Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.589 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.692 ' HA ' HD13 ' A' ' 61' ' ' ILE . 1.2 p-10 44.22 76.36 0.09 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.742 0.306 . . . . 0.0 111.124 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' H ' HG21 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -131.09 29.42 4.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.852 -179.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.754 HG21 ' HA ' ' A' ' 106' ' ' ILE . 25.3 t 58.64 105.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.698 0.285 . . . . 0.0 110.95 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 83.9 m -112.65 127.23 56.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.87 0.367 . . . . 0.0 111.246 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.466 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.7 OUTLIER -80.69 144.83 31.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.416 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.548 ' HE3' ' HB3' ' A' ' 57' ' ' LYS . 49.2 tpp -71.63 -35.39 70.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.977 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 m 61.21 29.84 18.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.904 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.47 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 2.8 tpt -110.97 -12.48 14.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.114 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 62.79 63.49 0.97 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.001 0.429 . . . . 0.0 110.427 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.61 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.2 mp -62.2 -48.42 80.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.45 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -131.15 151.45 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.359 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -93.48 140.67 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.592 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.97 -34.33 5.5 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.166 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.589 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.5 OUTLIER -120.92 -167.36 1.47 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.923 0.392 . . . . 0.0 111.208 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.3 OUTLIER -137.65 128.89 27.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.988 179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -95.38 105.98 17.99 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 51.1 m-85 -115.93 123.99 49.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.851 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.786 ' CD2' HG13 ' A' ' 54' ' ' VAL . 13.3 p90 -115.85 132.48 56.63 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.347 0.594 . . . . 0.0 112.133 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.702 ' HA ' HD11 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -133.7 129.26 36.5 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.175 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.848 HG22 HG13 ' A' ' 91' ' ' VAL . 10.9 p -93.76 153.43 18.32 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.895 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -45.29 148.57 0.61 Allowed 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.63 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.51 -21.28 24.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.834 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.87 23.68 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.05 91.29 8.97 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.688 0.28 . . . . 0.0 110.842 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.88 -15.39 42.63 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.455 2.103 . . . . 0.0 112.145 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -96.36 29.42 2.88 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.057 0.456 . . . . 0.0 110.092 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 90' ' ' THR . 52.3 m -153.19 68.62 0.81 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.709 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.848 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -67.94 -178.79 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.174 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.503 ' H ' HG12 ' A' ' 91' ' ' VAL . 91.8 m-85 -157.14 99.67 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.043 HG11 HG12 ' A' ' 50' ' ' ILE . 15.0 t -104.83 118.84 52.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.047 0.451 . . . . 0.0 111.52 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.503 ' SG ' HD22 ' A' ' 109' ' ' LEU . 32.0 p -112.02 131.03 55.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.873 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.526 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.5 m-85 -102.16 91.02 4.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.928 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.901 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -88.05 176.41 7.31 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.445 -179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.763 HD13 ' CA ' ' A' ' 32' ' ' GLY . 7.4 mt -90.58 128.85 36.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.808 0.337 . . . . 0.0 110.849 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.0 -33.46 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.663 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -64.03 -32.24 73.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.022 0.439 . . . . 0.0 110.593 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.485 HG23 ' HD2' ' A' ' 101' ' ' PRO . 64.1 mt -76.15 138.08 68.58 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.87 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.2 Cg_endo -59.3 167.74 5.75 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.406 2.071 . . . . 0.0 112.128 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.483 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -87.6 58.08 4.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.792 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.67 HG23 ' HE1' ' A' ' 135' ' ' PHE . 4.2 tp -141.09 -37.67 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.625 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.695 ' HG ' HD11 ' A' ' 108' ' ' ILE . 16.1 tp -61.54 -59.8 12.37 Favored Pre-proline 0 C--N 1.331 -0.205 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.901 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.3 Cg_endo -47.76 -33.54 19.34 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.494 2.129 . . . . 0.0 110.908 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.754 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.2 mp -67.96 -38.97 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.822 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.59 ' O ' HG21 ' A' ' 131' ' ' ILE . 6.6 mtt-85 -76.36 -29.78 57.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.424 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.695 HD11 ' HG ' ' A' ' 104' ' ' LEU . 9.4 mm -61.63 -51.15 76.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.8 0.333 . . . . 0.0 110.34 179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.601 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -69.24 -61.66 1.7 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.412 ' HA ' ' HG2' ' A' ' 113' ' ' GLN . 48.2 t -56.0 -24.48 39.09 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.498 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -80.06 -43.01 10.12 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -59.19 -35.08 72.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.412 ' HG2' ' HA ' ' A' ' 110' ' ' SER . 10.4 pt20 -77.97 -9.92 59.34 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.136 -0.483 . . . . 0.0 109.728 178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -78.39 -23.02 46.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.599 ' HB2' ' CE1' ' A' ' 127' ' ' HIS . 3.5 m-85 -87.16 -96.31 0.09 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.064 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.428 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 0.1 OUTLIER 160.81 -25.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.549 0.34 . . . . 0.0 110.817 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.685 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 53.6 m -117.55 96.23 5.3 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.263 0.554 . . . . 0.0 111.195 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 0.3 OUTLIER -151.27 46.35 0.82 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.713 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.97 33.81 4.81 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.493 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -145.7 161.99 38.61 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.158 178.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.49 ' HA ' ' N ' ' A' ' 20' ' ' SER . 8.4 p30 -78.74 24.52 0.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.639 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -170.15 28.8 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.609 ' CD2' ' O ' ' A' ' 117' ' ' SER . 5.8 tt -132.43 -45.67 0.9 Allowed 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.059 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -59.46 -42.44 91.99 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 177.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 82.7 p -48.58 -28.03 3.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.152 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.6 OUTLIER -56.99 -59.04 5.64 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.829 ' HB2' HD23 ' A' ' 112' ' ' LEU . 9.6 m170 -60.04 -33.67 72.34 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.803 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.532 ' O ' HD13 ' A' ' 132' ' ' LEU . 48.4 t -53.31 -43.04 49.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 120.302 -0.559 . . . . 0.0 109.961 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.91 -44.67 18.66 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 119.928 -1.13 . . . . 0.0 112.629 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -69.07 -21.02 64.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.691 0.281 . . . . 0.0 111.059 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 127' ' ' HIS . 55.6 mt -90.47 -27.86 5.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.684 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -63.76 -48.19 77.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.153 178.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -64.88 -40.71 95.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 30.3 t -86.29 4.42 39.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.316 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.67 ' HE1' HG23 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -78.35 -44.52 24.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.71 0.291 . . . . 0.0 110.599 179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.508 ' HA ' HD12 ' A' ' 139' ' ' LEU . 21.8 p80 -72.82 -38.32 67.18 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.778 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.443 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 1.7 mm-40 -51.6 -31.46 25.02 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.945 0.402 . . . . 0.0 110.101 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -75.52 -35.88 60.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.859 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.525 HD21 HG12 ' A' ' 103' ' ' ILE . 27.3 mt -65.24 -33.26 75.57 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.79 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.7 t -76.02 -48.11 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.103 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -61.45 -32.47 72.45 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.966 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.39 -26.43 67.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.531 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -84.83 55.57 3.51 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -178.07 37.32 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -112.59 -34.42 5.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.974 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -172.5 81.85 0.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.791 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 51.4 mt -141.2 -64.19 0.45 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -63.56 -31.61 72.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 14.2 p . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.946 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.3 mmm . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.797 0.332 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.45 ' HG3' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER -159.62 119.79 3.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.12 133.93 52.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.555 ' HB3' HD12 ' A' ' 100' ' ' ILE . 19.8 m-85 -113.86 127.09 55.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.782 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.921 ' HA ' HD21 ' A' ' 132' ' ' LEU . 0.7 OUTLIER -138.53 124.47 20.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.349 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.898 HG11 HG22 ' A' ' 9' ' ' VAL . 27.8 t -65.0 154.24 7.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.245 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.406 ' N ' HG12 ' A' ' 6' ' ' VAL . 1.5 m -114.01 -44.22 3.17 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.709 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 15.8 m-85 -139.98 107.01 5.44 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.898 HG22 HG11 ' A' ' 6' ' ' VAL . 1.9 t -116.1 99.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.105 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 28.1 tt0 -108.1 123.15 48.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.926 0.393 . . . . 0.0 111.809 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.87 ' CG2' HD13 ' A' ' 124' ' ' LEU . 11.0 t -85.73 138.06 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.933 HD13 HG23 ' A' ' 93' ' ' VAL . 1.4 mp -113.56 114.79 47.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 2.0 tppt? -97.36 104.93 16.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.787 0.327 . . . . 0.0 110.632 178.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.06 26.91 15.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.298 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.684 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 77.7 34.55 38.84 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.911 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -140.47 17.93 2.38 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.592 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 58.69 155.97 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.346 179.083 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.54 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -145.49 -50.33 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.278 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.632 178.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.775 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -123.94 176.32 6.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.969 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -170.06 129.0 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.457 . . . . 0.0 111.349 -179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.9 t -116.46 69.45 0.75 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.872 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.709 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 3.0 m-85 -106.41 86.51 2.36 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.878 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.9 147.66 62.25 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.934 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.85 -179.14 4.89 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.746 2.297 . . . . 0.0 111.628 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.474 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 2.0 p90 172.36 -24.05 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.479 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 25' ' ' PHE . 34.8 mt-30 65.8 140.08 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.321 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -53.56 -41.86 66.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.522 -179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.4 t30 74.51 -61.81 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.634 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -177.41 -37.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -68.04 -81.63 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.452 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 5' ' ' ASN . 17.4 p90 -89.26 110.33 21.11 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.739 0.304 . . . . 0.0 111.148 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 33' ' ' THR . . . -86.15 124.04 6.71 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.715 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.846 ' CB ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER 174.71 -82.73 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.742 0.306 . . . . 0.0 111.09 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.574 ' O ' ' HB ' ' A' ' 35' ' ' THR . 10.5 mt -78.51 146.11 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.755 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 169.27 -31.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.482 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 m -172.94 -40.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.211 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.8 -35.02 51.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.273 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -109.9 31.44 5.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -123.55 28.28 7.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.96 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -110.91 -37.9 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.872 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.728 HG23 HG13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -51.74 134.73 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.66 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.564 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.9 t -94.79 151.15 38.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.701 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.495 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 72.1 Cg_exo -47.17 -26.7 5.61 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 121.88 1.72 . . . . 0.0 110.8 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.564 ' HB ' HG23 ' A' ' 42' ' ' THR . 57.4 t -61.89 -40.62 87.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.244 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.581 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.728 HG13 HG23 ' A' ' 41' ' ' ILE . 16.8 mm -58.12 -45.13 88.61 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.593 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.625 ' CE1' HG22 ' A' ' 41' ' ' ILE . 27.6 m-85 -75.22 -40.14 59.38 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.399 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.592 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.74 -28.79 70.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.275 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.42 ' N ' ' O ' ' A' ' 44' ' ' VAL . 32.5 m-20 -89.25 -29.63 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.607 HD13 ' HB3' ' A' ' 73' ' ' LEU . 5.2 mt -60.92 -59.67 5.01 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.057 HG22 HD23 ' A' ' 55' ' ' LEU . 4.6 mt -53.28 -64.22 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.339 -1.755 . . . . 0.0 110.212 177.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.592 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.7 tpp -49.69 -43.16 47.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.39 -1.277 . . . . 0.0 112.552 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.08 -11.41 38.75 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.746 ' HB2' HD21 ' A' ' 73' ' ' LEU . 32.9 mmm -127.68 -68.29 0.79 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.462 0.541 . . . . 0.0 112.462 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.801 HG22 ' HG3' ' A' ' 69' ' ' MET . 63.8 t -58.16 -56.68 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.68 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.057 HD23 HG22 ' A' ' 50' ' ' ILE . 2.8 mm? -44.86 -57.82 6.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.809 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 37.9 Cg_endo -66.96 5.04 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.049 1.833 . . . . 0.0 112.25 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.62 22.42 1.46 Allowed 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.071 0.462 . . . . 0.0 110.14 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 91' ' ' VAL . 4.9 p -84.93 166.18 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.858 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.467 HG22 ' HE2' ' A' ' 81' ' ' TYR . 19.0 m -138.34 146.26 50.61 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.541 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.41 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 83.4 Cg_endo -76.87 30.42 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.34 2.027 . . . . 0.0 112.325 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.805 HD12 ' H ' ' A' ' 65' ' ' LYS . 34.7 mm 39.75 96.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.439 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -93.81 -24.3 17.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.002 0.43 . . . . 0.0 110.587 179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.73 40.34 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.076 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -127.86 -66.58 0.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.913 0.387 . . . . 0.0 111.164 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.805 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.2 OUTLIER 75.07 106.51 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.759 -179.675 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.84 HG21 ' HA ' ' A' ' 106' ' ' ILE . 2.9 t 67.95 70.47 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.88 0.371 . . . . 0.0 110.541 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.7 m -98.97 126.26 44.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.314 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 5.0 ttpt -73.99 132.58 42.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.356 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.801 ' HG3' HG22 ' A' ' 54' ' ' VAL . 16.5 mmm -55.62 -32.81 63.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.932 0.396 . . . . 0.0 110.741 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 t 59.52 24.62 13.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.994 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.538 ' HB2' HD12 ' A' ' 73' ' ' LEU . 28.0 mmm -103.82 -5.08 22.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.094 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.32 55.49 4.22 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.126 0.488 . . . . 0.0 110.044 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.746 HD21 ' HB2' ' A' ' 53' ' ' MET . 10.3 mp -57.41 -52.17 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.008 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.64 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -131.99 155.17 41.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.852 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -96.7 140.63 31.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.316 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.682 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.62 -33.8 5.86 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.121 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.467 ' HD1' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -130.71 168.23 17.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.755 0.312 . . . . 0.0 111.023 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 81.7 m-20 -108.2 130.6 55.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.392 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.462 ' SG ' HD13 ' A' ' 73' ' ' LEU . 11.3 p -90.53 112.35 23.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.441 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 53.4 m-85 -121.57 149.7 42.74 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.563 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.615 ' CD1' HG13 ' A' ' 54' ' ' VAL . 44.7 p90 -144.39 128.98 18.12 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.05 0.452 . . . . 0.0 111.19 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 3.3 t -132.89 116.4 16.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.521 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.901 HG22 HG13 ' A' ' 91' ' ' VAL . 34.6 p -77.61 148.48 35.1 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.059 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -43.32 163.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.332 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -88.64 -15.28 35.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.485 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.97 16.7 1.94 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.37 100.21 2.09 Favored Pre-proline 0 C--N 1.33 -0.247 0 C-N-CA 121.207 -0.197 . . . . 0.0 111.305 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.13 -13.03 37.59 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.322 2.015 . . . . 0.0 112.099 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.99 30.14 2.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.073 0.464 . . . . 0.0 110.469 179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 90' ' ' THR . 17.5 m -153.74 70.34 0.83 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.66 0.743 . . . . 0.0 109.835 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.901 HG13 HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -71.12 175.87 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.126 -179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.544 ' H ' HG12 ' A' ' 91' ' ' VAL . 45.3 m-85 -144.97 100.12 3.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.324 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.99 HG11 HG12 ' A' ' 50' ' ' ILE . 41.0 t -93.16 130.03 42.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.991 0.425 . . . . 0.0 111.384 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 41.4 t -127.56 133.45 49.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.659 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -114.49 97.58 6.39 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.804 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.876 HG21 ' HD3' ' A' ' 105' ' ' PRO . 2.6 p -102.27 127.64 49.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.879 0.371 . . . . 0.0 111.167 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.846 HD22 ' CB ' ' A' ' 33' ' ' THR . 34.3 mt -37.05 133.52 0.62 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.055 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.682 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.41 -31.51 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.23 -30.4 71.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.005 0.431 . . . . 0.0 110.157 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.555 HD12 ' HB3' ' A' ' 4' ' ' PHE . 7.3 mm -67.38 136.66 93.46 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.923 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.464 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 60.2 Cg_endo -72.45 179.55 5.0 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.246 1.964 . . . . 0.0 111.574 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.46 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -91.38 60.0 4.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.845 0.355 . . . . 0.0 110.585 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.57 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 3.3 tp -148.73 -38.42 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.834 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.679 HD11 ' CD1' ' A' ' 132' ' ' LEU . 9.4 tp -62.19 -60.72 9.3 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.441 -0.504 . . . . 0.0 109.658 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.876 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.6 Cg_endo -47.85 -32.47 17.44 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.563 2.176 . . . . 0.0 111.239 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.84 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.7 mp -67.93 -36.45 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.106 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.523 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -83.73 -19.95 34.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.117 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 104' ' ' LEU . 11.7 mm -72.36 -49.47 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 120.809 0.338 . . . . 0.0 110.133 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.77 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -72.72 -49.4 31.4 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.7 p -63.95 -30.27 71.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.494 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -74.71 -43.32 29.26 Favored Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.856 HD23 ' HB2' ' A' ' 127' ' ' HIS . 11.5 mt -56.17 -35.36 67.12 Favored 'General case' 0 CA--C 1.521 -0.168 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -13.35 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.133 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.02 -22.43 55.78 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.472 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.482 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 5.9 m-85 -86.46 -94.37 0.09 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.886 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 162.19 -25.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.66 0.267 . . . . 0.0 110.904 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -91.82 -91.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.485 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 123' ' ' LEU . 3.1 p30 39.27 32.12 0.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.674 0.273 . . . . 0.0 111.097 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.15 33.83 5.03 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -148.59 150.78 33.9 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.48 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.437 ' HA ' ' N ' ' A' ' 20' ' ' SER . 5.0 p30 -71.34 29.12 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.785 0.326 . . . . 0.0 111.569 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 120' ' ' THR . 10.3 tt0 -170.91 27.53 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.595 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.2 tt -133.26 -49.77 0.86 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.689 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.87 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.31 -45.54 76.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.447 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 78.4 p -47.64 -30.12 3.47 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.375 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -60.16 -56.27 23.67 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.973 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.856 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.4 m170 -60.91 -31.75 71.25 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.793 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.634 HG13 ' CG2' ' A' ' 108' ' ' ILE . 47.7 t -55.63 -46.43 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.924 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -78.31 -40.69 18.91 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.33 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -67.98 -24.25 65.12 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.591 HD11 ' HB3' ' A' ' 127' ' ' HIS . 63.0 mt -88.17 -28.02 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.921 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.6 OUTLIER -61.78 -49.84 74.74 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.526 178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -46.48 82.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.991 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 24.0 t -72.51 -15.1 61.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.936 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.57 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 23.4 t80 -55.65 -56.45 20.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.233 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 -51.76 -43.32 62.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.945 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.45 -30.54 41.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.891 0.377 . . . . 0.0 110.106 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 7.6 mm-40 -80.25 -34.11 37.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.071 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.554 HD21 ' CZ ' ' A' ' 135' ' ' PHE . 16.1 mt -69.74 -30.32 67.89 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.104 0.478 . . . . 0.0 110.091 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.1 t -77.45 -48.29 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.381 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -63.47 -33.9 76.58 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.026 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -63.03 -31.72 72.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.032 179.378 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.411 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -65.87 -29.81 70.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.852 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.5 43.8 1.06 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.5 -46.71 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 56.9 p -147.04 72.31 1.26 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.863 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.411 HD12 ' O ' ' A' ' 143' ' ' ARG . 1.6 mt -85.91 -176.22 5.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.19 35.91 20.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.957 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.92 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptm . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.851 0.357 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 tptt 60.98 71.31 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.878 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' HG3' ' CD2' ' A' ' 136' ' ' HIS . 0.4 OUTLIER -128.54 46.99 2.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.805 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' CZ ' ' HG2' ' A' ' 101' ' ' PRO . 27.1 m-85 62.11 -178.81 0.13 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.054 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.654 ' HA ' HD21 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -167.44 107.44 0.58 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.074 -179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.923 HG11 HG22 ' A' ' 9' ' ' VAL . 54.9 t -60.79 145.9 11.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.683 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.656 ' OG ' HD11 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -84.19 -69.48 0.64 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.793 -179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.674 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 8.4 m-85 -136.13 116.03 13.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.898 0.38 . . . . 0.0 111.845 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.923 HG22 HG11 ' A' ' 6' ' ' VAL . 2.3 t -106.84 92.03 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.961 0.41 . . . . 0.0 110.868 179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.2 tt0 -95.82 108.69 21.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.8 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.96 ' CG2' HD13 ' A' ' 124' ' ' LEU . 33.5 t -81.07 145.32 9.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 91' ' ' VAL . 2.2 mp -129.34 124.89 60.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HG3' HD13 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -108.91 102.62 11.61 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.381 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 64.79 39.56 6.1 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.881 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.78 20.8 67.47 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.888 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -141.78 118.57 11.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 120.957 0.408 . . . . 0.0 110.26 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.415 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 3.6 m -47.84 128.55 13.4 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.338 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.568 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -105.62 -42.26 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-O 121.643 0.735 . . . . 0.0 109.362 178.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.901 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.4 OUTLIER -131.29 176.35 8.36 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.197 -179.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.441 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 4.0 m -170.5 121.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.879 0.371 . . . . 0.0 111.68 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.521 ' HB3' HG23 ' A' ' 9' ' ' VAL . 33.9 t -107.58 70.22 0.77 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.674 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.1 m-85 -105.97 84.25 2.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.609 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 19.1 pt20 -105.26 139.0 19.71 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.42 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -79.73 147.47 19.5 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.616 2.211 . . . . 0.0 111.977 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CE1' ' O ' ' A' ' 23' ' ' GLN . 38.6 p90 179.04 119.68 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.892 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.766 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.6 pt20 -86.56 46.69 1.38 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 120.631 0.253 . . . . 0.0 111.151 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt 59.68 108.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.811 0.338 . . . . 0.0 110.812 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -170.22 136.44 1.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.043 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 57.84 21.98 8.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.262 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 174.41 161.77 0.19 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.934 0.397 . . . . 0.0 110.849 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.76 106.7 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.65 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.403 ' HA2' ' CD1' ' A' ' 97' ' ' LEU . . . -127.54 -176.86 14.61 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.756 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.561 ' HB ' HD22 ' A' ' 97' ' ' LEU . 11.3 m -155.87 -44.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.925 0.393 . . . . 0.0 110.921 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 27.1 mt -60.36 162.3 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -164.78 -69.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.527 178.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.498 ' N ' ' OG1' ' A' ' 35' ' ' THR . 1.2 m -140.37 -44.75 0.41 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.185 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.3 -28.6 68.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.395 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.457 ' O ' HG23 ' A' ' 34' ' ' ILE . 1.3 m-20 -116.48 32.37 6.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.113 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -129.54 28.38 5.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.005 0.431 . . . . 0.0 110.975 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -111.77 -35.74 5.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.959 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.674 HG22 ' CE1' ' A' ' 46' ' ' PHE . 1.1 mt -51.24 116.51 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.79 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.85 HG22 HD12 ' A' ' 45' ' ' ILE . 1.8 t -77.08 153.18 82.51 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.522 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.438 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.1 Cg_exo -48.16 -21.78 3.19 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 121.785 1.656 . . . . 0.0 110.788 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.622 ' HB ' HG23 ' A' ' 42' ' ' THR . 90.7 t -65.3 -49.35 79.27 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.058 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.85 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -57.28 -31.29 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.674 ' CE1' HG22 ' A' ' 41' ' ' ILE . 98.3 m-85 -80.8 -44.05 19.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.569 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.627 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -65.17 -26.02 67.98 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.291 179.756 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -89.99 -29.54 18.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.645 HD11 HG13 ' A' ' 74' ' ' ILE . 2.7 mt -60.75 -59.51 5.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.018 HG12 HG11 ' A' ' 93' ' ' VAL . 4.9 mt -53.87 -64.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.984 177.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.627 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.8 OUTLIER -49.73 -40.72 41.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.289 -1.323 . . . . 0.0 112.902 -179.427 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -91.16 -19.74 22.75 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.487 ' HB2' HD21 ' A' ' 73' ' ' LEU . 93.8 mmm -120.14 -60.14 1.72 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.497 ' HA ' ' HE3' ' A' ' 69' ' ' MET . 96.4 t -64.55 -51.38 68.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.986 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -55.63 -52.45 71.93 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 14.7 Cg_exo -69.07 3.66 2.32 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.352 2.034 . . . . 0.0 112.159 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.93 23.61 1.37 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.03 0.443 . . . . 0.0 110.192 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.46 HG23 ' CD1' ' A' ' 81' ' ' TYR . 4.4 p -85.92 165.35 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.797 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.519 HG23 ' H ' ' A' ' 61' ' ' ILE . 15.3 m -141.96 146.35 40.14 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.135 179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.481 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 60.8 Cg_endo -74.94 23.38 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.953 1.768 . . . . 0.0 112.33 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.566 HD12 ' H ' ' A' ' 65' ' ' LYS . 21.0 mm 51.65 158.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.307 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.505 ' N ' HG22 ' A' ' 61' ' ' ILE . 2.1 mptp? -134.02 -42.87 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.191 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.39 31.61 0.25 Allowed Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.697 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.441 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 2.4 t-20 -121.55 -66.16 1.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.87 0.366 . . . . 0.0 111.21 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.566 ' H ' HD12 ' A' ' 61' ' ' ILE . 12.6 mmtt 70.93 116.75 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.608 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.898 HG13 HD23 ' A' ' 109' ' ' LEU . 3.1 t 75.04 49.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.68 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.0 m -80.7 125.41 30.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.283 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -71.75 130.67 41.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.497 ' HE3' ' HA ' ' A' ' 54' ' ' VAL . 53.3 tpp -57.53 -25.24 59.59 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.06 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.4 t 53.04 26.96 5.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.085 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.431 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 8.9 tpt -106.45 -11.0 16.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.149 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.87 58.06 1.28 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.88 0.371 . . . . 0.0 110.515 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.573 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.5 mp -59.86 -46.05 90.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.701 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.645 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -133.25 157.03 42.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.686 179.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -99.95 140.84 33.59 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.394 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.587 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.41 -33.92 5.81 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.241 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.54 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -132.79 168.36 18.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.882 0.372 . . . . 0.0 111.088 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 94.7 m-20 -106.57 143.25 34.94 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.402 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.422 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 6.4 m -106.98 114.77 29.06 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' HB3' HG12 ' A' ' 66' ' ' VAL . 87.7 m-85 -121.78 137.74 54.65 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.322 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.482 ' HB3' HG11 ' A' ' 54' ' ' VAL . 49.2 p90 -127.05 128.82 46.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.0 0.429 . . . . 0.0 111.467 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -133.35 118.91 19.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.96 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.634 HG22 HG13 ' A' ' 91' ' ' VAL . 40.3 p -80.63 150.43 29.46 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.563 179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -46.14 146.84 1.2 Allowed 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.276 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -63.03 -15.81 57.7 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.89 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.51 22.03 0.54 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.659 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.74 95.0 3.76 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 120.471 0.177 . . . . 0.0 111.178 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.33 -15.55 45.62 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.333 2.022 . . . . 0.0 111.887 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -96.23 30.39 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 121.042 0.448 . . . . 0.0 110.093 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 65.1 m -154.36 73.72 0.93 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.66 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.634 HG13 HG22 ' A' ' 83' ' ' THR . 0.6 OUTLIER -72.83 176.0 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.223 -179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.583 ' H ' HG12 ' A' ' 91' ' ' VAL . 97.4 m-85 -150.68 94.88 2.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.826 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.018 HG11 HG12 ' A' ' 50' ' ' ILE . 44.0 t -98.09 121.02 48.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.246 -179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.567 ' CB ' HD21 ' A' ' 109' ' ' LEU . 37.5 t -114.51 139.98 49.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.312 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 6.8 m-85 -115.04 102.66 10.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.511 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.665 HG21 ' HD3' ' A' ' 105' ' ' PRO . 9.9 p -109.69 127.46 54.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.977 0.418 . . . . 0.0 111.141 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.561 HD22 ' HB ' ' A' ' 33' ' ' THR . 44.5 mt -38.32 132.9 1.03 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.326 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.587 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.94 -30.15 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.685 -178.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.11 -28.08 67.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 110.742 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.421 HD12 ' HB3' ' A' ' 4' ' ' PHE . 5.2 mm -68.26 131.57 91.92 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.205 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.432 ' HG2' ' CZ ' ' A' ' 4' ' ' PHE . 39.1 Cg_exo -60.0 179.65 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.211 1.941 . . . . 0.0 111.628 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -98.72 62.58 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.682 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.608 ' HA ' HD13 ' A' ' 106' ' ' ILE . 4.3 tp -155.08 -37.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.783 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.699 ' HG ' HD11 ' A' ' 108' ' ' ILE . 5.3 tp -60.51 -61.55 7.73 Favored Pre-proline 0 C--N 1.332 -0.185 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.665 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.3 Cg_endo -45.48 -37.54 14.97 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.794 2.329 . . . . 0.0 111.147 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.861 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -63.62 -37.44 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.152 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.553 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.7 OUTLIER -83.49 -18.23 39.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.841 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.867 HG23 HG13 ' A' ' 128' ' ' VAL . 15.4 mm -70.63 -47.89 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.898 HD23 HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -74.37 -47.42 34.27 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.5 t -64.53 -29.11 70.14 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -75.73 -45.55 16.96 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.173 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.952 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.76 -33.93 67.09 Favored 'General case' 0 CA--C 1.521 -0.152 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -70.79 -16.11 62.72 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.209 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.08 -21.6 59.85 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.363 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.492 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.5 m-85 -85.39 -94.13 0.08 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.948 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 4.9 tp10 161.57 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.776 0.322 . . . . 0.0 110.659 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 13.5 m -91.32 -91.07 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.368 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.549 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.1 p-10 39.04 32.83 0.07 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.595 0.236 . . . . 0.0 111.021 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.37 34.81 4.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -150.13 151.1 32.6 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.708 179.029 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.441 ' HA ' ' N ' ' A' ' 20' ' ' SER . 7.3 p30 -70.67 28.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.825 0.345 . . . . 0.0 111.919 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.509 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 tt0 -172.17 28.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.603 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.9 tt -131.74 -50.33 0.97 Allowed 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.96 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.93 -44.94 78.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 19.1 t -47.7 -30.22 3.65 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.168 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.13 -58.17 8.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.138 179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.952 ' HB2' HD23 ' A' ' 112' ' ' LEU . 6.7 m170 -57.66 -39.36 76.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.643 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.867 HG13 HG23 ' A' ' 108' ' ' ILE . 42.9 t -50.52 -46.2 26.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.412 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.03 -47.28 47.0 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 119.779 -1.201 . . . . 0.0 112.324 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -65.28 -23.39 67.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.863 0.363 . . . . 0.0 110.82 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 ' O ' ' A' ' 107' ' ' ARG . 37.8 mt -85.49 -27.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.654 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.5 OUTLIER -65.66 -46.52 78.84 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.678 179.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -67.66 -44.0 78.9 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.553 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.7 m -80.3 -4.17 52.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.815 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.733 ' CE1' HD11 ' A' ' 139' ' ' LEU . 26.6 t80 -55.62 -62.14 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.139 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.54 ' HA ' HD12 ' A' ' 139' ' ' LEU . 7.4 m-70 -50.68 -41.31 55.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.332 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.01 -33.01 23.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.935 0.398 . . . . 0.0 110.353 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 1.5 mm-40 -79.33 -34.02 42.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.966 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.733 HD11 ' CE1' ' A' ' 135' ' ' PHE . 18.0 mt -69.84 -30.11 67.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.232 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.5 t -77.21 -47.49 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.583 0.706 . . . . 0.0 109.423 179.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -65.09 -32.0 73.49 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.093 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -65.9 -32.88 74.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.484 179.461 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.539 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -67.08 -21.4 65.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.153 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -104.1 35.43 2.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.054 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 11.6 mt-30 -126.87 -42.93 1.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 t -137.06 80.78 1.83 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.94 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 143' ' ' ARG . 0.2 OUTLIER -162.53 30.74 0.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.797 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -102.25 31.25 4.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.2 -0.905 . . . . 0.0 110.808 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.9 92.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.84 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.39 161.04 23.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.836 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.464 ' CZ ' ' HD2' ' A' ' 101' ' ' PRO . 6.1 m-85 -145.69 161.54 39.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.096 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.746 ' HA ' HD21 ' A' ' 132' ' ' LEU . 3.9 t-20 -168.88 111.33 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.966 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.932 HG11 HG22 ' A' ' 9' ' ' VAL . 3.5 t -54.19 123.09 4.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.616 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -53.93 -55.73 24.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.49 -179.291 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.655 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 6.5 m-85 -145.47 140.52 27.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.9 0.381 . . . . 0.0 111.653 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.932 HG22 HG11 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -131.35 97.2 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.348 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.562 ' HG2' ' HG ' ' A' ' 20' ' ' SER . 1.2 mt-10 -112.86 124.7 53.21 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.86 0.362 . . . . 0.0 111.647 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.956 HG23 HD13 ' A' ' 124' ' ' LEU . 98.2 t -89.79 159.9 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.83 HD11 HG21 ' A' ' 50' ' ' ILE . 3.3 mt -137.66 117.4 15.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.602 ' CG ' HD13 ' A' ' 18' ' ' ILE . 3.2 tttp -107.36 115.5 30.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.056 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 61.4 32.74 18.97 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.573 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.0 27.91 57.44 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.378 -0.915 . . . . 0.0 111.283 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -144.92 121.57 11.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.894 0.378 . . . . 0.0 110.086 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -51.88 122.55 8.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.145 -178.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.602 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -98.19 -47.94 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.488 0.661 . . . . 0.0 109.603 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 124' ' ' LEU . 54.7 p -122.08 171.35 9.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.625 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.607 ' N ' HD22 ' A' ' 124' ' ' LEU . 11.8 m -166.54 128.05 1.75 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.985 0.421 . . . . 0.0 112.021 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.486 ' N ' HD21 ' A' ' 124' ' ' LEU . 32.0 t -119.91 69.39 0.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.655 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.5 m-85 -112.04 94.2 4.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.939 -178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.414 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 2.2 pp0? -139.13 149.38 60.92 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.718 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.99 177.88 3.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.725 2.283 . . . . 0.0 111.673 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 7' ' ' SER . 3.4 p90 176.86 -26.47 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.41 ' CG ' ' HA ' ' A' ' 35' ' ' THR . 7.2 mt-30 64.99 139.61 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.882 0.372 . . . . 0.0 110.258 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 0.7 OUTLIER -51.46 156.85 1.16 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.247 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -122.7 46.58 2.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.702 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 72.48 -62.4 0.47 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.969 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -53.79 -67.0 0.29 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 40.5 p90 -101.32 108.31 19.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.812 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' CB ' ' A' ' 27' ' ' LYS . . . -97.34 133.37 11.34 Favored Glycine 0 C--N 1.329 0.183 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.57 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.772 ' HB ' HD22 ' A' ' 97' ' ' LEU . 0.0 OUTLIER -178.44 -78.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.905 0.384 . . . . 0.0 111.401 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.568 ' O ' ' HB ' ' A' ' 35' ' ' THR . 4.2 mt -84.46 150.24 4.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.83 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.568 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 169.22 -31.7 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.549 179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -157.45 -78.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.401 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.19 -37.88 37.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.782 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -98.22 33.41 2.19 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.026 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -127.31 29.89 5.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.926 0.393 . . . . 0.0 110.95 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -115.31 -38.61 3.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.352 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.66 HD12 HD13 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -53.57 118.44 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.078 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.976 HG22 HD12 ' A' ' 45' ' ' ILE . 9.5 t -81.43 152.19 69.91 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.177 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.511 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 75.6 Cg_exo -46.51 -23.06 1.99 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.066 1.844 . . . . 0.0 111.239 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.736 ' HB ' HG23 ' A' ' 42' ' ' THR . 49.2 t -64.82 -47.51 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.518 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.976 HD12 HG22 ' A' ' 42' ' ' THR . 1.9 mp -58.94 -33.32 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 CA-C-O 121.214 0.53 . . . . 0.0 109.618 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.491 ' O ' HD12 ' A' ' 50' ' ' ILE . 66.1 m-85 -81.06 -41.98 21.75 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.541 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.633 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -64.69 -29.15 70.14 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.023 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -88.27 -27.31 21.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.71 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.4 mt -63.79 -61.11 2.51 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.966 HG12 HG11 ' A' ' 93' ' ' VAL . 6.8 mt -49.63 -62.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.446 -1.706 . . . . 0.0 109.736 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.595 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -54.33 -41.09 68.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 113.845 -1.525 . . . . 0.0 113.591 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -90.89 -20.42 22.27 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.455 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 69.0 mmm -119.66 -52.3 2.24 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.445 ' HA ' ' CE ' ' A' ' 69' ' ' MET . 84.3 t -69.59 -60.78 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.867 HD23 HG22 ' A' ' 50' ' ' ILE . 1.3 mm? -46.41 -51.09 37.1 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 12.6 Cg_exo -70.08 2.87 3.31 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.262 1.975 . . . . 0.0 112.059 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -145.49 23.97 1.42 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-O 121.058 0.456 . . . . 0.0 110.086 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.491 HG23 ' CD1' ' A' ' 81' ' ' TYR . 5.0 p -87.67 166.06 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.914 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.558 HG23 ' H ' ' A' ' 61' ' ' ILE . 12.1 m -140.57 146.16 43.7 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.899 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.506 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 58.5 Cg_endo -73.71 24.08 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 121.931 1.754 . . . . 0.0 112.476 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.708 HD12 ' H ' ' A' ' 65' ' ' LYS . 30.0 mm 50.12 158.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.394 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.498 ' N ' HG22 ' A' ' 61' ' ' ILE . 6.4 mmtm -135.84 -44.94 0.66 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.175 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.17 29.69 0.41 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.545 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.51 -71.28 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.963 0.411 . . . . 0.0 110.985 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.708 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.0 OUTLIER 71.72 120.35 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.554 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.799 HG21 ' HA ' ' A' ' 106' ' ' ILE . 2.6 t 76.25 44.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.497 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.6 m -78.61 139.84 38.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.365 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.447 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.31 127.45 33.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.511 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.498 ' HG2' ' CG ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -54.04 -36.5 63.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 -179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.6 m 63.97 25.44 13.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.894 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.498 ' CG ' ' HG2' ' A' ' 69' ' ' MET . 23.6 mmt -104.82 -0.66 26.97 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.944 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.06 56.28 5.4 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.098 0.475 . . . . 0.0 110.507 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.71 ' HB3' HD22 ' A' ' 49' ' ' LEU . 7.5 mp -60.44 -39.45 87.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.652 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.66 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -147.01 151.77 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.489 179.02 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -96.77 138.67 33.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.335 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 111.94 -31.91 6.71 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.397 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -129.48 163.92 24.85 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.15 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 75.8 m-20 -103.49 132.03 50.1 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.432 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 20.9 p -94.83 95.72 8.87 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.561 ' HB3' HG12 ' A' ' 66' ' ' VAL . 73.2 m-85 -110.33 133.59 53.11 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.552 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.511 ' HB3' HG22 ' A' ' 93' ' ' VAL . 46.6 p90 -127.31 139.84 52.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.896 0.379 . . . . 0.0 111.455 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -143.55 125.09 14.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.779 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.798 HG22 HG13 ' A' ' 91' ' ' VAL . 41.4 p -86.94 158.12 19.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.95 153.37 2.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.037 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.83 -9.71 58.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.765 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.26 22.56 0.24 Allowed 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.667 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -151.76 98.97 2.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.477 0.18 . . . . 0.0 111.23 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.31 -13.61 40.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.445 2.097 . . . . 0.0 112.009 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -97.56 28.81 3.57 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.049 0.452 . . . . 0.0 110.023 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 90' ' ' THR . 32.3 m -152.73 73.63 1.02 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.408 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 83' ' ' THR . 0.5 OUTLIER -73.55 -179.68 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.435 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.633 ' H ' HG12 ' A' ' 91' ' ' VAL . 69.1 m-85 -156.06 98.61 1.89 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.754 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.966 HG11 HG12 ' A' ' 50' ' ' ILE . 65.0 t -106.86 133.52 51.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.98 0.419 . . . . 0.0 111.151 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 31.5 p -129.21 122.45 29.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.087 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.501 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.7 m-85 -92.05 87.45 6.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.725 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.809 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -75.72 -170.94 1.43 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.775 0.322 . . . . 0.0 110.931 -179.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.772 HD22 ' HB ' ' A' ' 33' ' ' THR . 82.0 mt -105.95 125.77 51.39 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.476 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -41.49 -30.58 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.608 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -88.51 36.94 0.81 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.817 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.415 HG12 ' CD1' ' A' ' 4' ' ' PHE . 47.9 mt -139.48 129.48 14.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.493 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.528 ' HB2' HG22 ' A' ' 103' ' ' ILE . 72.9 Cg_exo -48.39 151.51 4.59 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.307 2.005 . . . . 0.0 112.395 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.443 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -82.46 58.03 3.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.496 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.603 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 3.2 tp -144.1 -35.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.762 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.717 HD21 HG23 ' A' ' 6' ' ' VAL . 6.3 tp -60.45 -63.99 3.62 Favored Pre-proline 0 C--N 1.331 -0.207 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.672 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.809 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -45.25 -35.51 11.33 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.726 2.284 . . . . 0.0 111.501 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.799 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.5 mp -63.35 -40.88 90.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.061 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 111' ' ' GLY . 0.6 OUTLIER -79.35 -19.68 49.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.813 179.307 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.888 HG13 HG21 ' A' ' 6' ' ' VAL . 19.9 mm -68.32 -49.99 61.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 120.704 0.288 . . . . 0.0 110.522 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.725 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -72.23 -50.16 29.5 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.122 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.39 -27.43 68.52 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -78.6 -42.15 14.42 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.852 HD23 ' HB2' ' A' ' 127' ' ' HIS . 20.4 mt -58.88 -28.23 65.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.76 -18.56 58.38 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.227 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.5 OUTLIER -73.57 -22.21 60.13 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.509 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 6.4 m-85 -83.64 -93.24 0.07 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 20.7 tt0 156.5 -22.61 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.352 0.261 . . . . 0.0 111.064 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.6 m -94.19 -90.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.0 OUTLIER 41.12 31.2 0.13 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.919 0.39 . . . . 0.0 110.879 -179.085 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.15 34.01 4.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.484 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -149.92 154.85 38.99 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.523 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HA ' ' H ' ' A' ' 20' ' ' SER . 12.6 m120 -74.06 22.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.394 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' A' ' 120' ' ' THR . 6.9 pt-20 -164.97 26.32 0.06 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.605 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.6 tt -127.11 -50.87 1.43 Allowed 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.683 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.956 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.52 -44.69 76.88 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.5 p -47.66 -30.36 3.69 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.231 178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.48 -56.27 21.98 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.326 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.852 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.0 m170 -60.39 -35.2 75.17 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.677 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.781 HG21 HG21 ' A' ' 9' ' ' VAL . 46.1 t -54.59 -45.66 71.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.02 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.51 28.77 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.435 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -69.31 -21.16 63.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.808 0.337 . . . . 0.0 110.871 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.597 HD11 ' HB3' ' A' ' 127' ' ' HIS . 62.4 mt -90.16 -27.38 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.746 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.2 OUTLIER -64.59 -47.84 77.18 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.359 178.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -63.42 -44.62 94.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.575 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.3 t -76.49 -8.71 57.74 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.744 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.603 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 16.8 t80 -51.57 -57.76 8.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.094 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.491 ' HA ' HD12 ' A' ' 139' ' ' LEU . 16.5 m170 -58.87 -40.72 85.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -52.76 -31.21 36.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.972 0.415 . . . . 0.0 110.007 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 18.2 mt-10 -77.82 -35.52 51.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.971 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 136' ' ' HIS . 20.5 mt -67.17 -29.92 69.74 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.185 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.5 t -78.19 -49.01 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.484 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.76 -31.35 72.5 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.041 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -63.84 -33.01 74.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.29 179.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -28.91 68.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.89 85.31 2.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.43 -78.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 43.6 p -108.91 39.98 1.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.849 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.34 130.78 53.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.967 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -33.12 48.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.809 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.856 179.969 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mmt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.77 0.319 . . . . 0.0 111.177 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.42 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 0.1 OUTLIER 60.34 97.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.824 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.96 -174.56 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -148.35 159.25 44.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.914 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -158.31 113.49 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.827 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.022 HG11 HG22 ' A' ' 9' ' ' VAL . 92.9 t -58.93 140.1 17.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.079 0.466 . . . . 0.0 110.978 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.461 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -71.68 -59.02 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.701 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.675 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 5.8 m-85 -149.35 115.84 5.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.848 0.356 . . . . 0.0 111.78 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.022 HG22 HG11 ' A' ' 6' ' ' VAL . 1.9 t -108.15 93.03 2.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.865 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.632 ' OE2' HG21 ' A' ' 17' ' ' THR . 0.1 OUTLIER -101.14 114.83 29.14 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.685 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.984 HG23 HD13 ' A' ' 124' ' ' LEU . 56.0 t -81.59 161.19 3.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.566 HG21 HD11 ' A' ' 55' ' ' LEU . 2.0 mp -142.01 121.08 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.693 -0.403 . . . . 0.0 112.045 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.522 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 12.8 tttt -107.07 97.24 7.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.703 179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 69.85 37.59 1.78 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.42 18.58 62.01 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.695 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 13' ' ' LYS . 7.6 pt-20 -144.8 119.22 9.62 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.632 HG21 ' OE2' ' A' ' 10' ' ' GLU . 18.6 m -50.14 130.78 23.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.507 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.522 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.36 -41.49 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.137 178.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.885 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -127.21 175.57 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.072 -179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.458 ' N ' HD22 ' A' ' 124' ' ' LEU . 17.0 p -170.38 134.65 1.17 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.997 0.427 . . . . 0.0 111.648 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' HB3' HG23 ' A' ' 9' ' ' VAL . 34.4 t -122.7 69.75 0.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.746 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.675 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -106.95 88.72 2.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.684 -178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 39.5 mt-30 -127.88 139.48 35.46 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.487 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.69 -179.07 4.78 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.546 2.164 . . . . 0.0 111.755 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' O ' ' A' ' 23' ' ' GLN . 1.0 OUTLIER 176.78 -29.67 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.675 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER 74.7 122.19 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 120.77 0.319 . . . . 0.0 110.413 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -51.82 -46.64 64.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.082 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 69.4 -66.16 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.941 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -158.58 -45.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.785 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -58.65 177.32 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.888 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CD1' ' HE2' ' A' ' 2' ' ' LYS . 20.4 m-85 -58.95 110.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.978 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.736 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . -173.97 -165.55 30.8 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.94 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.464 HG21 ' HA2' ' A' ' 76' ' ' GLY . 18.8 m -157.61 -44.12 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.884 0.373 . . . . 0.0 111.017 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.548 ' O ' ' HB ' ' A' ' 35' ' ' THR . 26.5 mt -55.06 154.58 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.951 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 169.5 -32.12 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.449 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.9 t -179.64 -60.33 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.021 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.06 -29.25 63.28 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.378 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -117.49 32.28 6.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.051 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.15 28.59 5.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.033 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -110.22 -38.39 5.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.887 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.689 HD13 ' CD1' ' A' ' 74' ' ' ILE . 1.1 mt -51.31 142.15 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.68 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.603 HG23 ' HB ' ' A' ' 44' ' ' VAL . 2.3 t -96.67 152.5 38.57 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 83.2 Cg_exo -46.43 -28.83 6.45 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 121.895 1.73 . . . . 0.0 110.669 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.603 ' HB ' HG23 ' A' ' 42' ' ' THR . 60.9 t -58.81 -40.28 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.548 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.597 ' HB ' HG23 ' A' ' 41' ' ' ILE . 23.5 mm -57.62 -46.34 86.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.839 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.549 ' O ' HD12 ' A' ' 50' ' ' ILE . 68.7 m-85 -75.41 -38.51 59.83 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.246 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.611 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.26 -30.15 71.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.155 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 44' ' ' VAL . 3.7 m-80 -87.59 -28.03 22.17 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.873 HD11 HG13 ' A' ' 74' ' ' ILE . 6.6 mt -64.21 -61.15 2.43 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 177.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.081 HG12 HG11 ' A' ' 93' ' ' VAL . 6.2 mt -48.9 -61.19 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 113.479 -1.691 . . . . 0.0 109.997 177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.536 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 1.4 ttm -57.28 -40.85 78.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.186 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' ASN . 6.5 t0 -91.18 -15.13 29.81 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -178.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.489 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 84.2 mmm -124.28 -56.48 1.62 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.478 HG13 ' CD2' ' A' ' 81' ' ' TYR . 72.1 t -64.44 -60.02 3.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.73 HD23 HG22 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -51.96 -50.35 78.8 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.261 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.592 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 25.9 Cg_exo -62.68 -2.28 3.31 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.383 2.055 . . . . 0.0 112.602 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -146.97 23.15 1.21 Allowed 'General case' 0 CA--C 1.521 -0.135 0 CA-C-O 121.012 0.434 . . . . 0.0 110.289 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.7 p -78.78 164.85 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.931 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 58' ' ' VAL . 29.7 m -147.3 147.17 27.65 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.936 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.473 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 64.0 Cg_endo -76.18 25.3 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 121.968 1.778 . . . . 0.0 112.83 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' A' ' 82' ' ' SER . 1.6 mp 51.31 159.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.538 -0.755 . . . . 0.0 112.083 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -123.7 -41.0 2.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.849 179.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -167.92 40.31 0.23 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.086 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 2.8 t-20 -136.74 -60.98 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.818 0.342 . . . . 0.0 111.325 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.498 ' C ' HG23 ' A' ' 66' ' ' VAL . 0.3 OUTLIER 72.89 128.9 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.479 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.849 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.4 t 73.89 49.96 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.967 0.413 . . . . 0.0 110.725 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 88.8 m -78.0 129.37 35.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 7.0 tttm -79.45 131.06 35.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.264 179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.479 ' HG2' HD11 ' A' ' 73' ' ' LEU . 20.0 tpp -56.78 -29.94 63.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.174 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.3 m 56.43 28.64 13.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.452 ' CB ' ' HG3' ' A' ' 69' ' ' MET . 37.8 tpp -108.66 -10.87 15.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.029 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.58 59.14 1.23 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.049 0.452 . . . . 0.0 110.43 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.654 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.6 mp -59.5 -50.1 75.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.774 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.873 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -128.75 155.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.651 179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -96.61 140.35 31.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.458 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.625 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 108.7 -32.25 7.1 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.382 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.63 ' HD2' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -133.87 167.96 19.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 111.25 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 84.0 m-20 -108.37 145.28 34.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.383 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 1.8 m -109.75 118.43 36.51 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.492 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 32.5 m-85 -126.13 138.97 53.72 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.12 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.478 ' CD2' HG13 ' A' ' 54' ' ' VAL . 26.8 p90 -124.78 133.69 53.05 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.073 0.463 . . . . 0.0 111.359 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.563 ' HA ' HD11 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -136.18 117.6 14.72 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.031 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.611 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 18.0 p -79.35 153.58 29.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.695 0.284 . . . . 0.0 110.828 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -51.37 146.42 7.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.096 0.474 . . . . 0.0 111.25 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -22.35 14.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.056 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.05 23.54 0.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.587 0.232 . . . . 0.0 111.582 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -144.56 94.57 5.55 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.88 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.35 -15.28 47.35 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.395 2.063 . . . . 0.0 111.98 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -96.35 28.2 3.4 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.171 0.51 . . . . 0.0 110.272 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 90' ' ' THR . 51.7 m -152.04 70.91 0.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.641 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.611 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.4 OUTLIER -72.34 177.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.134 -179.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.57 ' H ' HG12 ' A' ' 91' ' ' VAL . 92.7 m-85 -151.1 93.69 1.95 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.112 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.081 HG11 HG12 ' A' ' 50' ' ' ILE . 51.5 t -95.6 120.54 45.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.973 0.416 . . . . 0.0 111.05 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.497 ' CB ' HD21 ' A' ' 109' ' ' LEU . 35.8 t -112.85 137.48 51.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.108 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 8.6 m-85 -112.88 99.2 7.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.618 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.825 HG21 ' HD3' ' A' ' 105' ' ' PRO . 2.0 p -104.33 125.72 50.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.058 0.456 . . . . 0.0 111.078 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.736 HD13 ' HA2' ' A' ' 32' ' ' GLY . 16.5 mt -39.9 134.74 1.4 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.057 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -46.2 -29.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.705 0.288 . . . . 0.0 111.493 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.37 -28.24 69.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.121 0.486 . . . . 0.0 110.478 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 16.4 mm -66.95 134.12 93.94 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.129 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -60.28 -159.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.134 1.889 . . . . 0.0 111.617 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 tttp -114.44 64.19 0.67 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.539 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.686 HG23 ' CE2' ' A' ' 135' ' ' PHE . 1.4 tp -161.79 -35.98 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.918 -179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.073 HD11 HD23 ' A' ' 132' ' ' LEU . 4.7 tp -58.73 -61.54 7.51 Favored Pre-proline 0 C--N 1.332 -0.183 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.048 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.825 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.8 Cg_endo -45.38 -36.36 12.97 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.592 2.195 . . . . 0.0 111.015 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.849 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -67.79 -37.31 78.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.06 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.636 ' O ' HG21 ' A' ' 131' ' ' ILE . 1.1 mmp_? -80.77 -24.34 38.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.701 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.904 HG23 HG13 ' A' ' 128' ' ' VAL . 31.9 mm -67.01 -54.36 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-O 120.766 0.317 . . . . 0.0 110.223 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -69.33 -53.33 20.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.907 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.9 t -59.91 -27.93 67.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.498 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -74.92 -45.89 19.17 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.3 mt -56.16 -31.14 63.11 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.9 mm100 -76.89 -15.76 59.59 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.058 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -75.43 -25.19 57.29 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 120.745 0.307 . . . . 0.0 110.313 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.537 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 3.5 m-85 -84.42 -92.57 0.08 Allowed 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.911 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 163.43 -29.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.059 0.457 . . . . 0.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.53 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 26.3 m -111.54 124.33 52.06 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.476 0.655 . . . . 0.0 111.061 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.496 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.7 p30 -169.67 36.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.944 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -109.89 33.38 4.44 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.529 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.28 155.15 43.72 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.901 178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.2 m120 -75.25 19.88 0.16 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.3 pm0 -161.53 24.59 0.12 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.529 ' CB ' HG23 ' A' ' 120' ' ' THR . 7.4 tt -123.07 -58.26 1.65 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.7 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.984 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -50.81 -44.79 59.15 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.411 ' HB3' ' CB ' ' A' ' 21' ' ' CYS . 78.6 p -49.32 -29.58 6.24 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.461 178.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.07 -59.98 4.06 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.427 -179.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.862 ' HB2' HD23 ' A' ' 112' ' ' LEU . 42.4 m170 -59.64 -32.17 70.19 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.877 -0.602 . . . . 0.0 109.949 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.904 HG13 HG23 ' A' ' 108' ' ' ILE . 56.9 t -55.26 -46.92 78.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -67.92 -42.9 84.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.11 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -69.62 -22.9 63.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.919 0.39 . . . . 0.0 110.494 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.636 HG21 ' O ' ' A' ' 107' ' ' ARG . 40.5 mt -90.38 -27.06 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 1.073 HD23 HD11 ' A' ' 104' ' ' LEU . 2.9 mt -65.02 -52.33 56.6 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.919 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -71.57 -32.65 68.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.939 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.5 m -95.77 24.27 5.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.957 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.715 ' CZ ' HD11 ' A' ' 139' ' ' LEU . 0.0 OUTLIER -100.25 -44.03 6.08 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.385 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -71.73 -36.57 70.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.946 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -52.59 -29.27 24.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.993 0.425 . . . . 0.0 110.396 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 93.4 mt-10 -78.8 -36.39 42.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.305 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.715 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 16.5 mt -68.89 -30.3 68.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.429 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 98.9 t -77.13 -48.05 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 CA-C-O 121.465 0.65 . . . . 0.0 109.55 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -64.19 -30.78 71.82 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.0 179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -68.24 -20.99 64.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.573 179.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.5 tpt85 -89.67 16.28 8.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.452 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -160.05 29.26 0.18 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.759 0.314 . . . . 0.0 110.859 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -113.77 -36.37 4.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.947 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 146' ' ' THR . 3.8 t -143.65 83.96 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.829 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 33.6 mt -140.79 96.79 3.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -125.64 81.18 1.96 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.845 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.806 0.336 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.54 119.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.923 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.1 173.38 7.97 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CE1' HG12 ' A' ' 100' ' ' ILE . 2.0 m-85 -131.53 -173.11 3.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.031 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -159.72 111.74 2.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.278 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.927 HG11 HG22 ' A' ' 9' ' ' VAL . 1.4 t -71.94 133.54 31.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.552 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.22 -63.16 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.792 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.577 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.1 m-85 -144.98 140.35 28.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.309 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.927 HG22 HG11 ' A' ' 6' ' ' VAL . 1.5 t -129.63 90.68 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.774 0.321 . . . . 0.0 110.475 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.423 ' HG3' ' CE2' ' A' ' 22' ' ' PHE . 1.1 tt0 -99.52 116.02 30.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.004 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.89 HG23 HD13 ' A' ' 124' ' ' LEU . 40.1 t -82.39 158.58 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.78 HD11 HG21 ' A' ' 50' ' ' ILE . 3.4 mt -141.01 119.58 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.667 ' CG ' HD13 ' A' ' 18' ' ' ILE . 1.8 tttt -104.68 99.76 9.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.893 0.378 . . . . 0.0 111.482 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 64.77 40.39 5.66 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.855 179.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.04 21.32 63.27 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.05 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -141.38 116.27 9.81 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 121.003 0.43 . . . . 0.0 110.194 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.3 m -50.84 126.03 14.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.823 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.667 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -103.96 -44.0 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.36 0 CA-C-O 121.457 0.646 . . . . 0.0 109.792 179.031 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -127.7 177.11 7.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.432 -179.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.464 ' N ' HD22 ' A' ' 124' ' ' LEU . 2.8 t -170.47 139.04 1.59 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.564 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.493 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 13.7 t -130.52 73.08 1.52 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.605 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 2.1 m-85 -107.35 88.78 2.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.815 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -101.78 126.24 34.61 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.212 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.39 149.35 35.01 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.466 2.111 . . . . 0.0 112.131 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.1 p90 -178.93 151.22 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.834 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.607 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 4.0 pt20 -104.2 62.18 0.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.744 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER 40.41 -170.13 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.008 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 66.9 m-80 -158.53 74.83 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.829 0.347 . . . . 0.0 111.202 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 61.18 -81.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.297 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -85.4 -80.62 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.178 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 28' ' ' ASN . 22.1 p90 -69.49 131.95 45.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.47 158.82 11.18 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.382 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.671 ' HB ' HD22 ' A' ' 97' ' ' LEU . 23.5 m -144.15 -43.6 0.26 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.747 0.308 . . . . 0.0 111.113 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 35' ' ' THR . 13.0 mt -57.83 155.42 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.349 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -175.91 -83.27 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.493 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -133.38 63.49 1.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.885 0.374 . . . . 0.0 111.045 -179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.83 -38.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.452 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 27.6 m-20 -112.47 31.37 6.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.741 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 28.67 7.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.847 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -117.4 -34.35 4.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.556 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -53.98 121.59 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.978 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.977 HG22 HD12 ' A' ' 45' ' ' ILE . 8.8 t -83.39 151.48 62.52 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.342 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 82.8 Cg_exo -46.0 -22.56 1.42 Allowed 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.189 1.926 . . . . 0.0 111.474 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.756 ' HB ' HG23 ' A' ' 42' ' ' THR . 97.1 t -65.58 -46.28 90.04 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.045 179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.977 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -59.41 -33.91 52.75 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.556 ' CE2' HG22 ' A' ' 41' ' ' ILE . 88.1 m-85 -79.36 -43.28 23.79 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.204 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.637 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.83 -27.83 69.44 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.069 179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 25.8 m-20 -88.33 -29.18 20.53 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.614 HD11 HG13 ' A' ' 74' ' ' ILE . 3.5 mt -62.57 -61.11 2.65 Favored 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.076 HG12 HG11 ' A' ' 93' ' ' VAL . 5.7 mt -50.44 -61.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 113.444 -1.707 . . . . 0.0 110.262 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.622 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -53.21 -46.01 68.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.055 -1.43 . . . . 0.0 113.198 -178.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.91 -14.14 32.24 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.496 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 74.1 mmm -123.02 -63.27 1.27 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.743 HG13 ' CD2' ' A' ' 81' ' ' TYR . 67.5 t -59.35 -55.73 21.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.755 HD23 HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -53.17 -54.37 45.45 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.663 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 31.3 Cg_exo -60.85 -4.24 3.45 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.15 1.9 . . . . 0.0 112.175 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.6 tptt -144.43 26.89 1.42 Allowed 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.096 0.474 . . . . 0.0 110.141 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.544 HG23 ' CD1' ' A' ' 81' ' ' TYR . 2.5 p -84.99 159.12 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.904 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' C ' ' H ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -144.57 148.75 41.27 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.021 179.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 72.9 Cg_endo -78.8 24.58 0.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.894 1.729 . . . . 0.0 112.029 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.7 HG21 ' HB3' ' A' ' 65' ' ' LYS . 23.6 mt 36.96 31.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.686 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.63 -12.92 0.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.036 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 61' ' ' ILE . . . 168.72 40.91 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.805 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.401 ' CB ' ' O ' ' A' ' 83' ' ' THR . 0.9 OUTLIER 55.24 117.46 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.997 0.427 . . . . 0.0 111.462 -179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.7 ' HB3' HG21 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -159.07 25.08 0.21 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.022 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.859 HG13 HD23 ' A' ' 109' ' ' LEU . 14.4 t 45.14 96.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.286 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.503 ' OG1' HD13 ' A' ' 61' ' ' ILE . 96.5 m -119.41 142.71 47.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.054 0.454 . . . . 0.0 111.892 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.448 ' HG3' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -90.36 133.93 34.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.426 179.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.51 ' HE3' ' CE2' ' A' ' 81' ' ' TYR . 0.6 OUTLIER -58.79 -30.09 67.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.126 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.67 30.08 16.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.971 0.415 . . . . 0.0 110.804 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HB3' ' HG2' ' A' ' 69' ' ' MET . 2.4 tpt -111.06 -13.2 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.097 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.75 55.1 1.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 110.428 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.56 ' HB3' HD22 ' A' ' 49' ' ' LEU . 9.5 mp -54.42 -43.38 71.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.818 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.614 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -135.44 159.18 40.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.735 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.436 ' N ' HG23 ' A' ' 74' ' ' ILE . 29.6 t70 -99.74 142.18 31.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.471 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.501 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 107.03 -34.7 5.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.127 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.486 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.5 176.14 8.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.789 0.328 . . . . 0.0 110.766 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 91.7 m-20 -110.98 162.24 15.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.069 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 3.5 t -121.97 101.49 7.59 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CE1' ' HG3' ' A' ' 68' ' ' LYS . 57.9 m-85 -108.67 147.07 32.45 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.575 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.743 ' CD2' HG13 ' A' ' 54' ' ' VAL . 33.9 p90 -137.66 123.14 19.62 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.091 0.472 . . . . 0.0 111.441 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.86 119.09 27.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.396 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.667 HG22 HG13 ' A' ' 91' ' ' VAL . 23.8 p -82.13 156.93 24.25 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.095 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 87' ' ' ASP . 18.6 t70 -53.41 152.12 5.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.084 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -28.49 53.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.891 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 23.55 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.654 0.264 . . . . 0.0 111.398 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 88' ' ' PRO . 1.0 OUTLIER -137.89 85.68 19.33 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.636 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 87' ' ' ASP . 15.0 Cg_endo -56.14 -18.19 22.6 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.523 2.149 . . . . 0.0 112.063 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.9 28.79 1.98 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.135 0.493 . . . . 0.0 110.216 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 13' ' ' LYS . 82.3 m -153.8 72.81 0.92 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.474 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.667 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -75.82 178.57 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.342 -179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.602 ' CD2' HG13 ' A' ' 11' ' ' VAL . 72.5 m-85 -152.15 88.48 1.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.116 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.076 HG11 HG12 ' A' ' 50' ' ' ILE . 44.0 t -90.91 125.14 43.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.003 0.43 . . . . 0.0 110.483 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.635 ' HB3' HD21 ' A' ' 109' ' ' LEU . 45.2 t -125.27 115.35 20.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.76 -179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.2 m-85 -82.97 122.7 28.63 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.88 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -122.6 129.8 52.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.205 0.526 . . . . 0.0 111.972 -179.044 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.671 HD22 ' HB ' ' A' ' 33' ' ' THR . 36.0 mt -44.13 124.33 3.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.019 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -45.3 -31.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.652 -179.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -63.88 -31.41 72.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.822 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.506 HG23 ' HD2' ' A' ' 101' ' ' PRO . 68.4 mt -76.39 138.2 67.67 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.049 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.506 ' HD2' HG23 ' A' ' 100' ' ' ILE . 19.4 Cg_endo -58.6 -164.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.501 2.134 . . . . 0.0 111.928 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.502 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -114.83 57.02 0.72 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.963 0.411 . . . . 0.0 111.138 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.767 HG23 ' CE2' ' A' ' 135' ' ' PHE . 6.3 tp -142.04 -35.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.605 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.843 HD21 HG23 ' A' ' 6' ' ' VAL . 5.0 tp -62.8 -62.57 5.45 Favored Pre-proline 0 C--N 1.332 -0.18 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.88 ' HD3' HG21 ' A' ' 96' ' ' THR . 3.2 Cg_endo -46.61 -30.4 8.81 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.442 2.094 . . . . 0.0 111.034 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.809 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 mp -71.35 -40.23 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.182 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.403 ' NH1' HD11 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -78.72 -25.81 44.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.455 179.174 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.649 HD11 ' HG ' ' A' ' 132' ' ' LEU . 15.8 mm -68.1 -46.02 82.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.457 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.859 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -72.01 -58.08 3.75 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -28.6 62.29 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.57 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -74.02 -47.3 19.29 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.921 -0.872 . . . . 0.0 110.921 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.886 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.9 mt -54.43 -26.07 28.55 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -71.89 -18.63 62.03 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.772 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 111' ' ' GLY . 0.8 OUTLIER -74.32 -21.37 59.74 Favored 'General case' 0 N--CA 1.457 -0.09 0 C-N-CA 120.734 -0.387 . . . . 0.0 110.047 179.371 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.501 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 8.9 m-85 -95.42 -49.98 5.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.858 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 115' ' ' TYR . 2.3 tt0 84.68 -22.72 0.19 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.729 ' O ' HD22 ' A' ' 123' ' ' LEU . 3.1 t -85.51 8.22 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.636 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 1.7 p-10 -69.84 55.43 0.13 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.833 0.349 . . . . 0.0 110.288 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.439 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -118.82 34.96 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.579 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -150.96 149.22 29.35 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.041 179.258 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.453 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.9 m-80 -69.63 25.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.609 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.9 tt0 -167.0 25.7 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.729 HD22 ' O ' ' A' ' 117' ' ' SER . 6.6 tt -128.0 -49.46 1.34 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.89 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -56.65 -45.19 81.78 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 177.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 2.1 m -46.39 -31.27 2.53 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.117 178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.77 -58.04 8.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.98 179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.886 ' HB2' HD23 ' A' ' 112' ' ' LEU . 2.6 m170 -58.76 -36.05 73.73 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.592 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.742 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.2 t -52.59 -48.53 47.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -71.29 -51.46 17.34 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.136 -1.031 . . . . 0.0 112.394 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -61.98 -20.92 64.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.756 0.312 . . . . 0.0 111.038 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.57 HD13 ' C ' ' A' ' 111' ' ' GLY . 66.8 mt -91.2 -27.64 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.742 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -63.8 -36.99 85.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.287 178.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -64.52 -34.2 77.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.265 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.87 -14.43 54.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.957 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.767 ' CE2' HG23 ' A' ' 103' ' ' ILE . 43.2 t80 -53.29 -60.16 3.64 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.027 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.555 ' HA ' HD12 ' A' ' 139' ' ' LEU . 27.6 p80 -56.31 -37.8 70.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.034 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.453 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 1.3 mm-40 -56.91 -30.9 64.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.161 0.505 . . . . 0.0 110.009 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.83 -34.93 44.78 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.968 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.765 HD11 ' CE1' ' A' ' 135' ' ' PHE . 25.3 mt -65.41 -32.46 74.1 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.627 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 82.9 t -75.49 -47.12 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.435 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.239 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -31.41 72.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.595 -1.184 . . . . 0.0 110.097 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.19 -29.74 69.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.729 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.707 ' O ' HD12 ' A' ' 147' ' ' LEU . 0.6 OUTLIER -57.29 -26.62 61.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.994 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -102.51 38.05 1.78 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.881 0.372 . . . . 0.0 111.061 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -114.23 -36.16 4.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.94 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 t -155.42 86.88 1.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 143' ' ' ARG . 12.8 mt -155.39 -176.88 6.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.835 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -59.41 -74.2 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.772 0.32 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.16 123.26 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.954 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.2 95.2 3.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.927 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' CD1' HG12 ' A' ' 100' ' ' ILE . 16.0 m-85 -60.05 -177.12 0.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -171.48 116.79 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.094 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.738 HG11 HG22 ' A' ' 9' ' ' VAL . 97.5 t -70.16 146.77 12.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.686 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.438 ' OG ' HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -81.72 -62.92 1.51 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.73 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 7.5 m-85 -143.48 111.78 6.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.738 HG22 HG11 ' A' ' 6' ' ' VAL . 3.2 t -106.35 97.35 5.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.577 178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.474 ' CG ' HG23 ' A' ' 17' ' ' THR . 2.5 tt0 -98.96 110.04 22.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.256 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.965 HG23 HD13 ' A' ' 124' ' ' LEU . 58.4 t -77.6 158.79 5.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.581 ' CD1' HG23 ' A' ' 93' ' ' VAL . 1.4 mp -147.16 120.41 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.547 ' HB2' HG12 ' A' ' 18' ' ' ILE . 0.4 OUTLIER -107.54 113.89 27.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.205 178.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 61.58 34.61 17.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.534 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.03 22.93 62.47 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.431 -0.89 . . . . 0.0 111.688 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -139.45 119.52 13.56 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.474 HG23 ' CG ' ' A' ' 10' ' ' GLU . 3.2 m -50.95 128.61 21.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.119 -0.491 . . . . 0.0 112.121 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -107.08 -42.02 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.617 0.723 . . . . 0.0 109.476 178.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.665 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -128.62 175.24 8.72 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.582 -1.19 . . . . 0.0 111.331 -179.057 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.512 ' N ' HD22 ' A' ' 124' ' ' LEU . 1.0 OUTLIER -170.11 124.16 0.74 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.385 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.509 ' HA ' ' HB3' ' A' ' 125' ' ' SER . 35.2 t -109.56 73.0 0.82 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.73 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -107.17 82.85 1.74 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.312 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -97.24 141.6 23.28 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.47 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.47 141.29 11.15 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.758 2.305 . . . . 0.0 112.04 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.449 ' HE1' HD11 ' A' ' 97' ' ' LEU . 37.2 p90 -179.16 143.67 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.861 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -100.89 54.29 0.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.896 179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER 71.12 3.15 4.54 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.877 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 55.75 -82.3 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 120.761 0.315 . . . . 0.0 111.317 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' N ' ' O ' ' A' ' 27' ' ' LYS . 1.3 tt0 -176.73 -39.61 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.816 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -72.08 -80.65 0.06 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.985 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.2 139.64 50.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.866 0.365 . . . . 0.0 110.861 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.559 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . 170.28 -166.82 40.0 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.6 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.746 ' HB ' HD22 ' A' ' 97' ' ' LEU . 89.1 m -155.23 -44.12 0.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 111.144 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.644 ' O ' HG22 ' A' ' 35' ' ' THR . 23.6 mt -59.83 153.13 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.297 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -175.07 -79.6 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.673 179.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.5 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.8 OUTLIER -134.48 60.66 1.69 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.801 0.334 . . . . 0.0 110.938 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.54 -43.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.972 0.415 . . . . 0.0 111.401 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 11.2 m120 -101.85 30.48 4.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.03 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -120.48 26.46 9.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.135 0.493 . . . . 0.0 110.691 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -114.08 -30.2 6.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.213 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.501 HG22 ' CE1' ' A' ' 46' ' ' PHE . 2.6 mm -56.31 113.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.458 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 1.007 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -78.56 151.54 77.44 Favored Pre-proline 0 CA--C 1.519 -0.24 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.489 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 87.2 Cg_exo -45.83 -22.37 1.24 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.099 1.866 . . . . 0.0 111.184 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.754 ' HB ' HG23 ' A' ' 42' ' ' THR . 66.1 t -66.24 -49.61 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.414 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.007 HD12 HG22 ' A' ' 42' ' ' THR . 2.3 mp -58.76 -31.97 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.524 ' O ' HD12 ' A' ' 50' ' ' ILE . 72.3 m-85 -80.09 -42.71 23.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.05 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.636 ' HD2' ' N ' ' A' ' 48' ' ' ASN . 0.0 OUTLIER -69.98 -23.9 63.24 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-O 121.162 0.505 . . . . 0.0 110.595 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.636 ' N ' ' HD2' ' A' ' 47' ' ' HIS . 4.9 t-20 -89.01 -33.83 17.04 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.392 -0.822 . . . . 0.0 108.857 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.69 HD22 ' HB3' ' A' ' 73' ' ' LEU . 4.9 mt -56.9 -61.36 2.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.065 HG22 HD23 ' A' ' 55' ' ' LEU . 5.3 mt -51.95 -62.43 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 113.615 -1.629 . . . . 0.0 110.431 177.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.623 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.05 -44.6 41.86 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.119 -178.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 48' ' ' ASN . 17.2 m-20 -91.15 -19.49 23.03 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.487 ' HB2' HD21 ' A' ' 73' ' ' LEU . 71.5 mmm -114.84 -61.18 1.79 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.836 HG22 ' HG3' ' A' ' 69' ' ' MET . 91.9 t -68.04 -56.05 14.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.065 HD23 HG22 ' A' ' 50' ' ' ILE . 2.7 mm? -46.54 -51.69 34.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 13.2 Cg_exo -69.91 3.22 2.97 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.519 2.146 . . . . 0.0 112.07 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.13 22.96 1.36 Allowed 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.985 0.422 . . . . 0.0 110.334 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.588 HG23 ' CD1' ' A' ' 81' ' ' TYR . 3.0 p -86.73 154.84 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.716 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 61' ' ' ILE . 3.4 m -129.82 148.0 67.73 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.872 178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HA ' HG21 ' A' ' 83' ' ' THR . 91.4 Cg_endo -78.15 23.33 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.668 1.579 . . . . 0.0 112.014 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.738 ' H ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER 41.73 -168.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.157 -0.928 . . . . 0.0 111.404 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.596 ' H ' HG22 ' A' ' 61' ' ' ILE . 16.4 tptt -96.29 -17.35 20.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.07 0.462 . . . . 0.0 110.175 179.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.72 40.59 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.517 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 71.6 74.39 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.296 . . . . 0.0 110.448 -179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.721 ' H ' HG21 ' A' ' 61' ' ' ILE . 6.9 mmtt -116.0 21.3 13.87 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.839 HG13 HD23 ' A' ' 109' ' ' LEU . 29.3 t 44.72 96.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.5 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.413 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 89.7 m -103.71 138.19 40.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.781 0.324 . . . . 0.0 111.65 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 8.6 ttpt -94.25 135.79 35.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.875 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.836 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -53.81 -29.56 41.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m 51.28 27.21 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.05 0.452 . . . . 0.0 110.816 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 14.0 tpt -112.7 -13.28 13.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 62.67 69.81 0.58 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.977 0.418 . . . . 0.0 110.599 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.69 ' HB3' HD22 ' A' ' 49' ' ' LEU . 6.8 mp -70.7 -49.65 44.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.617 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -126.69 158.34 37.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.606 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.427 ' N ' HG23 ' A' ' 74' ' ' ILE . 24.2 t0 -99.34 141.12 32.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.431 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.59 -34.06 5.71 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.098 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -131.58 168.89 16.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.828 0.347 . . . . 0.0 111.105 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 64.9 m-20 -112.75 125.76 54.68 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.566 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 10.7 m -86.17 121.65 29.07 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 74.7 m-85 -124.02 164.61 19.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.344 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.707 ' CD2' HG13 ' A' ' 54' ' ' VAL . 29.9 p90 -154.98 121.46 5.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.019 0.438 . . . . 0.0 111.149 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -125.08 119.26 28.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.378 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 23.8 p -85.31 143.53 28.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.9 0.381 . . . . 0.0 111.073 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 2.8 t0 -46.82 135.97 8.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.366 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -58.11 -30.07 66.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.258 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.9 18.9 7.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.624 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -154.98 92.16 2.86 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.619 0.247 . . . . 0.0 111.441 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.07 -17.0 53.87 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.325 2.017 . . . . 0.0 111.779 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp -95.13 33.55 1.52 Allowed 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.413 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 90' ' ' THR . 16.2 m -152.87 69.57 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.535 0.683 . . . . 0.0 109.751 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 92' ' ' TYR . 1.2 t -65.91 173.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.148 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.605 ' H ' HG12 ' A' ' 91' ' ' VAL . 56.1 m-85 -147.1 95.04 2.5 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.224 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.964 HG21 HG21 ' A' ' 50' ' ' ILE . 21.5 t -86.21 137.21 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.918 0.389 . . . . 0.0 111.542 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.801 ' HB2' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -132.08 128.79 38.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.798 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.497 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 6.5 m-85 -109.97 85.64 2.14 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.373 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.945 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -91.31 128.2 37.04 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.156 0.503 . . . . 0.0 111.179 -179.086 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.746 HD22 ' HB ' ' A' ' 33' ' ' THR . 13.1 mt -46.35 127.35 8.92 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.213 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.24 -30.59 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.695 -179.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.05 -32.22 70.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.67 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.431 HG23 ' HD2' ' A' ' 101' ' ' PRO . 43.0 mt -83.31 136.94 42.67 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.808 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.431 ' HD2' HG23 ' A' ' 100' ' ' ILE . 19.4 Cg_endo -58.28 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.501 2.134 . . . . 0.0 112.311 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.485 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -111.56 63.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.011 0.434 . . . . 0.0 110.938 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.487 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 5.5 tp -145.13 -43.26 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.047 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.012 HD11 ' HG ' ' A' ' 132' ' ' LEU . 2.8 tp -58.08 -60.21 10.83 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.945 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.9 Cg_endo -47.28 -35.39 20.37 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.641 2.227 . . . . 0.0 111.18 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.793 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.5 mp -67.02 -38.07 80.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.775 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.526 ' O ' HG21 ' A' ' 131' ' ' ILE . 21.5 mmm180 -79.42 -26.95 41.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.177 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.791 HG23 HG13 ' A' ' 128' ' ' VAL . 22.6 mm -62.97 -47.87 90.73 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.129 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.069 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.839 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -70.73 -56.34 6.62 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.0 179.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 32.7 t -56.3 -26.15 51.04 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.568 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -74.38 -47.17 17.63 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.268 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.955 HD23 ' HB2' ' A' ' 127' ' ' HIS . 9.9 mt -54.98 -31.33 60.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -72.08 -17.72 61.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.253 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -73.37 -22.38 60.28 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.28 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.514 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 5.5 m-85 -85.68 -93.66 0.08 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.857 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 8.0 tt0 161.89 -25.69 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.674 0.273 . . . . 0.0 111.031 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.23 -89.48 0.24 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.652 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.518 ' N ' HD22 ' A' ' 123' ' ' LEU . 2.0 p-10 40.87 31.37 0.12 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.831 0.348 . . . . 0.0 110.89 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -112.5 34.38 4.37 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.502 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -145.99 151.58 38.0 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.606 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.449 ' HA ' ' N ' ' A' ' 20' ' ' SER . 4.9 p30 -72.0 22.16 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.49 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.6 tt0 -165.71 26.93 0.05 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.61 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.2 tt -130.0 -50.23 1.12 Allowed 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.44 -179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.965 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -54.36 -46.89 73.09 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 11.7 p -47.48 -29.65 2.9 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.544 178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.45 -59.1 5.76 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.114 179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.955 ' HB2' HD23 ' A' ' 112' ' ' LEU . 5.5 m170 -55.99 -38.5 70.53 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.527 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.841 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.0 t -49.61 -51.14 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -64.95 -48.65 68.94 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.152 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -20.97 66.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.718 0.294 . . . . 0.0 111.091 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.568 HD13 ' HA3' ' A' ' 111' ' ' GLY . 31.3 mt -90.66 -29.25 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 1.012 ' HG ' HD11 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -62.02 -42.18 98.88 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.153 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -66.72 -32.19 73.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.658 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -80.04 -12.66 59.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.171 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.973 ' CE2' HD21 ' A' ' 139' ' ' LEU . 5.9 t80 -47.67 -52.12 19.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.923 0.392 . . . . 0.0 111.105 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.551 ' HA ' HD12 ' A' ' 139' ' ' LEU . 94.5 m-70 -56.65 -42.36 78.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.007 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -51.08 -32.25 21.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.99 0.424 . . . . 0.0 110.237 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -78.15 -35.41 48.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.914 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.973 HD21 ' CE2' ' A' ' 135' ' ' PHE . 24.6 mt -66.09 -33.07 74.95 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.796 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.47 -47.48 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.076 178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -33.28 74.04 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.891 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -34.28 77.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.276 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.78 63.71 2.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.828 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.45 ' N ' HD13 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -177.85 -42.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.954 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -80.07 135.45 36.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.4 t 43.6 54.98 5.2 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.47 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.45 HD13 ' N ' ' A' ' 144' ' ' ASN . 1.1 tp -85.37 110.99 19.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.923 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -79.86 71.55 6.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.87 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 73.1 m . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.763 -179.892 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptp . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.741 0.305 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HD2' ' CG ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -74.0 154.09 39.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.45 76.3 1.68 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.853 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CD2' HG12 ' A' ' 100' ' ' ILE . 5.8 m-85 -78.12 -175.23 4.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.76 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.678 ' HA ' HD21 ' A' ' 132' ' ' LEU . 3.9 t-20 -171.21 110.13 0.32 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.24 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.806 HG21 HG13 ' A' ' 108' ' ' ILE . 51.7 t -62.33 133.11 28.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.617 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.481 ' HB2' ' CD1' ' A' ' 8' ' ' TYR . 0.3 OUTLIER -62.48 -61.43 2.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.111 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.66 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 6.2 m-85 -148.56 112.41 5.12 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.805 HG22 HG11 ' A' ' 6' ' ' VAL . 4.7 t -105.19 101.45 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.536 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.611 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.1 tt0 -109.96 121.58 45.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.844 0.354 . . . . 0.0 111.726 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.916 HG23 HD13 ' A' ' 124' ' ' LEU . 98.1 t -80.65 161.44 3.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.573 HG21 HD11 ' A' ' 55' ' ' LEU . 2.9 mp -142.89 113.21 2.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.54 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -98.95 110.29 22.92 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.892 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m120 61.86 34.45 17.02 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.149 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.43 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 78.06 26.1 60.72 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.377 -0.916 . . . . 0.0 111.032 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' N ' HG23 ' A' ' 12' ' ' ILE . 64.8 mm-40 -138.23 114.25 10.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.955 0.407 . . . . 0.0 109.938 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.611 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -49.46 130.84 20.57 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.959 -178.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.54 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -113.61 -47.11 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 109.993 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.765 ' OG ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -118.44 172.01 7.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.224 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.58 ' N ' HD22 ' A' ' 124' ' ' LEU . 58.0 p -170.16 125.99 0.79 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 15.8 t -113.24 69.68 0.7 Allowed 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.66 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -105.3 90.59 3.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.933 -178.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.07 139.94 21.87 Favored Pre-proline 0 C--N 1.333 -0.146 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.393 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -80.31 147.84 18.43 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.646 2.231 . . . . 0.0 112.261 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' HZ ' ' HA ' ' A' ' 7' ' ' SER . 38.5 p90 178.77 136.87 0.09 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.792 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 22.3 mt-30 -99.1 60.37 1.2 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.988 0.423 . . . . 0.0 110.707 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.0 ttmt 64.17 129.97 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.819 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -85.17 -80.36 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.191 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -134.59 75.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.154 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 55.2 23.84 5.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.24 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.438 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . 4.3 m-85 -123.82 31.3 5.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.719 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.618 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . -150.21 -152.55 5.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.602 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.773 ' HB ' HD22 ' A' ' 97' ' ' LEU . 94.5 m -159.73 -41.93 0.05 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.693 0.282 . . . . 0.0 111.089 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.732 HG13 HD21 ' A' ' 97' ' ' LEU . 6.3 mt -59.41 141.24 16.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.329 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -173.04 -78.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.812 179.18 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.499 ' N ' ' OG1' ' A' ' 35' ' ' THR . 26.0 m -131.85 61.53 1.65 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.784 0.326 . . . . 0.0 111.015 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 36' ' ' SER . . . 176.79 -35.3 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.568 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 77' ' ' PHE . 10.4 m120 -110.8 32.26 5.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.508 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.43 26.77 6.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.068 0.461 . . . . 0.0 110.666 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -121.64 29.22 7.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.771 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.792 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.1 mt -124.5 122.18 63.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.417 -179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.932 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -83.14 151.34 63.06 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.459 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.493 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 85.5 Cg_exo -45.29 -22.92 1.01 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.27 1.98 . . . . 0.0 111.697 179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.761 ' HB ' HG23 ' A' ' 42' ' ' THR . 47.4 t -66.56 -44.74 89.95 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.071 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.932 HD12 HG22 ' A' ' 42' ' ' THR . 1.8 mp -59.1 -32.01 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.792 ' CE2' HG22 ' A' ' 41' ' ' ILE . 38.6 m-85 -81.58 -43.47 18.62 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.059 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.65 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.66 -29.13 70.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.346 -179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.11 -28.37 19.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.504 HD11 HG13 ' A' ' 74' ' ' ILE . 3.3 mt -62.68 -60.39 3.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.003 HG12 HG11 ' A' ' 93' ' ' VAL . 5.3 mt -51.79 -63.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 113.348 -1.751 . . . . 0.0 109.73 177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.65 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.27 -43.43 61.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.136 -1.393 . . . . 0.0 113.18 -179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -90.64 -15.65 30.06 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.574 ' HB2' HD21 ' A' ' 73' ' ' LEU . 65.2 mmm -123.57 -69.76 0.8 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.803 HG13 ' CD1' ' A' ' 81' ' ' TYR . 93.0 t -52.33 -51.7 30.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.694 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.9 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -53.87 -59.15 10.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.669 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 30.4 Cg_endo -64.27 3.93 0.69 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.093 1.862 . . . . 0.0 112.487 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.62 22.7 1.63 Allowed 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.099 0.476 . . . . 0.0 110.129 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.482 HG23 ' CD2' ' A' ' 81' ' ' TYR . 4.6 p -87.8 166.88 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.469 ' H ' HG22 ' A' ' 58' ' ' VAL . 34.6 m -148.67 148.04 26.75 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.244 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.413 ' O ' ' O ' ' A' ' 61' ' ' ILE . 64.3 Cg_endo -78.18 25.73 0.51 Allowed 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.048 1.832 . . . . 0.0 112.762 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.542 HG21 ' C ' ' A' ' 64' ' ' ASN . 3.4 mp 53.04 160.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.315 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' N ' HG22 ' A' ' 61' ' ' ILE . 0.2 OUTLIER -117.74 -65.81 1.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.055 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.4 31.8 3.2 Favored Glycine 0 CA--C 1.519 0.292 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.602 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.542 ' C ' HG21 ' A' ' 61' ' ' ILE . 6.8 t30 -146.5 -146.0 0.18 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.67 141.46 0.15 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.597 0.237 . . . . 0.0 110.738 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 109' ' ' LEU . 11.8 t 66.35 72.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.101 0 CA-C-O 120.839 0.352 . . . . 0.0 110.457 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.5 m -93.31 144.74 25.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 111.694 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HD2' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -90.9 133.72 35.02 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.499 179.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.671 ' HG3' HG22 ' A' ' 54' ' ' VAL . 10.7 mmm -54.4 -32.51 57.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.846 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.9 m 58.34 27.32 15.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.132 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 40.3 mmm -107.71 -15.68 14.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.03 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 66.89 61.8 0.51 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.896 0.379 . . . . 0.0 110.374 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.574 HD21 ' HB2' ' A' ' 53' ' ' MET . 7.8 mp -62.44 -46.95 86.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.131 0.491 . . . . 0.0 110.382 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.721 HD13 HD12 ' A' ' 41' ' ' ILE . 1.5 mt -136.47 154.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.447 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.403 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 6.3 t0 -94.06 139.47 30.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.629 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.674 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 105.06 -32.42 7.51 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.506 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.585 ' O ' HG13 ' A' ' 98' ' ' VAL . 6.2 m-85 -110.31 -179.47 3.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.03 0.443 . . . . 0.0 111.876 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -129.4 113.17 14.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.936 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.1 p -83.66 108.79 16.97 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.458 ' O ' HG13 ' A' ' 93' ' ' VAL . 47.4 m-85 -121.97 155.73 34.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.199 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.803 ' CD1' HG13 ' A' ' 54' ' ' VAL . 17.8 p90 -147.57 137.64 22.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.06 0.457 . . . . 0.0 111.263 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.572 ' OG ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -140.85 117.66 11.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.775 -179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 6.8 p -82.53 146.89 28.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.802 0.334 . . . . 0.0 110.786 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -46.52 138.4 5.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.0 0.429 . . . . 0.0 111.209 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 11.2 p30 -51.91 -24.93 7.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.981 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.52 20.52 1.69 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -146.48 93.41 4.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.66 0.267 . . . . 0.0 111.129 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -63.3 -14.59 43.01 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.309 2.006 . . . . 0.0 111.934 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.13 30.98 2.27 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.313 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 90' ' ' THR . 19.3 m -154.58 71.09 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -70.07 175.96 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.668 -179.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.557 ' H ' HG12 ' A' ' 91' ' ' VAL . 43.3 m-85 -151.12 97.88 2.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.931 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.003 HG11 HG12 ' A' ' 50' ' ' ILE . 24.5 t -101.44 127.13 55.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.242 0.544 . . . . 0.0 111.692 -179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.74 ' HB2' HD21 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -114.95 117.43 30.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.06 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.54 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 1.1 m-85 -92.66 73.92 5.03 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.909 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.65 -174.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.012 0.434 . . . . 0.0 111.22 -178.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.773 HD22 ' HB ' ' A' ' 33' ' ' THR . 57.4 mt -101.1 126.08 47.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.288 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 76' ' ' GLY . 1.0 OUTLIER -42.61 -36.13 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.76 -179.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.56 -38.83 92.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.493 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 101' ' ' PRO . 86.1 mt -65.28 139.07 97.36 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.803 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 100' ' ' ILE . 16.6 Cg_endo -57.48 -171.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.528 2.152 . . . . 0.0 112.277 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.22 67.39 0.65 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.558 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 8.1 tp -154.66 -38.36 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.633 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.731 ' HG ' HD11 ' A' ' 108' ' ' ILE . 19.1 tp -57.7 -61.03 8.09 Favored Pre-proline 0 C--N 1.331 -0.198 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.167 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.909 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.6 Cg_endo -48.39 -34.98 26.85 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.575 2.183 . . . . 0.0 111.08 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.846 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.1 mp -67.02 -34.54 70.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.939 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.614 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.92 -27.76 33.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 179.127 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.806 HG13 HG21 ' A' ' 6' ' ' VAL . 7.9 mm -64.19 -46.69 92.73 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.441 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -74.92 -49.59 19.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.188 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.1 t -62.97 -27.91 69.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -78.15 -46.37 9.28 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.826 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.6 mt -57.39 -32.04 66.42 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -73.51 -17.07 61.26 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.929 178.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.69 -22.4 59.95 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.432 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.499 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 6.8 m-85 -85.02 -94.36 0.08 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.797 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 2.7 tt0 159.25 -23.98 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 122.346 0.259 . . . . 0.0 110.856 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.9 m -92.12 -93.06 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.681 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.524 ' N ' HD22 ' A' ' 123' ' ' LEU . 2.0 p30 41.27 30.94 0.14 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.823 0.344 . . . . 0.0 110.991 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.51 31.17 5.81 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.504 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.47 157.46 44.23 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.24 178.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HA ' ' N ' ' A' ' 20' ' ' SER . 3.6 p30 -78.13 20.73 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.081 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.0 tp10 -163.63 25.48 0.08 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.639 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt -126.35 -49.06 1.55 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.916 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.93 -45.68 78.69 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.434 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -45.59 -30.61 1.54 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.178 178.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.45 -57.85 11.01 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.956 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.826 ' HB2' HD23 ' A' ' 112' ' ' LEU . 4.4 m170 -58.87 -37.3 76.21 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.641 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.68 HG13 HG23 ' A' ' 108' ' ' ILE . 43.6 t -51.78 -45.2 37.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.414 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.3 -45.7 37.6 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 119.9 -1.143 . . . . 0.0 112.153 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -66.17 -22.52 66.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.869 0.366 . . . . 0.0 110.946 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.614 HG21 ' O ' ' A' ' 107' ' ' ARG . 32.8 mt -90.32 -28.09 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.725 HD11 HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -63.6 -42.52 98.22 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.355 179.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.18 -40.45 74.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.5 m -81.41 -15.86 53.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.151 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.981 ' CE2' HD11 ' A' ' 139' ' ' LEU . 0.3 OUTLIER -53.3 -57.9 8.95 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.991 -179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.43 ' CE1' ' HB3' ' A' ' 2' ' ' LYS . 97.7 m-70 -61.21 -45.9 92.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.714 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -50.0 -29.11 7.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.938 0.399 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 0.8 OUTLIER -77.62 -36.39 51.71 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.11 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.981 HD11 ' CE2' ' A' ' 135' ' ' PHE . 19.2 mt -67.08 -29.36 69.11 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.247 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.6 t -77.62 -48.03 24.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.504 0.668 . . . . 0.0 109.522 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -65.43 -33.23 75.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.12 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -64.38 -33.23 75.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.267 179.352 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.48 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -61.29 -25.45 67.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.99 179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -107.23 55.67 0.65 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.886 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -145.92 101.3 3.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.86 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.8 t 43.15 92.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 143' ' ' ARG . 0.7 OUTLIER -121.56 141.59 50.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.739 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -130.91 33.14 4.24 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.791 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 19.9 p . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.323 -0.846 . . . . 0.0 110.956 179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mtm . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.953 0.406 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 59.08 107.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -140.34 -169.63 2.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.686 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 2.7 m-85 -100.15 152.44 20.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.971 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 179.77 107.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.176 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.974 HG23 HD21 ' A' ' 104' ' ' LEU . 2.9 t -68.03 144.74 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.47 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.451 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -90.26 -61.68 1.63 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.796 -179.235 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.682 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 5.1 m-85 -131.37 141.77 49.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.742 ' O ' HD21 ' A' ' 124' ' ' LEU . 0.2 OUTLIER -148.69 100.22 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 12.0 pt-20 -115.02 138.41 50.89 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 121.095 0.474 . . . . 0.0 111.496 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.863 HG23 HD13 ' A' ' 124' ' ' LEU . 53.0 t -90.86 151.59 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.893 HD13 HG23 ' A' ' 93' ' ' VAL . 4.1 mp -131.53 123.8 53.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.556 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 2.7 tttt -113.09 114.83 27.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.54 33.75 8.39 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.618 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.573 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 81.68 24.12 56.63 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.939 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.791 ' O ' HG23 ' A' ' 12' ' ' ILE . 1.3 tt0 -114.58 -142.91 0.38 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.647 0.26 . . . . 0.0 110.583 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 1.8 m -153.68 75.26 1.03 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.921 0.391 . . . . 0.0 110.769 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -58.49 -43.08 86.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.704 -179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.686 ' OG ' HD13 ' A' ' 124' ' ' LEU . 4.0 p -122.41 170.01 10.39 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.865 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 30.6 m -168.23 118.27 0.77 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.0 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.582 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 15.8 t -111.48 68.92 0.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.682 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -116.1 87.72 2.74 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 1.2 mp0 -125.2 148.76 61.72 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.84 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.36 140.46 15.33 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.788 2.325 . . . . 0.0 111.359 179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -137.82 -33.24 0.72 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.776 -179.367 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.565 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 2.5 tt0 56.0 53.2 9.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER 38.16 91.66 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.529 -179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -91.76 97.04 10.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.593 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 65.54 -72.22 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.915 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -83.44 143.6 30.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.971 0.415 . . . . 0.0 111.616 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.657 ' CE2' HD12 ' A' ' 97' ' ' LEU . 1.7 t80 59.71 158.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.263 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' HA2' ' CB ' ' A' ' 27' ' ' LYS . . . -152.69 123.5 1.46 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.906 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.717 HG21 HD22 ' A' ' 97' ' ' LEU . 19.9 m -163.93 -73.12 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.898 0.38 . . . . 0.0 111.365 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.594 HG13 HD21 ' A' ' 97' ' ' LEU . 10.6 mt -77.76 151.1 5.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.498 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.578 HG22 ' C ' ' A' ' 34' ' ' ILE . 0.6 OUTLIER -174.31 -84.8 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.178 178.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.488 ' N ' ' OG1' ' A' ' 35' ' ' THR . 65.8 m -128.25 42.87 3.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.778 0.323 . . . . 0.0 110.93 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.88 -46.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.121 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 73.7 m-20 -106.21 30.57 5.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.871 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.29 27.54 7.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.953 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -107.95 -36.27 6.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.772 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.634 HD12 HD13 ' A' ' 74' ' ' ILE . 1.0 OUTLIER -56.58 119.83 2.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.68 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 1.08 HG22 HD12 ' A' ' 45' ' ' ILE . 13.2 t -81.14 157.23 71.23 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.389 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.618 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 54.2 Cg_exo -50.88 -21.74 8.96 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 121.917 1.744 . . . . 0.0 111.051 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.703 ' HB ' HG23 ' A' ' 42' ' ' THR . 48.1 t -66.16 -47.8 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.402 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.08 HD12 HG22 ' A' ' 42' ' ' THR . 1.9 mp -58.58 -33.3 48.13 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.305 0.574 . . . . 0.0 109.687 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 41' ' ' ILE . 68.3 m-85 -81.36 -40.84 22.9 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.732 178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.658 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -67.09 -27.28 67.22 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.872 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 -88.28 -28.64 20.96 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.656 HD22 ' HB3' ' A' ' 73' ' ' LEU . 3.8 mt -61.47 -60.23 4.03 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.014 HG22 HD23 ' A' ' 55' ' ' LEU . 6.4 mt -51.52 -64.69 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 113.534 -1.666 . . . . 0.0 109.723 177.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.594 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.5 OUTLIER -49.8 -40.37 41.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.661 -179.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -91.14 -16.62 27.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.495 ' N ' ' O ' ' A' ' 49' ' ' LEU . 69.3 mmm -124.64 -68.69 0.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 81' ' ' TYR . 90.5 t -51.99 -51.52 29.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.697 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.014 HD23 HG22 ' A' ' 50' ' ' ILE . 1.8 mm? -56.59 -58.19 18.76 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.849 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 28.0 Cg_endo -63.25 1.73 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.113 1.875 . . . . 0.0 112.662 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HB3' ' HE1' ' A' ' 69' ' ' MET . 3.2 tptt -147.24 26.35 1.07 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-O 121.106 0.479 . . . . 0.0 109.942 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.7 p -85.27 167.74 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.895 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.5 ' H ' HG22 ' A' ' 58' ' ' VAL . 17.3 m -137.74 146.34 52.48 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.157 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 73.2 Cg_endo -75.72 29.75 0.38 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.121 1.881 . . . . 0.0 112.19 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.779 HD12 ' H ' ' A' ' 65' ' ' LYS . 31.6 mm 41.72 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.217 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.0 -25.75 17.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.573 179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.29 40.22 0.1 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.988 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -126.64 -62.76 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 0.0 111.166 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.779 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER 68.74 99.78 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.979 -179.82 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.849 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.5 t 76.06 65.06 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.664 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.9 m -92.82 135.38 34.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.436 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.455 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 3.2 tttt -87.09 125.6 34.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.414 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.565 ' HG2' HD11 ' A' ' 73' ' ' LEU . 1.4 ttm -52.34 -36.08 52.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.7 m 58.47 24.48 11.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.649 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.519 ' CG ' ' HG2' ' A' ' 69' ' ' MET . 17.3 mmt -101.2 6.43 43.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.775 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 55.39 53.05 10.38 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.987 0.422 . . . . 0.0 110.69 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.656 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.2 mp -59.98 -32.83 71.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.623 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.634 HD13 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -153.42 151.49 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.673 179.615 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -95.71 138.9 32.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.606 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 111.31 -32.8 6.22 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.204 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.483 ' HD2' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -131.74 175.46 9.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.342 . . . . 0.0 111.004 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.2 OUTLIER -119.56 123.92 45.13 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.749 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 3.8 t -82.01 101.03 10.06 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 68' ' ' LYS . 19.6 m-85 -109.26 126.09 52.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.491 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.537 ' HB3' HG11 ' A' ' 54' ' ' VAL . 52.5 p90 -120.12 135.64 54.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.072 0.463 . . . . 0.0 111.28 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.616 ' HG ' ' HB2' ' A' ' 92' ' ' TYR . 0.7 OUTLIER -138.91 116.29 11.2 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.418 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.885 HG22 HG13 ' A' ' 91' ' ' VAL . 74.5 p -86.11 154.16 21.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.848 0.356 . . . . 0.0 111.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -49.6 155.21 0.83 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.208 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -68.25 -20.85 64.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.716 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.2 22.27 0.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.593 0.235 . . . . 0.0 111.611 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -143.59 89.88 7.31 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.995 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.2 -16.93 43.22 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.362 2.041 . . . . 0.0 111.982 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -94.67 30.59 2.0 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.447 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 90' ' ' THR . 22.0 m -154.84 73.23 0.88 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.806 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.885 HG13 HG22 ' A' ' 83' ' ' THR . 0.7 OUTLIER -75.96 177.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.447 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.619 ' H ' HG12 ' A' ' 91' ' ' VAL . 36.2 m-85 -149.42 106.89 3.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.979 HG21 HG21 ' A' ' 50' ' ' ILE . 44.3 t -104.89 137.59 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.19 0.519 . . . . 0.0 111.754 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.565 ' SG ' HG13 ' A' ' 9' ' ' VAL . 45.3 t -138.7 110.27 7.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.727 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.534 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.5 m-85 -87.0 83.93 7.41 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.925 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -82.01 130.18 35.0 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.885 -178.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.717 HD22 HG21 ' A' ' 33' ' ' THR . 87.0 mt -46.61 126.88 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.698 179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -44.45 -33.06 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -178.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.433 ' HB2' ' HH ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -61.03 -18.18 56.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.342 -179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.496 HG13 ' OH ' ' A' ' 31' ' ' TYR . 4.7 mt -87.26 136.47 33.54 Favored Pre-proline 0 N--CA 1.461 0.113 0 CA-C-O 120.501 0.191 . . . . 0.0 110.773 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 4' ' ' PHE . 38.0 Cg_exo -59.56 -157.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.304 2.003 . . . . 0.0 111.645 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.415 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.4 OUTLIER -112.83 63.7 0.63 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.693 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.547 ' HA ' HD13 ' A' ' 106' ' ' ILE . 3.3 tp -150.91 -40.81 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.843 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.033 HD11 HD11 ' A' ' 108' ' ' ILE . 29.1 tp -58.14 -62.28 5.83 Favored Pre-proline 0 C--N 1.331 -0.216 0 C-N-CA 120.331 -0.547 . . . . 0.0 110.125 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.925 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.7 Cg_endo -49.05 -27.32 11.85 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.265 1.976 . . . . 0.0 111.486 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.849 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.3 mp -76.15 -34.68 26.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.633 ' O ' HG21 ' A' ' 131' ' ' ILE . 4.0 mmp_? -84.07 -27.51 28.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.395 179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.033 HD11 HD11 ' A' ' 104' ' ' LEU . 7.7 mm -71.35 -51.6 32.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.812 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.749 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -66.63 -55.71 14.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.595 178.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.4 t -60.78 -25.86 66.84 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.667 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -71.32 -50.8 19.96 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.431 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.986 HD23 ' HB2' ' A' ' 127' ' ' HIS . 5.3 mt -52.94 -27.84 20.77 Favored 'General case' 0 N--CA 1.461 0.106 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.82 -21.47 57.26 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.604 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.416 ' HG3' ' CD1' ' A' ' 115' ' ' TYR . 0.4 OUTLIER -75.18 -19.53 59.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.906 -0.317 . . . . 0.0 110.452 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 116' ' ' GLU . 29.7 m-85 -82.12 -92.57 0.06 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.71 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 16.0 tt0 157.94 -25.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 122.697 0.399 . . . . 0.0 110.621 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -92.89 -92.75 0.16 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.567 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.529 ' N ' HD22 ' A' ' 123' ' ' LEU . 4.0 p-10 40.61 31.26 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.96 0.409 . . . . 0.0 110.98 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.93 33.64 4.48 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.487 HG23 HD13 ' A' ' 123' ' ' LEU . 0.1 OUTLIER -144.93 159.62 42.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.751 0.31 . . . . 0.0 110.421 179.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.433 ' HA ' ' N ' ' A' ' 20' ' ' SER . 6.1 p30 -78.78 19.43 0.51 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.299 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -163.41 24.82 0.08 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-O 121.054 0.454 . . . . 0.0 109.799 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.623 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt -124.53 -49.66 1.77 Allowed 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.463 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.863 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.23 -47.43 75.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.515 ' H ' HD23 ' A' ' 124' ' ' LEU . 96.6 p -46.23 -31.94 2.76 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.301 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -55.36 34.09 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.07 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.986 ' HB2' HD23 ' A' ' 112' ' ' LEU . 7.8 m170 -58.3 -37.29 74.75 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.549 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.784 HG13 ' CG2' ' A' ' 108' ' ' ILE . 46.9 t -50.48 -49.89 23.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.359 -0.382 . . . . 0.0 109.976 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -69.72 -49.24 37.57 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.843 -1.17 . . . . 0.0 112.334 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.8 mm100 -64.18 -18.77 64.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.645 0.26 . . . . 0.0 111.246 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.667 HD13 ' HA3' ' A' ' 111' ' ' GLY . 53.6 mt -90.71 -28.43 4.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.712 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -64.1 -40.71 96.81 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.06 178.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.75 -32.4 74.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.433 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.99 -15.92 37.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.927 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.983 ' CZ ' HD21 ' A' ' 139' ' ' LEU . 34.3 t80 -50.81 -38.41 48.38 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.714 0.293 . . . . 0.0 110.919 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.497 ' HA ' HD12 ' A' ' 139' ' ' LEU . 9.5 m170 -60.2 -45.92 91.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.616 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -50.35 -29.41 9.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.084 179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -78.36 -35.99 46.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.888 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.983 HD21 ' CZ ' ' A' ' 135' ' ' PHE . 30.9 mt -63.72 -35.03 79.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.307 0.575 . . . . 0.0 109.558 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 79.5 t -74.62 -47.78 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.01 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -61.37 -30.08 70.31 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.581 -1.191 . . . . 0.0 109.989 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -16.35 63.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.701 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.654 ' O ' HD11 ' A' ' 147' ' ' LEU . 2.9 ttp180 -90.55 21.89 3.74 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.367 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -127.16 -43.93 1.62 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.703 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -60.23 -77.77 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -111.97 127.98 56.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.872 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.654 HD11 ' O ' ' A' ' 143' ' ' ARG . 5.6 mp -124.23 179.57 4.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t30 60.3 30.96 20.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.791 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.851 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.715 0.293 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 61.38 113.2 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.837 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 tpp180 -88.61 -167.01 1.75 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.463 ' CD2' HG12 ' A' ' 100' ' ' ILE . 2.3 m-85 -142.84 -178.23 5.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.984 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.47 118.79 4.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.301 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.806 HG11 ' CG2' ' A' ' 9' ' ' VAL . 0.5 OUTLIER -71.98 146.07 11.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.438 179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.462 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -83.44 -59.9 2.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.0 111.563 -179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.654 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 11.4 m-85 -146.66 125.11 12.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.732 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.806 ' CG2' HG11 ' A' ' 6' ' ' VAL . 2.4 t -120.19 93.76 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.0 OUTLIER -100.95 116.83 33.73 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.207 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.033 HG23 HD13 ' A' ' 124' ' ' LEU . 95.0 t -89.28 136.34 23.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.668 HG21 HD11 ' A' ' 55' ' ' LEU . 2.2 mp -114.2 119.11 60.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HB2' HD13 ' A' ' 18' ' ' ILE . 3.5 tttt -104.86 107.88 19.08 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.083 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 61.96 37.71 14.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.629 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.15 26.24 60.28 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.407 -0.902 . . . . 0.0 111.637 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.72 115.9 6.12 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.0 109.993 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 24.7 m -47.1 127.74 10.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.208 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.599 ' CD1' HG12 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -99.91 -42.38 10.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 120' ' ' THR . 94.4 p -132.7 177.12 7.88 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.592 ' N ' HD22 ' A' ' 124' ' ' LEU . 0.3 OUTLIER -169.85 125.8 0.83 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.062 0.458 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.561 ' N ' HD21 ' A' ' 124' ' ' LEU . 36.5 t -107.64 69.79 0.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.825 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.654 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -106.12 84.83 2.1 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.467 -179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.83 142.96 25.91 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.548 -179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -82.59 145.63 13.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.819 2.346 . . . . 0.0 112.253 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.3 p90 179.19 115.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.811 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 3.5 pt20 -78.8 59.15 2.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.753 0.311 . . . . 0.0 111.193 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.5 tttt 58.22 162.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.082 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 66.9 m-80 -114.23 43.71 1.82 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.857 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 45.36 35.44 1.88 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.393 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -175.89 -55.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.807 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -123.5 102.69 8.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.947 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 162.46 -171.16 38.25 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.534 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.743 ' HB ' HD22 ' A' ' 97' ' ' LEU . 23.2 m -163.89 -42.46 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 110.88 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.705 HG13 HD21 ' A' ' 97' ' ' LEU . 13.8 mt -56.19 161.89 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.313 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -173.0 -79.27 0.01 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.673 179.127 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.51 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.4 OUTLIER -134.67 -57.46 0.83 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.929 0.395 . . . . 0.0 111.181 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.65 -26.24 65.37 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.336 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.427 ' O ' HG23 ' A' ' 34' ' ' ILE . 8.2 m120 -120.36 32.14 6.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.195 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -131.54 27.39 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.978 0.418 . . . . 0.0 110.886 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -109.92 -36.47 5.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.805 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.713 HG22 ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -50.93 116.5 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.754 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.831 HG22 HD12 ' A' ' 45' ' ' ILE . 2.7 t -78.68 149.66 74.84 Favored Pre-proline 0 CA--C 1.518 -0.279 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.623 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.52 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 1.8 Cg_endo -45.19 -22.57 0.86 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.016 1.811 . . . . 0.0 111.079 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.655 ' HB ' HG23 ' A' ' 42' ' ' THR . 97.6 t -64.51 -47.29 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.893 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.831 HD12 HG22 ' A' ' 42' ' ' THR . 1.7 mp -58.33 -32.71 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.094 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.713 ' CE2' HG22 ' A' ' 41' ' ' ILE . 90.0 m-85 -80.71 -43.29 20.52 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.337 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.662 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.03 -28.19 69.92 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -87.82 -30.73 19.99 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.819 HD11 HG13 ' A' ' 74' ' ' ILE . 5.3 mt -61.71 -61.61 2.39 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.013 HG22 HD23 ' A' ' 55' ' ' LEU . 5.6 mt -50.04 -61.7 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.976 177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.662 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.1 OUTLIER -51.72 -43.4 62.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.066 -1.424 . . . . 0.0 113.075 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.86 -19.58 23.22 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.518 ' HB2' HD21 ' A' ' 73' ' ' LEU . 85.0 mmm -118.23 -65.68 1.15 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.665 HG22 ' HG3' ' A' ' 69' ' ' MET . 94.9 t -58.3 -57.72 9.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.8 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.013 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -44.91 -57.15 7.45 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.7 Cg_endo -65.92 4.63 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 121.969 1.779 . . . . 0.0 112.426 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 0.0 OUTLIER -145.89 23.38 1.38 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-O 121.124 0.488 . . . . 0.0 110.07 179.331 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.486 HG23 ' CD2' ' A' ' 81' ' ' TYR . 5.1 p -86.33 166.65 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.878 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG22 ' HE2' ' A' ' 81' ' ' TYR . 32.6 m -135.97 146.66 57.68 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.101 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.416 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 72.5 Cg_endo -75.84 28.81 0.38 Allowed 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 122.166 1.911 . . . . 0.0 112.561 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.846 HD12 ' H ' ' A' ' 65' ' ' LYS . 38.9 mm 41.13 103.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.631 179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 -26.43 14.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.56 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -173.69 39.27 0.14 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.274 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -130.11 -69.25 0.67 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.846 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.3 OUTLIER 72.37 108.89 0.07 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.08 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.961 HG21 ' HA ' ' A' ' 106' ' ' ILE . 2.7 t 72.71 59.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.795 179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.7 m -92.3 135.68 33.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.46 ' CE ' ' CZ ' ' A' ' 80' ' ' PHE . 8.0 ttmt -81.44 128.39 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.665 ' HG3' HG22 ' A' ' 54' ' ' VAL . 16.3 mmm -52.8 -25.59 11.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.193 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 m 53.97 25.89 5.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.9 tpt -104.34 -17.15 14.92 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 65.94 62.2 0.62 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.895 0.379 . . . . 0.0 110.763 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.546 ' HB3' HD13 ' A' ' 49' ' ' LEU . 7.9 mp -66.18 -52.6 46.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.739 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.819 HG13 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -122.35 158.86 26.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.911 179.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 74' ' ' ILE . 23.3 t0 -104.23 141.53 36.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.424 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.618 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.39 -34.48 5.37 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.164 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -126.17 -171.76 2.46 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.672 0.272 . . . . 0.0 110.56 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 2.4 m-20 -127.97 127.4 43.19 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.726 0.298 . . . . 0.0 110.768 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 9.2 p -82.5 103.41 12.02 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.46 ' CZ ' ' CE ' ' A' ' 68' ' ' LYS . 29.5 m-85 -115.91 136.34 53.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.45 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.604 ' CB ' HG22 ' A' ' 93' ' ' VAL . 48.8 p90 -130.92 140.01 50.14 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.957 0.408 . . . . 0.0 111.846 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.456 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 2.0 t -144.28 123.34 12.84 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.45 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.941 HG22 HG13 ' A' ' 91' ' ' VAL . 44.8 p -87.0 153.28 21.68 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.092 0.472 . . . . 0.0 110.964 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -47.09 158.36 0.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.209 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -83.51 0.73 45.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.559 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -159.48 21.63 0.18 Allowed 'General case' 0 C--O 1.232 0.174 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -160.77 102.08 1.31 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 120.53 0.205 . . . . 0.0 111.329 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.28 -15.11 48.55 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.452 2.101 . . . . 0.0 111.803 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -95.81 30.37 2.39 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.144 0.497 . . . . 0.0 110.14 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.412 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 86.0 m -151.51 71.86 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.674 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.941 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -73.55 178.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.501 -179.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.552 ' H ' HG12 ' A' ' 91' ' ' VAL . 49.1 m-85 -152.98 84.19 1.21 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.175 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.779 HG11 HG12 ' A' ' 50' ' ' ILE . 59.8 t -98.52 132.32 43.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.82 0.343 . . . . 0.0 111.411 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.701 ' HB3' HG13 ' A' ' 9' ' ' VAL . 21.5 p -139.48 131.44 27.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.097 0.475 . . . . 0.0 111.789 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.48 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 37.7 m-85 -89.33 91.07 8.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.061 178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.899 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -85.92 137.0 33.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.928 0.394 . . . . 0.0 111.219 -179.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.743 HD22 ' HB ' ' A' ' 33' ' ' THR . 89.1 mt -48.5 127.75 13.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.498 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.8 OUTLIER -50.78 -37.91 16.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.358 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -58.15 -25.33 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.573 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' A' ' 101' ' ' PRO . 76.2 mt -80.2 138.43 52.52 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.876 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' A' ' 100' ' ' ILE . 22.3 Cg_endo -60.98 176.99 0.77 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.459 2.106 . . . . 0.0 112.069 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -94.37 61.15 2.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.784 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.682 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 6.1 tp -149.59 -32.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.996 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.716 HD11 HD11 ' A' ' 108' ' ' ILE . 16.4 tp -61.59 -62.17 6.42 Favored Pre-proline 0 C--O 1.226 -0.143 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.049 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.899 ' HD3' HG21 ' A' ' 96' ' ' THR . 7.6 Cg_endo -49.02 -29.71 16.35 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.397 2.065 . . . . 0.0 111.354 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.961 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 mp -72.73 -35.94 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.924 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.54 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.83 -26.62 34.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.077 178.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.716 HD11 HD11 ' A' ' 104' ' ' LEU . 19.6 mm -73.83 -51.27 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.229 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.543 ' HA ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -67.28 -57.37 6.8 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.4 t -59.22 -25.91 64.41 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.587 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -73.97 -45.98 24.5 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 178.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 127' ' ' HIS . 10.4 mt -55.2 -26.7 40.96 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -71.62 -18.92 62.18 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.435 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -71.91 -21.55 61.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.93 0.395 . . . . 0.0 109.966 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.499 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 3.4 m-85 -93.14 -170.68 2.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.468 179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -127.12 2.4 6.47 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.718 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 1.3 p -114.81 -93.53 0.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.554 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.5 p-10 41.13 31.82 0.16 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.49 35.2 4.12 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -151.1 149.86 30.01 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.396 178.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.412 ' HA ' ' H ' ' A' ' 20' ' ' SER . 40.6 t-20 -69.64 28.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.781 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -169.92 27.1 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 123' ' ' LEU . 6.0 tt -132.28 -49.64 0.93 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 1.033 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -54.7 -45.98 74.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.4 t -47.67 -29.78 3.26 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.359 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.25 -57.82 11.34 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.015 179.869 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.906 ' HB2' HD23 ' A' ' 112' ' ' LEU . 4.1 m170 -57.06 -36.65 70.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.609 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.703 HG13 HD12 ' A' ' 108' ' ' ILE . 44.3 t -51.79 -48.3 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.21 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.679 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -72.26 -48.93 22.8 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.06 -1.067 . . . . 0.0 112.54 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -20.69 66.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.722 0.296 . . . . 0.0 110.701 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.587 HD13 ' HA3' ' A' ' 111' ' ' GLY . 70.3 mt -90.89 -28.2 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.679 HD12 ' HA2' ' A' ' 129' ' ' GLY . 1.1 mt -61.49 -43.69 98.41 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.028 178.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -60.55 -31.0 70.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.629 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.25 16.55 26.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.163 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.682 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 1.1 t80 -88.64 -43.48 11.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.446 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.45 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.8 OUTLIER -75.27 -30.94 60.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.802 179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.79 -28.62 57.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.482 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -80.53 -35.86 33.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.387 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.567 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 5.3 mt -70.79 -30.09 66.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.974 0.416 . . . . 0.0 109.942 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 136' ' ' HIS . 88.7 t -75.14 -46.8 38.34 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.97 -30.38 64.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.843 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.78 -36.61 70.06 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.382 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.56 -24.8 49.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.096 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -114.26 30.18 7.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.015 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.469 ' O ' HG22 ' A' ' 146' ' ' THR . 0.0 OUTLIER -111.91 94.79 5.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.864 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 145' ' ' GLN . 11.2 t 46.21 47.67 13.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.438 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 61.6 mt -117.01 79.52 1.34 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -99.44 91.78 5.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 0.0 110.828 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.975 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.784 0.326 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -158.5 151.1 22.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.418 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -117.25 -178.02 3.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.832 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' CD2' HG12 ' A' ' 100' ' ' ILE . 10.5 m-85 -157.63 -176.91 6.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.903 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.793 ' HA ' HD21 ' A' ' 132' ' ' LEU . 1.6 t30 -174.65 146.61 1.0 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.942 0.401 . . . . 0.0 111.282 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.902 HG13 HG23 ' A' ' 96' ' ' THR . 1.5 t -93.05 122.3 44.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.842 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.544 ' OG ' HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -53.74 -55.92 21.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.963 -179.134 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.649 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 4.4 m-85 -147.57 116.38 6.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.762 HG13 ' SG ' ' A' ' 94' ' ' CYS . 3.1 t -108.51 97.27 5.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.797 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.472 ' HG2' ' CG2' ' A' ' 17' ' ' THR . 1.4 tt0 -105.46 115.63 30.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.731 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.929 ' CG2' HD13 ' A' ' 124' ' ' LEU . 6.1 t -79.98 159.54 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.629 HD11 HG21 ' A' ' 50' ' ' ILE . 2.5 mp -140.15 114.1 6.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 18' ' ' ILE . 21.4 tttm -96.93 106.54 18.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.459 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 57.68 39.96 26.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.301 179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.482 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 77.92 26.74 59.8 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.359 -0.924 . . . . 0.0 111.228 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -144.56 110.82 5.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 121.042 0.448 . . . . 0.0 110.069 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.472 ' CG2' ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -42.99 130.23 4.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.647 -0.706 . . . . 0.0 112.478 -178.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -108.76 -47.56 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.304 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.997 178.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.591 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -127.53 176.62 7.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.217 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.527 ' N ' HD22 ' A' ' 124' ' ' LEU . 2.0 m -168.67 128.35 1.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.504 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 35.9 t -115.29 69.42 0.72 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.649 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -105.73 91.93 3.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.785 -178.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.05 139.94 25.7 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.505 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.75 146.03 18.47 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.687 2.258 . . . . 0.0 111.619 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 45.4 p90 -179.34 126.23 0.09 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.711 0.291 . . . . 0.0 111.31 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.63 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 1.3 pt20 -86.41 54.64 3.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.973 0.416 . . . . 0.0 110.14 178.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.34 -166.83 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.672 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -135.31 -67.93 0.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.725 0.297 . . . . 0.0 111.101 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -124.09 -76.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -108.42 -52.15 2.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.657 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' CD1' ' HA ' ' A' ' 4' ' ' PHE . 45.7 p90 -63.27 -172.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.717 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.55 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . 88.45 174.35 47.32 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.682 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.873 ' HB ' HD22 ' A' ' 97' ' ' LEU . 92.6 m -157.82 -43.19 0.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.8 0.333 . . . . 0.0 110.95 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.63 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 27.2 mt -59.31 159.16 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.939 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -174.06 -79.82 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.843 178.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.491 ' N ' ' OG1' ' A' ' 35' ' ' THR . 2.6 m -143.67 64.06 1.34 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.943 0.402 . . . . 0.0 111.041 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.26 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.842 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 48.3 m-20 -101.64 30.81 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.649 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -123.73 26.58 7.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.906 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -108.33 -37.34 6.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.605 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.655 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.19 117.73 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.56 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.868 HG22 HD12 ' A' ' 45' ' ' ILE . 3.8 t -78.28 151.06 77.9 Favored Pre-proline 0 CA--C 1.518 -0.277 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 72.4 Cg_exo -47.32 -21.05 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 121.848 1.699 . . . . 0.0 111.042 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.667 ' HB ' HG23 ' A' ' 42' ' ' THR . 46.7 t -65.79 -45.97 90.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.183 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.868 HD12 HG22 ' A' ' 42' ' ' THR . 1.7 mp -59.57 -33.5 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.655 ' CE2' HG22 ' A' ' 41' ' ' ILE . 74.3 m-85 -80.11 -43.82 21.05 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.447 178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.611 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -64.24 -28.24 69.6 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.414 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -89.49 -29.7 18.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.858 HD11 HG13 ' A' ' 74' ' ' ILE . 3.6 mt -60.67 -60.5 3.7 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.049 HG22 HD23 ' A' ' 55' ' ' LEU . 5.1 mt -51.95 -64.35 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 113.564 -1.653 . . . . 0.0 109.704 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.611 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -49.72 -38.18 32.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.204 -1.362 . . . . 0.0 112.787 -179.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -91.04 -23.27 20.41 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.452 ' N ' ' O ' ' A' ' 49' ' ' LEU . 40.7 mmm -119.14 -69.14 0.87 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.887 HG22 ' HG3' ' A' ' 69' ' ' MET . 88.8 t -53.52 -53.29 25.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.848 -178.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.049 HD23 HG22 ' A' ' 50' ' ' ILE . 3.3 mm? -51.85 -58.74 10.04 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.0 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 33.2 Cg_endo -65.38 6.44 0.41 Allowed 'Trans proline' 0 CA--C 1.528 0.215 0 C-N-CA 122.197 1.931 . . . . 0.0 112.719 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 0.1 OUTLIER -151.0 25.04 0.74 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.066 0.46 . . . . 0.0 110.099 179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 81' ' ' TYR . 9.8 p -82.49 146.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.265 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.503 ' C ' ' H ' ' A' ' 61' ' ' ILE . 5.2 t -96.79 138.87 21.36 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.115 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.505 ' HA ' HG21 ' A' ' 83' ' ' THR . 65.4 Cg_endo -74.19 28.16 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 121.814 1.676 . . . . 0.0 111.952 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.503 ' H ' ' C ' ' A' ' 59' ' ' VAL . 29.1 mm 18.52 85.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.959 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.71 -40.5 8.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.126 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -118.05 -32.22 1.44 Allowed Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.928 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.47 ' O ' HG23 ' A' ' 61' ' ' ILE . 1.4 t30 -82.89 -160.29 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.44 117.65 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.717 0.294 . . . . 0.0 111.122 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 1.03 HG21 ' HA ' ' A' ' 106' ' ' ILE . 5.4 t 65.33 60.97 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.699 0.285 . . . . 0.0 111.217 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.577 HG22 ' CE1' ' A' ' 81' ' ' TYR . 1.4 t -92.8 144.56 25.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.748 0.309 . . . . 0.0 111.113 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.45 ' HD2' ' CE1' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -83.23 142.2 31.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.722 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.887 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -60.18 -33.4 72.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.802 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.1 m 59.2 26.21 14.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.306 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.418 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 14.2 mmm -111.66 -0.25 16.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.469 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.87 59.62 3.41 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 121.123 0.487 . . . . 0.0 110.516 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.851 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.9 mp -60.45 -45.79 92.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.858 HG13 HD11 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -139.26 156.32 27.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.684 179.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -102.47 138.84 38.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.375 179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 113.7 -31.35 6.64 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.416 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.502 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -125.74 -165.0 1.36 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.879 0.371 . . . . 0.0 110.929 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 1.9 m-20 -137.83 117.94 13.49 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.189 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.728 ' SG ' HD13 ' A' ' 73' ' ' LEU . 23.4 p -87.38 115.51 24.84 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE1' ' HD2' ' A' ' 68' ' ' LYS . 49.4 m-85 -123.83 151.74 43.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.867 178.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.832 ' CD2' HG13 ' A' ' 54' ' ' VAL . 30.0 p90 -141.87 135.36 29.46 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.155 0.502 . . . . 0.0 111.676 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.5 t -140.06 123.78 17.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.591 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 29.0 p -82.09 147.61 29.0 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.93 0.395 . . . . 0.0 111.029 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -46.93 141.38 4.11 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.119 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -69.05 -11.65 60.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.621 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.22 19.26 1.74 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.68 0.276 . . . . 0.0 111.568 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -161.98 91.24 1.39 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.655 0.264 . . . . 0.0 111.503 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.2 -18.54 30.24 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.482 2.121 . . . . 0.0 111.99 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.3 mttt -92.7 30.91 1.45 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.001 0.429 . . . . 0.0 110.485 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 90' ' ' THR . 20.5 m -152.74 70.45 0.89 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.639 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.624 HG12 ' H ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -65.5 178.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.124 -179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.624 ' H ' HG12 ' A' ' 91' ' ' VAL . 97.3 m-85 -153.56 92.38 1.57 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.758 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.981 HG11 HG12 ' A' ' 50' ' ' ILE . 24.6 t -97.05 122.87 49.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.244 0.545 . . . . 0.0 111.786 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.872 ' SG ' HG11 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -108.92 145.67 35.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.63 179.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB2' ' O ' ' A' ' 8' ' ' TYR . 2.4 m-85 -121.82 80.48 1.69 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.902 HG23 HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -77.4 177.72 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.027 0.441 . . . . 0.0 110.729 -179.163 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.873 HD22 ' HB ' ' A' ' 33' ' ' THR . 12.7 mt -93.9 127.78 39.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.262 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -40.55 -32.66 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.21 -34.51 78.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.091 0.472 . . . . 0.0 110.576 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 4' ' ' PHE . 29.2 mt -73.16 136.95 78.87 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.879 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.437 ' HD2' HG23 ' A' ' 100' ' ' ILE . 24.3 Cg_endo -61.24 -168.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.386 2.058 . . . . 0.0 112.232 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.558 ' HD3' HD11 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -108.04 67.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.66 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.735 HG23 ' CE1' ' A' ' 135' ' ' PHE . 1.6 tp -150.51 -33.59 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.712 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.982 HD11 HD12 ' A' ' 132' ' ' LEU . 19.8 tp -59.6 -60.14 11.55 Favored Pre-proline 0 C--N 1.332 -0.168 0 C-N-CA 120.919 -0.313 . . . . 0.0 110.241 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.847 ' HD3' HG21 ' A' ' 96' ' ' THR . 9.4 Cg_endo -51.21 -36.72 57.2 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.285 1.99 . . . . 0.0 111.193 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 1.03 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.2 mp -62.02 -40.47 87.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.231 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.46 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -81.73 -23.99 36.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.983 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.9 HD11 HD12 ' A' ' 132' ' ' LEU . 10.3 mm -71.85 -44.32 67.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.868 HD23 HG13 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -75.07 -50.9 14.92 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 21.8 t -60.64 -30.8 70.1 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 177.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.583 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -73.8 -48.94 15.19 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 178.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.4 mt -56.13 -32.15 63.97 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -72.5 -17.26 61.76 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.158 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.09 -24.94 62.4 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.498 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 10.0 m-85 -86.75 -171.54 3.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.493 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -121.32 -1.19 9.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.613 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.7 m -114.8 -94.06 0.48 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.53 ' N ' HD22 ' A' ' 123' ' ' LEU . 4.4 p30 40.26 32.33 0.13 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-O 120.782 0.325 . . . . 0.0 111.078 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.413 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -114.94 36.09 4.02 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -178.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.0 OUTLIER -148.81 151.42 34.76 Favored 'General case' 0 CA--C 1.523 -0.091 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.008 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.458 ' HA ' ' N ' ' A' ' 20' ' ' SER . 1.6 m-80 -70.54 21.95 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.582 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.1 tt0 -166.23 28.41 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.601 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.9 tt -132.34 -50.1 0.93 Allowed 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.704 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.929 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.59 -45.58 77.4 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.429 ' HB3' ' HA ' ' A' ' 21' ' ' CYS . 80.3 p -46.37 -30.24 2.03 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.408 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.0 -57.13 14.45 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.687 179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.906 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.3 m170 -61.25 -31.44 71.24 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.698 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.889 HG13 HD12 ' A' ' 108' ' ' ILE . 48.4 t -56.41 -42.23 74.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.526 -0.47 . . . . 0.0 109.839 178.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.527 ' HA2' ' HB2' ' A' ' 132' ' ' LEU . . . -74.94 -50.4 8.79 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.11 179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -26.74 67.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.053 0.454 . . . . 0.0 110.446 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.583 HD13 ' C ' ' A' ' 111' ' ' GLY . 61.7 mt -89.94 -25.82 5.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.982 HD12 HD11 ' A' ' 104' ' ' LEU . 2.9 tp -55.91 -45.7 78.61 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.782 177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.23 -44.84 64.55 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.802 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.43 -26.23 67.87 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.897 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.852 ' CZ ' HD11 ' A' ' 139' ' ' LEU . 1.6 t80 -54.46 -67.57 0.25 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.766 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 18.3 t-160 -56.99 -41.36 78.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.813 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -52.35 -27.46 15.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.985 0.421 . . . . 0.0 110.317 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.88 -32.67 34.82 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.367 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.852 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 11.4 mt -73.82 -29.3 62.08 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.365 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.0 t -76.3 -48.81 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.49 0 CA-C-O 121.587 0.708 . . . . 0.0 109.202 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -61.48 -33.2 73.37 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.688 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -25.18 65.49 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.203 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.465 ' NH1' HD11 ' A' ' 147' ' ' LEU . 0.3 OUTLIER -96.03 26.74 3.98 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.076 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -150.32 31.07 0.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.86 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -112.47 -76.63 0.59 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 146' ' ' THR . 3.3 t -134.35 99.75 4.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.998 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.465 HD11 ' NH1' ' A' ' 143' ' ' ARG . 9.4 mt -128.46 -71.91 0.63 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -85.49 -31.5 22.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.799 -179.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.8 mtp . . . . . 0 N--CA 1.487 1.405 0 CA-C-O 120.842 0.353 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' HE3' ' CE2' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -135.12 132.37 38.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -125.28 -166.43 1.54 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.523 ' CE2' HG23 ' A' ' 100' ' ' ILE . 6.2 m-85 -161.88 177.56 9.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.079 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.876 ' HA ' HD21 ' A' ' 132' ' ' LEU . 1.5 t-20 -175.68 100.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.299 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.981 HG11 HG22 ' A' ' 9' ' ' VAL . 20.2 t -61.32 119.97 6.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.378 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.526 ' HB3' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -55.79 -54.88 39.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.724 -179.255 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.628 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 6.6 m-85 -142.49 135.44 28.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.85 0.357 . . . . 0.0 111.841 -179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.981 HG22 HG11 ' A' ' 6' ' ' VAL . 0.8 OUTLIER -129.76 93.11 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.793 179.247 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 2.2 mt-10 -106.11 120.77 42.66 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.577 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.994 HG23 HD13 ' A' ' 124' ' ' LEU . 23.6 t -85.32 159.87 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.727 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.838 HD11 HG21 ' A' ' 50' ' ' ILE . 3.6 mt -138.42 117.54 14.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.693 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -106.04 109.3 21.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.88 0.371 . . . . 0.0 111.487 179.338 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 61.18 37.34 17.58 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.633 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.75 26.6 58.39 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.954 . . . . 0.0 111.483 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -146.1 117.54 7.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.017 0.437 . . . . 0.0 110.279 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -48.01 126.99 11.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.142 -179.165 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.693 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -104.76 -45.39 9.07 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.457 0.646 . . . . 0.0 109.927 178.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.828 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -125.16 175.87 7.1 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.397 -179.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.533 ' HA ' ' HA ' ' A' ' 10' ' ' GLU . 59.5 p -170.19 127.57 0.84 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.509 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 25.5 t -121.58 69.72 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.666 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.628 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -106.56 97.66 7.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.54 -179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -113.69 144.11 30.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.53 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.42 141.08 9.89 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.747 2.298 . . . . 0.0 111.559 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 27' ' ' LYS . 44.1 p90 -179.79 118.13 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.094 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.671 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 19.3 mt-30 -73.77 67.55 1.19 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.954 0.407 . . . . 0.0 110.654 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -55.51 90.65 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.979 -179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.04 90.38 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.908 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -176.16 -164.28 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.824 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 45.0 m-20 -53.91 -25.74 21.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.285 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 3' ' ' ARG . 16.8 p90 -135.47 93.5 2.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.93 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . 177.17 167.62 35.81 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.712 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.822 ' HB ' HD22 ' A' ' 97' ' ' LEU . 19.9 m -158.24 -43.01 0.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.771 0.32 . . . . 0.0 111.73 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.827 HG13 HD21 ' A' ' 97' ' ' LEU . 8.1 mt -64.96 151.95 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.671 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -165.9 -70.47 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.567 178.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.522 ' N ' ' OG1' ' A' ' 35' ' ' THR . 50.7 p -143.12 -46.72 0.3 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.074 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.78 -30.66 71.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.175 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 75.2 m-20 -116.13 30.71 7.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.987 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -126.15 26.28 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.172 0.51 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -111.59 -32.31 6.72 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.032 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.578 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.2 mm -54.63 119.97 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.63 179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.973 HG22 HD12 ' A' ' 45' ' ' ILE . 10.1 t -82.9 150.77 62.68 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.469 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.502 ' HD2' ' OG1' ' A' ' 42' ' ' THR . 84.6 Cg_exo -44.79 -23.43 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.294 1.996 . . . . 0.0 111.779 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.76 ' HB ' HG23 ' A' ' 42' ' ' THR . 33.6 t -66.76 -46.45 85.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.176 179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.973 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -58.26 -33.87 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.578 ' CE2' HG22 ' A' ' 41' ' ' ILE . 88.6 m-85 -80.33 -41.48 24.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.401 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.623 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -64.59 -28.05 69.36 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.933 179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -89.2 -28.55 19.9 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.832 HD11 HG13 ' A' ' 74' ' ' ILE . 4.1 mt -62.33 -60.96 2.82 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 177.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.031 HG12 HG11 ' A' ' 93' ' ' VAL . 6.3 mt -50.48 -63.16 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 113.5 -1.682 . . . . 0.0 109.703 177.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.62 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.2 OUTLIER -51.55 -41.57 61.19 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 113.959 -1.473 . . . . 0.0 113.068 -179.18 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.94 -22.42 20.87 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 -178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.452 ' C ' ' HD2' ' A' ' 56' ' ' PRO . 33.2 mmm -116.77 -60.0 1.9 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.944 HG22 ' HG3' ' A' ' 69' ' ' MET . 82.7 t -61.38 -60.88 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.952 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.967 HD23 HG22 ' A' ' 50' ' ' ILE . 2.0 mm? -45.4 -54.95 13.09 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.602 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 17.6 Cg_exo -66.61 3.3 1.51 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.266 1.977 . . . . 0.0 112.45 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HB3' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -147.56 24.89 1.09 Allowed 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.974 0.416 . . . . 0.0 110.254 179.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.6 p -86.28 169.15 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.833 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.553 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -136.38 148.18 63.09 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.38 179.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HA ' ' OG1' ' A' ' 83' ' ' THR . 95.0 Cg_endo -80.18 27.35 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.08 1.853 . . . . 0.0 111.662 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.946 HD11 ' HA ' ' A' ' 82' ' ' SER . 4.3 mt 36.55 101.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.94 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -60.66 2.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.539 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.95 -23.17 2.79 Favored Glycine 0 N--CA 1.452 -0.247 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.717 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.33 -157.56 0.08 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.598 0.237 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.567 ' HA ' HD13 ' A' ' 61' ' ' ILE . 5.0 mmtt 178.11 118.35 0.04 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.61 0.243 . . . . 0.0 111.072 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.77 HG21 ' HA ' ' A' ' 106' ' ' ILE . 17.6 t 61.77 68.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.782 0.325 . . . . 0.0 110.914 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.484 HG22 ' CE1' ' A' ' 81' ' ' TYR . 4.1 t -99.22 151.31 21.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.866 0.365 . . . . 0.0 111.253 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.449 ' HE2' ' CE1' ' A' ' 80' ' ' PHE . 10.6 ttmt -86.14 141.38 29.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.495 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.944 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -55.31 -30.23 59.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.957 179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.3 m 60.98 26.26 16.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.059 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 20.5 mmm -115.89 -2.72 12.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.187 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 56.95 59.09 3.63 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 121.091 0.472 . . . . 0.0 110.629 -179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.74 HD11 ' SD ' ' A' ' 69' ' ' MET . 7.1 mp -57.75 -53.99 51.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.671 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.832 HG13 HD11 ' A' ' 49' ' ' LEU . 0.2 OUTLIER -130.3 158.31 42.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.845 179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.422 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.0 t0 -102.98 138.58 39.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.231 179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 112.52 -30.45 7.54 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.495 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -135.49 165.83 24.6 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.741 0.305 . . . . 0.0 110.806 179.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.491 ' OD2' HG12 ' A' ' 98' ' ' VAL . 5.8 m-20 -104.65 126.29 51.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.86 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 95' ' ' PHE . 27.7 t -93.57 105.83 17.85 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CE1' ' HE2' ' A' ' 68' ' ' LYS . 34.1 m-85 -116.13 137.35 52.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.545 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.863 ' CD2' HG13 ' A' ' 54' ' ' VAL . 7.5 p90 -124.67 139.81 53.52 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-O 121.108 0.48 . . . . 0.0 111.41 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.946 ' HA ' HD11 ' A' ' 61' ' ' ILE . 2.5 t -141.5 118.48 11.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.527 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.846 HG22 HG13 ' A' ' 91' ' ' VAL . 74.3 p -81.58 150.48 28.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.944 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -46.39 148.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.17 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.25 -8.46 53.74 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.706 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -157.28 22.9 0.3 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 121.026 -0.269 . . . . 0.0 111.606 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -156.47 88.94 2.75 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.745 0.307 . . . . 0.0 111.304 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.49 -19.51 23.21 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.604 2.202 . . . . 0.0 112.133 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.2 32.66 1.28 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.975 0.416 . . . . 0.0 110.397 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 90' ' ' THR . 21.7 m -156.42 71.09 0.69 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.576 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.846 HG13 HG22 ' A' ' 83' ' ' THR . 0.6 OUTLIER -71.35 178.28 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.196 -179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.62 ' H ' HG12 ' A' ' 91' ' ' VAL . 84.8 m-85 -153.01 98.59 2.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.211 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.031 HG11 HG12 ' A' ' 50' ' ' ILE . 43.1 t -106.17 129.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.959 0.409 . . . . 0.0 111.372 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.558 ' HB3' HG13 ' A' ' 9' ' ' VAL . 28.2 p -128.41 117.46 21.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.308 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.571 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 16.0 m-85 -85.72 78.13 9.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.787 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.862 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -65.52 -172.27 0.11 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.758 0.314 . . . . 0.0 110.599 -179.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.827 HD21 HG13 ' A' ' 34' ' ' ILE . 71.7 mt -102.26 129.82 48.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.465 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.491 HG12 ' OD2' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -46.01 -36.12 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.815 0.34 . . . . 0.0 111.617 -179.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.82 -29.61 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.395 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.523 HG23 ' CE2' ' A' ' 4' ' ' PHE . 60.2 mt -81.48 129.96 63.83 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.82 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.472 ' HD2' ' CE2' ' A' ' 4' ' ' PHE . 16.4 Cg_endo -57.66 -176.5 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.491 2.127 . . . . 0.0 111.932 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.493 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -99.91 63.13 1.18 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.542 ' CA ' HD13 ' A' ' 106' ' ' ILE . 4.6 tp -144.02 -37.61 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.609 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.809 HD21 HG23 ' A' ' 6' ' ' VAL . 2.5 tp -63.89 -63.61 3.73 Favored Pre-proline 0 C--N 1.331 -0.234 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.862 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -45.47 -30.19 5.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.627 2.218 . . . . 0.0 111.388 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.77 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.3 mp -66.92 -41.71 87.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.727 179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.493 ' O ' HG21 ' A' ' 131' ' ' ILE . 6.9 mmt180 -80.95 -17.76 49.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.678 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.691 HG13 HG21 ' A' ' 6' ' ' VAL . 16.2 mm -70.53 -48.62 58.15 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-O 120.722 0.296 . . . . 0.0 110.215 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.666 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -73.12 -51.49 17.77 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.08 -28.33 69.0 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.496 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -76.69 -43.88 17.23 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.897 HD23 ' HB2' ' A' ' 127' ' ' HIS . 16.9 mt -56.82 -35.62 69.0 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -14.52 61.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.083 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.16 -23.86 59.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.239 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.491 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.7 m-85 -84.33 -93.08 0.08 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.848 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.432 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.0 OUTLIER 161.26 -26.38 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 111.068 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.3 m -92.13 -90.81 0.17 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.533 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.557 ' N ' HD22 ' A' ' 123' ' ' LEU . 22.6 p30 40.73 32.47 0.15 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.672 0.272 . . . . 0.0 110.67 -179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.99 34.52 4.8 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.559 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -150.71 149.24 29.55 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.554 178.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.443 ' HA ' ' N ' ' A' ' 20' ' ' SER . 0.4 OUTLIER -68.91 28.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.858 -179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.534 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.6 tp10 -169.93 27.93 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.589 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.8 tt -132.9 -49.32 0.88 Allowed 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.507 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.994 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.66 -44.71 77.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.406 ' HB3' ' HB2' ' A' ' 21' ' ' CYS . 89.2 p -47.63 -30.73 3.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.16 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -60.91 -60.4 3.85 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.105 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.897 ' HB2' HD23 ' A' ' 112' ' ' LEU . 5.3 m170 -57.98 -36.88 73.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.704 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.636 HG11 HG21 ' A' ' 9' ' ' VAL . 42.4 t -53.28 -43.97 52.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.219 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -77.06 -44.82 12.76 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 119.934 -1.127 . . . . 0.0 112.109 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -65.25 -23.0 66.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.626 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 127' ' ' HIS . 57.3 mt -90.03 -26.34 5.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.876 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.4 OUTLIER -63.72 -47.83 79.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.545 178.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -66.68 -44.32 82.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.889 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -73.21 -18.06 61.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.844 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.792 ' CE1' HD21 ' A' ' 139' ' ' LEU . 15.9 t80 -50.62 -66.68 0.35 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.145 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.418 ' HA ' HD12 ' A' ' 139' ' ' LEU . 2.4 t-160 -50.82 -48.35 59.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -49.29 -31.25 8.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.001 0.429 . . . . 0.0 110.383 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -80.11 -34.74 37.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.98 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.792 HD21 ' CE1' ' A' ' 135' ' ' PHE . 18.8 mt -67.95 -33.68 75.14 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.101 0.476 . . . . 0.0 109.781 179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 88.3 t -73.92 -47.1 44.25 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 CA-C-O 121.645 0.736 . . . . 0.0 109.031 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -35.6 77.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.672 178.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -28.48 68.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.175 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.565 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -77.98 -3.29 41.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.574 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -104.6 -37.04 7.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.712 0.291 . . . . 0.0 111.085 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -75.88 -73.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.032 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.39 145.78 29.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.86 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 143' ' ' ARG . 0.3 OUTLIER -170.48 48.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -97.73 37.33 1.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.902 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.77 0.319 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.5 ' HZ2' ' HB3' ' A' ' 31' ' ' TYR . 3.3 tttp -176.45 85.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -73.0 91.56 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.912 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.668 ' CE2' HG23 ' A' ' 100' ' ' ILE . 3.3 m-85 -58.81 159.64 6.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.876 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -168.07 115.85 0.72 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.461 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.049 HG11 HG22 ' A' ' 9' ' ' VAL . 2.1 t -72.35 147.42 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.342 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -87.88 -49.9 6.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.548 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.714 ' HB2' ' HB2' ' A' ' 95' ' ' PHE . 10.1 m-85 -143.57 134.71 25.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.973 0.416 . . . . 0.0 111.96 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.049 HG22 HG11 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -134.65 93.7 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.821 179.162 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.6 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.5 mt-10 -107.72 120.23 41.66 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.994 0.426 . . . . 0.0 111.812 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.987 HG23 HD13 ' A' ' 124' ' ' LEU . 75.8 t -82.69 158.74 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.83 HD11 HG21 ' A' ' 50' ' ' ILE . 4.4 mt -137.51 115.9 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.615 ' CG ' HD13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -105.28 109.34 21.29 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.934 0.397 . . . . 0.0 111.284 179.278 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 63.81 34.28 12.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.611 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 78.66 26.39 58.95 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.347 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -143.93 117.34 9.09 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.039 0.447 . . . . 0.0 109.863 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.6 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -51.61 125.21 14.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.727 -178.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.615 HD13 ' CG ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -102.19 -49.47 10.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 121.445 0.64 . . . . 0.0 109.87 178.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 120' ' ' THR . 55.0 p -120.87 174.38 6.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.695 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.537 ' N ' HD22 ' A' ' 124' ' ' LEU . 92.1 p -170.06 134.44 1.26 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.155 0.502 . . . . 0.0 111.815 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 28.7 t -124.86 69.71 1.12 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.434 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.637 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.9 m-85 -106.95 101.91 11.31 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.054 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -143.24 145.29 31.83 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.721 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.401 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 79.2 Cg_endo -77.1 -176.44 3.2 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.693 2.262 . . . . 0.0 111.759 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 7' ' ' SER . 1.5 p90 172.7 -6.62 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 34' ' ' ILE . 4.9 tt0 63.94 145.71 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 120.813 0.34 . . . . 0.0 110.514 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 34' ' ' ILE . 5.3 tmtt? -80.91 141.57 34.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -124.45 -166.1 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.644 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -49.83 119.22 3.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.896 0.379 . . . . 0.0 110.603 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.445 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.0 m120 61.31 157.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.285 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.5 ' HB3' ' HZ2' ' A' ' 2' ' ' LYS . 48.2 p90 45.67 -168.19 0.01 OUTLIER 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.122 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.798 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . 71.08 164.34 5.73 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.403 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.793 ' HB ' HD22 ' A' ' 97' ' ' LEU . 22.6 m -164.38 -42.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.82 0.343 . . . . 0.0 111.159 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.742 HG13 HD21 ' A' ' 97' ' ' LEU . 12.0 mt -55.89 156.88 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.331 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.547 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.4 OUTLIER 169.69 -32.62 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.767 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -174.65 -74.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.185 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.35 -27.41 3.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.393 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.479 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 24.1 m-20 -118.35 31.34 6.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.809 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 39' ' ' GLU . 51.5 tt0 -128.86 26.9 5.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.16 0.505 . . . . 0.0 110.832 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -113.66 -33.49 5.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.155 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.686 HG22 ' CE2' ' A' ' 46' ' ' PHE . 2.2 mm -52.87 130.62 14.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.676 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.71 HG23 ' HB ' ' A' ' 44' ' ' VAL . 11.2 t -91.24 151.25 42.74 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.714 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.506 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 75.0 Cg_exo -46.71 -25.93 4.07 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.293 1.995 . . . . 0.0 111.384 179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.71 ' HB ' HG23 ' A' ' 42' ' ' THR . 74.2 t -66.65 -38.45 81.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.714 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.603 HG13 HG23 ' A' ' 41' ' ' ILE . 15.2 mm -59.8 -44.21 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.686 ' CE2' HG22 ' A' ' 41' ' ' ILE . 10.7 m-85 -75.83 -40.09 55.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.178 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.651 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -62.73 -30.27 71.3 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.178 179.823 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -87.65 -29.56 21.08 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.643 HD22 HD23 ' A' ' 73' ' ' LEU . 4.1 mt -61.53 -59.72 4.8 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.069 HG12 HG11 ' A' ' 93' ' ' VAL . 7.0 mt -50.79 -63.82 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.016 177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.537 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.4 OUTLIER -52.21 -41.74 62.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.99 -1.459 . . . . 0.0 113.048 -179.021 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -90.76 -20.62 22.18 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.601 ' HB2' HD21 ' A' ' 73' ' ' LEU . 47.9 mmm -118.28 -59.95 1.84 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 69' ' ' MET . 90.8 t -63.55 -60.18 3.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.009 HD23 HG22 ' A' ' 50' ' ' ILE . 2.4 mm? -44.57 -53.69 14.29 Favored Pre-proline 0 C--N 1.331 -0.214 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.8 Cg_exo -67.0 3.95 1.35 Allowed 'Trans proline' 0 CA--C 1.531 0.357 0 C-N-CA 122.225 1.95 . . . . 0.0 112.457 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.28 28.07 0.58 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.139 0.495 . . . . 0.0 110.194 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 91' ' ' VAL . 9.4 p -83.76 150.35 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.94 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.584 HG23 ' HE1' ' A' ' 81' ' ' TYR . 3.8 t -102.58 138.77 19.73 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.429 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' HD2' ' CG1' ' A' ' 59' ' ' VAL . 67.7 Cg_endo -74.45 28.03 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.795 1.664 . . . . 0.0 111.575 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.79 HD12 ' H ' ' A' ' 65' ' ' LYS . 18.3 mm 23.22 101.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.008 -0.996 . . . . 0.0 113.266 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.54 -26.91 10.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.573 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.15 30.22 0.22 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.491 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -118.12 -51.5 2.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.79 ' H ' HD12 ' A' ' 61' ' ' ILE . 0.0 OUTLIER 63.29 105.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.215 179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.839 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.0 t 69.78 79.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.13 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.9 m -101.2 130.06 47.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.931 0.396 . . . . 0.0 111.223 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.459 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -81.74 134.95 35.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.456 179.583 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.778 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -58.13 -26.25 62.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.107 -179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.7 t 50.94 28.46 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.011 0.434 . . . . 0.0 110.951 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 36.5 tpp -107.3 -18.1 13.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.001 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.61 63.76 0.41 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.028 0.442 . . . . 0.0 110.716 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.643 HD23 HD22 ' A' ' 49' ' ' LEU . 7.1 mp -65.32 -59.22 4.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.452 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.539 HG13 HD11 ' A' ' 49' ' ' LEU . 1.3 mt -121.51 155.44 25.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.342 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 17.0 t0 -97.3 140.02 32.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.52 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.754 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 107.47 -33.15 6.54 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.293 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 74' ' ' ILE . 2.1 m-85 -116.35 175.26 5.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.266 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.6 OUTLIER -120.75 121.68 38.74 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.244 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.45 ' HG ' ' HE1' ' A' ' 95' ' ' PHE . 6.1 m -86.98 106.19 17.64 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.459 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 65.8 m-85 -120.81 149.0 43.25 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.505 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 93' ' ' VAL . 35.3 p90 -144.87 131.07 19.49 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.154 0.502 . . . . 0.0 111.585 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.427 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 2.2 t -132.05 120.75 22.8 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.638 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.984 HG22 HG13 ' A' ' 91' ' ' VAL . 63.1 p -89.97 150.13 22.27 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.969 0.414 . . . . 0.0 111.133 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -47.66 149.61 1.19 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -69.97 -16.47 63.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.69 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.75 20.13 1.3 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.699 0.259 . . . . 0.0 111.699 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.0 93.8 3.62 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.554 0.216 . . . . 0.0 111.263 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.31 -16.28 50.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.387 2.058 . . . . 0.0 111.896 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 30.39 2.17 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 121.098 0.475 . . . . 0.0 110.519 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 90' ' ' THR . 34.5 m -150.84 69.59 0.97 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.535 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.984 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -72.47 176.17 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.512 -179.37 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.562 ' H ' HG12 ' A' ' 91' ' ' VAL . 38.3 m-85 -151.21 91.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.163 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.069 HG11 HG12 ' A' ' 50' ' ' ILE . 41.5 t -99.27 132.6 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.154 0.502 . . . . 0.0 111.37 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 42.3 t -127.38 123.15 35.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.148 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.714 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 7.2 m-85 -95.8 84.45 3.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.79 178.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.912 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -74.45 -167.38 0.53 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.973 0.416 . . . . 0.0 110.907 -179.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.798 HD13 ' HA2' ' A' ' 32' ' ' GLY . 13.5 mt -106.36 127.48 53.3 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.351 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -45.54 -35.93 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.75 0.309 . . . . 0.0 111.697 -179.212 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.0 -31.27 71.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.022 0.439 . . . . 0.0 110.383 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.668 HG23 ' CE2' ' A' ' 4' ' ' PHE . 62.9 mt -76.34 132.99 71.95 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.764 179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.56 -168.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.369 2.046 . . . . 0.0 112.127 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.97 67.39 0.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.642 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.503 ' HA ' HD13 ' A' ' 106' ' ' ILE . 4.7 tp -152.03 -40.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.953 HD11 HD11 ' A' ' 108' ' ' ILE . 12.1 tp -56.15 -63.99 2.78 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.129 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.912 ' HD3' HG21 ' A' ' 96' ' ' THR . 6.1 Cg_endo -47.57 -30.02 11.5 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.447 2.098 . . . . 0.0 111.51 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.839 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.8 mp -72.0 -41.05 68.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.575 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.508 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.2 OUTLIER -79.01 -28.12 43.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.731 179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.953 HD11 HD11 ' A' ' 104' ' ' LEU . 7.8 mm -68.08 -49.81 64.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.529 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.668 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -67.25 -54.8 17.61 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 85.1 p -60.38 -27.39 67.39 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.529 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -74.02 -44.36 30.31 Favored Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.933 HD23 ' HB2' ' A' ' 127' ' ' HIS . 17.0 mt -55.24 -28.87 56.25 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -70.02 -19.07 63.33 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.365 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -72.06 -20.88 61.6 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.51 ' HB2' ' CE1' ' A' ' 127' ' ' HIS . 6.3 m-85 -101.45 -29.88 11.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.063 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 4.6 mt-10 83.33 -51.86 0.15 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.005 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 6.8 m -46.43 -95.92 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.691 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.573 ' H ' HD22 ' A' ' 123' ' ' LEU . 2.4 p30 42.07 31.9 0.27 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.725 0.298 . . . . 0.0 110.706 -179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.57 33.01 4.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -152.95 148.85 27.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.559 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.41 ' HA ' ' H ' ' A' ' 20' ' ' SER . 5.0 p30 -69.95 23.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.424 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.526 ' H ' ' C ' ' A' ' 120' ' ' THR . 2.4 tt0 -163.84 24.86 0.08 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.618 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.7 tt -123.81 -56.89 1.65 Allowed 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.727 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.987 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.13 -45.16 64.85 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.432 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 90.0 p -47.76 -31.42 4.82 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.365 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.08 -56.69 16.33 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.264 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.933 ' HB2' HD23 ' A' ' 112' ' ' LEU . 3.4 m170 -60.17 -35.29 75.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.81 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.913 ' O ' HD12 ' A' ' 132' ' ' LEU . 46.7 t -53.16 -47.18 56.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.563 -0.455 . . . . 0.0 109.827 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -72.71 -37.74 57.39 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.193 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -74.43 -18.45 60.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.73 0.3 . . . . 0.0 111.344 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.529 HG21 ' HA3' ' A' ' 111' ' ' GLY . 26.4 mt -90.56 -28.0 4.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.913 HD12 ' O ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER -67.63 -52.04 42.97 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.485 179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.52 -29.45 64.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.968 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.0 m -98.27 -12.08 21.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CE2' HD21 ' A' ' 139' ' ' LEU . 6.6 t80 -58.44 -57.54 12.46 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.999 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.462 ' HA ' HD12 ' A' ' 139' ' ' LEU . 18.3 p80 -49.67 -37.8 30.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.024 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' N ' ' ND1' ' A' ' 136' ' ' HIS . 0.4 OUTLIER -55.52 -29.73 59.42 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -36.12 58.84 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.819 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.786 HD21 ' CE2' ' A' ' 135' ' ' PHE . 22.8 mt -66.05 -30.44 70.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.062 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.7 t -78.01 -49.15 22.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.437 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -63.15 -32.15 73.46 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.013 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.05 -31.72 72.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.222 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.797 ' O ' HD21 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -58.27 -26.13 62.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.035 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.629 ' HA ' HD21 ' A' ' 147' ' ' LEU . 42.8 m-20 -119.37 62.79 0.8 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.977 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -131.31 -45.76 1.0 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.064 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.5 t -150.58 85.3 1.37 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.845 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.797 HD21 ' O ' ' A' ' 143' ' ' ARG . 1.0 OUTLIER -106.82 177.76 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 -179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -79.14 78.19 5.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.808 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.18 -0.914 . . . . 0.0 110.874 179.968 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.1 132.59 48.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.84 30.72 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.896 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.734 ' CE2' HG23 ' A' ' 100' ' ' ILE . 2.3 m-85 54.67 175.61 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.088 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -177.67 108.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.307 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.948 HG11 HG22 ' A' ' 9' ' ' VAL . 1.4 t -68.05 141.16 18.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.31 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.454 ' OG ' ' HG ' ' A' ' 97' ' ' LEU . 0.0 OUTLIER -74.98 -63.13 1.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.16 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.64 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 3.0 m-85 -140.34 131.19 25.96 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.954 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.948 HG22 HG11 ' A' ' 6' ' ' VAL . 2.1 t -117.42 85.76 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.378 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.419 ' CG ' ' CG2' ' A' ' 17' ' ' THR . 0.9 OUTLIER -91.32 111.99 23.72 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.922 HG23 HD13 ' A' ' 124' ' ' LEU . 97.6 t -85.22 158.35 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.95 HD11 HG21 ' A' ' 50' ' ' ILE . 3.1 mt -138.69 121.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.833 0.349 . . . . 0.0 111.686 -179.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.573 ' HB3' HG23 ' A' ' 18' ' ' ILE . 6.2 tttt -110.82 102.94 11.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.91 0.386 . . . . 0.0 111.582 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 67.81 37.99 3.03 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.87 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.35 24.79 60.38 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.383 -0.913 . . . . 0.0 111.815 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.41 120.57 8.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.887 0.375 . . . . 0.0 110.256 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -53.31 120.84 6.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.753 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.573 HG23 ' HB3' ' A' ' 13' ' ' LYS . 0.3 OUTLIER -95.37 -51.09 11.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.016 178.65 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 120' ' ' THR . 57.9 p -123.08 177.93 5.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.953 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.451 ' H ' ' HA ' ' A' ' 121' ' ' ASN . 29.5 m -170.5 142.95 2.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.962 0.411 . . . . 0.0 111.322 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 23.6 t -125.64 70.33 1.19 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.862 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.64 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 3.8 m-85 -106.2 88.83 2.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.713 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.406 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -125.82 141.66 39.97 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.401 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 71.7 Cg_endo -74.7 -178.12 3.86 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.531 2.154 . . . . 0.0 111.791 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.728 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 1.1 p90 174.38 -21.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.481 ' HG3' ' HB ' ' A' ' 35' ' ' THR . 0.5 OUTLIER 68.95 132.63 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -51.24 -55.86 15.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.125 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 56.58 -81.71 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.415 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -167.72 -35.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.239 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -68.61 64.56 0.11 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.217 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' CE2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 45.49 93.66 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.462 179.772 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -169.76 159.95 32.83 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.578 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.928 ' HB ' HD22 ' A' ' 97' ' ' LEU . 37.8 m -129.03 -39.71 1.55 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.137 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.728 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 8.3 mt -51.7 158.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.346 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.656 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -176.01 -82.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.966 178.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.5 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -133.91 -40.95 0.84 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.734 0.302 . . . . 0.0 111.273 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.78 -28.56 55.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.559 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -115.12 31.9 6.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.249 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.6 26.16 4.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.016 0.436 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.53 -35.83 6.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.609 178.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.596 HG22 ' CE2' ' A' ' 46' ' ' PHE . 1.0 OUTLIER -52.69 115.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.514 178.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.837 ' CG2' HD12 ' A' ' 45' ' ' ILE . 1.4 t -76.01 152.29 84.38 Favored Pre-proline 0 CA--C 1.517 -0.327 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.671 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 74.4 Cg_exo -47.88 -21.73 2.8 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 121.84 1.693 . . . . 0.0 110.709 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 ' HB ' HG23 ' A' ' 42' ' ' THR . 96.0 t -65.86 -48.68 81.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.175 179.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.837 HD12 ' CG2' ' A' ' 42' ' ' THR . 1.7 mp -57.4 -33.27 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 C-N-CA 120.23 -0.588 . . . . 0.0 109.418 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.596 ' CE2' HG22 ' A' ' 41' ' ' ILE . 89.4 m-85 -81.0 -42.71 20.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.427 178.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.643 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -62.98 -28.19 69.92 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.011 179.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 -88.5 -30.07 19.64 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.515 HD13 ' HB3' ' A' ' 73' ' ' LEU . 4.8 mt -60.84 -60.23 4.13 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.965 HG12 HG11 ' A' ' 93' ' ' VAL . 5.7 mt -52.09 -62.78 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.164 -1.834 . . . . 0.0 110.065 177.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.643 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -50.26 -44.89 53.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.909 -179.067 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -90.86 -15.25 30.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.674 ' HB2' HD21 ' A' ' 73' ' ' LEU . 0.6 OUTLIER -122.12 -69.38 0.83 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.872 HG22 ' HG3' ' A' ' 69' ' ' MET . 70.9 t -53.93 -51.3 46.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.786 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.922 HD23 HG22 ' A' ' 50' ' ' ILE . 2.3 mm? -54.09 -58.39 13.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.96 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 25.3 Cg_endo -63.19 2.8 0.72 Allowed 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 122.154 1.902 . . . . 0.0 112.662 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.422 ' CB ' ' HE3' ' A' ' 69' ' ' MET . 0.0 OUTLIER -146.48 25.23 1.22 Allowed 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 120.941 0.401 . . . . 0.0 110.092 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.434 HG22 ' H ' ' A' ' 59' ' ' VAL . 3.9 p -87.78 165.27 2.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.934 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 58' ' ' VAL . 35.2 m -151.3 147.65 20.86 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.068 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.604 ' C ' HD12 ' A' ' 61' ' ' ILE . 66.6 Cg_endo -78.53 24.89 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.123 1.882 . . . . 0.0 112.939 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.691 HG22 ' H ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER 46.94 176.57 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.831 178.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.691 ' H ' HG22 ' A' ' 61' ' ' ILE . 43.0 mmtm -139.54 -46.16 0.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.05 0.452 . . . . 0.0 110.808 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.76 45.2 0.69 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.039 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.623 ' C ' HG21 ' A' ' 61' ' ' ILE . 0.8 OUTLIER 177.55 59.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.824 0.345 . . . . 0.0 110.766 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.483 ' N ' HG21 ' A' ' 61' ' ' ILE . 5.0 mmtp -43.39 156.41 0.05 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.205 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.884 HG21 ' HA ' ' A' ' 106' ' ' ILE . 3.3 t 71.27 69.68 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 120.868 0.366 . . . . 0.0 110.174 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.458 ' HB ' ' CE2' ' A' ' 81' ' ' TYR . 97.3 m -95.13 144.34 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.439 ' HG3' ' CZ ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -93.48 125.54 38.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.783 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.872 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -46.92 -33.85 4.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.06 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.1 p 56.71 26.92 11.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.16 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.471 ' HB2' HD12 ' A' ' 73' ' ' LEU . 1.5 mmt -107.83 -3.51 18.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.964 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.87 55.29 4.65 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.092 0.473 . . . . 0.0 110.408 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.754 HD11 ' SD ' ' A' ' 69' ' ' MET . 10.7 mp -55.77 -49.94 71.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 75' ' ' ASP . 0.2 OUTLIER -136.25 161.3 37.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.486 ' N ' HG23 ' A' ' 74' ' ' ILE . 19.5 t70 -100.09 140.25 34.59 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.275 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.54 -34.73 5.21 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.039 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.463 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -129.12 -179.02 4.88 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.707 0.289 . . . . 0.0 110.633 179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.508 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 19.6 m-20 -123.45 125.22 44.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.838 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.498 ' SG ' HD13 ' A' ' 73' ' ' LEU . 6.5 p -80.97 101.61 9.62 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.569 ' O ' HG13 ' A' ' 93' ' ' VAL . 63.4 m-85 -110.19 157.96 18.86 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.255 178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.808 ' CD1' HG13 ' A' ' 54' ' ' VAL . 9.8 p90 -149.99 132.09 15.35 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.17 0.51 . . . . 0.0 111.463 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.497 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 28.6 t -134.81 117.39 15.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.689 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.659 HG22 HG13 ' A' ' 91' ' ' VAL . 5.0 p -84.79 148.21 26.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.946 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -46.02 144.54 1.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.193 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -53.88 -21.99 8.94 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.952 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.04 23.29 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.69 0.281 . . . . 0.0 111.507 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -143.57 92.34 6.57 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.002 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.56 -15.13 43.97 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.27 1.98 . . . . 0.0 111.98 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -95.97 29.79 2.62 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.242 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 90' ' ' THR . 32.4 m -153.05 69.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.582 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -71.29 177.06 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.566 -179.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.511 ' H ' HG12 ' A' ' 91' ' ' VAL . 53.7 m-85 -151.64 83.34 1.29 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.387 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.965 HG11 HG12 ' A' ' 50' ' ' ILE . 32.5 t -89.08 133.47 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.965 0.412 . . . . 0.0 110.998 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . . . . . . . . . 52.2 t -131.07 119.17 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.882 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.508 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 10.1 m-85 -86.95 83.3 7.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.383 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.851 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -83.49 133.66 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 111.985 -178.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.928 HD22 ' HB ' ' A' ' 33' ' ' THR . 61.9 mt -46.57 125.4 7.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.052 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.1 OUTLIER -47.03 -33.48 2.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.748 0.309 . . . . 0.0 111.32 -179.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -60.43 -30.5 69.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.734 HG23 ' CE2' ' A' ' 4' ' ' PHE . 58.9 mt -78.77 132.32 64.91 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.899 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.06 -167.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.393 2.062 . . . . 0.0 112.007 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.593 ' HG2' HD11 ' A' ' 106' ' ' ILE . 2.2 tttt -108.67 67.0 0.65 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.663 ' HA ' HD13 ' A' ' 106' ' ' ILE . 3.0 tp -150.97 -38.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.749 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.88 HD21 HG23 ' A' ' 6' ' ' VAL . 5.0 tp -60.36 -62.3 6.22 Favored Pre-proline 0 C--N 1.329 -0.297 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.781 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.851 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.8 Cg_endo -46.23 -34.21 13.29 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.335 2.024 . . . . 0.0 111.308 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.884 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.2 mp -65.98 -38.77 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.546 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -82.02 -27.12 33.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.676 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.872 ' CG2' HG13 ' A' ' 128' ' ' VAL . 10.8 mm -68.09 -47.98 76.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.428 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.806 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -71.78 -54.93 8.64 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 27.4 t -59.32 -28.78 67.12 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.54 ' HA3' HG21 ' A' ' 131' ' ' ILE . . . -73.88 -47.66 18.95 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.282 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.921 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.1 mt -56.36 -31.56 63.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -74.95 -14.3 60.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.148 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -75.74 -24.41 56.11 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.343 179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.542 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 8.1 m-85 -86.17 -93.15 0.09 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.979 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 0.9 OUTLIER 160.38 -28.07 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.782 0.433 . . . . 0.0 110.297 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.485 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 72.4 p -107.33 127.27 53.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.491 0.662 . . . . 0.0 111.191 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 5.6 p30 -172.65 36.2 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.085 -0.962 . . . . 0.0 109.053 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -107.73 32.83 4.42 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.316 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.635 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -148.39 144.96 27.83 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.515 -0.474 . . . . 0.0 110.279 178.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.451 ' HA ' ' H ' ' A' ' 20' ' ' SER . 2.2 m120 -68.5 29.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.882 0.372 . . . . 0.0 111.834 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 120' ' ' THR . 11.1 tt0 -169.78 26.05 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.635 ' CB ' HG23 ' A' ' 120' ' ' THR . 8.5 tt -124.08 -58.01 1.57 Allowed 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.922 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -51.26 -43.84 61.63 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 177.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.465 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 88.4 p -47.7 -29.31 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.509 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -63.3 -61.81 2.11 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.126 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.921 ' HB2' HD23 ' A' ' 112' ' ' LEU . 35.2 m170 -57.24 -35.57 69.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.754 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.872 HG13 ' CG2' ' A' ' 108' ' ' ILE . 50.0 t -51.58 -48.88 35.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -69.06 -46.9 57.09 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.987 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -64.01 -20.33 65.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.734 0.302 . . . . 0.0 110.659 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.546 HG21 ' O ' ' A' ' 107' ' ' ARG . 44.7 mt -90.7 -28.45 4.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.764 ' CD2' HD11 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -62.36 -39.85 94.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.94 178.536 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.48 -32.96 72.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.455 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.26 24.29 7.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.843 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.6 ' CE2' HG23 ' A' ' 103' ' ' ILE . 1.1 t80 -93.54 -40.27 10.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.376 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -66.83 -30.78 71.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.593 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -30.02 31.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.417 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -36.22 45.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.984 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' A' ' 135' ' ' PHE . 22.5 mt -65.42 -33.48 76.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.766 179.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.9 t -74.71 -47.32 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-O 121.628 0.727 . . . . 0.0 109.183 178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -62.31 -32.55 73.31 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.017 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -34.04 76.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.474 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.678 ' O ' HD13 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -58.23 -23.44 55.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.087 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -84.83 -52.55 5.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.874 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -78.25 123.8 27.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.81 105.21 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.678 HD13 ' O ' ' A' ' 143' ' ' ARG . 4.1 tt -171.86 -45.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.967 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -97.11 29.77 3.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.876 179.898 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.802 0.334 . . . . 0.0 111.144 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -97.97 175.98 5.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.998 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 32.3 mmm-85 -147.18 -177.78 5.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.927 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.711 ' HE2' HG23 ' A' ' 100' ' ' ILE . 0.1 OUTLIER -148.01 139.15 23.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.715 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -166.12 106.93 0.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.215 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.026 HG22 HG23 ' A' ' 96' ' ' THR . 1.2 t -60.34 144.95 12.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.357 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.519 ' HA ' ' HZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -69.52 -71.49 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.291 -179.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.684 ' HB3' ' CD2' ' A' ' 22' ' ' PHE . 3.4 m-85 -134.23 142.03 47.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.989 0.423 . . . . 0.0 111.992 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.811 HG22 HG11 ' A' ' 6' ' ' VAL . 1.7 t -129.77 94.89 2.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.169 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 1.8 mt-10 -105.17 118.15 35.81 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.942 0.401 . . . . 0.0 111.978 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.911 ' CG2' HD13 ' A' ' 124' ' ' LEU . 16.8 t -84.53 158.04 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.728 HG21 HD11 ' A' ' 55' ' ' LEU . 2.1 mp -141.52 117.24 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -178.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HB2' ' CD1' ' A' ' 18' ' ' ILE . 10.1 tttt -101.35 107.53 18.91 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.276 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 59.22 37.63 23.72 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.809 179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.26 24.65 56.68 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.757 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -143.3 112.97 6.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.947 0.404 . . . . 0.0 110.108 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 18.3 m -46.46 125.69 7.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.333 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.489 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -100.98 -39.74 7.22 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.253 178.452 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.8 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -131.49 174.68 9.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.106 -179.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.492 ' N ' HD22 ' A' ' 124' ' ' LEU . 8.9 p -170.32 123.29 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.036 0.446 . . . . 0.0 111.704 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 26.0 t -113.97 69.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.684 ' CD2' ' HB3' ' A' ' 8' ' ' TYR . 2.0 m-85 -110.29 88.24 2.71 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.21 0.529 . . . . 0.0 110.982 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.404 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -130.32 148.57 70.4 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.508 -179.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.74 179.24 6.19 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.735 2.29 . . . . 0.0 111.949 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' HZ ' ' HA ' ' A' ' 7' ' ' SER . 2.3 p90 174.87 -25.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.604 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 9.6 tt0 71.61 60.9 0.15 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-O 121.042 0.449 . . . . 0.0 110.836 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -80.88 125.64 30.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.861 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -176.92 -51.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.996 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -56.47 -26.82 55.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.959 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -106.08 -61.52 1.5 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.948 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -178.28 94.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.918 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.622 ' CA ' HD13 ' A' ' 97' ' ' LEU . . . -178.74 -143.51 5.29 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.782 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.57 ' O ' HG22 ' A' ' 35' ' ' THR . 61.8 m -164.05 -39.25 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.782 0.325 . . . . 0.0 111.349 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.612 ' O ' HG22 ' A' ' 35' ' ' THR . 3.1 mt -48.23 151.14 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.73 -179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.612 HG22 ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER -173.93 -80.79 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.821 179.114 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.504 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -141.21 -44.39 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.943 0.401 . . . . 0.0 111.225 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.04 -33.96 77.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.324 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 -112.43 31.68 6.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.044 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.75 28.58 5.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.969 0.414 . . . . 0.0 110.914 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.7 -33.89 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.908 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.643 HG23 ' HB ' ' A' ' 45' ' ' ILE . 1.5 mt -51.73 140.23 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.767 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.553 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.5 t -94.6 151.66 39.36 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.465 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 80.0 Cg_exo -46.57 -28.25 6.11 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 121.825 1.683 . . . . 0.0 110.652 178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.553 ' HB ' HG23 ' A' ' 42' ' ' THR . 58.8 t -59.44 -42.14 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.566 178.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.643 ' HB ' HG23 ' A' ' 41' ' ' ILE . 23.4 mm -55.72 -51.68 56.63 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.519 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.686 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.518 ' O ' HD12 ' A' ' 50' ' ' ILE . 44.0 m-85 -71.34 -37.74 71.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.505 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.646 ' HA ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -63.02 -31.04 72.09 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.224 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -87.46 -28.69 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.658 HD11 HG13 ' A' ' 74' ' ' ILE . 3.7 mt -61.91 -59.97 4.33 Favored 'General case' 0 CA--C 1.512 -0.513 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.995 HG22 HD23 ' A' ' 55' ' ' LEU . 6.5 mt -50.31 -64.05 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 113.373 -1.739 . . . . 0.0 109.898 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.511 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.6 OUTLIER -53.13 -40.32 64.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.348 -178.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.72 -21.85 21.38 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 -177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.485 ' HB2' HD21 ' A' ' 73' ' ' LEU . 83.1 mmm -118.38 -59.34 1.9 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 81' ' ' TYR . 84.2 t -62.81 -59.94 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.995 HD23 HG22 ' A' ' 50' ' ' ILE . 2.9 mm? -45.33 -54.26 15.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 16.0 Cg_exo -67.78 4.32 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.269 1.98 . . . . 0.0 112.465 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 2.1 mptt -145.49 21.86 1.5 Allowed 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 120.94 0.4 . . . . 0.0 110.461 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 59' ' ' VAL . 4.4 p -87.22 167.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 58' ' ' VAL . 34.3 m -137.1 147.58 59.21 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.928 178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' A' ' 61' ' ' ILE . 72.3 Cg_endo -76.69 19.86 0.63 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.858 1.705 . . . . 0.0 112.546 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.588 HG21 ' N ' ' A' ' 65' ' ' LYS . 8.5 mm 50.47 164.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.197 -0.91 . . . . 0.0 112.142 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.515 ' N ' HG22 ' A' ' 61' ' ' ILE . 11.6 mmtt -69.57 -12.18 61.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.088 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.01 -28.21 0.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.789 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 173.27 108.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.647 0.26 . . . . 0.0 110.725 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.588 ' N ' HG21 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -161.67 169.88 20.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.077 0.465 . . . . 0.0 111.466 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 106' ' ' ILE . 98.7 t -131.29 90.53 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.17 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.473 ' CG2' ' CE1' ' A' ' 81' ' ' TYR . 3.4 t -98.34 168.5 10.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.993 0.425 . . . . 0.0 111.628 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -105.53 139.11 40.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.569 179.64 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.618 ' CG ' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -49.27 -29.01 5.26 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.042 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 68.1 p 52.12 26.29 3.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.154 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 62.5 tpp -113.95 -10.87 12.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.157 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.72 58.88 2.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.503 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.5 mp -59.87 -62.38 1.91 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.76 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.658 HG13 HD11 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -120.03 155.44 22.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.673 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -96.9 140.68 31.1 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.432 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.661 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 109.0 -32.74 6.64 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.275 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.462 ' HB3' ' O ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -126.62 163.1 24.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.937 0.399 . . . . 0.0 111.114 179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.503 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.9 OUTLIER -105.88 130.25 53.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.515 179.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 9.0 m -94.99 112.71 24.39 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 68' ' ' LYS . 44.0 m-85 -122.54 140.84 52.32 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.539 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.772 ' CD2' HG13 ' A' ' 54' ' ' VAL . 7.2 p90 -131.5 134.3 46.0 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.142 0.496 . . . . 0.0 111.305 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.479 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 11.4 t -136.17 118.57 15.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.61 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.686 HG22 HG13 ' A' ' 91' ' ' VAL . 64.8 p -85.0 144.41 28.31 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 90' ' ' THR . 7.5 t0 -43.65 148.19 0.37 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.588 -179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -73.31 -20.43 60.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.618 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.53 19.59 2.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.549 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -159.87 90.1 1.86 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.445 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -56.78 -18.8 28.45 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.619 2.212 . . . . 0.0 111.915 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -92.85 29.84 1.71 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.104 0.478 . . . . 0.0 110.679 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 90' ' ' THR . 23.3 m -149.51 68.08 1.02 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.26 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.686 HG13 HG22 ' A' ' 83' ' ' THR . 0.7 OUTLIER -64.27 179.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.211 -179.387 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.648 ' H ' HG12 ' A' ' 91' ' ' VAL . 98.0 m-85 -154.89 79.16 1.06 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.85 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.903 HG11 HG12 ' A' ' 50' ' ' ILE . 86.8 t -88.29 127.31 41.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.104 0.478 . . . . 0.0 111.312 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.466 ' HB2' HG13 ' A' ' 9' ' ' VAL . 43.4 t -125.9 117.51 23.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.5 m-85 -87.28 78.81 8.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.088 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.026 HG23 HG22 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -64.5 -165.94 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.898 0.38 . . . . 0.0 111.162 -179.368 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.622 HD13 ' CA ' ' A' ' 32' ' ' GLY . 56.4 mt -105.71 131.68 52.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.271 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.2 OUTLIER -46.84 -34.65 2.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.872 0.367 . . . . 0.0 111.336 -179.702 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -33.63 74.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.525 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.711 HG23 ' HE2' ' A' ' 4' ' ' PHE . 98.0 mt -72.76 129.96 86.06 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.816 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.81 -172.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.251 1.967 . . . . 0.0 111.516 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 64.13 0.88 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.908 0.385 . . . . 0.0 110.724 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.541 HG23 ' HZ ' ' A' ' 135' ' ' PHE . 0.4 OUTLIER -148.42 -38.29 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.86 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.624 HD11 ' CD2' ' A' ' 132' ' ' LEU . 16.9 tp -62.5 -62.25 6.08 Favored Pre-proline 0 CA--C 1.521 -0.136 0 C-N-CA 120.295 -0.562 . . . . 0.0 109.735 179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.862 ' HD3' HG21 ' A' ' 96' ' ' THR . 8.1 Cg_endo -48.71 -28.09 12.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.256 1.971 . . . . 0.0 110.908 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.68 ' HA ' HG21 ' A' ' 66' ' ' VAL . 13.2 mt -70.72 -64.6 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.691 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -55.61 -24.37 32.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.236 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.826 HD11 ' HG ' ' A' ' 132' ' ' LEU . 8.2 mm -72.58 -47.04 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.973 179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.557 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -63.47 -65.56 0.67 Allowed 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 28.9 t -51.94 -27.85 14.55 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.628 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -68.75 -50.2 37.7 Favored Glycine 0 N--CA 1.444 -0.78 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.714 178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.969 HD23 ' HB2' ' A' ' 127' ' ' HIS . 5.4 mt -54.85 -35.04 63.57 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -72.95 -16.35 61.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.197 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -74.61 -22.84 58.73 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.341 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.501 ' CD2' ' CD2' ' A' ' 127' ' ' HIS . 4.0 m-85 -82.37 -91.94 0.07 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 25.5 tt0 164.55 -27.96 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.629 0.252 . . . . 0.0 110.919 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.2 -90.27 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.712 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.562 ' N ' HD22 ' A' ' 123' ' ' LEU . 1.2 p-10 38.42 33.2 0.06 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.009 0.433 . . . . 0.0 110.977 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.09 34.52 4.61 Favored 'General case' 0 C--O 1.232 0.14 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -178.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -147.39 152.92 38.96 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.603 178.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.454 ' HA ' ' N ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -71.75 28.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.798 0.332 . . . . 0.0 111.737 -179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -172.29 28.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.569 HD23 ' C ' ' A' ' 123' ' ' LEU . 5.9 tt -134.69 -49.5 0.77 Allowed 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.6 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.911 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -55.79 -44.96 78.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.421 ' HB3' ' CB ' ' A' ' 21' ' ' CYS . 78.7 p -47.69 -30.25 3.65 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.252 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.04 -59.93 4.59 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.254 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.969 ' HB2' HD23 ' A' ' 112' ' ' LEU . 8.4 m170 -54.89 -37.99 67.0 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.617 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.742 HG13 HD12 ' A' ' 108' ' ' ILE . 41.9 t -51.67 -50.29 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.547 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.28 -48.82 36.05 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.656 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -19.5 65.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.757 0.313 . . . . 0.0 111.233 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 127' ' ' HIS . 69.9 mt -90.81 -27.4 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.826 ' HG ' HD11 ' A' ' 108' ' ' ILE . 0.4 OUTLIER -63.24 -46.09 88.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.113 178.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.38 -39.49 79.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.738 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -84.63 0.92 48.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.056 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.541 ' HZ ' HG23 ' A' ' 103' ' ' ILE . 17.1 t80 -65.96 -51.37 59.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.835 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.498 ' O ' HG23 ' A' ' 140' ' ' VAL . 90.5 m-70 -54.44 -31.07 54.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.884 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.0 -31.54 63.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.026 0.441 . . . . 0.0 110.362 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -80.0 -34.2 38.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.201 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.19 -31.69 67.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.014 0.435 . . . . 0.0 110.068 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 136' ' ' HIS . 91.6 t -74.11 -47.34 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -30.92 63.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.773 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.62 -29.18 66.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.497 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.81 ' HA ' HD11 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -78.26 59.83 2.38 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.888 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -177.68 -41.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -123.54 140.21 53.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 60.5 77.95 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.81 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.81 HD11 ' HA ' ' A' ' 143' ' ' ARG . 21.2 mt -145.75 141.89 28.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -84.44 77.9 9.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.823 0.344 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.405 ' HD3' ' CD1' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -93.72 159.13 15.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.859 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.425 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 10.1 mtm180 -131.77 159.81 37.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.643 ' HB3' HD13 ' A' ' 104' ' ' LEU . 22.1 m-85 -135.14 162.69 31.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.608 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.766 ' HA ' HD21 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -177.85 118.89 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.475 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.689 ' CG1' HG22 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -80.53 90.32 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.443 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.1 OUTLIER -37.37 -49.78 1.01 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.927 -178.535 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.614 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 9.1 m-85 -146.17 112.3 5.76 Favored 'General case' 0 C--O 1.219 -0.526 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.612 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.689 HG22 ' CG1' ' A' ' 6' ' ' VAL . 2.3 t -110.78 95.92 4.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.131 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.62 ' CD ' HG21 ' A' ' 17' ' ' THR . 0.4 OUTLIER -104.17 112.51 25.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.917 0.389 . . . . 0.0 111.882 -179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.949 HG23 HD13 ' A' ' 124' ' ' LEU . 76.4 t -81.68 156.06 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.671 HD11 HG21 ' A' ' 50' ' ' ILE . 2.2 mp -132.62 123.31 49.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.74 0.305 . . . . 0.0 111.428 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.532 ' HB2' HD13 ' A' ' 18' ' ' ILE . 6.3 tttm -108.06 90.41 3.29 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 74.01 40.86 0.43 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.879 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.85 20.24 63.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.344 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 16' ' ' GLU . 5.1 pt-20 -146.56 118.98 8.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.052 0.453 . . . . 0.0 110.11 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.62 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -51.81 124.9 13.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.852 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.56 HD11 ' CG1' ' A' ' 11' ' ' VAL . 0.3 OUTLIER -100.3 -50.31 10.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 120' ' ' THR . 45.0 p -121.54 176.11 5.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.006 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -170.24 141.83 2.12 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.987 0.422 . . . . 0.0 111.766 -179.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 37.6 t -128.74 69.23 1.38 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.444 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.4 m-85 -105.97 99.91 9.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.088 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.408 ' O ' ' CE1' ' A' ' 25' ' ' PHE . 3.1 mp0 -141.45 138.77 17.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.397 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -73.18 178.77 6.15 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.559 2.173 . . . . 0.0 111.842 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.454 ' CE2' ' HG3' ' A' ' 27' ' ' LYS . 1.9 p90 178.52 -25.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 35' ' ' THR . 12.8 mt-30 73.85 57.01 0.1 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.007 0.432 . . . . 0.0 110.756 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HG3' ' CE2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -72.18 108.11 5.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.771 179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.28 176.07 6.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 57.8 77.85 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.413 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 11.9 t-20 60.41 159.31 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.742 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CE2' ' HB2' ' A' ' 3' ' ' ARG . 17.9 p90 42.77 33.93 0.53 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.398 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.731 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . -151.65 165.01 30.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.952 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.528 ' HB ' HD22 ' A' ' 97' ' ' LEU . 17.1 m -163.86 -43.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.735 0.303 . . . . 0.0 111.0 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.53 ' O ' ' HB ' ' A' ' 35' ' ' THR . 24.2 mt -64.92 153.59 7.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.252 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 34' ' ' ILE . 0.5 OUTLIER 170.81 -31.9 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.645 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.0 t -176.92 -68.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.136 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.06 -26.52 6.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.395 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -123.85 31.27 5.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -126.05 26.8 6.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.042 0.449 . . . . 0.0 110.949 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -110.49 -36.53 5.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.548 179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.777 HG23 HG13 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -47.14 135.73 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.0 178.834 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.515 HG23 ' HB ' ' A' ' 44' ' ' VAL . 1.3 t -94.14 151.76 39.85 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.635 -179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 71.4 Cg_exo -47.22 -27.01 6.08 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 121.852 1.701 . . . . 0.0 110.513 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.515 ' HB ' HG23 ' A' ' 42' ' ' THR . 58.9 t -61.21 -42.68 94.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.571 178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.777 HG13 HG23 ' A' ' 41' ' ' ILE . 16.0 mm -56.94 -46.93 83.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.396 0.617 . . . . 0.0 109.638 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.653 ' O ' HD12 ' A' ' 50' ' ' ILE . 26.1 m-85 -73.17 -39.89 65.27 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.401 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.609 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.29 -31.26 72.36 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.318 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.5 OUTLIER -88.48 -29.64 19.99 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.885 HD11 HG13 ' A' ' 74' ' ' ILE . 6.1 mt -61.11 -60.79 3.21 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 177.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.096 HG22 HD23 ' A' ' 55' ' ' LEU . 5.6 mt -51.1 -63.97 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.839 177.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.609 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 6.0 tpp -50.08 -40.55 45.91 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.965 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.16 -21.45 21.15 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.559 ' HB2' HD21 ' A' ' 73' ' ' LEU . 56.1 mmm -117.69 -69.0 0.88 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.798 HG13 ' CD1' ' A' ' 81' ' ' TYR . 65.4 t -56.01 -55.9 15.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.786 -178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.096 HD23 HG22 ' A' ' 50' ' ' ILE . 3.4 mm? -47.13 -58.29 7.51 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.044 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 34.8 Cg_endo -65.99 6.82 0.42 Allowed 'Trans proline' 0 N--CA 1.464 -0.232 0 C-N-CA 122.143 1.895 . . . . 0.0 112.742 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.95 25.12 0.65 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 121.036 0.446 . . . . 0.0 110.099 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.596 HG21 HG11 ' A' ' 91' ' ' VAL . 8.8 p -81.84 150.85 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.084 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 61' ' ' ILE . 14.9 t -103.14 137.92 19.4 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.531 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' O ' ' C ' ' A' ' 61' ' ' ILE . 74.5 Cg_endo -74.25 29.76 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.241 1.961 . . . . 0.0 112.126 179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.488 ' H ' ' C ' ' A' ' 59' ' ' VAL . 26.1 mm 14.53 93.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.977 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.83 -50.52 3.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.099 0.476 . . . . 0.0 110.161 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -108.73 -28.86 4.35 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.652 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.439 ' O ' HG23 ' A' ' 61' ' ' ILE . 2.7 m-80 -84.46 -161.91 0.61 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.65 114.7 0.05 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.58 0.229 . . . . 0.0 110.974 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.824 HG21 ' HA ' ' A' ' 106' ' ' ILE . 4.4 t 67.79 75.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.828 0.347 . . . . 0.0 110.717 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.7 m -104.65 141.28 36.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 111.176 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.478 ' HG3' ' CD2' ' A' ' 80' ' ' PHE . 4.0 ttpt -84.62 141.99 30.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.641 ' CG ' HG22 ' A' ' 54' ' ' VAL . 6.4 mmm -58.27 -32.51 68.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.766 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 m 61.79 26.97 16.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.988 0.423 . . . . 0.0 110.945 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.42 ' HG2' ' HB3' ' A' ' 69' ' ' MET . 18.4 mmm -110.81 -11.27 14.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.86 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 62.84 59.85 1.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.106 0.479 . . . . 0.0 110.076 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.709 ' HB3' HD22 ' A' ' 49' ' ' LEU . 8.6 mp -58.63 -49.96 75.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.696 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.885 HG13 HD11 ' A' ' 49' ' ' LEU . 1.1 mt -137.26 154.7 30.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.791 179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.41 ' N ' ' CG2' ' A' ' 74' ' ' ILE . 29.6 t70 -95.3 142.96 27.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.543 179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.628 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 104.89 -35.36 5.12 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.954 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.798 ' O ' HG13 ' A' ' 98' ' ' VAL . 2.3 m-85 -113.01 -170.08 1.6 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 0.0 110.812 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 96' ' ' THR . 0.6 OUTLIER -144.06 118.36 9.59 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.199 179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.501 ' SG ' HG21 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -86.36 103.2 14.72 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -178.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.478 ' CD2' ' HG3' ' A' ' 68' ' ' LYS . 41.5 m-85 -118.46 119.48 34.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.976 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.798 ' CD1' HG13 ' A' ' 54' ' ' VAL . 33.0 p90 -109.83 151.45 26.99 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.304 0.573 . . . . 0.0 112.092 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.421 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 3.1 t -149.12 119.35 7.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.925 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.995 HG22 HG13 ' A' ' 91' ' ' VAL . 76.8 p -88.92 151.54 22.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 111.384 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -49.09 140.83 8.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.072 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -60.7 -16.74 42.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.889 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.35 22.29 0.94 Allowed 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -151.46 97.33 3.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 120.57 0.224 . . . . 0.0 111.377 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.08 -14.71 46.7 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.247 1.964 . . . . 0.0 111.976 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.81 30.04 2.81 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.285 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.568 HG22 ' O ' ' A' ' 90' ' ' THR . 23.9 m -152.73 69.98 0.88 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.657 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.995 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -74.09 178.56 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.324 -179.662 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.576 ' H ' HG12 ' A' ' 91' ' ' VAL . 49.6 m-85 -151.78 104.68 3.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.985 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.988 HG11 HG12 ' A' ' 50' ' ' ILE . 28.1 t -108.29 115.35 48.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.189 0.519 . . . . 0.0 111.493 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.403 ' SG ' HD21 ' A' ' 109' ' ' LEU . 28.3 p -111.17 116.06 30.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.101 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 8' ' ' TYR . 2.6 m-85 -89.23 84.22 6.5 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.537 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.528 ' CG2' HG13 ' A' ' 6' ' ' VAL . 8.1 p -85.89 156.91 20.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.776 0.322 . . . . 0.0 110.881 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.731 HD13 ' HA2' ' A' ' 32' ' ' GLY . 34.5 mt -69.59 127.81 34.29 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.573 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.798 HG13 ' O ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -42.66 -34.56 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.057 -179.229 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.412 ' HB3' ' N ' ' A' ' 31' ' ' TYR . 1.0 OUTLIER -62.44 -36.68 83.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.749 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.438 HG13 ' HB2' ' A' ' 97' ' ' LEU . 0.9 OUTLIER -63.38 136.39 96.68 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.775 179.537 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.42 ' HD2' HG23 ' A' ' 100' ' ' ILE . 23.3 Cg_endo -61.68 -167.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.184 1.923 . . . . 0.0 111.914 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.464 ' C ' HD13 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -108.75 66.78 0.64 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.895 -179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.462 HG23 ' CE1' ' A' ' 135' ' ' PHE . 6.3 tp -151.65 -44.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.656 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.643 HD13 ' HB3' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -57.97 -62.59 5.18 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.479 ' CD ' ' HB3' ' A' ' 104' ' ' LEU . 3.8 Cg_endo -46.53 -34.87 15.63 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.547 2.164 . . . . 0.0 111.098 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.8 mp -68.69 -37.27 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.897 178.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 104' ' ' LEU . 0.5 OUTLIER -81.41 -22.54 38.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.602 179.007 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 132' ' ' LEU . 35.5 mm -68.36 -48.16 74.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.361 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.819 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -73.88 -52.61 12.41 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.2 t -58.93 -29.18 66.91 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.547 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -75.47 -46.82 13.9 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.844 HD23 ' HB2' ' A' ' 127' ' ' HIS . 17.2 mt -56.22 -32.19 64.2 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -76.26 -15.88 59.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.213 178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -74.3 -25.46 59.59 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.783 0.325 . . . . 0.0 110.138 179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.504 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 3.6 m-85 -86.15 -90.68 0.1 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 1.2 tt0 159.69 -30.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.865 0.466 . . . . 0.0 109.767 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.883 ' HB3' HD21 ' A' ' 123' ' ' LEU . 0.3 OUTLIER -103.32 137.15 41.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.511 ' N ' HD22 ' A' ' 123' ' ' LEU . 0.9 OUTLIER 176.61 34.47 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.829 -1.078 . . . . 0.0 109.349 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.23 32.94 4.76 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -145.94 146.39 31.03 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.479 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.456 ' HA ' ' N ' ' A' ' 20' ' ' SER . 10.6 p30 -69.25 26.37 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.896 0.379 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.0 mt-10 -167.6 26.86 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.883 HD21 ' HB3' ' A' ' 117' ' ' SER . 8.2 tt -124.76 -57.25 1.55 Allowed 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.637 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.949 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.67 -41.49 63.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.431 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 13.5 t -49.61 -29.28 6.89 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.233 178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -61.73 -63.74 1.17 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.297 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.844 ' HB2' HD23 ' A' ' 112' ' ' LEU . 18.7 m170 -59.21 -30.6 68.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.03 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 124' ' ' LEU . 49.0 t -57.67 -41.95 80.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.0 178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.36 -48.71 10.34 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.137 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.71 -26.5 68.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.865 0.364 . . . . 0.0 110.585 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.547 HD13 ' C ' ' A' ' 111' ' ' GLY . 70.6 mt -85.49 -26.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.775 HD12 HD11 ' A' ' 108' ' ' ILE . 0.9 OUTLIER -60.95 -46.47 90.57 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.146 178.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.01 -43.93 73.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.052 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.18 -24.75 64.09 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.967 ' CZ ' HD11 ' A' ' 139' ' ' LEU . 0.8 OUTLIER -56.41 -44.99 80.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.425 ' HA ' HD12 ' A' ' 139' ' ' LEU . 9.8 m-70 -60.98 -45.23 95.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.826 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.8 -28.98 7.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.202 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -77.77 -35.45 51.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.105 179.154 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.967 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 17.7 mt -68.1 -28.59 67.48 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.327 179.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.34 -48.7 22.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-O 121.564 0.697 . . . . 0.0 109.585 179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.3 tp10 -65.53 -28.69 69.36 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.327 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -67.94 -31.48 71.25 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.47 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -54.91 -28.63 52.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.224 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -104.2 54.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 146' ' ' THR . 4.8 mm-40 -134.08 102.47 5.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.815 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 145' ' ' GLN . 15.2 t 44.63 40.8 4.34 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.471 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 mt -113.69 -66.93 1.04 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 60.11 35.37 21.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.915 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tpp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.79 0.329 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt 62.33 150.57 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.436 ' HB2' ' CB ' ' A' ' 99' ' ' ASP . 0.4 OUTLIER 59.72 42.87 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.99 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.809 ' HA ' HD13 ' A' ' 100' ' ' ILE . 1.5 m-30 -76.29 -166.07 0.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.043 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.934 ' HA ' HD21 ' A' ' 132' ' ' LEU . 43.1 t-20 78.11 138.41 0.07 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.013 0.435 . . . . 0.0 111.592 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.952 HG11 HG22 ' A' ' 9' ' ' VAL . 80.3 t -70.99 152.92 8.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.612 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.808 ' OG ' HD11 ' A' ' 34' ' ' ILE . 0.2 OUTLIER -96.41 -71.11 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.899 -179.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.709 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . 27.4 m-85 -128.87 111.97 13.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.332 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.952 HG22 HG11 ' A' ' 6' ' ' VAL . 2.3 t -103.91 97.82 6.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.824 0.345 . . . . 0.0 111.27 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.491 ' HG2' HG23 ' A' ' 17' ' ' THR . 1.2 tt0 -100.05 114.19 27.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.673 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.97 ' CG2' HD13 ' A' ' 124' ' ' LEU . 26.3 t -84.27 159.62 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 91' ' ' VAL . 3.6 mp -141.3 122.2 13.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.042 0.448 . . . . 0.0 112.046 -178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.549 ' HB2' HD13 ' A' ' 18' ' ' ILE . 12.1 tttm -104.15 99.05 8.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.363 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 63.34 41.68 7.49 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.387 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 55' ' ' LEU . . . 78.39 23.64 64.96 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.457 -0.878 . . . . 0.0 111.582 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -143.25 111.9 6.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.93 0.395 . . . . 0.0 110.319 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.491 HG23 ' HG2' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -45.15 126.41 6.1 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.309 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -105.18 -44.48 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.914 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.773 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.9 OUTLIER -127.76 178.16 6.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.375 -179.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.487 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 18.0 m -170.75 131.16 0.85 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.54 -179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.501 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 29.2 t -115.13 69.46 0.72 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.709 ' CE1' ' HB3' ' A' ' 8' ' ' TYR . 1.7 m-85 -107.66 87.65 2.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.472 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 4.0 mt-30 -126.06 111.77 24.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.941 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.76 164.89 10.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.49 2.126 . . . . 0.0 112.138 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.472 ' CD1' ' O ' ' A' ' 23' ' ' GLN . 0.1 OUTLIER -153.43 -31.37 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.478 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.631 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 33.5 tt0 67.91 37.95 2.96 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.994 0.426 . . . . 0.0 110.193 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? 58.37 91.91 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.572 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -51.9 -80.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -150.64 -74.61 0.16 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 110.712 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -83.3 -30.65 27.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 3' ' ' ARG . 2.1 p90 -122.47 154.63 37.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.868 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.45 132.5 6.92 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.557 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.684 ' HB ' HD22 ' A' ' 97' ' ' LEU . 88.9 m -118.84 -36.02 3.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.959 0.409 . . . . 0.0 110.684 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.808 HD11 ' OG ' ' A' ' 7' ' ' SER . 10.3 mt -53.0 155.92 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.498 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -173.13 -86.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.609 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.531 ' N ' ' OG1' ' A' ' 35' ' ' THR . 30.8 m -126.27 -2.95 6.9 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -111.15 -26.9 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.656 0.265 . . . . 0.0 111.324 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.573 ' O ' HG23 ' A' ' 34' ' ' ILE . 5.3 m-20 -124.47 31.09 5.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.0 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.555 ' HB2' HG22 ' A' ' 34' ' ' ILE . 0.5 OUTLIER -124.8 26.75 7.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.466 . . . . 0.0 111.029 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -112.37 -35.36 5.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.858 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.666 HG22 ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -55.38 123.79 7.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.955 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.885 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -86.08 149.36 50.0 Favored Pre-proline 0 CA--C 1.519 -0.228 0 CA-C-O 120.65 0.262 . . . . 0.0 110.435 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.554 ' HA ' ' CE1' ' A' ' 22' ' ' PHE . 2.0 Cg_endo -44.15 -22.75 0.57 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.713 2.275 . . . . 0.0 112.071 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.707 ' HB ' HG23 ' A' ' 42' ' ' THR . 5.3 t -67.73 -44.18 85.99 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.639 179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.885 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -59.12 -31.74 46.5 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.666 ' CE2' HG22 ' A' ' 41' ' ' ILE . 66.3 m-85 -80.14 -43.44 21.63 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.349 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.622 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -66.27 -25.84 67.06 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.537 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 44' ' ' VAL . 15.0 m-20 -90.4 -29.82 17.78 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.588 HD22 ' HB3' ' A' ' 73' ' ' LEU . 2.7 mt -58.34 -57.8 11.31 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.041 HG22 HD23 ' A' ' 55' ' ' LEU . 4.3 mt -57.97 -66.01 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 112.946 -1.934 . . . . 0.0 110.209 177.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.622 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 5.3 tpp -46.91 -41.64 16.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.65 -1.159 . . . . 0.0 112.713 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.08 -25.45 19.62 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.477 ' HB2' HD21 ' A' ' 73' ' ' LEU . 70.5 mmm -114.21 -63.71 1.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.708 HG13 ' CD1' ' A' ' 81' ' ' TYR . 55.9 t -62.23 -58.87 5.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.041 HD23 HG22 ' A' ' 50' ' ' ILE . 3.1 mm? -44.38 -55.9 9.13 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 55' ' ' LEU . 15.3 Cg_exo -68.5 5.11 1.36 Allowed 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.305 2.003 . . . . 0.0 112.03 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 mmtt -145.31 21.52 1.54 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.987 0.423 . . . . 0.0 110.311 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.515 HG23 ' CD2' ' A' ' 81' ' ' TYR . 3.9 p -84.77 165.56 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.935 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 61' ' ' ILE . 16.2 m -147.98 146.17 22.97 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.986 179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.502 ' HA ' HG21 ' A' ' 83' ' ' THR . 59.7 Cg_endo -74.44 25.48 0.35 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 121.992 1.795 . . . . 0.0 112.548 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.799 HD13 ' HE3' ' A' ' 65' ' ' LYS . 1.5 mp 52.05 155.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.221 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' N ' ' CG2' ' A' ' 61' ' ' ILE . 4.2 mmtt -126.75 -39.91 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.655 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.55 43.41 0.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.819 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 1.5 m-20 -139.18 -57.53 0.6 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.834 0.349 . . . . 0.0 111.188 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.799 ' HE3' HD13 ' A' ' 61' ' ' ILE . 0.1 OUTLIER 66.82 124.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.494 -179.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.845 HG21 ' HA ' ' A' ' 106' ' ' ILE . 7.0 t 68.94 62.06 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.877 0.37 . . . . 0.0 110.406 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.5 m -93.66 141.55 28.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.219 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 80' ' ' PHE . 9.4 tttm -87.95 137.63 32.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.324 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.557 ' HE1' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -54.79 -25.97 31.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.897 0.379 . . . . 0.0 110.709 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 t 53.93 25.5 5.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.374 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.626 ' HG2' HD12 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -118.23 1.9 11.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.177 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 56.71 78.6 0.21 Allowed 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 121.087 0.47 . . . . 0.0 110.457 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.847 HD13 ' SG ' ' A' ' 79' ' ' CYS . 11.0 mp -74.51 -42.77 58.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.646 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.55 HD11 ' CG2' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -138.1 155.46 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.719 179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -96.74 139.74 32.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.29 179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 110.18 -33.63 5.88 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.156 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.5 ' CE2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -134.26 176.26 8.76 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.826 0.346 . . . . 0.0 111.03 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 42.6 m-20 -113.67 129.2 56.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.564 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.847 ' SG ' HD13 ' A' ' 73' ' ' LEU . 25.1 p -90.4 112.55 24.19 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.515 ' O ' HG13 ' A' ' 93' ' ' VAL . 44.8 m-85 -119.84 153.72 35.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.374 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.708 ' CD1' HG13 ' A' ' 54' ' ' VAL . 38.4 p90 -144.38 128.04 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.117 0.484 . . . . 0.0 111.645 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.561 ' HA ' HD11 ' A' ' 61' ' ' ILE . 1.8 t -133.71 121.76 22.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.667 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 19.4 p -80.94 153.49 27.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.978 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -49.13 151.52 1.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.994 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.97 -6.72 49.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.658 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -153.49 20.48 0.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 111.709 0.262 . . . . 0.0 111.709 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -159.5 102.67 1.5 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 120.655 0.264 . . . . 0.0 111.318 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.05 -13.35 39.45 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.394 2.062 . . . . 0.0 112.013 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.1 mttt -96.65 30.48 2.6 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.351 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 90' ' ' THR . 20.1 m -153.57 71.9 0.9 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.559 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 83' ' ' THR . 0.3 OUTLIER -70.16 177.47 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.317 -179.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.58 ' H ' HG12 ' A' ' 91' ' ' VAL . 95.7 m-85 -152.38 96.8 2.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.863 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.009 HG11 HG12 ' A' ' 50' ' ' ILE . 77.4 t -100.28 128.2 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.619 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' VAL . 20.4 p -124.85 138.07 54.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.168 0.508 . . . . 0.0 111.117 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 7.3 m-85 -106.0 89.41 3.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.737 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.849 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.6 OUTLIER -89.17 124.51 34.42 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.157 -179.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.684 HD22 ' HB ' ' A' ' 33' ' ' THR . 28.8 mt -42.53 135.36 2.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -46.26 -27.36 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 3' ' ' ARG . 2.5 m-20 -68.56 -22.03 64.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.792 0.33 . . . . 0.0 111.102 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.809 HD13 ' HA ' ' A' ' 4' ' ' PHE . 3.7 mm -70.49 135.99 86.22 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.287 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.497 ' HD3' ' CE2' ' A' ' 4' ' ' PHE . 38.2 Cg_endo -66.14 -164.61 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.305 2.004 . . . . 0.0 111.583 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -108.08 66.49 0.65 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.764 0.316 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.716 HG23 ' CZ ' ' A' ' 135' ' ' PHE . 6.1 tp -164.67 -34.75 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.744 ' O ' HG12 ' A' ' 108' ' ' ILE . 3.8 tp -62.32 -62.8 5.09 Favored Pre-proline 0 C--N 1.333 -0.142 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.652 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.849 ' HD3' HG21 ' A' ' 96' ' ' THR . 2.2 Cg_endo -44.99 -31.74 5.77 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.502 2.135 . . . . 0.0 111.155 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.845 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.0 mp -73.18 -41.76 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.231 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.641 ' O ' HG21 ' A' ' 131' ' ' ILE . 1.9 mmt180 -76.77 -23.2 52.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.794 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.858 ' CG2' HG13 ' A' ' 128' ' ' VAL . 7.1 mm -70.11 -59.63 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.235 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.544 HD23 HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -61.8 -55.59 28.43 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.8 t -59.6 -25.5 64.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.525 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -72.59 -47.02 29.15 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.526 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.957 HD23 ' HB2' ' A' ' 127' ' ' HIS . 8.1 mt -55.88 -26.26 46.42 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -18.01 61.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.34 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -70.13 -23.97 63.1 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.604 ' CB ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 m-85 -100.43 -166.48 1.33 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.591 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -124.79 -2.4 7.82 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.528 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 49.6 m -127.69 123.34 35.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.464 0.65 . . . . 0.0 111.094 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.483 ' HA ' HD22 ' A' ' 123' ' ' LEU . 0.6 OUTLIER -171.5 38.05 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.142 -0.936 . . . . 0.0 108.765 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.462 ' HA ' ' OG ' ' A' ' 19' ' ' SER . . . -114.2 36.19 3.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.323 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.55 ' O ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -147.82 152.14 37.16 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 120.329 -0.548 . . . . 0.0 111.366 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.487 ' HA ' ' N ' ' A' ' 20' ' ' SER . 66.4 m-20 -71.6 22.13 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.484 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 120' ' ' THR . 1.2 tm-20 -164.66 26.21 0.06 Allowed 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.525 ' CB ' HG23 ' A' ' 120' ' ' THR . 6.9 tt -124.92 -56.73 1.55 Allowed 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.702 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.97 HD13 ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.46 -41.07 62.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.461 ' N ' ' HG ' ' A' ' 124' ' ' LEU . 78.4 p -51.46 -31.42 23.26 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.34 178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -61.14 -61.54 2.49 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.453 -179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.957 ' HB2' HD23 ' A' ' 112' ' ' LEU . 54.2 m170 -59.15 -32.95 70.34 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.084 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.858 HG13 ' CG2' ' A' ' 108' ' ' ILE . 62.0 t -53.45 -45.06 57.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -74.69 -43.92 27.42 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 119.803 -1.189 . . . . 0.0 111.574 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -63.7 -21.3 66.33 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.927 0.394 . . . . 0.0 110.601 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.641 HG21 ' O ' ' A' ' 107' ' ' ARG . 28.0 mt -90.11 -27.24 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.934 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.3 OUTLIER -61.38 -41.97 97.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.172 178.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 29.6 m-20 -65.64 -39.32 91.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.85 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.78 -15.63 44.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.186 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.716 ' CZ ' HG23 ' A' ' 103' ' ' ILE . 2.8 t80 -53.15 -56.64 14.8 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.494 ' HA ' HD12 ' A' ' 139' ' ' LEU . 27.1 p80 -59.77 -42.56 93.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -50.46 -30.75 13.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.007 0.432 . . . . 0.0 110.026 179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 73.1 mm-40 -75.62 -36.57 60.2 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.972 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.56 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 23.2 mt -65.71 -30.57 71.26 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.229 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.4 t -78.03 -49.18 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.472 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -62.85 -31.29 72.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.974 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.0 OUTLIER -64.76 -25.45 67.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.421 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.14 56.79 2.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.912 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.413 ' C ' HD12 ' A' ' 147' ' ' LEU . 25.6 t30 -179.83 -41.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.725 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -81.55 169.8 16.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.958 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 13.5 p 54.67 31.53 15.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 144' ' ' ASN . 3.1 mt -127.89 -179.13 4.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.938 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.3 -31.21 14.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.85 -179.946 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.775 0.322 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 30' ' ' ASN . 10.0 tttt -166.7 147.72 6.08 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.893 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' O ' HD23 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -107.9 43.24 1.23 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.724 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' HG23 ' A' ' 100' ' ' ILE . 26.0 m-85 63.06 169.38 0.14 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.918 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.494 ' HA ' HD21 ' A' ' 132' ' ' LEU . 1.3 t30 -166.03 111.63 0.85 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.034 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.812 HG21 HG13 ' A' ' 108' ' ' ILE . 71.0 t -63.0 142.29 16.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.822 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.441 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.5 OUTLIER -63.81 -67.15 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.251 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.645 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 2.2 m-85 -150.02 121.57 7.99 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.452 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.699 HG22 HG11 ' A' ' 6' ' ' VAL . 2.1 t -107.57 95.59 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.303 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' SER . 3.0 tt0 -105.31 117.29 33.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.973 0.416 . . . . 0.0 111.626 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.903 HG23 HD13 ' A' ' 124' ' ' LEU . 11.9 t -83.18 155.09 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.556 178.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.681 HG21 HD11 ' A' ' 55' ' ' LEU . 3.2 mp -131.63 118.35 38.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.54 ' N ' HG12 ' A' ' 18' ' ' ILE . 3.2 tptt -103.68 104.8 14.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.386 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 65.8 23.33 11.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.512 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.468 ' HA2' ' CG2' ' A' ' 12' ' ' ILE . . . 76.38 38.88 32.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.549 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.72 18.19 1.82 Allowed 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER 60.08 150.17 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.008 179.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.54 HG12 ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -139.59 -47.51 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.921 178.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.549 ' HB2' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -126.56 175.02 8.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.346 -179.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.483 ' N ' ' HA ' ' A' ' 121' ' ' ASN . 11.6 p -170.48 121.55 0.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.592 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 27.2 t -108.58 71.0 0.77 Allowed 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.645 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.5 m-85 -106.15 83.08 1.84 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.904 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.77 141.84 23.59 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.195 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.35 152.7 20.82 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.634 2.223 . . . . 0.0 112.38 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' CZ ' HD12 ' A' ' 34' ' ' ILE . 27.2 p90 177.37 155.34 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.613 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.635 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 53.9 mt-30 -116.77 36.03 4.34 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.984 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 29' ' ' GLU . 7.3 tttt 80.5 -9.59 1.35 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.995 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 61.05 -81.16 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.812 0.339 . . . . 0.0 111.005 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 27' ' ' LYS . 5.2 tt0 -140.52 -48.26 0.43 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.784 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.424 ' O ' ' HD3' ' A' ' 2' ' ' LYS . 1.7 t-20 -141.09 -177.22 5.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.742 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 40.44 77.35 0.05 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.608 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . -176.61 -165.54 32.34 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.81 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.766 ' HB ' HD22 ' A' ' 97' ' ' LEU . 18.1 m -163.85 -43.55 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.897 0.38 . . . . 0.0 110.833 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.642 HG13 HD21 ' A' ' 97' ' ' LEU . 6.2 mt -61.87 142.74 15.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.278 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.635 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.5 OUTLIER -172.75 -81.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.632 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.51 ' N ' ' OG1' ' A' ' 35' ' ' THR . 0.3 OUTLIER -131.36 59.86 1.68 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.769 0.319 . . . . 0.0 110.992 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.19 -42.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.173 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -105.94 30.09 6.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.56 28.54 6.56 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -113.35 -35.75 5.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.097 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.715 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -54.41 124.58 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.102 179.29 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.904 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -86.97 149.65 48.23 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.562 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.513 ' HA ' ' CE2' ' A' ' 22' ' ' PHE . 3.4 Cg_exo -43.52 -23.28 0.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.679 2.253 . . . . 0.0 112.098 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.703 ' HB ' HG23 ' A' ' 42' ' ' THR . 3.5 t -66.88 -48.98 78.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.449 179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.904 HD12 HG22 ' A' ' 42' ' ' THR . 2.3 mp -54.09 -36.39 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.715 ' CE1' HG22 ' A' ' 41' ' ' ILE . 66.8 m-85 -76.49 -43.11 41.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.35 177.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.675 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.91 -23.49 67.37 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.346 179.896 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' N ' ' O ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -86.47 -33.54 20.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.679 179.845 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 73' ' ' LEU . 12.2 mt -58.78 -63.36 1.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.063 HG12 HG11 ' A' ' 93' ' ' VAL . 3.9 mt -49.39 -58.89 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 113.732 -1.576 . . . . 0.0 111.044 177.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.675 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -53.79 -56.78 14.45 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.345 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.04 -9.71 44.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -177.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.646 ' HB3' HD21 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -117.47 -62.14 1.61 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -177.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.564 HG13 ' CD1' ' A' ' 81' ' ' TYR . 59.3 t -68.0 -59.75 3.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.927 0.394 . . . . 0.0 111.914 -178.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.681 ' CD2' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER -43.04 -51.48 13.01 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -179.131 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 24.6 Cg_endo -63.18 -1.63 3.12 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 121.809 1.672 . . . . 0.0 112.344 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HB3' ' HE1' ' A' ' 69' ' ' MET . 0.0 OUTLIER -147.86 23.11 1.1 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 121.05 0.452 . . . . 0.0 109.993 179.185 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 81' ' ' TYR . 2.8 p -76.37 155.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.774 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 61' ' ' ILE . 33.0 m -146.08 147.07 30.55 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.107 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.776 ' C ' HD12 ' A' ' 61' ' ' ILE . 60.6 Cg_endo -76.14 25.81 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.852 1.702 . . . . 0.0 112.214 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.798 HD13 ' HG3' ' A' ' 65' ' ' LYS . 0.3 OUTLIER 47.5 173.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.082 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.564 ' H ' HG22 ' A' ' 61' ' ' ILE . 2.0 mmtt -98.53 -75.81 0.55 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.931 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.65 17.35 2.43 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.984 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -117.02 -30.58 5.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.812 0.339 . . . . 0.0 110.984 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.798 ' HG3' HD13 ' A' ' 61' ' ' ILE . 6.5 mptt 58.32 155.54 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.254 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.851 HG13 HD23 ' A' ' 109' ' ' LEU . 2.8 t 66.52 63.19 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.862 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.7 m -86.04 134.08 33.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.016 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 4.5 ttpp -85.03 130.06 34.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.028 0.442 . . . . 0.0 110.827 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.619 ' HG2' HD11 ' A' ' 73' ' ' LEU . 6.7 tpt -50.79 -27.48 7.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.412 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 48.38 28.25 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.189 0.519 . . . . 0.0 110.74 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.424 ' O ' ' HG3' ' A' ' 71' ' ' MET . 4.0 tpp -109.95 -12.31 14.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.987 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 63.51 61.79 1.0 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.463 . . . . 0.0 109.786 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.658 ' HB3' HD13 ' A' ' 49' ' ' LEU . 9.5 mp -66.13 -45.23 81.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.03 -179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.625 HD11 ' CG2' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -132.71 159.7 43.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.029 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.431 ' N ' HG23 ' A' ' 74' ' ' ILE . 7.7 t70 -101.97 142.03 33.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.397 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.68 -35.59 4.91 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.842 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CE1' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -133.38 175.25 9.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.788 0.328 . . . . 0.0 110.819 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 40.8 m-20 -113.11 152.58 29.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.508 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 68' ' ' LYS . 4.9 t -111.65 116.06 30.16 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CZ ' ' CD ' ' A' ' 68' ' ' LYS . 85.5 m-85 -123.28 144.57 49.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.248 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CD1' HG13 ' A' ' 54' ' ' VAL . 39.1 p90 -135.17 125.01 25.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.11 0.481 . . . . 0.0 111.533 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.453 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.5 t -129.21 121.06 26.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.668 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.68 ' H ' HD11 ' A' ' 61' ' ' ILE . 8.4 p -82.18 150.75 27.23 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.699 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -46.51 149.65 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.984 0.421 . . . . 0.0 111.134 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.56 -17.45 46.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.981 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -156.16 22.65 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -146.1 94.55 4.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.713 0.292 . . . . 0.0 111.054 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -63.72 -15.09 46.74 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.416 2.077 . . . . 0.0 112.166 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.7 mmtp -96.0 26.32 4.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.072 0.463 . . . . 0.0 110.268 179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 90' ' ' THR . 38.0 m -150.7 69.5 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 83' ' ' THR . 0.2 OUTLIER -69.06 178.7 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.14 -179.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.537 ' H ' HG12 ' A' ' 91' ' ' VAL . 96.2 m-85 -153.16 91.6 1.54 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.446 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.063 HG11 HG12 ' A' ' 50' ' ' ILE . 35.4 t -91.43 125.17 44.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.066 0.46 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.431 ' SG ' HG11 ' A' ' 6' ' ' VAL . 44.3 t -120.44 126.12 49.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.29 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ASP . 5.9 m-85 -99.06 116.86 32.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.372 178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.956 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.1 OUTLIER -119.9 132.86 55.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.085 0.469 . . . . 0.0 111.636 -179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.766 HD22 ' HB ' ' A' ' 33' ' ' THR . 31.3 mt -49.91 125.59 12.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.036 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -43.73 -31.14 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.71 -179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -62.37 -35.14 78.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.78 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.499 HG23 ' HD2' ' A' ' 101' ' ' PRO . 40.5 mt -74.18 138.25 75.47 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.967 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.499 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.9 Cg_endo -57.9 -169.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.468 2.112 . . . . 0.0 112.273 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -109.03 67.29 0.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.693 HG23 ' CE2' ' A' ' 135' ' ' PHE . 1.1 tp -153.27 -38.22 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.441 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.803 ' HG ' HD11 ' A' ' 108' ' ' ILE . 25.1 tp -59.33 -57.17 29.02 Favored Pre-proline 0 C--N 1.331 -0.204 0 C-N-CA 120.625 -0.43 . . . . 0.0 109.901 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.956 ' HD3' HG21 ' A' ' 96' ' ' THR . 7.5 Cg_endo -49.9 -37.45 46.07 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 122.422 2.081 . . . . 0.0 111.039 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.833 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.9 mp -67.0 -32.4 57.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.815 178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.609 ' O ' HG21 ' A' ' 131' ' ' ILE . 0.1 OUTLIER -81.73 -26.62 34.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.594 179.329 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.812 HG13 HG21 ' A' ' 6' ' ' VAL . 5.9 mm -66.92 -47.96 80.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.372 179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.851 HD23 HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -73.77 -58.2 3.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.181 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.1 t -56.46 -30.57 63.04 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.493 ' HA3' HD13 ' A' ' 131' ' ' ILE . . . -76.25 -43.3 21.13 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 178.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.722 HD23 ' HB2' ' A' ' 127' ' ' HIS . 7.0 mt -57.85 -31.51 66.74 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.67 -14.73 59.94 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.94 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.25 -21.31 56.5 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.451 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.571 ' HB2' ' CE1' ' A' ' 127' ' ' HIS . 5.1 m-85 -88.58 -97.86 0.09 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.999 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 115' ' ' TYR . 34.6 tp10 159.04 -22.46 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 122.672 0.389 . . . . 0.0 110.873 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.676 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 5.9 t -121.75 99.75 6.63 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.28 0.562 . . . . 0.0 111.243 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -152.34 45.43 0.73 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.333 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -110.21 33.89 4.21 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.55 HG23 HD13 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -144.11 157.52 44.26 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.236 178.791 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.483 ' HA ' ' N ' ' A' ' 20' ' ' SER . 78.7 m-20 -74.62 17.09 0.22 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.689 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 120' ' ' THR . 0.8 OUTLIER -163.67 29.03 0.08 Allowed 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.582 ' O ' HD23 ' A' ' 123' ' ' LEU . 5.9 tt -131.04 -45.82 1.02 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.575 -179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.903 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -59.78 -43.04 94.57 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.7 p -46.65 -27.15 1.07 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.64 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.4 OUTLIER -59.06 -56.79 17.73 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.295 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.722 ' HB2' HD23 ' A' ' 112' ' ' LEU . 8.1 m170 -60.87 -36.5 79.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.87 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.636 HG13 ' CG2' ' A' ' 108' ' ' ILE . 46.0 t -52.06 -44.09 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.889 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -75.97 -47.05 12.03 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 119.771 -1.204 . . . . 0.0 112.371 179.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -64.94 -21.13 66.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.773 0.32 . . . . 0.0 111.2 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 127' ' ' HIS . 60.7 mt -90.5 -28.09 4.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.68 HD11 HG23 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -66.93 -35.07 79.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.351 178.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 22.4 t0 -69.57 -38.89 77.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.762 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.0 t -84.08 -13.62 52.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.984 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.796 ' CE1' HD11 ' A' ' 139' ' ' LEU . 13.2 t80 -54.91 -55.1 34.23 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.996 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.525 ' HA ' HD12 ' A' ' 139' ' ' LEU . 18.6 p80 -58.33 -38.09 76.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.883 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HG2' ' CE1' ' A' ' 136' ' ' HIS . 6.0 mm-40 -54.56 -31.49 56.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.111 0.482 . . . . 0.0 110.225 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.42 -34.88 47.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.913 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.796 HD11 ' CE1' ' A' ' 135' ' ' PHE . 23.5 mt -66.74 -35.11 79.35 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.793 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 81.5 t -74.18 -47.33 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 115.409 -0.814 . . . . 0.0 108.818 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.19 -33.87 74.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.743 178.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -16.97 64.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.414 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.436 ' HD3' HD11 ' A' ' 147' ' ' LEU . 0.1 OUTLIER -93.62 33.49 1.27 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.255 -179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -148.99 29.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.851 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -152.92 -72.35 0.14 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.851 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 p -98.33 59.99 1.36 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.874 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.436 HD11 ' HD3' ' A' ' 143' ' ' ARG . 2.3 tt -109.98 118.94 37.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -108.37 -31.53 7.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.988 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.911 -179.987 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.871 0.367 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.77 147.41 51.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.88 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.403 ' O ' ' CD2' ' A' ' 4' ' ' PHE . 1.4 mmp_? -115.22 179.5 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.003 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.407 ' CE1' HG23 ' A' ' 100' ' ' ILE . 18.0 m-85 -159.64 173.12 16.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.935 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.69 ' HA ' HD21 ' A' ' 132' ' ' LEU . 1.7 m120 -175.72 132.97 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.815 HG13 HG23 ' A' ' 96' ' ' THR . 3.4 t -82.08 109.23 15.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.425 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 0.2 OUTLIER -39.18 -59.42 1.02 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.239 -179.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.678 ' HB3' ' CE2' ' A' ' 22' ' ' PHE . 7.6 m-85 -148.68 113.12 5.3 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.404 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.861 HG13 ' SG ' ' A' ' 94' ' ' CYS . 2.8 t -107.12 100.75 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.412 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.677 ' CD ' HG21 ' A' ' 17' ' ' THR . 1.0 OUTLIER -111.36 128.89 56.11 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.105 0.478 . . . . 0.0 111.769 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.886 HG23 HD13 ' A' ' 124' ' ' LEU . 53.1 t -98.1 143.46 12.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.536 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.967 HD11 HG21 ' A' ' 50' ' ' ILE . 2.7 mp -117.24 118.32 58.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.684 ' HB2' HD13 ' A' ' 18' ' ' ILE . 7.0 tptt -99.72 102.24 13.64 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.871 -0.332 . . . . 0.0 111.419 178.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 62.01 39.75 12.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.562 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.53 24.4 60.77 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.827 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -145.12 113.75 6.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.931 0.396 . . . . 0.0 110.102 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.677 HG21 ' CD ' ' A' ' 10' ' ' GLU . 0.2 OUTLIER -50.24 126.78 15.6 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.715 -179.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.684 HD13 ' HB2' ' A' ' 13' ' ' LYS . 0.7 OUTLIER -105.01 -50.45 8.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.415 179.129 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 120' ' ' THR . 63.9 p -119.26 172.43 7.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.266 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.548 ' N ' HD22 ' A' ' 124' ' ' LEU . 6.5 m -168.28 133.47 1.77 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.928 0.394 . . . . 0.0 112.054 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.514 ' HB3' ' HB ' ' A' ' 9' ' ' VAL . 36.0 t -116.88 69.42 0.75 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.678 ' CE2' ' HB3' ' A' ' 8' ' ' TYR . 1.6 m-85 -104.62 96.58 6.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.298 -178.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -135.62 129.23 18.37 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.426 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -81.36 151.37 17.64 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.658 2.239 . . . . 0.0 112.008 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' HZ ' ' HA ' ' A' ' 7' ' ' SER . 0.1 OUTLIER -134.95 -29.87 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.813 -179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 35' ' ' THR . 22.1 tt0 78.27 29.42 0.45 Allowed 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.963 0.411 . . . . 0.0 110.808 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.86 169.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.018 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -169.19 -159.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.502 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.48 63.92 0.27 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.891 0.377 . . . . 0.0 110.764 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -179.28 -168.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.546 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -75.84 103.57 5.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.072 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.579 ' HA2' HD13 ' A' ' 97' ' ' LEU . . . -142.85 -176.12 16.62 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.53 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.854 ' HB ' HD22 ' A' ' 97' ' ' LEU . 96.0 m -159.31 -43.38 0.05 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.827 0.346 . . . . 0.0 111.331 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.647 HG13 HD21 ' A' ' 97' ' ' LEU . 8.5 mt -53.47 143.52 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.412 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 26' ' ' GLN . 0.4 OUTLIER 176.62 -32.66 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.434 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.5 t -167.07 -80.66 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.784 0.326 . . . . 0.0 111.454 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.08 -25.23 4.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.536 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.524 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 2.9 m120 -122.68 31.74 5.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.049 -179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -134.26 27.3 3.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.094 0.473 . . . . 0.0 110.971 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -118.42 -28.91 5.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.455 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.672 HG22 ' CE2' ' A' ' 46' ' ' PHE . 3.7 mm -55.98 125.13 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.934 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.959 HG22 HD12 ' A' ' 45' ' ' ILE . 8.9 t -85.44 149.54 52.16 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.512 ' O ' ' HB3' ' A' ' 47' ' ' HIS . 2.2 Cg_endo -44.87 -22.04 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.354 2.036 . . . . 0.0 111.583 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.761 ' HB ' HG23 ' A' ' 42' ' ' THR . 93.6 t -66.9 -45.73 86.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.11 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.959 HD12 HG22 ' A' ' 42' ' ' THR . 2.1 mp -59.62 -34.55 55.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.225 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.672 ' CE2' HG22 ' A' ' 41' ' ' ILE . 39.1 m-85 -79.41 -42.87 24.51 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.316 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.659 ' O ' ' HB2' ' A' ' 51' ' ' MET . 0.0 OUTLIER -63.54 -30.51 71.62 Favored 'General case' 0 C--O 1.226 -0.172 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.657 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 49' ' ' LEU . 25.8 p30 -89.51 -26.04 21.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.622 HD22 HD23 ' A' ' 73' ' ' LEU . 3.6 mt -64.54 -61.16 2.38 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.016 HG12 HG11 ' A' ' 93' ' ' VAL . 6.4 mt -49.53 -62.93 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 113.441 -1.709 . . . . 0.0 109.493 176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.659 ' HB2' ' O ' ' A' ' 47' ' ' HIS . 0.0 OUTLIER -51.21 -43.0 61.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.836 -1.529 . . . . 0.0 113.173 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -90.84 -15.16 30.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.579 ' HB2' HD21 ' A' ' 73' ' ' LEU . 90.9 mmm -123.76 -70.49 0.76 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.855 HG13 ' CD2' ' A' ' 81' ' ' TYR . 88.6 t -51.39 -50.08 29.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.889 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.948 HD23 HG22 ' A' ' 50' ' ' ILE . 3.0 mm? -56.18 -58.9 13.74 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.168 -0.469 . . . . 0.0 112.032 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 55' ' ' LEU . 23.5 Cg_endo -62.31 4.71 0.3 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.285 1.99 . . . . 0.0 113.12 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' HB3' ' CE ' ' A' ' 69' ' ' MET . 1.6 tptp -153.25 26.98 0.52 Allowed 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.112 0.482 . . . . 0.0 110.164 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG21 HG11 ' A' ' 91' ' ' VAL . 7.7 p -82.22 150.67 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.161 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' A' ' 81' ' ' TYR . 9.0 t -97.71 138.41 21.05 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.399 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 61' ' ' ILE . 71.1 Cg_endo -76.23 27.83 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.912 1.741 . . . . 0.0 111.696 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 61' ' ' ILE . 26.4 mm 20.25 81.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-N 115.025 -0.989 . . . . 0.0 113.01 179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.37 -42.8 11.33 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.174 0.511 . . . . 0.0 110.048 179.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.06 -26.51 1.86 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.113 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.439 ' O ' HG23 ' A' ' 61' ' ' ILE . 10.7 m120 -79.61 -159.27 0.19 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.703 0.287 . . . . 0.0 110.649 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.521 ' C ' HG23 ' A' ' 66' ' ' VAL . 0.0 OUTLIER 177.67 103.1 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.901 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.903 HG13 HD23 ' A' ' 109' ' ' LEU . 3.6 t 74.91 71.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.77 0.319 . . . . 0.0 110.598 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 68.8 m -97.25 138.57 34.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.967 0.413 . . . . 0.0 111.503 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.469 ' CD ' ' CZ ' ' A' ' 80' ' ' PHE . 1.3 ttpm? -82.52 132.39 35.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.287 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.483 ' HG2' ' CB ' ' A' ' 71' ' ' MET . 0.0 OUTLIER -53.83 -29.82 42.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.034 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.76 27.96 11.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.212 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.483 ' CB ' ' HG2' ' A' ' 69' ' ' MET . 6.1 tpt -106.97 -15.55 14.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.207 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 65.04 59.84 0.83 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.011 0.434 . . . . 0.0 110.338 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.622 HD23 HD22 ' A' ' 49' ' ' LEU . 8.0 mp -62.91 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.445 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.505 HG21 ' CD1' ' A' ' 77' ' ' PHE . 0.3 OUTLIER -135.5 155.08 36.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.504 179.62 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -99.71 138.62 36.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.517 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.592 ' O ' HG22 ' A' ' 98' ' ' VAL . . . 113.24 -32.32 6.18 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.532 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.687 ' O ' HG13 ' A' ' 98' ' ' VAL . 1.7 m-85 -118.21 -168.13 1.47 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.963 0.411 . . . . 0.0 111.485 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 95' ' ' PHE . 0.4 OUTLIER -136.11 118.76 16.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.13 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 13.6 p -87.64 108.42 19.08 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 53.8 m-85 -121.55 151.1 40.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.896 178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.855 ' CD2' HG13 ' A' ' 54' ' ' VAL . 11.9 p90 -144.52 139.61 28.33 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.09 0.472 . . . . 0.0 111.974 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.432 ' O ' ' CD1' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -142.3 124.38 15.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.563 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 1.032 HG22 HG13 ' A' ' 91' ' ' VAL . 45.0 p -90.01 152.77 21.03 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.456 179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -46.85 162.3 0.05 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.862 0.363 . . . . 0.0 111.167 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -70.89 -22.91 62.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.682 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.45 22.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -139.93 91.48 10.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 120.647 0.26 . . . . 0.0 110.763 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.57 -14.23 38.4 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.378 2.052 . . . . 0.0 112.045 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.3 29.72 1.86 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.104 0.478 . . . . 0.0 110.216 178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 90' ' ' THR . 18.0 m -156.85 71.78 0.69 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.524 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.032 HG13 HG22 ' A' ' 83' ' ' THR . 0.3 OUTLIER -81.26 173.11 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.935 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.628 ' HD2' HG13 ' A' ' 11' ' ' VAL . 14.1 m-85 -141.72 153.17 44.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.213 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.016 HG11 HG12 ' A' ' 50' ' ' ILE . 14.6 t -152.63 122.18 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.867 0.365 . . . . 0.0 110.977 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' CYS . . . . . 0.861 ' SG ' HG13 ' A' ' 9' ' ' VAL . 13.9 m -112.41 114.14 26.69 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.304 0.573 . . . . 0.0 111.824 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 46' ' ' PHE . 1.3 m-85 -90.15 71.53 7.29 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.751 178.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.864 HG21 ' HD3' ' A' ' 105' ' ' PRO . 0.0 OUTLIER -72.37 -176.38 1.84 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.933 0.397 . . . . 0.0 111.489 -178.485 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.854 HD22 ' HB ' ' A' ' 33' ' ' THR . 23.0 mt -97.41 127.87 43.73 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.321 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -43.64 -33.69 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.534 -179.279 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -38.88 92.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.552 179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 101' ' ' PRO . 62.6 mt -66.93 138.34 95.1 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.902 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 100' ' ' ILE . 18.7 Cg_endo -59.94 -168.17 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.516 2.144 . . . . 0.0 112.348 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.6 tttt -108.69 67.19 0.65 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.758 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.535 ' CA ' HD13 ' A' ' 106' ' ' ILE . 2.7 tp -154.54 -38.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.845 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.804 HD21 HG22 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -57.06 -64.98 1.97 Allowed Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.02 179.566 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.864 ' HD3' HG21 ' A' ' 96' ' ' THR . 5.6 Cg_endo -47.34 -31.17 12.42 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.565 2.177 . . . . 0.0 111.492 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.759 ' HA ' HG21 ' A' ' 66' ' ' VAL . 3.4 mp -68.91 -34.46 64.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.819 179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.509 ' O ' HG21 ' A' ' 131' ' ' ILE . 14.0 mmp_? -84.85 -22.64 29.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.345 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.752 ' CG2' HG13 ' A' ' 128' ' ' VAL . 21.0 mm -70.1 -45.18 77.05 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 CA-C-O 120.808 0.337 . . . . 0.0 110.148 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.903 HD23 HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -76.34 -50.13 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.855 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.5 t -61.95 -30.63 71.04 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.481 ' C ' HD13 ' A' ' 131' ' ' ILE . . . -75.48 -47.2 12.9 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.829 HD23 ' HB2' ' A' ' 127' ' ' HIS . 12.8 mt -56.58 -30.47 63.23 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -79.0 -16.72 56.51 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.196 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -25.11 54.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.75 0.31 . . . . 0.0 110.38 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.529 ' CD1' ' CD2' ' A' ' 127' ' ' HIS . 5.2 m-85 -82.33 -91.86 0.07 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.81 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.427 ' CB ' ' O ' ' A' ' 115' ' ' TYR . 1.2 pt-20 160.56 -28.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.414 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.536 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 19.5 m -111.89 129.54 56.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.517 0.675 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.456 ' HA ' HD22 ' A' ' 123' ' ' LEU . 1.0 OUTLIER -172.3 35.19 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.039 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -108.86 33.28 4.32 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.536 HG23 ' CB ' ' A' ' 123' ' ' LEU . 0.1 OUTLIER -145.62 148.06 32.71 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.469 178.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HA ' ' H ' ' A' ' 20' ' ' SER . 72.0 m-20 -69.73 22.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.526 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.52 ' H ' ' C ' ' A' ' 120' ' ' THR . 5.2 tp10 -162.87 25.24 0.09 Allowed 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.536 ' CB ' HG23 ' A' ' 120' ' ' THR . 7.7 tt -123.76 -57.22 1.64 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.614 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.886 HD13 HG23 ' A' ' 11' ' ' VAL . 0.0 OUTLIER -52.5 -42.1 63.99 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.53 ' H ' HD23 ' A' ' 124' ' ' LEU . 83.4 p -52.1 -28.68 18.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.243 178.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 123' ' ' LEU . 0.3 OUTLIER -62.21 -61.72 2.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.227 -179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.829 ' HB2' HD23 ' A' ' 112' ' ' LEU . 26.5 m170 -59.88 -31.56 69.9 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.1 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 124' ' ' LEU . 56.2 t -56.54 -42.38 75.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.64 -44.45 15.74 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.876 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -66.97 -21.4 65.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 127' ' ' HIS . 59.4 mt -90.02 -28.07 5.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.69 HD21 ' HA ' ' A' ' 5' ' ' ASN . 0.4 OUTLIER -62.86 -43.67 98.17 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.366 178.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.89 -35.38 80.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.7 t -83.8 -20.84 32.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.079 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.921 ' CZ ' HD11 ' A' ' 139' ' ' LEU . 1.5 t80 -50.88 -53.87 28.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.97 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.468 ' HA ' HD12 ' A' ' 139' ' ' LEU . 62.5 m-70 -59.34 -43.89 92.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -50.01 -30.15 10.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.074 0.464 . . . . 0.0 110.375 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 1.7 mp0 -78.68 -34.17 46.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.058 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.921 HD11 ' CZ ' ' A' ' 135' ' ' PHE . 15.9 mt -70.34 -28.93 65.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.25 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 95.2 t -77.21 -48.67 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-O 121.473 0.654 . . . . 0.0 109.472 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -62.97 -34.8 78.3 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.831 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.4 ' HB3' ' O ' ' A' ' 138' ' ' GLU . 0.1 OUTLIER -64.53 -24.99 67.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.135 179.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.519 ' CG ' HD11 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -91.03 44.94 1.22 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.062 -179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -143.52 30.95 1.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.838 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -128.7 -66.8 0.82 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 146' ' ' THR . 8.1 t -124.03 86.32 2.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.934 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.519 HD11 ' CG ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -107.32 -28.59 9.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.949 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.77 37.81 9.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.886 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 32.6 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.942 179.999 . . . . . . . . 0 0 . 1 stop_ save_